Citrus Sinensis ID: 006982
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 623 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ASS4 | 620 | Probably inactive leucine | yes | no | 0.937 | 0.941 | 0.651 | 0.0 | |
| O04567 | 601 | Probable inactive recepto | no | no | 0.890 | 0.923 | 0.472 | 1e-143 | |
| C0LGI5 | 591 | Probable LRR receptor-lik | no | no | 0.900 | 0.949 | 0.449 | 1e-141 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.796 | 0.416 | 0.398 | 6e-98 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.760 | 0.392 | 0.401 | 6e-94 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.760 | 0.392 | 0.399 | 3e-93 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.825 | 0.429 | 0.384 | 3e-92 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.796 | 0.425 | 0.382 | 6e-91 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.756 | 0.461 | 0.414 | 5e-90 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.791 | 0.423 | 0.396 | 7e-90 |
| >sp|Q9ASS4|Y5838_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At5g48380 OS=Arabidopsis thaliana GN=At5g48380 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/594 (65%), Positives = 472/594 (79%), Gaps = 10/594 (1%)
Query: 32 KEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMG 91
+ ++ CL++ K +EDP YL S+W F N+T G+ICKF+GV CWH DENRVL+++L+ G
Sbjct: 29 QANIDCLRTFKSQVEDPNRYL-STWVFGNETAGYICKFSGVTCWHDDENRVLSIKLSGYG 87
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
L+G FP ++ C+ +TGLDLS N GPLP +IS L+ +T LDLS N+FSG IP ++N
Sbjct: 88 LRGVFPPAVKLCADLTGLDLSRNNFSGPLPANISTLIPLVTILDLSYNSFSGEIPMLISN 147
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF-VNLTLSADSVTNNQ 210
T+LN+L L HN+F+G +PPQL QLGRLK+FSV++N L G IP F L + NN
Sbjct: 148 ITFLNTLMLQHNQFTGTLPPQLAQLGRLKTFSVSDNRLVGPIPNFNQTLQFKQELFANNL 207
Query: 211 GLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKKKDDDPEG 270
LCG+PLD CK S VI AA+GG+T AALVVG+V+FFYFR++ +KK DDPEG
Sbjct: 208 DLCGKPLDDCKSASSSRGKVVII-AAVGGLTAAALVVGVVLFFYFRKLGAVRKKQDDPEG 266
Query: 271 NKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGT 330
N+WAKSL G KG+KV +F+KS++KM+LSDLMKAT F K+NII +GRTGTMYK LEDG+
Sbjct: 267 NRWAKSLKGQKGVKVFMFKKSVSKMKLSDLMKATEEFKKDNIIATGRTGTMYKGRLEDGS 326
Query: 331 SLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDL 390
LM+KRLQDSQRSEKEF AEM TLGSVKNRNLVPLLG+C+A KERLL+Y++M NG LYD
Sbjct: 327 LLMIKRLQDSQRSEKEFDAEMKTLGSVKNRNLVPLLGYCVANKERLLMYEYMANGYLYDQ 386
Query: 391 LHPADDTG-KSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKIS 449
LHPAD+ K +DWP RLKIAIG A+G AWLHH+CNPRIIHRNISSKCILL +FEPKIS
Sbjct: 387 LHPADEESFKPLDWPSRLKIAIGTAKGLAWLHHSCNPRIIHRNISSKCILLTAEFEPKIS 446
Query: 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGER 509
DFGLARLMNPIDTHLSTFVNGEFGD GYVAPEY+RT+VATPKGDVYSFG VLLELVTG++
Sbjct: 447 DFGLARLMNPIDTHLSTFVNGEFGDFGYVAPEYSRTMVATPKGDVYSFGVVLLELVTGQK 506
Query: 510 PTNVAKA------PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACN 563
T+V K E FKGNLVEWI +LSS +LQ+AID+ L+ GVD+E+F+ LKVACN
Sbjct: 507 ATSVTKVSEEKAEEENFKGNLVEWITKLSSESKLQEAIDRSLLGNGVDDEIFKVLKVACN 566
Query: 564 CVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEELIVAR 617
CVLP I K+RPTMFEVYQ LRAIGE Y+FT +D+I++PS+SG+ D +EELIVAR
Sbjct: 567 CVLPEIAKQRPTMFEVYQLLRAIGESYNFTADDDILIPSESGEGDFIEELIVAR 620
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O04567|Y1719_ARATH Probable inactive receptor kinase At1g27190 OS=Arabidopsis thaliana GN=At1g27190 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 510 bits (1313), Expect = e-143, Method: Compositional matrix adjust.
Identities = 267/565 (47%), Positives = 373/565 (66%), Gaps = 10/565 (1%)
Query: 31 TKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDM 90
++D+ CL+ +K+SL DP + L SSW+F N + ICK TGV CW+ ENR+++L+L M
Sbjct: 24 AEDDVLCLQGLKNSLIDPSSRL-SSWSFPNSSASSICKLTGVSCWNEKENRIISLQLQSM 82
Query: 91 GLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLA 150
L G+ P ++ C S+ LDLS N L G +P I + +L +LDLS N GSIP+ +
Sbjct: 83 QLAGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGGSIPTQIV 142
Query: 151 NCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210
C +LN+L L N+ SG IP QL +L RL+ S+A N LSG+IP+ + D + N
Sbjct: 143 ECKFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSELA-RFGGDDFSGNN 201
Query: 211 GLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFFYF-RRMSMRKKKD---- 265
GLCG+PL C G G + +I A + G +L VG+V+F++F R RKKK
Sbjct: 202 GLCGKPLSRC-GALNGRNLSIIIVAGVLGAV-GSLCVGLVIFWWFFIREGSRKKKGYGAG 259
Query: 266 DDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKAL 325
+ + W L K ++V+LF+K I K++L DLM ATN+FS NI S RTG YKA
Sbjct: 260 KSKDDSDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDVSSRTGVSYKAD 319
Query: 326 LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385
L DG++L VKRL EK+F +EM LG +++ NLVPLLG+C+ + ERLLVYKHM NG
Sbjct: 320 LPDGSALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDERLLVYKHMVNG 379
Query: 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE 445
+L+ LH +DWP R I +GAA+G AWLHH C P +H+ ISS ILLDDDF+
Sbjct: 380 TLFSQLHNGGLCDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILLDDDFD 439
Query: 446 PKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELV 505
+I+D+GLA+L+ D++ S+F NG+ G+LGYVAPEY+ T+VA+ KGDVY FG VLLELV
Sbjct: 440 ARITDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIVLLELV 499
Query: 506 TGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCV 565
TG++P +V E FKG+LV+W++Q TG+ +DAID+ + KG D E+ QFLK+AC+CV
Sbjct: 500 TGQKPLSVINGVEGFKGSLVDWVSQYLGTGRSKDAIDRSICDKGHDEEILQFLKIACSCV 559
Query: 566 LPTIPKERPTMFEVYQFLRAIGERY 590
+ + PKERPTM +VY+ L+ + +++
Sbjct: 560 V-SRPKERPTMIQVYESLKNMADKH 583
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGI5|Y1699_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g69990 OS=Arabidopsis thaliana GN=At1g69990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 265/590 (44%), Positives = 381/590 (64%), Gaps = 29/590 (4%)
Query: 17 VSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWH 76
+S+ ++ S ++D+ CLK K SL+DP N LN+ W+F N + ICK TGV CW+
Sbjct: 4 ISIFFVIILMSSSHAEDDVLCLKGFKSSLKDPSNQLNT-WSFPNSSSS-ICKLTGVSCWN 61
Query: 77 PDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDL 136
ENR+L+L+L M L GQ P ++ C S+ LDLS N G +P I + +L +LDL
Sbjct: 62 AKENRILSLQLQSMQLSGQIPESLKLCRSLQSLDLSFNDFSGLIPSQICSWLPYLVTLDL 121
Query: 137 SSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196
S N SGSIPS + +C +LNSL L+ N+ +G IP +L +L RL+ S+A+N LSGSIP+
Sbjct: 122 SGNKLSGSIPSQIVDCKFLNSLALNQNKLTGSIPSELTRLNRLQRLSLADNDLSGSIPSE 181
Query: 197 VNLTLSADSVTNNQGLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFFYF- 255
++ D N GLCG+PL C G+ G + +I A + G +L VG MF++F
Sbjct: 182 LS-HYGEDGFRGNGGLCGKPLSNC-GSFNGKNLTIIVTAGVIGAV-GSLCVGFGMFWWFF 238
Query: 256 ----RRMS-----MRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNS 306
R+M+ K KDD + W L K ++V+LF+K I K++L DL++ATN
Sbjct: 239 IRDRRKMNNYGYGAGKCKDD----SDWIGLLRSHKLVQVTLFQKPIVKIKLVDLIEATNG 294
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQD-SQRSEKEFVAEMATLGSVKNRNLVPL 365
F NI+ S R+G YKA L DG++L VKRL + SEK+F +E+ LG +++ NLVPL
Sbjct: 295 FDSGNIVVSSRSGVSYKADLPDGSTLEVKRLSSCCELSEKQFRSEINKLGQIRHPNLVPL 354
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
LGFC+ + E LLVYKHM NG+LY L D +DWP R+++A+GAARG AWLHH C
Sbjct: 355 LGFCVVEDEILLVYKHMANGTLYSQLQQWD-----IDWPTRVRVAVGAARGLAWLHHGCQ 409
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART 485
P +H+ ISS ILLD+DF+ ++ D+GL +L++ D+ S+F NG+F GYVAPEY+ T
Sbjct: 410 PLYMHQYISSNVILLDEDFDARVIDYGLGKLVSSQDSKDSSFSNGKF---GYVAPEYSST 466
Query: 486 LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCL 545
+VA+ GDVY FG VLLE+VTG++P + E FK +LVEW+++ S G+ +DAID+ +
Sbjct: 467 MVASLSGDVYGFGIVLLEIVTGQKPVLINNGEEGFKESLVEWVSKHLSNGRSKDAIDRRI 526
Query: 546 VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTE 595
KG D+E+ Q L++AC+CV+ PKERP M +VY+ L+ +G+++ F +E
Sbjct: 527 FGKGYDDEIMQVLRIACSCVVSR-PKERPLMIQVYESLKNLGDQHGFFSE 575
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (920), Expect = 6e-98, Method: Compositional matrix adjust.
Identities = 219/550 (39%), Positives = 318/550 (57%), Gaps = 54/550 (9%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
++ L L + L G P S+ L+L+ NKL GP+P + L LT +DLS NN
Sbjct: 653 KLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKE-LTHMDLSFNN 711
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT----- 195
SG + S L+ L L ++ N+F+G+IP +LG L +L+ V+ NLLSG IPT
Sbjct: 712 LSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGL 771
Query: 196 ----FVNLT-------LSADSV---------TNNQGLCGEPLDA-CKGTSKGPHTGVIAG 234
F+NL + +D V + N+ LCG + + CK T + +
Sbjct: 772 PNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEG----TKLRSA 827
Query: 235 AAIGGVTFAALVVGIVMFFYFRRMSM--RKKKDDDPEGNKWAKS----------LTGTKG 282
I G+ ++ V F RR +M R K+ DDPE + ++ L+G++
Sbjct: 828 WGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRS 887
Query: 283 -----IKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRL 337
I +++FE+ + K+RL D+++AT+ FSK NIIG G GT+YKA L ++ VK+L
Sbjct: 888 REPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKL 947
Query: 338 QDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADD 396
+++ + +EF+AEM TLG VK+ NLV LLG+C +E+LLVY++M NGSL L
Sbjct: 948 SEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTG 1007
Query: 397 TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456
+ +DW +RLKIA+GAARG A+LHH P IIHR+I + ILLD DFEPK++DFGLARL
Sbjct: 1008 MLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARL 1067
Query: 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516
++ ++H+ST + G F GY+ PEY ++ AT KGDVYSFG +LLELVTG+ PT
Sbjct: 1068 ISACESHVSTVIAGTF---GYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTG-PDF 1123
Query: 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTM 576
E+ GNLV W Q + G+ D ID LV+ + N + L++A C+ T P +RP M
Sbjct: 1124 KESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAET-PAKRPNM 1182
Query: 577 FEVYQFLRAI 586
+V + L+ I
Sbjct: 1183 LDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (885), Expect = 6e-94, Method: Compositional matrix adjust.
Identities = 204/508 (40%), Positives = 292/508 (57%), Gaps = 34/508 (6%)
Query: 105 SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNR 164
SM LDLS NKL G +P ++ + +L+ L+L N+ SG IP L + L L +NR
Sbjct: 664 SMIFLDLSYNKLEGSIPKELGAMY-YLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNR 722
Query: 165 FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPL------- 217
F+G IP L L L ++NN LSG IP D N LCG PL
Sbjct: 723 FNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCGYPLPLPCSSG 782
Query: 218 ---DACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKKKDDDPEGNKWA 274
DA + +AG+ G+ F+ + ++ R+KK+ E
Sbjct: 783 PKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDG 842
Query: 275 KSLTGTK-------------GIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTM 321
S + T I ++ FEK + K+ +DL++ATN F ++++GSG G +
Sbjct: 843 HSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDV 902
Query: 322 YKALLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380
YKA L+DG+ + +K+L S + ++EF AEM T+G +K+RNLVPLLG+C +ERLLVY+
Sbjct: 903 YKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 962
Query: 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440
+M GSL D+LH TG ++WP R KIAIGAARG A+LHHNC P IIHR++ S +LL
Sbjct: 963 YMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLL 1022
Query: 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTV 500
D++ E ++SDFG+ARLM+ +DTHLS V+ G GYV PEY ++ + KGDVYS+G V
Sbjct: 1023 DENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVV 1080
Query: 501 LLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAK--GVDNELFQFL 558
LLEL+TG++PT+ A + NLV W+ +L + G++ D D+ L+ + ++ EL Q L
Sbjct: 1081 LLELLTGKQPTDSADFGDN---NLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHL 1136
Query: 559 KVACNCVLPTIPKERPTMFEVYQFLRAI 586
KVAC C L +RPTM +V + I
Sbjct: 1137 KVACAC-LDDRHWKRPTMIQVMAMFKEI 1163
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 203/508 (39%), Positives = 291/508 (57%), Gaps = 34/508 (6%)
Query: 105 SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNR 164
SM LDLS NKL G +P ++ + +L+ L+L N+ SG IP L + L L +NR
Sbjct: 664 SMIFLDLSYNKLEGSIPKELGAMY-YLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNR 722
Query: 165 FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPL------- 217
F+G IP L L L ++NN LSG IP D N LCG PL
Sbjct: 723 FNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCGYPLPIPCSSG 782
Query: 218 ---DACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKKKDDDPEGNKWA 274
DA + +AG+ G+ F+ + ++ R+KK+ E
Sbjct: 783 PKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDG 842
Query: 275 KSLTGTK-------------GIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTM 321
S + T I ++ FEK + K+ +DL++ATN F ++++GSG G +
Sbjct: 843 HSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDV 902
Query: 322 YKALLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380
YKA L+DG+ + +K+L S + ++EF AEM T+G +K+RNLVPLLG+C +ERLLVY+
Sbjct: 903 YKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 962
Query: 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440
+M GSL D+LH G ++WP R KIAIGAARG A+LHHNC P IIHR++ S +LL
Sbjct: 963 YMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLL 1022
Query: 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTV 500
D++ E ++SDFG+ARLM+ +DTHLS V+ G GYV PEY ++ + KGDVYS+G V
Sbjct: 1023 DENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVV 1080
Query: 501 LLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAK--GVDNELFQFL 558
LLEL+TG++PT+ A + NLV W+ +L + G++ D D+ L+ + ++ EL Q L
Sbjct: 1081 LLELLTGKQPTDSADFGDN---NLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHL 1136
Query: 559 KVACNCVLPTIPKERPTMFEVYQFLRAI 586
KVAC C L +RPTM +V + I
Sbjct: 1137 KVACAC-LDDRHWKRPTMIQVMAMFKEI 1163
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (870), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 212/552 (38%), Positives = 305/552 (55%), Gaps = 38/552 (6%)
Query: 102 NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161
N SM LD+S N L G +P +I + +L L+L N+ SGSIP + + LN L L
Sbjct: 652 NNGSMMFLDMSYNMLSGYIPKEIGSMP-YLFILNLGHNDISGSIPDEVGDLRGLNILDLS 710
Query: 162 HNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQGLCGEPLDAC 220
N+ G+IP + L L ++NN LSG IP T NN GLCG PL C
Sbjct: 711 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 770
Query: 221 KGT----------SKGPHTGVIAGAAIGGVTFAALVV-GIVMF------------FYFRR 257
+ S G +AG+ G+ F+ + + G+++
Sbjct: 771 DPSNADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEM 830
Query: 258 MSMRKKKDDDPEGNKWAKSLTGTK---GIKVSLFEKSITKMRLSDLMKATNSFSKNNIIG 314
+ D N LTG K I ++ FEK + K+ +DL++ATN F +++IG
Sbjct: 831 YAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIG 890
Query: 315 SGRTGTMYKALLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK 373
SG G +YKA+L+DG+++ +K+L S + ++EF+AEM T+G +K+RNLVPLLG+C
Sbjct: 891 SGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGD 950
Query: 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNI 433
ERLLVY+ M GSL D+LH G ++W R KIAIG+ARG A+LHHNC+P IIHR++
Sbjct: 951 ERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDM 1010
Query: 434 SSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGD 493
S +LLD++ E ++SDFG+ARLM+ +DTHLS V+ G GYV PEY ++ + KGD
Sbjct: 1011 KSSNVLLDENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKGD 1068
Query: 494 VYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAK--GVD 551
VYS+G VLLEL+TG+RPT+ +P+ NLV W+ Q + ++ D D L+ + ++
Sbjct: 1069 VYSYGVVLLELLTGKRPTD---SPDFGDNNLVGWVKQHAKL-RISDVFDPELMKEDPALE 1124
Query: 552 NELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILE 611
EL Q LKVA C L RPTM +V + I ++ I D G + I
Sbjct: 1125 IELLQHLKVAVAC-LDDRAWRRPTMVQVMAMFKEIQAGSGIDSQSTIRSIEDGGFSTIEM 1183
Query: 612 ELIVAREGPENK 623
+ +E PE K
Sbjct: 1184 VDMSIKEVPEGK 1195
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 6e-91, Method: Compositional matrix adjust.
Identities = 204/533 (38%), Positives = 299/533 (56%), Gaps = 37/533 (6%)
Query: 105 SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNR 164
SM D+S N + G +P + G+L L+L N +G+IP + + L L HN
Sbjct: 640 SMIYFDISYNAVSGFIPPGYGNM-GYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNN 698
Query: 165 FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQGLCGEPLDACKGT 223
G +P LG L L V+NN L+G IP LT NN GLCG PL C
Sbjct: 699 LQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSA 758
Query: 224 SKGPHTG-------VIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKKKDDDPEGNKWAKS 276
+ P T +A A I G+ F+ + +++ +R +RK + + + K+ +S
Sbjct: 759 PRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYR---VRKVQKKEQKREKYIES 815
Query: 277 LTGTKG-------------IKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYK 323
L + I V+ FEK + K+ + L++ATN FS ++GSG G +YK
Sbjct: 816 LPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYK 875
Query: 324 ALLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382
A L DG+ + +K+L + + + ++EF+AEM T+G +K+RNLVPLLG+C +ERLLVY++M
Sbjct: 876 AQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 935
Query: 383 PNGSLYDLLH--PADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440
GSL +LH + G ++W R KIAIGAARG A+LHH+C P IIHR++ S +LL
Sbjct: 936 KWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLL 995
Query: 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTV 500
D+DFE ++SDFG+ARL++ +DTHLS V+ G GYV PEY ++ T KGDVYS+G +
Sbjct: 996 DEDFEARVSDFGMARLVSALDTHLS--VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVI 1053
Query: 501 LLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA-KGVDNELFQFLK 559
LLEL++G++P + + E NLV W QL + + +D LV K D ELF +LK
Sbjct: 1054 LLELLSGKKPIDPGEFGE--DNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLK 1111
Query: 560 VACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEE 612
+A C L P +RPTM ++ + E T EDE + + ++EE
Sbjct: 1112 IASQC-LDDRPFKRPTMIQLMAMFK---EMKADTEEDESLDEFSLKETPLVEE 1160
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (851), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 202/487 (41%), Positives = 281/487 (57%), Gaps = 16/487 (3%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQ 168
+DLS N L G + + L L L+L +NN SG+IP+NL+ T L L L HN SG
Sbjct: 538 IDLSYNSLNGSIWPEFGDLRQ-LHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGN 596
Query: 169 IPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQGLCGEPLDACKGTSKGP 227
IPP L +L L +FSVA N LSG IPT V T S NQGLCGE C T + P
Sbjct: 597 IPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGEHASPCHITDQSP 656
Query: 228 H-TGVIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKKK-----DDDPEGNKWAKSLT-GT 280
H + V + I + A+ G+ F + + + DPE A + G+
Sbjct: 657 HGSAVKSKKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKADADEIELGS 716
Query: 281 KGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQ-D 339
+ + + + S ++ L D++K+T+SF++ NIIG G G +YKA L DGT + +KRL D
Sbjct: 717 RSVVLFHNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRLSGD 776
Query: 340 SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGK 399
+ + ++EF AE+ TL ++ NLV LLG+C K ++LL+Y +M NGSL LH D
Sbjct: 777 TGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVDGPP 836
Query: 400 SVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459
S+DW RL+IA GAA G A+LH +C P I+HR+I S ILL D F ++DFGLARL+ P
Sbjct: 837 SLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGLARLILP 896
Query: 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPET 519
DTH++T + G LGY+ PEY + VAT KGDVYSFG VLLEL+TG RP +V K P
Sbjct: 897 YDTHVTTDL---VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMDVCK-PRG 952
Query: 520 FKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEV 579
+ +L+ W+ Q+ + + + D + K E+ L++AC C L PK RPT ++
Sbjct: 953 SR-DLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRC-LGENPKTRPTTQQL 1010
Query: 580 YQFLRAI 586
+L I
Sbjct: 1011 VSWLENI 1017
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (850), Expect = 7e-90, Method: Compositional matrix adjust.
Identities = 214/540 (39%), Positives = 300/540 (55%), Gaps = 47/540 (8%)
Query: 105 SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNR 164
SM LDLS N + G +P + G+L L+L N +G+IP + + L L HN
Sbjct: 640 SMIYLDLSYNAVSGSIPLGYGAM-GYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHND 698
Query: 165 FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQGLCGEPLDACKGT 223
G +P LG L L V+NN L+G IP LT NN GLCG PL C
Sbjct: 699 LQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSG 758
Query: 224 SK------GPHTGVIAGAAIGGVTFAAL-VVGIVMFFYFRRMSMRKKKDDDPEGNKWAKS 276
S+ P IA G+ F+ + +V ++M Y R +K+K + K+ +S
Sbjct: 759 SRPTRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQRE----KYIES 814
Query: 277 LTGTK-------------GIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYK 323
L + I V+ FEK + K+ + L++ATN FS +++IGSG G +YK
Sbjct: 815 LPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYK 874
Query: 324 ALLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382
A L DG+ + +K+L Q + + ++EF+AEM T+G +K+RNLVPLLG+C +ERLLVY++M
Sbjct: 875 AKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 934
Query: 383 PNGSLYDLLHPADDTGKS-VDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441
GSL +LH G +DW R KIAIGAARG A+LHH+C P IIHR++ S +LLD
Sbjct: 935 KYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLD 994
Query: 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVL 501
DF ++SDFG+ARL++ +DTHLS V+ G GYV PEY ++ T KGDVYS+G +L
Sbjct: 995 QDFVARVSDFGMARLVSALDTHLS--VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVIL 1052
Query: 502 LELVTGERPTNVAKAPETF--KGNLVEWIAQLSSTGQLQDAIDKCLVA-KGVDNELFQFL 558
LEL++G++P + PE F NLV W QL + + +D LV K D EL +L
Sbjct: 1053 LELLSGKKPID----PEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYL 1108
Query: 559 KVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEELIVARE 618
K+A C L P +RPTM +V + E TE+ DS D +L+E + E
Sbjct: 1109 KIASQC-LDDRPFKRPTMIQVMTMFK---ELVQVDTEN------DSLDEFLLKETPLVEE 1158
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 623 | ||||||
| 359497728 | 625 | PREDICTED: probably inactive leucine-ric | 0.995 | 0.992 | 0.729 | 0.0 | |
| 296083571 | 619 | unnamed protein product [Vitis vinifera] | 0.972 | 0.978 | 0.739 | 0.0 | |
| 147766948 | 619 | hypothetical protein VITISV_037939 [Viti | 0.950 | 0.956 | 0.745 | 0.0 | |
| 358248884 | 592 | probably inactive leucine-rich repeat re | 0.940 | 0.989 | 0.742 | 0.0 | |
| 357507899 | 615 | Probably inactive leucine-rich repeat re | 0.961 | 0.973 | 0.725 | 0.0 | |
| 356531854 | 617 | PREDICTED: probably inactive leucine-ric | 0.966 | 0.975 | 0.722 | 0.0 | |
| 296083399 | 625 | unnamed protein product [Vitis vinifera] | 0.982 | 0.979 | 0.702 | 0.0 | |
| 359495880 | 621 | PREDICTED: probably inactive leucine-ric | 0.982 | 0.985 | 0.702 | 0.0 | |
| 449462467 | 614 | PREDICTED: probably inactive leucine-ric | 0.966 | 0.980 | 0.688 | 0.0 | |
| 449502101 | 614 | PREDICTED: LOW QUALITY PROTEIN: probably | 0.966 | 0.980 | 0.684 | 0.0 |
| >gi|359497728|ref|XP_003635622.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2485), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/624 (72%), Positives = 537/624 (86%), Gaps = 4/624 (0%)
Query: 1 MALFISMELKSRSL---VGVSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWN 57
M F++M SR L + + +CLL C SLSY T+ DL CLK IK+SL+DP+ YLNSSW+
Sbjct: 1 MGSFMNMAPGSRGLTVAIAIMLCLLWCSSLSYATESDLYCLKGIKNSLDDPYRYLNSSWD 60
Query: 58 FNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLY 117
FNN TEGFIC+FTG+ECWHPDENRVLN++L DMGLKGQFPR I+NC+S+TGLDLSSN LY
Sbjct: 61 FNNKTEGFICRFTGIECWHPDENRVLNIKLADMGLKGQFPRAIKNCTSLTGLDLSSNDLY 120
Query: 118 GPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLG 177
G +P DI+ ++ F+T+LDLSSNNFSG IP L+NC+YLN LKLD+N+ SG IP +LG L
Sbjct: 121 GSIPSDINDIIKFMTTLDLSSNNFSGPIPLGLSNCSYLNVLKLDNNQLSGTIPLELGLLN 180
Query: 178 RLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPLDACKGTSKGPHTGVIAGAAI 237
R+K+FSV+NNLL+G +P F ++ ++ADS NN GLCG + C+ SK H G+IAGAA+
Sbjct: 181 RMKTFSVSNNLLTGPVPQFASVNVTADSYANNPGLCGYASNPCQAPSKKMHAGIIAGAAM 240
Query: 238 GGVTFAALVVGIVMFFYFRRMSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRL 297
G VT +ALVVG+ + FY+R +S+++KK++DPEGNKWA+S+ GTKGIKVS+FEKSI+KMRL
Sbjct: 241 GAVTISALVVGLGLSFYYRNVSVKRKKEEDPEGNKWARSIKGTKGIKVSMFEKSISKMRL 300
Query: 298 SDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSV 357
SDLMKATN+FSK+NIIGSGRTGTMYKA+LEDGTSLMVKRLQDSQ SEKEF++EMATLGSV
Sbjct: 301 SDLMKATNNFSKDNIIGSGRTGTMYKAVLEDGTSLMVKRLQDSQHSEKEFMSEMATLGSV 360
Query: 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF 417
K+RNLVPLLGFC+AKKERLLVY++MPNG+L+D LHP D K+++WP RLKI IGAAR F
Sbjct: 361 KHRNLVPLLGFCVAKKERLLVYRNMPNGNLHDQLHPMDGGDKTLEWPLRLKIGIGAARAF 420
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
AWLHHNCNPRI+HRNISSKCILLD DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY
Sbjct: 421 AWLHHNCNPRILHRNISSKCILLDADFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 480
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537
VAPEY RTLVATPKGDVYSFGTVLLELVTGERP +VAKAPE FKGNLVEWI QLSS +L
Sbjct: 481 VAPEYTRTLVATPKGDVYSFGTVLLELVTGERPIHVAKAPEDFKGNLVEWITQLSSNNKL 540
Query: 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDE 597
DAID+ LV KG D+ELFQFLKVAC CVLP PKERPTMFE++QFLRAIGERY+FT +D+
Sbjct: 541 HDAIDESLVGKGFDSELFQFLKVACTCVLPE-PKERPTMFELFQFLRAIGERYNFTVDDD 599
Query: 598 IMLPSDSGDADILEELIVAREGPE 621
I PSD+G D ++ELIVAREG E
Sbjct: 600 IGAPSDTGGEDNMDELIVAREGDE 623
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083571|emb|CBI23562.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 958 bits (2476), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/607 (73%), Positives = 529/607 (87%), Gaps = 1/607 (0%)
Query: 15 VGVSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVEC 74
+ + +CLL C SLSY T+ DL CLK IK+SL+DP+ YLNSSW+FNN TEGFIC+FTG+EC
Sbjct: 12 IAIMLCLLWCSSLSYATESDLYCLKGIKNSLDDPYRYLNSSWDFNNKTEGFICRFTGIEC 71
Query: 75 WHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134
WHPDENRVLN++L DMGLKGQFPR I+NC+S+TGLDLSSN LYG +P DI+ ++ F+T+L
Sbjct: 72 WHPDENRVLNIKLADMGLKGQFPRAIKNCTSLTGLDLSSNDLYGSIPSDINDIIKFMTTL 131
Query: 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194
DLSSNNFSG IP L+NC+YLN LKLD+N+ SG IP +LG L R+K+FSV+NNLL+G +P
Sbjct: 132 DLSSNNFSGPIPLGLSNCSYLNVLKLDNNQLSGTIPLELGLLNRMKTFSVSNNLLTGPVP 191
Query: 195 TFVNLTLSADSVTNNQGLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFFY 254
F ++ ++ADS NN GLCG + C+ SK H G+IAGAA+G VT +ALVVG+ + FY
Sbjct: 192 QFASVNVTADSYANNPGLCGYASNPCQAPSKKMHAGIIAGAAMGAVTISALVVGLGLSFY 251
Query: 255 FRRMSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIG 314
+R +S+++KK++DPEGNKWA+S+ GTKGIKVS+FEKSI+KMRLSDLMKATN+FSK+NIIG
Sbjct: 252 YRNVSVKRKKEEDPEGNKWARSIKGTKGIKVSMFEKSISKMRLSDLMKATNNFSKDNIIG 311
Query: 315 SGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374
SGRTGTMYKA+LEDGTSLMVKRLQDSQ SEKEF++EMATLGSVK+RNLVPLLGFC+AKKE
Sbjct: 312 SGRTGTMYKAVLEDGTSLMVKRLQDSQHSEKEFMSEMATLGSVKHRNLVPLLGFCVAKKE 371
Query: 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNIS 434
RLLVY++MPNG+L+D LHP D K+++WP RLKI IGAAR FAWLHHNCNPRI+HRNIS
Sbjct: 372 RLLVYRNMPNGNLHDQLHPMDGGDKTLEWPLRLKIGIGAARAFAWLHHNCNPRILHRNIS 431
Query: 435 SKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDV 494
SKCILLD DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY RTLVATPKGDV
Sbjct: 432 SKCILLDADFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTRTLVATPKGDV 491
Query: 495 YSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNEL 554
YSFGTVLLELVTGERP +VAKAPE FKGNLVEWI QLSS +L DAID+ LV KG D+EL
Sbjct: 492 YSFGTVLLELVTGERPIHVAKAPEDFKGNLVEWITQLSSNNKLHDAIDESLVGKGFDSEL 551
Query: 555 FQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEELI 614
FQFLKVAC CVLP PKERPTMFE++QFLRAIGERY+FT +D+I PSD+G D ++ELI
Sbjct: 552 FQFLKVACTCVLPE-PKERPTMFELFQFLRAIGERYNFTVDDDIGAPSDTGGEDNMDELI 610
Query: 615 VAREGPE 621
VAREG E
Sbjct: 611 VAREGDE 617
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147766948|emb|CAN63265.1| hypothetical protein VITISV_037939 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2437), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/593 (74%), Positives = 518/593 (87%), Gaps = 1/593 (0%)
Query: 29 YGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLT 88
Y T+ DL CLK+IK SL+DP+ YLNSSW+FNN TEGFIC+FTG+ECWHPDENRVLN++L
Sbjct: 26 YATESDLYCLKAIKKSLDDPYRYLNSSWDFNNKTEGFICRFTGIECWHPDENRVLNIKLA 85
Query: 89 DMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN 148
DMGLKGQFPR I+NC+S+TGLDLSSN LYG +P DI+ ++ F+T+LDLSSNNFSG IP
Sbjct: 86 DMGLKGQFPRAIKNCTSLTGLDLSSNDLYGSIPSDINDIIKFMTTLDLSSNNFSGPIPLX 145
Query: 149 LANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTN 208
L+NC+YLN LKLD+N+ SG IP +LG L R+K+FSV+NNLL+G +P F ++ ++ADS N
Sbjct: 146 LSNCSYLNVLKLDNNQLSGTIPLELGLLNRMKTFSVSNNLLTGPVPQFASVNVTADSYAN 205
Query: 209 NQGLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKKKDDDP 268
N GLCG + C+ SK H G+IAGAA+G VT +ALVVG+ + FY+R +S+++KK++DP
Sbjct: 206 NPGLCGYASNPCQAPSKKMHAGIIAGAAMGAVTISALVVGLGLSFYYRNVSVKRKKEEDP 265
Query: 269 EGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLED 328
EGNKWA+S+ GTKGIKVS+FEKSI+KMRLSDLMKATN+FSK+NIIGSGRTGTMYKA+LED
Sbjct: 266 EGNKWARSIKGTKGIKVSMFEKSISKMRLSDLMKATNNFSKDNIIGSGRTGTMYKAVLED 325
Query: 329 GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLY 388
GTSLMVKRLQDSQ SEKEF++EMATLGSVK+RNLVPLLGFC+AKKERLLVY++MPNG+L+
Sbjct: 326 GTSLMVKRLQDSQHSEKEFMSEMATLGSVKHRNLVPLLGFCVAKKERLLVYRNMPNGNLH 385
Query: 389 DLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448
D LHP D K ++WP RLKI IGAAR FAWLHHNCNPRI+HRNISSKCILLD DFEPKI
Sbjct: 386 DQLHPMDGGDKXLEWPLRLKIGIGAARAFAWLHHNCNPRILHRNISSKCILLDADFEPKI 445
Query: 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGE 508
SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY RTLVATPKGDVYSFGTVLLELVTGE
Sbjct: 446 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTRTLVATPKGDVYSFGTVLLELVTGE 505
Query: 509 RPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPT 568
RP +VAKAPE FKGNLVEWI QLSS +L DAID+ LV KG D+ELFQFLKVAC CVLP
Sbjct: 506 RPIHVAKAPEDFKGNLVEWITQLSSNNKLHDAIDESLVGKGFDSELFQFLKVACTCVLPE 565
Query: 569 IPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEELIVAREGPE 621
PKERPTMFE++QFLRAIGERY+FT +D+I PSD+G D ++ELIVAREG E
Sbjct: 566 -PKERPTMFELFQFLRAIGERYNFTVDDDIGAPSDTGGEDNMDELIVAREGDE 617
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248884|ref|NP_001239701.1| probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Glycine max] gi|223452311|gb|ACM89483.1| leucine-rich repeat family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2361), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/591 (74%), Positives = 511/591 (86%), Gaps = 5/591 (0%)
Query: 30 GTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTD 89
GT D+ CLKS+K +L+DP+NYL SWNFNN+TEG+ICKFTGVECWHPDEN+VLNL+L++
Sbjct: 4 GTDSDIFCLKSVKRTLDDPYNYL-QSWNFNNNTEGYICKFTGVECWHPDENKVLNLKLSN 62
Query: 90 MGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL 149
MGLKG FPRGI+NCSSMTGLD S N+L +P DIS L+ F+T+LDLSSN+F+G IP++L
Sbjct: 63 MGLKGPFPRGIQNCSSMTGLDFSLNRLSKTIPADISTLLTFVTTLDLSSNDFTGEIPASL 122
Query: 150 ANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNN 209
+NCTYLN+++LD N+ +GQIP L QL RLK FSVANNLL+G +P F N SA+S NN
Sbjct: 123 SNCTYLNTIRLDQNQLTGQIPANLSQLPRLKLFSVANNLLTGQVPIFANGVASANSYANN 182
Query: 210 QGLCGEPL-DACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKKKDDDP 268
GLCG+PL DAC+ + +T VIAGAA+GGVT AAL +GI MFFY RR+S RKK ++DP
Sbjct: 183 SGLCGKPLLDACQAKASKSNTAVIAGAAVGGVTVAALGLGIGMFFYVRRISYRKK-EEDP 241
Query: 269 EGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLED 328
EGNKWA+SL GTK IKVS+FEKSI+KM L+DLMKAT++F K+NIIG+GR+GT+YKA+L D
Sbjct: 242 EGNKWARSLKGTKTIKVSMFEKSISKMNLNDLMKATDNFGKSNIIGTGRSGTVYKAVLHD 301
Query: 329 GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLY 388
GTSLMVKRLQ+SQ SEKEF++EM LGSVK+RNLVPLLGFC+AKKER LVYK+MPNG+L+
Sbjct: 302 GTSLMVKRLQESQHSEKEFLSEMNILGSVKHRNLVPLLGFCVAKKERFLVYKNMPNGTLH 361
Query: 389 DLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448
D LHP D ++DWP RLKIAIGAA+G AWLHH+CNPRIIHRNISSKCILLD DFEPKI
Sbjct: 362 DQLHP-DAGACTMDWPLRLKIAIGAAKGLAWLHHSCNPRIIHRNISSKCILLDADFEPKI 420
Query: 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGE 508
SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY +TLVATPKGD+YSFGTVLLELVTGE
Sbjct: 421 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTKTLVATPKGDIYSFGTVLLELVTGE 480
Query: 509 RPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPT 568
RPT+V+KAPETFKGNLVEWI Q SS +L +AID+ LV KGVD ELFQFLKVACNCV
Sbjct: 481 RPTHVSKAPETFKGNLVEWIQQQSSNAKLHEAIDESLVGKGVDQELFQFLKVACNCV-TA 539
Query: 569 IPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEELIVAREG 619
+PKERPTMFEVYQ LRAIG Y+FTTEDEIMLP D+GDAD LEELIVAREG
Sbjct: 540 MPKERPTMFEVYQLLRAIGINYNFTTEDEIMLPMDTGDADNLEELIVAREG 590
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507899|ref|XP_003624238.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|124361026|gb|ABN08998.1| Protein kinase [Medicago truncatula] gi|355499253|gb|AES80456.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2344), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/608 (72%), Positives = 523/608 (86%), Gaps = 9/608 (1%)
Query: 14 LVGVSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVE 73
+V S+ ++ C ++YGT+ D+ CLK +K+SL+DP NYL +W+FNN TEG ICKFTGVE
Sbjct: 13 IVSFSLLVISC-GITYGTETDILCLKRVKESLKDPNNYLQ-NWDFNNKTEGSICKFTGVE 70
Query: 74 CWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133
CWHPDENRVLNL+L++MGLKG+FPRGI+NCSS+TGLD S N L +P D+S L+GF+T+
Sbjct: 71 CWHPDENRVLNLKLSNMGLKGEFPRGIQNCSSLTGLDFSLNSLSKSIPADVSTLIGFVTT 130
Query: 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSI 193
LDLSSN+F+G IP +LANCTYLNS+KLD N+ +GQIP + G L RLK+FSV+NNLLSG +
Sbjct: 131 LDLSSNDFTGEIPVSLANCTYLNSIKLDQNQLTGQIPLEFGGLTRLKTFSVSNNLLSGQV 190
Query: 194 PTFVNL-TLSADSVTNNQGLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMF 252
PTF+ ++ADS NN GLCG PL+AC +SK +T VIAGAA+GG T AAL VG+ +
Sbjct: 191 PTFIKQGIVTADSFANNSGLCGAPLEACSKSSK-TNTAVIAGAAVGGATLAALGVGVGLL 249
Query: 253 FYFRRMSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNI 312
F+ R +S R KK++DPEGNKWA+ L GTK IKVS+FEKSI+KM LSDLMKATN+FSK+N+
Sbjct: 250 FFVRSVSHR-KKEEDPEGNKWARILKGTKKIKVSMFEKSISKMNLSDLMKATNNFSKSNV 308
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
IG+GR+GT+YKA+L+DGTSLMVKRL +SQ SE+EF AEMATLG+V++RNLVPLLGFC+AK
Sbjct: 309 IGTGRSGTVYKAVLDDGTSLMVKRLLESQHSEQEFTAEMATLGTVRHRNLVPLLGFCLAK 368
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGK-SVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
KERLLVYK+MPNG+L+D LHP D G+ +++W RLKIAIGAA+GFAWLHHNCNPRIIHR
Sbjct: 369 KERLLVYKNMPNGTLHDKLHP--DAGECTMEWSVRLKIAIGAAKGFAWLHHNCNPRIIHR 426
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK 491
NISSKCILLD DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY TLVATPK
Sbjct: 427 NISSKCILLDVDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTTTLVATPK 486
Query: 492 GDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVD 551
GDVYSFGTVLLELVTGERPT++AKAPETFKGNLVEWI QLS +L+DAID+ LV KGVD
Sbjct: 487 GDVYSFGTVLLELVTGERPTHIAKAPETFKGNLVEWIMQLSVNSKLKDAIDESLVGKGVD 546
Query: 552 NELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILE 611
+ELFQFLKVACNCV T PKERPTMFEVYQFLR IG RY+F TEDEIM+ +D+GDA LE
Sbjct: 547 HELFQFLKVACNCVSST-PKERPTMFEVYQFLRDIGSRYNFITEDEIMILTDNGDAGKLE 605
Query: 612 ELIVAREG 619
ELIVAREG
Sbjct: 606 ELIVAREG 613
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531854|ref|XP_003534491.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 900 bits (2327), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/606 (72%), Positives = 511/606 (84%), Gaps = 4/606 (0%)
Query: 14 LVGVSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVE 73
++ VS LL+ + GT+ DL CLKS+K +LEDP+NYL SWNFNN+TEG+ICKF GVE
Sbjct: 14 VIIVSFFLLILCGMVCGTESDLFCLKSVKSALEDPYNYL-QSWNFNNNTEGYICKFIGVE 72
Query: 74 CWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133
CWHPDEN+VLNL+L++MGLKG FPRGI+NC+SMTGLD S N+L +P DIS L+ F+T+
Sbjct: 73 CWHPDENKVLNLKLSNMGLKGPFPRGIQNCTSMTGLDFSLNRLSKTIPADISTLLTFVTT 132
Query: 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSI 193
LDLSSN+F+G IP++L+NCTYLN+L+LD N+ +G IP L QL RLK FSVANNLL+G +
Sbjct: 133 LDLSSNDFTGEIPASLSNCTYLNTLRLDQNQLTGHIPANLSQLPRLKLFSVANNLLTGPV 192
Query: 194 PTFVNLTLSADSVTNNQGLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMFF 253
P F AD+ NN GLCG PL C+ S +T VIAGAA+GGVT AAL +GI MFF
Sbjct: 193 PPFKPGVAGADNYANNSGLCGNPLGTCQVGSSKSNTAVIAGAAVGGVTVAALGLGIGMFF 252
Query: 254 YFRRMSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNII 313
Y RR+S RKK ++DPEGNKWA+SL GTK IKVS+FEKSI+KM L+DLMKAT++FSK+NII
Sbjct: 253 YVRRISYRKK-EEDPEGNKWARSLKGTKKIKVSMFEKSISKMNLNDLMKATDNFSKSNII 311
Query: 314 GSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK 373
G+GR+G +YKA+L DGTSLMVKRLQ+SQ SEKEF++EM LGSVK+RNLVPLLGFC+AKK
Sbjct: 312 GTGRSGIVYKAVLHDGTSLMVKRLQESQYSEKEFLSEMNILGSVKHRNLVPLLGFCVAKK 371
Query: 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNI 433
ERLLVYK+MPNG+L+D LHP D ++DWP RLKIAIGAA+G AWLHH+CNPRIIHRNI
Sbjct: 372 ERLLVYKNMPNGTLHDQLHP-DAGACTMDWPLRLKIAIGAAKGLAWLHHSCNPRIIHRNI 430
Query: 434 SSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGD 493
SSKCILLD DFEP ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY +TLVATPKGD
Sbjct: 431 SSKCILLDADFEPTISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTKTLVATPKGD 490
Query: 494 VYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNE 553
+YSFGTVLLELVTGERPT+VAKAPETFKGNLVEWI Q SS +L + ID+ LV KGVD E
Sbjct: 491 IYSFGTVLLELVTGERPTHVAKAPETFKGNLVEWIQQQSSNAKLHEVIDESLVGKGVDQE 550
Query: 554 LFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEEL 613
LFQFLKVA NCV +PKERPTMFEVYQFL+AIG Y+FT EDEIMLP D+GDAD LEEL
Sbjct: 551 LFQFLKVASNCV-TAMPKERPTMFEVYQFLKAIGINYNFTIEDEIMLPIDTGDADNLEEL 609
Query: 614 IVAREG 619
IVAREG
Sbjct: 610 IVAREG 615
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083399|emb|CBI23354.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/622 (70%), Positives = 520/622 (83%), Gaps = 10/622 (1%)
Query: 7 MELKSRSLVGVS-----VCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNND 61
M L S+ LV V+ V LL S+ Y T+ D+ CLK+IK+SL+DP NYLN SWNFNN+
Sbjct: 1 MALTSKYLVVVAHSLIWVVLLSYSSVCYATETDIYCLKTIKNSLQDPNNYLNFSWNFNNN 60
Query: 62 TEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLP 121
TEGFICKF G++CWHPDENRVLN+RL+DMGLKGQFPRGIRNCSS+TGLDLS+NKL G +P
Sbjct: 61 TEGFICKFAGIDCWHPDENRVLNIRLSDMGLKGQFPRGIRNCSSLTGLDLSNNKLSGSIP 120
Query: 122 DDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKS 181
DIS+L+ F+T+L+LSSN+F+G IP +LANC++LN LKLD+NR +G IP QL QL RLK+
Sbjct: 121 SDISELLKFVTTLELSSNSFAGDIPPSLANCSFLNVLKLDNNRLTGTIPLQLSQLNRLKT 180
Query: 182 FSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPL-DACKGTSKGPHTGVIAGAAIGGV 240
FSVANNLL+G IP +N T D NN GLCG+P D C+ + K G+IAGAA+GGV
Sbjct: 181 FSVANNLLTGQIPN-INSTTRED-YANNPGLCGKPFFDLCQASPKKFRIGIIAGAAVGGV 238
Query: 241 TFAALVVGIVMFFYFRRMSMRKKK-DDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSD 299
T +VV I++++ R + ++KKK +DDP+GNKW KS+ G KG+KVS+FEKSI+KMRLSD
Sbjct: 239 TITVIVVVIILYYISRGVVIKKKKKEDDPDGNKWTKSIKGLKGLKVSMFEKSISKMRLSD 298
Query: 300 LMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN 359
LMKATN+F+KNNIIG GRTG++YKA+L DG SLMVKRLQDSQRSEKEFV+EM TLG+VK+
Sbjct: 299 LMKATNNFNKNNIIGDGRTGSVYKAVLPDGCSLMVKRLQDSQRSEKEFVSEMNTLGTVKH 358
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
RNLVPL+GFCMAKKERLLVYKHM NG+LYD LHP + K ++WP RL+IAIG A+G AW
Sbjct: 359 RNLVPLMGFCMAKKERLLVYKHMANGNLYDQLHPLEPEAKGMEWPLRLRIAIGTAKGLAW 418
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
LHH+CNPRIIHRNISSKCILLD++FEPK+SDFGLARLMNP+DTHLSTFVNGEFGDLGYVA
Sbjct: 419 LHHSCNPRIIHRNISSKCILLDENFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 478
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539
PEY RTLVATPKGDVYSFGTVLLEL+TGERPT+V+ AP+ FKG+LVEWI LSS LQ
Sbjct: 479 PEYLRTLVATPKGDVYSFGTVLLELITGERPTHVSNAPDGFKGSLVEWITDLSSNSLLQT 538
Query: 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIM 599
AIDK L+ KG D EL QFL+VAC CV T PKERPTMFEVYQ LRAIGERYHFTT+DEI
Sbjct: 539 AIDKSLLGKGFDGELMQFLRVACKCVSET-PKERPTMFEVYQLLRAIGERYHFTTDDEIF 597
Query: 600 LPSDSGDADILEELIVAREGPE 621
+PS++ DAD+ +ELIVARE E
Sbjct: 598 VPSNTADADLPDELIVARETKE 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495880|ref|XP_002267164.2| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2253), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/622 (70%), Positives = 520/622 (83%), Gaps = 10/622 (1%)
Query: 7 MELKSRSLVGVS-----VCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNND 61
M L S+ LV V+ V LL S+ Y T+ D+ CLK+IK+SL+DP NYLN SWNFNN+
Sbjct: 1 MALTSKYLVVVAHSLIWVVLLSYSSVCYATETDIYCLKTIKNSLQDPNNYLNFSWNFNNN 60
Query: 62 TEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLP 121
TEGFICKF G++CWHPDENRVLN+RL+DMGLKGQFPRGIRNCSS+TGLDLS+NKL G +P
Sbjct: 61 TEGFICKFAGIDCWHPDENRVLNIRLSDMGLKGQFPRGIRNCSSLTGLDLSNNKLSGSIP 120
Query: 122 DDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKS 181
DIS+L+ F+T+L+LSSN+F+G IP +LANC++LN LKLD+NR +G IP QL QL RLK+
Sbjct: 121 SDISELLKFVTTLELSSNSFAGDIPPSLANCSFLNVLKLDNNRLTGTIPLQLSQLNRLKT 180
Query: 182 FSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPL-DACKGTSKGPHTGVIAGAAIGGV 240
FSVANNLL+G IP +N T D NN GLCG+P D C+ + K G+IAGAA+GGV
Sbjct: 181 FSVANNLLTGQIPN-INSTTRED-YANNPGLCGKPFFDLCQASPKKFRIGIIAGAAVGGV 238
Query: 241 TFAALVVGIVMFFYFRRMSMRKKK-DDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSD 299
T +VV I++++ R + ++KKK +DDP+GNKW KS+ G KG+KVS+FEKSI+KMRLSD
Sbjct: 239 TITVIVVVIILYYISRGVVIKKKKKEDDPDGNKWTKSIKGLKGLKVSMFEKSISKMRLSD 298
Query: 300 LMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN 359
LMKATN+F+KNNIIG GRTG++YKA+L DG SLMVKRLQDSQRSEKEFV+EM TLG+VK+
Sbjct: 299 LMKATNNFNKNNIIGDGRTGSVYKAVLPDGCSLMVKRLQDSQRSEKEFVSEMNTLGTVKH 358
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
RNLVPL+GFCMAKKERLLVYKHM NG+LYD LHP + K ++WP RL+IAIG A+G AW
Sbjct: 359 RNLVPLMGFCMAKKERLLVYKHMANGNLYDQLHPLEPEAKGMEWPLRLRIAIGTAKGLAW 418
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
LHH+CNPRIIHRNISSKCILLD++FEPK+SDFGLARLMNP+DTHLSTFVNGEFGDLGYVA
Sbjct: 419 LHHSCNPRIIHRNISSKCILLDENFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 478
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539
PEY RTLVATPKGDVYSFGTVLLEL+TGERPT+V+ AP+ FKG+LVEWI LSS LQ
Sbjct: 479 PEYLRTLVATPKGDVYSFGTVLLELITGERPTHVSNAPDGFKGSLVEWITDLSSNSLLQT 538
Query: 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIM 599
AIDK L+ KG D EL QFL+VAC CV T PKERPTMFEVYQ LRAIGERYHFTT+DEI
Sbjct: 539 AIDKSLLGKGFDGELMQFLRVACKCVSET-PKERPTMFEVYQLLRAIGERYHFTTDDEIF 597
Query: 600 LPSDSGDADILEELIVAREGPE 621
+PS++ DAD+ +ELIVARE E
Sbjct: 598 VPSNTADADLPDELIVARETKE 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462467|ref|XP_004148962.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2230), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/606 (68%), Positives = 497/606 (82%), Gaps = 4/606 (0%)
Query: 14 LVGVSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVE 73
+ G V LL C ++ T+ DL CL+SIK+S +DP YL +SW+F+N +EG IC+FTG+
Sbjct: 11 VAGFVVVLLSCNGFTFATESDLFCLRSIKNSFQDPNEYL-TSWDFSNRSEGVICRFTGIM 69
Query: 74 CWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133
CWHPDENRVL++ L++MGLKGQFP GI+NC+S+TGLDLS N++ G +P DI +V + +
Sbjct: 70 CWHPDENRVLSITLSNMGLKGQFPTGIKNCTSLTGLDLSFNQMSGEIPMDIGSIVKYAAT 129
Query: 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSI 193
LDLSSN+F+G IP ++A+ +YLN LKLDHN+ SGQIPP+L LGRL FSVA+NLL G +
Sbjct: 130 LDLSSNDFTGPIPKSIADISYLNILKLDHNQLSGQIPPELSLLGRLTEFSVASNLLIGPV 189
Query: 194 PTF-VNLTLSADSVTNNQGLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMF 252
P F NLT AD NN GLC PL +C S PHT VIAGAAIGGVT AA+ VGI MF
Sbjct: 190 PKFGSNLTNKADMYANNPGLCDGPLKSCSSASNNPHTSVIAGAAIGGVTVAAVGVGIGMF 249
Query: 253 FYFRRMSMRKKK-DDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNN 311
FYFR SM+K+K DDDPEGNKWA+++ G KGIK+S+ EKS+ KM LSDLMKATN+FSKN+
Sbjct: 250 FYFRSASMKKRKRDDDPEGNKWARNIKGAKGIKISVVEKSVPKMSLSDLMKATNNFSKNS 309
Query: 312 IIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
IIGSGRTG +Y+A+ EDGTSLMVKRLQ+SQR+EKEF++EMATLGSVK+ NLVPLLGFCMA
Sbjct: 310 IIGSGRTGCIYRAVFEDGTSLMVKRLQESQRTEKEFLSEMATLGSVKHANLVPLLGFCMA 369
Query: 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
KKER+LVYK MPNG+L+D LHP D K ++W RLKI I AA+G AWLHHNCNPRIIHR
Sbjct: 370 KKERILVYKDMPNGTLHDQLHPEDGDVKPMEWSLRLKIGIRAAKGLAWLHHNCNPRIIHR 429
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK 491
NISSKCILLD+ FEPKISDFGLARLMNPIDTHLSTFVNGEFGD+GYVAPEY+RTLVATPK
Sbjct: 430 NISSKCILLDETFEPKISDFGLARLMNPIDTHLSTFVNGEFGDIGYVAPEYSRTLVATPK 489
Query: 492 GDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVD 551
GDVYSFG VLLELVTGE+PT+V+KAPE FKGNLVEWI +LS ++Q+A+D V K VD
Sbjct: 490 GDVYSFGVVLLELVTGEKPTHVSKAPEDFKGNLVEWITKLSEESKVQEALDATFVGKNVD 549
Query: 552 NELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILE 611
EL QFLKVA +CV+PT KERPTMFEVYQ LRAIGE Y+FT+EDEIM+P++S LE
Sbjct: 550 GELLQFLKVARSCVVPT-AKERPTMFEVYQLLRAIGEGYNFTSEDEIMMPTNSECETGLE 608
Query: 612 ELIVAR 617
ELIVA
Sbjct: 609 ELIVAH 614
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449502101|ref|XP_004161543.1| PREDICTED: LOW QUALITY PROTEIN: probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2222), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/606 (68%), Positives = 495/606 (81%), Gaps = 4/606 (0%)
Query: 14 LVGVSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVE 73
+ G V LL C ++ T+ DL CL+SIK+S +DP YL +SW+F+N +EG IC+F G+
Sbjct: 11 VAGFVVVLLSCNGFTFATESDLFCLRSIKNSFQDPNEYL-TSWDFSNRSEGVICRFAGIM 69
Query: 74 CWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133
CWHPDENRVL++ L++MGLKGQFP GI+NC+S+TGLDLS N++ G +P DI +V + +
Sbjct: 70 CWHPDENRVLSITLSNMGLKGQFPTGIKNCTSLTGLDLSFNQMSGEIPTDIGSIVKYAAT 129
Query: 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSI 193
LDLSSN+F+G IP ++A+ +YLN LKLDHN+ SGQIPP+L LGRL FSVA+NLL G +
Sbjct: 130 LDLSSNDFTGPIPKSIADISYLNILKLDHNQLSGQIPPELSLLGRLTEFSVASNLLIGPV 189
Query: 194 PTF-VNLTLSADSVTNNQGLCGEPLDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVMF 252
P F NLT AD NN GLC PL +C S PHT VIAGAAIGGVT AA+ VGI MF
Sbjct: 190 PKFGSNLTNKADMYANNPGLCDGPLKSCSSASNNPHTSVIAGAAIGGVTVAAVGVGIGMF 249
Query: 253 FYFRRMSMRKKK-DDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNN 311
FYFR SM+K+K DDDPEGNKWA+++ G KGIK+S+ EKS+ KM LSDLMKATN+FSKN+
Sbjct: 250 FYFRSASMKKRKRDDDPEGNKWARNIKGAKGIKISVVEKSVPKMSLSDLMKATNNFSKNS 309
Query: 312 IIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
IIGSGRTG +Y+A+ EDGTSLMVKRLQ+SQR+EKEF++EMATLGSVK+ NLVPLLGFCMA
Sbjct: 310 IIGSGRTGCIYRAVFEDGTSLMVKRLQESQRTEKEFLSEMATLGSVKHANLVPLLGFCMA 369
Query: 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
KER+LVYK MPNG+L+D LHP D K ++W RLKI I AA+G AWLHHNCNPRIIHR
Sbjct: 370 XKERILVYKDMPNGTLHDQLHPEDGDVKPMEWSLRLKIGIRAAKGLAWLHHNCNPRIIHR 429
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK 491
NISSKCILLD+ FEPKISDFGLARLMNPIDTHLSTFVNGEFGD+GYVAPEY+RTLVATPK
Sbjct: 430 NISSKCILLDETFEPKISDFGLARLMNPIDTHLSTFVNGEFGDIGYVAPEYSRTLVATPK 489
Query: 492 GDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVD 551
GDVYSFG VLLELVTGE+PT+V+KAPE FKGNLVEWI +LS ++Q+A+D V K VD
Sbjct: 490 GDVYSFGVVLLELVTGEKPTHVSKAPEDFKGNLVEWITKLSEESKVQEALDATFVGKNVD 549
Query: 552 NELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILE 611
EL QFLKVA +CV+PT KERPTMFEVYQ LRAIGE Y+FT+EDEIM+P++S LE
Sbjct: 550 GELLQFLKVARSCVVPT-AKERPTMFEVYQLLRAIGEGYNFTSEDEIMMPTNSECETGLE 608
Query: 612 ELIVAR 617
ELIVA
Sbjct: 609 ELIVAH 614
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 623 | ||||||
| TAIR|locus:2165981 | 620 | BIR1 "AT5G48380" [Arabidopsis | 0.932 | 0.937 | 0.640 | 1.1e-206 | |
| TAIR|locus:2205834 | 601 | AT1G27190 [Arabidopsis thalian | 0.914 | 0.948 | 0.463 | 2.9e-135 | |
| TAIR|locus:2088937 | 605 | AT3G28450 [Arabidopsis thalian | 0.892 | 0.919 | 0.472 | 1.2e-134 | |
| TAIR|locus:2020558 | 591 | AT1G69990 [Arabidopsis thalian | 0.884 | 0.932 | 0.451 | 5.9e-128 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.550 | 0.305 | 0.446 | 1.3e-87 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.797 | 0.416 | 0.395 | 3.7e-87 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.791 | 0.422 | 0.368 | 4.6e-82 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.746 | 0.461 | 0.395 | 5.2e-81 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.821 | 0.428 | 0.367 | 8.9e-80 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.804 | 0.846 | 0.367 | 3.9e-76 |
| TAIR|locus:2165981 BIR1 "AT5G48380" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1999 (708.7 bits), Expect = 1.1e-206, P = 1.1e-206
Identities = 380/593 (64%), Positives = 462/593 (77%)
Query: 34 DLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLK 93
++ CL++ K +EDP YL S+W F N+T G+ICKF+GV CWH DENRVL+++L+ GL+
Sbjct: 31 NIDCLRTFKSQVEDPNRYL-STWVFGNETAGYICKFSGVTCWHDDENRVLSIKLSGYGLR 89
Query: 94 GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCT 153
G FP ++ C+ +TGLDLS N GPLP +IS L+ +T LDLS N+FSG IP ++N T
Sbjct: 90 GVFPPAVKLCADLTGLDLSRNNFSGPLPANISTLIPLVTILDLSYNSFSGEIPMLISNIT 149
Query: 154 YLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLS--ADSVTNNQG 211
+LN+L L HN+F+G +PPQL QLGRLK+FSV++N L G IP F N TL + NN
Sbjct: 150 FLNTLMLQHNQFTGTLPPQLAQLGRLKTFSVSDNRLVGPIPNF-NQTLQFKQELFANNLD 208
Query: 212 LCGEPLDACKGTSKGPHXXXXXXXXXXXXXXXXLVVGIVMFFYFRRMSMRKKKDDDPEGN 271
LCG+PLD CK S LVVG+V+FFYFR++ +KK DDPEGN
Sbjct: 209 LCGKPLDDCKSASSS-RGKVVIIAAVGGLTAAALVVGVVLFFYFRKLGAVRKKQDDPEGN 267
Query: 272 KWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTS 331
+WAKSL G KG+KV +F+KS++KM+LSDLMKAT F K+NII +GRTGTMYK LEDG+
Sbjct: 268 RWAKSLKGQKGVKVFMFKKSVSKMKLSDLMKATEEFKKDNIIATGRTGTMYKGRLEDGSL 327
Query: 332 LMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL 391
LM+KRLQDSQRSEKEF AEM TLGSVKNRNLVPLLG+C+A KERLL+Y++M NG LYD L
Sbjct: 328 LMIKRLQDSQRSEKEFDAEMKTLGSVKNRNLVPLLGYCVANKERLLMYEYMANGYLYDQL 387
Query: 392 HPADDTG-KSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450
HPAD+ K +DWP RLKIAIG A+G AWLHH+CNPRIIHRNISSKCILL +FEPKISD
Sbjct: 388 HPADEESFKPLDWPSRLKIAIGTAKGLAWLHHSCNPRIIHRNISSKCILLTAEFEPKISD 447
Query: 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
FGLARLMNPIDTHLSTFVNGEFGD GYVAPEY+RT+VATPKGDVYSFG VLLELVTG++
Sbjct: 448 FGLARLMNPIDTHLSTFVNGEFGDFGYVAPEYSRTMVATPKGDVYSFGVVLLELVTGQKA 507
Query: 511 TNVAKAPE------TFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNC 564
T+V K E FKGNLVEWI +LSS +LQ+AID+ L+ GVD+E+F+ LKVACNC
Sbjct: 508 TSVTKVSEEKAEEENFKGNLVEWITKLSSESKLQEAIDRSLLGNGVDDEIFKVLKVACNC 567
Query: 565 VLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEELIVAR 617
VLP I K+RPTMFEVYQ LRAIGE Y+FT +D+I++PS+SG+ D +EELIVAR
Sbjct: 568 VLPEIAKQRPTMFEVYQLLRAIGESYNFTADDDILIPSESGEGDFIEELIVAR 620
|
|
| TAIR|locus:2205834 AT1G27190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1325 (471.5 bits), Expect = 2.9e-135, P = 2.9e-135
Identities = 270/583 (46%), Positives = 374/583 (64%)
Query: 32 KEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMG 91
++D+ CL+ +K+SL DP + L SSW+F N + ICK TGV CW+ ENR+++L+L M
Sbjct: 25 EDDVLCLQGLKNSLIDPSSRL-SSWSFPNSSASSICKLTGVSCWNEKENRIISLQLQSMQ 83
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
L G+ P ++ C S+ LDLS N L G +P I + +L +LDLS N GSIP+ +
Sbjct: 84 LAGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGGSIPTQIVE 143
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQG 211
C +LN+L L N+ SG IP QL +L RL+ S+A N LSG+IP+ + D + N G
Sbjct: 144 CKFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSEL-ARFGGDDFSGNNG 202
Query: 212 LCGEPLDACKGTSKGPHXXXXXXXXXXXXXXXXLVVGIVMFF-YFRRMSMRKKKD----D 266
LCG+PL C G G + L VG+V+F+ +F R RKKK
Sbjct: 203 LCGKPLSRC-GALNGRNLSIIIVAGVLGAVGS-LCVGLVIFWWFFIREGSRKKKGYGAGK 260
Query: 267 DPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALL 326
+ + W L K ++V+LF+K I K++L DLM ATN+FS NI S RTG YKA L
Sbjct: 261 SKDDSDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDVSSRTGVSYKADL 320
Query: 327 EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGS 386
DG++L VKRL EK+F +EM LG +++ NLVPLLG+C+ + ERLLVYKHM NG+
Sbjct: 321 PDGSALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDERLLVYKHMVNGT 380
Query: 387 LYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446
L+ LH +DWP R I +GAA+G AWLHH C P +H+ ISS ILLDDDF+
Sbjct: 381 LFSQLHNGGLCDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILLDDDFDA 440
Query: 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506
+I+D+GLA+L+ D++ S+F NG+ G+LGYVAPEY+ T+VA+ KGDVY FG VLLELVT
Sbjct: 441 RITDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIVLLELVT 500
Query: 507 GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVL 566
G++P +V E FKG+LV+W++Q TG+ +DAID+ + KG D E+ QFLK+AC+CV+
Sbjct: 501 GQKPLSVINGVEGFKGSLVDWVSQYLGTGRSKDAIDRSICDKGHDEEILQFLKIACSCVV 560
Query: 567 PTIPKERPTMFEVYQFLRAIGERYHFTTE--DEIMLPSDSGDA 607
PKERPTM +VY+ L+ + ++ H +E DE L + +A
Sbjct: 561 SR-PKERPTMIQVYESLKNMADK-HGVSEHYDEFPLVFNKQEA 601
|
|
| TAIR|locus:2088937 AT3G28450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1319 (469.4 bits), Expect = 1.2e-134, P = 1.2e-134
Identities = 270/571 (47%), Positives = 371/571 (64%)
Query: 32 KEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMG 91
++D+ CL+ +K SL DP N L S WNF+N T GF+C F GV CW+ ENRV+NL L DMG
Sbjct: 31 EDDIRCLRGLKASLTDPQNALKS-WNFDNTTLGFLCNFVGVSCWNNQENRVINLELRDMG 89
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
L G+ P ++ C+S+ LDLSSN+L G +P ++ + FL SLDLS+N +G IP +LA
Sbjct: 90 LSGKIPDSLQYCASLQKLDLSSNRLSGNIPTELCNWLPFLVSLDLSNNELNGEIPPDLAK 149
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQ 210
C+++NSL L NR SGQIP Q LGRL FSVANN LSG IP F + + S+D + N+
Sbjct: 150 CSFVNSLVLSDNRLSGQIPVQFSALGRLGRFSVANNDLSGRIPVFFSSPSYSSDDFSGNK 209
Query: 211 GLCGEPLDA-CKGTSKGPHXXXXXXXXXXXXXXXXLVVGIVMFFYFRRMSMRKKKDDDPE 269
GLCG PL + C G SK L GI ++Y + + R++
Sbjct: 210 GLCGRPLSSSCGGLSKKNLGIIIAAGVFGAAASMLLAFGI-WWYYHLKWTRRRRSGLTEV 268
Query: 270 G-NKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLED 328
G + A+ L K +VSLF+K + K++L DLM ATN+F+ NII S RTGT YKALL D
Sbjct: 269 GVSGLAQRLRSHKLTQVSLFQKPLVKVKLGDLMAATNNFNSENIIVSTRTGTTYKALLPD 328
Query: 329 GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLY 388
G++L VK L + E+EF EM L +++ NL PLLGFC+ ++E+ LVYK+M NG+L+
Sbjct: 329 GSALAVKHLSTCKLGEREFRYEMNQLWELRHSNLAPLLGFCVVEEEKFLVYKYMSNGTLH 388
Query: 389 DLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448
LL D +DW R +I +GAARG AWLHH C P I+H+NI S IL+D+DF+ +I
Sbjct: 389 SLL---DSNRGELDWSTRFRIGLGAARGLAWLHHGCRPPILHQNICSSVILIDEDFDARI 445
Query: 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGE 508
D GLARLM P D + S+F+ G+ G+ GYVAPEY+ T++A+ KGDVY G VLLEL TG
Sbjct: 446 IDSGLARLMVPSDNNESSFMTGDLGEFGYVAPEYSTTMLASLKGDVYGLGVVLLELATGL 505
Query: 509 RPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPT 568
+ A E FKG+LV+W+ QL S+G++ + D+ + KG D E+ +F+++A NCV +
Sbjct: 506 K----AVGGEGFKGSLVDWVKQLESSGRIAETFDENIRGKGHDEEISKFVEIALNCV-SS 560
Query: 569 IPKERPTMFEVYQFLRAIGER--YHFTTEDE 597
PKER +MF+ YQ L+AI E+ Y F+ +D+
Sbjct: 561 RPKERWSMFQAYQSLKAIAEKQGYSFSEQDD 591
|
|
| TAIR|locus:2020558 AT1G69990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1256 (447.2 bits), Expect = 5.9e-128, P = 5.9e-128
Identities = 263/582 (45%), Positives = 372/582 (63%)
Query: 32 KEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMG 91
++D+ CLK K SL+DP N LN+ W+F N + ICK TGV CW+ ENR+L+L+L M
Sbjct: 19 EDDVLCLKGFKSSLKDPSNQLNT-WSFPNSSSS-ICKLTGVSCWNAKENRILSLQLQSMQ 76
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
L GQ P ++ C S+ LDLS N G +P I + +L +LDLS N SGSIPS + +
Sbjct: 77 LSGQIPESLKLCRSLQSLDLSFNDFSGLIPSQICSWLPYLVTLDLSGNKLSGSIPSQIVD 136
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQG 211
C +LNSL L+ N+ +G IP +L +L RL+ S+A+N LSGSIP+ ++ D N G
Sbjct: 137 CKFLNSLALNQNKLTGSIPSELTRLNRLQRLSLADNDLSGSIPSELS-HYGEDGFRGNGG 195
Query: 212 LCGEPLDACKGTSKGPHXXXXXXXXXXXXXXXXLVVGIVMFFYF-----RRMS-----MR 261
LCG+PL C G+ G + L VG MF++F R+M+
Sbjct: 196 LCGKPLSNC-GSFNGKNLTIIVTAGVIGAVGS-LCVGFGMFWWFFIRDRRKMNNYGYGAG 253
Query: 262 KKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTM 321
K KDD + W L K ++V+LF+K I K++L DL++ATN F NI+ S R+G
Sbjct: 254 KCKDD----SDWIGLLRSHKLVQVTLFQKPIVKIKLVDLIEATNGFDSGNIVVSSRSGVS 309
Query: 322 YKALLEDGTSLMVKRLQDS-QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380
YKA L DG++L VKRL + SEK+F +E+ LG +++ NLVPLLGFC+ + E LLVYK
Sbjct: 310 YKADLPDGSTLEVKRLSSCCELSEKQFRSEINKLGQIRHPNLVPLLGFCVVEDEILLVYK 369
Query: 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440
HM NG+LY L D +DWP R+++A+GAARG AWLHH C P +H+ ISS ILL
Sbjct: 370 HMANGTLYSQLQQWD-----IDWPTRVRVAVGAARGLAWLHHGCQPLYMHQYISSNVILL 424
Query: 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTV 500
D+DF+ ++ D+GL +L++ D+ S+F NG+FG YVAPEY+ T+VA+ GDVY FG V
Sbjct: 425 DEDFDARVIDYGLGKLVSSQDSKDSSFSNGKFG---YVAPEYSSTMVASLSGDVYGFGIV 481
Query: 501 LLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKV 560
LLE+VTG++P + E FK +LVEW+++ S G+ +DAID+ + KG D+E+ Q L++
Sbjct: 482 LLEIVTGQKPVLINNGEEGFKESLVEWVSKHLSNGRSKDAIDRRIFGKGYDDEIMQVLRI 541
Query: 561 ACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTE--DEIML 600
AC+CV+ PKERP M +VY+ L+ +G+++ F +E DE L
Sbjct: 542 ACSCVVSR-PKERPLMIQVYESLKNLGDQHGFFSEYSDEFPL 582
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 1.3e-87, Sum P(2) = 1.3e-87
Identities = 160/358 (44%), Positives = 221/358 (61%)
Query: 273 WAKSLTGTKGIKVSL--FEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGT 330
W ++L+GT + ++L FEK + + L+DL++ATN F IGSG G +YKA L+DG
Sbjct: 771 WRQNLSGTNLLSINLAAFEKPLQNLTLADLVEATNGFHIACQIGSGGFGDVYKAQLKDGK 830
Query: 331 SLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYD 389
+ +K+L S + ++EF AEM T+G +K+RNLVPLLG+C A +ERLLVY +M GSL D
Sbjct: 831 VVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGSLED 890
Query: 390 LLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKIS 449
+LH GK ++W R KIA+GAARG A+LHHNC P IIHR++ S +L+D+ E ++S
Sbjct: 891 VLHDRKKIGKKLNWEARRKIAVGAARGLAFLHHNCIPHIIHRDMKSSNVLIDEQLEARVS 950
Query: 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGER 509
DFG+ARLM+ +DTHLS V+ G GYV PEY ++ T KGDVYS+G VLLEL+TG+
Sbjct: 951 DFGMARLMSVVDTHLS--VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLELLTGKP 1008
Query: 510 PTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAK--GVDNELFQFLKVACNCVLP 567
PT+ A E NLV W+ Q + ++ D D L+ + V+ EL + LK+AC C L
Sbjct: 1009 PTDSADFGED--NNLVGWVKQHTKL-KITDVFDPELLKEDPSVELELLEHLKIACAC-LD 1064
Query: 568 TIPKERPTMFEVYQFLRAI--GERYHFTTEDEIMLPSDSGDADILEELIVAREGPENK 623
P RPTM +V + I G T D G +L+ + RE E K
Sbjct: 1065 DRPSRRPTMLKVMAMFKEIQAGSTVDSKTSSAAAGSIDEGGYGVLD--MPLREAKEEK 1120
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 871 (311.7 bits), Expect = 3.7e-87, P = 3.7e-87
Identities = 207/523 (39%), Positives = 300/523 (57%)
Query: 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNF 141
++ L LT L G P + N +T +DLS N L G L ++S + L L + N F
Sbjct: 678 LVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEK-LVGLYIEQNKF 736
Query: 142 SGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF-VNLT 200
+G IPS L N T L L + N SG+IP ++ L L+ ++A N L G +P+ V
Sbjct: 737 TGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQD 796
Query: 201 LSADSVTNNQGLCGEPLDA-CKGTSKGPHXXXXXXXXXXXXXXXXLVVGIVMFFYFRRMS 259
S ++ N+ LCG + + CK +G +V V M+
Sbjct: 797 PSKALLSGNKELCGRVVGSDCK--IEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMT 854
Query: 260 MRKKKDDDPEGNKWAKS----------LTGTKG-----IKVSLFEKSITKMRLSDLMKAT 304
R K+ DDPE + ++ L+G++ I +++FE+ + K+RL D+++AT
Sbjct: 855 KRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEAT 914
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLV 363
+ FSK NIIG G GT+YKA L ++ VK+L +++ + +EF+AEM TLG VK+ NLV
Sbjct: 915 DHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLV 974
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
LLG+C +E+LLVY++M NGSL L + +DW +RLKIA+GAARG A+LHH
Sbjct: 975 SLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHG 1034
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
P IIHR+I + ILLD DFEPK++DFGLARL++ ++H+ST + G FG Y+ PEY
Sbjct: 1035 FIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFG---YIPPEYG 1091
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543
++ AT KGDVYSFG +LLELVTG+ PT E+ GNLV W Q + G+ D ID
Sbjct: 1092 QSARATTKGDVYSFGVILLELVTGKEPTG-PDFKESEGGNLVGWAIQKINQGKAVDVIDP 1150
Query: 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
LV+ + N + L++A C+ T P +RP M +V + L+ I
Sbjct: 1151 LLVSVALKNSQLRLLQIAMLCLAET-PAKRPNMLDVLKALKEI 1192
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 4.6e-82, Sum P(2) = 4.6e-82
Identities = 198/538 (36%), Positives = 291/538 (54%)
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
+ G P G N + L+L N++ G +PD L + LDLS NN G +P +L +
Sbjct: 651 VSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKA-IGVLDLSHNNLQGYLPGSLGS 709
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSV---ANNLLSGSIPTFVNLTLSADSVTN 208
++L+ L + +N +G IP G G+L +F V ANN SG + L
Sbjct: 710 LSFLSDLDVSNNNLTGPIP--FG--GQLTTFPVSRYANN--SG----LCGVPLRP----- 754
Query: 209 NQGLCGE-PLDACKGTSKGPHXXXXXXXXXXXXXXXXLVVGIVMFFY-FRRMSMRKKKDD 266
CG P V +VM Y R++ +++K +
Sbjct: 755 ----CGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKRE 810
Query: 267 D-----P-EGN-KWA-KSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRT 318
P G+ W S+ I V+ FEK + K+ + L++ATN FS ++GSG
Sbjct: 811 KYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGF 870
Query: 319 GTMYKALLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377
G +YKA L DG+ + +K+L + + + ++EF+AEM T+G +K+RNLVPLLG+C +ERLL
Sbjct: 871 GEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLL 930
Query: 378 VYKHMPNGSLYDLLHPADDT--GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISS 435
VY++M GSL +LH G ++W R KIAIGAARG A+LHH+C P IIHR++ S
Sbjct: 931 VYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKS 990
Query: 436 KCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVY 495
+LLD+DFE ++SDFG+ARL++ +DTHLS V+ G GYV PEY ++ T KGDVY
Sbjct: 991 SNVLLDEDFEARVSDFGMARLVSALDTHLS--VSTLAGTPGYVPPEYYQSFRCTAKGDVY 1048
Query: 496 SFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA-KGVDNEL 554
S+G +LLEL++G++P + + E NLV W QL + + +D LV K D EL
Sbjct: 1049 SYGVILLELLSGKKPIDPGEFGED--NNLVGWAKQLYREKRGAEILDPELVTDKSGDVEL 1106
Query: 555 FQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEE 612
F +LK+A C L P +RPTM ++ + E T EDE + + ++EE
Sbjct: 1107 FHYLKIASQC-LDDRPFKRPTMIQLMAMFK---EMKADTEEDESLDEFSLKETPLVEE 1160
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 5.2e-81, P = 5.2e-81
Identities = 193/488 (39%), Positives = 273/488 (55%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQ 168
++L N L GP+ ++ L L DL N SGSIPS+L+ T L +L L +NR SG
Sbjct: 528 IELGHNNLSGPIWEEFGNLKK-LHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGS 586
Query: 169 IPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPLDACKGTSKGPH 228
IP L QL L FSVA N LSG IP+ +S + LCGE C S+G
Sbjct: 587 IPVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNHLCGEHRFPC---SEGTE 643
Query: 229 XXXXXXXXXXXXXXXXLVVGIVM--FFYFRRMSM------RKKKDDDPE---GNKWAKSL 277
+ +GI F +S+ R+ + DPE +
Sbjct: 644 SALIKRSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKE 703
Query: 278 TGTKGIK-VSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKR 336
G G K V LF+ + ++ DL+ +TNSF + NIIG G G +YKA L DG + +K+
Sbjct: 704 LGEIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKK 763
Query: 337 LQ-DSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPAD 395
L D + E+EF AE+ TL ++ NLV L GFC K +RLL+Y +M NGSL LH +
Sbjct: 764 LSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERN 823
Query: 396 DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455
D + W RL+IA GAA+G +LH C+P I+HR+I S ILLD++F ++DFGLAR
Sbjct: 824 DGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLAR 883
Query: 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515
LM+P +TH+ST + G LGY+ PEY + VAT KGDVYSFG VLLEL+T +RP ++ K
Sbjct: 884 LMSPYETHVSTDL---VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCK 940
Query: 516 APETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPT 575
P+ + +L+ W+ ++ + + D + +K D E+F+ L++AC C L PK+RPT
Sbjct: 941 -PKGCR-DLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLC-LSENPKQRPT 997
Query: 576 MFEVYQFL 583
++ +L
Sbjct: 998 TQQLVSWL 1005
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 8.9e-80, P = 8.9e-80
Identities = 202/550 (36%), Positives = 300/550 (54%)
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
L G P+ I + + L+L N + G +PD++ L G L LDLSSN G IP ++
Sbjct: 666 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG-LNILDLSSNKLDGRIPQAMSA 724
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQG 211
T L + L +N SG IP ++G+ ++F A L + P L +N G
Sbjct: 725 LTMLTEIDLSNNNLSGPIP----EMGQFETFPPAKFLNN---PGLCGYPLPRCDPSNADG 777
Query: 212 LCGEPLDACKGTSKGPHXXXXXXXXXXXXXXXXLVVGIVMFFYFRRMSMRKKKDD----- 266
+ + P + G+++ R RKK+ +
Sbjct: 778 YAHHQ----RSHGRRP-ASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYA 832
Query: 267 DPEGNKWAKS-------LTGTK---GIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSG 316
+ GN ++ LTG K I ++ FEK + K+ +DL++ATN F +++IGSG
Sbjct: 833 EGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSG 892
Query: 317 RTGTMYKALLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375
G +YKA+L+DG+++ +K+L S + ++EF+AEM T+G +K+RNLVPLLG+C ER
Sbjct: 893 GFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDER 952
Query: 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISS 435
LLVY+ M GSL D+LH G ++W R KIAIG+ARG A+LHHNC+P IIHR++ S
Sbjct: 953 LLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKS 1012
Query: 436 KCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVY 495
+LLD++ E ++SDFG+ARLM+ +DTHLS V+ G GYV PEY ++ + KGDVY
Sbjct: 1013 SNVLLDENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKGDVY 1070
Query: 496 SFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAK--GVDNE 553
S+G VLLEL+TG+RPT+ +P+ NLV W+ Q + ++ D D L+ + ++ E
Sbjct: 1071 SYGVVLLELLTGKRPTD---SPDFGDNNLVGWVKQHAKL-RISDVFDPELMKEDPALEIE 1126
Query: 554 LFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDSGDADILEEL 613
L Q LKVA C L RPTM +V + I ++ I D G + I
Sbjct: 1127 LLQHLKVAVAC-LDDRAWRRPTMVQVMAMFKEIQAGSGIDSQSTIRSIEDGGFSTIEMVD 1185
Query: 614 IVAREGPENK 623
+ +E PE K
Sbjct: 1186 MSIKEVPEGK 1195
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
Identities = 196/533 (36%), Positives = 290/533 (54%)
Query: 67 CKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISK 126
C + GV C RV+ L LT + G P I + L L +N LYG +P +
Sbjct: 62 CNWNGVTC-DAKTKRVITLNLTYHKIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGN 120
Query: 127 LVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVAN 186
L + L SN F+G IP+ + + L L + N SG IP LGQL +L +F+V+N
Sbjct: 121 CTA-LEEIHLQSNYFTGPIPAEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSN 179
Query: 187 NLLSGSIPTFVNLT-LSADSVTNNQGLCGEPLDA-CKGTSKGPHXXXXXXXXXXXXXXXX 244
N L G IP+ L+ S +S N LCG+ +D C+ S P
Sbjct: 180 NFLVGQIPSDGVLSGFSKNSFIGNLNLCGKHVDVVCQDDSGNPSSHSQSGQNQKKNSGKL 239
Query: 245 LV-----VG---IVMFFYFRRMSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMR 296
L+ VG +V F + KK E AK + G G + +F +
Sbjct: 240 LISASATVGALLLVALMCFWGCFLYKKLGK-VEIKSLAKDVGG--GASIVMFHGDLPYSS 296
Query: 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKR-LQDSQRSEKEFVAEMATLG 355
D++K ++ +IIG G GT+YK ++DG +KR L+ ++ ++ F E+ LG
Sbjct: 297 -KDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEILG 355
Query: 356 SVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR 415
S+K+R LV L G+C + +LL+Y ++P GSL + LH + G+ +DW R+ I IGAA+
Sbjct: 356 SIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHV--ERGEQLDWDSRVNIIIGAAK 413
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G ++LHH+C+PRIIHR+I S ILLD + E ++SDFGLA+L+ ++H++T V G FG
Sbjct: 414 GLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG-- 471
Query: 476 GYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG-NLVEWIAQLSST 534
Y+APEY ++ AT K DVYSFG ++LE+++G+RPT+ A E KG N+V W+ L S
Sbjct: 472 -YLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTD-ASFIE--KGLNVVGWLKFLISE 527
Query: 535 GQLQDAID-KCLVAKGVDNE-LFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585
+ +D +D C +G+ E L L +A CV P+ P+ERPTM V Q L +
Sbjct: 528 KRPRDIVDPNC---EGMQMESLDALLSIATQCVSPS-PEERPTMHRVVQLLES 576
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ASS4 | Y5838_ARATH | No assigned EC number | 0.6515 | 0.9373 | 0.9419 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 623 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-59 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-34 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-26 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-25 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-22 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.002 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 0.002 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.002 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| cd12087 | 38 | cd12087, TM_EGFR-like, Transmembrane domain of the | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.004 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 8e-59
Identities = 155/517 (29%), Positives = 247/517 (47%), Gaps = 52/517 (10%)
Query: 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDIS---KLVGFLTSLDL 136
R+ NL L+ G PR + + S + L LS NKL G +PD++S KLV SLDL
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV----SLDL 530
Query: 137 SSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-T 195
S N SG IP++ + L+ L L N+ SG+IP LG + L ++++N L GS+P T
Sbjct: 531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
Query: 196 FVNLTLSADSVTNNQGLCGEP----LDACKGTSKGPHTGVIAGAAIGGVTFAALVVGIVM 251
L ++A +V N LCG L CK K P +G ALV +
Sbjct: 591 GAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFV 650
Query: 252 FFYFRRMSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNN 311
F R K+ ++ E W +K KSIT ++D++ + + N
Sbjct: 651 FIRGRNNLELKRVEN--EDGTWELQFFDSK------VSKSIT---INDILSSLK---EEN 696
Query: 312 IIGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
+I G+ G YK +++G +VK + D +A+M G +++ N+V L+G C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM---GKLQHPNIVKLIGLCR 753
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
++K L+++++ +L ++L +++ W RR KIAIG A+ +LH C+P ++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 431 RNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATP 490
N+S + I++D EP + L + T F++ YVAPE T T
Sbjct: 807 GNLSPEKIIIDGKDEPHL----RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITE 857
Query: 491 KGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGV 550
K D+Y FG +L+EL+TG+ P + G++VEW S L ID +
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 551 --DNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585
NE+ + + +A +C T P RP +V + L +
Sbjct: 915 VNQNEIVEVMNLALHCT-ATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 76/292 (26%), Positives = 127/292 (43%), Gaps = 48/292 (16%)
Query: 311 NIIGSGRTGTMYKALL--EDGTSLMV--KRLQDSQRSE--KEFVAEMATLGSVKNRNLVP 364
+G G G +YK L +DG + V K L++ E K+F+ E + + + N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLL-----HPADDTGKSVDWPRRLKIAIGAARGFAW 419
LLG C ++ LV ++M G L D L ++ L AI A+G +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV- 478
L + +HR+++++ L+ +D KISDFGL+R + D G +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD-------YYRKKTGGKLP 170
Query: 479 ----APEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKG-NLVEWIAQLS 532
APE + + T K DV+SFG +L E+ T G P + G + E + L
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---------YPGLSNEEVLEYLR 221
Query: 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584
+L + +EL++ + +C P++RPT E+ + L
Sbjct: 222 KGYRLPK-------PEYCPDELYELML---SCWQL-DPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 313 IGSGRTGTMYKALL---EDGTSLMV--KRLQD--SQRSEKEFVAEMATLGSVKNRNLVPL 365
+G G G +YK L +GT V K L++ S+ +EF+ E + + + + N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
LG C + +V ++MP G L D L G+ + L++A+ A+G +L
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART 485
+HR+++++ L+ ++ KISDFGL+R + D + G + ++APE +
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKD 178
Query: 486 LVATPKGDVYSFGTVLLELVT-GERP 510
T K DV+SFG +L E+ T GE+P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRL--QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
+G G GT+Y A + G + +K + +DS +E + E+ L + + N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ LV ++ GSL DLL + + L+I + G +LH N II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 430 HRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV- 487
HR++ + ILLD D+ + K++DFGL++L+ + L T V G Y+APE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV----GTPAYMAPEVLLGKGY 170
Query: 488 ATPKGDVYSFGTVLLEL 504
+ K D++S G +L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 70/204 (34%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 312 IIGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRSEKEFV---AEMATLGSVKNRNLVPLLG 367
+GSG GT+YKA G + VK L+ K+ E+ L + + N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
K LV ++ G L+D L G + KIA+ RG +LH N
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE-YARTL 486
IIHR++ + ILLD++ KI+DFGLA+ + + L+TFV G Y+APE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV----GTPWYMAPEVLLGGN 174
Query: 487 VATPKGDVYSFGTVLLELVTGERP 510
PK DV+S G +L EL+TG+ P
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 308 SKNNIIGSGRTGTMYKALLEDGTSLM-----VKRLQD--SQRSEKEFVAEMATLGSVKNR 360
+ +G G G +YK L+ VK L++ S++ +EF+ E + + +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
N+V LLG C ++ ++V ++MP G L D L + K + L A+ ARG +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYL 119
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV-- 478
IHR+++++ L+ ++ KISDFGL+R + D + G +
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV--------KGGKLPI 168
Query: 479 ---APEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSST 534
APE + T K DV+SFG +L E+ T GE P E ++E++ +
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-----VLEYLKK---- 219
Query: 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583
G C EL++ + C P++RPT E+ + L
Sbjct: 220 GYRLPKPPNC------PPELYKLML-QC---WAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 40/286 (13%)
Query: 308 SKNNIIGSGRTGTMYKALLEDGTSLM-----VKRLQ-DSQRSE-KEFVAEMATLGSVKNR 360
+ +G G G +YK L+ VK L+ D+ + +EF+ E + + +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
N+V LLG C ++ +V ++M G L L + L A+ ARG +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYL 118
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY--V 478
IHR+++++ L+ ++ KISDFGL+R + D + G L +
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR-----GGKLPIRWM 170
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537
APE + T K DV+SFG +L E+ T GE+P E ++E++ G
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLEYLKN----GYR 221
Query: 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583
C EL+ + C P++RPT E+ + L
Sbjct: 222 LPQPPNC------PPELYDLML---QC-WAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-26
Identities = 68/198 (34%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 21 LLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDEN 80
L + S E+L L S K S+ DP YL S+WN + D +C + G+ C + +
Sbjct: 17 FFLFLNFSMLHAEELELLLSFKSSINDPLKYL-SNWNSSAD----VCLWQGITC--NNSS 69
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
RV+++ L+ + G+ I + ++LS+N+L GP+PDDI L L+LS+NN
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV-NL 199
F+GSIP L +L L +N SG+IP +G LK + N+L G IP + NL
Sbjct: 130 FTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 200 T-LSADSVTNNQGLCGEP 216
T L ++ +NQ + P
Sbjct: 188 TSLEFLTLASNQLVGQIP 205
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 65/252 (25%), Positives = 107/252 (42%), Gaps = 28/252 (11%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKNRNLV 363
+ +G G G +Y A + G + +K + + ++ + + E+ L +K+ N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
L + + LV ++ G L+DLL + +LH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 424 CNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
I+HR++ K ILLD+D K++DFGLAR ++P L+TFV G Y+APE
Sbjct: 117 ---GIVHRDL--KPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV----GTPEYMAPE 166
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERP-------TNVAKAPETFKGNLVEWIAQLSST 534
D++S G +L EL+TG+ P + K K +S
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP- 225
Query: 535 GQLQDAIDKCLV 546
+ +D I K LV
Sbjct: 226 -EAKDLIRKLLV 236
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 69/179 (38%), Positives = 98/179 (54%), Gaps = 16/179 (8%)
Query: 108 GLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSG 167
GL L + L G +P+DISKL L S++LS N+ G+IP +L + T L L L +N F+G
Sbjct: 422 GLGLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 168 QIPPQLGQLGRLKSFSVANNLLSGSIPTFVN---LTLSADSVTNNQGLCGEP-LDACKGT 223
IP LGQL L+ ++ N LSG +P + L ++ + T+N GLCG P L AC
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC--- 537
Query: 224 SKGPHTGVIAGAAIG---GVTFAALV-VGIVMFFYFRRMSMRKKKDDDPEGNKWAKSLT 278
GPH V GA IG GV+ A L V M ++ RR ++ + + +AK+ T
Sbjct: 538 --GPHLSV--GAKIGIAFGVSVAFLFLVICAMCWWKRRQNILRAQRIAAREAPYAKART 592
|
Length = 623 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 60/215 (27%), Positives = 113/215 (52%), Gaps = 23/215 (10%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTS----LMVKRLQD--SQRSEKEFVAEMATLGSVKN 359
K ++GSG GT+YK + + +G + +K L++ S ++ KE + E + SV +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKS---VDWPRRLKIAIGAARG 416
++V LLG C++ + L+ + MP G L D + D S ++W ++ A+G
Sbjct: 69 PHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
++L R++HR+++++ +L+ KI+DFGLA+L++ + G +
Sbjct: 122 MSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH--AEGGKVPIK 176
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
++A E + T K DV+S+G + EL+T G +P
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 9e-22
Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 48/284 (16%)
Query: 306 SFSKNNIIGSGRTGTMYKALLEDGTSLM-VKRLQDSQRSEKEFVA---EMATLGSVKNRN 361
+++ ++G G G++Y AL +D LM VK ++ S SE+E A E+ L S+++ N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 362 LVPLLGFCM--AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP--RRLKIAIGAARGF 417
+V G K + +++ GSL LL + P R+ I G
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQI--LEGL 114
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
A+LH N I+HR+I IL+D D K++DFG A+ + I+T T G +
Sbjct: 115 AYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT--GSVRGTPYW 169
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERP-TNVAKA-PETFKGNLVEWI----AQL 531
+APE R D++S G ++E+ TG+ P + + +K L
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL 229
Query: 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPT 575
S + +D + KCL D PK+RPT
Sbjct: 230 SE--EAKDFLRKCLR---RD------------------PKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVAEMATLGSVKNRNLVP 364
F IG G G +YKA G + +K ++ +S+ +++ + E+ L K+ N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLK------IAIGAARGFA 418
G + K E +V + GSL DLL + L + +G
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK---------STNQTLTESQIAYVCKELLKGLE 112
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+LH N IIHR+I + ILL D E K+ DFGL+ ++ +T V G ++
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMV----GTPYWM 164
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERP 510
APE K D++S G +EL G+ P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 56/195 (28%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+G+G+ G +++ L + T + VK L+ K+F+AE + +++ L+ L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH-HNCNPRIIHR 431
+ +V + M GSL + L G+++ P+ + +A A G A+L N IHR
Sbjct: 74 EPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQN----YIHR 127
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK 491
+++++ +L+ ++ K++DFGLAR+ I + G + + APE A + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARV---IKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 492 GDVYSFGTVLLELVT 506
DV+SFG +L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 19/195 (9%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
IG G G + G + VK L+D + + F+AE + + ++++ NLV LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSV-DWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
+V ++M GSL D L G++V ++L A+ G +L +HR
Sbjct: 73 NPLYIVTEYMAKGSLVDYLR---SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL--GYVAPEYARTLVAT 489
+++++ +L+ +D K+SDFGLA+ + G L + APE R +
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 490 PKGDVYSFGTVLLEL 504
K DV+SFG +L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
S +G+G+ G ++ T + VK L+ S + F+ E + +++ LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L C ++ +V ++M GSL D L GK + P+ + +A A G A+L
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLESR- 122
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
IHR+++++ IL+ ++ KI+DFGLARL+ D + +F + + APE A
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAREGAKF-PIKWTAPEAAN 177
Query: 485 TLVATPKGDVYSFGTVLLELVT 506
T K DV+SFG +L E+VT
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 311 NIIGSGRTGTMYKALLE---DGTSLMV--KRLQDSQ--RSEKEFVAEMATLGSVKNRNLV 363
+G G G + + D T V K L S + +F E+ L ++ + N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 364 PLLGFCMAKKER--LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
G C R L+ +++P+GSL D L D ++ R L + +G +L
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLG 126
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
+ R IHR+++++ IL++ + KISDFGLA+++ + GE Y APE
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERPT 511
RT + DV+SFG L EL T P+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPL 365
F+ +GSG G +++ L ++ + +K L D +++F E+ L +++++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
C + ++ + M GSL L + G+ + + +A A G A+L
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLM-NPIDTHLSTFVNGEFGDLGYVAPEYAR 484
IHR+++++ IL+ +D K++DFGLARL+ + + + APE A
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-----PYKWTAPEAAS 177
Query: 485 TLVATPKGDVYSFGTVLLELVT 506
+ K DV+SFG +L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 91.7 bits (226), Expect = 7e-20
Identities = 76/311 (24%), Positives = 113/311 (36%), Gaps = 22/311 (7%)
Query: 313 IGSGRTGTMYKALLEDGTSL--MVKRLQDSQRSEKEFVAEMATLGSVK-NRNLVPLLGFC 369
+G G G +Y A +L + K+L+ + + F+ E+ L S+ N+V L F
Sbjct: 8 LGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ LV +++ GSL DLL + L I +LH II
Sbjct: 68 QDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALEYLHSK---GII 123
Query: 430 HRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLST--FVNGEFGDLGYVAPEYARTL 486
HR+I + ILLD D K+ DFGLA+L+ + S + G GY+APE L
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 487 V---ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543
A+ D++S G L EL+TG P K ++ I +L +
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ-TLKIILELPTPSLASPLSPS 242
Query: 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSD 603
LK L PK R + + D L
Sbjct: 243 NPELI--SKAASDLLKKL----LAKDPKNRLSSSSD--LSHDLLAHLKLKESDLSDLLKP 294
Query: 604 SGDADILEELI 614
A + L
Sbjct: 295 DDSAPLRLSLP 305
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 311 NIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
+ +G G+ G +Y+ + + ++ VK L++ +EF+ E A + +K+ NLV LLG C
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ ++ + M G+L D L + V+ L +A + +L I
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQ--EVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 430 HRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
HR+++++ L+ ++ K++DFGL+RLM DT+ T G + + APE +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY--TAHAGAKFPIKWTAPESLAYNKFS 183
Query: 490 PKGDVYSFGTVLLELVT 506
K DV++FG +L E+ T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 36/281 (12%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQ--DSQRSEKEFVAEMATLGSVKNRN 361
+ + ++G G +G +YK G +K++ + K+ + E+ TL S ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 362 LVPLLG-FCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--KIAIGAARGF 417
+V G F K+ + +V ++M GSL DLL K P + IA +G
Sbjct: 61 VVKCYGAFY--KEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGL 112
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+LH IIHR+I +L++ E KI+DFG+++++ +TFV G + Y
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTY 166
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537
++PE + + D++S G LLE G+ P P F L++ I
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF--ELMQAICD------- 217
Query: 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFE 578
L A+ E F+ C+ PK+RP+ E
Sbjct: 218 GPPPS--LPAEEFSPEFRDFISA---CLQKD-PKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 287 LFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEK 345
+ EK + + + D K F K IG G +GT+Y A+ + G + +K++ Q+ +K
Sbjct: 4 ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60
Query: 346 EFVA-EMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP 404
E + E+ + KN N+V L + E +V +++ GSL D++ T +D
Sbjct: 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEG 115
Query: 405 RRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464
+ + + +LH N ++IHR+I S ILL D K++DFG + P +
Sbjct: 116 QIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
ST V + ++APE PK D++S G + +E+V GE P
Sbjct: 173 STMVGTPY----WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 57/215 (26%), Positives = 115/215 (53%), Gaps = 18/215 (8%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQD--SQRSEKEFVAEMATLGSVK 358
+ +K +IG+G G +++ +L+ ++ +K L+ +++ ++F++E + +G
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
+ N++ L G K +++ ++M NG+L L D S L+ G A G
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMK 121
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM--NPIDTHLSTFVNGEFGDLG 476
+L + +HR+++++ IL++ + E K+SDFGL+R++ +P T+ ++ G +
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS---GGKIPIR 175
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ APE T DV+SFG V+ E+++ GERP
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 75/255 (29%), Positives = 113/255 (44%), Gaps = 33/255 (12%)
Query: 311 NIIGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSE-KEFVAEMATLGSVKNRNLVPLL 366
N IG G G +Y A+ L+ G + VK R+QD+ KE EM L +K+ NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 367 GFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
G + +++ + ++ G+L +LL G+ +D + G A+LH +
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I+HR+I I LD + K+ DFG A + T + V G Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 487 VATPKG---DVYSFGTVLLELVTGERP----TNV--------AKAPETFKGNLVEWIAQL 531
G D++S G V+LE+ TG+RP N A +L QL
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL-----QL 233
Query: 532 SSTGQLQDAIDKCLV 546
S G +D +D+CL
Sbjct: 234 SPEG--KDFLDRCLE 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+G+G+ G ++ T + VK L+ S + F+ E + +++ LV L +++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVSE 72
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
+ +V ++M GSL D L D G+++ P + +A A G A++ IHR+
Sbjct: 73 EPIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRD 127
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
+ S IL+ D KI+DFGLARL I+ + T G + + APE A T K
Sbjct: 128 LRSANILVGDGLVCKIADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 493 DVYSFGTVLLELVTGER 509
DV+SFG +L ELVT R
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRL----QDSQRSEKEFVAEMATLGS 356
+ + +IG G G + + L + + +K L D QR + F+ E + +G
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQ 61
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ N++ L G + +++ ++M NGSL L D + + + G A G
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASG 118
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+L +HR+++++ IL++ + K+SDFGL+R + + +T G +
Sbjct: 119 MKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KGGKIPIR 173
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ APE T DV+SFG V+ E+++ GERP
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 17/223 (7%)
Query: 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSL----MVKRLQD--SQRSEKEFVAEMATLGS 356
K ++GSG GT++K + + +G S+ +K +QD +++ +E M +GS
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ + +V LLG C +L V + P GSL D + D S+D R L + A+G
Sbjct: 66 LDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKG 121
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+L + ++HRN++++ ILL D +I+DFG+A L+ P D F + +
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY--FYSEHKTPIK 176
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPE 518
++A E T + DV+S+G + E+++ G P + E
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+G G G ++ T + +K L+ + F+ E + +++ LVPL +++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVSE 72
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
+ +V + M GSL D L D GK + P+ + +A A G A++ IHR+
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRD 127
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
+ + IL+ D+ KI+DFGLARL I+ + T G + + APE A T K
Sbjct: 128 LRAANILVGDNLVCKIADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 493 DVYSFGTVLLELVTGER 509
DV+SFG +L ELVT R
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 4e-17
Identities = 77/287 (26%), Positives = 133/287 (46%), Gaps = 27/287 (9%)
Query: 287 LFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEK 345
+ EK + + + D K F K IG G +GT+Y A+ + G + ++++ Q+ +K
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 346 EFVA-EMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP 404
E + E+ + KN N+V L + E +V +++ GSL D++ T +D
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEG 116
Query: 405 RRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464
+ + + +LH N ++IHR+I S ILL D K++DFG + P +
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP---TNVAKAPETFK 521
ST V + ++APE PK D++S G + +E++ GE P N +A
Sbjct: 174 STMVGTPY----WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 522 GNLVEWIAQLSSTGQL-QDAIDKCL----VAKGVDNELF--QFLKVA 561
N + + +D +++CL +G EL QFLK+A
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 27/287 (9%)
Query: 287 LFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEK 345
+ EK T + + D K F K IG G +GT+Y A+ + G + +K++ Q+ +K
Sbjct: 4 ILEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK 60
Query: 346 EFVA-EMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP 404
E + E+ + K+ N+V L + E +V +++ GSL D++ T +D
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEG 115
Query: 405 RRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464
+ + + +LH N ++IHR+I S ILL D K++DFG + P +
Sbjct: 116 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP---TNVAKAPETFK 521
ST V + ++APE PK D++S G + +E+V GE P N +A
Sbjct: 173 STMVGTPY----WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 522 GNLVEWIAQLSS-TGQLQDAIDKCLVA----KGVDNELFQ--FLKVA 561
N + + +D +++CL +G EL Q FLK+A
Sbjct: 229 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 35/280 (12%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+G+G+ G ++ T + +K L+ S + F+AE + +++ LV L + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVVT 71
Query: 373 KERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
+E + ++ ++M NGSL D L G + + + +A A G A++ IHR
Sbjct: 72 QEPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK 491
++ + IL+ + KI+DFGLARL I+ + T G + + APE T K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 492 GDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGV 550
DV+SFG +L E+VT G P PE + NL G D C
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-NL--------ERGYRMPRPDNC------ 228
Query: 551 DNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590
EL++ ++ C P+ERPT +++LR++ E +
Sbjct: 229 PEELYELMR---LCWKEK-PEERPT----FEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+G+G+ G ++ + T + VK L+ S + F+ E + ++++ LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
+ ++ ++M GSL D L D G V P+ + + A G A++ IHR+
Sbjct: 74 EPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRD 128
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
+ + +L+ + KI+DFGLAR+ I+ + T G + + APE T K
Sbjct: 129 LRAANVLVSESLMCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 493 DVYSFGTVLLELVT 506
DV+SFG +L E+VT
Sbjct: 186 DVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ---DSQRSEKEFVAEMATLGSVKNRNL 362
+ ++IG G G +YK L LE G + +K++ + + K + E+ L ++K+ N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA---RGFAW 419
V +G ++ ++ NGSL ++ +S+ +A+ +G A+
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAY 114
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
LH +IHR+I + IL D K++DFG+A +N + ++ V G ++A
Sbjct: 115 LH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV----GTPYWMA 167
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERP 510
PE A+ D++S G ++EL+TG P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 287 LFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEK 345
+ EK T + + D K + K IG G +GT++ A+ + G + +K++ ++ +K
Sbjct: 4 IMEKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60
Query: 346 EFVA-EMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP 404
E + E+ + +KN N+V L + E +V +++ GSL D++ T +D
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEA 115
Query: 405 RRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464
+ + + +LH N ++IHR+I S +LL D K++DFG + P +
Sbjct: 116 QIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
ST V + ++APE PK D++S G + +E+V GE P
Sbjct: 173 STMVGTPY----WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
IG G G +YK +L+ T + VK R +++F+ E L + N+V L+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRR--LKIAIGAARGFAWLH-HNCNPR 427
K+ +V + +P GSL L K + L++++ AA G +L NC
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR-----KKKNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF-VNGEFGDL--GYVAPEYAR 484
IHR+++++ L+ ++ KISDFG++R + + V+ + + APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 485 TLVATPKGDVYSFGTVLLELVTG 507
T + DV+S+G +L E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 68/252 (26%), Positives = 108/252 (42%), Gaps = 29/252 (11%)
Query: 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKR--LQDSQRSEK-EFVAEMATLGSVKNRNL 362
F N IG G G ++K + + D +K+ L R E+ E + E L + + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVD--WPRRLKIAIGAARGFAWL 420
+ + K + +V ++ NG L+ LL D W + I G A L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHL 117
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
H +I+HR+I S + LD KI D G+A+L++ + F N G Y++P
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD----NTNFANTIVGTPYYLSP 170
Query: 481 EYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQ-----LSS-- 533
E K DV++ G VL E TG+ P + +G L+ I + +S
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QGALILKIIRGVFPPVSQMY 225
Query: 534 TGQLQDAIDKCL 545
+ QL ID+CL
Sbjct: 226 SQQLAQLIDQCL 237
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 42/270 (15%)
Query: 334 VKRLQDSQRSEKE---FVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYD 389
VK L+D +EK+ V+EM + + K++N++ LLG C + +V ++ +G+L D
Sbjct: 47 VKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD 105
Query: 390 LLH----PADDTGKSVDWPRRLKI--------AIGAARGFAWLHHNCNPRIIHRNISSKC 437
L P + P + A ARG +L + + IHR+++++
Sbjct: 106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARN 162
Query: 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSF 497
+L+ +D KI+DFGLAR ++ ID + T NG + ++APE V T + DV+SF
Sbjct: 163 VLVTEDHVMKIADFGLARDIHHIDYYRKT-TNGRL-PVKWMAPEALFDRVYTHQSDVWSF 220
Query: 498 GTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQ 556
G +L E+ T G P E FK L E G + C EL+
Sbjct: 221 GVLLWEIFTLGGSPYPGIPVEELFK-LLKE--------GYRMEKPQNC------TQELYH 265
Query: 557 FLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ +C +P +RPT ++ + L +
Sbjct: 266 LM---RDC-WHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 49/199 (24%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
IGSG+ G ++ + + +K +++ SE++F+ E + + + LV L G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
LV++ M +G L D L L + + G A+L + +IHR+
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
++++ L+ ++ K+SDFG+ R + +D ++ +F + + +PE + K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKF-PVKWSSPEVFSFSKYSSKS 182
Query: 493 DVYSFGTVLLELVT-GERP 510
DV+SFG ++ E+ + G+ P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 313 IGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVP 364
+G G G +YK L TS+ +K L+++ + ++EF E + +++ N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLL---HPADD---------TGKSVDWPRRLKIAIG 412
LLG C ++ ++++++ +G L++ L P D S+D L IAI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 413 AARGFAWL--HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNG 470
A G +L HH +HR+++++ L+ + KISDFGL+R + D + +
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY--RVQSK 185
Query: 471 EFGDLGYVAPEYARTLVATPKGDVYSFGTVLLEL 504
+ ++ PE T + D++SFG VL E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 49/140 (35%), Positives = 73/140 (52%), Gaps = 26/140 (18%)
Query: 84 NLRLTDMG---LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKL------------- 127
+L++ D+G L G+ P + N +S+ L L+SN+L G +P ++ ++
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 128 -------VGFLTSL---DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLG 177
+G LTSL DL NN +G IPS+L N L L L N+ SG IPP + L
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 178 RLKSFSVANNLLSGSIPTFV 197
+L S +++N LSG IP V
Sbjct: 285 KLISLDLSDNSLSGEIPELV 304
|
Length = 968 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 64/250 (25%), Positives = 115/250 (46%), Gaps = 12/250 (4%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+G+G+ G ++ A T + VK ++ S + F+AE + ++++ LV L + K
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 72
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
+ ++ + M GSL D L D G P+ + + A G A++ IHR+
Sbjct: 73 EPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 127
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
+ + IL+ KI+DFGLAR+ I+ + T G + + APE T K
Sbjct: 128 LRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 493 DVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSST--GQLQDAIDKCLVAKG 549
DV+SFG +L+E+VT G P PE + + +L + + +C +
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244
Query: 550 VDNELFQFLK 559
+ F++++
Sbjct: 245 EERPTFEYIQ 254
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 26/246 (10%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE--KEFVAEMATLGSVKNRNLVPLLGFC 369
+G+G +G + K L G + VK ++ K+ + E+ L + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--KIAIGAARGFAWLHHNCNPR 427
+ + ++M GSL +L P R+ KIA+ +G +LH
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGR-----IPERILGKIAVAVLKGLTYLHEKHK-- 121
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
IIHR++ IL++ + K+ DFG++ + +++ TFV G Y+APE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV----GTSSYMAPERIQGND 175
Query: 488 ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQ-----LSS---TGQLQD 539
+ K D++S G L+EL TG P P L+++I L S + QD
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235
Query: 540 AIDKCL 545
++ CL
Sbjct: 236 FVNLCL 241
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+G G G ++ T + +K L+ S + F+ E + +++ LV L +++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 72
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
+ +V ++M GSL D L + GK + P+ + +A A G A++ +HR+
Sbjct: 73 EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRD 127
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
+ + IL+ ++ K++DFGLARL I+ + T G + + APE A T K
Sbjct: 128 LRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 493 DVYSFGTVLLELVTGER 509
DV+SFG +L EL T R
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSL--MVKRLQD--SQRSEKEFVAEMATLGSV-K 358
N ++IG G G + KA + +DG + +KR+++ S+ ++F E+ L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHP------------ADDTGKSVDWPRR 406
+ N++ LLG C + L ++ P+G+L D L A+ T ++ +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 407 LKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466
L A ARG +L + IHR+++++ IL+ +++ KI+DFGL+R
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EV 176
Query: 467 FVNGEFGDLG--YVAPEYARTLVATPKGDVYSFGTVLLELVT 506
+V G L ++A E V T DV+S+G +L E+V+
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 24/230 (10%)
Query: 300 LMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSL----MVKRLQD--SQRSEKEFVAEMA 352
++K T F K ++GSG GT+YK L + +G + +K L++ S ++ KE + E
Sbjct: 3 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 353 TLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKS---VDWPRRLKI 409
+ SV N ++ LLG C+ +L + + MP G L D + D S ++W
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 114
Query: 410 AIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVN 469
+ A+G +L R++HR+++++ +L+ KI+DFGLA+L+ +
Sbjct: 115 CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA--E 169
Query: 470 GEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPE 518
G + ++A E + T + DV+S+G + EL+T G +P + A E
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 40/276 (14%)
Query: 327 EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMP 383
++ ++ VK L+D +++ + V+EM + + K++N++ LLG C ++ ++
Sbjct: 45 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 104
Query: 384 NGSLYDLLHP--------ADDTGKSVDWPRRLKIAIGA----ARGFAWLHHNCNPRIIHR 431
G+L + L + D + D K + ARG +L + + IHR
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHR 161
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK 491
+++++ +L+ ++ KI+DFGLAR +N ID + T NG + ++APE V T +
Sbjct: 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT-TNGRL-PVKWMAPEALFDRVYTHQ 219
Query: 492 GDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGV 550
DV+SFG ++ E+ T G P + G VE + +L G D C
Sbjct: 220 SDVWSFGVLMWEIFTLGGSP---------YPGIPVEELFKLLKEGHRMDKPANC------ 264
Query: 551 DNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
NEL+ ++ +C IP RPT ++ + L I
Sbjct: 265 TNELYMMMR---DC-WHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 66/227 (29%), Positives = 113/227 (49%), Gaps = 18/227 (7%)
Query: 300 LMKATNSFSKNNIIGSGRTGTMYKAL-LEDG------TSLMVKRLQDSQRSEKEFVAEMA 352
++K T K ++GSG GT+YK + + DG ++ V R S ++ KE + E
Sbjct: 3 ILKET-ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 353 TLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIG 412
+ V + + LLG C+ +L V + MP G L D + D S D L +
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL---LNWCVQ 117
Query: 413 AARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
A+G ++L R++HR+++++ +L+ KI+DFGLARL++ +T +G
Sbjct: 118 IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA--DGGK 172
Query: 473 GDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPE 518
+ ++A E T + DV+S+G + EL+T G +P + A E
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 55/180 (30%), Positives = 84/180 (46%), Gaps = 10/180 (5%)
Query: 334 VKRLQDSQRSE--KEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL 391
VK L+ + S+ +F+ E A + S+ + NL+ L G + ++V + P GSL D L
Sbjct: 28 VKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRL 86
Query: 392 HPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451
D A+ A G +L R IHR+++++ ILL D + KI DF
Sbjct: 87 R--KDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDF 141
Query: 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
GL R + + H + + + APE RT + DV+ FG L E+ T GE P
Sbjct: 142 GLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 73/274 (26%), Positives = 131/274 (47%), Gaps = 42/274 (15%)
Query: 330 TSLMVKRLQDSQRSEKEF---VAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPNG 385
T + VK L+ S +EK+ ++EM + + K++N++ LLG C ++ ++ G
Sbjct: 51 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 386 SLYDLL------------HPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNI 433
+L + L +P + + + + A ARG +L + + IHR++
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDL 166
Query: 434 SSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGD 493
+++ +L+ +D KI+DFGLAR ++ ID + T NG + ++APE + T + D
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKT-TNGRL-PVKWMAPEALFDRIYTHQSD 224
Query: 494 VYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDN 552
V+SFG +L E+ T G P + G VE + +L G D C N
Sbjct: 225 VWSFGVLLWEIFTLGGSP---------YPGVPVEELFKLLKEGHRMDKPSNC------TN 269
Query: 553 ELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
EL+ ++ +C +P +RPT ++ + L I
Sbjct: 270 ELYMMMR---DC-WHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 313 IGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVP 364
+G G G +Y+ L E T + +K + + S R EF+ E + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLH---PADDTGKSVDWPRRLKI---AIGAARGFA 418
LLG + L+V + M G L L P + + P K A A G A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG-- 476
+L + +HR+++++ ++ +D KI DFG+ R + D + G G L
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY----YRKGGKGLLPVR 186
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
++APE + V T K DV+SFG VL E+ T E+P
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/210 (28%), Positives = 112/210 (53%), Gaps = 23/210 (10%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSL----MVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVP 364
++GSG GT+YK + + +G ++ +K L ++ ++ EF+ E + S+ + +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKS---VDWPRRLKIAIGAARGFAWLH 421
LLG C++ +L V + MP+G L D +H D S ++W + A+G +L
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
R++HR+++++ +L+ KI+DFGLARL+ + + +G + ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALE 181
Query: 482 YARTLVATPKGDVYSFGTVLLELVT-GERP 510
T + DV+S+G + EL+T G +P
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 68/285 (23%), Positives = 117/285 (41%), Gaps = 43/285 (15%)
Query: 313 IGSGRTGTMYKA--LLEDGTSLMV--KRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLL 366
+G G G++ K L++ G + V K L+ +KEF+ E + + + + +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 367 GFCMAKKERLLVYKHMPNGSLYDLL--HPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
G C + +LV + P G L L + A A G A+L
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK- 114
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE--Y 482
+HR+++++ +LL + + KISDFG++R + + G + L + APE
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW-PLKWYAPECIN 171
Query: 483 ARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541
+ K DV+S+G L E + G +P K E IA L S +L
Sbjct: 172 YGKF--SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--------IAMLESGERL-PRP 220
Query: 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
++C E++ + P++RPT E+ R
Sbjct: 221 EEC------PQEIYSIM----LSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 67/261 (25%), Positives = 121/261 (46%), Gaps = 38/261 (14%)
Query: 330 TSLMVKRLQD--SQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPNGS 386
++ VK L+D + + + V+EM + + K++N++ LLG C ++ ++ G+
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 387 LYDLLHPADDTG------------KSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNIS 434
L + L G + + + + A ARG +L + + IHR+++
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161
Query: 435 SKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDV 494
++ +L+ +D KI+DFGLAR ++ ID + T NG + ++APE V T + DV
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKT-TNGRL-PVKWMAPEALFDRVYTHQSDV 219
Query: 495 YSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNEL 554
+SFG +L E+ T + G VE + +L G D C +EL
Sbjct: 220 WSFGVLLWEIFT--------LGGSPYPGIPVEELFKLLKEGHRMDKPANC------THEL 265
Query: 555 FQFLKVACNCVLPTIPKERPT 575
+ ++ + V P +RPT
Sbjct: 266 YMIMRECWHAV----PSQRPT 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 326 LEDGTS--LMVKRLQDSQRSE-KEFVAEMATLGSVKNRNLVPLLGFC--MAKKERLLVYK 380
L+D T + VK+LQ S ++F E+ L S+++ N+V G C ++ LV +
Sbjct: 28 LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87
Query: 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440
++P GSL D L + +D + L A +G +L + R +HR+++++ IL+
Sbjct: 88 YLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILV 141
Query: 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTV 500
+ + KI DFGL +++ P D + + APE + DV+SFG V
Sbjct: 142 ESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200
Query: 501 LLELVT 506
L EL T
Sbjct: 201 LYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 312 IIGSGRTGTMYKALL--EDGTSL-----MVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
I+G G G++ + L +DG+ L +K + +EF++E A + + N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 365 LLGFCMAKKER------LLVYKHMPNGSLYDLLHPADDTGKSVDWPRR--LKIAIGAARG 416
L+G C +++ M +G L+ L + G P + LK + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID----THLSTFVNGEF 472
+L N IHR+++++ +L +D ++DFGL++ + D ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM----- 177
Query: 473 GDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ ++A E V T K DV++FG + E+ T G+ P
Sbjct: 178 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 41/283 (14%)
Query: 313 IGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVP 364
+G G G +Y+ + E T + +K + + S R EF+ E + + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHP--ADDTGKSVDWPRRLK----IAIGAARGFA 418
LLG + L++ + M G L L + V P LK +A A G A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG-- 476
+L+ N + +HR+++++ ++ +DF KI DFG+ R + D + G G L
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVR 186
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536
+++PE + V T DV+SFG VL E+ T +A+ P ++G E + + G
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQP--YQGMSNEQVLRFVMEGG 238
Query: 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEV 579
L D D C + LF+ +++ PK RP+ E+
Sbjct: 239 LLDKPDNC------PDMLFELMRMCWQ----YNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+G+G+ G + + +K +++ SE EF+ E + + + LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
+ +V ++M NG L + L + GK + L++ G A+L + + IHR+
Sbjct: 72 RPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
++++ L+DD K+SDFGL+R + +D ++ V +F + + PE + K
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKF-PVRWSPPEVLLYSKFSSKS 182
Query: 493 DVYSFGTVLLELVT-GERP 510
DV++FG ++ E+ + G+ P
Sbjct: 183 DVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 30/216 (13%)
Query: 311 NIIGSGRTGTMYKALLE-DGTSL--MVKRLQD--SQRSEKEFVAEMATLGSV-KNRNLVP 364
++IG G G + +A+++ DG + +K L++ S+ ++F E+ L + + N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLH--------PA----DDTGKSVDWPRRLKIAIG 412
LLG C + + ++ P G+L D L PA T ++ + L+ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 413 AARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
A G + + + IHR+++++ +L+ ++ KI+DFGL+R +V
Sbjct: 128 VATG---MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKTM 177
Query: 473 GDLG--YVAPEYARTLVATPKGDVYSFGTVLLELVT 506
G L ++A E V T K DV+SFG +L E+V+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (178), Expect = 4e-14
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 68/293 (23%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKNRNLVPLLGF 368
IG G G +Y DG ++K + S SEKE + E+ L + + N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
K + +V ++ G L + GK + L + +LH +I
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KI 124
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE------Y 482
+HR+I + I L + K+ DFG++++++ T V G Y++PE Y
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV----GTPYYLSPELCQNKPY 180
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN----LVEWI---------A 529
K D++S G VL EL T + P F+G L I +
Sbjct: 181 ------NYKSDIWSLGCVLYELCTLKHP---------FEGENLLELALKILKGQYPPIPS 225
Query: 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582
Q SS +L++ + L P+ERP++ ++ Q
Sbjct: 226 QYSS--ELRNLVSSLLQKD---------------------PEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 44/284 (15%)
Query: 327 EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMP 383
+ ++ VK L+D + + + ++EM + + K++N++ LLG C + ++ ++
Sbjct: 42 DQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAA 101
Query: 384 NGSLYDLLH----PADDTG--------KSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
G+L + L P D + + + + A ARG +L + R IHR
Sbjct: 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHR 158
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK 491
+++++ +L+ +D KI+DFGLAR ++ ID + T NG + ++APE V T +
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT-SNGRL-PVKWMAPEALFDRVYTHQ 216
Query: 492 GDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGV 550
DV+SFG ++ E+ T G P E FK L G D C
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYPGIPVEELFK---------LLREGHRMDKPSNC------ 261
Query: 551 DNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR----AIGERY 590
+EL+ ++ + V P +RPT ++ + L A+ E Y
Sbjct: 262 THELYMLMRECWHAV----PTQRPTFKQLVEALDKVLAAVSEEY 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 27/202 (13%)
Query: 312 IIGSGRTGTMYKALLEDGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
++G G G ++K L+D T + VK ++ Q + +F++E L + N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH-HNCNPRI 428
++ +V + +P G L D K+ + +K A+ AA G A+L NC
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKT---KQLVKFALDAAAGMAYLESKNC---- 114
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG-------YVAPE 481
IHR+++++ L+ ++ KISDFG++R + +G + G + APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED----------DGIYSSSGLKQIPIKWTAPE 164
Query: 482 YARTLVATPKGDVYSFGTVLLE 503
+ + DV+S+G +L E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 312 IIGSGRTGTMYKALLED--GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
IG G G + +L D G + VK +++ ++ F+AE + + +++ NLV LLG
Sbjct: 13 TIGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVI 68
Query: 370 MAKKERL-LVYKHMPNGSLYDLLHPADDTGKSV-DWPRRLKIAIGAARGFAWLHHNCNPR 427
+ +K L +V ++M GSL D L G+SV LK ++ +L N
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
+HR+++++ +L+ +D K+SDFGL + + V + APE R
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKK 175
Query: 488 ATPKGDVYSFGTVLLEL 504
+ K DV+SFG +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 16/213 (7%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQ----DSQRSEKEFVA---EMATLGSVKN 359
++K ++G G GT+Y L G + VK+++ + +EKE+ E+ L S+K+
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
N+V LG C+ + + +P GS+ +L + G + P K G A+
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPE-PVFCKYTKQILDGVAY 117
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL--STFVNGEFGDLGY 477
LH+NC ++HR+I ++L + K+ DFG AR + + H S + G +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
+APE K D++S G + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 23/223 (10%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+GSG+ G ++ + +K +++ SE +F+ E + + + NLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
+ +V ++M NG L + L + +W L + +L N IHR+
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKGKLGT-EW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE---YARTLVAT 489
++++ L+ +D K+SDFGLAR + +D ++ +F + + PE Y+R +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKF-PVKWAPPEVFDYSRF---S 179
Query: 490 PKGDVYSFGTVLLELVTGERPTNVAKAP-ETFK-GNLVEWIAQ 530
K DV+SFG ++ E+ + K P E F +VE ++
Sbjct: 180 SKSDVWSFGVLMWEVFSE------GKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 30/216 (13%)
Query: 311 NIIGSGRTGTMYKALLE-DGTSL--MVKRLQD--SQRSEKEFVAEMATLGSVKNR-NLVP 364
++IG G G + KA ++ DG + +KR+++ S+ ++F E+ L + + N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLH--------PA----DDTGKSVDWPRRLKIAIG 412
LLG C + L ++ P+G+L D L PA + T ++ + L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 413 AARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
ARG +L + IHR+++++ IL+ +++ KI+DFGL+R +V
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTM 170
Query: 473 GDLG--YVAPEYARTLVATPKGDVYSFGTVLLELVT 506
G L ++A E V T DV+S+G +L E+V+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 312 IIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
IIG G G + + G + VK ++ + + F+ E A + + ++NLV LLG +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL- 69
Query: 372 KKERLLVYKHMPNGSLYDLLHPADDTGKS-VDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
+V + M G+L + L G++ V + L+ ++ A G +L + +++H
Sbjct: 70 HNGLYIVMELMSKGNLVNFLR---TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123
Query: 431 RNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATP 490
R+++++ IL+ +D K+SDFGLAR + + S + + APE + +
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKL------PVKWTAPEALKHKKFSS 176
Query: 491 KGDVYSFGTVLLELVT-GERP 510
K DV+S+G +L E+ + G P
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 79/300 (26%), Positives = 136/300 (45%), Gaps = 56/300 (18%)
Query: 311 NIIGSGRTGTMY----KALLEDGTS---LMVKRLQDSQRSE--KEFVAEMATLGSVKNRN 361
N +GSG G +Y +L G+ + VK L+ + KEF+ E + + + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL------KIAIGAAR 415
+V LLG C+ + + ++ + M G DLL D P L I + A+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 416 GFAWLHHNCNPRIIHRNISSK-CILLDDDFEP----KISDFGLARLMNPIDTHLSTF--V 468
G +L IHR+++++ C++ + ++ KI DFGLAR D + S +
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRK 169
Query: 469 NGEFGDLG--YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525
GE G L ++APE T + DV+SFG ++ E++T G++P N
Sbjct: 170 EGE-GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--------NNQ 220
Query: 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585
E + +++ G+LQ + C ++++Q + NC P ERPT + + L+
Sbjct: 221 EVLQHVTAGGRLQKP-ENC------PDKIYQLMT---NC-WAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 51/277 (18%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
IG G +G +YKA G + +K+++ +++++ + E+ + K+ N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDW-PRRLKIAIGAA------RGFAWLHHNC 424
E +V ++M GSL D+ + R+ A +G +LH
Sbjct: 87 GDELWVVMEYMDGGSLTDI----------ITQNFVRMNEPQIAYVCREVLQGLEYLHSQ- 135
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+IHR+I S ILL D K++DFG A + + ++ V G ++APE +
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV----GTPYWMAPEVIK 189
Query: 485 TLVATPKGDVYSFGTVLLELVTGERP-----------TNVAKAPETFKGNLVEWIAQLSS 533
PK D++S G + +E+ GE P K K + S
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKN-----PEKWSP 244
Query: 534 TGQLQDAIDKCLVAKGVDN-----ELFQ--FLKVACN 563
+ +D ++KCLV K + EL Q FLK AC
Sbjct: 245 --EFKDFLNKCLV-KDPEKRPSAEELLQHPFLKKACP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-13
Identities = 49/131 (37%), Positives = 64/131 (48%), Gaps = 10/131 (7%)
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
L G P + N ++ L L NKL GP+P I L L SLDLS N+ SG IP +
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK-LISLDLSDNSLSGEIPELVIQ 306
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-------TFVNLTLSAD 204
L L L N F+G+IP L L RL+ + +N SG IP L LS +
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 205 SVTNN--QGLC 213
++T +GLC
Sbjct: 367 NLTGEIPEGLC 377
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 309 KNNIIGSGRTGTMYKAL-LEDGTSLMVKRL--QDSQRSEKEFVA-----EMATLGSVKNR 360
K +G+G + Y+A ++ GT + VK++ + SE+E V E+ + + +
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
+++ +LG L + M GS+ LL ++V ++ RG ++L
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYL 119
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEP-KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
H N +IIHR++ +L+D + +I+DFG A + T F G + ++A
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERPTN 512
PE R DV+S G V++E+ T + P N
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-13
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 78 DENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKL--VGFLTSLD 135
+ L L L+G+ P+ + C S+ + L N G LP + +KL V FL D
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL---D 434
Query: 136 LSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195
+S+NN G I S + L L L N+F G +P G RL++ ++ N SG++P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPR 493
Query: 196 -------FVNLTLSADSVTNNQGLCGEPLDACK 221
+ L LS + ++ G + L +CK
Sbjct: 494 KLGSLSELMQLKLSENKLS---GEIPDELSSCK 523
|
Length = 968 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 45/293 (15%)
Query: 312 IIGSGRTGTMYKA-----LLEDGTSL-MVKRLQ--DSQRSEKEFVAEMATLGSVKNRNLV 363
+G G G ++ A E G +L +VK LQ + + EF E+ + ++N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLL---HPADDTGKS--VDWPRRLKIAIGAARGFA 418
LLG C + ++ ++ G L L D+ K + +++ + A G
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG-- 129
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF--VNGEFGDLG 476
+ H N R +HR+++++ L+ E K+S L++ D + S + + L
Sbjct: 130 -MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-----DVYNSEYYKLRNALIPLR 183
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTG 535
++APE + + K DV+SFG ++ E+ T GE P F G LS
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP---------FYG--------LSDEE 226
Query: 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588
L L + + K+ C PK+RP+ E+ + A+GE
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVN-PKDRPSFSEL---VSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 42/232 (18%)
Query: 307 FSKNNI-----IGSGRTGTMYKA----LL--EDGTSLMVKRLQD--SQRSEKEFVAEMAT 353
+ +NNI IG G G +++A LL E T + VK L++ S + +F E A
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 354 LGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL--------HPADDTGKSV---- 401
+ + N+V LLG C K L++++M G L + L + S
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 402 ------DWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455
+L IA A G A+L + +HR+++++ L+ ++ KI+DFGL+R
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 456 LMNPIDTHLSTFVNGEFGDLGYVAPE---YARTLVATPKGDVYSFGTVLLEL 504
+ D + ++ + + ++ PE Y R T + DV+++G VL E+
Sbjct: 179 NIYSADYYKAS--ENDAIPIRWMPPESIFYNRY---TTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 12/208 (5%)
Query: 311 NIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKNRNLVPLL 366
IG G GT+ K DG L+ K + +EKE V+E+ L +K+ N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 367 G--FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-- 422
+ + +V ++ G L L+ K ++ +I H+
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY 482
+ ++HR++ I LD + K+ DFGLA+++ + T+V G Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV----GTPYYMSPEQ 181
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERP 510
+ K D++S G ++ EL P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 51/208 (24%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 312 IIGSGRTGTMYKALLE----DGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVPL 365
+IG+G G + + L+ + +K L+ +++ ++F++E + +G + N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
G + +++ + M NG+L L D + L+ G A G +L
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---SE 124
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLM--NPIDTHLSTFVNGEFGDLGYVAPEYA 483
+HR+++++ IL++ + K+SDFGL+R + + D ++ + G+ + + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI-PIRWTAPEAI 183
Query: 484 RTLVATPKGDVYSFGTVLLELVT-GERP 510
T DV+S+G V+ E+++ GERP
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRL------QDSQRSEKEFVAEMATLGSVK 358
+ K ++GSG G++Y+ L L+DG VK + Q Q + K+ E+A L ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 359 NRNLVPLLGFCMAKKERLLVY-KHMPNGSLYDLLHPADDTGKSV--DWPRRLKIAIGAAR 415
+ N+V LG +++ L ++ + +P GSL LL + V + R++
Sbjct: 61 HPNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LL 113
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G +LH +HR+I IL+D + K++DFG+A+ + S F +
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPY--- 166
Query: 476 GYVAPEYARTLVATPKG------DVYSFGTVLLELVTGERP 510
++APE V +G D++S G +LE+ TG+ P
Sbjct: 167 -WMAPE-----VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 41/118 (34%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L L G+ P + + + L L SNK G +P ++ K LT LDLS+NN +G
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN-LTVLDLSTNNLTGE 371
Query: 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT-FVNLTL 201
IP L + L L L N G+IP LG L+ + +N SG +P+ F L L
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 311 NIIGSGRTGTMYKAL-LEDGTSLMVKR--LQDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
+IG G T +Y A+ L + + +KR L+ Q S E E+ + + N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
+ E LV ++ GSL D++ + G +D + +G +LH N
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 428 IIHRNISSKCILLDDDFEPKISDFGL-ARLMNPID-THLS--TFVNGEFGDLGYVAPEYA 483
IHR+I + ILL +D KI+DFG+ A L + D T TFV G ++APE
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV----GTPCWMAPEVM 178
Query: 484 RTLVA-TPKGDVYSFGTVLLELVTGERP 510
+ K D++SFG +EL TG P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 50/230 (21%)
Query: 313 IGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVP 364
+G G G ++ D + VK L++ S + K+F E L + ++ N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRR----------LKIAIGAA 414
G C ++V+++M +G L L + P L+IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR-------------LMNPID 461
G +L + +HR+++++ L+ D KI DFG++R M PI
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
++ PE T + DV+SFG VL E+ T G++P
Sbjct: 190 ---------------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 309 KNNIIGSGRTGTMYKALLEDGTSLM-VKRLQDSQRSEKE----------FVAEMATLGSV 357
K +IGSG G++Y + LM VK+++ S E+A L +
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF 417
++ N+V LG + + +++P GS+ LL + + + +G
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGL 119
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM--NPIDTHLSTFVNGEFGDL 475
+LH N IIHR+I IL+D+ KISDFG+++ + N + T + G +
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 476 GYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
++APE + T K D++S G +++E++TG+ P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 6e-12
Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 45/240 (18%)
Query: 312 IIGSGRTGTMYKA-LLEDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLL 366
IIG G T+ A E +K L Q + K E L + + L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 367 GFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPR----RLKIAIGAARGFAWLH 421
+ +E L V ++ PNG L + R + +A+ +LH
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLAL------EYLH 119
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID-------------------- 461
IIHR++ + ILLD D KI+DFG A++++P
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521
++FV G YV+PE A D+++ G ++ +++TG+ P + TF+
Sbjct: 177 RRFASFV----GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEF---VAEMATLGSVKNRNLV 363
F+K IG G G +YK + ++ ++ D + +E E E+ L + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
G + + ++ +++ GS DLL P ++ I +G +LH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLH-- 118
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+ R IHR+I + +LL + + K++DFG+A + +TFV F ++APE
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF----WMAPEVI 173
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERP 510
+ K D++S G +EL GE P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 36/257 (14%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNR 360
F +G G G++YKA+ E G + +K + +D Q KE ++ L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSP 58
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
+V G + +V ++ GS+ D++ T K++ I +G +L
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYL 115
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
H N + IHR+I + ILL+++ + K++DFG++ + +T + F ++AP
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF----WMAP 168
Query: 481 EYARTLVATPKGDVYSFGTVLLELVTGE------RPTNV-----AKAPETFKGNLVEWIA 529
E + + K D++S G +E+ G+ P K P T + +W
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS-DPEKWSP 227
Query: 530 QLSSTGQLQDAIDKCLV 546
+ + D + KCLV
Sbjct: 228 EFN------DFVKKCLV 238
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 15/185 (8%)
Query: 328 DGTSLMV--KRLQ--DSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER--LLVYKH 381
DGT MV K L+ Q++ + E+ L ++ + N+V G C + + L+ ++
Sbjct: 30 DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89
Query: 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441
+P GSL D L P + + L A G A+LH + IHR+++++ +LLD
Sbjct: 90 VPLGSLRDYL-PKHKLNLA----QLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLD 141
Query: 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVL 501
+D KI DFGLA+ + + +G+ + + A E + + DV+SFG L
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGD-SPVFWYAVECLKENKFSYASDVWSFGVTL 200
Query: 502 LELVT 506
EL+T
Sbjct: 201 YELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEF---VAEMATLGSVKNRNLV 363
F+K IG G G ++K + ++ ++ D + +E E E+ L + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
G + + ++ +++ GS DLL P +D + I +G +LH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH-- 118
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+ + IHR+I + +LL + E K++DFG+A + +TFV F ++APE
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF----WMAPEVI 173
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERP 510
+ K D++S G +EL GE P
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 9e-12
Identities = 42/117 (35%), Positives = 60/117 (51%), Gaps = 2/117 (1%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L L++ L G+ P I + SS+ LDL N L G +P+ ++ L L L L+SN G
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTS-LEFLTLASNQLVGQ 203
Query: 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
IP L L + L +N SG+IP ++G L L + N L+G IP + NL
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260
|
Length = 968 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 41/288 (14%)
Query: 313 IGSGRTGTMYKALLED------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVP 364
+G G G +Y+ D T + VK + +S R EF+ E + + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLH-----PADDTGKSVDWPRRL-KIAIGAARGFA 418
LLG + L+V + M +G L L ++ G+ + + ++A A G A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL--G 476
+L+ + +HR+++++ ++ DF KI DFG+ R + D + G G L
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVR 186
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536
++APE + V T D++SFG VL E+ T++A+ P ++G E + + G
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI------TSLAEQP--YQGLSNEQVLKFVMDGG 238
Query: 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584
D D C E L C PK RPT E+ L+
Sbjct: 239 YLDQPDNC-------PERVTDLMRMC---WQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 313 IGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKNRNLVPLLGF 368
+G G G++YK L D +K + S+KE V E+ L SV + N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
+ + +V ++ P G L + K + +I I RG LH +I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA 488
+HR++ S ILL + KI D G+++++ + G Y+APE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLK------KNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 489 TPKGDVYSFGTVLLELVTGERPTN 512
+ K D++S G +L E+ T P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 47/172 (27%), Positives = 89/172 (51%), Gaps = 8/172 (4%)
Query: 340 SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGK 399
+++ ++F++E + +G + N++ L G K ++V ++M NGSL L D
Sbjct: 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT 104
Query: 400 SVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459
+ L+ G A G +L + +HR+++++ IL++ + K+SDFGL+R++
Sbjct: 105 VIQLVGMLR---GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158
Query: 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
T G+ + + APE T DV+S+G V+ E+++ GERP
Sbjct: 159 DPEAAYTTRGGKI-PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 53/220 (24%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 312 IIGSGRTGTMYKAL------LEDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLV 363
+G G G + KA T++ VK L++ S ++ ++E L V + +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTG------------KSVDWPRRLKIAI 411
L G C LL+ ++ GSL L + G +D P + +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 412 GAARGFAW-----LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466
G FAW + + +++HR+++++ +L+ + + KISDFGL+R + D+++
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186
Query: 467 FVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506
+ + ++A E + T + DV+SFG +L E+VT
Sbjct: 187 --SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 57/260 (21%), Positives = 103/260 (39%), Gaps = 29/260 (11%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
+ +G G G++ K L++ + + + +K+ + E+ S K+ +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 368 FCMAKKERLL--VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
+ + + ++ GSL + G + KIA +G ++LH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLA-RLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+IIHR+I ILL + K+ DFG++ L+N + TF F Y+APE +
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSF----YMAPERIQ 176
Query: 485 TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS----------- 533
+ DV+S G LLE+ P P L+ +I + +
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236
Query: 534 --TGQLQDAIDKCLVAKGVD 551
+ + +D I +CL
Sbjct: 237 KWSEEFKDFIKQCLEKDPTR 256
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 70/276 (25%), Positives = 125/276 (45%), Gaps = 28/276 (10%)
Query: 313 IGSGRTGTMYKALLED-GTSLMVKR--LQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
IG G TG + A ++ G + VK+ L+ QR E F E+ + ++ N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ E +V + + G+L D++ T ++ + + + + + LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 430 HRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
HR+I S ILL D K+SDFG ++ + V + ++APE L
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY----WMAPELISRLPYG 194
Query: 490 PKGDVYSFGTVLLELVTGERP---TNVAKAPETFKGNLVEWIAQLSSTGQ-LQDAIDKCL 545
P+ D++S G +++E+V GE P KA + + NL + L L+ +D+ L
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254
Query: 546 V----AKGVDNELFQ--FLKVAC--NCVLPTIPKER 573
V + EL + FL A +C++P + + R
Sbjct: 255 VRDPAQRATAAELLKHPFLAKAGPPSCIVPLMRQNR 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRL--QDSQRSEKEFVAEMATLGSVKNRNLVPLLGF 368
++G G G +Y A L + +K + +DS+ + E+A +K+RN+V LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGS 73
Query: 369 CMAKKERLLVYKHMPNGSLYDLLH----PADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
+ + +P GSL LL P D +++ + + + G +LH N
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN- 127
Query: 425 NPRIIHRNISSKCILLDD-DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+I+HR+I +L++ KISDFG ++ + I+ TF G L Y+APE
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT----GTLQYMAPE-- 179
Query: 484 RTLVATPKG-----DVYSFGTVLLELVTGERP 510
+ P+G D++S G ++E+ TG+ P
Sbjct: 180 -VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 313 IGSGRTGTMYKALLEDGTS---LMVKRLQDSQRSEKE--FVAEMATLGSVKNRNLVPLLG 367
IG+G G + G S ++VK L+ S +++ F+ E+ + + N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 368 FCMAKKERLLVYKHMPNGSLYDLL-----HPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
C+ LLV + P G L + L A K V ++A A G WLH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMACEVASGLLWLHQ 118
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE- 481
IH +++ + L D KI D+GLA P D +++ + L ++APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK--DCHAVPLRWLAPEL 173
Query: 482 ----YARTLVA--TPKGDVYSFGTVLLELVT-GERP 510
L T K +++S G + EL T ++P
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 1/115 (0%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
R+ L+L G+ P+ + +++T LDLS+N L G +P+ + G L L L SN+
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS-SGNLFKLILFSNS 391
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195
G IP +L C L ++L N FSG++P + +L + ++NN L G I +
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 57/229 (24%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE-----FVAEMATLGSVKNR 360
+ K IG G G +YKA + G + +K+++ EKE + E+ L +++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHP 58
Query: 361 NLVPLLGFC--MAKKERLLVYKHMPNGSLYDL----LHPADDTGKSVDWPRRLKIAIGAA 414
N+V L K +V+++M +DL P +K
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPE------------VKFTESQI 102
Query: 415 R--------GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466
+ G +LH N I+HR+I IL+++D K++DFGLAR + +
Sbjct: 103 KCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK--RNSAD 157
Query: 467 FVNGEFGDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
+ N L Y PE Y P+ D++S G +L EL G+
Sbjct: 158 YTNRVI-TLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNR 360
N + ++G G G + K G + +K+ ++S+ E K + E+ L +++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
N+V L K LV++++ +L +LL A G D R + + A+
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELLE-ASPGGLPPDAVRSYIWQL--LQAIAYC 116
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDLGYVA 479
H + IIHR+I + IL+ + K+ DFG AR + + L+ +V + Y A
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW----YRA 169
Query: 480 PEYARTLVATPK----GDVYSFGTVLLELVTGE 508
PE LV DV++ G ++ EL+ GE
Sbjct: 170 PE---LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ---DSQRSEKEFVA---EMATLGSV 357
++ + ++G G G +Y ++ G L VK++ DS ++KE A E+ L ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 358 KNRNLVPLLGFCMAKKERLLVY-KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
++ +V G C+ E L ++ ++MP GS+ D L ++V R+ I G
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV--TRKYTRQI--LEG 116
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+LH N I+HR+I IL D K+ DFG ++ + I + T + G
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS-GTGMKSVTGTPY 172
Query: 477 YVAPE------YARTLVATPKGDVYSFGTVLLELVTGERP 510
+++PE Y R K DV+S G ++E++T + P
Sbjct: 173 WMSPEVISGEGYGR------KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEF---VAEMATLGSVKNRNLV 363
F+K IG G G ++K + ++ ++ D + +E E E+ L + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLH--PADDTGKSVDWPRRLKIAIGAARGFAWLH 421
G + + ++ +++ GS DLL P D+ + LK G +LH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK-------GLDYLH 118
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
+ + IHR+I + +LL + + K++DFG+A + +TFV F ++APE
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF----WMAPE 171
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERPTN 512
+ K D++S G +EL GE P +
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVK-------RLQDSQRSEKEFVAEMATLGSVKNRNLV 363
+IG G G +Y L D + R+ D + E+ F+ E + + N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 364 PLLGFCMAKK-ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
LLG C+ + L+V +M +G DL + + + + A+G +L
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHG---DLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL-- 114
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL--GYVAP 480
+ + +HR+++++ +LD+ F K++DFGLAR + D + N L ++A
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI--YDKEYYSVHNHTGAKLPVKWMAL 171
Query: 481 EYARTLVATPKGDVYSFGTVLLELVT 506
E +T T K DV+SFG +L EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRS---EKEFVAEMATLGSVKNRNLVPLLGF 368
IG G G ++K E G + +K+ +S+ +K + E+ L +K+ NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH-HNCNPR 427
K++ LV+++ + +L+ + + V KI + + H HNC
Sbjct: 69 FRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
IHR++ + IL+ + K+ DFG AR++ + +V + Y APE LV
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW----YRAPEL---LV 173
Query: 488 AT----PKGDVYSFGTVLLELVTGE 508
P DV++ G V EL+TG+
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 303 ATNSFS---KNNIIGSGRTGTMYKALLEDGTSLMVKRL-----QDSQRSEKEFVAEMATL 354
A S S + N IGSG GT+YK + L ++ +D+ R ++ E+ L
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEIL 126
Query: 355 GSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA 414
V + N+V E ++ + M GSL + H AD+ + D R++
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQFLA-DVARQI------L 178
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL----MNPIDTHLSTFVNG 470
G A+LH I+HR+I +L++ KI+DFG++R+ M+P N
Sbjct: 179 SGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--------CNS 227
Query: 471 EFGDLGYVAPEYARTLVATPK-----GDVYSFGTVLLELVTGERPTNVAK 515
G + Y++PE T + GD++S G +LE G P V +
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 71/287 (24%), Positives = 132/287 (45%), Gaps = 37/287 (12%)
Query: 311 NIIGSGRTGTMYKALLEDGTS-----LMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLV 363
+++ G G ++ +L D + VK ++D S+ + E L + ++N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 364 PLLGFCMAKKERLLV-YKHMPNGSLYDLL----HPADDTGKSVDWPRRLKIAIGAARGFA 418
P+L C+ E V Y +M G+L L + +++ + + +AI A G +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+LH +IH++I+++ ++D++ + KI+D L+R + P+D H + E + ++
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH--CLGDNENRPVKWM 186
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537
A E + DV+SFG +L EL+T G+ P V P E A L +L
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTP-YVEIDPF-------EMAAYLKDGYRL 238
Query: 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584
I+ C +ELF + C P+ERP+ ++ Q L
Sbjct: 239 AQPIN-C------PDELFAVM----ACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKR--LQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
IG G TG + A G + VK+ L+ QR E F E+ + ++ N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNIVEMYSSY 85
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ E +V + + G+L D++ T ++ + + + + ++LH +I
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLH---AQGVI 137
Query: 430 HRNISSKCILLDDDFEPKISDFGL-ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA 488
HR+I S ILL D K+SDFG A++ + S G ++APE L
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL-----VGTPYWMAPEVISRLPY 192
Query: 489 TPKGDVYSFGTVLLELVTGERP 510
+ D++S G +++E+V GE P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 313 IGSGRTGTMYKA----LL--EDGTSLMVKRLQD-SQRSEKEFVAEMATLGSVKNRNLVPL 365
+G G G ++ A LL +D + VK L++ S+ + ++F E L ++++++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLL--HPAD----DTGKSV-----DWPRRLKIAIGAA 414
G C + L+V+++M +G L L H D G+ V + L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE-FG 473
G +L + +HR+++++ L+ KI DFG++R + D + V G
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTML 186
Query: 474 DLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ ++ PE T + D++SFG VL E+ T G++P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 40/114 (35%), Positives = 56/114 (49%), Gaps = 1/114 (0%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
++++L L+D L G+ P + ++ L L SN G +P ++ L L L L SN
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR-LQVLQLWSNK 343
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194
FSG IP NL L L L N +G+IP L G L + +N L G IP
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 318 TGTMY--KALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375
TG +Y K L ++ ++ + +E+ L + + +V L + +E+
Sbjct: 17 TGKLYAMKVL--KKKKIIKRKEVEHTLTER------NILSRINHPFIVKLH-YAFQTEEK 67
Query: 376 L-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR--------GFAWLHHNCNP 426
L LV ++ P G L+ L + + + AR +LH +
Sbjct: 68 LYLVLEYAPGGELFSHLS------------KEGRFSEERARFYAAEIVLALEYLH---SL 112
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
II+R++ + ILLD D K++DFGLA+ ++ + +TF G Y+APE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC----GTPEYLAPEVLLGK 168
Query: 487 VATPKGDVYSFGTVLLELVTGERP 510
D +S G +L E++TG+ P
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 33/220 (15%)
Query: 307 FSKNN-----IIGSGRTGTMYKA----LLEDGTSL--MVKRLQDSQR-SEKE-FVAE--- 350
F +NN +G+G G + +A L + + VK L+ + SE+E ++E
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 351 MATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIA 410
M+ LG+ + N+V LLG C L++ ++ G L + L ++ +++ L +
Sbjct: 92 MSHLGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE--DLLSFS 147
Query: 411 IGAARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR-LMNPIDTHLSTFV 468
A+G A+L NC IHR+++++ +LL KI DFGLAR +MN S +V
Sbjct: 148 YQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND-----SNYV 198
Query: 469 --NGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506
+ ++APE V T + DV+S+G +L E+ +
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 25/277 (9%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRN 361
+ F K + +G+G G ++K + +M ++L + + + E+ L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--KIAIGAARGFAW 419
+V G + E + +HM GSL +L A G+ P ++ K++I +G +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRI---PEQILGKVSIAVIKGLTY 118
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
L +I+HR++ IL++ E K+ DFG++ + ID+ ++FV G Y++
Sbjct: 119 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV----GTRSYMS 170
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERPTNV--AKAPETFKGNLVEWIAQLSSTGQL 537
PE + + + D++S G L+E+ G P AK E G VE S T
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230
Query: 538 QDAIDKCLVAKGVDNE----LFQFLKVACNCVLPTIP 570
+ L + G D+ +F+ L N P +P
Sbjct: 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP 267
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 55/193 (28%), Positives = 84/193 (43%), Gaps = 16/193 (8%)
Query: 318 TGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377
TG MY L KR++ ++ E + E L V +R +V L K L
Sbjct: 24 TGKMYAC-----KKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77
Query: 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKC 437
V M G L ++ + G + R + A G LH RI++R++ +
Sbjct: 78 VLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPEN 132
Query: 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSF 497
ILLDD +ISD GLA + T + G G +GY+APE + T D ++
Sbjct: 133 ILLDDHGHIRISDLGLAVHVPEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 187
Query: 498 GTVLLELVTGERP 510
G +L E++ G+ P
Sbjct: 188 GCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 41/213 (19%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNRNLVPLL-- 366
IG G G ++KA E G ++ +K++ + + + E+ L + ++ +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 367 ---GFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA------RGF 417
G LV ++MP L ++L D R L A + +G
Sbjct: 68 FPHGSGFV-----LVMEYMP-SDLSEVLR---------DEERPLPEAQVKSYMRMLLKGV 112
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
A++H N I+HR++ +L+ D KI+DFGLARL + + L + + Y
Sbjct: 113 AYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH---QVATRWY 166
Query: 478 VAPEY---ARTLVATPKGDVYSFGTVLLELVTG 507
APE AR P D+++ G + EL+ G
Sbjct: 167 RAPELLYGARKY--DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372
+GSG+ G ++ + +K + + SE++F+ E + + + LV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 373 KERLLVYKHMPNGSLYDLLHPADDT-GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
K +V + M NG L + L K + L + G +L N IHR
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYLERN---SFIHR 124
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK 491
+++++ L+ K+SDFG+ R + +D ++ +F + + PE + K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSK 181
Query: 492 GDVYSFGTVLLELVT-GERP 510
DV+SFG ++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
+G+G G + K + +M ++L + + + E+ L + +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ E + +HM GSL +L A + + K++I RG A+L +I+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLREK--HQIM 126
Query: 430 HRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
HR++ IL++ E K+ DFG++ + ID+ ++FV G Y++PE + +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV----GTRSYMSPERLQGTHYS 180
Query: 490 PKGDVYSFGTVLLELVTGERPTNVAKAPE 518
+ D++S G L+EL G P A E
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 313 IGSGRTGTMYKALLE-DGTSLMVKR--LQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
IG G TG + A + G + VK+ L+ QR E F E+ + + N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDMYNSY 88
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ E +V + + G+L D++ T ++ + + + R ++LH N +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLH---NQGVI 140
Query: 430 HRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
HR+I S ILL D K+SDFG ++ + V + ++APE L
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY----WMAPEVISRLPYG 196
Query: 490 PKGDVYSFGTVLLELVTGERP 510
+ D++S G +++E++ GE P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 70/238 (29%), Positives = 106/238 (44%), Gaps = 23/238 (9%)
Query: 287 LFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYK-ALLEDGTSLMVKRLQDSQRSEK 345
LF + + + L L T+++ IG G G +YK +DG+ VK L ++
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63
Query: 346 EFVAEMATLGSVKNR-NLVPLLG-FCMAKK----ERLLVYKHMPNGSLYDLLHPADDTGK 399
E AE L S+ N N+V G F A K + LV + GS+ +L+ G+
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 400 SVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459
+D I GA G LH+N RIIHR++ ILL + K+ DFG++ +
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 460 IDTHLSTFVNGEFGDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGERP 510
+T V F ++APE Y + A + DV+S G +EL G+ P
Sbjct: 181 TRLRRNTSVGTPF----WMAPEVIACEQQYDYSYDA--RCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNRNLVPLLGF 368
IG G G +YKA G + +K+++ SE K + E+ L + + N++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
K + LV++ M DL D + + +G A+ H + I
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE-YARTLV 487
+HR++ + +L++ + K++DFGLAR + +V + Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW----YRAPELLLGDKG 175
Query: 488 ATPKGDVYSFGTVLLELVTGERP 510
+ D++S G + EL++ RP
Sbjct: 176 YSTPVDIWSVGCIFAELLSR-RP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 309 KNNIIGSGRTGTMYKAL-LEDGTSLMVKRL--------QDSQRSE---KEFVAEMATLGS 356
K +IG G G +Y AL + G + VK++ + R + K +E+ TL
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ + N+V LGF ++ + +++P GS+ L T + G
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEG 120
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
A+LH + I+HR++ + +L+D D KISDFG+++ + I + G +
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN--MSMQGSVF 175
Query: 477 YVAPE----YARTLVATPKGDVYSFGTVLLELVTGERP 510
++APE Y++ A K D++S G V+LE+ G RP
Sbjct: 176 WMAPEVIHSYSQGYSA--KVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKR--LQDSQRS-EKEFVAEMATLGSVKNRNLVPLLGFC 369
+G+G G++ K ++M K+ ++ S K+ + E+ + ++ +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 370 MAKKERLLVYKHMPNGSLYDLLH-----PADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
+ + + + M GSL + P + GK IA+ G +L++
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK---------IAVAVVEGLTYLYNV- 122
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLA-RLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
RI+HR+I IL++ + K+ DFG++ L+N I TFV G Y++PE
Sbjct: 123 -HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFV----GTSTYMSPERI 174
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERP 510
+ T K DV+S G ++EL G+ P
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 36/136 (26%), Positives = 59/136 (43%), Gaps = 17/136 (12%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL--------MNPIDTHLSTFVNGEFG 473
H+ IIHR++ IL+D + K++DFGL+++ +N + V G
Sbjct: 110 HSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV----G 163
Query: 474 DLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK---GNLVEWIAQ 530
Y+APE + D +S G +L E + G P + E F+ +EW
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED 223
Query: 531 LSSTGQLQDAIDKCLV 546
+ + + D I K LV
Sbjct: 224 VEVSDEAIDLISKLLV 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 47/207 (22%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEK--EFVAEMATLGSVKNRNLVPLLGFCM 370
+G G G +YKA ++ ++ + E+ +F+ E+ L K+ N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
+ + ++ + G+L ++ + + + P+ + +LH + ++IH
Sbjct: 73 YENKLWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 431 RNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY--ARTLVA 488
R++ + ILL D + K++DFG++ TF+ G ++APE T
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI----GTPYWMAPEVVACETFKD 182
Query: 489 TP---KGDVYSFGTVLLELVTGERPTN 512
P K D++S G L+EL E P +
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 51/196 (26%), Positives = 95/196 (48%), Gaps = 18/196 (9%)
Query: 327 EDGTSLMVKRLQD-SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385
+D + VK L+D S + K+F E L ++++ ++V G C+ ++V+++M +G
Sbjct: 33 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 386 SLYDLL--HPAD-------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSK 436
L L H D + + + L IA A G +L + +HR+++++
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATR 149
Query: 437 CILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE-FGDLGYVAPEYARTLVATPKGDVY 495
L+ ++ KI DFG++R + D + V G + ++ PE T + DV+
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVW 206
Query: 496 SFGTVLLELVT-GERP 510
S G VL E+ T G++P
Sbjct: 207 SLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 65/297 (21%), Positives = 125/297 (42%), Gaps = 55/297 (18%)
Query: 313 IGSGRTGTMYKALLEDGTSLM---VKRLQDS--QRSEKE-FVAEMATLGSVKNRNLVPLL 366
+G G G++ + L S++ VK ++ + RSE E F++E + + N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 367 GFCMAKKER------LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--KIAIGAARGFA 418
G C+ E +++ M +G L+ L + P ++ K A G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG-- 476
+L + IHR+++++ +L+++ ++DFGL++ NG++ G
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK----------KIYNGDYYRQGRI 173
Query: 477 ------YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIA 529
++A E V T K DV+SFG + E+ T G+ P P + +++
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLR 228
Query: 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
Q + Q D +D L + + +C L PK+RP+ + L
Sbjct: 229 QGNRLKQPPDCLD-GLYS------------LMSSCWLLN-PKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 306 SFSKNNIIGSGRTGTMYKA---LLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL 362
++ K + +G G T++K L E+ +L RL+ + + + E++ L ++K+ N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
V L ++ LV++++ + DL D+ G + RG ++ H
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDLGYVAPE 481
+I+HR++ + +L+++ E K++DFGLAR + P T+ + V L Y P+
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT-----LWYRPPD 173
Query: 482 --YARTLVATPKGDVYSFGTVLLELVTGERP 510
T +TP D++ G +L E+ TG RP
Sbjct: 174 VLLGSTEYSTPI-DMWGVGCILYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 341 QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL-VYKHMPNGSLYDLLH-----PA 394
+ F E A + + N+V LL A L V++++P +L ++L PA
Sbjct: 19 EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPA 78
Query: 395 DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDF 451
+TG RL + + A L N I+HR++ + I++ K+ DF
Sbjct: 79 GETG-------RLMLQVLDA-----LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126
Query: 452 GLARLMNPIDTHLSTFVNGEFGDLG---YVAPEYARTLVATPKGDVYSFGTVLLELVTGE 508
G+ L+ + + LG Y APE R TP D+Y++G + LE +TG+
Sbjct: 127 GIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
Query: 509 R 509
R
Sbjct: 187 R 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 25/199 (12%)
Query: 330 TSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYD 389
S+++K L R F + + + +++LV L G C+ E ++V +++ G L
Sbjct: 31 VSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDV 89
Query: 390 LLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEP 446
LH S+ W +L +A A +L +++H N+ K IL+ +
Sbjct: 90 FLHREK-NNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGY 143
Query: 447 ----KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK--GDVYSFGTV 500
K+SD G+ + + + + ++APE R A+ D +SFGT
Sbjct: 144 VPFIKLSDPGIPITVLSREERVE--------RIPWIAPECIRNGQASLTIAADKWSFGTT 195
Query: 501 LLELVT-GERPTNVAKAPE 518
LLE+ + GE P + + E
Sbjct: 196 LLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 50/208 (24%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 319 GTMYKALLEDGTSLMVKRLQDSQRSEK--EFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376
G +Y ++ + +K L+D ++ EF E + + + + N+V LLG ++
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 377 LVYKHMPNGSLYDLL---HPADDTG----------KSVDWPRRLKIAIGAARGFAWLHHN 423
++++++ G L++ L P D G S+D L IAI A G +L +
Sbjct: 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+H++++++ IL+ + KISD GL+R + D + + ++ PE
Sbjct: 144 F---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAI 198
Query: 484 RTLVATPKGDVYSFGTVLLELVT-GERP 510
+ D++SFG VL E+ + G +P
Sbjct: 199 MYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 28/227 (12%)
Query: 306 SFSKNNIIGSGRTGTMYKA---LLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL 362
++ K + +G G T+YK L ++ +L RL+ + + + E++ L +K+ N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
V L +K LV++++ DL DD G S++ RG + H
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDLGYVAPE 481
+++HR++ + +L+++ E K++DFGLAR + P T+ + V L Y P+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT-----LWYRPPD 174
Query: 482 --YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526
T +T + D++ G + E+ TG RP F G+ VE
Sbjct: 175 ILLGSTDYST-QIDMWGVGCIFYEMSTG-RP--------LFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ---DSQRSEKEFVA---EMATLGSVK 358
++ + ++G G G +Y ++ G L K++Q +S + KE A E+ L +++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 359 NRNLVPLLGFCMAKKERLLV--YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ +V G + E+ L ++MP GS+ D L +SV +I G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EG 118
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
++LH N I+HR+I IL D K+ DFG ++ + I T + G
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI-CMSGTGIRSVTGTPY 174
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
+++PE K DV+S G ++E++T + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (139), Expect = 6e-09
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-----EMATLGSVKNR 360
+ K +G G G +YKA + G + +K+++ +E+E + E++ L +K+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLK-IAIGAARGFAW 419
N+V LL +++ LV+++ DL D + P +K I RG A+
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLS-PNLIKSIMYQLLRGLAY 113
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR-LMNPIDTHLSTFVNGEFGDLGYV 478
H + RI+HR++ + IL++ D K++DFGLAR P+ T+ V L Y
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT-----LWYR 165
Query: 479 APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
APE Y + D++S G + E++TG+
Sbjct: 166 APEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKR--LQDSQRSEKEFVAEMATLGSVKNRN 361
F+ IG G G +YKA+ + +K L++++ ++ E+ L ++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 362 LVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI---GAARGF 417
+ G K +L ++ ++ GS DLL P IA G
Sbjct: 61 ITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY--------IAFILREVLLGL 111
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+LH IHR+I + ILL ++ + K++DFG++ + + +TFV F +
Sbjct: 112 EYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF----W 164
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
+APE + K D++S G +EL GE P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 79/312 (25%), Positives = 136/312 (43%), Gaps = 53/312 (16%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDS--QRSEK--EFVAEMATLGSVKNRN 361
F+ IG G G +Y A + + +K++ S Q +EK + + E+ L +K+ N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
+ G + + LV ++ GS DLL + V+ I GA +G A+LH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLH 142
Query: 422 -HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
HN +IHR+I + ILL + + K++DFG A + +P + +FV + ++AP
Sbjct: 143 SHN----MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN----SFVGTPY----WMAP 190
Query: 481 EYARTLVATPKG------DVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS- 533
E ++A +G DV+S G +EL + P F N + + ++
Sbjct: 191 E---VILAMDEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSALYHIAQN 239
Query: 534 -TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHF 592
+ LQ NE + + + L IP++RPT E+ + + + ER
Sbjct: 240 ESPTLQ------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287
Query: 593 TTEDEIMLPSDS 604
D I D+
Sbjct: 288 VLIDLIQRTKDA 299
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
+ H R++HR+I SK I L + + K+ DFG ARL+ + T+V + YV
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY----YVP 168
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERP 510
PE + K D++S G +L EL T + P
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNRN 361
+F K IG G G +YKA G + +K+++ +E + E++ L + + N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
+V LL + + LV++ + + L + + +G + + + +G A+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH 117
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDLGYVAP 480
+ R++HR++ + +L++ + K++DFGLAR P+ T+ V L Y AP
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT-----LWYRAP 169
Query: 481 E------YARTLVATPKGDVYSFGTVLLELVT 506
E Y T V D++S G + E+VT
Sbjct: 170 EILLGCKYYSTAV-----DIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 20/224 (8%)
Query: 300 LMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFV-AEMATLGSVK 358
L T F +IG G G +YKA + L+ ++ D E+E + E L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 359 N-RNLVPLLGFCMAKKERL------LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI 411
N N+ G + K LV + GS+ DL+ GK + I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 412 GAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE 471
RG A+LH N ++IHR+I + ILL + E K+ DFG++ ++ +TF+
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP 177
Query: 472 FGDLGYVAPE-----YARTLVATPKGDVYSFGTVLLELVTGERP 510
+ ++APE + DV+S G +EL G+ P
Sbjct: 178 Y----WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 312 IIGSGRTGTMYKALLED-GTSLMVKRLQ---DSQRSEKEFVA---EMATLGSVKNRNLVP 364
++G G G +Y D G L VK++Q +S + KE A E+ L ++ + +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 365 LLGFCMAKKERLL--VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
G ER L +HMP GS+ D L ++V R+ I G ++LH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT--RKYTRQI--LEGVSYLHS 124
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY 482
N I+HR+I IL D K+ DFG ++ + I T + G +++PE
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS-GTGMKSVTGTPYWMSPEV 180
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERP 510
K D++S G ++E++T E+P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLT-EKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 30/238 (12%)
Query: 290 KSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFV 348
+S+ + LS L F ++G+G G +YK ++ G +K + ++ E+E
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK 60
Query: 349 AEMATLGSVKN-RNLVPLLGFCMAKK------ERLLVYKHMPNGSLYDLLHPADDTGKSV 401
E+ L + RN+ G + K + LV + GS+ DL+
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 402 DWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461
DW + I RG A LH + ++IHR+I + +LL ++ E K+ DFG++ ++
Sbjct: 121 DWIAYICREI--LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 462 THLSTFVNGEFGDLGYVAPEYARTLVATP---------KGDVYSFGTVLLELVTGERP 510
+TF+ + ++APE ++A + D++S G +E+ G P
Sbjct: 176 GRRNTFIGTPY----WMAPE----VIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNRNLVPLLG 367
++G G G + K E G + +K+ +S+ + K + E+ L +++ NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
KK LV++ + + L DL + +D R K RG + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---N 120
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
IIHR+I + IL+ K+ DFG AR + + +V + Y APE LV
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW----YRAPEL---LV 173
Query: 488 ATPKG----DVYSFGTVLLELVTGE 508
K D+++ G ++ E++TGE
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 31/218 (14%)
Query: 312 IIGSGRTGT-MYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
++GSG TGT + + DG VK + SE + A + + N + F +
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDF-----FSI 93
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA------------ 418
K K N ++ D + D + +K R F
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 419 -WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL-- 475
+HH + +IHR+I S ILL + K+ DFG ++ + V+ + G
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-------MYAATVSDDVGRTFC 206
Query: 476 ---GYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
YVAPE R + K D++S G +L EL+T +RP
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 36/137 (26%), Positives = 54/137 (39%), Gaps = 27/137 (19%)
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
+LH + IIHR+I ILLD+ I+DF +A + P T G
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-----DTLTTSTSGTP 163
Query: 476 GYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN---LVEWIA--- 529
GY+APE + D +S G E + G+RP ++G+ + + I
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP---------YRGHSRTIRDQIRAKQ 214
Query: 530 ----QLSSTGQLQDAID 542
L +AID
Sbjct: 215 ETADVLYPATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVA-----EMATLGSVKNRNLVP 364
IG G G +YKA G + +K RL+ +E E V E++ L + + N+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE----TEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGA-ARGFAWLHHN 423
LL ++ + LV++ + DL D + + P +K + +G A+ H +
Sbjct: 63 LLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDLGYVAPE- 481
R++HR++ + +L+D + K++DFGLAR P+ T+ V L Y APE
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT-----LWYRAPEI 170
Query: 482 -YARTLVATPKGDVYSFGTVLLELVTGERP 510
+TP D++S G + E+V RP
Sbjct: 171 LLGSRQYSTPV-DIWSIGCIFAEMVNR-RP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 55/288 (19%)
Query: 313 IGSGRTGTMYKALLEDGTSLM-VKRLQDS--QRSEK--EFVAEMATLGSVKNRNLVPLLG 367
IG G G +Y A ++ VK++ S Q +EK + + E+ L +K+ N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
C K+ + GS DLL + V+ I GA +G A+LH +
Sbjct: 89 -CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHSHN--- 141
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
+IHR+I + ILL + + K++DFG A +P + +FV + ++APE ++
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN----SFVGTPY----WMAPE---VIL 190
Query: 488 ATPKG------DVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE---WIAQLSSTGQLQ 538
A +G DV+S G +EL + P F N + IAQ + + LQ
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSALYHIAQ-NDSPTLQ 241
Query: 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEV--YQFLR 584
NE + + L IP+ERP E+ + F+R
Sbjct: 242 ------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 58/209 (27%), Positives = 84/209 (40%), Gaps = 20/209 (9%)
Query: 318 TGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377
TG +Y L KRL+ + E V E L V +R +V L K + L
Sbjct: 17 TGKLYAC-----KKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSLAYAFQTKTDLCL 70
Query: 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKC 437
V M G L ++ D+ PR G LH RII+R++ +
Sbjct: 71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPEN 127
Query: 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSF 497
+LLD+D +ISD GLA + D T G G G++APE + D ++
Sbjct: 128 VLLDNDGNVRISDLGLA--VELKDGQSKT--KGYAGTPGFMAPELLQGEEYDFSVDYFAL 183
Query: 498 GTVLLELVTGERPTNVAKAPETFKGNLVE 526
G L E++ A+ P +G VE
Sbjct: 184 GVTLYEMIA-------ARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTS---LMVKRLQDSQRSEKE-------FVAEMATLGS 356
F K N IG G G +Y+A D TS + +K++ R + E + E+ L +
Sbjct: 9 FEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKV----RMDNERDGIPISSLREITLLLN 62
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSL------YDLLHPADDTGKSVDWPRRLKIA 410
+++ N+V L ++V KH+ + L DL D+ + +
Sbjct: 63 LRHPNIVELK--------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 411 IGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNG 470
+ RG +LH N IIHR++ +LL D KI+DFGLAR ++ V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 471 EFGDLGYVAPEYA-RTLVATPKGDVYSFGTVLLELVTGE 508
L Y APE T D+++ G +L EL+ +
Sbjct: 171 ---TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 327 EDGTSLMVKRLQDSQRS-EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385
+D + VK L+D + K+F E L ++++ ++V G C ++V+++M +G
Sbjct: 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 92
Query: 386 SLYDLL--HPADDTGKSVDWPRR----------LKIAIGAARGFAWLHHNCNPRIIHRNI 433
L L H D PR+ L IA A G +L + +HR++
Sbjct: 93 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDL 149
Query: 434 SSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE-FGDLGYVAPEYARTLVATPKG 492
+++ L+ + KI DFG++R + D + V G + ++ PE T +
Sbjct: 150 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTES 206
Query: 493 DVYSFGTVLLELVT-GERP 510
DV+SFG +L E+ T G++P
Sbjct: 207 DVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 311 NIIGSGRTGTMYKALL----EDGTSLMVK----RLQDSQRSEKEFVAEMATLGSVKNRNL 362
+G G G +Y+ L D L V S++ E +F+ E + ++N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLL---HPADDTGKSVDWPRRLKIAIGAARGFAW 419
V L+G + R ++ + M G L L P + S+ L A A+G +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 420 LHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLARLMNPIDTHLSTF--VNGE-FG 473
L N IHR+I+++ LL KI+DFG+AR D + +++ G
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAML 183
Query: 474 DLGYVAPEYARTLVATPKGDVYSFGTVLLEL 504
+ ++ PE + T K DV+SFG +L E+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 318 TGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL- 376
TG MY L KR++ ++ E + E L V +R +V L + K+ L
Sbjct: 24 TGKMYAC-----KKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSL-AYAYETKDALC 76
Query: 377 LVYKHMPNGSL----YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
LV M G L Y++ +P D +++ + L G L RI++R+
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL------CCGLEDLQRE---RIVYRD 127
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
+ + ILLDD +ISD GLA + +T V G G +GY+APE T
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 493 DVYSFGTVLLELVTGERP 510
D + G ++ E++ G+ P
Sbjct: 183 DWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 312 IIGSGRTGTMYKALLEDGTS----LMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVPL 365
I+G+GR G + + L+ + + + L+ S + + F+AE TLG + N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLL--HPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
G ++V ++M NG+L L H + + + G A G +L
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGLASGMKYL--- 123
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+H+ +++ +L++ D KIS F RL + T ++G+ L + APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL-WAAPEAI 180
Query: 484 RTLVATPKGDVYSFGTVLLELVT-GERP 510
+ + DV+SFG V+ E+++ GERP
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 307 FSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKN 359
+ K IG G G KA+L EDG ++K + S+ S KE E+A L ++K+
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYD-------LLHPADDTGKSVDWPRRLKIAIG 412
N+V +V + G LY +L P D +DW ++ +A
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFVQICLA-- 113
Query: 413 AARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
L H + +I+HR+I S+ I L D K+ DFG+AR++N T + +
Sbjct: 114 -------LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY 166
Query: 473 GDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506
Y++PE K D+++ G VL E+ T
Sbjct: 167 ----YLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLM-VKRLQDSQRSEK---EFVAEMATLGSVKNR 360
N F ++G G G + K ++ ++ +K+ +DS+ +E+ + E+ L ++K
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 361 NLVPL-----------LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKI 409
N+V L L F +K L + + MPNG P +++
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP----------------PEKVRS 104
Query: 410 AI-GAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFV 468
I + W H N I+HR+I + +L+ + K+ DFG AR +LS
Sbjct: 105 YIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFAR-------NLSEGS 154
Query: 469 NGEFGDLGYVAPEYART---LVATPKG---DVYSFGTVLLELVTGE 508
N + + YVA + R+ L+ P G D++S G +L EL G+
Sbjct: 155 NANYTE--YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 313 IGSGRTGTMYKALL------EDGTSLMVKRLQDSQRS--EKEFVAEMATLGSVKNRNLVP 364
+G R G +YK L E ++ +K L+D +EF E +++ N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLL---HPADDTGKSVD---------WPRRLKIAIG 412
LLG ++ +++ + + L++ L P D G + D + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 413 AARGFAWL--HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNG 470
A G +L HH ++H++++++ +L+ D KISD GL R + D + +
Sbjct: 133 IAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY--KLMGN 185
Query: 471 EFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ +++PE + D++S+G VL E+ + G +P
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 63/260 (24%), Positives = 114/260 (43%), Gaps = 49/260 (18%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLE-DG--TSLMVKRLQDSQRSEKEFVAEMATLGSVKNRN 361
+S+ K +G G T+YK + +G +L V RLQ+ + + + E + L +K+ N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI-GAARGFAWL 420
+V L K+ LV++++ DL D + P +K+ + RG +++
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLH-PENVKLFLFQLLRGLSYI 119
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
H I+HR++ + +L+ D E K++DFGLAR + +H T+ N E L Y P
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSH--TYSN-EVVTLWYRPP 172
Query: 481 -------EYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533
EY+ L D++ G + +E++ G +A
Sbjct: 173 DVLLGSTEYSTCL------DMWGVGCIFVEMIQG--------------------VAAFPG 206
Query: 534 TGQLQDAIDKCLVAKGVDNE 553
+QD +++ + G NE
Sbjct: 207 MKDIQDQLERIFLVLGTPNE 226
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ---DSQRSEKEFVAEMATLGSVKNRN 361
+ K IG G GT++KA E + +KR++ D + + E+ L +K++N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
+V L + K+ LV+++ DL D +D +G A+ H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQ----DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 422 -HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDLGYVA 479
HN ++HR++ + +L++ + E K++DFGLAR P+ + + V L Y
Sbjct: 117 SHN----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVT-----LWYRP 167
Query: 480 PE--YARTLVATPKGDVYSFGTVLLELVTGERP 510
P+ + L +T D++S G + EL RP
Sbjct: 168 PDVLFGAKLYSTSI-DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 49/275 (17%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDS--QRSEK--EFVAEMATLGSVKNRNLVPLLG 367
IG G G +Y A + + + +K++ S Q +EK + + E+ L +++ N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH-HNCNP 426
+ + LV ++ GS DLL + V+ + GA +G A+LH HN
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHSHN--- 135
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
+IHR++ + ILL + K+ DFG A +M P + FV + ++APE +
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----XFVGTPY----WMAPE---VI 183
Query: 487 VATPKG------DVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540
+A +G DV+S G +EL ER P F N ++ L Q +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL--AER------KPPLFNMNA---MSALYHIAQNESP 232
Query: 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPT 575
+ ++ + + L IP++RPT
Sbjct: 233 ALQ-------SGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 54/193 (27%), Positives = 81/193 (41%), Gaps = 16/193 (8%)
Query: 318 TGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377
TG MY L KRL+ + E+ + E L V +R +V L K + L
Sbjct: 17 TGKMYAC-----KKLDKKRLKKRK-GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCL 70
Query: 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKC 437
V M G L ++ + G R + A G LH RI++R++ +
Sbjct: 71 VMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPEN 125
Query: 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSF 497
+LLDD +ISD GLA ++ + G G GY+APE + V D ++
Sbjct: 126 VLLDDHGNVRISDLGLA-----VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180
Query: 498 GTVLLELVTGERP 510
G L E++ G P
Sbjct: 181 GCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVA-EMATLGSVKN---R 360
+ + +IG G G +Y+ + G + +K + D+ + + E+A L ++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLH--PADDTGKSVDWPRRLKIAIGAARGFA 418
N+ G + ++ ++ GS+ L+ P + SV R + +A+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-IIREVLVAL------K 115
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
++H +IHR+I + IL+ + K+ DFG+A L+N + STFV G ++
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV----GTPYWM 168
Query: 479 APEYARTLVA-TPKGDVYSFGTVLLELVTGERP 510
APE K D++S G + E+ TG P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 11/194 (5%)
Query: 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSE--KEFVAEMATLGSVKNRNLVPLLGFC 369
IG G G ++ L D T + VK +++ + +F+ E L + N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
K+ +V + + G L G + +++ AA G +L I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 430 HRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
HR+++++ L+ + KISDFG++R D ++ + + + APE +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 490 PKGDVYSFGTVLLE 503
+ DV+SFG +L E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 49/197 (24%), Positives = 81/197 (41%), Gaps = 24/197 (12%)
Query: 318 TGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377
TG MY L KR++ ++ E + E L V ++ +V L K L
Sbjct: 24 TGKMYAC-----KRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCL 77
Query: 378 VYKHMPNGSL----YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNI 433
V M G L Y++ +P + +++ + AA L ++R++
Sbjct: 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFY---------AAEILCGLEDLHRENTVYRDL 128
Query: 434 SSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGD 493
+ ILLDD +ISD GLA + + G G +GY+APE T D
Sbjct: 129 KPENILLDDYGHIRISDLGLA-----VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183
Query: 494 VYSFGTVLLELVTGERP 510
+ G ++ E++ G+ P
Sbjct: 184 YWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 313 IGSGRTGTMYKALL-----EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
+GSG G + K + + ++ V + ++ + E + E + + N +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
C A+ +LV + G L L D + +++ + G +L
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEGK---N 115
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
+HR+++++ +LL + KISDFGL++ + D++ G++ L + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW-PLKWYAPECINFRK 174
Query: 488 ATPKGDVYSFGTVLLELVT-GERPTNVAKAPE 518
+ + DV+S+G + E + G++P K PE
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 40/153 (26%), Positives = 76/153 (49%), Gaps = 23/153 (15%)
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
RI+HR+++ I+L +D + I+DFGLA+ P ++ L++ V G + Y PE +
Sbjct: 134 RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTSVV----GTILYSCPEIVKNE 188
Query: 487 VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLV 546
K DV++FG +L ++ T + P + N+ LS ++ +A+ + L
Sbjct: 189 PYGEKADVWAFGCILYQMCTLQ--------PPFYSTNM------LSLATKIVEAVYEPL- 233
Query: 547 AKGVDNELFQFLKVACNCVLPTIPKERPTMFEV 579
+G+ +E + +C L + RP + +V
Sbjct: 234 PEGMYSEDVTDVITSC---LTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 311 NIIGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
I+G G GT+YKA L L VK L + +K+ ++E+ L + ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
+ + + M GSL D + + +IA+ +G +L + +
Sbjct: 67 AFFVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYL---WSLK 115
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLAR-LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I+HR++ +L++ + K+ DFG++ L+N I T+V G Y+APE
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK---TYV----GTNAYMAPERISGE 168
Query: 487 VATPKGDVYSFGTVLLELVTGERP 510
DV+S G +EL G P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 47/205 (22%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEK--EFVAEMATLGSVKNRNLVPLLGFCM 370
+G G G +YKA ++ +L ++ +++ E+ +++ E+ L + + +V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
+ ++ + P G++ ++ D + + P+ I +LH + +IIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLH---SMKIIH 133
Query: 431 RNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA--RTLVA 488
R++ + +LL D + K++DFG++ +F+ + ++APE T+
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY----WMAPEVVMCETMKD 189
Query: 489 TP---KGDVYSFGTVLLELVTGERP 510
TP K D++S G L+E+ E P
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 70/255 (27%), Positives = 115/255 (45%), Gaps = 48/255 (18%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDS--QRSEK--EFVAEMATLGSVKNRNLVPLLG 367
IG G G +Y A + + +K++ S Q +EK + + E+ L +++ N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
+ + LV ++ GS D+L + K + I GA +G A+LH +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
IHR+I + ILL + K++DFG A L++P + +FV + ++APE ++
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----SFVGTPY----WMAPE---VIL 184
Query: 488 ATPKG------DVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE---WIAQ-----LSS 533
A +G DV+S G +EL ER P F N + IAQ LSS
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AER------KPPLFNMNAMSALYHIAQNDSPTLSS 236
Query: 534 TG---QLQDAIDKCL 545
++ +D CL
Sbjct: 237 NDWSDYFRNFVDSCL 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 313 IGSGRTGTMYKALLE-DGTSLMVKR--LQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
IG G TG + A + G + VK L+ QR E F E+ + +++N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEMYKSY 87
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ +E ++ + + G+L D++ + + + + +LH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQ---GVI 139
Query: 430 HRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY-ARTLVA 488
HR+I S ILL D K+SDFG ++ + V + ++APE +RT
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY----WMAPEVISRTPYG 195
Query: 489 TPKGDVYSFGTVLLELVTGERP 510
T + D++S G +++E+V GE P
Sbjct: 196 T-EVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQR----SEKEFVAEMATLGSVKNRNLVPL 365
IG G GT+YKA G + +K R+Q ++ S VA + L + + N+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 366 LGFC-MAKKER----LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
+ C ++ +R LV++H+ + L L G + + L RG +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDFL 124
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
H NC I+HR++ + IL+ + K++DFGLAR+ + L+ V L Y AP
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVV----TLWYRAP 176
Query: 481 E-YARTLVATPKGDVYSFGTVLLEL 504
E ++ ATP D++S G + E+
Sbjct: 177 EVLLQSTYATPV-DMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 33/146 (22%), Positives = 69/146 (47%), Gaps = 22/146 (15%)
Query: 329 GTSLMVK----RLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384
G L+V R ++ + +F+ E+ L +K+ N++ LLG C+ + ++ ++M N
Sbjct: 44 GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 385 GSLYDLLH---------------PADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
G L L P ++ + L +A+ A G +L + +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 430 HRNISSKCILLDDDFEPKISDFGLAR 455
HR+++++ L+ ++ KI+DFG++R
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 50/220 (22%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA---EMATLGSVKNRNL 362
+ K ++G G G ++ D +++K++ Q ++ E +A E L + + N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPAD----DTGKSVDWPRRLKIAIGAARGFA 418
+ + K ++V ++ P G+L + + D + + ++ +A
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA-------- 113
Query: 419 WLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
LHH I+HR++ ++ ILLD KI DFG++++++ + T V G Y
Sbjct: 114 -LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTVV----GTPCY 167
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAP 517
++PE K D+++ G VL EL + +R A P
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 38/232 (16%)
Query: 306 SFSKNNIIGSGRTGTMYKA---LLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL 362
++ K +G G T++K L E+ +L RL+ + + + E++ L +K+ N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
V L K LV++++ DL DD G + RG A+ H
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDK----DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDLGYVAP- 480
+++HR++ + +L+++ E K++DFGLAR + P T+ + V L Y P
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVT-----LWYRPPD 174
Query: 481 ------EYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526
EY+ + D++ G + E+ +G RP F G+ VE
Sbjct: 175 VLLGSSEYSTQI------DMWGVGCIFFEMASG-RP--------LFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 44/144 (30%), Positives = 63/144 (43%), Gaps = 11/144 (7%)
Query: 368 FC-MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
FC KE L NG DL+ +G+ D R A G +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGG--DLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKK--- 115
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
II+R++ +LLD D KI+DFG+ + + STF G Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC----GTPDYIAPEILKGQ 171
Query: 487 VATPKGDVYSFGTVLLELVTGERP 510
D +SFG +L E++ G+ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 68/296 (22%), Positives = 132/296 (44%), Gaps = 40/296 (13%)
Query: 307 FSKNNIIGSGRTGTMYKALL--EDGT--SLMVKRLQ---DSQRSEKEFVAEMATLGSVKN 359
F+ ++G G G++ +A L EDG+ + VK L+ S +EF+ E A + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 360 RNLVPLLGFCMAK--KERL----LVYKHMPNGSLYDLLHPADDTGKSVDWPRR--LKIAI 411
N++ L+G + K RL ++ M +G L+ L + + P + ++ I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 412 GAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE 471
A G +L + IHR+++++ +L+++ ++DFGL++ + D + +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 472 FGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQ 530
+ ++A E V T DV++FG + E++T G+ P + E +
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN--------Y 227
Query: 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
L +L+ D CL ++++ + C C P PK RP+ + L I
Sbjct: 228 LIKGNRLKQPPD-CL------EDVYELM---CQCWSP-EPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 52/219 (23%), Positives = 83/219 (37%), Gaps = 31/219 (14%)
Query: 339 DSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL-LVYKHMPNG---SLYDLLHPA 394
++ AE A + V L + K+ L LV +++ G SL L
Sbjct: 35 IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL 94
Query: 395 DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454
+ DW + + G LH IIHR+I + +L+D K++DFGL+
Sbjct: 95 PE-----DWAK--QYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLS 144
Query: 455 R--LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTN 512
R L N FV G Y+APE + D +S G V+ E + G P +
Sbjct: 145 RNGLENK------KFV----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
Query: 513 VAKAPETFK---GNLVEWIAQL--SSTGQLQDAIDKCLV 546
F + W ++ + + D I++ L
Sbjct: 195 AETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 24/136 (17%)
Query: 381 HMPNGSLYDLLHPADDTGKSVDWPRRL------KIAIGAARGFAWLHHNCNPRIIHRNIS 434
HM GSL +L A R+ KI+I RG +L +I+HR++
Sbjct: 80 HMDGGSLDQVLKKA----------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVK 127
Query: 435 SKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDV 494
IL++ E K+ DFG++ + ID+ ++FV G Y++PE + T + D+
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV----GTRSYMSPERLQGTHYTVQSDI 181
Query: 495 YSFGTVLLELVTGERP 510
+S G L+E+ G P
Sbjct: 182 WSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 47/193 (24%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 334 VKRLQD--SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL 391
VK L+ ++ + +F+ E+ + +KN N++ LLG C++ ++ ++M NG L L
Sbjct: 49 VKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL 108
Query: 392 HPADDTGK--------SVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD 443
+ SV L +A+ A G +L + +HR+++++ L+ +
Sbjct: 109 SQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNH 165
Query: 444 FEPKISDFGLARLMNPIDTHLSTFVNGE-FGDLGYVAPEYARTLVATPKGDVYSFGTVLL 502
+ KI+DFG++R + D + + G + ++A E T DV++FG L
Sbjct: 166 YTIKIADFGMSRNLYSGDYYR---IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 503 ELVT--GERPTNV 513
E+ T E+P ++
Sbjct: 223 EMFTLCKEQPYSL 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 55/239 (23%), Positives = 105/239 (43%), Gaps = 25/239 (10%)
Query: 313 IGSGRTGTMYKALLEDGTS---LMVKRLQDSQRSEK---EFVAEMATLGSVKNRNLVPLL 366
+GSG GT+ K + + S + VK L++ E + E + + N +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 367 GFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
G C A+ +LV + G L L K V ++ + G +L
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET--- 114
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
+HR+++++ +LL KISDFGL++ + + + +G++ + + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW-PVKWYAPECMNYY 173
Query: 487 VATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544
+ K DV+SFG ++ E + G++P K E + Q+ +G+ + +C
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---------VTQMIESGERMECPQRC 223
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 43/218 (19%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE----FVA--EMATLGSVKN 359
+ K +G G +YKA E G + +K+++ +R E + F A E+ L +K+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDL----------LHPADDTGKSVDWPRRLKI 409
N++ LL K LV++ M DL L PAD KS
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME----TDLEKVIKDKSIVLTPADI--KS--------Y 107
Query: 410 AIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVN 469
+ RG +LH N I+HR++ +L+ D K++DFGLAR + ++ V
Sbjct: 108 MLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 470 GEFGDLGYVAPEY---ARTLVATPKGDVYSFGTVLLEL 504
+ Y APE AR D++S G + EL
Sbjct: 165 TRW----YRAPELLFGARHY--GVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 312 IIGSGRTGTMYKALLED-GTSLMVKRLQ---DSQRSEKEFVA---EMATLGSVKNRNLVP 364
++G G G +Y D G L VK++ DSQ + KE A E+ L ++++ +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 365 LLGFCMAKKERLL--VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
G +E+ L ++MP GS+ D L ++V RR I +G ++LH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT--RRYTRQI--LQGVSYLHS 124
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY 482
N I+HR+I IL D K+ DFG ++ + I T + G +++PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS-GTGIKSVTGTPYWMSPEV 180
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERP 510
K DV+S ++E++T + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 28/207 (13%)
Query: 313 IGSGRTGTMYKA--LLEDGTSLMVKRLQDSQRSEKEF-------VAEMATLGSVKNRNLV 363
IG G G ++KA L G + +KR++ Q E+ VA + L + ++ N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 364 PLLGFC-MAKKER----LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
L C +++ +R LV++H+ + L L + G + + + + RG
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLD 124
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+LH + R++HR++ + IL+ + K++DFGLAR+ + L++ V L Y
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVV----TLWYR 176
Query: 479 APE-YARTLVATPKGDVYSFGTVLLEL 504
APE ++ ATP D++S G + E+
Sbjct: 177 APEVLLQSSYATPV-DLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 24/197 (12%)
Query: 318 TGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377
TG MY L KR++ ++ E + E L V +R +V L K L
Sbjct: 24 TGKMYAC-----KKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77
Query: 378 VYKHMPNGSL----YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNI 433
V M G L Y++ +P D ++V + AA L RI++R++
Sbjct: 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFY---------AAEITCGLEDLHRERIVYRDL 128
Query: 434 SSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGD 493
+ ILLDD +ISD GLA + +T + G G +GY+APE + T D
Sbjct: 129 KPENILLDDYGHIRISDLGLAVEIPEGET-----IRGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 494 VYSFGTVLLELVTGERP 510
+ G ++ E++ G+ P
Sbjct: 184 WWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
IGSG G +YKA + G + +K ++ + + E++ L ++ N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI---GAARGFAWLHHNCNPR 427
+ + +V ++ GSL D+ L+IA +G A+LH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLS------ELQIAYVCRETLKGLAYLHET---G 121
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS---TFVNGEFGDLGYVAPEYAR 484
IHR+I ILL +D + K++DFG++ + ++ +F+ G ++APE A
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQ---LTATIAKRKSFI----GTPYWMAPEVAA 174
Query: 485 TLVATP---KGDVYSFGTVLLELVTGERP 510
K D+++ G +EL + P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 47/205 (22%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 312 IIGSGRTG--TMYKALLEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKNRNLVPLL 366
++G G G T+Y+ ED + ++ K + ++ SEKE + E+ L +++ N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 367 GFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIA--IGAARGFAWLHHNC 424
M L+ ++ G+LYD + + + + +++H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ----LFEEEMVLWYLFQIVSAVSYIHKA- 120
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
I+HR+I + I L K+ DFG+++++ + T V G Y++PE +
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV----GTPYYMSPELCQ 174
Query: 485 TLVATPKGDVYSFGTVLLELVTGER 509
+ K D+++ G VL EL+T +R
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN-RNLVP 364
F ++G+G G +YK ++ G +K + + E+E E+ L + RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 365 LLGFCMAKK------ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
G + K + LV + GS+ DL+ +W + I RG +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI--LRGLS 125
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
LH + ++IHR+I + +LL ++ E K+ DFG++ ++ +TF+ + ++
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY----WM 178
Query: 479 APEYARTLVATP------KGDVYSFGTVLLELVTGERP 510
APE P K D++S G +E+ G P
Sbjct: 179 APEVI-ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 47/149 (31%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
KE L NG DL+ D G+ D R A G +LH II+R+
Sbjct: 68 KEHLFFVMEFLNGG--DLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSK---GIIYRD 121
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG 492
+ ++LD D KI+DFG+ + D STF G Y+APE + L T
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC----GTPDYIAPEILQGLKYTFSV 177
Query: 493 DVYSFGTVLLELVTGERPTNVAKAPETFK 521
D +SFG +L E++ G+ P + E F+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 43/135 (31%), Positives = 62/135 (45%), Gaps = 24/135 (17%)
Query: 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441
G L+ +L D G ++ R IA F +LH+ II+R++ + +LLD
Sbjct: 75 CLGGELWTILR---DRGLFDEYTARFYIA-CVVLAFEYLHNR---GIIYRDLKPENLLLD 127
Query: 442 DDFEPKISDFGLAR-LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG-----DVY 495
+ K+ DFG A+ L + T TF G YVAPE + KG D +
Sbjct: 128 SNGYVKLVDFGFAKKLKSGQKTW--TFC----GTPEYVAPE-----IILNKGYDFSVDYW 176
Query: 496 SFGTVLLELVTGERP 510
S G +L EL+TG P
Sbjct: 177 SLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 31/197 (15%)
Query: 330 TSLMVKRLQDSQRSEKEFVAEMATLGS-VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLY 388
T +++K L S R+ E E A++ S + +++LV G C+ E ++V +++ GSL
Sbjct: 28 TEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSL- 86
Query: 389 DLLHPADDTGKSVDWPRRLKIAIGAARGFAW-LHHNCNPRIIHRNISSKCILL-----DD 442
D + ++ W +L++ A+ AW LH + + H N+ +K +LL
Sbjct: 87 DTYLKKNKNLINISW--KLEV----AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRK 140
Query: 443 DFEP---KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE---YARTLVATPKGDVYS 496
P K+SD G++ + P + L + +V PE + L + D +S
Sbjct: 141 TGNPPFIKLSDPGISITVLPKEILLER--------IPWVPPECIENPQNL--SLAADKWS 190
Query: 497 FGTVLLELVTG-ERPTN 512
FGT L E+ +G ++P +
Sbjct: 191 FGTTLWEIFSGGDKPLS 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 313 IGSGRTGTMYKALLEDG---TSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLG 367
IG+G G + + G ++VK L+ S + + +F+ E S+++ NL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL-KIAIGAARGFAWLHHNCNP 426
C LLV + P G L L P L ++A A G LH N
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE----- 481
IH +++ + LL D KI D+GL+ D +++ + + L ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP--DQLWVPLRWIAPELVDEV 177
Query: 482 YARTLVA--TPKGDVYSFGTVLLELVT-GERP 510
+ LV T + +V+S G + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 307 FSKNNIIGSGRTGTMYKA---LLEDGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNL 362
+ K IG G G +YKA + + +L RL Q+ + + E++ L +++ N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI-GAARGFAWLH 421
V L ++K LV++++ DL D + PR +K + RG A+ H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 422 HNCNPRIIHRNISSKCILLDDDFEP-KISDFGLARLMN-PIDTHLSTFVNGEFGDLGYVA 479
+ R++HR++ + +L+D K++DFGLAR P+ T V L Y A
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT-----LWYRA 171
Query: 480 PEY---ARTLVATPKGDVYSFGTVLLELVTGERP 510
PE +R +TP D++S G + E+V ++P
Sbjct: 172 PEILLGSRHY-STPV-DIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 40/123 (32%), Positives = 64/123 (52%), Gaps = 14/123 (11%)
Query: 395 DDTGKSVDWPRR----LKIAIGAARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPKIS 449
D+ WP L+ + A+G +L NC IHR+++++ +LL D KI
Sbjct: 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKIC 254
Query: 450 DFGLAR-LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-G 507
DFGLAR +MN D++ N + ++APE V T + DV+S+G +L E+ + G
Sbjct: 255 DFGLARDIMN--DSNYVVKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 311
Query: 508 ERP 510
+ P
Sbjct: 312 KSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 57/255 (22%), Positives = 101/255 (39%), Gaps = 39/255 (15%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVK---RLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
+G G G++YK L M RL+ + + + E+ L + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRII 429
+ + ++M GSL D L+ + + +I +G +L N II
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 430 HRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
HR++ +L++ + + K+ DFG++ + +++ G Y+APE ++
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 490 PKG------DVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS---------- 533
DV+S G +LE+ G P PET+ AQLS+
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYA----NIFAQLSAIVDGDPPTLP 231
Query: 534 ---TGQLQDAIDKCL 545
+ QD + KCL
Sbjct: 232 SGYSDDAQDFVAKCL 246
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 313 IGSGRTGTMYKALLEDGTSLM-VKRLQDS--QRSEKEFVAEM-ATLGSVKNRNLVPLLG- 367
IG G GT+ K L + ++M VKR++ + ++ +K + ++ + S +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 368 --------FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--KIAIGAARGF 417
CM L+ + Y ++ + KSV P + KIA+ +
Sbjct: 72 LFREGDCWICME-----LMDISLDK--FYKYVY---EVLKSV-IPEEILGKIAVATVKAL 120
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA-RLMNPI-DTHLSTFVNGEFGDL 475
+L IIHR++ ILLD + K+ DFG++ +L++ I T D
Sbjct: 121 NYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR----------DA 168
Query: 476 G---YVAPEYARTLVATPKG-----DVYSFGTVLLELVTGERP 510
G Y+APE R + G DV+S G L E+ TG+ P
Sbjct: 169 GCRPYMAPE--RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 50/248 (20%), Positives = 107/248 (43%), Gaps = 27/248 (10%)
Query: 312 IIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEK----EFVAEMATLGSVKNRNLVPLLG 367
+I ++YK + + ++++ + + K E+ L + + N++ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 368 FCMAKKERL----LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
F + + L L+ ++ G L ++L D K + + +L +AI +G L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKY 141
Query: 424 CN-PRIIHRNISSKCILLDDDFEPKISDFGLARLM-NPIDTHLSTFVNGEFGDLGYVAPE 481
N P ++N++S L+ ++++ KI GL +++ +P +++ V + L + E
Sbjct: 142 TNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSE 198
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK---GNLVEWIAQLSSTGQLQ 538
Y T K D+YS G VL E+ TG+ P E + L +++
Sbjct: 199 Y------TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK 252
Query: 539 DAIDKCLV 546
++ C
Sbjct: 253 CIVEACTS 260
|
Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 306 SFSKNNIIGSGRTGTMYKA---LLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL 362
+F + +G G T+YK + +L L + + + E++ + +K+ N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA------RG 416
V L + + +LV+++M DL D G L + +G
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK----DLKKYMDTHGV----RGALDPNTVKSFTYQLLKG 112
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDL 475
A+ H N R++HR++ + +L++ E K++DFGLAR P+ +TF N E L
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV----NTFSN-EVVTL 164
Query: 476 GYVAPEY---ARTLVATPKGDVYSFGTVLLELVTG 507
Y AP+ +RT + D++S G ++ E++TG
Sbjct: 165 WYRAPDVLLGSRTY--STSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 311 NIIGSGRTGTMYKAL-LEDGTSLMVKRLQ---DSQRSEKEFVAEMATLGSVKNR---NLV 363
IG G GT+YKA L G + +K+++ + + E+A L +++ N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 364 PLLGFCMAKK-ER----LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
LL C + +R LV++H+ + L L G + + L + RG
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQL--LRGVD 121
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+LH + RI+HR++ + IL+ D + KI+DFGLAR+ + + L++ V L Y
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV----TLWYR 173
Query: 479 APE------YARTLVATPKGDVYSFGTVLLEL 504
APE YA + D++S G + EL
Sbjct: 174 APEVLLQSSYATPV------DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF-GDLGYVAPEYARTL 486
II+R++ + ILLD++ K++DFGL++ ID + F G + Y+APE
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAY---SFCGTVEYMAPEVVNRR 173
Query: 487 VATPKGDVYSFGTVLLELVTGERP 510
T D +SFG ++ E++TG P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-EMATLGSVKNRNLVPLLGFCM 370
+GSG G +YKA L G VK ++ + + E+ + K+ N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP-RRLKIAI---GAARGFAWLHHNCNP 426
++++ + ++ GSL D+ H V P L+IA +G A+LH
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH--------VTGPLSELQIAYVCRETLQGLAYLHSKGK- 127
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
+HR+I ILL D+ + K++DFG+A + +F+ + ++APE A
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY----WMAPEVA--- 178
Query: 487 VATPKG-------DVYSFGTVLLELVTGERP 510
A K D+++ G +EL + P
Sbjct: 179 -AVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 11/120 (9%)
Query: 95 QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVG---FLTSLDLSSNNFSGSIPSNLAN 151
P +RN ++ LDLS N L D+ KL+ L +LDLS N S +P +
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDL-----SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL 207
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
+ L L L +N ++ L L L ++NN L + NL+ L ++NNQ
Sbjct: 208 LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 312 IIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVA---EMATLGSVKNRNLVPLLG 367
IG G G +Y A + D ++K + ++ KE A E+ L +K+ N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVD----WPRRLKIAIGAARGFAWLHHN 423
+V ++ G L ++ S D W ++I++G L H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG-------LKHI 117
Query: 424 CNPRIIHRNISSKCILLDDD-FEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY 482
+ +I+HR+I S+ I L + K+ DFG+AR +N T V + Y++PE
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY----YLSPEI 173
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERP 510
+ K D++S G VL EL T + P
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 34/141 (24%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
RG ++H + IIHR++ I +++D E KI DFGLAR D ++ +V +
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVATRW-- 180
Query: 475 LGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527
Y APE Y +T+ D++S G ++ EL+TG+ F G+ +
Sbjct: 181 --YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGK---------TLFPGS--DH 221
Query: 528 IAQLSSTGQLQDAIDKCLVAK 548
I QL L D+ L+ K
Sbjct: 222 IDQLKRIMNLVGTPDEELLQK 242
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRS---EKEFVAEMATLGSVKNRNLVPLLG- 367
+GSG G++ A + G + VK+L +S K E+ L +K+ N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 368 FCMAK--KERLLVY--KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
F A+ +E VY H+ L +++ T V + + RG ++H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIH-- 137
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE-- 481
+ IIHR++ + +++D E KI DFGLAR H + G Y APE
Sbjct: 138 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 189
Query: 482 -----YARTLVATPKGDVYSFGTVLLELVTG 507
Y +T+ D++S G ++ EL+TG
Sbjct: 190 LNWMHYNQTV------DIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
R ++H + HR++ K IL + D + KI DFGLAR+ DT + F
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAIFWTDYVAT 169
Query: 475 LGYVAPEYARTLVA--TPKGDVYSFGTVLLELVTGE 508
Y APE + + TP D++S G + E++TG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNR-NLVPLLGFCM 370
IG G G ++K L ++G+ VK L ++E AE L ++ + N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 371 AKKER-----LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
K + LV + GS+ DL+ G+ ++ P I A G LH N
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-- 143
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY--- 482
+ IHR++ ILL + K+ DFG++ + +T V F ++APE
Sbjct: 144 -KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF----WMAPEVIAC 198
Query: 483 ARTLVAT--PKGDVYSFGTVLLELVTGERP 510
+ L +T + DV+S G +EL G+ P
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 15/90 (16%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLA-RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
+IHR++ ILLD K+ DFG++ RL +D+ T G Y+APE R
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRL---VDSKAKT---RSAGCAAYMAPE--RID 187
Query: 487 VATPKG------DVYSFGTVLLELVTGERP 510
P DV+S G L+EL TG+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 9e-06
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 26/107 (24%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
RG +LH + N +IHR++ IL++ + + KI DFGLAR ++P +
Sbjct: 114 RGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------ 164
Query: 475 LGYV------APEYARTLVATPKG-----DVYSFGTVLLELVTGERP 510
YV APE L+ + D++S G + EL+T +P
Sbjct: 165 -EYVVTRWYRAPE----LLLSSSRYTKAIDIWSVGCIFAELLTR-KP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 306 SFSKNNIIGSGRTGTMYKA---LLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL 362
++ K + +G G T+YK L +L RL+ + + + E + L +K+ N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI-GAARGFAWLH 421
V L KK LV++++ DL DD G + +++ + RG A+ H
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLDT----DLKQYMDDCGGGLS-MHNVRLFLFQLLRGLAYCH 120
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP- 480
R++HR++ + +L+ + E K++DFGLAR + + T+ N E L Y P
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSK--TYSN-EVVTLWYRPPD 173
Query: 481 ------EYARTLVATPKGDVYSFGTVLLELVTGERPT 511
EY+ +L D++ G + E+ TG RP
Sbjct: 174 VLLGSTEYSTSL------DMWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 37/220 (16%)
Query: 307 FSKNNIIGSGRTGTMYKA--LLEDGTSLMVK-RLQDSQRSEKEFVA-----EMATLGSVK 358
++K IG G G +YK M K RL+ SE+E V E++ L ++
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE----SEEEGVPSTAIREISLLKELQ 57
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDT--GKSVDWPRRLKIAI-GAAR 415
+ N+V L M + L+++ + DL D G+ +D +K + +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMD-AELVKSYLYQILQ 112
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PID--THLSTFVNGEF 472
G + H R++HR++ + +L+D+ K++DFGLAR P+ TH E
Sbjct: 113 GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-------EV 162
Query: 473 GDLGYVAPE--YARTLVATPKGDVYSFGTVLLELVTGERP 510
L Y APE +TP D++S GT+ E+ T ++P
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPV-DIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 46/225 (20%)
Query: 311 NIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKE-----FVAEMATLGSVKNRNLVP 364
IG G G +YKA +D G + +K+++ +EKE + E+ L + +RN+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHRNIVN 70
Query: 365 L----------LGFCMAKKERLLVYKHMPNGSLYDLL-----HPADDTGKSVDWPRRLKI 409
L L F K LV+++M + L LL H ++D KS ++L
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSF--MKQL-- 125
Query: 410 AIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVN 469
G + H +HR+I ILL++ + K++DFGLARL N ++ T
Sbjct: 126 ----LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT--- 175
Query: 470 GEFGDLGYVAPEYARTLVA----TPKGDVYSFGTVLLELVTGERP 510
+ L Y PE L+ P DV+S G +L EL T ++P
Sbjct: 176 NKVITLWYRPPEL---LLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 27/95 (28%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
RG ++H + ++HR++ IL++++ + KI DFGLAR+ +P ++ +V+ +
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRY-- 170
Query: 475 LGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGE 508
Y APE T + D++S G + E++ G+
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 61/258 (23%), Positives = 115/258 (44%), Gaps = 38/258 (14%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEK--EFVAEMATLGSVKNRNLVPLLGFCM 370
+G G G +YKA ++ L ++ D++ E+ +++ E+ L S + N+V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
+ ++ + G++ ++ + + + P+ + +LH N +IIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 431 RNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE--YARTLVA 488
R++ + IL D + K++DFG++ +F+ + ++APE T
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY----WMAPEVVMCETSKD 182
Query: 489 TP---KGDVYSFGTVLLELVTGERPTN----------VAKA-PETFKGNLVEWIAQLSS- 533
P K DV+S G L+E+ E P + +AK+ P T +AQ S
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--------LAQPSRW 234
Query: 534 TGQLQDAIDKCLVAKGVD 551
+ + +D + KCL K VD
Sbjct: 235 SSEFKDFLKKCL-EKNVD 251
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 19/244 (7%)
Query: 312 IIGSGRTG-TMYKALLEDGTSLMVKRLQDS---QRSEKE-FVAEMATLGSVKNRNLVPLL 366
++G G G M L E G VK L+ Q + E + E L +N + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 367 GFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
C +RL NG DL+ + + D R A +LH +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG--DLMFHIQKS-RRFDEARARFYAAEITSALMFLH---DK 115
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLAR--LMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
II+R++ +LLD + K++DFG+ + + N T STF G Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFC----GTPDYIAPEILQ 169
Query: 485 TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544
++ P D ++ G +L E++ G P + F+ L + + + Q I K
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229
Query: 545 LVAK 548
+ K
Sbjct: 230 FMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 17/99 (17%)
Query: 414 ARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM--NPIDTHLSTFVNGE 471
ARG +L + + IHR+++++ ILL ++ KI DFGLAR + +P +V
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------DYVRK- 232
Query: 472 FGD----LGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506
GD L ++APE V T + DV+SFG +L E+ +
Sbjct: 233 -GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 14/118 (11%)
Query: 414 ARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFG 473
A+G +L + + IHR+++++ ILL ++ KI DFGLAR + ++ G
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK------G 239
Query: 474 D----LGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVE 526
D L ++APE V T + DV+SFG +L E+ + G P K E F L E
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVA--EMATLGSVKN 359
A S+ +G G T+YK + +G + +K + F A E + L +K+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNG-SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
N+V L K+ V+++M + Y + HP +V RL RG A
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNV----RL-FMFQLLRGLA 117
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEF--GDL 475
++H I+HR++ + +L+ E K++DFGLAR + P T+ S V + D+
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174
Query: 476 GYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPT--NVAKAPE 518
A +Y+ L D++ G + +E++ G+ P V+ E
Sbjct: 175 LLGATDYSSAL------DIWGAGCIFIEMLQGQ-PAFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 46/185 (24%), Positives = 90/185 (48%), Gaps = 17/185 (9%)
Query: 329 GTSLMVKRLQDSQRSEK--EFVAEMATLGSVKNRNLVPLLGFCMAKKER--LLVYKHMPN 384
G + VK L+ + E+ L ++ + N+V G C L+ + +P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF 444
GSL + L P + ++ ++LK A+ +G +L + +HR+++++ +L++ +
Sbjct: 93 GSLKEYL-PRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146
Query: 445 EPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE---YARTLVATPKGDVYSFGTVL 501
+ KI DFGL + + D T + + + APE ++ +A+ DV+SFG L
Sbjct: 147 QVKIGDFGLTKAIET-DKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS---DVWSFGVTL 202
Query: 502 LELVT 506
EL+T
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 39/131 (29%), Positives = 65/131 (49%), Gaps = 13/131 (9%)
Query: 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHNCNPRIIHRNISSKC 437
YK + + +LL +DD + + L ARG +L NC +HR+++++
Sbjct: 214 YKGSNDSEVKNLL--SDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARN 267
Query: 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVN--GEFGDLGYVAPEYARTLVATPKGDVY 495
+LL KI DFGLAR + H S +V+ F + ++APE + T DV+
Sbjct: 268 VLLAQGKIVKICDFGLARDI----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323
Query: 496 SFGTVLLELVT 506
S+G +L E+ +
Sbjct: 324 SYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 10/119 (8%)
Query: 395 DDTGKSVDWPRRLKIAIGAARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453
++ ++D L + A+G ++L NC IHR+++++ ILL KI DFGL
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGL 260
Query: 454 ARLMNPIDTHLSTFVNGEFG-DLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
AR I + V G + ++APE V T + DV+S+G +L E+ + G P
Sbjct: 261 AR---DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE 445
SL D G ++ KIA+ + +LH + +IHR++ +L++ + +
Sbjct: 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQ 142
Query: 446 PKISDFGLARLMNPIDTHLSTFVNGEFGDLG---YVAPEYARTLVAT-PKG-----DVYS 496
K+ DFG++ +D+ T D G Y+APE R KG DV+S
Sbjct: 143 VKLCDFGISG--YLVDSVAKTI------DAGCKPYMAPE--RINPELNQKGYDVKSDVWS 192
Query: 497 FGTVLLELVTGERPTNVAKAP-ETFKGNLVEWIAQLSSTG---QLQDAIDKCL 545
G ++EL TG P + K P + K + E QL + + QD ++KCL
Sbjct: 193 LGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCL 245
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
C +RL NG DL++ G+ + P + A A G +LH + I
Sbjct: 69 CFQTMDRLYFVMEYVNGG--DLMYQIQQVGRFKE-PHAVFYAAEIAIGLFFLH---SKGI 122
Query: 429 IHRNISSKCILLDDDFEPKISDFGLAR--LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I+R++ ++LD + KI+DFG+ + + + + T TF G Y+APE
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT--KTFC----GTPDYIAPEIIAYQ 176
Query: 487 VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLV 546
D ++FG +L E++ G+ P E F+ + +A S + AI K L+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 236
Query: 547 AK 548
K
Sbjct: 237 TK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 46/155 (29%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 368 FC-MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
+C KE L NG DL+ K D PR A G +LH +
Sbjct: 62 YCTFQTKENLFFVMEYLNGG--DLMFHIQSCHK-FDLPRATFYAAEIICGLQFLH---SK 115
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I++R++ ILLD D KI+DFG+ + D TF G Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAPEILLGQ 171
Query: 487 VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521
D +SFG +L E++ G+ P + E F+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 9/118 (7%)
Query: 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYL 155
P+ + N S++ LDLS NK+ LP +I L L LDLS+N+ + S+L+N L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSA-LEELDLSNNSII-ELLSSLSNLKNL 234
Query: 156 NSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS-----GSIPTFVNLTLSADSVTN 208
+ L+L +N+ +P +G L L++ ++NN +S GS+ L LS +S++N
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSN 291
|
Length = 394 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 57/248 (22%), Positives = 101/248 (40%), Gaps = 48/248 (19%)
Query: 285 VSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTM----YKALLEDGTSLMVKRLQDS 340
++ ++ +I K+R DL + +IG G G + +K+ + ++ + +
Sbjct: 25 LNRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 82
Query: 341 QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGK 399
+RS+ F E + + N V L + L +V ++MP G L +L+ D K
Sbjct: 83 KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK 142
Query: 400 SVDWPR----RLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455
W R + +A+ A + IHR++ +LLD K++DFG
Sbjct: 143 ---WARFYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 456 LMNP-----IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVY--------SFGTVLL 502
MN DT + G Y++PE ++ + GD Y S G L
Sbjct: 191 KMNKEGMVRCDTAV--------GTPDYISPE----VLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 503 ELVTGERP 510
E++ G+ P
Sbjct: 239 EMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRLQDS----QRSEKEFVAEMATL-GSVKNRNLVPL 365
+IG G G + A DG VK LQ ++ +K +AE L +VK+ LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 366 LGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
+ ++L V ++ G L+ L +S PR A A +LH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH--- 113
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYVAPE-- 481
+ II+R++ + ILLD ++DFGL + + T STF G Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTFC----GTPEYLAPEVL 168
Query: 482 ----YARTLVATPKGDVYSFGTVLLELVTGERP 510
Y RT+ D + G VL E++ G P
Sbjct: 169 RKQPYDRTV------DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 51/186 (27%), Positives = 74/186 (39%), Gaps = 12/186 (6%)
Query: 342 RSE-KEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKS 400
RSE +AE L V +VPL F E+L + NG +L H G+
Sbjct: 34 RSEVTHTLAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGG--ELFHHLQREGRF 90
Query: 401 VDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460
R A L + +I+R++ + ILLD + DFGL +L
Sbjct: 91 DLSRARFYTA----ELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146
Query: 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETF 520
D +TF G Y+APE T D ++ G +L E++TG P E +
Sbjct: 147 DDKTNTFC----GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202
Query: 521 KGNLVE 526
+ L E
Sbjct: 203 RKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
II+R+I + ILLD + ++DFGL++ + + G + Y+APE R
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA---YSFCGTIEYMAPEVIRG-- 180
Query: 488 ATPKG-----DVYSFGTVLLELVTGERPTNV 513
G D +S G + EL+TG P V
Sbjct: 181 -GSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEF-----VAEMATLGSVKNRNLVPLL 366
+G G G +YKA ++ G + +K++ +EK+ + E+ L +K+ N+VPL+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 367 GFCMA-------KKERLLVYKHMP--NGSLYDLLHPADDTGKSVDW-PRRLK-IAIGAAR 415
MA K++R VY P + L LL SV ++K +
Sbjct: 74 D--MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-----NPSVKLTESQIKCYMLQLLE 126
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G +LH N I+HR+I + IL+D+ KI+DFGLAR P D G G
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR---PYDGPPPNPKGGGGGGT 180
Query: 476 G----------YVAPEYARTLVA-----TPKGDVYSFGTVLLELVTGERP 510
Y PE L+ T D++ G V E+ T RP
Sbjct: 181 RKYTNLVVTRWYRPPE----LLLGERRYTTAVDIWGIGCVFAEMFTR-RP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 313 IGSGRTGTMYKALLEDGTS---LMVKRLQDSQRSEKEFVA--------EMATLGSVKNRN 361
IG G G +YKA ++G +K+ + +KE E+A L +K+ N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLRELKHEN 63
Query: 362 LVPLLGFCMAKKERL--LVYKHMPNGSLYDLLHPADD--TGKSVDWPRR-LK-IAIGAAR 415
+V L+ + ++ L++ + + +DL K V P +K +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEP----KISDFGLARLMN-PIDTHLSTFVNG 470
G +LH N ++HR++ IL+ + KI D GLARL N P+ ++
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD--LDP 174
Query: 471 EFGDLGYVAPEY---ARTLVATPKGDVYSFGTVLLELVT 506
+ Y APE AR T D+++ G + EL+T
Sbjct: 175 VVVTIWYRAPELLLGARHY--TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-EMATLGSVKNRNLVPLLGFCM 370
IGSG G +YKA + G +K ++ + V E+ + K+ N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP-RRLKIAIGAARGFAWLHHNCNPRII 429
+ + + + GSL D+ H V P +IA + L++ + +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH--------VTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 430 HRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
HR+I ILL D+ K++DFG++ + +F+ + ++APE A
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY----WMAPEVA---AVE 181
Query: 490 PKG------DVYSFGTVLLELVTGERP 510
KG D+++ G +EL + P
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQ---DSQRSEKEFVAEMATLGSVKNRNLVPLLGF 368
IGSG G + A G ++ VK+L +Q K E+ L V ++N++ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 369 CMAKK-----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
+K + + + + + +L ++H +D R + G LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLH-- 140
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+ IIHR++ I++ D KI DFGLAR + ++ +V + Y APE
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC-TNFMMTPYVVTRY----YRAPEVI 194
Query: 484 RTLVATPKGDVYSFGTVLLELVTG 507
+ D++S G ++ ELV G
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
L H N +++R++ ILLD+ +ISD GLA + H S G GY+A
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMA 163
Query: 480 PEYARTLVA-TPKGDVYSFGTVLLELVTGERP 510
PE + VA D +S G +L +L+ G P
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 30/232 (12%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTS--LMVKRLQDSQRSEKE---FVAEMATLGSVKN 359
F +++G G G + + + E T +K ++ S +E F E + S+ N
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 360 RNLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPR----RLKIAIGAA 414
+P L + K+ L LV ++ P G L LL+ +D D + L +AI +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE-DMAQFYLAELVLAIHSV 118
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
+ +HR+I + +L+D K++DFG A + S G
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL---PVGT 166
Query: 475 LGYVAPEYARTLVATPKG------DVYSFGTVLLELVTGERPTNVAKAPETF 520
Y+APE T+ KG D +S G + E++ G P + + +T+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 12/105 (11%)
Query: 407 LKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466
L I R +LH N RIIHR+I ++ I ++ + + DFG A P+D +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDIN--- 236
Query: 467 FVNGEFGDLGYVAPEYARTLVATPKG---DVYSFGTVLLELVTGE 508
N +G G +A L P G D++S G VL E+ T
Sbjct: 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 15/98 (15%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT-HLSTFVNGEFG 473
RG +LH + I+HR+I +L++ + KI DFGLAR+ P ++ H++ V ++
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 474 DLGYVAPEYARTLVATP----KGDVYSFGTVLLELVTG 507
Y APE L+ + D++S G + EL+
Sbjct: 170 ---YRAPE---ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 59/271 (21%), Positives = 110/271 (40%), Gaps = 57/271 (21%)
Query: 259 SMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRT 318
++RK K+ D N++ K + + +++ + + K +IG G
Sbjct: 14 ALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVK-----------------VIGRGAF 56
Query: 319 GTM----YKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374
G + +K+ + ++ + + +RS+ F E + + N V L FC + +
Sbjct: 57 GEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-FCAFQDD 115
Query: 375 RLL--VYKHMPNGSLYDLLHPADDTGKSVDWPR----RLKIAIGAARGFAWLHHNCNPRI 428
+ L V ++MP G L +L+ D K W + + +A+ A +
Sbjct: 116 KYLYMVMEYMPGGDLVNLMSNYDVPEK---WAKFYTAEVVLALDAIHSMG---------L 163
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPID-THLSTFVNGEFGDLGYVAPEYARTLV 487
IHR++ +LLD K++DFG M+ T V G Y++PE ++
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV----GTPDYISPE----VL 215
Query: 488 ATPKGDVY--------SFGTVLLELVTGERP 510
+ GD Y S G L E++ G+ P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 14/144 (9%)
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
C K+RL NG DL+ + K D PR A +LH + +
Sbjct: 64 CFQTKDRLFFVMEYVNGG--DLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRH---GV 117
Query: 429 IHRNISSKCILLDDDFEPKISDFGLAR--LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I+R++ ILLD + K++DFG+ + ++N + T +TF G Y+APE + L
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFC----GTPDYIAPEILQEL 171
Query: 487 VATPKGDVYSFGTVLLELVTGERP 510
P D ++ G ++ E++ G+ P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 414 ARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFG 473
ARG +L + + IHR+++++ ILL ++ KI DFGLAR + D +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL- 238
Query: 474 DLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
L ++APE V T + DV+SFG +L E+ + G P
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 60/234 (25%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNRNLVPLLGF 368
+GSG GT+ AL G + +K+L +SE K E+ L +K+ N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 369 CMAKKERLLVYKHMPNGSLYD-----LLHP--ADDTGKSVDWPR----RLKIAI-GAARG 416
P+ SL L+ P D GK + + R++ + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
++H IIHR++ + +++D E KI DFGLAR D+ ++ +V +
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRW---- 180
Query: 477 YVAPE-------YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN 523
Y APE Y +T+ D++S G ++ E++TG +P FKG+
Sbjct: 181 YRAPEVILNWMHYTQTV------DIWSVGCIMAEMLTG-KP--------LFKGH 219
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 7/92 (7%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
L H N +++R++ ILLD+ +ISD GLA + H S G GY+A
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMA 163
Query: 480 PEYARTLVA-TPKGDVYSFGTVLLELVTGERP 510
PE + A D +S G +L +L+ G P
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
C +RL NG DL++ GK + P+ + A + G +LH I
Sbjct: 69 CFQTVDRLYFVMEYVNGG--DLMYHIQQVGKFKE-PQAVFYAAEISVGLFFLHRR---GI 122
Query: 429 IHRNISSKCILLDDDFEPKISDFGLAR--LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I+R++ ++LD + KI+DFG+ + +++ + T TF G Y+APE +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR--TFC----GTPDYIAPE---II 173
Query: 487 VATPKG---DVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543
P G D +++G +L E++ G+ P + E F+ + ++ S + +I K
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK 233
Query: 544 CLVAK 548
L+ K
Sbjct: 234 GLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 13/101 (12%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM--NPID--THLSTFVNG 470
RG ++H +IHR++ +L+++D E +I DFG+AR + +P + ++ +V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-- 172
Query: 471 EFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERP 510
Y APE +L T D++S G + E++ G R
Sbjct: 173 --ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 312 IIGSGRTGTMYKALLE-DGTSLMVKRLQD----SQRSEKEFVAEM-ATLGSVKNRNLVPL 365
+IG G G + A + DG VK LQ +++ +K +AE L +VK+ LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 366 LGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
+ E+L V + G L+ L +S PR A A +LH
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH--- 113
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+ I++R++ + ILLD ++DFGL + +TF G Y+APE R
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC----GTPEYLAPEVIR 169
Query: 485 TLVATPKGDVYSFGTVLLELVTGERP 510
D + G VL E++ G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 312 IIGSGRTGTMYKALLE----DGTSLMVKRLQDS----QRSEKEFVAEMATL-GSVKNRNL 362
+IG G G K LL DG+ VK LQ ++ + +AE L ++K+ L
Sbjct: 2 VIGKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 363 VPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
V L + E+L V ++ G L+ H + + PR A A +LH
Sbjct: 59 VGL-HYSFQTAEKLYFVLDYVNGGELF--FHLQRE--RCFLEPRARFYAAEVASAIGYLH 113
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYVAP 480
+ II+R++ + ILLD ++DFGL + + P +T STF G Y+AP
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFC----GTPEYLAP 165
Query: 481 EYARTLVATPKGDVYSFGTVLLELVTGERP 510
E R D + G VL E++ G P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 28/131 (21%), Positives = 65/131 (49%), Gaps = 12/131 (9%)
Query: 334 VKRLQD--SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL 391
VK L++ ++ + +F+ E+ + +K+ N++ LL C+ ++ ++M NG L L
Sbjct: 51 VKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL 110
Query: 392 -------HPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF 444
++ + + +A A G +L + +HR+++++ L+ ++
Sbjct: 111 SRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNY 167
Query: 445 EPKISDFGLAR 455
KI+DFG++R
Sbjct: 168 TIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
C K+RL NG DL+ +G+ D PR A G +LH I
Sbjct: 64 CFQTKDRLFFVMEYVNGG--DLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLHER---GI 117
Query: 429 IHRNISSKCILLDDDFEPKISDFGLAR--LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I+R++ +LLD + KI+DFG+ + ++ + T STF G Y+APE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFC----GTPDYIAPEILSYQ 171
Query: 487 VATPKGDVYSFGTVLLELVTGERP 510
P D ++ G +L E++ G+ P
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 31/180 (17%)
Query: 339 DSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDT 397
+S EK T S ++ LV L C ++ + V ++ G L ++H D
Sbjct: 44 ESLMCEKRI---FETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV 97
Query: 398 GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL- 456
PR + A G +LH N +I++R++ +LLD + KI+DFGL +
Sbjct: 98 ---FSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151
Query: 457 MNPIDTHLSTFVNGEFGDLGYVAPE------YARTLVATPKGDVYSFGTVLLELVTGERP 510
M D STF G ++APE Y R + D + G ++ E++ GE P
Sbjct: 152 MGFGDR-TSTFC----GTPEFLAPEVLTETSYTRAV------DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
H+ N ++HR++ +L++ D E KI DFGLAR + + F+ Y APE
Sbjct: 122 HSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 482 YARTLVATPKG-DVYSFGTVLLELVTGERP 510
+ + K DV+S G +L EL+ G +P
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELL-GRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 15/92 (16%)
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG-YVAPEYART 485
+IHR++ ILL+ D K++DFGLAR ++ ++ N E L YVA + R
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE------NPENPVLTDYVATRWYRA 180
Query: 486 ---LVATP---KG-DVYSFGTVLLELVTGERP 510
L+ + KG D++S G +L E++ G +P
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLG-KP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 64/290 (22%), Positives = 111/290 (38%), Gaps = 42/290 (14%)
Query: 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ----DSQRSEKEFVAEMATLGSVK 358
+F IG G+ +YKA+ L DG + +K++Q ++ ++ + E+ L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
+ N++ L + E +V + G L ++ + + K +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+H RI+HR+I + + K+ D GL R + T + V G Y+
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYM 173
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG---NLVEWIAQLSSTG 535
+PE K D++S G +L E+ + P F G NL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---------FYGDKMNLYS--------- 215
Query: 536 QLQDAIDKC----LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
L I+KC L A EL + C+ P P++RP + V Q
Sbjct: 216 -LCKKIEKCDYPPLPADHYSEELRDLVSR---CINP-DPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 3e-04
Identities = 17/44 (38%), Positives = 22/44 (50%), Gaps = 5/44 (11%)
Query: 33 EDLACLKSIKDSL-EDPFNYLNSSWNFNNDTEGFICKFTGVECW 75
+D L + K SL DP L SSWN ++ C +TGV C
Sbjct: 3 DDRDALLAFKSSLNGDPSGAL-SSWNPSSSD---PCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 28/196 (14%)
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF-GDLGYVAPEYART 485
+++HR++ S I L K+ DFG ++ + +S V F G Y+APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS---DSVSLDVASSFCGTPYYLAPELWER 245
Query: 486 LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCL 545
+ K D++S G +L EL+T RP FKG I Q G+ C
Sbjct: 246 KRYSKKADMWSLGVILYELLTLHRP---------FKGPSQREIMQQVLYGKYDPF--PCP 294
Query: 546 VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLRAIGERYH-FTTEDEIMLPS 602
V+ G +K + +L P RPT ++ FL+ + + E + P
Sbjct: 295 VSSG--------MKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPH 346
Query: 603 DSGDADILEELIVARE 618
D +IL +L + E
Sbjct: 347 DR--EEILRQLQESGE 360
|
Length = 478 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 12/93 (12%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR--LMNPIDTHLSTFVNGEF 472
G +LH RIIHR++ ++ I ++D + I D G A+ ++ P L+
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA------- 217
Query: 473 GDLGYVAPEYARTLVATPKGDVYSFGTVLLELV 505
G + APE K D++S G VL E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 19/97 (19%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH---LSTFVNGEFGDLGYV 478
H+ N ++HR++ +LL+ + + KI DFGLAR+ +P H L+ +V + Y
Sbjct: 123 HSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW----YR 176
Query: 479 APEYARTLVATPKG-----DVYSFGTVLLELVTGERP 510
APE ++ KG D++S G +L E+++ RP
Sbjct: 177 APE----IMLNSKGYTKAIDIWSVGCILAEMLSN-RP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 414 ARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
A G +L NC +HR+++++ +L+ + KI DFGLAR + ++S F
Sbjct: 249 ANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTF 302
Query: 473 GDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506
L ++APE + T DV+SFG +L E+ T
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 20/207 (9%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLG 367
IG G+ +Y+A L D + +K++Q + ++ ++ V E+ L + + N++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL----HHN 423
+ E +V + G L ++ K +RL + F L H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMI-------KYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+ R++HR+I + + K+ D GL R + T + V + Y++PE
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY----YMSPERI 178
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERP 510
K D++S G +L E+ + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 23/101 (22%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
RG ++H + IIHR++ + +++D E +I DFGLAR D ++ +V +
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRW-- 180
Query: 475 LGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
Y APE Y +T+ D++S G ++ EL+ G+
Sbjct: 181 --YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 18/194 (9%)
Query: 318 TGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377
TG MY L KRL+ + EK + E L V + +V L +K L
Sbjct: 17 TGKMYAC-----KKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCL 70
Query: 378 VYKHMPNGSL-YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSK 436
V M G L Y + + + + ++ R + + G LH + I++R++ +
Sbjct: 71 VMSLMNGGDLKYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPE 124
Query: 437 CILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYS 496
+LLDD ++SD GLA + T + G GY+APE + + D ++
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGKT-----ITQRAGTNGYMAPEILKEEPYSYPVDWFA 179
Query: 497 FGTVLLELVTGERP 510
G + E+V G P
Sbjct: 180 MGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
II+R++ +LLD D K++D+G+ + + P DT STF G Y+APE R
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-TSTFC----GTPNYIAPEILRGE 171
Query: 487 VATPKGDVYSFGTVLLELVTGERPTNV 513
D ++ G ++ E++ G P ++
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 61/288 (21%), Positives = 115/288 (39%), Gaps = 44/288 (15%)
Query: 306 SFSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRLQ----DSQRSEKEFVAEMATLGSVKNR 360
+F IG G+ +Y+A L DG + +K++Q ++ + + E+ L + +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF--- 417
N++ + E +V + G L ++ K +RL + F
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMI-------KHFKKQKRLIPEKTVWKYFVQL 115
Query: 418 -AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+ L H + R++HR+I + + K+ D GL R + T + V +
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY---- 171
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536
Y++PE K D++S G +L E+ + P F G+ + +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---------FYGDKMNLYS------- 215
Query: 537 LQDAIDKC----LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVY 580
L I++C L + EL Q + + C+ P P++RP + VY
Sbjct: 216 LCKKIEQCDYPPLPSDHYSEELRQLVNM---CINPD-PEKRPDITYVY 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 10/109 (9%)
Query: 397 TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR- 455
TGK++ + + I G ++H RI+HR++ +K I L ++ KI DFG++R
Sbjct: 99 TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL 154
Query: 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLEL 504
LM D +TF G Y++PE + K D++S G +L E+
Sbjct: 155 LMGSCDL-ATTFT----GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 18/146 (12%)
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
C +RL NG DL++ GK + P + A A G +LH + I
Sbjct: 69 CFQTMDRLYFVMEYVNGG--DLMYHIQQVGKFKE-PHAVFYAAEIAIGLFFLH---SKGI 122
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
I+R++ ++LD + KI+DFG+ + + T TF G Y+APE +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-TRTFC----GTPDYIAPE---IIA 174
Query: 488 ATPKG---DVYSFGTVLLELVTGERP 510
P G D ++FG +L E++ G+ P
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 22/102 (21%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM-NPIDTHLSTFVNGEFG 473
G A LH N I+HR++ + +LL++ KI DFGLAR +P+ + V
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT---- 169
Query: 474 DLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
L Y APE Y + D++S G + EL+T +
Sbjct: 170 -LWYRAPELLLGAKEY------STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 27/102 (26%), Positives = 54/102 (52%), Gaps = 20/102 (19%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTH---LSTFVNG 470
RG ++H + ++HR++ + ++ +D KI DFGLAR+++P +H LS +
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 471 EFGDLGYVAPEYARTLVATPKG-----DVYSFGTVLLELVTG 507
++ Y +P L+ +P D+++ G + E++TG
Sbjct: 182 KW----YRSPR----LLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 23/204 (11%)
Query: 313 IGSGRTGTM---YKALLEDGTSLM-VKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGF 368
IGSG G + Y A+LE ++ + R +Q K E+ + V ++N++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 369 CMAKK-----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
+K + + + + + +L ++ +D R + G LH
Sbjct: 92 FTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-- 143
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+ IIHR++ I++ D KI DFGLAR S + Y APE
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVI 197
Query: 484 RTLVATPKGDVYSFGTVLLELVTG 507
+ D++S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLAR-LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I++R+I + ILLD + ++DFGL++ ++ +F G + Y+APE R
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC----GTIEYMAPEIIRGK 181
Query: 487 VATPKG-DVYSFGTVLLELVTGERP 510
K D +S G ++ EL+TG P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.002
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 51/220 (23%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA--EMATLGSVK-NRNLVPLLGF 368
+G G G++Y A E G + +K+++ S +E + E+ +L + + N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR--------GFAWL 420
E V+++M G+LY L+ D GK + R G A +
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLM--KDRKGK--------PFSESVIRSIIYQILQGLAHI 115
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR---LMNPIDTHLSTFVNGEFGDLGY 477
H + HR++ + +L+ KI+DFGLAR P ++ST Y
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST--------RWY 164
Query: 478 VAPE-------YARTLVATPKGDVYSFGTVLLELVTGERP 510
APE Y+ + D+++ G ++ EL T RP
Sbjct: 165 RAPEILLRSTSYSSPV------DIWALGCIMAELYTL-RP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 20/88 (22%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE------ 481
IIHR++ + +++D E KI DFGLAR D ++ +V + Y APE
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRW----YRAPEVILNWM 190
Query: 482 -YARTLVATPKGDVYSFGTVLLELVTGE 508
Y +T+ D++S G ++ E++TG+
Sbjct: 191 HYNQTV------DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 20/106 (18%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE------ 481
IHR++ + L+D K++DFGL+ + T+ N G Y+APE
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLS-------KGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527
Y T+ D +S G +L E + G P + + ET++ NL W
Sbjct: 175 YDFTV------DYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 29/112 (25%), Positives = 57/112 (50%), Gaps = 6/112 (5%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
II+R++ +LLD + K++D+G+ + + P DT STF G Y+APE R
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC----GTPNYIAPEILRGE 171
Query: 487 VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538
D ++ G ++ E++ G P ++ + + N +++ Q+ Q++
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|213052 cd12087, TM_EGFR-like, Transmembrane domain of the Epidermal Growth Factor Receptor family of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.002
Identities = 10/39 (25%), Positives = 23/39 (58%), Gaps = 1/39 (2%)
Query: 225 KGPHTGVIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKK 263
+ T IA +GG+ +++G+++F + RR +++K
Sbjct: 1 RTSKTTSIAAGVVGGL-LVLVILGLIVFLFRRRRHIKRK 38
|
PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. They are receptor PTKs (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane (TM) helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. They are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. The TM domain not only serves as a membrane anchor, but also plays an important role in receptor dimerization and optimal activation. Mutations in the TM domain of EGFR family RTKs have been associated with increased breast cancer risk. Length = 38 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 37/117 (31%), Positives = 52/117 (44%), Gaps = 28/117 (23%)
Query: 409 IAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFV 468
I GA RG +LH N IHRNI + IL+ D GL L +HL + V
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGD--------GLVSLSGL--SHLYSLV 152
Query: 469 -NGEFGDLGYVAPEYARTLVA--TP------------KGDVYSFGTVLLELVTGERP 510
NG+ + Y P+++ +++ +P K D+YS G EL TG P
Sbjct: 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 24/80 (30%), Positives = 39/80 (48%), Gaps = 5/80 (6%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
IIHR++ I++ D KI DFGLAR ++ +V + Y APE +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRY----YRAPEVILGMG 193
Query: 488 ATPKGDVYSFGTVLLELVTG 507
D++S G ++ E++ G
Sbjct: 194 YKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 8/99 (8%)
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
+HR+I +LLD + +++DFG MN T S+ G Y++PE + +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA---VGTPDYISPEILQAM 178
Query: 487 -----VATPKGDVYSFGTVLLELVTGERPTNVAKAPETF 520
P+ D +S G + E++ GE P ET+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
II+R++ +LLD + K++D+G+ + + P DT STF G Y+APE R
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-TSTFC----GTPNYIAPEILR-- 169
Query: 487 VATPKGDVYSF-------GTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531
G+ Y F G ++ E++ G P ++ + N +++ Q+
Sbjct: 170 -----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 623 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.15 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.91 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.84 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.76 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.75 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.65 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.63 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.63 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.61 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.57 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.4 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.39 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.38 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.28 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.26 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.23 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.22 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.21 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.15 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.1 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.04 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.0 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.99 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 97.97 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.91 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.87 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-60 Score=558.93 Aligned_cols=472 Identities=31% Similarity=0.553 Sum_probs=358.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|+++|.+|..+.++++|+.|+|++|.+.|.+|..+.++.+ |++|+|++|+++|.+|..++++++|+.|+
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK-LVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccC-CCEEECCCCcccccCChhHhCcccCCEEE
Confidence 46889999999999999999999999999999999999999999999755 99999999999999999999999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc-ccccccccCCCCCCCCCCC----CCCCCCCCCCCccceee
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-LTLSADSVTNNQGLCGEPL----DACKGTSKGPHTGVIAG 234 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~l~~~~~----~~c~~~~~~~~~~~i~~ 234 (623)
|++|+++|.+|..+.++++|+.|++++|+++|.+|.... ..+....+.+|+.+|+.+. ++|...........+++
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~ 633 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehh
Confidence 999999999999999999999999999999999997533 2566778999999998653 45643222111112222
Q ss_pred ehhhhHHHHHHHHHHhheeeeeeecccccCCCCCCCcccccccCCCCCceeeeee-ccccccCHHHHHHHhccCccccee
Q 006982 235 AAIGGVTFAALVVGIVMFFYFRRMSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFE-KSITKMRLSDLMKATNSFSKNNII 313 (623)
Q Consensus 235 ~~i~~v~~~~l~~~i~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~f~~~~~l 313 (623)
+++++ ++++++++++ ++++++++..+..........|. ...+. .....++++++. ..|...++|
T Consensus 634 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~---~~~~~~~~i 698 (968)
T PLN00113 634 CTLGA-FLVLALVAFG-FVFIRGRNNLELKRVENEDGTWE----------LQFFDSKVSKSITINDIL---SSLKEENVI 698 (968)
T ss_pred HHHHH-HHHHHHHHHH-HHHHHhhhccccccccccccccc----------ccccccccchhhhHHHHH---hhCCcccEE
Confidence 22211 1111111211 22222211111111000111111 11111 111223444443 457778899
Q ss_pred eccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHhhhcc
Q 006982 314 GSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLH 392 (623)
Q Consensus 314 G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~ 392 (623)
|+|+||.||+|+. .++..||+|++...... ...|++.+++++|||||+++++|.+.+..++||||+++|+|.++++
T Consensus 699 g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 775 (968)
T PLN00113 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775 (968)
T ss_pred ccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh
Confidence 9999999999996 57899999998654322 2356889999999999999999999999999999999999999994
Q ss_pred CCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCC
Q 006982 393 PADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472 (623)
Q Consensus 393 ~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~ 472 (623)
.++|.++.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||........ ....
T Consensus 776 -------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--------~~~~ 839 (968)
T PLN00113 776 -------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--------TKCF 839 (968)
T ss_pred -------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--------CCcc
Confidence 38999999999999999999998777799999999999999999998875 6655433211 1124
Q ss_pred CcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcC--CC
Q 006982 473 GDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAK--GV 550 (623)
Q Consensus 473 gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~ 550 (623)
+|++|+|||++.+..++.++|||||||++|||+||+.||+... .....+.+|.............+|+.+... ..
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 7899999999999999999999999999999999999995422 223457778776655555666677766432 24
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 551 DNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 551 ~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.+++.++.+++.+|+. .+|++||+|+||++.|+++....
T Consensus 917 ~~~~~~~~~l~~~Cl~-~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 917 QNEIVEVMNLALHCTA-TDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHHHHHHHhhCc-CCchhCcCHHHHHHHHHHhhccc
Confidence 5677788999999998 99999999999999999986543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-57 Score=469.80 Aligned_cols=291 Identities=47% Similarity=0.763 Sum_probs=255.4
Q ss_pred cccccCHHHHHHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEecccccc-HHHHHHHHHHhCCCCCCCCcceeEEE
Q 006982 291 SITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRS-EKEFVAEMATLGSVKNRNLVPLLGFC 369 (623)
Q Consensus 291 ~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~ 369 (623)
....|++.++..||++|+..++||+|+||.||+|.+.+|+.||||++...... .++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45578999999999999999999999999999999999999999988776544 67799999999999999999999999
Q ss_pred EeCC-eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 370 MAKK-ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 370 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.|+|+||||||+|||+|+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999875543 8999999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~ 528 (623)
+|||+|+.......+..... .||.+|+||||...+..+.|+|||||||+|+|++||+.|.+.... .....+..|+
T Consensus 219 sDFGLa~~~~~~~~~~~~~~---~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~ 293 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV---MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWA 293 (361)
T ss_pred cCccCcccCCccccceeeec---CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHH
Confidence 99999976543122211110 589999999999999999999999999999999999998875442 2233489999
Q ss_pred HHHhccCchhhhhchhhh-cCCCH-HHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 529 AQLSSTGQLQDAIDKCLV-AKGVD-NELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
........+.+++|+.+. ..... +++.+++++|+.|+. .+|++||+|.||+++|+.+...
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~-~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLR-PDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcC-cCCCcCcCHHHHHHHHHhhccc
Confidence 988888899999999987 44443 789999999999999 8899999999999999776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=382.55 Aligned_cols=256 Identities=33% Similarity=0.475 Sum_probs=204.2
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEecccccc---HHHHHHHHHHhCCCCCCCCcceeEEEEeCC-eeeEEEecCCCC
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRS---EKEFVAEMATLGSVKNRNLVPLLGFCMAKK-ERLLVYKHMPNG 385 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~g 385 (623)
.+.||+|+||+||+|.+.....||+|++...... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999985555999999865433 558999999999999999999999999887 789999999999
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCCCceeeCCCC-CeEEeecccccccCCCCCc
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR-IIHRNISSKCILLDDDF-EPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-i~H~dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~ 463 (623)
+|.++++.. ....+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 999999864 346899999999999999999999999 6 99999999999999997 99999999998765421
Q ss_pred ccccccCCCCcccccCccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 464 LSTFVNGEFGDLGYVAPEYAR--TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
.......||+.|||||++. ...|+.|+|||||||++|||+||+.||...... . ....+ ........+
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~----~~~~v---~~~~~Rp~~- 267 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-Q----VASAV---VVGGLRPPI- 267 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-H----HHHHH---HhcCCCCCC-
Confidence 1111245999999999999 669999999999999999999999999864331 0 11111 101000000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCC
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHF 592 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~ 592 (623)
.......+..+++ .|+. .||+.||++.+++..|+.+......
T Consensus 268 -----p~~~~~~l~~l~~---~CW~-~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 268 -----PKECPPHLSSLME---RCWL-VDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -----CccCCHHHHHHHH---HhCC-CCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 0113344444444 4777 9999999999999999998776553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=371.04 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=210.6
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHhh
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYD 389 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 389 (623)
.+.||+|.||.||.|.+.....||+|.++......+.|.+|+++|++++|+|||+++|+|...+..+||||||+.|+|.+
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~ 290 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLD 290 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHH
Confidence 56899999999999999988899999999888888999999999999999999999999999889999999999999999
Q ss_pred hccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccccc
Q 006982 390 LLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVN 469 (623)
Q Consensus 390 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 469 (623)
+|... .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+......+.. ..
T Consensus 291 yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~---~~ 362 (468)
T KOG0197|consen 291 YLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA---SE 362 (468)
T ss_pred Hhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee---cC
Confidence 99762 357789999999999999999999999 99999999999999999999999999999554332221 22
Q ss_pred CCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcC
Q 006982 470 GEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAK 548 (623)
Q Consensus 470 ~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 548 (623)
+..-+..|.|||.+....++.|||||||||+||||+| |+.||..... .+.+....+..++ -..+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~GyRl-------p~P~ 427 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLERGYRL-------PRPE 427 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhccCcC-------CCCC
Confidence 2334678999999999999999999999999999999 8888865322 2223333222221 1233
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 549 GVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 549 ~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.+++++.++ ...|+. .+|++|||++.+...|+++...
T Consensus 428 ~CP~~vY~l---M~~CW~-~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 GCPDEVYEL---MKSCWH-EDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCHHHHHH---HHHHhh-CCcccCCCHHHHHHHHHHhhhc
Confidence 456666664 446776 8999999999999999988654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.53 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=198.0
Q ss_pred cccceeeccCccEEEEEEeC-CCcEEEEEEecc--ccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-eeeEEEecCC
Q 006982 308 SKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK-ERLLVYKHMP 383 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~ 383 (623)
+..+.||+|..|+|||+.++ +++.+|+|.+.. .....+++.+|++++.+.+||+||.++|.|+.+. +..++||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34578999999999999976 678899999943 3445678999999999999999999999999998 5999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|||++++... +.+++...-+|+.+|.+||.|||+.. +|+||||||+|||++..|++||+|||.++.+...
T Consensus 162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999633 56899999999999999999999732 8999999999999999999999999999987542
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
..++-+||..|||||.+.+..|+.++||||||+.++|+.+|+.||..... ......+.+.....+. -+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll~~Iv~~p------pP 300 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELLCAIVDEP------PP 300 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHHHHHhcCC------CC
Confidence 33455699999999999999999999999999999999999999975411 1111222211111110 01
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+......+++..++ .||.+.||.+||+++|+++.
T Consensus 301 ~lP~~~fS~ef~~FV----~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFV----SCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHH----HHHhcCCcccCCCHHHHhcC
Confidence 111112334444443 34445999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=347.32 Aligned_cols=201 Identities=27% Similarity=0.410 Sum_probs=177.7
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
..+|...+.||+|+|++||+|+++ ++.+||||.+.... ...+....|+.+|+.++|||||.+++++++++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356777888999999999999965 68999999996553 34556789999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC------CCeEEeeccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD------FEPKISDFGL 453 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~------~~~kl~Dfgl 453 (623)
|||.||+|.++++.. ..+++.....++.|+|.||++||++ +|+||||||+|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999743 4689999999999999999999999 99999999999999764 4689999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
|+.+.+.. ...+.+|++-|||||++...+|+.|+|+||.|+|+|++++|+.||+..+.
T Consensus 162 AR~L~~~~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQPGS-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCCchh-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 99987532 22334599999999999999999999999999999999999999985433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=365.02 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=205.3
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecc----ccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQD----SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
..|...+.||+|||..+|.++. ..|..||+|++.+ .....+...+||++.++++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 7899999999976 3455677899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
|+|++|+|.++++ ..++++++++..+..||+.||.|||+. +|+|||||-.|++++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999996 347899999999999999999999999 999999999999999999999999999999875
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.+....+. +|||-|+|||++.....+..+||||+|||+|-|++|++||......+.+. .... .+
T Consensus 171 ~~Erk~Tl----CGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~--------~Ik~----~~ 234 (592)
T KOG0575|consen 171 DGERKKTL----CGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN--------KIKL----NE 234 (592)
T ss_pred ccccccee----cCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH--------HHHh----cC
Confidence 54433343 49999999999998889999999999999999999999998643322211 1000 01
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
..- ......+..+++.-.+. .+|.+|||+++|+..
T Consensus 235 Y~~----P~~ls~~A~dLI~~lL~----~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 YSM----PSHLSAEAKDLIRKLLR----PNPSERPSLDEVLDH 269 (592)
T ss_pred ccc----ccccCHHHHHHHHHHhc----CCcccCCCHHHHhcC
Confidence 111 11234455555554443 899999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=345.28 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=195.2
Q ss_pred hccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccc--------cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQR--------SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 374 (623)
.+.|...+.||+|+||.|-+|. .++|+.||||++.+... ......+|+++|.+++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3457778999999999999998 56899999999975421 12235799999999999999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC---CCeEEeec
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD---FEPKISDF 451 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~---~~~kl~Df 451 (623)
.|+|+||++||+|.+++- ..+.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999985 345678888899999999999999999 99999999999999765 78999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV---ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~ 528 (623)
|+|+.... ..++.+.+||+.|.|||++.+.. +..++|+||+|||||-+++|..||....... .+.+-+
T Consensus 324 GlAK~~g~-----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----sl~eQI 394 (475)
T KOG0615|consen 324 GLAKVSGE-----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----SLKEQI 394 (475)
T ss_pred chhhcccc-----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----cHHHHH
Confidence 99998753 34556667999999999997654 3348899999999999999999998643321 122111
Q ss_pred HHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 529 AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+... .+- .+......++...+++-.+ ..||++|||++|+++.
T Consensus 395 ~~G~y------~f~-p~~w~~Iseea~dlI~~mL----~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRY------AFG-PLQWDRISEEALDLINWML----VVDPENRPSADEALNH 437 (475)
T ss_pred hcCcc------ccc-ChhhhhhhHHHHHHHHHhh----EeCcccCcCHHHHhcC
Confidence 11000 000 0011123444555544333 3889999999998764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=369.29 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=209.3
Q ss_pred CcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 307 FSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
....+.||+|.||.||+|.. ++.+.||||.+++.. ....+|++|++.++.++|||||+++|+|.+++..++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 33456799999999999984 245679999998754 3578899999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCC------C----CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 379 YKHMPNGSLYDLLHPADD------T----GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
+|||..|||.++|..... . ..+++..+.+.||.|||.||.||-++ .++||||..+|+||.++..+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 999999999999953221 1 23488999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~ 527 (623)
+|||+++.+...+++... ....-+.+|||||.+..+++|.+||||||||+|||+++ |+.||.+....+
T Consensus 645 sDfGLsRdiYssDYYk~~--~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--------- 713 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVR--GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--------- 713 (774)
T ss_pred cccccchhhhhhhhhccc--CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---------
Confidence 999999987765554321 12234689999999999999999999999999999998 999998654422
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
+-..++.+.+... .+..+.++.++ .+.|+. .+|++||+++||...|+...+..
T Consensus 714 VIe~i~~g~lL~~------Pe~CP~~vY~L---M~~CW~-~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRAGQLLSC------PENCPTEVYSL---MLECWN-ENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHcCCcccC------CCCCCHHHHHH---HHHHhh-cCcccCCCHHHHHHHHHHHHhcC
Confidence 1222223332221 22344444444 457887 89999999999999999876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=332.09 Aligned_cols=241 Identities=22% Similarity=0.275 Sum_probs=197.0
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|+..++||+|+||.||.++.+ +++.+|+|++++.. ...+...+|..+|.+++||+||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357899999999999999999965 58889999997753 3456788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+.||.|+.+|+ ....+++..+.-++.+|+.||.|||+. +|+||||||+|||+|++|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999996 345789998999999999999999999 99999999999999999999999999999643
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..+... ++-+||+.|||||++....|+..+|.||+|+++|||++|.+||...+. .++........
T Consensus 177 ~~~~~t----~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k--- 241 (357)
T KOG0598|consen 177 KDGDAT----RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGK--- 241 (357)
T ss_pred cCCCcc----ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCc---
Confidence 332222 234599999999999999999999999999999999999999986432 33333332221
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP 574 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP 574 (623)
..........+..++++-.+. .||++|-
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~----rdp~~RL 269 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLK----RDPRQRL 269 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhc----cCHHHhc
Confidence 000112245566666665544 7899995
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.14 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=201.1
Q ss_pred cCcccceeeccCccEEEEEE-eCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEE-EEeCCe-eeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGF-CMAKKE-RLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lV~ 379 (623)
+|.+.++||+|.||+|||+. ..+|..+|.|.++-.. ...+.+..|+.+|++++|||||+++++ +.++.+ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 47778899999999999998 5689999999987533 445678899999999999999999984 444555 78999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP-RIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
||+..|+|...++......+.+++...++++.|+++||.++|+..+. .|.||||||.||++|++|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999987666678899999999999999999999994322 38999999999999999999999999999986
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.... +....+|||.||+||.+....|+.||||||+||++|||..-..||.+.. +.+....... ++.
T Consensus 180 s~~t----fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L~~KI~q-gd~- 245 (375)
T KOG0591|consen 180 SKTT----FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSLCKKIEQ-GDY- 245 (375)
T ss_pred chhH----HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHHHHHHHc-CCC-
Confidence 5432 3344569999999999999999999999999999999999999998641 1111111111 100
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
+.+..+..++++..++ -.|.. .||+.||+...++..+.
T Consensus 246 ----~~~p~~~YS~~l~~li---~~ci~-vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 ----PPLPDEHYSTDLRELI---NMCIA-VDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----CCCcHHHhhhHHHHHH---HHHcc-CCcccCCCcchHHHHHH
Confidence 0011122344444444 45666 89999998655444443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.87 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=209.5
Q ss_pred CcccceeeccCccEEEEEEeC----CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 307 FSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
..+.++||.|.||.||+|.++ ....||+|.++... ....+|+.|..+|.++.||||++|.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 345689999999999999965 24569999999764 456789999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
||+||+|+.+|.... ..+++.+..-++.+||.||.||-+. +++||||.++||||+.+..+||+|||+++.+...
T Consensus 711 yMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999997654 4599999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
. .......+..-+.+|.|||.+...++|.++||||||||+||.++ |.+||-+.... +.+.
T Consensus 785 ~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------dVIk---------- 845 (996)
T KOG0196|consen 785 P-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVIK---------- 845 (996)
T ss_pred C-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------HHHH----------
Confidence 3 22222222224689999999999999999999999999999887 99998653221 1111
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.+++-.+-..+.+.-..+-++++.|++ .|-.+||.+++++..|+++..
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWq-kdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQ-KDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHH-HHhhcCCCHHHHHHHHHHHhc
Confidence 122222222234455667778889988 999999999999999998543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=338.18 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=199.0
Q ss_pred ccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCC-e
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKK-E 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~ 374 (623)
++|...+.||+|+||.||+|.. .++..||+|+++... .....+.+|++++.++ +||||+++++++...+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 5688889999999999999974 235679999987543 2345788999999999 8999999999887654 5
Q ss_pred eeEEEecCCCCCHhhhccCCCCC---------------------------------------------------------
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDT--------------------------------------------------------- 397 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 397 (623)
.++||||+++|+|.+++......
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 78999999999999998643210
Q ss_pred -CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCccc
Q 006982 398 -GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476 (623)
Q Consensus 398 -~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~ 476 (623)
...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........ .......++..
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~~ 241 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSARLPLK 241 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCCCCCcc
Confidence 13478889999999999999999999 9999999999999999999999999999865432111 11112235688
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHH
Q 006982 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELF 555 (623)
Q Consensus 477 y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 555 (623)
|+|||++.+..++.++|||||||++|||++ |..||......+ ....... .+.... ......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~-~~~~~~------~~~~~~~--- 304 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLK-DGTRMR------APENATP--- 304 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHh-cCCCCC------CCCCCCH---
Confidence 999999998899999999999999999997 999997532211 1111111 111000 0011222
Q ss_pred HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 556 QFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 556 ~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.+..++..|+. .||++|||+.|+++.|+++..
T Consensus 305 ~l~~li~~cl~-~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 305 EIYRIMLACWQ-GDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHcc-CChhhCcCHHHHHHHHHHHHh
Confidence 34556667877 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.23 Aligned_cols=205 Identities=27% Similarity=0.379 Sum_probs=177.4
Q ss_pred hccCcccceeeccCccEEEEEE-eCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 377 (623)
.+.|+..+.||+|.||.||+|+ ..+|+.||+|++.... ....-..+||.+|+++.||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3567888999999999999999 5689999999996543 3456678999999999999999999999877 68999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+|||+. +|.-++.. .+-.|+..++..++.|++.||+|+|++ +|.|||||.+|||||.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999987 99988853 345799999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPE 518 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~ 518 (623)
....... ...++-|.+|+|||++.+ ..|+.++|+||.||||.||++|+..|.+.+..+
T Consensus 269 ~~~~~~~---~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 269 TPSGSAP---YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE 327 (560)
T ss_pred cCCCCcc---cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence 6643321 233457999999999876 479999999999999999999999998765433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.53 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=203.8
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 374 (623)
.++....+.+.....||+|.||+||+|.|. -.||||+++... ...+.|.+|+.++++-||.||+-++|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444444556677889999999999999986 368999997543 345789999999999999999999999998877
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.||+.+|+|-+|+.++|..+ ..|+..+.+.||.|+|+||.|||.+ +|||||||+.||++.+++.|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999999654 5799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART---LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
..-..- ..........|..-|||||++.. .+|+..+||||||+|+|||++|..||.. ...+.. + | +
T Consensus 536 tvk~~w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqI---i--f---m 604 (678)
T KOG0193|consen 536 TVKTRW--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQI---I--F---M 604 (678)
T ss_pred eeeeee--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhhe---E--E---E
Confidence 753211 00111122337788999999964 4689999999999999999999999983 222111 0 0 0
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
+..+. -..|..........++.+ ++..|+. .++++||.+.+++..|+++..
T Consensus 605 VGrG~--l~pd~s~~~s~~pk~mk~---Ll~~C~~-~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 VGRGY--LMPDLSKIRSNCPKAMKR---LLSDCWK-FDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ecccc--cCccchhhhccCHHHHHH---HHHHHHh-cCcccCccHHHHHHHHHHhhh
Confidence 00000 011111111223444444 4456877 999999999999999988765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.54 Aligned_cols=197 Identities=27% Similarity=0.414 Sum_probs=177.4
Q ss_pred ccCcccceeeccCccEEEEEE-eCCCcEEEEEEecccccc-HHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRS-EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
..|.....||+|+.|.||.|. ..+++.||+|++....+. .+-..+|+.+|+..+|+|||++++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 356777889999999999998 567899999999876554 445789999999999999999999999899999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+.+. ...+++.+...|+.++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999983 45699999999999999999999999 999999999999999999999999999998876544
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
... +.+||+.|||||+.....|..|+||||+|++++||+-|..||-.
T Consensus 425 KR~----TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 425 KRS----TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred ccc----cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 332 34599999999999999999999999999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=357.17 Aligned_cols=258 Identities=25% Similarity=0.452 Sum_probs=205.5
Q ss_pred CcccceeeccCccEEEEEEeCC--Cc----EEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 307 FSKNNIIGSGRTGTMYKALLED--GT----SLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
....+.||+|.||.||.|...+ |. .||+|.++.. .....+|.+|..+|++++|||||+++|+|.+....+|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 4456789999999999999643 43 4899999765 45677899999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCC---CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 379 YKHMPNGSLYDLLHPADDT---GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
+|||++|+|..+|+..+.. ...+.....+.++.|||+|+.||+++ ++|||||.++|+|++....+||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999765322 35688999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCcccccccCC-CCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhc
Q 006982 456 LMNPIDTHLSTFVNGE-FGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSS 533 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~ 533 (623)
.+...++... ++. .-...|||||.+..+.++.|+|||||||+|||++| |..||...... +.......
T Consensus 851 Diy~~~yyr~---~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--------~v~~~~~~ 919 (1025)
T KOG1095|consen 851 DIYDKDYYRK---HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--------EVLLDVLE 919 (1025)
T ss_pred hhhhchheec---cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--------HHHHHHHh
Confidence 6654333221 111 24579999999999999999999999999999999 88888754331 11111122
Q ss_pred cCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 534 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.+++ -...++++.+. +++..|+. .+|++||++..+++++..+...
T Consensus 920 ggRL-------~~P~~CP~~ly---~lM~~CW~-~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 GGRL-------DPPSYCPEKLY---QLMLQCWK-HDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCcc-------CCCCCCChHHH---HHHHHHcc-CChhhCccHHHHHhhhhhhhhh
Confidence 2211 11233444444 55556766 9999999999999999887554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=319.81 Aligned_cols=246 Identities=19% Similarity=0.296 Sum_probs=192.9
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEecccccc----HHHHHHHHHHhCCCCCCCCcceeEEEEe----CCeeeEEEec
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRS----EKEFVAEMATLGSVKNRNLVPLLGFCMA----KKERLLVYKH 381 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 381 (623)
...||+|++|.||+|.+ +|+.||+|++...... .+.+.+|++++.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46899999999999998 5889999999765332 3567899999999999999999999877 3467899999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.. ...++|..+++++.+++.|+.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999963 346899999999999999999999742 68899999999999999999999999998654311
Q ss_pred CcccccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +..........-
T Consensus 178 -------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~-- 240 (283)
T PHA02988 178 -------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--------EIYDLIINKNNS-- 240 (283)
T ss_pred -------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcCCC--
Confidence 12347889999999976 67899999999999999999999999753221 111111111000
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
..+ ....++++. +++..|+. .||++|||++|+++.|+.+.
T Consensus 241 ---~~~-~~~~~~~l~---~li~~cl~-~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 ---LKL-PLDCPLEIK---CIVEACTS-HDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---CCC-CCcCcHHHH---HHHHHHhc-CCcccCcCHHHHHHHHHHHH
Confidence 000 001233333 44456766 99999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=335.63 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=203.7
Q ss_pred ccCcccceeeccCccEEEEEEeCC--C--cE-EEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED--G--TS-LMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
++....++||+|+||.||+|++.. + .. ||+|..+.. .....+|.+|.++|++++|||||+++|++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344445899999999999999653 2 23 899988742 34567899999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|||+|+||+|.++|.... ..++..+++.++.++|+||+|||+. +++||||.++|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999997543 3699999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
.-.. ....... ..-+..|+|||.+....|+.++|||||||++||+++ |..||.+.... ....++.. .
T Consensus 311 ~~~~--~~~~~~~--~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI~~---~ 378 (474)
T KOG0194|consen 311 AGSQ--YVMKKFL--KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKIVK---N 378 (474)
T ss_pred CCcc--eeecccc--ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHHHh---c
Confidence 5431 1111101 124678999999999999999999999999999998 88898754321 22222211 1
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCC
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHF 592 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~ 592 (623)
+.- .......+.++..++. .|+. .+|++||+|.++.+.|+.+......
T Consensus 379 ~~r------~~~~~~~p~~~~~~~~---~c~~-~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 379 GYR------MPIPSKTPKELAKVMK---QCWK-KDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred Ccc------CCCCCCCHHHHHHHHH---Hhcc-CChhhccCHHHHHHHHHHHHhcccc
Confidence 000 0011134445555544 6777 9999999999999999998776543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.68 Aligned_cols=202 Identities=22% Similarity=0.304 Sum_probs=175.7
Q ss_pred hccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccccHHH--HHHHHHHhCCCC-CCCCcceeEEEEeCC-eeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE--FVAEMATLGSVK-NRNLVPLLGFCMAKK-ERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lV 378 (623)
.++|...+.||.|.||.||+|+ ..++..||+|+++......++ -.+|+..|++++ ||||+++.+++.+++ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3567788999999999999999 557899999999876655444 368999999998 999999999999888 89999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
||||+. +|+++++.. +..+++..+..|+.||.+||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+.
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999965 999999754 47899999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCcccccccCCCCcccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYAR-TLVATPKGDVYSFGTVLLELVTGERPTNVAKAP 517 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~ 517 (623)
..... .. .+.|-+|+|||++. ...|+.+.|+||+|||++|+.+-+.-|.+....
T Consensus 162 SkpPY-Te----YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~ 216 (538)
T KOG0661|consen 162 SKPPY-TE----YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI 216 (538)
T ss_pred cCCCc-ch----hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH
Confidence 54332 22 23688999999875 678999999999999999999999999875543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=306.41 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=198.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccccc---HHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRS---EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
+.|+...++|+|+||.|||++.+ +|+.||||+|..++.. .+-.++|+++|++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45778889999999999999966 5999999999876542 4567899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|++. ++.+-|... ...++.....+++.|++.|+.|+|++ +++||||||+||||+.++.+||+|||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 444444322 24577888999999999999999999 9999999999999999999999999999998743
Q ss_pred CCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccccc------HHHHHHHHhc
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN------LVEWIAQLSS 533 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~------l~~~~~~~~~ 533 (623)
......+ +.|-+|+|||.+.+ .+|...+||||.||++.||++|..-|.+..+.+...-. +...-.+...
T Consensus 155 gd~YTDY----VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 GDNYTDY----VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred cchhhhh----hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 2222222 36889999999987 68999999999999999999999988876553321110 0000011111
Q ss_pred c-Cchhhhhchhhhc-----CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 534 T-GQLQDAIDKCLVA-----KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 534 ~-~~~~~~~d~~l~~-----~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. +....+.-+.... ...+.-..-++.++-.|.. .||.+|++.+|++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~-~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLK-MDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhc-CCccccccHHHHhc
Confidence 1 1111111111000 0011112245677778888 99999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=313.70 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=202.0
Q ss_pred hccCcccceeeccCccEEEEEE-eCCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...++||.|..++||+|. .+.+..||||++.-.. ...+.+.+|+..|+.++||||++.+..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3568888999999999999999 4578999999997654 335788999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
||.+||+.++++..-. ..+++..+..|..++.+||.|||.+ |.||||+|+.||||+++|.+||+|||....+...
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999976554 3489999999999999999999999 9999999999999999999999999999877554
Q ss_pred CCcccccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
........+.-+||+.|||||++.. ..|+.|+||||||+...|+.+|..||....+-.. + ...+.......
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv----L---l~tLqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV----L---LLTLQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH----H---HHHhcCCCCCc
Confidence 4322222255679999999999653 3589999999999999999999999975322110 0 11111111100
Q ss_pred h--hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 D--AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~--~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+ .++..-. ..... .+-+..-.|+. .||++|||++++++
T Consensus 253 ~t~~~~~d~~-k~~~k---sf~e~i~~CL~-kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDED-KKFSK---SFREMIALCLV-KDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHh-hhhcH---HHHHHHHHHhh-cCcccCCCHHHHhc
Confidence 0 0000000 00111 33344456777 99999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=328.52 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=201.0
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeee
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 376 (623)
...+|..++.||+|+|++|++|+. ..++++|+|++.+.. ...+-...|-++|.+| .||.|++|+..|++....|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788899999999999999994 568999999997643 3344566788888888 8999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||+++|+|.++|+.. +.|++.....++.+|+.||+|||+. |||||||||+|||+|+|++++|+|||-|+.
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999754 5699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc-----cc----ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHH
Q 006982 457 MNPIDTH-----LS----TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 457 ~~~~~~~-----~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~ 527 (623)
+.+.... .. .....-+||..|.+||++.....+..+|+|+||||||.|+.|.+||.+......++.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk----- 298 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK----- 298 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH-----
Confidence 8653222 11 001224699999999999999999999999999999999999999986443221111
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+.. ++-.+. .+.++.+..+++-.+. .||.+|+|.+++-+.
T Consensus 299 I~~----------l~y~fp-~~fp~~a~dLv~KLLv----~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQA----------LDYEFP-EGFPEDARDLIKKLLV----RDPSDRLTSQQIKAH 338 (604)
T ss_pred HHH----------hcccCC-CCCCHHHHHHHHHHHc----cCccccccHHHHhhC
Confidence 100 111111 1234455555554443 789999999887664
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=314.48 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=201.2
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||++.++++..+++|.+.........+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 35777889999999999999998888999999876666677899999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.++++... ..++|..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999986432 3588999999999999999999999 9999999999999999999999999999865332111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+......... ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~~---~~- 222 (256)
T cd05114 157 --SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFRL---YR- 222 (256)
T ss_pred --ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCC---CC-
Confidence 1112235678999999988889999999999999999999 8889864322 1111111111100 00
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
..... ..+..++.+|+. .+|++||+++|+++.|
T Consensus 223 ---~~~~~---~~~~~li~~c~~-~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 ---PKLAS---MTVYEVMYSCWH-EKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCC---HHHHHHHHHHcc-CCcccCcCHHHHHHhh
Confidence 01112 345677778887 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.33 Aligned_cols=264 Identities=20% Similarity=0.333 Sum_probs=197.4
Q ss_pred ccCcccceeeccCccEEEEEEeCC-----------------CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcce
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-----------------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPL 365 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l 365 (623)
++|...+.||+|+||.||++.+++ +..||+|.+.... .....+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999997532 3369999987542 234578999999999999999999
Q ss_pred eEEEEeCCeeeEEEecCCCCCHhhhccCCC---------------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 006982 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPAD---------------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430 (623)
Q Consensus 366 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H 430 (623)
++++.+.+..++|+||+++|+|.+++.... .....++|...++++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999885421 1123578899999999999999999999 9999
Q ss_pred cCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh--CC
Q 006982 431 RNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT--GE 508 (623)
Q Consensus 431 ~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt--g~ 508 (623)
|||||+|||+++++.+||+|||+++........ .......++..|+|||++....++.++||||||+++|||++ +.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee--EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999865432221 11122335788999999988889999999999999999997 45
Q ss_pred CCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 509 RPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 509 ~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.||...... .....+.............. .....+ ..+.+++..|+. .+|++|||+.||.+.|++
T Consensus 240 ~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~li~~cl~-~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDE-----QVIENAGEFFRDQGRQVYLF---RPPPCP---QGLYELMLQCWS-RDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHH-----HHHHHHHHHhhhcccccccc---CCCCCC---HHHHHHHHHHcc-CCchhCcCHHHHHHHHhC
Confidence 666543221 11122221111100000000 001122 245566677887 999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.12 Aligned_cols=259 Identities=26% Similarity=0.395 Sum_probs=195.7
Q ss_pred ccCcccceeeccCccEEEEEEeCC-CcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC--eeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK--ERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 380 (623)
.++...+.||+|+||+||++...+ |...|||...... ...+.+.+|+.+|.+++|||||+.+|.....+ ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346667899999999999999654 8999999886542 11456889999999999999999999855554 5789999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-CCCeEEeecccccccCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFGLARLMNP 459 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-~~~~kl~Dfgla~~~~~ 459 (623)
|+++|+|.+++.... + .+++.....+..|+++||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999997543 2 699999999999999999999999 9999999999999999 79999999999997763
Q ss_pred CCCcccccccCCCCcccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLV-ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
... .........||+.|||||++..+. ...++||||+||++.||+||+.||... .....++-.........
T Consensus 171 ~~~-~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 171 KGT-KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSLP 242 (313)
T ss_pred ccc-cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCCC
Confidence 111 111122345999999999999643 335999999999999999999999742 11112222211111111
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
.+. ...+++..+++ ..|.. .+|++|||++++++..--..
T Consensus 243 ~ip------~~ls~~a~~Fl---~~C~~-~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 EIP------DSLSDEAKDFL---RKCFK-RDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCC------cccCHHHHHHH---HHHhh-cCcccCcCHHHHhhChhhhc
Confidence 111 11233444444 35666 89999999999998775443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=323.65 Aligned_cols=285 Identities=24% Similarity=0.409 Sum_probs=212.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCc----EEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGT----SLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
.+|+..+.||+|+||.||+|.+. ++. .||+|.++... ...+.+.+|+.++..++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 333 48999986432 3456788999999999999999999999764 5679
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|+|.+++... ...+++...+.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999643 24588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....... ...+..++..|+|||++....++.++|||||||++|||++ |+.||...... .+..... ....
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----~~~~~~~---~~~~ 229 (316)
T cd05108 160 GADEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILE---KGER 229 (316)
T ss_pred cCCCcce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHh---CCCC
Confidence 5422211 1122234678999999999999999999999999999998 99998643211 1111111 0000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCC----CCCcccccCCCCCCchhhHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHF----TTEDEIMLPSDSGDADILEE 612 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~----~~~~~~~~~~~~~~~~~~~~ 612 (623)
. . ........+.+++..|+. .+|.+||++.+++..+..+..+... ...+...+|++.+.......
T Consensus 230 ~--------~--~~~~~~~~~~~li~~cl~-~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (316)
T cd05108 230 L--------P--QPPICTIDVYMIMVKCWM-IDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRAL 298 (316)
T ss_pred C--------C--CCCCCCHHHHHHHHHHcc-CChhhCcCHHHHHHHHHHHHcCCchheEecCCcccCCCCCchhHHHhhh
Confidence 0 0 001111345566778887 8999999999999999988765532 22444456666655444444
Q ss_pred HHHhc
Q 006982 613 LIVAR 617 (623)
Q Consensus 613 ~~~~~ 617 (623)
.+.++
T Consensus 299 ~~~~~ 303 (316)
T cd05108 299 MDEED 303 (316)
T ss_pred hcccC
Confidence 44333
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.30 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=203.5
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|++|.||+|...+++.|++|.++......+.+.+|++++++++|||++++++++...+..++|+||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 45788899999999999999988888999999987665677899999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
++|.+++.... +..++|..+..++.|++.|+.|||+. +++||||||+||++++++.++|+|||+++........
T Consensus 86 ~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 86 GSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred CcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 99999996432 35689999999999999999999999 9999999999999999999999999999876532111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
...+...+..|+|||+..+..++.++||||||+++|||++ |+.||...... .... ........
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~---~~~~~~~~------ 223 (261)
T cd05068 160 --AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVLQ---QVDQGYRM------ 223 (261)
T ss_pred --ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHH---HHHcCCCC------
Confidence 1111223468999999998889999999999999999999 99898643211 1111 11110000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
.........+.+++.+|+. .+|.+||+++++.+.|+++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~-~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 ----PCPPGCPKELYDIMLDCWK-EDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCCcCCHHHHHHHHHHhh-cCcccCCCHHHHHHHHhcC
Confidence 0001112345566677887 8999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=309.95 Aligned_cols=272 Identities=24% Similarity=0.328 Sum_probs=209.0
Q ss_pred HhccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeC----CeeeEE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK----KERLLV 378 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~lV 378 (623)
..++....+.||+|.||.||+|.|+ |..||||+|....+....-+.|+..-..+||+||+.+++.-..+ .+.+||
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 3456777889999999999999997 88999999976654444445566666677999999999875543 367899
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN-----CNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
++|.+.|||+|+|. ...++-...++++..+|.||+|||.+ .+|.|+|||||+.||||..++.+.|+|+|+
T Consensus 288 TdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999994 36788999999999999999999965 578999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCC------CCcchhHHHHHHHHHHHHhCC----------CCCCCCCCc
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV------ATPKGDVYSFGTVLLELVTGE----------RPTNVAKAP 517 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DV~sfGvil~elltg~----------~P~~~~~~~ 517 (623)
|..............+.++||.+|||||++...- .-..+||||||+|+||+.-.. .||++..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9988766555666677889999999999986432 124699999999999988532 345432222
Q ss_pred ccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 518 ETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 518 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
+...+. ....+-..++.-.+...+. ..+.+..+.++...|+- .+|..|-|+--+-+.|.++.+
T Consensus 443 DPs~ee----MrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~-~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEE----MRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWY-ANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHH----HhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhc-CCchhhhHHHHHHHHHHHHhc
Confidence 111111 1111112222222333332 34788889999999988 899999999999999988764
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=314.83 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=203.6
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|...++..|++|.+.......+.+.+|+.++++++|+|++++++++...+..++|+||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 46788899999999999999988889999999876555667899999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.++++... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||+++........
T Consensus 86 ~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 86 GSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 99999996432 35688999999999999999999998 9999999999999999999999999999876432111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
......++..|+|||+.....++.++|||||||++|||+| |+.||...... .....+.... .. +
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~~~---~~-----~ 224 (261)
T cd05072 160 --AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----DVMSALQRGY---RM-----P 224 (261)
T ss_pred --ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-----HHHHHHHcCC---CC-----C
Confidence 1112235678999999988889999999999999999998 99998642211 1111111100 00 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
. ....++ .+.+++.+|+. .+|++||+++++.+.|+++
T Consensus 225 ~--~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 R--MENCPD---ELYDIMKTCWK-EKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C--CCCCCH---HHHHHHHHHcc-CCcccCcCHHHHHHHHhcC
Confidence 0 011222 34556667877 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.93 Aligned_cols=198 Identities=23% Similarity=0.334 Sum_probs=178.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||.|+||.|..++.+ +|..+|+|++.... ...++..+|..+|..+.||+++++.+.+.+....++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45777899999999999999954 68899999997653 33456788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||++||.|+.+++. .+.++++.+..+|.+|+.|++|||+. .|++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999963 46799999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
. .-+.+||+.|+|||.+.+..+...+|.|||||++|||+.|..||.+...
T Consensus 197 r-------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 R-------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred c-------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 2 1233599999999999999999999999999999999999999987654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.77 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=197.0
Q ss_pred ccCcccceeeccCccEEEEEEeC----CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|.+. .+..|++|.++... .....+.+|+.++.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45788899999999999999853 35689999987643 2345788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++... ...++|.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999998643 24689999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
.... .......++..|+|||++.+..++.++|||||||++||+++ |+.||...... +........ ..
T Consensus 159 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~-~~ 226 (266)
T cd05064 159 SEAI---YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDG-FR 226 (266)
T ss_pred ccch---hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCC-CC
Confidence 2111 11112235678999999998999999999999999999875 99999653221 111111110 00
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
... ....+. .+.+++..|+. .+|++||+++++.+.|.++
T Consensus 227 -----~~~-~~~~~~---~~~~li~~c~~-~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -----LPA-PRNCPN---LLHQLMLDCWQ-KERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCC-CCCCCH---HHHHHHHHHcC-CCchhCCCHHHHHHHHHhh
Confidence 000 111222 34455566776 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=330.55 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=198.3
Q ss_pred ccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
++|...+.||+|+||.||+|++ .++..||+|+++... ...+.+.+|++++..+ +||||++++++|......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688889999999999999973 245689999987543 3345688999999999 899999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCC-----------------------------------------------------------
Q 006982 376 LLVYKHMPNGSLYDLLHPADD----------------------------------------------------------- 396 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 396 (623)
++||||+++|+|.++++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999854221
Q ss_pred ------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 397 ------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 397 ------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
....++|..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc-
Confidence 112578999999999999999999998 9999999999999999999999999999865432211
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+++..... .
T Consensus 271 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~~~~---~------ 336 (375)
T cd05104 271 -VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYKMIKEGYR---M------ 336 (375)
T ss_pred -cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHHHHHhCcc---C------
Confidence 11112235678999999999999999999999999999998 88888643221 111111111000 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
......+. .+.+++..|+. .||++||+++||++.|++
T Consensus 337 -~~~~~~~~---~l~~li~~cl~-~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 -LSPECAPS---EMYDIMKSCWD-ADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCCCCH---HHHHHHHHHcc-CChhHCcCHHHHHHHHHh
Confidence 00111223 34455567877 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=327.42 Aligned_cols=245 Identities=27% Similarity=0.455 Sum_probs=195.5
Q ss_pred cccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 308 SKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
+..+-||+|+.|.||+|+++ +..||||+++.-. +.+|+-|++++||||+.+.|+|....-.+||||||+.|-|
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 34567999999999999997 6789999875332 3578889999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+.|+ .+..+.......+..+||.||.|||.+ .|||||||+-||||+.+..+||+|||-++......+..+
T Consensus 200 ~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS-- 270 (904)
T KOG4721|consen 200 YEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS-- 270 (904)
T ss_pred HHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh--
Confidence 99996 446677788889999999999999999 999999999999999999999999999998765432222
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhc
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA 547 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 547 (623)
-.||..|||||++...++++|+||||||||||||+||..||.+.+......+.- . ....+ ...
T Consensus 271 ---FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG---------s-NsL~L----pvP 333 (904)
T KOG4721|consen 271 ---FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG---------S-NSLHL----PVP 333 (904)
T ss_pred ---hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc---------C-Ccccc----cCc
Confidence 248999999999999999999999999999999999999997644322111100 0 00011 112
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 548 KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 548 ~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
...++.+.-+++ .|+. ..|..||++.+++..|+-...+
T Consensus 334 stcP~GfklL~K---qcw~-sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 334 STCPDGFKLLLK---QCWN-SKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred ccCchHHHHHHH---HHHh-cCCCCCccHHHHHHHHhhcCHH
Confidence 234445554444 3555 6799999999999999865444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=319.04 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=199.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccH---HHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+..+.. +...+|++++++++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999965 67889999997765444 557889999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+.| +|+.+|.. ...+++.....++.+++.||.|||+. +|.|||+||+|||++.++.+|++|||+|+-+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99999963 46799999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... .....||+-|||||+..+..|+..+|.||+|||+||+++|++||... .+.+.++....++.
T Consensus 154 t~v----ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~v---- 217 (808)
T KOG0597|consen 154 TSV----LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDPV---- 217 (808)
T ss_pred cee----eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCCC----
Confidence 221 22234999999999999999999999999999999999999999642 23333333332211
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
........+...+++-.+. .||..|.+-.+++..
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~----kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLI----KDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CCcccccHHHHHHHHHHhh----cChhhcccHHHHhcC
Confidence 0001123344445444333 899999999887653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.61 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=201.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.+|...+.||+|+||.||+|... .++.|++|.+.........+.+|++++.+++|||++++++++......++|+||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 34777889999999999999965 58889999988766566789999999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999986432 25689999999999999999999999 9999999999999999999999999999876432211
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+..........
T Consensus 161 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~------ 223 (263)
T cd05052 161 ---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKGYR------ 223 (263)
T ss_pred ---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCC------
Confidence 1112224678999999998899999999999999999998 8888864321 111111111000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
... ....+.+ +.+++..|+. .+|++||++.++++.|+.+
T Consensus 224 ~~~-~~~~~~~---~~~li~~cl~-~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MER-PEGCPPK---VYELMRACWQ-WNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCC-CCCCCHH---HHHHHHHHcc-CCcccCCCHHHHHHHHHhh
Confidence 000 1112333 4445567777 8999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.70 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=197.8
Q ss_pred hccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 374 (623)
.++|...+.||+|+||.||++... ++..||+|+++... .....+.+|+++++.+ +|+||++++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 346888999999999999998742 34579999997543 2345688999999999 89999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCC----------------------------------------------------------
Q 006982 375 RLLVYKHMPNGSLYDLLHPADD---------------------------------------------------------- 396 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 396 (623)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998853210
Q ss_pred --------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccc
Q 006982 397 --------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFV 468 (623)
Q Consensus 397 --------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 468 (623)
....+++...++++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~ 271 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVK 271 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--eec
Confidence 113478899999999999999999999 9999999999999999999999999999865432111 111
Q ss_pred cCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhc
Q 006982 469 NGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA 547 (623)
Q Consensus 469 ~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 547 (623)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..... ..... ... ..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~----~~~~~-----~~~-~~ 337 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKM----VKRGY-----QMS-RP 337 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHH----HHccc-----Ccc-CC
Confidence 22235678999999998899999999999999999997 999987532211 11110 00000 000 00
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 548 KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 548 ~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
...+.+ +.+++..|+. .||++||++.+|++.|+++
T Consensus 338 ~~~~~~---l~~li~~cl~-~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPE---IYSIMKMCWN-LEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHH
Confidence 112233 3444456776 9999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.16 Aligned_cols=268 Identities=25% Similarity=0.372 Sum_probs=195.5
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC----eeeEEEecCCCC
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----ERLLVYKHMPNG 385 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e~~~~g 385 (623)
.++||+|+||.||||++. ++.||||++.......-.-+++|..+-.++|+||++++++-.... +.+||++|.+.|
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kG 293 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKG 293 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCC
Confidence 568999999999999996 489999999765433333344555566779999999999876554 789999999999
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhc------CCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN------CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
+|.++|. ...++|....+|+..+++||+|||+. .+|+|+|||||++||||..|+++.|+|||+|..+.+
T Consensus 294 sL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 294 SLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred cHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 9999994 46799999999999999999999976 367899999999999999999999999999999876
Q ss_pred CCCcccccccCCCCcccccCcccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLV------ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 533 (623)
...... ..+.+||.+|||||++.+.. .-.+.||||+|.|||||++...-++. .....++.-+..-+...-.
T Consensus 369 ~~~~~d--~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 369 GKPQGD--THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred CCCCcc--hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhcCCCC
Confidence 433322 23478999999999997542 12378999999999999997765532 1111121111111111000
Q ss_pred cCchhhhh---------chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 534 TGQLQDAI---------DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 534 ~~~~~~~~---------d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
-+++++.+ -..+.. ...+..+.+..-.|+. .||+.|.|+.=|-+.+.++..-.
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWD-hDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWD-HDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcC-CchhhhhhhHHHHHHHHHHhccC
Confidence 01111111 111111 1344455555567777 99999999999999998875444
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.41 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=205.3
Q ss_pred HhccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccc-cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR-SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+..+|...+.||+|+||.||+|...++..+++|.+..... ....+..|+++++.++|||++++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3456888899999999999999988899999999876543 456788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.++++... +..+++.++..++.|++.|+.|||+. +++|+||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999997543 35689999999999999999999999 99999999999999999999999999998764321
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
.. .....++..|+|||......++.++||||||+++|||++ |+.||...... .....+. ..
T Consensus 159 ~~----~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~---~~------ 220 (261)
T cd05148 159 YL----SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-----EVYDQIT---AG------ 220 (261)
T ss_pred cc----ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHH---hC------
Confidence 11 112336778999999988889999999999999999998 89998643211 1111111 00
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
............+.+++.+|+. .+|++|||++++++.|+.+
T Consensus 221 ----~~~~~~~~~~~~~~~~i~~~l~-~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 ----YRMPCPAKCPQEIYKIMLECWA-AEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcC-CCchhCcCHHHHHHHHhcC
Confidence 0000011112345566678887 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=319.11 Aligned_cols=221 Identities=24% Similarity=0.322 Sum_probs=185.4
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
..++|....+||+|+||.||.++.+ +|..+|+|+++++. ...+....|-.+|....+|+||+++..|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999965 68999999998764 345678889999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+|||++..+|.. ...|++..+..++.+++.|+..+|.. |||||||||+|+|||..|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999963 35688888889999999999999999 9999999999999999999999999999532
Q ss_pred CC----------------------CCCc-----cc----------------ccccCCCCcccccCcccccCCCCCcchhH
Q 006982 458 NP----------------------IDTH-----LS----------------TFVNGEFGDLGYVAPEYARTLVATPKGDV 494 (623)
Q Consensus 458 ~~----------------------~~~~-----~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV 494 (623)
.. .+.. .. ......+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0000 00 00113579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 495 YSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 495 ~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
||+|||+|||+.|.+||...+..+.+ ..+..|...+
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~-rkI~nwr~~l 407 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETY-RKIVNWRETL 407 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhhhc
Confidence 99999999999999999986665433 3455555433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.88 Aligned_cols=254 Identities=20% Similarity=0.310 Sum_probs=198.9
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc----c--ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCe
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS----Q--RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKE 374 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 374 (623)
..+.|...+.||+|.||.||.|.. .++..||+|++... . ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346788899999999999999985 46899999976543 1 22445668999999999 9999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-CCeEEeeccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-FEPKISDFGL 453 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-~~~kl~Dfgl 453 (623)
.++||||+.+|+|.+++.. ...+.+..+.+++.|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999964 35688899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV-AT-PKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
+..... ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++...... ....
T Consensus 168 s~~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--------~~ki 235 (370)
T KOG0583|consen 168 SAISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--------YRKI 235 (370)
T ss_pred ccccCC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH--------HHHH
Confidence 997631 122344556999999999999877 76 789999999999999999999986332211 1111
Q ss_pred hc-cCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 532 SS-TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 532 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.. .-.+...++ ..+...++. +|+. .+|.+|+++.+++ .-.-++.
T Consensus 236 ~~~~~~~p~~~~--------S~~~~~Li~---~mL~-~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 236 RKGEFKIPSYLL--------SPEARSLIE---KMLV-PDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred hcCCccCCCCcC--------CHHHHHHHH---HHcC-CCcccCCCHHHHh-hChhhcc
Confidence 11 011111110 333333333 3333 9999999999998 4444444
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=312.88 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=199.7
Q ss_pred ccCcccceeeccCccEEEEEEeCC------CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||+|.... ...|++|.+.... .....+.+|++.+.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778999999999999998643 2578999886543 23456889999999999999999999999988999
Q ss_pred EEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC
Q 006982 377 LVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF 444 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~ 444 (623)
+++||+++|+|.+++..... ....+++...+.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999864321 114688999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccccccc
Q 006982 445 EPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGN 523 (623)
Q Consensus 445 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~ 523 (623)
.++|+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-----~ 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYY--RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-----E 234 (283)
T ss_pred cEEECCCcceeeccccccc--cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----H
Confidence 9999999999865432211 11122346788999999988889999999999999999998 99998753221 1
Q ss_pred HHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 524 LVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 524 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
+...+. ....... ....+. .+.++...|+. .+|.+||+++||++.|+++
T Consensus 235 ~~~~i~----~~~~~~~------~~~~~~---~~~~l~~~c~~-~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIR----SRQLLPC------PEDCPA---RVYALMIECWN-EIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHH----cCCcCCC------cccCCH---HHHHHHHHHcc-CChhhCcCHHHHHHHHhcC
Confidence 111111 1111110 111223 34555567877 9999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=313.83 Aligned_cols=198 Identities=27% Similarity=0.378 Sum_probs=172.1
Q ss_pred CcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 307 FSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
|...+.||+|+||.||++.. .+++.||+|.+.... .....+.+|++++.+++|+|++++.+++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66788999999999999985 578999999986432 2234578899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998875432 24689999999999999999999999 99999999999999999999999999998754321
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 157 T-----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred e-----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 1 12345899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=314.06 Aligned_cols=248 Identities=34% Similarity=0.506 Sum_probs=188.1
Q ss_pred cceeeccCccEEEEEEeC-----CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 310 NNIIGSGRTGTMYKALLE-----DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.+.||.|.||.||+|.+. .+..|+||.++... ...+.+.+|++.+.+++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 578999999999999976 35779999996543 33678999999999999999999999999888899999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.++|+.. ....+++.+++.|+.|+++||+|||+. +++|+||+++||++++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999755 235789999999999999999999999 999999999999999999999999999987632211
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
. ...........|+|||.+....++.++||||||+++|||++ |+.||.... ..+...... .......
T Consensus 159 ~--~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~~-~~~~~~~- 226 (259)
T PF07714_consen 159 Y--KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKLK-QGQRLPI- 226 (259)
T ss_dssp E--EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHHH-TTEETTS-
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-cccccee-
Confidence 1 11122336788999999998889999999999999999999 678875421 112222221 1111111
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
....+.. +..++..|+. .+|++||++.++++.|
T Consensus 227 -----~~~~~~~---~~~li~~C~~-~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -----PDNCPKD---IYSLIQQCWS-HDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----BTTSBHH---HHHHHHHHT--SSGGGS--HHHHHHHH
T ss_pred -----ccchhHH---HHHHHHHHcC-CChhhCcCHHHHHhcC
Confidence 1112333 4455567777 9999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=308.01 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=199.8
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|...++..+|+|.+.........+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 35777889999999999999988777899999886666667899999999999999999999999988889999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++........
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999986432 3689999999999999999999999 9999999999999999999999999999865432111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
...+..++..|+|||+..+..++.++||||||+++|||++ |..||...... +........... .
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~-~---- 221 (256)
T cd05113 157 --SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRL-Y---- 221 (256)
T ss_pred --ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCC-C----
Confidence 1112335678999999988889999999999999999999 99998643221 111111111000 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
...... ..+.+++..|+. .+|.+||++.++++.|+
T Consensus 222 --~~~~~~---~~~~~li~~cl~-~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 --RPHLAS---EKVYAIMYSCWH-EKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCC---HHHHHHHHHHcC-CCcccCCCHHHHHHhhC
Confidence 000112 345556667877 99999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.07 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=200.6
Q ss_pred ccCcccceeeccCccEEEEEEeCC----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|.+.. ...|++|.+.... .....+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468888999999999999999742 4579999886543 2345788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++.... ..+++..+++++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999986432 3689999999999999999999998 99999999999999999999999999999765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.+..... .
T Consensus 158 ~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~---~ 227 (266)
T cd05033 158 DSEATYTT--KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVIKAVEDGYR---L 227 (266)
T ss_pred ccccceec--cCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHHHHHHcCCC---C
Confidence 22211111 12235678999999998899999999999999999998 99998542211 11111111000 0
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
+. ....+ ..+.+++..|+. .+|++||++.||+++|+++
T Consensus 228 -----~~--~~~~~---~~l~~li~~cl~-~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -----PP--PMDCP---SALYQLMLDCWQ-KDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CC--CCCCC---HHHHHHHHHHcC-CCcccCcCHHHHHHHHHhh
Confidence 00 00112 235566677887 8999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=307.00 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=200.1
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|..+++..+++|.+.......+.+.+|++++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 457778999999999999999888889999999876666778999999999999999999999875 4567899999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
++|.++++... ...+++.+++.++.+++.||+|||+. +++||||||+||++++++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999996432 24689999999999999999999999 99999999999999999999999999998754322111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
..+..++..|+|||+..+..++.++||||||+++|||++ |..||..... .+..........
T Consensus 160 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~------- 221 (260)
T cd05070 160 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERGYR------- 221 (260)
T ss_pred ---ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC-------
Confidence 112235678999999988889999999999999999999 8888864321 111111111000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
..........+.+++.+|+. .+|++|||++++.+.|++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~-~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ---MPCPQDCPISLHELMLQCWK-KDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCcCCHHHHHHHHHHcc-cCcccCcCHHHHHHHHhc
Confidence 00011112345566667777 899999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=306.96 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=198.1
Q ss_pred cCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
+|+..+.||+|+||.||++.++++..+++|.+.........+.+|++++++++||||+++++++......++|+||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 46778899999999999999887788999998766556678889999999999999999999999999999999999999
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccc
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 465 (623)
+|.+++.... ..++|..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 85 CLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc--
Confidence 9999986432 3689999999999999999999999 9999999999999999999999999999865432111
Q ss_pred ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 466 TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 466 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
...+..++..|+|||++.+..++.++||||||+++|||++ |+.||...... .... ..... ....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~---~~~~~------~~~~ 221 (256)
T cd05059 157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVE---SVSAG------YRLY 221 (256)
T ss_pred -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHH---HHHcC------CcCC
Confidence 1112224568999999998889999999999999999999 78888643221 1111 11000 0000
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.....+ ..+.+++.+|+. .+|++|||+.|+++.|
T Consensus 222 -~~~~~~---~~~~~li~~cl~-~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 -RPKLAP---TEVYTIMYSCWH-EKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCC---HHHHHHHHHHhc-CChhhCcCHHHHHHHh
Confidence 001122 245566677877 8999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.70 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=200.5
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|...+...|++|++.......+.+.+|++++.+++||||+++++++.. ...++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 4588889999999999999998877789999998765566789999999999999999999998754 557899999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||.++........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 85 GSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999996432 24679999999999999999999999 9999999999999999999999999999866432211
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
......++..|+|||+.....++.++||||||+++|||+| |..||...... +...........
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~------ 222 (262)
T cd05071 159 --ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRM------ 222 (262)
T ss_pred --cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCCCC------
Confidence 1112336678999999988889999999999999999999 78788643221 101111000000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
....+....+.+++..|+. .+|++||+++++.+.|++.
T Consensus 223 ----~~~~~~~~~l~~li~~~l~-~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 ----PCPPECPESLHDLMCQCWR-KEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----CCccccCHHHHHHHHHHcc-CCcccCCCHHHHHHHHHHh
Confidence 0011122345667778887 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=298.35 Aligned_cols=202 Identities=23% Similarity=0.282 Sum_probs=173.3
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccccc---HHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRS---EKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 378 (623)
++|.+.+.|++|.||.||+|+. +++..||+|+++..... .-.-.+||.+|.+++|||||.+..+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 5688889999999999999995 46889999999865532 23457899999999999999999988754 578999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
||||+. +|..+++.. .+++...+...+..|+.+|++|||+. .|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 999999743 36788999999999999999999999 89999999999999999999999999999887
Q ss_pred CCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAP 517 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~ 517 (623)
..-..... .+-|..|+|||.+.+ ..|+...|+||+|||+.||+++++-|.+....
T Consensus 229 sp~k~~T~----lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 229 SPLKPYTP----LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred CCcccCcc----eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence 64333322 235899999998876 46899999999999999999999998875543
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.29 Aligned_cols=260 Identities=20% Similarity=0.302 Sum_probs=202.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|+.. +++.|++|.+... ......+.+|+++++.++|||++++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999954 7899999987542 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.........+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998854333345688899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||..... ....+........
T Consensus 159 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~---- 224 (267)
T cd08228 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCD---- 224 (267)
T ss_pred hhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCC----
Confidence 221 11223478899999999888889999999999999999999999864321 1112211111100
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
.+........ ..+.+++..|+. .+|++||++.+|++.+++++
T Consensus 225 --~~~~~~~~~~---~~~~~li~~cl~-~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 --YPPLPTEHYS---EKLRELVSMCIY-PDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCChhhcC---HHHHHHHHHHCC-CCcccCcCHHHHHHHHHHhc
Confidence 0000000112 234455556776 99999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.20 Aligned_cols=261 Identities=23% Similarity=0.407 Sum_probs=203.0
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+++.. ++..+++|.+.... ...+.+.+|++.+.+++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999742 34568889886544 334678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC
Q 006982 378 VYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE 445 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~ 445 (623)
||||+++++|.+++..... ....++|..+++++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999864321 124589999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccH
Q 006982 446 PKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNL 524 (623)
Q Consensus 446 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l 524 (623)
++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 162 ~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------- 232 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------- 232 (291)
T ss_pred EEECCCCcccccCCCcee--ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 999999999865432211 11122346788999999998899999999999999999999 99998643221
Q ss_pred HHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 525 VEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
+...... ....... ....+ ..+.+++..|+. .+|++||++.+|+++|+++...
T Consensus 233 -~~~~~~~-~~~~~~~------~~~~~---~~~~~li~~~l~-~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 -EVIECIT-QGRVLER------PRVCP---KEVYDIMLGCWQ-REPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHHHh-CCCCCCC------CccCC---HHHHHHHHHHcc-cChhhCcCHHHHHHHHHHHHhh
Confidence 1111111 1111000 00112 245566677887 9999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.22 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=198.9
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC-Ce
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK-KE 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 374 (623)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+..|++++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888899999999999999632 34689999987543 2345678899999999 899999999988755 45
Q ss_pred eeEEEecCCCCCHhhhccCCCCC---------------------------------------------------------
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDT--------------------------------------------------------- 397 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 397 (623)
.++++||+++|+|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 77999999999999998542210
Q ss_pred CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccc
Q 006982 398 GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477 (623)
Q Consensus 398 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y 477 (623)
...++|..+.+++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++.+...... .......++..|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~~y 241 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDARLPLKW 241 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--hhccCCCCCccc
Confidence 13689999999999999999999999 9999999999999999999999999999876432211 111223356789
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHH
Q 006982 478 VAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQ 556 (623)
Q Consensus 478 ~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 556 (623)
+|||++.+..++.++|||||||++|||++ |..||......+ .+...+ ....... ..... ...
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~~~~----~~~~~~~------~~~~~---~~~ 304 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCRRL----KEGTRMR------APEYA---TPE 304 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHHHHH----hccCCCC------CCccC---CHH
Confidence 99999999999999999999999999998 999986532211 111111 1100000 00111 234
Q ss_pred HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 557 FLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 557 ~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
+.+++.+|+. .+|++||++.|+++.|+++.+
T Consensus 305 ~~~l~~~cl~-~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWH-NNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHh
Confidence 5666778887 899999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=321.12 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=210.1
Q ss_pred ccCcccceeeccCccEEEEEEeCC-CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.+..-.++||-|.||.||.|.|+. ...||||.++......++|+.|..+|+.++|||+|+++|+|......|||+|||.
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 344556889999999999999874 6789999999988889999999999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.++|..... ..++-...+.+|.||+.||+||..+ ++|||||.++|+|+.++..+||+|||+++++....+.
T Consensus 347 yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred CccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 9999999975432 4566777899999999999999999 9999999999999999999999999999988653321
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
...+..-.+.|.|||.+....++.|+|||+|||+||||.| |..||.+.+.. .+.++++
T Consensus 422 ---AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS------------------qVY~LLE 480 (1157)
T KOG4278|consen 422 ---AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------------QVYGLLE 480 (1157)
T ss_pred ---cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH------------------HHHHHHh
Confidence 1122224678999999999999999999999999999998 99998763221 1222333
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
+-.+-++.+..-.++-++...|+. ++|.+||+++|+.+.++.+-..-+
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~-WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWN-WSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhc-CCcccCccHHHHHHHHHHHhcccc
Confidence 222222222233344555567777 999999999999999987644433
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.84 Aligned_cols=262 Identities=21% Similarity=0.334 Sum_probs=200.2
Q ss_pred hccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 374 (623)
.++|...++||+|+||.||+|... .+..||+|++.... ...+.+.+|++++.++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888899999999999999852 23469999996543 23467899999999995 9999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCC----------------------------------------------------------
Q 006982 375 RLLVYKHMPNGSLYDLLHPADD---------------------------------------------------------- 396 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 396 (623)
.++||||+++|+|.++++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998854210
Q ss_pred ----------------------------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC
Q 006982 397 ----------------------------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD 442 (623)
Q Consensus 397 ----------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~ 442 (623)
....+++..++.++.|++.||+|||+. +|+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 013478889999999999999999999 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 006982 443 DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFK 521 (623)
Q Consensus 443 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~ 521 (623)
++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---- 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---- 346 (400)
T ss_pred CCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----
Confidence 999999999999865432211 11122346788999999988889999999999999999997 99998643211
Q ss_pred ccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
..+...+.. .... . ...... ..+.+++..|+. .+|++||++.+|.++|+++.+
T Consensus 347 ~~~~~~~~~---~~~~------~-~~~~~~---~~l~~li~~cl~-~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 STFYNKIKS---GYRM------A-KPDHAT---QEVYDIMVKCWN-SEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHhc---CCCC------C-CCccCC---HHHHHHHHHHCc-cCHhHCcCHHHHHHHHHHHcC
Confidence 011111110 0000 0 001112 235556667877 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=289.18 Aligned_cols=202 Identities=22% Similarity=0.335 Sum_probs=175.3
Q ss_pred ccCcccceeeccCccEEEEEE-eCCCcEEEEEEecccccc---HHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRS---EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.+|...+++|+|.||.||+|+ .++|+.||+|+++..... .....+|++.|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357778999999999999999 568999999999765432 4567899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
||+. +|...+++. ...++-.+...++.++.+|++|+|.+ .|.||||||.|+|++.+|.+||+|||+|+...+.
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9987 999999753 35788899999999999999999999 8999999999999999999999999999988754
Q ss_pred CCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAP 517 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~ 517 (623)
...... .+-|-.|+|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+..+-
T Consensus 155 ~~~~~~----~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 155 NRIQTH----QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred Cccccc----ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 433222 145789999998875 57999999999999999999998777765543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.11 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=199.1
Q ss_pred ccCcccceeeccCccEEEEEEeCC------CcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||+|...+ +..|++|.+..... ..+.+.+|++++.+++|||++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998643 47899999876533 3568999999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCC----------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 377 LVYKHMPNGSLYDLLHPAD----------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
+||||+++|+|.+++.... .....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999996532 1234588999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~ 525 (623)
+|+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 162 kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------- 231 (280)
T cd05049 162 KIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------- 231 (280)
T ss_pred EECCcccceecccCcce--ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence 99999999865332211 11112235788999999999999999999999999999998 99998643221
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
+...... .+..... ....+. .+.+++..|+. .+|++||++.||++.|+
T Consensus 232 ~~~~~~~-~~~~~~~------~~~~~~---~~~~li~~~l~-~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECIT-QGRLLQR------PRTCPS---EVYDIMLGCWK-RDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHH-cCCcCCC------CCCCCH---HHHHHHHHHcC-CCcccCCCHHHHHHHhh
Confidence 1111111 1110000 011222 34455556776 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.63 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=196.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCc----EEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGT----SLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|.+. ++. .+++|.+.... ....++..|+..+.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45777899999999999999964 344 47777775432 233567888889999999999999998754 45678
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
++||+++|+|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999643 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ...+.+. .+.
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~----~~~ 228 (279)
T cd05111 160 YPDDKKY--FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----EVPDLLE----KGE 228 (279)
T ss_pred cCCCccc--ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH----CCC
Confidence 4332211 1122346788999999998899999999999999999998 99998653211 1111111 111
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.. .. ..... ..+.+++..|+. .+|++|||+.|+++.|..+..+
T Consensus 229 ~~--~~----~~~~~---~~~~~li~~c~~-~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 RL--AQ----PQICT---IDVYMVMVKCWM-IDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred cC--CC----CCCCC---HHHHHHHHHHcC-CCcccCcCHHHHHHHHHHHHhC
Confidence 00 00 01111 234556678888 8999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.47 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=201.1
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...++||+|+||.||+|..++++.|++|.+.........+.+|++++++++|+|++++++++. .+..++++||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 467888999999999999999989999999999877666778999999999999999999999864 4568999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... +..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05067 85 GSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence 99999986433 35689999999999999999999998 9999999999999999999999999999865422111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
......++..|+|||++....++.++||||||+++||+++ |+.||...... +........... .
T Consensus 159 --~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~-~---- 223 (260)
T cd05067 159 --AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYRM-P---- 223 (260)
T ss_pred --cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCCC-C----
Confidence 1112235678999999988889999999999999999999 99999753321 111111110000 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.....+. ++.+++.+|+. .+|++||+++++...|+.
T Consensus 224 --~~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 --RPDNCPE---ELYELMRLCWK-EKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCH---HHHHHHHHHcc-CChhhCCCHHHHHHHhhc
Confidence 0111223 34555557776 899999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=320.05 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=194.0
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 377 (623)
-++|...++||+|.||.|+++..+ ++..+|||.+++.. ...+..+.|-+++... +||.+++++.+|+++++.+.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467888999999999999999965 67889999998753 3456677787777666 69999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+.||++..+.+ ...+++..+.-+|..|+.||.|||++ +||+||||-+|||+|.+|++||+|||+++..
T Consensus 447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999665553 35799999999999999999999999 9999999999999999999999999999964
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
-..+...+++ +||+.|||||++.+..|+..+|.|||||+||||+.|..||.+++..+.+...+ .
T Consensus 519 m~~g~~TsTf----CGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--------~---- 582 (694)
T KOG0694|consen 519 MGQGDRTSTF----CGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--------N---- 582 (694)
T ss_pred CCCCCccccc----cCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--------c----
Confidence 3222333344 49999999999999999999999999999999999999998765433221111 1
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTM 576 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~ 576 (623)
|.-+-....+.|...+++..+. .+|++|.-+
T Consensus 583 ----d~~~yP~~ls~ea~~il~~ll~----k~p~kRLG~ 613 (694)
T KOG0694|consen 583 ----DEVRYPRFLSKEAIAIMRRLLR----KNPEKRLGS 613 (694)
T ss_pred ----CCCCCCCcccHHHHHHHHHHhc----cCcccccCC
Confidence 0111111234566666665554 789999866
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.83 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=197.9
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|++|.||++...++..+++|.+.......+.+.+|++++++++|||++++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 457778899999999999999887778999998766556678899999999999999999998875 4567899999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.++++... ...++|..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999996532 34589999999999999999999998 9999999999999999999999999999865432211
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
......++..|+|||+..+..++.++||||||+++|||++ |+.||...... ....+. ...... +
T Consensus 159 --~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~---~~~~~~-----~ 223 (260)
T cd05069 159 --ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----EVLEQV---ERGYRM-----P 223 (260)
T ss_pred --ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH---HcCCCC-----C
Confidence 1112235678999999988889999999999999999999 88898653221 111111 111000 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.....+.+ +..++..|+. .+|++||++++|.+.|++
T Consensus 224 --~~~~~~~~---~~~li~~~l~-~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 --CPQGCPES---LHELMKLCWK-KDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCcccCHH---HHHHHHHHcc-CCcccCcCHHHHHHHHhc
Confidence 00112233 3444456776 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=309.01 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=198.6
Q ss_pred cCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
+|...+.||+|+||.||+|... ....+++|.+.... .....+.+|+.++.+++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667889999999999999853 23568888886543 234578899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCC--------------------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCc
Q 006982 378 VYKHMPNGSLYDLLHPAD--------------------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKC 437 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~N 437 (623)
|+||+++|+|.+++.... .....+++.+++.++.|++.|++|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999975421 1124588999999999999999999998 99999999999
Q ss_pred eeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 006982 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKA 516 (623)
Q Consensus 438 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~ 516 (623)
|++++++.+||+|||+++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVK--RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhc--ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999986543222111 112235678999999988889999999999999999998 9999864321
Q ss_pred cccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 517 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
. .+.++...... .. ......+ .+.+++..|+. .+|++||+++|+++.|+++-.
T Consensus 236 ~-----~~~~~~~~~~~---------~~-~~~~~~~---~~~~~i~~cl~-~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 E-----RLFNLLKTGYR---------ME-RPENCSE---EMYNLMLTCWK-QEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-----HHHHHHhCCCC---------CC-CCCCCCH---HHHHHHHHHcc-CCcccCCCHHHHHHHHHHHHh
Confidence 1 11111111000 00 0111223 35556677877 899999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=318.63 Aligned_cols=246 Identities=23% Similarity=0.335 Sum_probs=197.5
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
-|..++.||+|+.|.|..|++ .+|+.+|||++.+.. .....+++|+-+|+.++|||+++++++++++.+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 355578899999999999995 589999999996642 223467899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++|.|++++-. .+.+.+..+.+++.||..|+.|+|+. +|+|||+||+|+|+|+.+++||+|||+|..-.+
T Consensus 93 yv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP- 164 (786)
T ss_pred ecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence 9999999999953 35688999999999999999999999 999999999999999999999999999986443
Q ss_pred CCcccccccCCCCcccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVAT-PKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.....+.+|++.|.|||++++.+|. .++||||+|||||.|+||+.||+++ ++.......... . .+
T Consensus 165 ----gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G-~-f~ 230 (786)
T KOG0588|consen 165 ----GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRG-V-FE 230 (786)
T ss_pred ----CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcC-c-cc
Confidence 2234456799999999999999885 6899999999999999999999853 222222211111 0 00
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
+ ......+...++.-++ ..||+.|.|++||++.-
T Consensus 231 M------Ps~Is~eaQdLLr~ml----~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 231 M------PSNISSEAQDLLRRML----DVDPSTRITTEEILKHP 264 (786)
T ss_pred C------CCcCCHHHHHHHHHHh----ccCccccccHHHHhhCc
Confidence 0 1123344444444333 38899999999998864
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.95 Aligned_cols=261 Identities=22% Similarity=0.384 Sum_probs=202.7
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
.+|...+.||+|+||.||++... ++..+++|.+.... ...+.+.+|++++.+++|||++++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 45778899999999999999842 34568899886543 345678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCC---------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 378 VYKHMPNGSLYDLLHPAD---------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
|+||+++++|.+++.... .....+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1223589999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~ 527 (623)
+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||...... +.
T Consensus 162 ~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~ 231 (288)
T cd05093 162 GDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EV 231 (288)
T ss_pred ccCCccccccCCcee--ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence 999999865432211 11122335778999999998889999999999999999998 88888643221 11
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
...... +.... . ....+ ..+.+++..|+. .+|.+|||+.||.+.|+++...
T Consensus 232 ~~~i~~-~~~~~-----~-~~~~~---~~l~~li~~~l~-~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQ-GRVLQ-----R-PRTCP---KEVYDLMLGCWQ-REPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHc-CCcCC-----C-CCCCC---HHHHHHHHHHcc-CChhhCCCHHHHHHHHHHHHHh
Confidence 111111 11000 0 01122 235666677887 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.60 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=196.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +++.||+|++.... .....+..|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 58899999997542 23456888999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999953 24688999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+..|...... ..
T Consensus 154 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~----~~ 221 (333)
T cd05600 154 -------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-ENLKYWKETLQR----PV 221 (333)
T ss_pred -------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-HHHHhccccccC----CC
Confidence 122345899999999999889999999999999999999999999753321110 001111000000 00
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
..++ .....+++..++ ..|+. .+|.+||+++++++.
T Consensus 222 ~~~~---~~~~s~~~~~li---~~~l~-~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDP---RFNLSDEAWDLI---TKLIN-DPSRRFGSLEDIKNH 257 (333)
T ss_pred CCcc---ccccCHHHHHHH---HHHhh-ChhhhcCCHHHHHhC
Confidence 0000 001234444444 45665 889999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.85 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=198.1
Q ss_pred HhccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 374 (623)
.+++|+..+.||+|+||.||+|... .+..||+|++.... ....++.+|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888999999999999998753 24679999886432 234568899999999999999999999999899
Q ss_pred eeEEEecCCCCCHhhhccCCCCC------CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDT------GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
.++|+||+++|+|.+++...... ...++|..++.++.|++.||.|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998643211 23468889999999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~ 527 (623)
+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... +.
T Consensus 161 ~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~ 230 (277)
T cd05062 161 GDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QV 230 (277)
T ss_pred CCCCCccccCCcceee--cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence 9999998654322211 1111235788999999998889999999999999999999 68888643211 11
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
...... ...... .....+ .+..++..|+. .+|++|||+.|+++.|++
T Consensus 231 ~~~~~~-~~~~~~------~~~~~~---~~~~li~~~l~-~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LRFVME-GGLLDK------PDNCPD---MLFELMRMCWQ-YNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHc-CCcCCC------CCCCCH---HHHHHHHHHcC-CChhhCcCHHHHHHHhhC
Confidence 111111 111000 011222 34556667877 999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.26 Aligned_cols=262 Identities=23% Similarity=0.403 Sum_probs=203.8
Q ss_pred hccCcccceeeccCccEEEEEEeCC-----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEe-CCee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED-----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMA-KKER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 375 (623)
.++|...++||+|+||.||+|...+ +..|++|++.... .....+.+|+.++.+++|||++++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3568888999999999999999765 6889999886542 335668899999999999999999998876 4678
Q ss_pred eEEEecCCCCCHhhhccCCCCC----CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 376 LLVYKHMPNGSLYDLLHPADDT----GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
++++||+++|+|.+++...... +..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998654321 25689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQ 530 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~ 530 (623)
|+++.+.+...... .....++..|+|||++....++.++||||||+++||+++ |+.||...... .+..++.
T Consensus 162 g~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~- 233 (280)
T cd05043 162 ALSRDLFPMDYHCL--GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-----EMAAYLK- 233 (280)
T ss_pred CCcccccCCceEEe--CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----HHHHHHH-
Confidence 99987644332211 112235778999999988889999999999999999999 99998653221 1111111
Q ss_pred HhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
....... ....++ .+.+++..|+. .+|++|||+.||++.|+++.++
T Consensus 234 --~~~~~~~-------~~~~~~---~~~~li~~~l~-~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 --DGYRLAQ-------PINCPD---ELFAVMACCWA-LDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --cCCCCCC-------CCcCCH---HHHHHHHHHcC-CChhhCCCHHHHHHHHHHHHhc
Confidence 1111000 011123 34556667877 8999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.40 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=201.7
Q ss_pred hccCcccceeeccCccEEEEEEeCC------CcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 374 (623)
.++|...+.||+|+||.||++...+ ...+++|.+.... .....+.+|++++.++ +|+||+++++++..+..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4568888999999999999998642 3578999887532 2345688999999999 89999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCC------------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC
Q 006982 375 RLLVYKHMPNGSLYDLLHPAD------------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD 442 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~ 442 (623)
.+++|||+++|+|.++++... .....+++..+++++.|++.|++|||+. +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 999999999999999986421 2345789999999999999999999998 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 006982 443 DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFK 521 (623)
Q Consensus 443 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~ 521 (623)
++.+||+|||+++.+........ .....++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred CCeEEeCccccccccccccceec--cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 99999999999987654222111 112235678999999988889999999999999999998 988886432211
Q ss_pred ccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
..+ ... ... ...........+.+++..|+. .+|++|||+.|+++.|+++.
T Consensus 243 --~~~---~~~-~~~---------~~~~~~~~~~~~~~li~~~l~-~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 --LFK---LLK-EGY---------RMEKPQNCTQELYHLMRDCWH-EVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHH---HHH-cCC---------cCCCCCCCCHHHHHHHHHHcc-cCcccCcCHHHHHHHHHHhh
Confidence 111 110 100 000011112345567778887 89999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.30 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=197.4
Q ss_pred CcccceeeccCccEEEEEEe-----CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeE
Q 006982 307 FSKNNIIGSGRTGTMYKALL-----EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLL 377 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 377 (623)
|...+.||+|+||.||++.. .++..||+|.+.... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988652 367889999987543 2456788999999999999999999998764 35789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++.. ..+++.+++.++.|++.|+.|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999952 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
........ ......++..|+|||......++.++||||||+++|||++|+.|+...... +. ....+.........+
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~-~~~~~~~~~~~~~~~ 233 (283)
T cd05080 158 PEGHEYYR-VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FE-EMIGPKQGQMTVVRL 233 (283)
T ss_pred CCcchhhc-cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hh-hhhcccccccchhhh
Confidence 43221110 011123566799999998888999999999999999999999998643221 00 000000000001111
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
.+.++..............+.+++..|+. .+|++|||+++|+++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~-~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWE-TEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhc-cChhhCCCHHHHHHHHHHhh
Confidence 22222211111111112345556667777 89999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.81 Aligned_cols=198 Identities=24% Similarity=0.385 Sum_probs=173.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|+..+.||+|+||.||++... ++..+|+|.+.... .....+.+|++++.+++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57888999999999999999965 67889999886542 2346789999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999963 245889999999999999999999862 59999999999999999999999999998653321
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 12234889999999999889999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=303.76 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=195.4
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee-----eEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER-----LLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-----~lV~ 379 (623)
.|...+++|+|+||.||+|... ++..||+|+.-...+- -.+|+++|+++.|||||+++.+|....+. .+|+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4566789999999999999964 5689999998655432 23799999999999999999988764322 4899
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-CCeEEeecccccccC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-FEPKISDFGLARLMN 458 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-~~~kl~Dfgla~~~~ 458 (623)
||||. +|.+.++.....+..++.....-+..|+.+||+|||+. +|+||||||+|+|+|.+ |.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99998 99999976544557788888888999999999999998 99999999999999965 999999999999988
Q ss_pred CCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC--
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG-- 535 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~-- 535 (623)
+.....+.. .|--|+|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+.+.... +...++ .+...
T Consensus 178 ~~epniSYi-----cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----L~eIik-~lG~Pt~ 247 (364)
T KOG0658|consen 178 KGEPNISYI-----CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----LVEIIK-VLGTPTR 247 (364)
T ss_pred cCCCceeEE-----EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH----HHHHHH-HhCCCCH
Confidence 766555444 4678999999876 4699999999999999999999999987544322 111111 11100
Q ss_pred -------------chhhhhchhh---hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH--HHHHhhcc
Q 006982 536 -------------QLQDAIDKCL---VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLRAIGER 589 (623)
Q Consensus 536 -------------~~~~~~d~~l---~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~--~L~~i~~~ 589 (623)
...++....+ .....+.+..+++ .+++. .+|.+|.++.|++. ..+++++.
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll---~~~L~-Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLL---SKLLQ-YSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHH---HHHhc-cChhhcCCHHHHhcchhhHHhhCc
Confidence 0011111111 1111233444444 44444 99999999999874 45666655
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.12 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=196.0
Q ss_pred ccCcccceeeccCccEEEEEEe-----CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-----EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
.+|+..+.||+|+||.||+|.. .++..+++|.+.... .....+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999984 356789999987533 233578899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCC-------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC
Q 006982 378 VYKHMPNGSLYDLLHPADD-------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF 444 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~ 444 (623)
||||+++|+|.+++..... ....+++.+.+.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853210 123578999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccccccc
Q 006982 445 EPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGN 523 (623)
Q Consensus 445 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~ 523 (623)
.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYR--VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----E 234 (283)
T ss_pred cEEeccccccccccCCccee--cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----H
Confidence 99999999998754322111 1122235678999999988889999999999999999998 88888642210 1
Q ss_pred HHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 524 LVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 524 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
..+.+ ....... .....+.++ ..++..|+. .+|++||++.++.+.|..
T Consensus 235 ~~~~~----~~~~~~~------~~~~~~~~~---~~li~~cl~-~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMV----RKRQLLP------CSEDCPPRM---YSLMTECWQ-EGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH----HcCCcCC------CCCCCCHHH---HHHHHHHcc-cCcccCcCHHHHHHHhhc
Confidence 11111 1111000 011123333 344456776 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.25 Aligned_cols=192 Identities=20% Similarity=0.246 Sum_probs=167.1
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
++||+|+||.||+++.. +|+.||+|++.... .....+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68899999987532 23356788999999999999999999999999999999999999
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccc
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 465 (623)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--
Confidence 99999863 34689999999999999999999999 9999999999999999999999999999753221111
Q ss_pred ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 466 TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 466 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred --ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 1223489999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=306.93 Aligned_cols=200 Identities=22% Similarity=0.295 Sum_probs=171.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|+||.||+++.+ ++..||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 57889999986542 234567899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|++++.+..+.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999987776543 224588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 154 SNA---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccc---cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 211 111234789999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=303.11 Aligned_cols=256 Identities=23% Similarity=0.404 Sum_probs=199.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CC---cEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DG---TSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|+..+.||+|+||.||+|... ++ ..+++|.+.... ...+.+..|++++.+++|||++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999965 33 378999886542 3356788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999998642 24689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
........ ......+..|+|||++....++.++|||||||++|||++ |+.||..... .++........
T Consensus 159 ~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~-- 227 (268)
T cd05063 159 DDPEGTYT-TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGF-- 227 (268)
T ss_pred ccccccee-ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCC--
Confidence 32211111 111223567999999988889999999999999999998 9999864221 11111111100
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
......+....+.+++..|+. .+|++||++.+|++.|+++
T Consensus 228 --------~~~~~~~~~~~~~~li~~c~~-~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 --------RLPAPMDCPSAVYQLMLQCWQ-QDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcC-CCcccCcCHHHHHHHHHhh
Confidence 000011112345677778887 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=300.66 Aligned_cols=260 Identities=20% Similarity=0.323 Sum_probs=204.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +++.|++|.++.. ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888899999999999999976 7899999988632 123567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.........+++.+++.++.+++.|+.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865433446689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+....... ...
T Consensus 159 ~~~~----~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~-- 225 (267)
T cd08224 159 KTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEK-CDY-- 225 (267)
T ss_pred CCcc----cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhc-CCC--
Confidence 2111 1123478889999999888899999999999999999999999864321 11121111110 000
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
...........+.+++..|+. .+|++||++.+|+++|+++.
T Consensus 226 ------~~~~~~~~~~~~~~~i~~cl~-~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 ------PPLPADHYSEELRDLVSRCIN-PDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------CCCChhhcCHHHHHHHHHHcC-CCcccCCCHHHHHHHHHHhc
Confidence 000000111234455566776 99999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=316.32 Aligned_cols=257 Identities=19% Similarity=0.221 Sum_probs=195.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|+..+.||+|+||.||++... +++.||+|++.... .....+..|++++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999865 68899999996532 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999963 34689999999999999999999999 999999999999999999999999999976532
Q ss_pred CCCcc-------------------------------cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 006982 460 IDTHL-------------------------------STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGE 508 (623)
Q Consensus 460 ~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~ 508 (623)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 11000 00012346899999999999989999999999999999999999
Q ss_pred CCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 509 RPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 509 ~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.||......+. ......... .+..+. .....++...++... |+...++..||+++|+++.
T Consensus 234 ~Pf~~~~~~~~--------~~~i~~~~~--~~~~p~--~~~~s~~~~~li~~l--~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQET--------YKKVMNWKE--TLIFPP--EVPISEKAKDLILRF--CCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHH--------HHHHHcCcC--cccCCC--cCCCCHHHHHHHHHH--cCChhhcCCCCCHHHHhCC
Confidence 99975332111 111110000 000000 011344555555443 3343556678999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=286.73 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=203.6
Q ss_pred hccCcccceeeccCccEEEEEE-eCCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----Ceee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KERL 376 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 376 (623)
.++|.+.+.+|+|||+-||.++ ..++..+|+|++.-.. .+.+..++|++..++++|||+++++++...+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3578889999999999999999 6678899999986554 6677889999999999999999999987544 3589
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
++++|...|+|.+.+......+..+++.+.++|+.++++||.+||+. .|+++||||||.|||+++++.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999987666677899999999999999999999997 34699999999999999999999999999976
Q ss_pred cCCC--CCccc---ccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHH
Q 006982 457 MNPI--DTHLS---TFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 457 ~~~~--~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~ 528 (623)
..-. ..... .-......|..|+|||.+. +...++++|||||||+||+|+.|..||+.....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------- 247 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------- 247 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence 4211 00000 0011234789999999885 456789999999999999999999999743221
Q ss_pred HHHhccCchhhh-hchhh---hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 529 AQLSSTGQLQDA-IDKCL---VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 529 ~~~~~~~~~~~~-~d~~l---~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
.+.+.-. ....+ .....++.+. ++..+|++ .||.+||+..+++..++.+
T Consensus 248 -----GgSlaLAv~n~q~s~P~~~~yse~l~---~lik~mlq-vdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 -----GGSLALAVQNAQISIPNSSRYSEALH---QLIKSMLQ-VDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CCeEEEeeeccccccCCCCCccHHHH---HHHHHHhc-CCcccCCCHHHHHHHHHhh
Confidence 1111100 11011 1112344444 44456666 9999999999999998875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.88 Aligned_cols=200 Identities=21% Similarity=0.333 Sum_probs=170.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||+|... ++..||+|.++... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 68899999986532 2345678999999999999999999999998899999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++ +|.+++... +..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 999988532 24578899999999999999999999 99999999999999999999999999997643221
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 158 K----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred c----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1123347899999998865 568999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=301.39 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=202.9
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|..+++..+++|.+.......+.+.+|+..+++++|+|++++++++......++|+||+++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 56888899999999999999988888999999987666778899999999999999999999999988899999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
++|.+++.... +..+++.++..++.+++.|+.|||+. +++|+||||+||++++++.++|+|||+++........
T Consensus 86 ~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (261)
T cd05034 86 GSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT- 159 (261)
T ss_pred CCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh-
Confidence 99999996532 35689999999999999999999999 9999999999999999999999999999876431111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
...+...+..|+|||.+.+..++.++||||||+++||+++ |+.||...... ........... .
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~------~ 223 (261)
T cd05034 160 --AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYR------M 223 (261)
T ss_pred --hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC------C
Confidence 1112224578999999998889999999999999999998 99998643211 11111111000 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.. ....++ .+.+++.+|+. .+|++||+++++.+.|+.
T Consensus 224 ~~-~~~~~~---~~~~~i~~~l~-~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PR-PPNCPE---ELYDLMLQCWD-KDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC-CCCCCH---HHHHHHHHHcc-cCcccCCCHHHHHHHHhc
Confidence 00 011122 34556667776 899999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=303.48 Aligned_cols=260 Identities=19% Similarity=0.315 Sum_probs=202.1
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|++|.||++.. .++..+++|.+.... .....+.+|+++++.++|||++++++++..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577789999999999999995 578999999876432 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++++|.+++.........+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999864333446789999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... .....++..|+|||++.+..++.++||||||+++|||++|..||...... ...+..... .
T Consensus 159 ~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~------~ 222 (267)
T cd08229 159 KTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIE------Q 222 (267)
T ss_pred CCcc----cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhh------c
Confidence 2211 12234788999999998888999999999999999999999998643211 111111111 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
...+........++ +..++..|+. .+|++||||.+|+++++++.
T Consensus 223 ~~~~~~~~~~~~~~---~~~li~~~l~-~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPPLPSDHYSEE---LRQLVNMCIN-PDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCCcccccHH---HHHHHHHhcC-CCcccCCCHHHHHHHHhhhc
Confidence 00011111112233 3344446766 89999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=312.37 Aligned_cols=196 Identities=19% Similarity=0.290 Sum_probs=172.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||++... +++.||+|++.... .....+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999965 68899999986432 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999863 24688999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 154 RT-------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred Cc-------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1234889999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.96 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=197.4
Q ss_pred ccCcccceeeccCccEEEEEEeCC-Cc--EEEEEEeccc--cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GT--SLMVKRLQDS--QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 378 (623)
++|+..++||+|+||.||+|..++ +. .+++|.++.. ....+.+.+|++++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998753 33 4688887642 22345788999999999 799999999999998899999
Q ss_pred EecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 379 YKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
+||+++|+|.++++.... ....+++..++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999864321 123588999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~ 525 (623)
||+|||++........ . .....+..|+|||+.....++.++|||||||++|||++ |..||......
T Consensus 159 kl~dfg~~~~~~~~~~---~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------- 225 (297)
T cd05089 159 KIADFGLSRGEEVYVK---K--TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------- 225 (297)
T ss_pred EECCcCCCccccceec---c--CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 9999999864321100 0 01113567999999988889999999999999999997 99998653221
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
+........ . .... ....+.+ +.+++..|+. .+|.+||+++++++.|+++.+.+
T Consensus 226 ~~~~~~~~~-~-----~~~~-~~~~~~~---~~~li~~~l~-~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 ELYEKLPQG-Y-----RMEK-PRNCDDE---VYELMRQCWR-DRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHhcC-C-----CCCC-CCCCCHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHHhh
Confidence 111111110 0 0000 0112233 4455556776 89999999999999999987655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=285.62 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=200.6
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|++.+.||+|.||.||.|+. +++..||+|++.+++ ....++.+|+++-+.++||||+++++||.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5688999999999999999994 568899999997764 34567899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||.++|++...|.... ...+++.....+..|+|.|+.|+|.. +|+||||||+|+|++..+..||+|||.+..-.
T Consensus 102 Eya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999997543 35688888999999999999999999 99999999999999999999999999997543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.....+ .+||..|.+||...+...+..+|+|++|++.||++.|..||......+.+.. +.. .+
T Consensus 176 -~~kR~t----lcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr-----I~k-------~~ 238 (281)
T KOG0580|consen 176 -SNKRKT----LCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR-----IRK-------VD 238 (281)
T ss_pred -CCCcee----eecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH-----HHH-------cc
Confidence 122222 3489999999999999999999999999999999999999986442222111 111 11
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
+.++ .....+..+++. .|.. .+|.+|.+..||++.-
T Consensus 239 ~~~p----~~is~~a~dlI~---~ll~-~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 239 LKFP----STISGGAADLIS---RLLV-KNPIERLALTEVMDHP 274 (281)
T ss_pred ccCC----cccChhHHHHHH---HHhc-cCccccccHHHHhhhH
Confidence 2222 123344444433 3444 8899999999988653
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=299.95 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=190.5
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
+.||+|+||.||+|... +++.+++|.+.... .....+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999964 78899999876432 3356789999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 152 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--AST 152 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccc--ccc
Confidence 9998532 24588999999999999999999999 999999999999999999999999999986542111 111
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhh
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLV 546 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 546 (623)
......+..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+.. .... . .
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----~~~~~~~~---~~~~-~------~ 217 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----QTREAIEQ---GVRL-P------C 217 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----HHHHHHHc---CCCC-C------C
Confidence 111123567999999998889999999999999999998 88888542111 01111100 0000 0 0
Q ss_pred cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 547 AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 547 ~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
....+. .+.+++..|+. .+|++|||+.+|.++|+
T Consensus 218 ~~~~~~---~~~~li~~~l~-~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPD---AVYRLMERCWE-YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCH---HHHHHHHHHcC-CChhhCcCHHHHHHHHh
Confidence 011122 44555567776 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=302.01 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=195.2
Q ss_pred CcccceeeccCccEEEEEEeCC----CcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe-----
Q 006982 307 FSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE----- 374 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 374 (623)
|...+.||+|+||.||+|.... +..||+|+++... .....+.+|++.++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 3679999987543 234578899999999999999999998876554
Q ss_pred -eeEEEecCCCCCHhhhccCCCC--CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 375 -RLLVYKHMPNGSLYDLLHPADD--TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 375 -~~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
.++++||+++|+|..++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999999854321 224689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQ 530 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~ 530 (623)
|+++.......... .....++..|+|||++....++.++||||||+++|||++ |..||...... +....
T Consensus 158 g~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~ 227 (273)
T cd05035 158 GLSKKIYSGDYYRQ--GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDY 227 (273)
T ss_pred cceeeccccccccc--cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH
Confidence 99987644322111 111224678999999988889999999999999999999 88888643211 11111
Q ss_pred HhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
....... .. ..... ..+.+++..|+. .||++||++.||++.|+++
T Consensus 228 ~~~~~~~-~~------~~~~~---~~~~~li~~~l~-~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRL-KQ------PEDCL---DELYDLMYSCWR-ADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHcCCCC-CC------CcCCC---HHHHHHHHHHcC-CChhhCcCHHHHHHHHHhh
Confidence 1111000 00 01122 245555566777 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=319.04 Aligned_cols=195 Identities=20% Similarity=0.301 Sum_probs=172.6
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999965 68899999986532 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999863 24578888999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
... ...||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~~-------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 171 RTF-------TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred Ccc-------eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 211 12489999999999998899999999999999999999999965
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=304.81 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=196.8
Q ss_pred hccCcccceeeccCccEEEEEEeCC------CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
.++|...+.||+|++|.||+|...+ +..|++|.+.... .....+..|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999999753 5678899876432 2345689999999999999999999999999899
Q ss_pred eEEEecCCCCCHhhhccCCCC---CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC---CeEEe
Q 006982 376 LLVYKHMPNGSLYDLLHPADD---TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF---EPKIS 449 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~---~~kl~ 449 (623)
++|+||+++|+|.++++.... ....++|..++.++.|++.|++|||+. +++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999865432 123589999999999999999999999 999999999999998654 59999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHH
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~ 528 (623)
|||+++.+....... .......+..|+|||++.+..++.++|||||||++|||++ |+.||...... +..
T Consensus 162 dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~~ 231 (277)
T cd05036 162 DFGMARDIYRASYYR--KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EVM 231 (277)
T ss_pred cCccccccCCcccee--cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence 999998763322111 1111223568999999998889999999999999999997 99998753221 111
Q ss_pred HHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 529 AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
......... . . ....+ ..+.+++..|+. .+|++||++.+|++.|+
T Consensus 232 ~~~~~~~~~-~-----~-~~~~~---~~~~~~i~~cl~-~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTGGGRL-D-----P-PKGCP---GPVYRIMTDCWQ-HTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHcCCcC-C-----C-CCCCC---HHHHHHHHHHcC-CCcccCcCHHHHHHHhh
Confidence 111111000 0 0 01112 245556667877 89999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=307.70 Aligned_cols=261 Identities=25% Similarity=0.409 Sum_probs=200.1
Q ss_pred hccCcccceeeccCccEEEEEEe--------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL--------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK 372 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 372 (623)
..+|...+.||+|+||.||++.. .++..|++|.+.... .....+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 35677889999999999999974 134579999886532 3346788999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl 440 (623)
...++||||+++|+|.+++..... ....++|.+++.++.|++.||.|||+. +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999865321 124578999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 006982 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPET 519 (623)
Q Consensus 441 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~ 519 (623)
++++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred cCCCcEEECCCccceecccccccc--cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 999999999999998764322211 1112235678999999988889999999999999999998 777875421
Q ss_pred ccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 520 FKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 520 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
..++.......... . .......+ +..++..|+. .+|++||++.|+++.|+++..
T Consensus 245 ----~~~~~~~~~~~~~~-~------~~~~~~~~---~~~li~~cl~-~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 ----VEELFKLLKEGHRM-D------KPANCTNE---LYMMMRDCWH-AIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ----HHHHHHHHHcCCcC-C------CCCCCCHH---HHHHHHHHcc-cChhhCCCHHHHHHHHHHHHH
Confidence 11222211111100 0 01112233 4445556776 899999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=327.87 Aligned_cols=252 Identities=18% Similarity=0.201 Sum_probs=194.4
Q ss_pred cCcccceeeccCccEEEEEEeC-C-CcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-D-GTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.|...+.||+|++|.||+|... + +..|++|.+.... .....+..|++++..++|||||++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999854 3 5678888764433 33456778999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998864333345688999999999999999999999 999999999999999999999999999987643211
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
. .......||++|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .. .
T Consensus 225 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~-~~----~ 289 (478)
T PTZ00267 225 L--DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYG-KY----D 289 (478)
T ss_pred c--ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-CC----C
Confidence 1 112234589999999999999999999999999999999999999964321 1111111111 00 0
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+ .......++. .++..|+. .+|++||++.+++.
T Consensus 290 ~--~~~~~s~~~~---~li~~~L~-~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 P--FPCPVSSGMK---ALLDPLLS-KNPALRPTTQQLLH 322 (478)
T ss_pred C--CCccCCHHHH---HHHHHHhc-cChhhCcCHHHHHh
Confidence 0 0011223333 44445666 99999999999864
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=300.10 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=200.1
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||++...++..+++|.+.........+.+|++++++++|+|++++.+++.+ ...++++||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 4677889999999999999998888889999987665556788999999999999999999999887 678999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... +..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 85 GSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 99999996532 35688999999999999999999998 9999999999999999999999999999865432111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
......++..|+|||++....++.++|+|||||++||+++ |+.||...... .+..+... .....
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~----~~~~~---- 223 (260)
T cd05073 159 --AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALER----GYRMP---- 223 (260)
T ss_pred --cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHhC----CCCCC----
Confidence 1112235678999999998889999999999999999999 89898643221 11111111 00000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.....+. .+..++.+|+. .+|++||++.++.+.|+.
T Consensus 224 --~~~~~~~---~~~~~i~~~l~-~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --RPENCPE---ELYNIMMRCWK-NRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CcccCCH---HHHHHHHHHcc-cCcccCcCHHHHHHHHhc
Confidence 0011222 34555567776 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.52 Aligned_cols=190 Identities=25% Similarity=0.298 Sum_probs=166.1
Q ss_pred eeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
||+|+||.||++... ++..||+|++... ......+.+|++++.+++||||+++++++.+.+..++|+||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 5788999998643 22345678899999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---- 149 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---- 149 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc----
Confidence 999963 24589999999999999999999999 9999999999999999999999999999864322111
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 1223589999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.49 Aligned_cols=263 Identities=22% Similarity=0.345 Sum_probs=208.3
Q ss_pred cCcccceeeccCccEEEEEEeCCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.....++||+|-||.|..+....+..||||.++... ....+|.+|+++|.+++|||||.++|+|..++..++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 345567899999999999999888999999998754 345789999999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++...... ...-....+|+.|||.||+||.+. +++||||.++|+|+|.++++||+|||+++-+...+++
T Consensus 619 nGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 619 NGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred cCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999765432 245566788999999999999998 9999999999999999999999999999977655443
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT--GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt--g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
... ...+-+.+|||||.+.-+++|.++|||+||+.+||+++ ...||....+. ...+-...+.+....+..+
T Consensus 694 ~vq--gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 694 RVQ--GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred eee--cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCCCcceec
Confidence 221 11234689999999999999999999999999999886 77788654332 2233333333332222111
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
. +....+. .+.++.+.|+. .|-++||+++++...|++..
T Consensus 767 ~---~P~~cp~---~lyelml~Cw~-~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 767 S---RPPACPQ---GLYELMLRCWR-RESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred c---CCCcCcH---HHHHHHHHHhc-hhhhcCCCHHHHHHHHHHhc
Confidence 1 1111233 44577788987 88999999999999998653
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.05 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=199.3
Q ss_pred ccCcccceeeccCccEEEEEEeC--------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE--------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKK 373 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 373 (623)
++|.+.+.||+|+||.||++... ++..+|+|.+.... .....+..|++++.++ +||||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888999999999999999752 23569999987542 2345688899999999 7999999999999999
Q ss_pred eeeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
..++|+||+++|+|.+++..... ....++|.++++++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999965322 123589999999999999999999998 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 006982 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETF 520 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~ 520 (623)
+++.+||+|||+++........... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKT--TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhcc--ccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 9999999999999865432111111 11124568999999988889999999999999999998 8888754211
Q ss_pred cccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 521 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.+...... .....+. ...... .+.+++..|+. .+|++||++.+|++.|+++.+.
T Consensus 249 ----~~~~~~~~-~~~~~~~------~~~~~~---~~~~li~~~l~-~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 ----EELFKLLK-EGHRMDK------PSNCTN---ELYMMMRDCWH-AVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ----HHHHHHHH-cCCCCCC------CCcCCH---HHHHHHHHHcc-cChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 1100000 011223 34445567777 8999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=310.69 Aligned_cols=198 Identities=23% Similarity=0.384 Sum_probs=172.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|+..+.||+|+||.||++... ++..+++|.+.... .....+.+|++++.+++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57888999999999999999965 67888999876532 2345788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.. ...+++.....++.+++.||.|||+.. +|+||||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 85 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999953 245788999999999999999999752 69999999999999999999999999997653211
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12234789999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.00 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=191.5
Q ss_pred cccceeeccCccEEEEEEeCCC-c--EEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------Cee
Q 006982 308 SKNNIIGSGRTGTMYKALLEDG-T--SLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------KER 375 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 375 (623)
...+.||+|+||.||+|...+. . .+|+|.++.. ....+.+..|++++.+++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999997543 2 5899988654 23346788899999999999999999987542 245
Q ss_pred eEEEecCCCCCHhhhccCCC--CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 376 LLVYKHMPNGSLYDLLHPAD--DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
++++||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999874322 1234589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHh
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLS 532 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~ 532 (623)
++......... ......+++.|+|||+.....++.++||||||+++|||++ |+.||...... +......
T Consensus 159 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~ 228 (272)
T cd05075 159 SKKIYNGDYYR--QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYLR 228 (272)
T ss_pred ccccCccccee--cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHH
Confidence 98764322111 1111235678999999998899999999999999999999 78888642211 1111111
Q ss_pred ccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 533 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
.. .... ......+ .+.+++..|+. .+|++|||+.++++.|+++
T Consensus 229 ~~-~~~~------~~~~~~~---~~~~li~~~l~-~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QG-NRLK------QPPDCLD---GLYSLMSSCWL-LNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cC-CCCC------CCCCCCH---HHHHHHHHHcC-CCcccCcCHHHHHHHHHhh
Confidence 11 1000 0011222 34555667776 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=305.48 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=196.6
Q ss_pred ccCcccceeeccCccEEEEEEe-----CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Ceee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-----EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 376 (623)
.+|...+.||+|+||.||++.. .++..|++|++.... ...+.+.+|++++.+++|||++++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677789999999999999974 357889999986543 3356788999999999999999999987543 4578
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||+++|+|.+++... ...++|..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999643 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC-
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG- 535 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~- 535 (623)
.......... .....++..|+|||++.+..++.++|||||||++|||++|..|+...... +........
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---------~~~~~~~~~~ 227 (284)
T cd05081 158 LPQDKEYYKV-REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---------FMRMMGNDKQ 227 (284)
T ss_pred ccCCCcceee-cCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---------hhhhcccccc
Confidence 6432221111 11112345699999998888999999999999999999988776432110 000000000
Q ss_pred ------chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 536 ------QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 536 ------~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
.+.+.+...............+.+++..|+. .+|++|||+.||++.|+.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~-~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWN-NDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcc-CChhhCCCHHHHHHHHHhcC
Confidence 0011111100000001111245566667887 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.16 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=193.2
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHh
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLY 388 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 388 (623)
++||+|+||.||+|...++..+++|.+.... .....+.+|++++.+++|||++++++++......++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999986543 23456889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccc
Q 006982 389 DLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFV 468 (623)
Q Consensus 389 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 468 (623)
+++... ...+++..++.++.+++.+|.|||+. +++||||||+||++++++.+||+|||++...........
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~--- 151 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS--- 151 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccC---
Confidence 998543 24578999999999999999999998 999999999999999999999999999975432211111
Q ss_pred cCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhc
Q 006982 469 NGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA 547 (623)
Q Consensus 469 ~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 547 (623)
....+++.|+|||+..+..++.++||||||+++||+++ |..||...... ............
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~---------- 213 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYRM---------- 213 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCCC----------
Confidence 11224678999999998889999999999999999998 99998643221 101111110000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 548 KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 548 ~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.........+..++..|+. .+|++||++.|+++.|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~-~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWD-YKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHHHHHHHHHHcc-cCcccCCCHHHHHHHhc
Confidence 0001112345666778887 89999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=298.36 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=199.5
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|... ++.|++|.+.......+++.+|+.++++++|+|++++++++.+....++|+||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 46778899999999999999875 78899999987655567899999999999999999999999988899999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
++|.+++.... ...++|..+..++.|++.|+.|||+. +++|+||||+||++++++.++|+|||.++.......
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999996432 23689999999999999999999999 999999999999999999999999999987632111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
....+..|+|||++....++.++||||||+++||+++ |..||...... .+...+.. ......
T Consensus 158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~----~~~~~~--- 220 (256)
T cd05039 158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPHVEK----GYRMEA--- 220 (256)
T ss_pred -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHhc----CCCCCC---
Confidence 1224678999999988889999999999999999997 99998643211 11111110 000000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
....+++ +.+++..|+. .+|++||++.|++++|+.+
T Consensus 221 ---~~~~~~~---~~~li~~~l~-~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 ---PEGCPPE---VYKVMKDCWE-LDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---ccCCCHH---HHHHHHHHhc-cChhhCcCHHHHHHHHhcC
Confidence 0112233 4445556776 8999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.74 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=198.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCc--EEEEEEeccc--cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGT--SLMVKRLQDS--QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 378 (623)
++|+..+.||+|+||.||+|... ++. .+++|.++.. ......+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999964 454 4577776543 23345788999999999 899999999999999999999
Q ss_pred EecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 379 YKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
+||+++|+|.++++.... ....+++.+++.++.|++.|++|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999864321 124688999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~ 525 (623)
||+|||+++...... .. .....+..|+|||++....++.++|||||||++|||+| |..||......
T Consensus 164 kl~dfg~~~~~~~~~---~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------- 230 (303)
T cd05088 164 KIADFGLSRGQEVYV---KK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 230 (303)
T ss_pred EeCccccCcccchhh---hc--ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------
Confidence 999999986432110 00 11124567999999988889999999999999999998 99998643221
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
+........... . .....+. .+.+++.+|+. .+|++||++++++..|+++.+...
T Consensus 231 ~~~~~~~~~~~~-~------~~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 231 ELYEKLPQGYRL-E------KPLNCDD---EVYDLMRQCWR-EKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHHhcCCcC-C------CCCCCCH---HHHHHHHHHcC-CChhhCcCHHHHHHHHHHHHHhhh
Confidence 111111100000 0 0001122 34556667877 999999999999999998755543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=302.63 Aligned_cols=258 Identities=24% Similarity=0.424 Sum_probs=199.0
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCc----EEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGT----SLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|.+ .++. .||+|.+.... .....+.+|+.++..+.|||++++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4678889999999999999985 3444 47999886532 335678899999999999999999999875 45779
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
++||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999643 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....... ...+..++..|+|||...+..++.++|||||||++|||++ |..||..... ..+..++......
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~-- 230 (279)
T cd05109 160 DIDETEY--HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLLEKGERL-- 230 (279)
T ss_pred cccccee--ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCcC--
Confidence 4322211 1112235678999999988889999999999999999998 8888864221 1122222211000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.. ...... .+.+++..|+. .||++||++.|+++.|+++..++
T Consensus 231 --~~------~~~~~~---~~~~li~~~l~-~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 --PQ------PPICTI---DVYMIMVKCWM-IDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --CC------CccCCH---HHHHHHHHHcC-CChhhCcCHHHHHHHHHHhhcCC
Confidence 00 011222 34556667887 99999999999999999887655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.96 Aligned_cols=192 Identities=21% Similarity=0.254 Sum_probs=166.8
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
+.||+|+||.||++... +|..||+|.+.... .....+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999954 68999999987532 23346778999999999999999999999999999999999999
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccc
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 465 (623)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--
Confidence 99998853 34689999999999999999999999 9999999999999999999999999998753221111
Q ss_pred ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 466 TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 466 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred --cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 1223489999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.92 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=185.8
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556788999999999999965 68999999986533 23467889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+.. ..++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986543 245677888999999999999999 999999999999999999999999999987643211
Q ss_pred cccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 463 HLSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ..............
T Consensus 224 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~- 293 (353)
T PLN00034 224 ----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCAICMSQP- 293 (353)
T ss_pred ----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhccCC-
Confidence 1123458999999998743 23456899999999999999999999732211 11111111000000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.. .......++. +++..|+. .||++||++.|+++.
T Consensus 294 -----~~-~~~~~~~~l~---~li~~~l~-~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -----PE-APATASREFR---HFISCCLQ-REPAKRWSAMQLLQH 328 (353)
T ss_pred -----CC-CCCccCHHHH---HHHHHHcc-CChhhCcCHHHHhcC
Confidence 00 0111233333 44446766 999999999999874
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.70 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=199.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999965 58899999986532 23457899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCC-------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 380 KHMPNGSLYDLLHPAD-------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
||+++|+|.+++.... .....+++..+++++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1123467888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcc--------------cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 006982 453 LARLMNPIDTHL--------------STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPE 518 (623)
Q Consensus 453 la~~~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~ 518 (623)
+++......... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998762111000 011112358999999999999999999999999999999999999996522110
Q ss_pred cccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHhhc
Q 006982 519 TFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-TMFEVYQFLRAIGE 588 (623)
Q Consensus 519 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-s~~ev~~~L~~i~~ 588 (623)
. . ........ .+. . .....+.. +.+++.+|+. .||++|| +++++.+.|+...+
T Consensus 239 i-----~-~~~~i~~P---~~~-~---p~~~iP~~---L~~LI~rcL~-~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 I-----S-YRDVILSP---IEV-A---PYREIPPF---LSQIAMKALA-VDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h-----h-hhhhccCh---hhc-c---ccccCCHH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHHh
Confidence 0 0 00000000 000 0 00112223 3445566776 9999995 67778888887644
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=306.83 Aligned_cols=200 Identities=22% Similarity=0.321 Sum_probs=169.4
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999965 68899999986543 233467789999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 5888877532 24578889999999999999999999 9999999999999999999999999999754321
Q ss_pred CCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 157 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 157 SH----TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred Cc----cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1123457899999998865 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=311.34 Aligned_cols=192 Identities=18% Similarity=0.249 Sum_probs=164.8
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||++... +++.+|+|+++... .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 67899999987532 2334577888888766 899999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~- 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT- 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc-
Confidence 999998853 24689999999999999999999999 9999999999999999999999999999753221111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 ---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ---cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 1223489999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.63 Aligned_cols=199 Identities=24% Similarity=0.342 Sum_probs=163.8
Q ss_pred cCcccceeeccCccEEEEEEeC--CCcEEEEEEecccc---ccHHHHHHHHHHhCCC---CCCCCcceeEEEEe-----C
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE--DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSV---KNRNLVPLLGFCMA-----K 372 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~ 372 (623)
+|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.++ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999863 46789999886432 2234455676665554 79999999999853 3
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
...++|+||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 45789999996 59999986432 24588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
+++...... ......||+.|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 998654321 1123348899999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.64 Aligned_cols=249 Identities=17% Similarity=0.235 Sum_probs=188.9
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++||+|+||.||++... ++..||+|+++... .....+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 68899999997532 2234577899999888 799999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~- 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT- 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCc-
Confidence 999998853 24689999999999999999999999 9999999999999999999999999999753221111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......++...........
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 223 (329)
T cd05588 153 ---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------ 223 (329)
T ss_pred ---cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------
Confidence 12234899999999999989999999999999999999999999753332211222223322222111110
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCC------HHHHHH
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPT------MFEVYQ 581 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs------~~ev~~ 581 (623)
+ ......++.+ ++..|+. .||.+||+ +.|+++
T Consensus 224 ~-p~~~~~~~~~---li~~~L~-~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 I-PRSLSVKASS---VLKGFLN-KDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C-CCCCCHHHHH---HHHHHhc-cCHHHcCCCCCCCCHHHHhc
Confidence 0 1112333333 3345555 99999997 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=311.55 Aligned_cols=241 Identities=18% Similarity=0.236 Sum_probs=189.0
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
++||+|+||.||++... ++..||+|++.... .....+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999954 68999999996532 23456788999999999999999999999999999999999999
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccc
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 465 (623)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-- 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--
Confidence 99998853 34689999999999999999999999 9999999999999999999999999998754321111
Q ss_pred ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhh
Q 006982 466 TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCL 545 (623)
Q Consensus 466 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 545 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ . ..+
T Consensus 152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~~-~------~~~ 214 (328)
T cd05593 152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILME-D------IKF 214 (328)
T ss_pred --cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhccC-C------ccC
Confidence 12234899999999999888999999999999999999999999653221 111111110 0 000
Q ss_pred hcCCCHHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 006982 546 VAKGVDNELFQFLKVACNCVLPTIPKERP-----TMFEVYQF 582 (623)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-----s~~ev~~~ 582 (623)
. .....++.+++ ..|+. .||++|| ++.|+++.
T Consensus 215 p-~~~~~~~~~li---~~~L~-~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 P-RTLSADAKSLL---SGLLI-KDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred C-CCCCHHHHHHH---HHHcC-CCHHHcCCCCCCCHHHHhcC
Confidence 0 11234444444 35555 9999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=311.62 Aligned_cols=200 Identities=22% Similarity=0.368 Sum_probs=166.7
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-----eee
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK-----ERL 376 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 376 (623)
+|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999954 68999999986432 23456889999999999999999999886432 478
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689998853 34589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 153 AFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccccCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 4321111 111223458999999999865 67899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=327.59 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=197.3
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-----
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----- 373 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 373 (623)
..++|...+.||+|+||+||+++. .+++.||+|++.... .....+.+|+..+..++|+|++++...+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346899999999999999999985 478999999986542 23456788999999999999999888765432
Q ss_pred ---eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEee
Q 006982 374 ---ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450 (623)
Q Consensus 374 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~D 450 (623)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 25799999999999999975444456789999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHH
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQ 530 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~ 530 (623)
||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+..
T Consensus 187 FGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~~~ 256 (496)
T PTZ00283 187 FGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVMHK 256 (496)
T ss_pred cccCeeccccccc--cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 9999875432111 111234589999999999999999999999999999999999999964321 122222
Q ss_pred HhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.... .. ++ + .....+++. .++..|+. .+|++||++.++++.
T Consensus 257 ~~~~-~~----~~-~-~~~~~~~l~---~li~~~L~-~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAG-RY----DP-L-PPSISPEMQ---EIVTALLS-SDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcC-CC----CC-C-CCCCCHHHH---HHHHHHcc-cChhhCcCHHHHHhC
Confidence 1111 00 00 0 111233333 44445665 899999999999864
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.07 Aligned_cols=251 Identities=22% Similarity=0.389 Sum_probs=200.1
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
.+|+..+.||+|+||.||++.+.++..+++|.+.........+.+|++++++++|||++++++++......++|+||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 35677889999999999999987788999999877666677899999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... ..+++..++.++.+++.|++|||+. +++|+||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 155 (256)
T cd05112 84 GCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-- 155 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence 99999986432 3578999999999999999999999 999999999999999999999999999986533211
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
....+..++.+|+|||++.+..++.++||||||+++|||++ |+.||..... ........... ....+
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~---~~~~~ 223 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGF---RLYKP 223 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCC---CCCCC
Confidence 11122235678999999998889999999999999999998 8999864221 11121111100 00011
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.... ..+.+++.+|+. .+|++||++.||+++|
T Consensus 224 ----~~~~---~~~~~l~~~~l~-~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 ----RLAS---QSVYELMQHCWK-ERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCCC---HHHHHHHHHHcc-cChhhCCCHHHHHHhh
Confidence 1112 345666778887 8999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.18 Aligned_cols=254 Identities=22% Similarity=0.263 Sum_probs=193.2
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc---------------cHHHHHHHHHHhCCCCCCCCccee
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR---------------SEKEFVAEMATLGSVKNRNLVPLL 366 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------~~~~~~~e~~~l~~l~h~niv~l~ 366 (623)
.-+.|.....||+|.||.|-+|+. .+++.||+|++.+... ..+...+||.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 346788899999999999999995 4799999999964321 124678999999999999999999
Q ss_pred EEEEeC--CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC
Q 006982 367 GFCMAK--KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF 444 (623)
Q Consensus 367 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~ 444 (623)
.+..+. +..|||+|||..|.+...-. ....++..++++++.++..||+|||.+ +|+||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 998765 57899999999998876542 223399999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccCCCC-CcccccccCCCCcccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 006982 445 EPKISDFGLARLMNPID-THLSTFVNGEFGDLGYVAPEYARTLV----ATPKGDVYSFGTVLLELVTGERPTNVAKAPET 519 (623)
Q Consensus 445 ~~kl~Dfgla~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~sfGvil~elltg~~P~~~~~~~~~ 519 (623)
++||+|||.+....... ...........||+.|+|||...++. .+.+.||||+||.||-|+.|+.||.+....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999999998653321 11122334467999999999887632 35689999999999999999999976432211
Q ss_pred ccccHHHHHHHHhccCchhhhhchhhhcC-C--CHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 520 FKGNLVEWIAQLSSTGQLQDAIDKCLVAK-G--VDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 520 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~--~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
+ ..++...|... . ..+++..+++- ++..||+.|.+..+|....-
T Consensus 328 ~-----------------~KIvn~pL~fP~~pe~~e~~kDli~~----lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 F-----------------DKIVNDPLEFPENPEINEDLKDLIKR----LLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred H-----------------HHHhcCcccCCCcccccHHHHHHHHH----HhhcChhheeehhhheecce
Confidence 1 12222223211 1 12333334333 33389999999998876553
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.75 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=197.5
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...+.||+|++|.||++..+ ++..|++|.+... ......+.+|++++++++|||++++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999965 6889999988643 23456788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.++++... ...+++..++.++.+++.||.|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997532 35689999999999999999999998 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
... ....+++.|+|||+..+..++.++||||||+++|||++|+.||...... .. ...... .....+
T Consensus 156 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~---~~~~~~-~~~~~~- 221 (256)
T cd08529 156 NFA----NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----AL---ILKIIR-GVFPPV- 221 (256)
T ss_pred chh----hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHc-CCCCCC-
Confidence 211 2234788999999999888999999999999999999999999653211 11 111110 000000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
....-..+.+++.+|+. .+|++||++.++++.
T Consensus 222 --------~~~~~~~~~~~i~~~l~-~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 --------SQMYSQQLAQLIDQCLT-KDYRQRPDTFQLLRN 253 (256)
T ss_pred --------ccccCHHHHHHHHHHcc-CCcccCcCHHHHhhC
Confidence 00111235556667877 899999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.29 Aligned_cols=256 Identities=20% Similarity=0.211 Sum_probs=193.6
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.|...+.||+|+||+||+|+. .++..||+|++.... .....+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999985 468899999996532 234568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999863 24578888999999999999999999 9999999999999999999999999998643110
Q ss_pred CCc-------------------------------------------ccccccCCCCcccccCcccccCCCCCcchhHHHH
Q 006982 461 DTH-------------------------------------------LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSF 497 (623)
Q Consensus 461 ~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sf 497 (623)
... .........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 0000112358999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHH
Q 006982 498 GTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMF 577 (623)
Q Consensus 498 Gvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ 577 (623)
||++|||++|+.||......+. ............+ + .......+...+++-. .|. ..+|..||+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~--------~~~i~~~~~~~~~--~--~~~~~s~~~~dli~~l-l~~-~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET--------QLKVINWENTLHI--P--PQVKLSPEAVDLITKL-CCS-AEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH--------HHHHHccccccCC--C--CCCCCCHHHHHHHHHH-ccC-cccccCCCCHH
Confidence 9999999999999975432111 0000000000000 0 0011345555555442 243 47778899999
Q ss_pred HHHHH
Q 006982 578 EVYQF 582 (623)
Q Consensus 578 ev~~~ 582 (623)
|++..
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.00 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=193.0
Q ss_pred ceeeccCccEEEEEEeCC----CcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLED----GTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+|.... +..+++|.+..... ..+.+.+|++++.++.|||++++++++. .+..++|+||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899999876543 4567899999999999999999999876 4467899999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++... ..+++..++.++.|++.|++|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999632 3689999999999999999999999 99999999999999999999999999998764432221
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
.. .....++..|+|||...+..++.++||||||+++|||++ |..||..... ..+..++.. ....
T Consensus 153 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~~~---~~~~------ 217 (257)
T cd05060 153 RA-TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAMLES---GERL------ 217 (257)
T ss_pred cc-ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHc---CCcC------
Confidence 11 112224568999999998889999999999999999998 9999864321 112222211 1000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
......+ ..+.+++.+|+. .+|++||++.++++.|+++.
T Consensus 218 -~~~~~~~---~~l~~li~~cl~-~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -PRPEECP---QEIYSIMLSCWK-YRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCC---HHHHHHHHHHhc-CChhhCcCHHHHHHHHHhcc
Confidence 0111122 244566667877 89999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=304.04 Aligned_cols=256 Identities=20% Similarity=0.337 Sum_probs=196.3
Q ss_pred cCcccceeeccCccEEEEEEeC------CCcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
+|...+.||+|+||.||+|... ++..||+|++..... ....+.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566788999999999999853 257899999975432 23568899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCC------------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC
Q 006982 378 VYKHMPNGSLYDLLHPAD------------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE 445 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~ 445 (623)
++||+++++|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999984211 1123588899999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccH
Q 006982 446 PKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNL 524 (623)
Q Consensus 446 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l 524 (623)
+||+|||+++........ .......+++.|+|||++....++.++||||||+++|||++ |..||.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------- 232 (283)
T cd05091 163 VKISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 232 (283)
T ss_pred eEecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 999999999865432211 11122335788999999988889999999999999999998 7778764211
Q ss_pred HHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 525 VEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.++....... ..... .....++ +..++..|+. .+|++||++++|+..|+.
T Consensus 233 ~~~~~~i~~~-~~~~~------~~~~~~~---~~~li~~cl~-~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 QDVIEMIRNR-QVLPC------PDDCPAW---VYTLMLECWN-EFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHcC-CcCCC------CCCCCHH---HHHHHHHHhC-CCcccCCCHHHHHHHhhC
Confidence 1222211111 11000 1112333 4455667887 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.51 Aligned_cols=196 Identities=21% Similarity=0.315 Sum_probs=171.8
Q ss_pred ccCcccceeeccCccEEEEEEeCC--CcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED--GTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|...+ +..||+|++.... .....+.+|++++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998543 3689999986432 2345678899999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999963 34688999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 183 ~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 183 TRT-------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCc-------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 311 1234899999999999888999999999999999999999999753
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.89 Aligned_cols=247 Identities=21% Similarity=0.397 Sum_probs=189.1
Q ss_pred eeccCccEEEEEEeC---CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 313 IGSGRTGTMYKALLE---DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++.. ...++|+||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999754 35579999886543 234568899999999999999999998864 567899999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++... ...+++..+++++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...........
T Consensus 82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~- 154 (257)
T cd05115 82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA- 154 (257)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec-
Confidence 9998632 24689999999999999999999999 9999999999999999999999999999865432221111
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhh
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLV 546 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 546 (623)
.....++..|+|||++....++.++||||||+++||+++ |..||...... ++......... .+ .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~-~~------~ 219 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGKR-LD------C 219 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCC-CC------C
Confidence 111224578999999988889999999999999999996 99998653221 11111111000 00 0
Q ss_pred cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 547 AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 547 ~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
.....+ ++.+++..|+. .+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~---~l~~li~~c~~-~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPP---EMYALMKDCWI-YKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCH---HHHHHHHHHcC-CChhhCcCHHHHHHHHhhh
Confidence 011233 34455667887 8999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.26 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=198.1
Q ss_pred hccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 374 (623)
.++|...+.||+|+||.||+|++. .+..||+|+++... ...+.+.+|++++.++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346777899999999999999853 34679999997543 22356889999999997 9999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCC----------------------------------------------------------
Q 006982 375 RLLVYKHMPNGSLYDLLHPADD---------------------------------------------------------- 396 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 396 (623)
.++|+||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864321
Q ss_pred ------------------------------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee
Q 006982 397 ------------------------------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440 (623)
Q Consensus 397 ------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl 440 (623)
....++|...++++.|++.||+|||+. +++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 113478888999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 006982 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPET 519 (623)
Q Consensus 441 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~ 519 (623)
++++.+||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++ |..||......+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred eCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 99999999999999865332111 11112346788999999988889999999999999999998 888986432211
Q ss_pred ccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 520 FKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 520 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
........+.. .. .......+ +.+++..|+. .+|.+||+++|+++.|+++
T Consensus 350 -------~~~~~~~~~~~--~~----~p~~~~~~---l~~li~~cl~-~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 -------QFYNAIKRGYR--MA----KPAHASDE---IYEIMQKCWE-EKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -------HHHHHHHcCCC--CC----CCCCCCHH---HHHHHHHHcC-CChhHCcCHHHHHHHHHHH
Confidence 01111100000 00 01112333 4444556777 8999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.03 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=198.0
Q ss_pred ccCcccceeeccCccEEEEEEeC----CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|... .+..+++|.++... ...+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 23478999886533 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999643 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
........ .....++..|+|||++.+..++.++||||||+++||+++ |..||...... .....+.. ....
T Consensus 158 ~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~~~~~~---~~~~ 228 (267)
T cd05066 158 DDPEAAYT-TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVIKAIEE---GYRL 228 (267)
T ss_pred cccceeee-cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHHHHHhC---CCcC
Confidence 42221111 111223568999999998889999999999999999887 99998643221 11111111 0000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
+ .....++ .+.+++..|+. .+|.+||+|.++++.|+++
T Consensus 229 -----~--~~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -----P--APMDCPA---ALHQLMLDCWQ-KDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----C--CCCCCCH---HHHHHHHHHcc-cCchhCCCHHHHHHHHHhh
Confidence 0 0011222 34455567777 8999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.02 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=194.3
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEE-eCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM-AKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~ 383 (623)
.+|...+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. ..+..++|+||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 35778899999999999999875 7789999886543 3567899999999999999999999765 4456889999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 157 (256)
T cd05082 84 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence 999999986432 24588999999999999999999999 999999999999999999999999999986533211
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
...++..|+|||++....++.++||||||+++|||++ |+.||.... ..+........ .-...
T Consensus 158 ------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~-- 220 (256)
T cd05082 158 ------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKG-YKMDA-- 220 (256)
T ss_pred ------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcC-CCCCC--
Confidence 1124568999999998889999999999999999998 998886421 12222211111 00000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
....+.+ +..++..|+. .+|++|||+.++++.|+++
T Consensus 221 ----~~~~~~~---~~~li~~~l~-~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 ----PDGCPPV---VYDVMKQCWH-LDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCHH---HHHHHHHHhc-CChhhCcCHHHHHHHHhcC
Confidence 0112333 3444556776 8999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.50 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=199.2
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
++|...+.||+|+||.||++... .+..||+|.++... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888999999999999999741 34579999887543 2345688999999999 799999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||+++|+|.++++... ...+++.++..++.|++.|+.|||+. +|+|+||||+||++++++.++++|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999996432 23489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
........ .......++..|+|||.+....++.++|||||||++|||++ |..||......+ .+...+..
T Consensus 190 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~~~~~~~---- 259 (302)
T cd05055 190 DIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KFYKLIKE---- 259 (302)
T ss_pred cccCCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HHHHHHHc----
Confidence 65432211 11112235778999999988889999999999999999998 999986532211 11111111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
.. ... .....++ .+.+++..|+. .+|++||++.|+++.|++.
T Consensus 260 ~~-----~~~-~~~~~~~---~~~~li~~cl~-~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GY-----RMA-QPEHAPA---EIYDIMKTCWD-ADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC-----cCC-CCCCCCH---HHHHHHHHHcC-CCchhCcCHHHHHHHHHhh
Confidence 00 000 0011222 35556667887 8999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.08 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=189.1
Q ss_pred eeeccCccEEEEEEe---CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 312 IIGSGRTGTMYKALL---EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
.||+|+||.||+|.+ .++..+++|+++... ...+++..|+.++.++.||||+++++++. .+..++|+||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999986543 23467889999999999999999999885 45678999999999
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccc
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 465 (623)
+|.+++.. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999953 24688999999999999999999999 999999999999999999999999999987654322211
Q ss_pred ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 466 TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 466 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
. .....++..|+|||.+....++.++||||||+++|||++ |..||..... .++.... .......
T Consensus 154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i-~~~~~~~----- 218 (257)
T cd05116 154 A-KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMI-ESGERME----- 218 (257)
T ss_pred e-cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HCCCCCC-----
Confidence 1 112234678999999988888999999999999999998 9999864321 1111111 1111000
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
. ....+.++. ++...|+. .+|++||++++|.+.|++
T Consensus 219 ~-~~~~~~~l~---~li~~~~~-~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 C-PQRCPPEMY---DLMKLCWT-YGVDERPGFAVVELRLRN 254 (257)
T ss_pred C-CCCCCHHHH---HHHHHHhc-cCchhCcCHHHHHHHHhc
Confidence 0 111233444 44556766 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.56 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=190.9
Q ss_pred ceeeccCccEEEEEEeCC-Cc--EEEEEEeccc--cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLED-GT--SLMVKRLQDS--QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++||+|+||.||+|..++ +. .+++|.++.. ......+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 43 4688887643 23446788999999999 899999999999999999999999999
Q ss_pred CCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 385 GSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 385 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
|+|.+++..... ....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999864321 123578999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHH
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
++....... .. .....+..|+|||++....++.++||||||+++|||++ |..||..... .+.....
T Consensus 158 l~~~~~~~~---~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~ 224 (270)
T cd05047 158 LSRGQEVYV---KK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKL 224 (270)
T ss_pred Cccccchhh---hc--cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHH
Confidence 986422110 00 11123567999999988889999999999999999997 9999864321 1111111
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
...... + . ..... ..+.+++..|+. .+|.+|||+.|++..|+++.
T Consensus 225 ~~~~~~-~-----~-~~~~~---~~~~~li~~~l~-~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQGYRL-E-----K-PLNCD---DEVYDLMRQCWR-EKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hCCCCC-C-----C-CCcCC---HHHHHHHHHHcc-cChhhCCCHHHHHHHHHHhh
Confidence 110000 0 0 00112 235566677877 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=306.57 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=196.2
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
..|+..+.||+|.||.||+|.. +.++.||+|++.-.. ......++|+.++.+.+++||.+.++.+......+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577778999999999999995 468899999997543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+.+|++.+.++. +..+++....-|..++..|+.|||++ +.+|||||+.|||+..+|.+|++|||++-.+....
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999963 34457777777899999999999999 99999999999999999999999999998876543
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
... .+-+||+-|||||++....|+.|+||||+|+..+||.+|.+|+....+. .+...+.+ -.
T Consensus 166 ~rr----~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-rvlflIpk-------------~~ 227 (467)
T KOG0201|consen 166 KRR----KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-RVLFLIPK-------------SA 227 (467)
T ss_pred hcc----ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-eEEEeccC-------------CC
Confidence 332 3445999999999999889999999999999999999999999765442 11111111 00
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
-+.+.+ .....+.+++. .|+. .+|+.||++.++++.
T Consensus 228 PP~L~~-~~S~~~kEFV~---~CL~-k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 228 PPRLDG-DFSPPFKEFVE---ACLD-KNPEFRPSAKELLKH 263 (467)
T ss_pred CCcccc-ccCHHHHHHHH---HHhh-cCcccCcCHHHHhhh
Confidence 111111 12222333322 3444 889999999998763
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=303.53 Aligned_cols=195 Identities=25% Similarity=0.353 Sum_probs=168.2
Q ss_pred eeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
||+|+||+||++... +++.||+|.+..... ..+.+..|++++.+++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 688999999865321 234577899999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++.........+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---- 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---- 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc----
Confidence 988754333446789999999999999999999999 9999999999999999999999999999865432221
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 12235889999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.16 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=201.2
Q ss_pred ccCcccceeeccCccEEEEEEeC--------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE--------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKK 373 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 373 (623)
.+|.+.+.||+|+||.||++... .+..|++|.++... ...+.+.+|++++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35788899999999999999742 12368999887532 3346788999999999 8999999999999999
Q ss_pred eeeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
..++++||+++|+|.+++..... ....++|.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999864321 234588999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 006982 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETF 520 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~ 520 (623)
+++.+||+|||+++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred CCCcEEECCcccceeccccccccc--ccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999986543221111 111224567999999998889999999999999999998 8888864221
Q ss_pred cccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 521 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
.++....... ...+. ..... ..+.+++..|+. .+|++||++.|+++.|+++.....
T Consensus 243 ----~~~~~~~~~~-~~~~~------~~~~~---~~l~~li~~cl~-~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 ----EELFKLLKEG-HRMDK------PANCT---HELYMIMRECWH-AVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ----HHHHHHHHcC-CCCCC------CCCCC---HHHHHHHHHHcc-cChhhCcCHHHHHHHHHHHhhhcC
Confidence 1222211111 00000 01112 245566677887 999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.82 Aligned_cols=193 Identities=24% Similarity=0.308 Sum_probs=166.9
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
++|...+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+||+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 5799999999999999999995 468899999653 2356789999999999999999999999999999999995
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 167 -~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 167 -TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred -CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 689888853 24588999999999999999999999 9999999999999999999999999999754321111
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 239 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 239 ---KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ---ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 11234589999999999988999999999999999999999988754
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.67 Aligned_cols=263 Identities=23% Similarity=0.351 Sum_probs=196.1
Q ss_pred ccCcccceeeccCccEEEEEEeCC---------------CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED---------------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLG 367 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~ 367 (623)
++|...+.||+|+||.||++...+ ...|++|.+.... .....+.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987542 2348899886532 23456889999999999999999999
Q ss_pred EEEeCCeeeEEEecCCCCCHhhhccCCCC--------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCcee
Q 006982 368 FCMAKKERLLVYKHMPNGSLYDLLHPADD--------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCIL 439 (623)
Q Consensus 368 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NIL 439 (623)
++...+..++||||+++++|.+++..... ....++|..++.++.|++.|++|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999854321 113478999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCc
Q 006982 440 LDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT--GERPTNVAKAP 517 (623)
Q Consensus 440 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt--g~~P~~~~~~~ 517 (623)
+++++.+||+|||++........ ........++..|+|||+.....++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999986543221 111122235678999999988889999999999999999998 55666542221
Q ss_pred ccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 518 ETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 518 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.................... .....+ ..+.+++.+|+. .+|++||++++|++.|+
T Consensus 240 -----~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~l~~li~~~l~-~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -----QVIENTGEFFRNQGRQIYLS---QTPLCP---SPVFKLMMRCWS-RDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -----HHHHHHHHhhhhccccccCC---CCCCCC---HHHHHHHHHHcC-CCchhCcCHHHHHHHHh
Confidence 11111111111000000000 000112 356677778887 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.15 Aligned_cols=274 Identities=26% Similarity=0.438 Sum_probs=216.4
Q ss_pred CcccceeeccCccEEEEEEe-CCC----cEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 307 FSKNNIIGSGRTGTMYKALL-EDG----TSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
....++||+|+||+||+|.+ .+| -+||+|++... ..+.+++.+|+.+|.+++|||+++++|+|..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568999999999999985 344 35888988664 355789999999999999999999999998876 77999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
+|||.|+|.++++..+ ..+--...+.+..|||+||.|||.+ +++||||.++||||..-..+||.|||+++.+.+
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999997644 4566778899999999999999999 999999999999999999999999999999887
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.+....... ..-.+.|||-|.+....++.++|||||||.+||++| |..|+...... ++.
T Consensus 851 d~~ey~~~~--gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------------eI~ 910 (1177)
T KOG1025|consen 851 DEKEYSAPG--GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------------EIP 910 (1177)
T ss_pred ccccccccc--cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------------Hhh
Confidence 655443322 223578999999999999999999999999999998 99998764332 122
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC-CC--CCcccccCCCCCCch
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH-FT--TEDEIMLPSDSGDAD 608 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~-~~--~~~~~~~~~~~~~~~ 608 (623)
+++..-.+-..++-.-.++-.+...|+. .|+..||+++++...+.+...+.+ +. +.+...+|++.+...
T Consensus 911 dlle~geRLsqPpiCtiDVy~~mvkCwm-id~~~rp~fkel~~~fs~~ardpqryl~i~~~~~~~~s~~~~~~ 982 (1177)
T KOG1025|consen 911 DLLEKGERLSQPPICTIDVYMVMVKCWM-IDADSRPTFKELAEEFSRMARDPQRYLVIQDERMILPSPESSLF 982 (1177)
T ss_pred HHHhccccCCCCCCccHHHHHHHHHHhc-cCcccCccHHHHHHHHHHHhcCcceEeeehhhcCCCCCCCcchH
Confidence 2222211111233344567777889999 999999999999999998766654 11 122255666666654
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.28 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=198.5
Q ss_pred ccCcccceeeccCccEEEEEEeCC------CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||+|...+ +..|++|.+.... .....+.+|+.++..++|||++++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 467888999999999999998642 3679999986543 33457889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCC------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEee
Q 006982 377 LVYKHMPNGSLYDLLHPADD------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~D 450 (623)
+|+||+++|+|.+++..... ....++|..++.++.|++.||.|||+. +++||||||+||++++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 99999999999999864322 123578999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHH
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIA 529 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~ 529 (623)
||+++......... ......++..|+|||.+....++.++|||||||++||+++ |..||...... ...++..
T Consensus 163 fg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~ 235 (277)
T cd05032 163 FGMTRDIYETDYYR--KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-----EVLKFVI 235 (277)
T ss_pred cccchhhccCcccc--cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-----HHHHHHh
Confidence 99998654322111 1112336788999999988889999999999999999998 88888642211 1111111
Q ss_pred HHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
........ ... ...+..++..|+. .+|++|||+.++++.|+
T Consensus 236 ----~~~~~~~~------~~~---~~~~~~li~~~l~-~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ----DGGHLDLP------ENC---PDKLLELMRMCWQ-YNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----cCCCCCCC------CCC---CHHHHHHHHHHcC-CChhhCCCHHHHHHHhc
Confidence 11111100 111 2345566667777 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.12 Aligned_cols=256 Identities=22% Similarity=0.387 Sum_probs=196.7
Q ss_pred cCcccceeeccCccEEEEEEeCC-C---cEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLED-G---TSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
+|...+.||+|+||.||+|.... + ..|++|.+... ......|..|+.++++++||||+++++++.+....++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999653 3 36999998753 234567999999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ...+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998643 24689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccc-cccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 460 IDTHLST-FVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 460 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
....... ...+...+..|+|||++....++.++||||||+++||+++ |..||...... ....++.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i~~~~---~~ 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAIEQDY---RL 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHcCC---cC
Confidence 2211110 0011112457999999998899999999999999999887 99998643211 1122221100 00
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
. .....+. .+.+++..|+. .+|.+||++.+|+..|+++
T Consensus 231 ~-------~~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 P-------PPMDCPT---ALHQLMLDCWQ-KDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-------CcccCCH---HHHHHHHHHcC-CChhhCcCHHHHHHHHHhh
Confidence 0 0011122 34556667877 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.06 Aligned_cols=192 Identities=22% Similarity=0.308 Sum_probs=165.7
Q ss_pred ceeeccCccEEEEEEe----CCCcEEEEEEecccc-----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 311 NIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+.||+|+||.||+++. .+++.||+|.++... .....+..|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357889999986532 2234577899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999853 24578888899999999999999999 99999999999999999999999999987543221
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 155 TV----THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred Cc----ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 11 1223489999999999988889999999999999999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.60 Aligned_cols=196 Identities=23% Similarity=0.340 Sum_probs=166.3
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHH---hCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMAT---LGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
|...+.||+|+||.||++... +++.||+|+++... ...+.+..|+++ +.+++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 68999999997532 223445556554 5677899999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|..+++. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999998842 4689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
..... .....|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 153 GFGDR----TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CCCCc----ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 21111 12234899999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=315.93 Aligned_cols=203 Identities=26% Similarity=0.323 Sum_probs=175.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +++.||+|++.... .....+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999965 68999999997542 33456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999643 4688999999999999999999998 999999999999999999999999999987644
Q ss_pred CCC-------------------------cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDT-------------------------HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 220 0001122345899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.26 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=194.3
Q ss_pred HHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC------C
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK------K 373 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~ 373 (623)
.+++.|+..+.||+|+||.||+|... +++.|++|.+.........+..|+.++.++ +|||++++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35567888899999999999999865 578899999876655667888999999998 799999999998753 3
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++|+||+++|+|.+++.... ...++|..+..++.|++.|++|||+. +|+|+||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 5789999999999999986432 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHH
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~ 528 (623)
+......... .....|+..|+|||++. ...++.++|||||||++|||++|+.||...... ....
T Consensus 158 ~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~ 226 (272)
T cd06637 158 SAQLDRTVGR----RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALF 226 (272)
T ss_pred ceeccccccc----CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHH
Confidence 9865432111 12234788999999986 345788999999999999999999999642211 1110
Q ss_pred HHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 529 AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .. ... .+.+.....+.+ +..+..+|+. .+|.+|||+.|+++
T Consensus 227 ~-~~-~~~-----~~~~~~~~~~~~---~~~li~~~l~-~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 L-IP-RNP-----APRLKSKKWSKK---FQSFIESCLV-KNHSQRPTTEQLMK 268 (272)
T ss_pred H-Hh-cCC-----CCCCCCCCcCHH---HHHHHHHHcC-CChhhCCCHHHHhh
Confidence 0 00 000 011111112233 3445557776 89999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.86 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=199.4
Q ss_pred ccCcccceeeccCccEEEEEEeC--------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE--------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKK 373 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 373 (623)
++|...+.||+|+||.||++... ....+++|.++... .....+..|++++.++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 24568999887543 2345688999999999 6999999999999988
Q ss_pred eeeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
..++|+||+++|+|.+++..... ....++|.++.+++.|++.||.|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 89999999999999999865321 124589999999999999999999998 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 006982 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETF 520 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~ 520 (623)
+++.+||+|||+++........... ....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKT--SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred CCCcEEEcccccccccccccccccc--ccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999999866432211111 11124567999999988889999999999999999999 88888643211
Q ss_pred cccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 521 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
+..... ......+. ...... ++..++.+|+. .+|++||++.|+++.|+++...
T Consensus 244 -----~~~~~~-~~~~~~~~------~~~~~~---~l~~li~~cl~-~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 -----ELFKLL-REGHRMDK------PSNCTH---ELYMLMRECWH-AVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -----HHHHHH-HcCCCCCC------CCCCCH---HHHHHHHHHcC-CCcccCcCHHHHHHHHHHHHHH
Confidence 111111 11110000 011223 34456667887 9999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=295.04 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=188.4
Q ss_pred ceeeccCccEEEEEEeC----CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEe-CCeeeEEEecCC
Q 006982 311 NIIGSGRTGTMYKALLE----DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMA-KKERLLVYKHMP 383 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~ 383 (623)
+.||+|+||.||+|... +...+++|.+... ....+.+.+|+.+++.++|||++++++++.. +...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988543 2335678899999999999999999998764 456789999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999996432 3467888899999999999999998 9999999999999999999999999999865432111
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGER-PTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~-P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.........++..|+|||++....++.++||||||+++|||++|.. ||.... ..+...........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~~~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--------SFDITVYLLQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHhcCCCC-----
Confidence 1111122335778999999988889999999999999999999654 454211 11111111111000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
......++ .+.+++..|+. .+|++||++.||++.|+++.
T Consensus 222 --~~~~~~~~---~~~~li~~cl~-~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 --LQPEYCPD---PLYEVMLSCWH-PKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCcCCH---HHHHHHHHHcC-CChhhCCCHHHHHHHHHHHh
Confidence 00111122 35566677887 89999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.02 Aligned_cols=261 Identities=24% Similarity=0.348 Sum_probs=197.0
Q ss_pred ccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC-Ce
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK-KE 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 374 (623)
++|...+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688899999999999999973 356789999997543 2345688999999999 689999999988654 45
Q ss_pred eeEEEecCCCCCHhhhccCCCC----------------------------------------------------------
Q 006982 375 RLLVYKHMPNGSLYDLLHPADD---------------------------------------------------------- 396 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 396 (623)
.++|+||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 6899999999999999864321
Q ss_pred -----CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCC
Q 006982 397 -----TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE 471 (623)
Q Consensus 397 -----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~ 471 (623)
....++|.++.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 241 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDA 241 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch--hhcCCC
Confidence 012478889999999999999999999 9999999999999999999999999999865322111 111122
Q ss_pred CCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCC
Q 006982 472 FGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGV 550 (623)
Q Consensus 472 ~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 550 (623)
.++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. ... ......... ....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~---~~~-~~~~~~~~~------~~~~ 307 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EF---CRR-LKEGTRMRA------PDYT 307 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HH---HHH-HhccCCCCC------CCCC
Confidence 35678999999988889999999999999999997 888986432210 01 111 111000000 0011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 551 DNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 551 ~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
. ..+.+++..|+. .+|++||++.|+++.|+.+.+
T Consensus 308 ~---~~~~~~~~~cl~-~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 T---PEMYQTMLDCWH-GEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred C---HHHHHHHHHHcc-CChhhCcCHHHHHHHHHHHHh
Confidence 1 235666677887 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.81 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=197.6
Q ss_pred HhccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 374 (623)
..++|.+.+.||+|+||.||+|..+ .+..||+|.+.... .....+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888999999999999999753 24579999886543 223467889999999999999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCC------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 375 RLLVYKHMPNGSLYDLLHPADD------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
.++||||+++|+|.+++..... ....+++.....++.|++.||.|||+. +|+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 123457788899999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~ 527 (623)
+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYRK--GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQV 230 (288)
T ss_pred CcCCccccccccccccc--cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999986543221111 111235678999999988889999999999999999998 7878864221 111
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
....... ..... ....+ ..+.+++..|+. .+|++|||+.++++.|++.
T Consensus 231 ~~~~~~~-~~~~~------~~~~~---~~~~~li~~~l~-~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFVMDG-GYLDQ------PDNCP---ERVTDLMRMCWQ-FNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHcC-CCCCC------CCCCC---HHHHHHHHHHcC-CChhHCcCHHHHHHHHHhh
Confidence 1111111 00000 01112 345555567777 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.95 Aligned_cols=256 Identities=22% Similarity=0.370 Sum_probs=195.7
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
.+|...+.||+|+||.||++... ++..+++|.+.... .....+.+|++++.+++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35667889999999999999742 35678899886543 345678999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCC-----------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 378 VYKHMPNGSLYDLLHPADD-----------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
++||+++|+|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999864321 113588999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~ 525 (623)
+|+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 162 kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------- 231 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------- 231 (280)
T ss_pred EECCCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------
Confidence 99999999765432211 11122235678999999998899999999999999999998 88888643221
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
+........... . .....+.. +.+++..|+. .||.+||++.||.+.|+
T Consensus 232 ~~~~~~~~~~~~-~------~~~~~~~~---~~~li~~cl~-~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAIECITQGREL-E------RPRTCPPE---VYAIMQGCWQ-REPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCccC-C------CCCCCCHH---HHHHHHHHcc-CChhhCCCHHHHHHHHh
Confidence 111111110000 0 00112233 3344556666 89999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.29 Aligned_cols=203 Identities=22% Similarity=0.292 Sum_probs=173.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||++... +++.||+|++.... .....+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999965 68899999997532 23355788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999863 24589999999999999999999999 999999999999999999999999999976432
Q ss_pred CCCcc----------------------------------cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 006982 460 IDTHL----------------------------------STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELV 505 (623)
Q Consensus 460 ~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ell 505 (623)
..... ........||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 00011235899999999999989999999999999999999
Q ss_pred hCCCCCCCC
Q 006982 506 TGERPTNVA 514 (623)
Q Consensus 506 tg~~P~~~~ 514 (623)
+|..||...
T Consensus 234 ~G~~Pf~~~ 242 (364)
T cd05599 234 VGYPPFCSD 242 (364)
T ss_pred cCCCCCCCC
Confidence 999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.89 Aligned_cols=203 Identities=20% Similarity=0.281 Sum_probs=173.2
Q ss_pred HHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
....++|...+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334567999999999999999999965 57889999986422 2345578899999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999952 3478888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL----VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....... .......||+.|+|||++... .++.++||||+||++|||++|+.||...
T Consensus 191 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 191 KMDETGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ecccCCc---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 7643221 112234589999999998653 3788999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=294.22 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=197.2
Q ss_pred ceeeccCccEEEEEEeCC----CcEEEEEEecccccc--HHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLED----GTSLMVKRLQDSQRS--EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+|...+ +..|++|.+...... .+.+.+|++.+..++|+|++++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999654 788999999765433 57889999999999999999999999998999999999999
Q ss_pred CCHhhhccCCCCC-----CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 385 GSLYDLLHPADDT-----GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 385 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
++|.+++...... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999754211 36789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
... ........++..|+|||.+....++.++||||+|+++|||++ |..||..... .+...........
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~- 226 (262)
T cd00192 158 DDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRL- 226 (262)
T ss_pred ccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCC-
Confidence 321 111223447889999999988889999999999999999999 6889875421 1111111111000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
. .....+ .++..++..|+. .+|++||++.|+++.|+
T Consensus 227 ~------~~~~~~---~~~~~li~~~l~-~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 P------KPEYCP---DELYELMLSCWQ-LDPEDRPTFSELVERLE 262 (262)
T ss_pred C------CCccCC---hHHHHHHHHHcc-CCcccCcCHHHHHHhhC
Confidence 0 001112 345556667777 99999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=299.94 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=198.5
Q ss_pred ccCcccceeeccCccEEEEEEeCC-----------------CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcce
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-----------------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPL 365 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l 365 (623)
++|...+.||+|+||.||++...+ +..|++|.+.... ...+.+.+|++++.+++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 468888999999999999988543 2458899886543 345678899999999999999999
Q ss_pred eEEEEeCCeeeEEEecCCCCCHhhhccCCCC-------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCce
Q 006982 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADD-------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCI 438 (623)
Q Consensus 366 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NI 438 (623)
++++..++..++|+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 9999999999999999999999999865431 123689999999999999999999998 999999999999
Q ss_pred eeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCC
Q 006982 439 LLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT--GERPTNVAKA 516 (623)
Q Consensus 439 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt--g~~P~~~~~~ 516 (623)
++++++.++|+|||+++........ .......++..|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eecCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999865432211 11112235778999999988889999999999999999998 6667753221
Q ss_pred cccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 517 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
. ..................... ....+ ..+.+++..|+. .+|++|||+.||++.|+
T Consensus 240 ~-----~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~l~~li~~cl~-~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 Q-----QVIENAGHFFRDDGRQIYLPR---PPNCP---KDIYELMLECWR-RDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H-----HHHHHHHhccccccccccCCC---ccCCC---HHHHHHHHHHhc-cChhcCCCHHHHHHHhc
Confidence 1 111111111111110000000 00111 346667778887 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=319.04 Aligned_cols=203 Identities=22% Similarity=0.261 Sum_probs=171.6
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688889999999999999985 478899999986532 23456788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999863 24588889999999999999999999 999999999999999999999999999964321
Q ss_pred CCCc-----------cc--------------------------------ccccCCCCcccccCcccccCCCCCcchhHHH
Q 006982 460 IDTH-----------LS--------------------------------TFVNGEFGDLGYVAPEYARTLVATPKGDVYS 496 (623)
Q Consensus 460 ~~~~-----------~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~s 496 (623)
.... .. .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 00 0001235899999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 006982 497 FGTVLLELVTGERPTNVA 514 (623)
Q Consensus 497 fGvil~elltg~~P~~~~ 514 (623)
|||++|||++|+.||...
T Consensus 234 lGvil~elltG~~Pf~~~ 251 (377)
T cd05629 234 LGAIMFECLIGWPPFCSE 251 (377)
T ss_pred cchhhhhhhcCCCCCCCC
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=300.46 Aligned_cols=199 Identities=27% Similarity=0.385 Sum_probs=171.9
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.|+..++||+|+||.||++... +++.||+|++.... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677899999999999999964 68899999986532 223457789999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999885432 24689999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 156 ET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred Cc-----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 11 12335889999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=300.81 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=194.9
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.+|...+.||+|++|.||+|.. .++..|++|.+.... .....+.+|+.+++.++|||++++++++......++|+||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4678889999999999999985 468899999886543 33567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999842 3578999999999999999999999 999999999999999999999999999886543221
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
. .....+++.|+|||++.+..++.++|||||||++|||++|+.||...... ..+... .... ....-.
T Consensus 172 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~~-~~~~-~~~~~~ 238 (296)
T cd06654 172 K----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLI-ATNG-TPELQN 238 (296)
T ss_pred c----cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHHH-hcCC-CCCCCC
Confidence 1 11234788999999998888899999999999999999999999653221 111110 0000 000000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
...... .+..+..+|+. .+|++||++.|+++.
T Consensus 239 ----~~~~~~---~l~~li~~~l~-~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 ----PEKLSA---IFRDFLNRCLD-MDVEKRGSAKELLQH 270 (296)
T ss_pred ----ccccCH---HHHHHHHHHCc-CCcccCcCHHHHhhC
Confidence 001112 23445556776 899999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.90 Aligned_cols=201 Identities=20% Similarity=0.276 Sum_probs=171.6
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
..++|...+.||+|+||.||+++.. ++..||+|.+.... .....+.+|+.++..++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567899999999999999999965 68899999986432 233457789999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999853 3477788889999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTL----VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 193 DANGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred cCCCcc---cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 432211 11234589999999998643 4789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.73 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=202.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-----CCcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-----DGTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 375 (623)
+.|...+.||+|+||.||++.+. ++..+|+|.+..... ..+.+.+|++.+++++|||++++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34666789999999999999854 367899999976654 36789999999999999999999999887 5578
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999996432 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccc-------cccHHHHH
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETF-------KGNLVEWI 528 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~-------~~~l~~~~ 528 (623)
......... .......++..|+|||...+..++.++||||||+++|||++|+.|+......... ......+.
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDYY-YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccccCCcce-eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 765322111 1111223556799999998888999999999999999999999998653221100 00011111
Q ss_pred HHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 529 AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
. .+...............+.+++.+|+. .+|++||+|.||+++|+.++
T Consensus 237 ~----------~~~~~~~~~~~~~~~~~~~~li~~cl~-~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 237 E----------LLKEGERLPRPPSCPDEVYDLMKLCWE-AEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred H----------HHHcCCcCCCCccCCHHHHHHHHHHhc-cChhhCCCHHHHHHHHhhcC
Confidence 1 111110000011112346667778887 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.53 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=198.7
Q ss_pred hccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
.++|...+.||+|+||.||++... ++..|++|.+.... ...+.+.+|+.++.+++|||++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999853 46789999987543 2346788999999999999999999999998899
Q ss_pred eEEEecCCCCCHhhhccCCCC------------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCc
Q 006982 376 LLVYKHMPNGSLYDLLHPADD------------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKC 437 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~N 437 (623)
++|+||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999863211 123578899999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 006982 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKA 516 (623)
Q Consensus 438 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~ 516 (623)
|++++++.++|+|||++..+....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYK--ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred eEecCCCceEECccccceecccCcccc--ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998654322110 1112234678999999988889999999999999999998 8888854221
Q ss_pred cccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 517 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.+...... ...... ...... ..+.+++.+|+. .+|++|||+.|+++.|++
T Consensus 239 --------~~~~~~~~-~~~~~~------~~~~~~---~~l~~li~~~l~-~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 --------EEVIYYVR-DGNVLS------CPDNCP---LELYNLMRLCWS-KLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHHHHHHh-cCCCCC------CCCCCC---HHHHHHHHHHcc-cCcccCCCHHHHHHHhhC
Confidence 11111111 111100 001112 345566677877 899999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=300.44 Aligned_cols=264 Identities=20% Similarity=0.329 Sum_probs=197.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-----------------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcce
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-----------------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPL 365 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l 365 (623)
++|+..+.||+|+||.||++... +...+++|.+.... .....+.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998533 23468999987542 334678999999999999999999
Q ss_pred eEEEEeCCeeeEEEecCCCCCHhhhccCCCCC-------CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCce
Q 006982 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDT-------GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCI 438 (623)
Q Consensus 366 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NI 438 (623)
++++...+..++|+||+++|+|.+++...... ...+++.+++.++.|++.|++|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999998653321 23478889999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCC
Q 006982 439 LLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT--GERPTNVAKA 516 (623)
Q Consensus 439 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt--g~~P~~~~~~ 516 (623)
++++++.++|+|||+++.+...... .......++..|+|||......++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999865432211 11111224678999999888889999999999999999998 6677754322
Q ss_pred cccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 517 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.+ .................. + .....+ ..+.+++..|+. .||++||++.||.+.|++
T Consensus 240 ~~-----~~~~~~~~~~~~~~~~~~-~--~~~~~~---~~~~~li~~cl~-~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQ-----VIENTGEFFRDQGRQVYL-P--KPALCP---DSLYKLMLSCWR-RNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-----HHHHHHHHHhhccccccC-C--CCCCCC---HHHHHHHHHHcC-CCcccCCCHHHHHHHHhC
Confidence 11 111111111000000000 0 001112 355667778887 999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.55 Aligned_cols=192 Identities=20% Similarity=0.243 Sum_probs=166.1
Q ss_pred ceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 311 NIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
+.||+|+||.||++.. .++..||+|.+.... .....+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478899999987532 23356778999999999999999999999999999999999999
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT- 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-
Confidence 99998853 3468999999999999999999997 6 8999999999999999999999999998754321111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 153 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred ---cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 1223489999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.87 Aligned_cols=200 Identities=19% Similarity=0.281 Sum_probs=163.7
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--------Ce
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--------KE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~ 374 (623)
.++|...+.||+|+||.||+|... ++..||+|++.... ....+|+.++++++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 457999999999999999999964 68899999885432 2345799999999999999999887532 13
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeeccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFGL 453 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgl 453 (623)
.++||||+++ +|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence 5689999985 78777654333446789999999999999999999999 999999999999999654 799999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
++.+...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 218 a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 218 AKNLLAGQRS-----VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred chhccCCCCc-----ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876432211 12347899999998865 468999999999999999999999997643
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=293.68 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=193.0
Q ss_pred ceeeccCccEEEEEEeCC--C--cEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLED--G--TSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|++|.||+|.+.+ + ..|++|.+..... ..+.+.+|++.+++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 3689999876543 45678999999999999999999999988 888999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++..... ..++|...+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999965432 4689999999999999999999999 99999999999999999999999999998765432221
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... +.............
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~---- 221 (257)
T cd05040 155 VM-EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGERLE---- 221 (257)
T ss_pred ec-ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCCcCC----
Confidence 11 112346789999999998899999999999999999999 99998643221 11111110000000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.....+ ..+..++..|+. .+|++||+++|+++.|.
T Consensus 222 --~~~~~~---~~~~~li~~~l~-~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 --RPEACP---QDIYNVMLQCWA-HNPADRPTFAALREFLP 256 (257)
T ss_pred --CCccCC---HHHHHHHHHHCC-CCcccCCCHHHHHHHhc
Confidence 001112 234455667776 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.74 Aligned_cols=193 Identities=23% Similarity=0.327 Sum_probs=165.2
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++||+|+||.||+|+.. +++.||+|++.... .....+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 57899999987532 2334567788888765 799999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~- 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT- 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc-
Confidence 999998853 34688999999999999999999999 9999999999999999999999999999754322111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 153 ---TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred ---ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 12234899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=296.40 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=199.8
Q ss_pred ccCcccceeeccCccEEEEEEeCC-Cc----EEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GT----SLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
.+|...+.||+|+||.||+|...+ |. .+++|.+.... .....+.+|+..+.+++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457778999999999999998643 32 58889886553 234678899999999999999999999987 78899
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999996432 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
........ ..+..++..|+|||.+....++.++||||||+++||+++ |+.||..... .++.........
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~ 229 (279)
T cd05057 160 DVDEKEYH--AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGER 229 (279)
T ss_pred cCccccee--cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCC
Confidence 54322211 112224678999999988889999999999999999998 9999865322 111111111000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.. ........+..++..|+. .+|.+||++.++++.|+++..+
T Consensus 230 --------~~--~~~~~~~~~~~~~~~~l~-~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 --------LP--QPPICTIDVYMVLVKCWM-IDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --------CC--CCCCCCHHHHHHHHHHcC-CChhhCCCHHHHHHHHHHHHhC
Confidence 00 000111245566678887 8999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.29 Aligned_cols=193 Identities=22% Similarity=0.324 Sum_probs=165.5
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+|+.+ +++.||+|++.... .....+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999986532 2345667788888766 699999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~- 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT- 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc-
Confidence 999998853 24688999999999999999999999 9999999999999999999999999998754322111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 153 ---TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred ---ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 12234899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=301.32 Aligned_cols=258 Identities=25% Similarity=0.441 Sum_probs=197.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCc----EEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGT----SLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|... ++. .+++|.+.... .....+.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777889999999999999853 443 47888876543 2234688999999999999999999998754 4679
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998643 23588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
...... ....+..++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+++.. ...
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~---~~~ 229 (303)
T cd05110 160 EGDEKE--YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----REIPDLLEK---GER 229 (303)
T ss_pred cCcccc--cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHC---CCC
Confidence 432211 11122335678999999998889999999999999999998 8899864211 111122111 000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
. . ........+..++..|+. .+|++||+++++++.|+++.++.
T Consensus 230 ~--------~--~~~~~~~~~~~li~~c~~-~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 L--------P--QPPICTIDVYMVMVKCWM-IDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C--------C--CCCCCCHHHHHHHHHHcC-CChhhCcCHHHHHHHHHHHHhch
Confidence 0 0 001112345666778888 89999999999999999986554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.22 Aligned_cols=199 Identities=22% Similarity=0.301 Sum_probs=168.7
Q ss_pred cCcccceeeccCccEEEEEEe----CCCcEEEEEEecccc-----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 306 SFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
+|...+.||+|+||.||+++. .++..||+|++.... ...+.+..|++++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477789999999999999885 357899999986432 2235678899999999 589999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999853 34588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 154 EFLSEEKER---TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred cccccCCCc---cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 653322111 1123489999999998765 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=297.07 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=182.6
Q ss_pred eeeccCccEEEEEEeCC---CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCC
Q 006982 312 IIGSGRTGTMYKALLED---GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGS 386 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 386 (623)
.||+|+||.||+|...+ ...+++|.+.... .....+.+|++.++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3468888775432 234568899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCC-CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccc
Q 006982 387 LYDLLHPADDT-GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465 (623)
Q Consensus 387 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 465 (623)
|.+++...... ....++...+.++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999654321 23457888899999999999999999 999999999999999999999999999875433221111
Q ss_pred ccccCCCCcccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 466 TFVNGEFGDLGYVAPEYART-------LVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 466 ~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
.....++..|+|||+... ..++.++|||||||++|||++ |..||......+ -........ .
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~~~~~-~ 227 (269)
T cd05042 159 --KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--------VLKQVVREQ-D 227 (269)
T ss_pred --cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------HHHHHhhcc-C
Confidence 122335678999998642 356889999999999999999 777876432211 011111110 0
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
..+.++.+.. ........+ ...| + .||++||+++||++.|.
T Consensus 228 ~~~~~~~~~~-~~~~~~~~~---~~~~-~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQLDL-KYSDRWYEV---MQFC-W-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCcccc-cCCHHHHHH---HHHH-h-cCcccccCHHHHHHHhc
Confidence 1111111111 122222222 2334 4 58999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=307.45 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=205.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe-eeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE-RLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 379 (623)
++|...+.+|+|+||.++..+++ +++.+++|.+.... .......+|+.++++++|||||.+.+.++.++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778899999999999998854 67889999886543 334467899999999999999999999999887 89999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
+|++||++.+.+.... +..+++.+..+++.|+..|+.|||+. +|.|||||+.||+++.+..+||+|||+|+.+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999997654 46789999999999999999999988 999999999999999999999999999999876
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... .....||+-||+||.+.+..|..|+||||+||++|||.+-+.+|...+. ...+.+....
T Consensus 159 ~~~~----a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~----- 221 (426)
T KOG0589|consen 159 EDSL----ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRG----- 221 (426)
T ss_pred chhh----hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhc-----
Confidence 5422 2344599999999999999999999999999999999999999975322 1112111111
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
..++ .......++..+++-++. .+|+.||++.+++.+-
T Consensus 222 ~~~P--lp~~ys~el~~lv~~~l~----~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 222 LYSP--LPSMYSSELRSLVKSMLR----KNPEHRPSALELLRRP 259 (426)
T ss_pred cCCC--CCccccHHHHHHHHHHhh----cCCccCCCHHHHhhCh
Confidence 0111 122355667777765444 8899999999999873
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.39 Aligned_cols=198 Identities=21% Similarity=0.253 Sum_probs=168.4
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCC-CCcceeEEEEeCCeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNR-NLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 379 (623)
+|...+.||+|+||.||+|+.. +++.||+|++.... ...+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777899999999999999965 57789999987532 2345678899999999765 5788889999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999853 24588999999999999999999999 999999999999999999999999999875322
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 154 GGKT----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CCCc----eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 1111 12234899999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.12 Aligned_cols=202 Identities=24% Similarity=0.265 Sum_probs=171.0
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.+++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999954 68899999986532 234568889999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999998632 4578888899999999999999999 9999999999999999999999999997532110
Q ss_pred CC-------------------------------------------cccccccCCCCcccccCcccccCCCCCcchhHHHH
Q 006982 461 DT-------------------------------------------HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSF 497 (623)
Q Consensus 461 ~~-------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sf 497 (623)
.. ..........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 00001112358999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 006982 498 GTVLLELVTGERPTNVA 514 (623)
Q Consensus 498 Gvil~elltg~~P~~~~ 514 (623)
||++|||++|+.||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ 251 (382)
T ss_pred hHHHHHHHhCCCCCCCC
Confidence 99999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.86 Aligned_cols=201 Identities=21% Similarity=0.249 Sum_probs=172.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||++... +++.||+|+++.... ..+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999964 688999999975432 3456888999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999643 24689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccCCCCcccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYAR------TLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 155 NKMV---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCce---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 2221 112235899999999986 456789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=300.59 Aligned_cols=264 Identities=25% Similarity=0.356 Sum_probs=200.9
Q ss_pred cCHHHHHHHhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC
Q 006982 295 MRLSDLMKATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK 372 (623)
Q Consensus 295 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 372 (623)
+.+.++..++++|...+.||+|+||.||++.. .+++.+++|.+.........+.+|+.++.++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455666788999999999999999999996 4688999999876554556788899999988 899999999998754
Q ss_pred C-----eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeE
Q 006982 373 K-----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPK 447 (623)
Q Consensus 373 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~k 447 (623)
+ ..++|+||+++|+|.++++........+++..++.++.|++.||.|||+. +++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 3 57899999999999998864333345789999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccCCCCcccccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccc
Q 006982 448 ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-----VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG 522 (623)
Q Consensus 448 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~ 522 (623)
|+|||++.......... ....++..|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 169 l~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---- 240 (291)
T cd06639 169 LVDFGVSAQLTSTRLRR----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---- 240 (291)
T ss_pred Eeecccchhcccccccc----cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH----
Confidence 99999998654322111 123478899999987543 36889999999999999999999986532211
Q ss_pred cHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 523 NLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 523 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+.+ .... ....+.+ ..+....+..++..|+. .+|++||++.|+++.
T Consensus 241 ~~~~----~~~~-~~~~~~~-------~~~~~~~l~~li~~~l~-~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 TLFK----IPRN-PPPTLLH-------PEKWCRSFNHFISQCLI-KDFEARPSVTHLLEH 287 (291)
T ss_pred HHHH----HhcC-CCCCCCc-------ccccCHHHHHHHHHHhh-cChhhCcCHHHHhcC
Confidence 1111 1100 0000100 11111235556667777 899999999998763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=296.78 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=191.9
Q ss_pred ceeeccCccEEEEEEeCC-------CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 311 NIIGSGRTGTMYKALLED-------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+.||+|+||.||+|+..+ +..+++|.+.... .....+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2578889876543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCC---CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-----CeEEeeccc
Q 006982 382 MPNGSLYDLLHPADD---TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-----EPKISDFGL 453 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-----~~kl~Dfgl 453 (623)
+++|+|.+++..... ....++|.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964321 224578999999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHh
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLS 532 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~ 532 (623)
++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +......
T Consensus 158 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~ 227 (269)
T cd05044 158 ARDIYKSDYYR--KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQHVT 227 (269)
T ss_pred ccccccccccc--cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHHHh
Confidence 98654322111 1112235688999999998899999999999999999998 99998643211 1111111
Q ss_pred ccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 533 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
..... . .....++ .+.+++..|+. .+|.+||++++|++.|++
T Consensus 228 ~~~~~-~------~~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 228 AGGRL-Q------KPENCPD---KIYQLMTNCWA-QDPSERPTFDRIQEILQN 269 (269)
T ss_pred cCCcc-C------CcccchH---HHHHHHHHHcC-CCcccCCCHHHHHHHHhC
Confidence 00000 0 0111223 34455567776 899999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=302.67 Aligned_cols=256 Identities=20% Similarity=0.222 Sum_probs=195.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999965 68899999986422 23455788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999532 24688899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
...... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+........
T Consensus 155 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~ 223 (331)
T cd05597 155 DGTVQS---NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNH 223 (331)
T ss_pred CCCccc---cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcC
Confidence 222111 11248999999999863 4578899999999999999999999965322 1111111111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.....+... ....++++..+++-.+ |.. .++..||++.++++.
T Consensus 224 ~~~~~~~~~---~~~~~~~~~~li~~ll-~~~-~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 KEHFQFPPD---VTDVSEEAKDLIRRLI-CSP-ETRLGRNGLQDFKDH 266 (331)
T ss_pred CCcccCCCc---cCCCCHHHHHHHHHHc-cCc-ccccCCCCHHHHhcC
Confidence 111111000 0113556666666533 543 566678999888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.85 Aligned_cols=192 Identities=25% Similarity=0.336 Sum_probs=163.9
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCC-CCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGS-VKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+|... ++..||+|.++... .....+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 57889999987542 233456677777765 4999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK- 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc-
Confidence 999999853 24688999999999999999999999 9999999999999999999999999998753221111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 153 ---TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred ---eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 1223489999999999988999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=297.09 Aligned_cols=263 Identities=21% Similarity=0.303 Sum_probs=197.7
Q ss_pred cCcccceeeccCccEEEEEEe-----CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Ceee
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-----EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERL 376 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 376 (623)
-|.+.+.||+|+||.||++.. .++..|++|.+.... .....+.+|++++++++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 367788999999999999974 357889999986442 3346789999999999999999999998875 5678
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||+++++|.+++... ...++|..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998532 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-------cccccHHHHHH
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPE-------TFKGNLVEWIA 529 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~-------~~~~~l~~~~~ 529 (623)
+....... .......++..|+|||++.+..++.++||||||+++|||++++.|........ ........++.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 159 IETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 64322211 11122346778999999988889999999999999999999887654321100 00001111111
Q ss_pred HHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
...... ...........+.+++..|+. .+|++||+++++++.|+++
T Consensus 238 ~~~~~~----------~~~~~~~~~~~~~~li~~~l~-~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK----------RLPRPPNCPEEVYQLMRKCWE-FQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc----------cCCCCCCCCHHHHHHHHHHcc-CCcccCcCHHHHHHHHHhh
Confidence 111000 000011112346666778887 8999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.75 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=186.3
Q ss_pred eeeccCccEEEEEEeCC---CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCC
Q 006982 312 IIGSGRTGTMYKALLED---GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGS 386 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 386 (623)
.||+|+||.||+|...+ +..+++|.++... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 3568999886543 234578899999999999999999999999889999999999999
Q ss_pred HhhhccCCCC-CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccc
Q 006982 387 LYDLLHPADD-TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465 (623)
Q Consensus 387 L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 465 (623)
|.++++.... .....++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||+++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 9999965332 223567888889999999999999999 9999999999999999999999999999754322211
Q ss_pred ccccCCCCcccccCcccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 466 TFVNGEFGDLGYVAPEYARTL-------VATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 466 ~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
.......++..|+|||++... .++.++||||||+++|||++ |+.||......+ ..... . ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~~~---~-~~~~ 227 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLTYT---V-REQQ 227 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHH---h-hccc
Confidence 111223467889999988532 35789999999999999996 999996532211 00100 0 0011
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
....++.+.. ...+++..+++ .|+ .+|++|||++||++.|+
T Consensus 228 ~~~~~~~~~~-~~~~~~~~l~~---~c~--~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKL-PLSDRWYEVMQ---FCW--LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCC-CCChHHHHHHH---HHh--cCcccCCCHHHHHHHhc
Confidence 1111222211 12334444443 454 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=309.52 Aligned_cols=192 Identities=23% Similarity=0.323 Sum_probs=166.9
Q ss_pred ceeeccCccEEEEEEe----CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 311 NIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
+.||+|+||.||+++. .+|+.||+|++.... .....+..|++++.+++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997543 233456789999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 9999999853 34689999999999999999999999 9999999999999999999999999999865432111
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....|++.|+|||.+....++.++|||||||++|||++|+.||..
T Consensus 155 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 155 ----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ----eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 1123489999999999988889999999999999999999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.48 Aligned_cols=203 Identities=24% Similarity=0.272 Sum_probs=171.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... .....+.+|++++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999954 68899999986532 23456788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999963 24578888899999999999999999 999999999999999999999999999853210
Q ss_pred CCC---------------------------------------cccccccCCCCcccccCcccccCCCCCcchhHHHHHHH
Q 006982 460 IDT---------------------------------------HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTV 500 (623)
Q Consensus 460 ~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvi 500 (623)
... ..........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 00000112358999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 006982 501 LLELVTGERPTNVA 514 (623)
Q Consensus 501 l~elltg~~P~~~~ 514 (623)
+|||++|+.||...
T Consensus 234 lyell~G~~Pf~~~ 247 (376)
T cd05598 234 LYEMLVGQPPFLAD 247 (376)
T ss_pred eeehhhCCCCCCCC
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.92 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=193.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|++|.||++... ++..+++|.+.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999854 68999999886432 123468889999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999853 24578899999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
........ ......++..|+|||++.+..++.++||||||+++|||++|+.||......+ . ..........
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~-~~~~~~~~~~ 225 (263)
T cd06625 155 QTICSSGT-GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-------A-IFKIATQPTN 225 (263)
T ss_pred cccccccc-cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-------H-HHHHhccCCC
Confidence 43211111 0012346789999999998889999999999999999999999986432210 0 0111000000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
..+. .....++. .+...|+. .+|.+|||+.|+++.
T Consensus 226 -----~~~~-~~~~~~~~---~li~~~l~-~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -----PQLP-SHVSPDAR---NFLRRTFV-ENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCC-ccCCHHHH---HHHHHHhh-cCcccCCCHHHHhhC
Confidence 0000 11223333 34446666 889999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=291.52 Aligned_cols=248 Identities=23% Similarity=0.392 Sum_probs=196.7
Q ss_pred ccCcccceeeccCccEEEEEEeCC-CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
++|+..+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|++++++++|||++++++++......++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 568888999999999999999765 78999999875543 6789999999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 82 AGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 99999998532 35689999999999999999999999 9999999999999999999999999999876543211
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
. ....++..|+|||++.+..++.++||||||+++|||++|+.||........ ... ...... +
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~--~~~~~~-----~ 217 (256)
T cd06612 156 R----NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFM--IPNKPP-----P 217 (256)
T ss_pred c----ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhh--hccCCC-----C
Confidence 1 112368899999999988899999999999999999999999875322110 000 000000 0
Q ss_pred hhh-cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 544 CLV-AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 544 ~l~-~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+. ......+ +.+++..|+. .+|++|||+.||++
T Consensus 218 ~~~~~~~~~~~---~~~~i~~~l~-~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPE---FNDFVKKCLV-KDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHH---HHHHHHHHHh-cChhhCcCHHHHhc
Confidence 000 0011223 4445556776 89999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.42 Aligned_cols=193 Identities=24% Similarity=0.313 Sum_probs=163.3
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCC-CCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGS-VKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+|... ++..||+|.++... ...+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 57889999987532 223445566666654 4899999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence 999999853 24588899999999999999999999 999999999999999999999999999986432221
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 112335899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=297.73 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=187.7
Q ss_pred eeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
||+|+||.||++..+ +|+.+|+|.+.... .....+..|++++.+++||||+++.+++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 68999999986432 2234556799999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----- 150 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----- 150 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-----
Confidence 99885432 24588999999999999999999999 999999999999999999999999999986543211
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhc
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA 547 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 547 (623)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ............ .. . ...
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~-~~----~--~~~ 219 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLED-EV----K--FEH 219 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhcc-cc----c--ccc
Confidence 112347899999999998889999999999999999999999996432210 011111111110 00 0 001
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 548 KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 548 ~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
....+++.+++ ..|+. .||++||++.|+++.+
T Consensus 220 ~~~~~~~~~li---~~~L~-~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDIC---RLFLA-KKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHH---HHHhc-cCHhhCCCCccchhhh
Confidence 12334444444 44555 9999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.40 Aligned_cols=258 Identities=20% Similarity=0.290 Sum_probs=197.6
Q ss_pred cCcccceeeccCccEEEEEEeCCC-cEEEEEEecc-ccccHHHHHHHHHHhCCCC-CCCCcceeE-EEEe------CCee
Q 006982 306 SFSKNNIIGSGRTGTMYKALLEDG-TSLMVKRLQD-SQRSEKEFVAEMATLGSVK-NRNLVPLLG-FCMA------KKER 375 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~~~~ 375 (623)
++++.++|.+|||+.||.|....+ ..+|+|++-. .+.+...+.+|+++|++|+ |+|||.+++ .... ..+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 456678999999999999997665 9999998754 4456678899999999996 999999999 3322 1367
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
+|.||||++|+|-+++..... ..|++.++++|+.++++|+++||.. +|+|||||||-+||||+.+++.||||||-+.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 899999999999999964433 3499999999999999999999986 7789999999999999999999999999997
Q ss_pred ccCCCC--Cccccccc---CCCCcccccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHH
Q 006982 456 LMNPID--THLSTFVN---GEFGDLGYVAPEYA---RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 456 ~~~~~~--~~~~~~~~---~~~gt~~y~aPE~~---~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~ 527 (623)
-....- ......+. ...-|+.|+|||.+ .+..+++|+|||++||+||-|.....||+......
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--------- 265 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--------- 265 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence 432211 11100110 13468999999976 46788999999999999999999999997532211
Q ss_pred HHHHhccCchhhhhchhhhc---CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 528 IAQLSSTGQLQDAIDKCLVA---KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
|++....- ..+.+.+..+ +..|++ .+|.+||++.+|++.+.+++.+.-
T Consensus 266 ------------Ilng~Y~~P~~p~ys~~l~~L---I~~mL~-~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 266 ------------ILNGNYSFPPFPNYSDRLKDL---IRTMLQ-PNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ------------EEeccccCCCCccHHHHHHHH---HHHHhc-cCcccCCCHHHHHHHHHHHhcCCC
Confidence 11111100 1123333333 344555 999999999999999999877643
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.21 Aligned_cols=193 Identities=26% Similarity=0.338 Sum_probs=164.4
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCC-CCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGS-VKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++||+|+||.||+|..+ ++..||+|.++... ........|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999997542 233456677777765 4899999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++........
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR- 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc-
Confidence 999999853 24588999999999999999999999 9999999999999999999999999998753221111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 153 ---ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred ---eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 12234899999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.43 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=197.0
Q ss_pred ccCcccceeeccCccEEEEEEeCC----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|...+ ...|++|...... ...+.+.+|+.++++++|||++++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 347778899999999999998643 2468889886543 345678999999999999999999998875 457899
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+++|+|.+++... ...+++..++.++.+++.||.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999643 23589999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
....... ....++..|+|||.+....++.++||||||+++||+++ |..||...... ....++. .....
T Consensus 159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~---~~~~~ 227 (270)
T cd05056 159 DESYYKA---SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DVIGRIE---NGERL 227 (270)
T ss_pred cccceec---CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH---cCCcC
Confidence 3321111 12224568999999988889999999999999999996 99999653321 1111111 11000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
. .....+.+ +.+++..|+. .+|.+|||+.++++.|+++..+
T Consensus 228 -~------~~~~~~~~---~~~li~~~l~-~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -P------MPPNCPPT---LYSLMTKCWA-YDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -C------CCCCCCHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHhc
Confidence 0 01112333 4445556776 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.96 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=192.0
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+|...+.||+|+||.||+|.. .++..|++|.+.... .....+.+|++++.+++|||++++++++...+..++|+||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999985 578899999986432 33457889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|..+. .+++.....++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999997653 367888899999999999999999 99999999999999999999999999998654321
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.....++..|+|||++.+..++.++||||||+++|||++|+.||.......... ....+........ .
T Consensus 150 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~------~ 217 (279)
T cd06619 150 -----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDED------P 217 (279)
T ss_pred -----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccC------C
Confidence 122347899999999998889999999999999999999999996532221111 1111111111000 0
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+.+.......+ +.+++..|+. .+|++||+++|+++.
T Consensus 218 ~~~~~~~~~~~---~~~li~~~l~-~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVLPVGQFSEK---FVHFITQCMR-KQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCcCCHH---HHHHHHHHhh-CChhhCCCHHHHhcC
Confidence 11111112233 4455556776 899999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=302.76 Aligned_cols=193 Identities=20% Similarity=0.260 Sum_probs=166.0
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||++... +++.||+|++.... ...+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57889999997542 2334577899998888 699999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT- 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc-
Confidence 999998853 24689999999999999999999999 9999999999999999999999999999753221111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 153 ---TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ---eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 12234899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.10 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=193.1
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.|+..+.||+|+||.||+|... ++..|++|.+.... ...+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999864 57889999886432 33457889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||++..+.....
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999842 4588999999999999999999998 999999999999999999999999999986643221
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.. ....++..|+|||++.+..++.++||||||+++|||++|+.|+....... ...+.. ... .
T Consensus 157 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~~~----~~~-----~ 218 (277)
T cd06642 157 KR----NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VLFLIP----KNS-----P 218 (277)
T ss_pred hh----hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HHhhhh----cCC-----C
Confidence 11 12247889999999998889999999999999999999999986432210 111100 000 0
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+.+.. ... ..+..++..|+. .+|++||++.|++..
T Consensus 219 ~~~~~-~~~---~~~~~li~~~l~-~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEG-QYS---KPFKEFVEACLN-KDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCc-ccC---HHHHHHHHHHcc-CCcccCcCHHHHHHh
Confidence 00111 112 234455567776 899999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=293.89 Aligned_cols=252 Identities=22% Similarity=0.267 Sum_probs=192.7
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|+. .++..|++|++.... .....+.+|+.++.+++|||++++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999995 568899999986543 33456788999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.++++. ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999853 24588999999999999999999999 999999999999999999999999999987643211
Q ss_pred cccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
. .....++..|+|||.+. ...++.++|||||||++|||++|+.||......+... .+ . ...
T Consensus 162 ~----~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~~----~-~~~--- 225 (267)
T cd06646 162 K----RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----LM----S-KSN--- 225 (267)
T ss_pred c----cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----ee----e-cCC---
Confidence 1 11234788999999874 3457889999999999999999999986432211100 00 0 000
Q ss_pred hhchhhhc-CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 540 AIDKCLVA-KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 540 ~~d~~l~~-~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
...+.+.. ...+.+ +.+++..|+. .+|++||+++++++.|
T Consensus 226 ~~~~~~~~~~~~~~~---~~~li~~~l~-~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKLKDKTKWSST---FHNFVKISLT-KNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCccccccCHH---HHHHHHHHhh-CChhhCcCHHHHhcCC
Confidence 00000000 011233 3344456665 8999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.84 Aligned_cols=207 Identities=21% Similarity=0.277 Sum_probs=175.3
Q ss_pred HHHHHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEe
Q 006982 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371 (623)
Q Consensus 297 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 371 (623)
+.++....++|...+.||+|+||.||++... +++.+|+|++.... .....+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3444555688999999999999999999965 57889999986422 233457789999999999999999999999
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
....++||||+++|+|.+++.. ..++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999852 3477888889999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL----VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
|+++.+...... ......||+.|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 187 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 187 GTCMKMNKEGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CceeEcCcCCcc---cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 999876432211 11234589999999998653 3789999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=303.18 Aligned_cols=197 Identities=22% Similarity=0.261 Sum_probs=167.7
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 379 (623)
+|...+.||+|+||.||+|... ++..||+|.+.... .....+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999865 57899999987532 2234466777777776 5789999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999853 24588999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 154 DGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred CCCc----cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 1111 1223489999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=299.28 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=198.0
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEe----
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMA---- 371 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 371 (623)
+.+..+.++|...+.||+|+||.||++... +++.+++|.+.........+.+|+.++.++ +|||++++++++..
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 444556788999999999999999999864 578999998876544556788899999999 69999999998843
Q ss_pred -CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEee
Q 006982 372 -KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450 (623)
Q Consensus 372 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~D 450 (623)
.+..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 3467999999999999998754333345688999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHH
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~ 525 (623)
||+++.+...... .....|+..|+|||++.. ..++.++|||||||++|||++|+.||........ +.
T Consensus 168 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----~~ 239 (286)
T cd06638 168 FGVSAQLTSTRLR----RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----LF 239 (286)
T ss_pred CCceeecccCCCc----cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH----Hh
Confidence 9999876432211 122348899999998753 4478899999999999999999999865322110 00
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
..... ......+ ...... .+..++.+|+. .+|++|||+.|+++.
T Consensus 240 ----~~~~~-~~~~~~~----~~~~~~---~~~~li~~~l~-~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 ----KIPRN-PPPTLHQ----PELWSN---EFNDFIRKCLT-KDYEKRPTVSDLLQH 283 (286)
T ss_pred ----hcccc-CCCcccC----CCCcCH---HHHHHHHHHcc-CCcccCCCHHHHhhc
Confidence 00000 0000000 011122 34455667777 999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.98 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=191.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Cee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 375 (623)
.+|...+.||+|+||.||+|... ++..|++|++.... .....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999864 58899999885431 2234678899999999999999999988763 567
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999853 24588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
.......... ......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~ 225 (266)
T cd06651 155 RLQTICMSGT-GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQP 225 (266)
T ss_pred ccccccccCC-ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCC
Confidence 6543211111 111234788999999999888999999999999999999999999643211 1111111000
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .+ ..+......++.++.|+. .+|++||+++||++
T Consensus 226 ~-----~~-----~~~~~~~~~~~~li~~~~-~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 T-----NP-----QLPSHISEHARDFLGCIF-VEARHRPSAEELLR 260 (266)
T ss_pred C-----CC-----CCchhcCHHHHHHHHHhc-CChhhCcCHHHHhc
Confidence 0 00 011222333444557888 79999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=286.75 Aligned_cols=279 Identities=22% Similarity=0.276 Sum_probs=202.6
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEe-----CCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMA-----KKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~ 375 (623)
..|...+.||+|+||.|+++.. .+|..||+|++... ....++-.+|++.|+.++|+||+.+.+.+.. -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3455568899999999999984 57899999999743 3445678899999999999999999998865 3568
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
|+|+|+|+ -+|...++ .++.++......+..|+.+||.|+|+. +|+||||||+|+|++.+...||+|||+|+
T Consensus 102 YiV~elMe-tDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred EEehhHHh-hHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 99999994 59999996 345589999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCcccccccCCCCcccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccH------HHHH
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYAR-TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL------VEWI 528 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l------~~~~ 528 (623)
..... .........+.|-.|+|||.+. ...|+...||||.|||+.||++|+.-|.+.+........+ .+..
T Consensus 174 ~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 174 YLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred ecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 87643 2223334455789999999875 4579999999999999999999999998754432211100 0000
Q ss_pred HHHhccCchhhhhchhhhc---------CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCCCcccc
Q 006982 529 AQLSSTGQLQDAIDKCLVA---------KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIM 599 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~~---------~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~~~~~~ 599 (623)
-...........+...-.. .........+++-.+. .||.+|+|++|.++.-- ...++..+.+...
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~----fdP~kRita~eAL~hPY--l~~~hdp~dEP~~ 325 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLV----FDPKKRITAEEALAHPY--LAPYHDPEDEPVC 325 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhc----cCccccCCHHHHhcChh--hhhhcCCccCCCC
Confidence 0111111111111111100 1234455566654433 89999999999876432 3444444433333
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.96 Aligned_cols=192 Identities=29% Similarity=0.340 Sum_probs=162.8
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHH-HhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMA-TLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+|... +++.||+|++.... .....+..|.. ++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999965 68999999986532 22234455554 46789999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-- 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence 999999863 34688999999999999999999999 999999999999999999999999999875322111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 11223489999999999998999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.12 Aligned_cols=199 Identities=24% Similarity=0.330 Sum_probs=168.2
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-----eee
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK-----ERL 376 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 376 (623)
+|+..+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 478999999986532 23457889999999999999999999998776 789
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||+. ++|.+.+. ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 58888874 235689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 153 EEPDESK---HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cccCccc---cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 5432211 11223478899999998764 47899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=293.64 Aligned_cols=254 Identities=20% Similarity=0.355 Sum_probs=194.6
Q ss_pred cCcccceeeccCccEEEEEEeCC--CcEEEEEEeccc-----------cccHHHHHHHHHHhCC-CCCCCCcceeEEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLED--GTSLMVKRLQDS-----------QRSEKEFVAEMATLGS-VKNRNLVPLLGFCMA 371 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~-----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 371 (623)
.|+..+.||+|+||.||+|.... +..+++|.+... ......+..|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999765 678999987532 1123456778888764 799999999999999
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
++..++|+||+++++|.+++.........+++..+++++.|++.||.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988543333456899999999999999999999631 7999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
|.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......
T Consensus 159 g~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~ 225 (269)
T cd08528 159 GLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLATKI 225 (269)
T ss_pred cceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHHHHH
Confidence 9998754422 11223478899999999988899999999999999999999999864321 1111111
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.. .... +. .......+ +..++.+|+. .||++||++.||..+++
T Consensus 226 ~~-~~~~----~~-~~~~~~~~---l~~li~~cl~-~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VE-AVYE----PL-PEGMYSED---VTDVITSCLT-PDAEARPDIIQVSAMIS 268 (269)
T ss_pred hh-ccCC----cC-CcccCCHH---HHHHHHHHCC-CCCccCCCHHHHHHHhc
Confidence 10 0000 00 01112233 3444557877 99999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=301.60 Aligned_cols=192 Identities=24% Similarity=0.316 Sum_probs=164.8
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||++... ++..||+|+++... .....+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999997542 2344567788888777 799999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT- 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc-
Confidence 999998853 24689999999999999999999999 9999999999999999999999999998753221111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 153 ---TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred ---ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 1123478999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=293.63 Aligned_cols=238 Identities=24% Similarity=0.376 Sum_probs=185.6
Q ss_pred ceeeccCccEEEEEEeCCCc-----------EEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 311 NIIGSGRTGTMYKALLEDGT-----------SLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
+.||+|+||.||+|...+.. .+++|.+.........+.+|+.++++++|||++++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999976433 57788776554446788999999999999999999999988 7789999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-------CeEEeecc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-------EPKISDFG 452 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-------~~kl~Dfg 452 (623)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999996432 2688999999999999999999998 999999999999999888 79999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHH
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL--VATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIA 529 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~ 529 (623)
++...... ....++..|+|||++... .++.++||||||+++|||++ |..|+...... .+..
T Consensus 154 ~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~~~~ 217 (259)
T cd05037 154 IPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------EKER 217 (259)
T ss_pred cccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------hHHH
Confidence 99865431 112356789999998876 78999999999999999999 56666543211 1111
Q ss_pred HHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
....... + ..... ..+.+++..|+. .+|.+||++.||++.|+
T Consensus 218 ~~~~~~~--------~-~~~~~---~~~~~li~~~l~-~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 218 FYQDQHR--------L-PMPDC---AELANLINQCWT-YDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHhcCCC--------C-CCCCc---hHHHHHHHHHhc-cChhhCCCHHHHHHhcC
Confidence 0000000 0 00011 455566677776 89999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=297.42 Aligned_cols=197 Identities=25% Similarity=0.390 Sum_probs=170.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||++... ++..+++|.+.... .....+.+|++++.+++||||+++++++.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999965 57888888886432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.++++.. ..+++..+..++.|++.||.|||+.+ +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999632 45889999999999999999999742 89999999999999999999999999987653211
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 1223478899999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.35 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=194.2
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+|...+.||+|+||.||++... ++..+++|.+... ....+.+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999965 6889999988543 234567888999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.... +..+++...+.++.|++.||.|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999885432 34678899999999999999999999 999999999999999999999999999986543221
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
. .....+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......... ..... +
T Consensus 156 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~-~- 220 (255)
T cd08219 156 Y----ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQ-GSYKP-L- 220 (255)
T ss_pred c----cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhc-CCCCC-C-
Confidence 1 1123478899999999888899999999999999999999999964321 111111111 11000 0
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
......++. .+..+|+. .+|++||++.|++..
T Consensus 221 ----~~~~~~~~~---~li~~~l~-~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----PSHYSYELR---SLIKQMFK-RNPRSRPSATTILSR 252 (255)
T ss_pred ----CcccCHHHH---HHHHHHHh-CCcccCCCHHHHhhc
Confidence 011223333 44446666 899999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.89 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=192.4
Q ss_pred HHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
..+++.+.....||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.++.+++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345566767789999999999999954 67889999886543 3456788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCcc--ChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-CCCeEEeeccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSV--DWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFGLAR 455 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-~~~~kl~Dfgla~ 455 (623)
+||+++++|.+++.... ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||++.
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 84 MEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999996432 234 7888899999999999999999 9999999999999976 6799999999997
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhc
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL--VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 533 (623)
........ .....+++.|+|||++... .++.++||||||+++|||++|+.||...... ....+......
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 228 (268)
T cd06624 158 RLAGINPC----TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMFK 228 (268)
T ss_pred ecccCCCc----cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhhc
Confidence 65432211 1122378899999998654 3788999999999999999999998642211 01111110000
Q ss_pred cCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 534 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .+.+ .....+++ ..++.+|+. .+|++|||+.|+++
T Consensus 229 ~-------~~~~-~~~~~~~~---~~li~~~l~-~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 I-------HPEI-PESLSAEA---KNFILRCFE-PDPDKRASAHDLLQ 264 (268)
T ss_pred c-------CCCC-CcccCHHH---HHHHHHHcC-CCchhCCCHHHHHh
Confidence 0 0000 11122333 344556776 89999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.31 Aligned_cols=197 Identities=20% Similarity=0.273 Sum_probs=169.0
Q ss_pred ccCcccceeeccCccEEEEEEeC---CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE---DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.+|...+.||+|+||.||++... .+..|++|.+... +...+|++++++++||||+++++++......++||||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 46899999999999999999753 3577899987643 2456899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+. ++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++......
T Consensus 168 ~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 168 YK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred cC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 96 68888883 235689999999999999999999999 99999999999999999999999999998654322
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
... ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 240 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 240 DTP--QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccc--cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 211 1123458999999999999899999999999999999999999997643
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.19 Aligned_cols=247 Identities=25% Similarity=0.424 Sum_probs=193.0
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||++.. ++..|++|...... ....+.+|+.++.+++|||++++++++..+ ..++|+||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4578889999999999999975 57789999886543 346788999999999999999999998654 47899999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... ...+++..++.++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999996432 24688999999999999999999998 99999999999999999999999999997643211
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||..... .+........... +
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~----~- 217 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKECVEKGYRM----E- 217 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhCCCCC----C-
Confidence 11124568999999988889999999999999999998 9999864322 1111111111000 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
. ....++ .+..++..|+. .+|++||+++++++.|++
T Consensus 218 -~-~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -P-PEGCPA---DVYVLMTSCWE-TEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -C-CCcCCH---HHHHHHHHHcC-CChhhCcCHHHHHHHHcc
Confidence 0 011223 34455667887 899999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=294.24 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=192.1
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHH---HHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEK---EFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
|+..+.||+|+||+||+++.. ++..+|+|++........ ....|+.++.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 466899999977654333 2345999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++. ....+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~- 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN- 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 9999999996 346689999999999999999999999 99999999999999999999999999998642111
Q ss_pred cccccccCCCCcccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR-TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
.......++..|+|||++. ...++.++||||+|+++|+|++|..||...... ........... ....
T Consensus 153 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-----~~~~~~~~~~~----~~~~ 220 (260)
T PF00069_consen 153 ---ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-----DQLEIIEKILK----RPLP 220 (260)
T ss_dssp ---SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-----HHHHHHHHHHH----THHH
T ss_pred ---cccccccccccccccccccccccccccccccccccccccccccccccccccch-----hhhhhhhhccc----cccc
Confidence 1223345789999999998 888999999999999999999999999753110 00111111000 0000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.......... ..+.++...|+. .||++||++.++++
T Consensus 221 ~~~~~~~~~~---~~l~~li~~~l~-~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SSSQQSREKS---EELRDLIKKMLS-KDPEQRPSAEELLK 256 (260)
T ss_dssp HHTTSHTTSH---HHHHHHHHHHSS-SSGGGSTTHHHHHT
T ss_pred ccccccchhH---HHHHHHHHHHcc-CChhHCcCHHHHhc
Confidence 0000001112 344444555665 99999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=287.80 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=192.3
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHh
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLY 388 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 388 (623)
++||+|+||.||++...+++.|++|.+..... ....+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999987799999998875432 4567899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccc
Q 006982 389 DLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFV 468 (623)
Q Consensus 389 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 468 (623)
+++... ...+++..++.++.+++.+++|||+. +++||||||+||++++++.++|+|||+++.......... .
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~--~ 152 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS--D 152 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec--c
Confidence 998643 23578999999999999999999999 999999999999999999999999999986542111111 0
Q ss_pred cCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhc
Q 006982 469 NGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA 547 (623)
Q Consensus 469 ~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 547 (623)
.....+..|+|||++.+..++.++||||||+++|||+| |..||...... .....+.. .... . ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----~~~~~~~~---~~~~------~-~~ 217 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----QTRERIES---GYRM------P-AP 217 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----HHHHHHhc---CCCC------C-CC
Confidence 11223567999999988889999999999999999999 88888643211 11111110 0000 0 01
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 548 KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 548 ~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
...+. .+..++..|+. .+|.+||++.|+++.|+
T Consensus 218 ~~~~~---~~~~li~~~l~-~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPE---EIYRLMLQCWA-YDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCH---HHHHHHHHHhc-cChhhCcCHHHHHHHhh
Confidence 11122 34555566776 89999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.38 Aligned_cols=195 Identities=21% Similarity=0.246 Sum_probs=166.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
..|.+.+.||+|+||.||++... .++.|++|... ...+.+|++++++++|+|||++++++......++|+||+.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 46888999999999999999975 47889999642 2345689999999999999999999999999999999995
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
++|.+++... ...++|.+++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 244 -~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 244 -SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred -CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 6998888532 24689999999999999999999999 9999999999999999999999999999865432111
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
....+..||..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 317 --~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 317 --PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred --ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 111234589999999999999999999999999999999998876543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=288.96 Aligned_cols=204 Identities=22% Similarity=0.295 Sum_probs=171.6
Q ss_pred ccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCC-CcceeEEEEeCC------
Q 006982 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRN-LVPLLGFCMAKK------ 373 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 373 (623)
..|...++||+|+||.||+|+ ..+|+.||+|++..... ......+|+.++.+++|+| ||++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346667789999999999999 45789999999976533 3455689999999999999 999999998877
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++|+||+.. +|..++.........++......++.|+.+||+|||++ +|+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 67899999976 99999975443223466678899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
|+...-... .....++|..|+|||++.+. .|+...||||+|||+.||++++.-|.+..+
T Consensus 167 Ara~~ip~~----~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 167 ARAFSIPMR----TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HHHhcCCcc----cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 996552211 12334579999999999876 789999999999999999999998877544
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=304.24 Aligned_cols=193 Identities=28% Similarity=0.350 Sum_probs=163.5
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHH-HhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMA-TLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+++.. +|+.+|+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999954 68999999986532 22344555555 46789999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~- 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT- 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC-
Confidence 999998853 35688999999999999999999999 9999999999999999999999999998753221111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 153 ---TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ---cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 12234899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.40 Aligned_cols=198 Identities=27% Similarity=0.389 Sum_probs=171.0
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
|+..+.||+|+||.||++... +++.||+|.+.... .....+..|+.++.+++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999965 68899999886532 2234577899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999885432 24588999999999999999999998 99999999999999999999999999997653221
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 157 T-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred c-----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 1 12335899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.90 Aligned_cols=258 Identities=21% Similarity=0.319 Sum_probs=198.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|+..+.||+|+||+||++... +++.|++|++... ....+.+.+|++++..++||||+++++++......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999965 6888999987543 23456789999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++.. ...+++..+..++.+++.++.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999853 245899999999999999999999742 79999999999999999999999999987543211
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccc---ccHHHHHHHHhccCchh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK---GNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~---~~l~~~~~~~~~~~~~~ 538 (623)
. ....|+..|+|||++.+..++.++|||||||++||+++|+.||.......... ....++.........
T Consensus 159 ~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (284)
T cd06620 159 A------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-- 230 (284)
T ss_pred c------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--
Confidence 1 12347899999999988889999999999999999999999997644321111 111122222111100
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
+.+.....+ ..+..++..|+. .||++||++.|++++..
T Consensus 231 ----~~~~~~~~~---~~~~~li~~~l~-~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 231 ----PRLPSSDFP---EDLRDFVDACLL-KDPTERPTPQQLCAMPP 268 (284)
T ss_pred ----CCCCchhcC---HHHHHHHHHHhc-CCcccCcCHHHHhcCcc
Confidence 000000012 234455567877 99999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.69 Aligned_cols=200 Identities=20% Similarity=0.335 Sum_probs=168.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||+|..+ ++..||+|.++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999865 67889999986432 2345677899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++ +|.+++... +..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 888887532 24578899999999999999999999 99999999999999999999999999997643221
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 159 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 159 KT----YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred cc----cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 112347889999998864 467899999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.14 Aligned_cols=248 Identities=24% Similarity=0.384 Sum_probs=194.2
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.+|...+.||+|+||.||++.. .++..|++|.+.... ...+.+.+|+.+++.++|+|++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999995 578999999986543 34466888999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999842 4578899999999999999999999 999999999999999999999999999986543222
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.. ....+++.|+|||.+.+..++.++|||||||++|||++|+.||........... ..... ......
T Consensus 171 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------~~~~~-~~~~~~ 237 (297)
T cd06656 171 KR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------IATNG-TPELQN 237 (297)
T ss_pred Cc----CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------eccCC-CCCCCC
Confidence 11 123478899999999988899999999999999999999999965332111000 00000 000000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.......+ ..++..|+. .+|++||+++++++
T Consensus 238 ----~~~~~~~~---~~li~~~l~-~~p~~Rps~~~il~ 268 (297)
T cd06656 238 ----PERLSAVF---RDFLNRCLE-MDVDRRGSAKELLQ 268 (297)
T ss_pred ----ccccCHHH---HHHHHHHcc-CChhhCcCHHHHhc
Confidence 00112222 334445665 89999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=293.08 Aligned_cols=247 Identities=20% Similarity=0.337 Sum_probs=198.1
Q ss_pred ccCcccceeeccCccEEEEEE-eCCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
.+|+..+.||+|.||.|-+|. +..|+.||||.+++.. .+.-.+.+|+++|..++||||+.++.+|++.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 356777899999999999998 5789999999997654 23345789999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||..+|.|++++. ..+.+++....+++.||..|+.|+|.+ +++|||||-+|||+|+++++||+|||++-.+..
T Consensus 133 EYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999995 446799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVAT-PKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
. .+..+-+|++-|.+||.+.+.+|. +.+|.||+||+||.++.|..||++.+ ....+++......
T Consensus 206 -~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQIs~GaY-- 270 (668)
T KOG0611|consen 206 -K----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQISRGAY-- 270 (668)
T ss_pred -c----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHhhcccc--
Confidence 2 233334589999999999998875 78999999999999999999998632 2233333322110
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.....+.....+++-.+. .+|++|.|+.||....-
T Consensus 271 -------rEP~~PSdA~gLIRwmLm----VNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 271 -------REPETPSDASGLIRWMLM----VNPERRATIEDIASHWW 305 (668)
T ss_pred -------cCCCCCchHHHHHHHHHh----cCcccchhHHHHhhhhe
Confidence 001112223333332222 77999999999987763
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.13 Aligned_cols=197 Identities=26% Similarity=0.365 Sum_probs=170.6
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
|+..+.||+|+||.||++... +++.+|+|.+.... .....+.+|++++.+++|+|++++.+++..++..++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999864 68899999986542 2234577899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999886432 24689999999999999999999999 99999999999999999999999999997654321
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
. .....|+..|+|||++.+..++.++|+||||+++|||++|..||..
T Consensus 157 ~-----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 157 S-----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred c-----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 1 1233589999999999988899999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=287.95 Aligned_cols=249 Identities=20% Similarity=0.334 Sum_probs=196.6
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|+..+.||+|+||.||.++. .++..+++|.+... ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477789999999999999884 46889999987643 23456788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999996432 35689999999999999999999998 99999999999999999999999999998764322
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
. ......+++.|+|||+..+..++.++||||||+++|||++|..||..... .+........ .....
T Consensus 156 ~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~-~~~~~- 221 (256)
T cd08221 156 S----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQG-NYTPV- 221 (256)
T ss_pred c----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcC-CCCCC-
Confidence 1 12234578999999999888889999999999999999999999864322 1111111111 00000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
......++. .++..|+. .+|.+||++.|+++.
T Consensus 222 -----~~~~~~~~~---~~i~~~l~-~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -----VSVYSSELI---SLVHSLLQ-QDPEKRPTADEVLDQ 253 (256)
T ss_pred -----ccccCHHHH---HHHHHHcc-cCcccCCCHHHHhhC
Confidence 011233333 44456776 889999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.20 Aligned_cols=246 Identities=23% Similarity=0.340 Sum_probs=193.9
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+|...+.||.|++|.||+|... +++.|++|.+.... .....+.+|++++++++|+|++++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999965 68899999986542 33457889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999953 2689999999999999999999999 999999999999999999999999999987754321
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.. ....++..|+|||++.+..++.++||||||+++|||+||+.||...... ....... .. ..
T Consensus 154 ~~----~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~-~~-----~~ 215 (274)
T cd06609 154 KR----NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIP-KN-----NP 215 (274)
T ss_pred cc----ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhh-hc-----CC
Confidence 11 1224778899999999888999999999999999999999999643211 1111000 00 00
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+.+.....++++ ..++..|+. .+|++||+++++++
T Consensus 216 ~~~~~~~~~~~~---~~~l~~~l~-~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEGNKFSKPF---KDFVSLCLN-KDPKERPSAKELLK 250 (274)
T ss_pred CCCcccccCHHH---HHHHHHHhh-CChhhCcCHHHHhh
Confidence 111111122333 334445665 89999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=288.58 Aligned_cols=238 Identities=23% Similarity=0.372 Sum_probs=181.8
Q ss_pred ceeeccCccEEEEEEeCC-------------CcEEEEEEeccccc-cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 311 NIIGSGRTGTMYKALLED-------------GTSLMVKRLQDSQR-SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
+.||+|+||.||+|++.+ ...|++|.+..... ....+.+|+.++.+++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 23588888765433 3456888999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC-------eEEe
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE-------PKIS 449 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~-------~kl~ 449 (623)
+|+||+++|+|..+++.. ...+++..+++++.|++.||+|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988632 24589999999999999999999999 9999999999999987664 8999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCccccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCcccccccHHHH
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR-TLVATPKGDVYSFGTVLLELV-TGERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~sfGvil~ell-tg~~P~~~~~~~~~~~~~l~~~ 527 (623)
|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+ . .
T Consensus 155 d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~-~- 219 (262)
T cd05077 155 DPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----K-E- 219 (262)
T ss_pred CCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----H-H-
Confidence 99998755321 1223678899999886 466899999999999999998 5888775422110 0 0
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
..... .. . ......+ .+..++..|+. .||.+||++.++++.+
T Consensus 220 --~~~~~-~~-~------~~~~~~~---~~~~li~~cl~-~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 --RFYEG-QC-M------LVTPSCK---ELADLMTHCMN-YDPNQRPFFRAIMRDI 261 (262)
T ss_pred --HHHhc-Cc-c------CCCCChH---HHHHHHHHHcC-CChhhCcCHHHHHHhc
Confidence 00000 00 0 0011123 34455567776 9999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=295.29 Aligned_cols=237 Identities=22% Similarity=0.335 Sum_probs=181.1
Q ss_pred eeeccCccEEEEEEeCC-------------------------CcEEEEEEeccccc-cHHHHHHHHHHhCCCCCCCCcce
Q 006982 312 IIGSGRTGTMYKALLED-------------------------GTSLMVKRLQDSQR-SEKEFVAEMATLGSVKNRNLVPL 365 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l 365 (623)
.||+|+||.||+|.+.. ...|++|.+..... ....+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13588888865432 34568889999999999999999
Q ss_pred eEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-
Q 006982 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF- 444 (623)
Q Consensus 366 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~- 444 (623)
++++.+....++||||+++|+|..++... ...+++..++.++.|+++||+|||+. +|+||||||+||++++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999999999999999999999998532 24688999999999999999999998 999999999999997644
Q ss_pred ------CeEEeecccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCC
Q 006982 445 ------EPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELV-TGERPTNVAKA 516 (623)
Q Consensus 445 ------~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~ell-tg~~P~~~~~~ 516 (623)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.....
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3799999988653221 11236788999998865 56899999999999999995 78988865322
Q ss_pred cccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 517 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.+ ...+..... . .. .... ..+..++..|+. .+|++||++.+|++.|
T Consensus 228 ~~-----~~~~~~~~~---~--------~~-~~~~---~~~~~li~~cl~-~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SE-----KERFYEKKH---R--------LP-EPSC---KELATLISQCLT-YEPTQRPSFRTILRDL 273 (274)
T ss_pred HH-----HHHHHHhcc---C--------CC-CCCC---hHHHHHHHHHcc-cChhhCcCHHHHHHhh
Confidence 11 111111000 0 00 0111 234556667877 9999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=289.74 Aligned_cols=254 Identities=20% Similarity=0.338 Sum_probs=195.3
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 379 (623)
+|...+.||+|+||.||++.. .++..+++|.+.... ...+.+..|++++++++|||++++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467788999999999999985 467889999886432 334568889999999999999999998764 34578999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC--NPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||+++++|.+++.........+++..++.++.+++.||.|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999654334567999999999999999999999321 229999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...... .....++..|+|||.+....++.++||||||+++|+|++|+.||..... ....... .....
T Consensus 161 ~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~ 227 (265)
T cd08217 161 GHDSSF----AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKI-KEGKF 227 (265)
T ss_pred cCCccc----ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHH-hcCCC
Confidence 543211 1223478999999999988899999999999999999999999975321 1111111 11110
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+.+. .... ..+..++..|+. .+|++||++.+|++.
T Consensus 228 -----~~~~-~~~~---~~~~~l~~~~l~-~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -----RRIP-YRYS---SELNEVIKSMLN-VDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCc-cccC---HHHHHHHHHHcc-CCcccCCCHHHHhhC
Confidence 0011 1112 344555667777 899999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.01 Aligned_cols=198 Identities=20% Similarity=0.255 Sum_probs=168.0
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 379 (623)
+|...+.||+|+||.||++... ++..||+|++.... ...+.+..|.+++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999864 68899999987532 23345778888888885 567888999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++.++..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999853 24689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 154 DGV----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CCc----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 111 112234899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=289.19 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=183.3
Q ss_pred eeeccCccEEEEEEeCCC---cEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCC
Q 006982 312 IIGSGRTGTMYKALLEDG---TSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGS 386 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 386 (623)
.||+|+||.||+|...++ ..+++|.+.... ...+.+.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985443 345666665432 345678999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccc
Q 006982 387 LYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466 (623)
Q Consensus 387 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 466 (623)
|.++++.........++.....++.|++.||+|||+. +++||||||+|||++.++.++|+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 156 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--IE 156 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh--hh
Confidence 9999975433334567778889999999999999998 999999999999999999999999999864322111 11
Q ss_pred cccCCCCcccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 467 FVNGEFGDLGYVAPEYART-------LVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 467 ~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
......++..|+|||++.. ..++.++||||||+++|||++ |..||..... .+........ ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~-~~~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKD-QQV 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhh-ccc
Confidence 1123347889999998743 245789999999999999997 4667653221 1111111111 112
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.+.++.+... ..+.+..++ ..|+ .+|++||++++|++.|.
T Consensus 228 ~~~~~~~~~~-~~~~~~~l~---~~c~--~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELP-YSERWYEVL---QFCW--LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCC-CcHHHHHHH---HHHh--hCcccCCCHHHHHHHhc
Confidence 2233332221 233333333 3455 56999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.63 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=197.6
Q ss_pred cCHHHHHHHhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEe-
Q 006982 295 MRLSDLMKATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMA- 371 (623)
Q Consensus 295 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 371 (623)
.++.++..+.+.|+..+.||+|+||.||+|.. .+++.+++|.+.........+..|+.++.++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 35566666778899999999999999999996 4688999999866555556788899999888 69999999999853
Q ss_pred -----CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 372 -----KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 372 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
....+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+|+||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 356789999999999999986433 24578888999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccc
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~ 521 (623)
+|+|||++......... .....|+..|+|||.+. ...++.++|||||||++|||++|+.||.........
T Consensus 161 ~l~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~- 235 (282)
T cd06636 161 KLVDFGVSAQLDRTVGR----RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL- 235 (282)
T ss_pred EEeeCcchhhhhccccC----CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-
Confidence 99999998765322111 12234788999999875 345788999999999999999999999643221110
Q ss_pred ccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.... ......+.....+.+ +.+++..|+. .+|.+||++.|+++
T Consensus 236 -------~~~~------~~~~~~~~~~~~~~~---~~~li~~cl~-~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -------FLIP------RNPPPKLKSKKWSKK---FIDFIEGCLV-KNYLSRPSTEQLLK 278 (282)
T ss_pred -------hhHh------hCCCCCCcccccCHH---HHHHHHHHhC-CChhhCcCHHHHhc
Confidence 0000 000111111112233 4444456666 99999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.22 Aligned_cols=192 Identities=26% Similarity=0.314 Sum_probs=161.6
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHH-HhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMA-TLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||++... ++..||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 57789999986532 22234444444 46788999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+.+.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~- 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT- 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC-
Confidence 999999863 24577888889999999999999999 9999999999999999999999999999754321111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 153 ---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred ---cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 1223489999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=301.92 Aligned_cols=192 Identities=27% Similarity=0.332 Sum_probs=162.3
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHH-HhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMA-TLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++||+|+||.||+|+.. ++..||+|++.... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999986532 22334555554 57889999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|..++.. ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET- 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc-
Confidence 999988853 34578888899999999999999998 9999999999999999999999999998753221111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 153 ---TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred ---cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 1223489999999999988899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=290.40 Aligned_cols=256 Identities=21% Similarity=0.387 Sum_probs=193.6
Q ss_pred CcccceeeccCccEEEEEEeC----CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------
Q 006982 307 FSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------ 373 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 373 (623)
|...+.||+|+||.||+|.+. ++..|++|++.... ...+++.+|++++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 36789999987543 23456889999999999999999999886542
Q ss_pred eeeEEEecCCCCCHhhhccCCC--CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 374 ERLLVYKHMPNGSLYDLLHPAD--DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
..++++||+++|+|.+++.... .....+++...++++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998874322 1123578899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQ 530 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~ 530 (623)
|+++.......... .....+++.|++||.+....++.++||||||+++|||++ |+.||...... .+..+...
T Consensus 158 g~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQ--GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIK 230 (273)
T ss_pred cccccccCCcceec--CCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHHHHHc
Confidence 99987643221111 111234678999999988888999999999999999999 88887643211 11111111
Q ss_pred HhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
..... ........+.+++..|+. .+|++||++.|+++.|+++
T Consensus 231 ---~~~~~----------~~~~~~~~~~~l~~~~l~-~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 ---GNRLK----------QPPDCLEDVYELMCQCWS-PEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CCcCC----------CCCCCCHHHHHHHHHHcC-CChhhCcCHHHHHHHHHhh
Confidence 10000 001112356667778887 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.54 Aligned_cols=248 Identities=22% Similarity=0.381 Sum_probs=194.0
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.+|+..+.||.|++|.||+|.. .+++.|++|.+.... ...+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3578889999999999999985 578999999886543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.. ..+++.++..++.+++.|++|||+. +++||||||+||++++++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999842 3589999999999999999999999 999999999999999999999999999886544322
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.. ....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... .......
T Consensus 171 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~~~-~~~~~~~ 237 (296)
T cd06655 171 KR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATN-GTPELQN 237 (296)
T ss_pred cC----CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc-CCcccCC
Confidence 11 1234788999999999888999999999999999999999999653221 001100000 0000000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.......+. .++..|+. .+|++||++.+++.
T Consensus 238 ----~~~~~~~~~---~li~~~l~-~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 ----PEKLSPIFR---DFLNRCLE-MDVEKRGSAKELLQ 268 (296)
T ss_pred ----cccCCHHHH---HHHHHHhh-cChhhCCCHHHHhh
Confidence 011223333 34446665 89999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=289.61 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=194.0
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.|+..+.||+|+||.||+|... ++..|++|.+.... .....+.+|++++++++|||++++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999965 58899999886432 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.. ..+++.+...++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999852 3578889999999999999999998 999999999999999999999999999986643221
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.. ....++..|+|||++.+..++.++|||||||++|||++|..||....... ..... ....
T Consensus 157 ~~----~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~-~~~~------ 217 (277)
T cd06640 157 KR----NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLI-PKNN------ 217 (277)
T ss_pred cc----ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhhhh-hcCC------
Confidence 11 12246788999999988889999999999999999999999986432210 00000 0000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
...........+.+++..|+. .+|++||++.|++..
T Consensus 218 ---~~~~~~~~~~~~~~li~~~l~-~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 ---PPTLTGEFSKPFKEFIDACLN-KDPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCCchhhhHHHHHHHHHHcc-cCcccCcCHHHHHhC
Confidence 000011122334455566776 899999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=286.94 Aligned_cols=249 Identities=20% Similarity=0.319 Sum_probs=192.3
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-CeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-KERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e 380 (623)
.|...+.||+|++|.||++..+ +++.+++|++.... ...+.+.+|++++++++|+|++++++.+... ...++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3777899999999999999965 57889999986432 3345688999999999999999999887644 45789999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++.... ...+++.+++.++.+++.|++|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999996432 35689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... .....+++.|+|||+..+..++.++||||||++++||++|+.||..... ......... +....
T Consensus 156 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~~~~-~~~~~- 221 (257)
T cd08223 156 CDM----ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYRIIE-GKLPP- 221 (257)
T ss_pred CCc----cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-cCCCC-
Confidence 211 1223478899999999998899999999999999999999999864221 111111111 11100
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+. ...+. .+.+++..|+. .+|++||++.++++.
T Consensus 222 ----~~-~~~~~---~~~~li~~~l~-~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ----MP-KDYSP---ELGELIATMLS-KRPEKRPSVKSILRQ 254 (257)
T ss_pred ----Cc-cccCH---HHHHHHHHHhc-cCcccCCCHHHHhcC
Confidence 00 11222 34455556766 899999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.05 Aligned_cols=193 Identities=22% Similarity=0.303 Sum_probs=164.1
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
...+|...+.||+|+||.||+|... ++..||+|..... ....|+.++.+++||||+++++++......++|+||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999965 5678899875432 234689999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+. |+|.+++.. ....++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 YS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 95 688888853 235689999999999999999999999 99999999999999999999999999997533211
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTN 512 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~ 512 (623)
. ..+..||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 212 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 A-----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred c-----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1 112348999999999999899999999999999999999666653
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=288.24 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=193.7
Q ss_pred cCcccceeeccCccEEEEEEeCCCcEEEEEEecccc-------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ-------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
+|...+.||+|+||.||+|...++..+|+|.+.... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998889999999886432 1234588899999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999532 4578999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCc--ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 459 PIDTH--LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 459 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
..... .........++..|+|||++.+..++.++||||||+++|||++|+.||...... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~ 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-------AAMFYIGAHRGL 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-------HHHHHhhhccCC
Confidence 21111 111122345789999999999888999999999999999999999999643211 000000000000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. +.+. ....+++.. +...|+. .+|++||++.|++.
T Consensus 227 ~-----~~~~-~~~~~~~~~---~i~~~l~-~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 M-----PRLP-DSFSAAAID---FVTSCLT-RDQHERPSALQLLR 261 (265)
T ss_pred C-----CCCC-CCCCHHHHH---HHHHHhc-CCcccCCCHHHHhc
Confidence 0 0111 123334444 4445666 88999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.64 Aligned_cols=256 Identities=18% Similarity=0.196 Sum_probs=193.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+++.+ +++.+|+|++.... .....+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999965 47789999986422 22345788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999642 24688999999999999999999999 999999999999999999999999999976533
Q ss_pred CCCcccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+........
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~ 223 (332)
T cd05623 155 DGTVQ---SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNH 223 (332)
T ss_pred CCcce---ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCC
Confidence 22111 11235899999999986 34678999999999999999999999975322 1112211111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.....+.. . .....+++..+++-.+ |.. .++..|+++.|+++.
T Consensus 224 ~~~~~~p~-~--~~~~s~~~~~li~~ll-~~~-~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KERFQFPA-Q--VTDVSEDAKDLIRRLI-CSR-EHRLGQNGIEDFKQH 266 (332)
T ss_pred CccccCCC-c--cccCCHHHHHHHHHHc-cCh-hhhcCCCCHHHHhCC
Confidence 10000000 0 0123455666665433 433 555668899998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=289.83 Aligned_cols=200 Identities=25% Similarity=0.338 Sum_probs=170.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|+..+.||+|++|.||+|..+ +++.|++|++.... ...+.+.+|++++++++|||++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35778899999999999999976 58999999886432 234567899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|..++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999999888742 24589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 154 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 154 GDD----YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred ccc----ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 211 112236788999999865 557899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=290.60 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=196.0
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|.....||+|+||.||+|+.+ +...+++|.+..... ..+.+.+|++++++++|+|++++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999964 245789998865433 3467899999999999999999999999988999
Q ss_pred EEEecCCCCCHhhhccCCCCC-----CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 377 LVYKHMPNGSLYDLLHPADDT-----GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
+|+||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654321 12689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQ 530 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~ 530 (623)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .. +..
T Consensus 162 ~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~---~~~ 230 (275)
T cd05046 162 SLSKDVYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EV---LNR 230 (275)
T ss_pred ccccccCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HH---HHH
Confidence 99875432111 11122345778999999988888999999999999999999 77888542211 11 111
Q ss_pred HhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.. ....... .....++ .+.+++..|+. .+|++||++.|++..|.
T Consensus 231 ~~-~~~~~~~-----~~~~~~~---~l~~~i~~~l~-~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQ-AGKLELP-----VPEGCPS---RLYKLMTRCWA-VNPKDRPSFSELVSALG 274 (275)
T ss_pred HH-cCCcCCC-----CCCCCCH---HHHHHHHHHcC-CCcccCCCHHHHHHHhc
Confidence 11 0000000 0111222 34455556766 89999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.34 Aligned_cols=200 Identities=23% Similarity=0.336 Sum_probs=169.2
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|+..+.||+|++|.||+|+.. ++..|++|++.... ...+.+.+|+.++.+++|||++++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999965 68899999986432 2346788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++ ++|.+++.... .+..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68988886433 235689999999999999999999999 99999999999999999999999999997654321
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
. ......+++.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 156 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 R----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred c----cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1 1122346889999998865 45688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=287.45 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=194.8
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|+..+.||+|+||.+|++.. .+++.|++|.+... ....+++.+|++++++++|||++++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 46889999998643 23345788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++.... ...+++.+++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999986432 24578999999999999999999998 99999999999999999999999999998654322
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
... ....|++.|+|||+..+..++.++|||||||+++||++|+.||..... .+.+....... ...
T Consensus 156 ~~~----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~-~~~-- 220 (256)
T cd08218 156 ELA----RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGS-YPP-- 220 (256)
T ss_pred hhh----hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCC-CCC--
Confidence 111 122378889999999988899999999999999999999999864221 12221111110 000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
....... .+..++..|+. .+|.+||++.||++
T Consensus 221 ----~~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 ----VSSHYSY---DLRNLVSQLFK-RNPRDRPSVNSILE 252 (256)
T ss_pred ----CcccCCH---HHHHHHHHHhh-CChhhCcCHHHHhh
Confidence 0011122 34445556776 88999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=294.87 Aligned_cols=198 Identities=25% Similarity=0.332 Sum_probs=162.8
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCC---CCCCCcceeEEEEeC-----C
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSV---KNRNLVPLLGFCMAK-----K 373 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~ 373 (623)
+|...+.||+|+||.||+|... +++.||+|.++... .....+.+|++++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777899999999999999865 68899999886432 1233455677666554 799999999988653 3
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++|+||+++ +|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 46899999985 8988886432 24589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++....... .....+|..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 155 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 155 ARIYSCQMA-----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccccCccc-----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 987643211 11234788999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=285.85 Aligned_cols=249 Identities=29% Similarity=0.466 Sum_probs=194.1
Q ss_pred cccceeeccCccEEEEEEeCC-----CcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 308 SKNNIIGSGRTGTMYKALLED-----GTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
+..+.||+|+||.||++...+ +..|++|.+..... ..+.+..|++.+..++|+|++++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999999754 47899999976543 46788999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999964321 2289999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
...... ...+++.|+|||.+.+..++.++||||+|++++||++ |+.||..... ............. .
T Consensus 157 ~~~~~~---~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~-~ 224 (258)
T smart00219 157 DYYKKK---GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRL-P 224 (258)
T ss_pred cccccc---cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCC-C
Confidence 221111 1236789999999988889999999999999999998 7777764211 1111111111000 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.....+. .+.+++..|+. .+|++|||+.|+++.|
T Consensus 225 ------~~~~~~~---~~~~~i~~~l~-~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ------KPENCPP---EIYKLMLQCWA-EDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCcCCH---HHHHHHHHHCc-CChhhCcCHHHHHhhC
Confidence 0011223 34445567777 9999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.09 Aligned_cols=196 Identities=28% Similarity=0.359 Sum_probs=166.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------ 373 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 373 (623)
.++|...+.||+|+||.||++... ++..||+|++... ......+.+|+.++..++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467899999999999999999864 6889999998653 233456789999999999999999999986543
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++||||+++ +|.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 6666663 2478888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 170 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 97643211 112234789999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=301.77 Aligned_cols=197 Identities=23% Similarity=0.313 Sum_probs=167.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------C
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------K 373 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 373 (623)
.++|...+.||+|+||.||++... .++.||+|++.... .....+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467899999999999999999954 68889999986532 3345678899999999999999999987543 3
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 46899999975 7777763 3478889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCCC-----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 98654321 1122357899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=294.38 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=196.0
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCC------e
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKK------E 374 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~ 374 (623)
++++|...+.||+|++|.||+|... ++..+++|.+.......+.+.+|++++.++ .|+|++++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4678999999999999999999975 578899999877666667899999999999 7999999999997654 4
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++|+||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccc
Confidence 7899999999999999865432346789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHH
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIA 529 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~ 529 (623)
......... .....++..|+|||++.. ..++.++||||||+++|||++|+.||....... .. .
T Consensus 161 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~----~ 228 (275)
T cd06608 161 AQLDSTLGR----RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR----AL----F 228 (275)
T ss_pred eecccchhh----hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH----HH----H
Confidence 765432211 122347889999998753 346789999999999999999999996432110 01 1
Q ss_pred HHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..... ....+. ......++ +.++..+|+. .||++|||+.|+++
T Consensus 229 ~~~~~-~~~~~~----~~~~~~~~---~~~li~~~l~-~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 KIPRN-PPPTLK----SPENWSKK---FNDFISECLI-KNYEQRPFMEELLE 271 (275)
T ss_pred Hhhcc-CCCCCC----chhhcCHH---HHHHHHHHhh-cChhhCcCHHHHhc
Confidence 11110 000000 00011223 3345556776 89999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=290.86 Aligned_cols=259 Identities=22% Similarity=0.287 Sum_probs=195.8
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 380 (623)
+|...+.||.|++|.||++... +++.+++|.+.... .....+.+|++++++++||||+++++++.+. ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777899999999999999974 57889999886543 2456788999999999999999999998654 35789999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++.........+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999998754333345688899999999999999999999 9999999999999999999999999998765321
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... ...++..|+|||.+.+..++.++||||+|+++|||++|+.||.....+.........++... ....+
T Consensus 159 ~~~------~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 228 (287)
T cd06621 159 LAG------TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPEL 228 (287)
T ss_pred ccc------cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhh
Confidence 111 12367889999999988899999999999999999999999976433111111122222110 00000
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
....... ..-...+.+++..|+. .+|++|||+.|+++
T Consensus 229 -~~~~~~~--~~~~~~~~~li~~~l~-~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 -KDEPGNG--IKWSEEFKDFIKQCLE-KDPTRRPTPWDMLE 265 (287)
T ss_pred -ccCCCCC--CchHHHHHHHHHHHcC-CCcccCCCHHHHHh
Confidence 0000000 0112234566677876 89999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=305.20 Aligned_cols=245 Identities=25% Similarity=0.413 Sum_probs=197.4
Q ss_pred cceeeccCccEEEEEEeC--CC--cEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 310 NNIIGSGRTGTMYKALLE--DG--TSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.++||+|.||.|++|.|. .| ..||||.++.... ....|.+|+.+|.+++|||+++++|+..+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 568999999999999975 34 3589999987543 56789999999999999999999999987 67889999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
.|+|.+.|++. ....|-......++.|||.||.||.++ ++|||||.++|+|+-....+||+|||+.+-+...+.+
T Consensus 194 lGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 194 LGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999872 335677888899999999999999999 9999999999999999999999999999988765544
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
. .+.....-.+.|.|||.+....++.++|||+|||.+|||+| |..||.+.... .+.+.+|
T Consensus 269 Y-vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------------qIL~~iD 329 (1039)
T KOG0199|consen 269 Y-VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------------QILKNID 329 (1039)
T ss_pred e-EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------------------HHHHhcc
Confidence 3 22222334678999999999999999999999999999998 88888753321 1112222
Q ss_pred hh--h-hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 543 KC--L-VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 543 ~~--l-~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.. | +...+.+ ++-+++..|+. .+|++|||+..+.+.+
T Consensus 330 ~~erLpRPk~cse---dIY~imk~cWa-h~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSE---DIYQIMKNCWA-HNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChH---HHHHHHHHhcc-CCccccccHHHHHHhH
Confidence 11 1 1223444 45555667887 9999999999998544
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=299.94 Aligned_cols=200 Identities=23% Similarity=0.254 Sum_probs=164.4
Q ss_pred cceeecc--CccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 310 NNIIGSG--RTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 310 ~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.++||+| +|++||++.. .+|..||+|++.... .....+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 6789999985 578999999997542 233467789999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999985432 23589999999999999999999999 9999999999999999999999999876543211110
Q ss_pred c---cccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 464 L---STFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 464 ~---~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
. ........++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 001112246778999999875 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.28 Aligned_cols=239 Identities=21% Similarity=0.351 Sum_probs=181.5
Q ss_pred ceeeccCccEEEEEEeCC--------CcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 311 NIIGSGRTGTMYKALLED--------GTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+.||+|+||.||+|.... ..++++|.+.... ...+.+.+|+.++..+.|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998642 2347788775443 3345788899999999999999999999998999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC--------eEEeeccc
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE--------PKISDFGL 453 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~--------~kl~Dfgl 453 (623)
+++|+|.++++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999996432 3689999999999999999999999 9999999999999987765 58999998
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCcccccccHHHHHHHH
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGE-RPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~-~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
+....... ...++..|+|||++.+ ..++.++||||||+++|||++|. .|+...... ......
T Consensus 155 ~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------~~~~~~ 218 (258)
T cd05078 155 SITVLPKE--------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------KKLQFY 218 (258)
T ss_pred ccccCCch--------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------HHHHHH
Confidence 87543311 1236788999999976 45789999999999999999995 444321110 000000
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
..... .......++.+++..|+. .+|++|||++++++.|+
T Consensus 219 ~~~~~------------~~~~~~~~~~~li~~~l~-~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 EDRHQ------------LPAPKWTELANLINQCMD-YEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hcccc------------CCCCCcHHHHHHHHHHhc-cChhhCCCHHHHHHhcC
Confidence 00000 001111234555666777 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=285.13 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=195.7
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999864 688999999876543 456789999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++.. +..+++..+..++.+++.|+.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999963 24578899999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLV---ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
...........++..|+|||++.... ++.++||||||+++||+++|+.||...... ......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-~~-- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHVGA-GH-- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHHHhc-CC--
Confidence 32222122345788999999998766 889999999999999999999999643211 000000000 00
Q ss_pred hhhchhhhcC-CCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCLVAK-GVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~-~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+.+... .....+ ..+...|+. .+|.+||++.|++.
T Consensus 224 ---~~~~~~~~~~~~~~---~~li~~~l~-~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIPDSLQLSPEG---KDFLDRCLE-SDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCCcccccCHHH---HHHHHHHcc-CCcccCCCHHHHhc
Confidence 0000000 112233 345557776 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.31 Aligned_cols=203 Identities=21% Similarity=0.293 Sum_probs=173.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|+..+.||+|+||.||++... ++..||+|++.... .....+..|++++.+++|||++++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999965 68899999986432 23456788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999863 34588999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 006982 460 IDTH-------------------------------LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGE 508 (623)
Q Consensus 460 ~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~ 508 (623)
.... .........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 000011235899999999999999999999999999999999999
Q ss_pred CCCCCC
Q 006982 509 RPTNVA 514 (623)
Q Consensus 509 ~P~~~~ 514 (623)
.||...
T Consensus 234 ~Pf~~~ 239 (360)
T cd05627 234 PPFCSE 239 (360)
T ss_pred CCCCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.14 Aligned_cols=199 Identities=22% Similarity=0.323 Sum_probs=160.8
Q ss_pred cceeeccCccEEEEEEeC---CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCeeeEEEecCCC
Q 006982 310 NNIIGSGRTGTMYKALLE---DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKERLLVYKHMPN 384 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~ 384 (623)
..+||+|+||.||+|... +++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999864 46789999986543 23457789999999999999999998865 3457899999864
Q ss_pred CCHhhhccCCC-----CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee----CCCCCeEEeeccccc
Q 006982 385 GSLYDLLHPAD-----DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL----DDDFEPKISDFGLAR 455 (623)
Q Consensus 385 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl----~~~~~~kl~Dfgla~ 455 (623)
+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 8888764321 1123588999999999999999999999 99999999999999 466789999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
......... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccc-cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 764322111 11223458999999999876 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=287.03 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=190.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|... +++.|++|.++... .....+.+|+.++..++|||++++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 45777889999999999999854 68899999886543 23356788999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.. ...+++.+.+.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999853 24688999999999999999999999 999999999999999999999999999876543211
Q ss_pred cccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
. .....|+..|+|||++. ...++.++|||||||++|||++|..||....... .. .........
T Consensus 162 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----~~----~~~~~~~~~-- 227 (267)
T cd06645 162 K----RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----AL----FLMTKSNFQ-- 227 (267)
T ss_pred c----cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----hH----HhhhccCCC--
Confidence 1 12234789999999874 4557899999999999999999999986432211 00 000000000
Q ss_pred hhchhhhc-CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVA-KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~-~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+.+.. ...++. +.+++..|+. .+|++||+++++++
T Consensus 228 --~~~~~~~~~~~~~---~~~li~~~l~-~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 --PPKLKDKMKWSNS---FHHFVKMALT-KNPKKRPTAEKLLQ 264 (267)
T ss_pred --CCcccccCCCCHH---HHHHHHHHcc-CCchhCcCHHHHhc
Confidence 000000 011223 3344555665 89999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=293.37 Aligned_cols=200 Identities=22% Similarity=0.347 Sum_probs=168.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||+|... ++..||+|.+... ......+.+|++++.+++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999865 6789999998643 23345678899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5999888543 24578999999999999999999999 99999999999999999999999999997643221
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 KT----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred Cc----ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 122346889999998765 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=324.46 Aligned_cols=262 Identities=21% Similarity=0.329 Sum_probs=194.8
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Ceee
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERL 376 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 376 (623)
..++|.+.+.||+|+||.||++... ++..+++|.+.... .....+..|+.++.+++|||||++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3467899999999999999999965 56788899886432 3346788999999999999999999988653 4678
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCC----CCcEecCCCCCceeeCC----------
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN----PRIIHRNISSKCILLDD---------- 442 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~i~H~dlk~~NILl~~---------- 442 (623)
+||||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+|+||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999996543334579999999999999999999998521 25999999999999964
Q ss_pred -------CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 443 -------DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 443 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
...+||+|||++..+..... .....||+.|+|||++.. ..++.++||||||||+|||++|+.||..
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~-----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM-----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc-----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 33589999999986543211 122358999999999854 4578999999999999999999999964
Q ss_pred CCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH--HHHHhhc
Q 006982 514 AKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLRAIGE 588 (623)
Q Consensus 514 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~--~L~~i~~ 588 (623)
... ....+....... .+.......++.. ++..|+. .+|.+||++.|++. .+..+..
T Consensus 246 ~~~-------~~qli~~lk~~p--------~lpi~~~S~eL~d---LI~~~L~-~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 246 ANN-------FSQLISELKRGP--------DLPIKGKSKELNI---LIKNLLN-LSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred CCc-------HHHHHHHHhcCC--------CCCcCCCCHHHHH---HHHHHhc-CChhHCcCHHHHhccHHHhhcCC
Confidence 322 112222111110 0111112334444 4445655 89999999999984 4554433
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=286.74 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=194.1
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
+|+..+.||+|++|.||++.. .++..+++|.+.... ...+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999984 578999999986432 124578899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeecccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFGLARL 456 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgla~~ 456 (623)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999863 24688999999999999999999999 999999999999998776 599999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
................++..|+|||.+.+..++.++||||+|+++|||++|+.||...... ..............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~ 228 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIASATT 228 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhccCC
Confidence 6543222111122234788999999998888899999999999999999999999643221 11111111000000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
........-..+..++..|+. .+|++||++.|+++
T Consensus 229 ---------~~~~~~~~~~~~~~~i~~~l~-~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---------APSIPEHLSPGLRDVTLRCLE-LQPEDRPPSRELLK 263 (268)
T ss_pred ---------CCCCchhhCHHHHHHHHHHcC-CCcccCcCHHHHhc
Confidence 000011111234455566776 99999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.59 Aligned_cols=197 Identities=23% Similarity=0.307 Sum_probs=166.9
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------ 372 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 372 (623)
..++|...+.||+|+||.||++... .+..||+|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999854 68899999987532 2345677899999999999999999988643
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
...++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999975 6777663 3478889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 165 LARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ccccCCCcc-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998654321 112235789999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.00 Aligned_cols=198 Identities=23% Similarity=0.317 Sum_probs=168.1
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc------cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR------SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
+|...+.||+|++|.||+|... +++.|++|.+..... ....+..|++++.+++|+|++++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999964 689999999975432 234567899999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+ +|+|.+++.... ..+++..++.++.|+++||.|||+. +++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999996432 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++|..||...
T Consensus 154 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 154 SPNRKM----THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred CCCccc----cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 432111 12235788999998854 45789999999999999999998777643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.46 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=190.8
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc----------cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----------SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
|.....||+|++|.||+|... ++..+++|.+..... ..+.+.+|++++.+++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 666789999999999999864 678999998864321 124578899999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999953 24588899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcc--cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhc
Q 006982 456 LMNPIDTHL--STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533 (623)
Q Consensus 456 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 533 (623)
......... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. +....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~-~~~~~- 225 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QA-IFKIG- 225 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HH-HHHHh-
Confidence 764311110 00111223788999999999888899999999999999999999999753211 00 00000
Q ss_pred cCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 534 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
....+.+.. ...+++.. +...|+. .+|.+||++.|+++
T Consensus 226 -----~~~~~~~~~-~~~~~~~~---li~~~l~-~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 -----ENASPEIPS-NISSEAID---FLEKTFE-IDHNKRPTAAELLK 263 (267)
T ss_pred -----ccCCCcCCc-ccCHHHHH---HHHHHcc-CCchhCcCHHHHhh
Confidence 000111111 12333333 3345665 89999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=290.19 Aligned_cols=252 Identities=21% Similarity=0.376 Sum_probs=191.6
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+|+..+.||+|+||.||++... ++..|++|.+... ......+.+|++++.+++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777899999999999999975 7899999988643 223457889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.... ....+++..+..++.+++.||.|||+++ +|+|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 9999999986432 1246899999999999999999999743 899999999999999999999999999976532211
Q ss_pred cccccccCCCCcccccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTL------VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ........... ..
T Consensus 159 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~-~~ 226 (286)
T cd06622 159 ------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSAIVD-GD 226 (286)
T ss_pred ------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHHHhh-cC
Confidence 123477899999998544 3478999999999999999999999643211 11111111000 00
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
. +.+.. ..++++ ..++.+|+. .+|++||++++++..
T Consensus 227 ~-----~~~~~-~~~~~~---~~li~~~l~-~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 P-----PTLPS-GYSDDA---QDFVAKCLN-KIPNRRPTYAQLLEH 262 (286)
T ss_pred C-----CCCCc-ccCHHH---HHHHHHHcc-cCcccCCCHHHHhcC
Confidence 0 00001 122333 344456766 899999999998863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=288.20 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=189.8
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
|+..+.||+|+||.||++... ++..+++|.+.... .....+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456788999999999999965 47788888886543 3456788999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|..++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~- 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc-
Confidence 9999987532 24689999999999999999999999 9999999999999999999999999999765322111
Q ss_pred cccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 465 STFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...... +........... .
T Consensus 160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~-~ 227 (282)
T cd06643 160 ---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPP-T 227 (282)
T ss_pred ---cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHhhcCCC-C
Confidence 12234789999999984 345778999999999999999999998643211 111111111000 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.. .....+.++ .+++..|+. .+|.+||++.++++.
T Consensus 228 ~~----~~~~~~~~~---~~li~~~l~-~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 LA----QPSRWSSEF---KDFLKKCLE-KNVDARWTTTQLLQH 262 (282)
T ss_pred CC----CccccCHHH---HHHHHHHcc-CChhhCcCHHHHhcC
Confidence 00 011123333 344456776 899999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=293.38 Aligned_cols=204 Identities=24% Similarity=0.320 Sum_probs=173.7
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
+|...+.||+|++|.||++... ++..+++|.+..... ..+.+..|++++.+++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788899999999999999976 489999999865432 34568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++... .+..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 82 YCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred ecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998643 235689999999999999999999999 9999999999999999999999999998765332
Q ss_pred CCccc-------------------------ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLS-------------------------TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
..... ...+...|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 11100 0111235788999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=291.44 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=169.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|+..+.||+|+||.||+|..+ +++.|++|++.... ...+.+.+|++++..++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35778899999999999999976 58899999886532 234568899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.++... ...++|..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999887742 23489999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 154 GEV----YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred ccc----cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 211 122347889999999865 45688999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=285.55 Aligned_cols=209 Identities=24% Similarity=0.277 Sum_probs=176.8
Q ss_pred cCcccceeeccCccEEEEEEeCC-CcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.|...+.||.|.-|+||.+...+ +...|+|++.+.. ....+...|-++|..+.||.++.+++.++.+...++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45567889999999999999775 5889999997653 334567789999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC-
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP- 459 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~- 459 (623)
||+||+|..+++... +..+++..+..++.++..||+|||-. |||.|||||+||||-++|++.|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999998654 47899999999999999999999999 999999999999999999999999998864311
Q ss_pred ------CC--------------------------Cc-------------------ccccccCCCCcccccCcccccCCCC
Q 006982 460 ------ID--------------------------TH-------------------LSTFVNGEFGDLGYVAPEYARTLVA 488 (623)
Q Consensus 460 ------~~--------------------------~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 488 (623)
.. .. .....+.-+||-.|+|||++.+..-
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 00 0001112358999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 006982 489 TPKGDVYSFGTVLLELVTGERPTNVAKAPET 519 (623)
Q Consensus 489 s~k~DV~sfGvil~elltg~~P~~~~~~~~~ 519 (623)
+.++|.|+|||++|||+.|+.||.+....+.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T 343 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET 343 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh
Confidence 9999999999999999999999988655433
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=282.83 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=195.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||++... +++.+++|.+.... ...+.+.+|++++++++|||++++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 46888899999999999999964 57889999986543 34567899999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999998643 24688999999999999999999998 999999999999999999999999999986543211
Q ss_pred cccccccCCCCcccccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTL---VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
. .....++..|+|||.+... .++.++||||||+++|||++|+.||........ . ...... ..
T Consensus 157 ~----~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~----~----~~~~~~-~~-- 221 (262)
T cd06613 157 K----RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA----L----FLISKS-NF-- 221 (262)
T ss_pred c----cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----H----HHHHhc-cC--
Confidence 1 1123477889999999776 789999999999999999999999975322110 0 000000 00
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
....+. ........+.+++.+|+. .+|.+|||+.+|+.
T Consensus 222 -~~~~~~--~~~~~~~~~~~li~~~l~-~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 -PPPKLK--DKEKWSPVFHDFIKKCLT-KDPKKRPTATKLLQ 259 (262)
T ss_pred -CCcccc--chhhhhHHHHHHHHHHcC-CChhhCCCHHHHhc
Confidence 000000 011112234555667776 89999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.97 Aligned_cols=201 Identities=23% Similarity=0.343 Sum_probs=168.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Cee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 375 (623)
.+|...+.||+|+||.||+|... ++..|++|.+.... ...+.+.+|++++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999964 58899999875321 1235678899999999999999999988764 456
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||+++++|.+++... ..+++...++++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 7999999999999998532 3478888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.......... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTICLSGT-GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccccc-ccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 6543211111 11223478899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.96 Aligned_cols=199 Identities=22% Similarity=0.325 Sum_probs=160.2
Q ss_pred cceeeccCccEEEEEEeC---CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCeeeEEEecCCC
Q 006982 310 NNIIGSGRTGTMYKALLE---DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKERLLVYKHMPN 384 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~ 384 (623)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 368999999999999965 35689999886543 23467789999999999999999998854 4567899999875
Q ss_pred CCHhhhccCCC-----CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee----CCCCCeEEeeccccc
Q 006982 385 GSLYDLLHPAD-----DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL----DDDFEPKISDFGLAR 455 (623)
Q Consensus 385 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl----~~~~~~kl~Dfgla~ 455 (623)
+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7777764221 1224588999999999999999999999 99999999999999 567799999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
......... .......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccc-cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 764322111 11223457899999999876 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.46 Aligned_cols=250 Identities=19% Similarity=0.300 Sum_probs=191.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+.|.+.+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|++++++++|||++++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778899999999999999975 58899999986543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|..++... ...+++..+..++.|++.++.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999887532 24589999999999999999999998 999999999999999999999999999875432111
Q ss_pred cccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
. .....+++.|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 166 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~- 232 (292)
T cd06644 166 R----RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEP- 232 (292)
T ss_pred c----cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCC-
Confidence 1 11233778999999984 345688999999999999999999998643211 11111111100
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.... .......+ +..+...|+. .+|++||++.|+++
T Consensus 233 ~~~~----~~~~~~~~---~~~li~~~l~-~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLS----QPSKWSME---FRDFLKTALD-KHPETRPSAAQLLE 268 (292)
T ss_pred ccCC----CCcccCHH---HHHHHHHHhc-CCcccCcCHHHHhc
Confidence 0000 00111223 3444556666 89999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.31 Aligned_cols=254 Identities=22% Similarity=0.395 Sum_probs=200.6
Q ss_pred cCcccceeeccCccEEEEEEeCC---Cc--EEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLED---GT--SLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~---~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.....++||.|-||.||+|.+.+ |. .||||.-+.. ....+.|..|..+|++++||||++++|+|.+ ...|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34456789999999999998532 33 4888887763 3456789999999999999999999999976 468999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
||.++-|.|.++|+... ..++......++.|+..+|+|||+. .++||||.++|||+....-+|++|||+++.+.
T Consensus 469 mEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999997543 4688889999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
....+..... .-+..|||||.+.-.+++.++|||-|||.+||++. |..||.+-...+.... +..++-
T Consensus 543 d~~yYkaS~~---kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~---------iEnGeR 610 (974)
T KOG4257|consen 543 DDAYYKASRG---KLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH---------IENGER 610 (974)
T ss_pred ccchhhcccc---ccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE---------ecCCCC
Confidence 6555443321 24678999999999999999999999999999997 9999986443321100 000100
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.. ....++..+. .+.-.|+. .+|.+||++.|+...|.++.+
T Consensus 611 lP------~P~nCPp~LY---slmskcWa-yeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LP------CPPNCPPALY---SLMSKCWA-YEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CC------CCCCCChHHH---HHHHHHhc-cCcccCCcHHHHHHHHHHHHH
Confidence 00 1112333333 44456766 999999999999999998876
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=295.82 Aligned_cols=201 Identities=21% Similarity=0.234 Sum_probs=171.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+++.. ++..||+|.+.... .....+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 67889999986532 22345788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999642 24688899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
..... .....||++|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 155 DGTVQ---SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCcee---eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 22211 112348999999999875 46788999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=311.10 Aligned_cols=201 Identities=16% Similarity=0.231 Sum_probs=162.0
Q ss_pred HHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCC------CCCcceeEEEEeC-
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN------RNLVPLLGFCMAK- 372 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~- 372 (623)
...+++|.+.+.||+|+||.||+|... .+..||||+++........+..|++++..++| .+++++++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 345678999999999999999999864 57889999997543334445556666655544 5688888888765
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC--------
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-------- 444 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-------- 444 (623)
...++|+|++ +++|.+++.. ...+++..+..|+.|++.||.|||+++ +|+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccc
Confidence 4678899988 7789988853 246899999999999999999999732 899999999999998765
Q ss_pred --------CeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 445 --------EPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 445 --------~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
.+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~~~-------~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERHSR-------TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccCCCCceEEECCCCccccCcccc-------ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886432211 12348999999999999999999999999999999999999997643
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=282.24 Aligned_cols=247 Identities=19% Similarity=0.336 Sum_probs=192.9
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...+.||+|++|.||++... ++..+++|.+.... .....+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777899999999999999854 68889999886432 3356788999999999999999999999988999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-CCeEEeecccccccCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-FEPKISDFGLARLMNPI 460 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-~~~kl~Dfgla~~~~~~ 460 (623)
+++++|.+++.... +..+++..+..++.+++.+++|||+. +++|+||+|+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999996432 34589999999999999999999999 99999999999999854 46899999999876432
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ......... ....+
T Consensus 156 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~ 221 (256)
T cd08220 156 SKA-----YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMSG-TFAPI 221 (256)
T ss_pred ccc-----cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHhc-CCCCC
Confidence 211 1234788999999999888899999999999999999999998653221 111111110 00000
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .....+ +.++...|+. .+|++|||+.|++.
T Consensus 222 ~------~~~~~~---l~~li~~~l~-~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 S------DRYSPD---LRQLILSMLN-LDPSKRPQLSQIMA 252 (256)
T ss_pred C------CCcCHH---HHHHHHHHcc-CChhhCCCHHHHhh
Confidence 0 112223 4455566776 89999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=282.54 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=192.3
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
+|...+.||+|++|.||+|... ++..|++|.+.... ...+.+.+|++++++++|+|++++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 78999999885432 2346788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999853 24588999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCcccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLV-ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||..... .............
T Consensus 154 ~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~ 220 (258)
T cd06632 154 EFS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKEL 220 (258)
T ss_pred ccc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcccC
Confidence 322 112234788999999987766 89999999999999999999999965321 1111111110011
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..+ .....+++.+ +..+|+. .+|.+||++.+++.
T Consensus 221 ~~~------~~~~~~~~~~---li~~~l~-~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPI------PDHLSDEAKD---FILKCLQ-RDPSLRPTAAELLE 254 (258)
T ss_pred CCc------CCCcCHHHHH---HHHHHhh-cCcccCcCHHHHhc
Confidence 000 1112333333 3445665 88999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=276.88 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=194.6
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEecc---ccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQD---SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++.|+.-++||+|.|+.||+..+ .+|+.+++|++.. ...+.+++.+|+++-+.++|||||++.....+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 34677778999999999999874 5788888888754 3346778899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC---CCCCeEEeecccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD---DDFEPKISDFGLARL 456 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~---~~~~~kl~Dfgla~~ 456 (623)
|+|.||+|..-+- ....+++..+-....||.++|.|.|.+ +|+|||+||+|+++. ...-+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999977652 225578888899999999999999999 999999999999994 445689999999998
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
+.. .....+..|||+|||||++...+|+..+|||+.|||||-++.|+.||.+.+... +.+.+.+...
T Consensus 163 l~~-----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-----lye~I~~g~y--- 229 (355)
T KOG0033|consen 163 VND-----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYEQIKAGAY--- 229 (355)
T ss_pred eCC-----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-----HHHHHhcccc---
Confidence 863 223456779999999999999999999999999999999999999998633221 1111111000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
++-.+. .+...++...+++..+. .||++|.|+.|.++
T Consensus 230 --d~~~~~--w~~is~~Ak~LvrrML~----~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 --DYPSPE--WDTVTPEAKSLIRRMLT----VNPKKRITADEALK 266 (355)
T ss_pred --CCCCcc--cCcCCHHHHHHHHHHhc----cChhhhccHHHHhC
Confidence 000111 12345566666655444 77888888877543
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=285.71 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=197.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|+..+.||.|+||.||+|... ++..+++|++.... ...+.+.+|++.++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888899999999999999954 67889999986543 3456789999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++..... ...+++.....++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999964322 24689999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
...........++..|+|||++... .++.++|||||||++|||++|+.||....... ...+.... ... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~---~~~---~ 226 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQN---DPP---S 226 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhcC---CCC---C
Confidence 2211111223478899999998776 78999999999999999999999997543211 11111110 000 0
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
...........+ .+..++..|+. .+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSK---SFRKMISLCLQ-KDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccH---HHHHHHHHHcC-CChhhCcCHHHHhh
Confidence 000000001122 34455556776 89999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=287.25 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=192.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|.+.+.||+|+||.||++... ++..+++|...... ...+.+..|++++++++|||++++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46788889999999999999964 68899999986543 34467889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++... +..+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998532 24689999999999999999999999 999999999999999999999999999876533221
Q ss_pred cccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
.. ....+++.|+|||++. ...++.++||||||+++|||++|+.||...... +..........
T Consensus 159 ~~----~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~- 225 (280)
T cd06611 159 KR----DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEP- 225 (280)
T ss_pred cc----ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCCC-
Confidence 11 1234788999999874 345678999999999999999999999653211 11111111000
Q ss_pred hhhhchhh-hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 538 QDAIDKCL-VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 538 ~~~~d~~l-~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+.+ .......++.+ +...|+. .+|.+||++.+|++.
T Consensus 226 -----~~~~~~~~~~~~~~~---li~~~l~-~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -----PTLDQPSKWSSSFND---FLKSCLV-KDPDDRPTAAELLKH 262 (280)
T ss_pred -----CCcCCcccCCHHHHH---HHHHHhc-cChhhCcCHHHHhcC
Confidence 000 01112333443 4445665 899999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=284.53 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=192.8
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
-|...+.||+|+||.||+|... ++..+|+|.+.... .....+.+|++.+.+++|||++++++++..+...++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3666789999999999999864 68899999876432 23457889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.. ..+++.....++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999852 4588999999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
. .....++..|+|||++.+..++.++|||||||++|||++|..||..... ..+..... ....
T Consensus 157 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~----- 218 (277)
T cd06641 157 K----RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIP-KNNP----- 218 (277)
T ss_pred h----hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHHh-cCCC-----
Confidence 1 1123478889999999888889999999999999999999999864221 11111110 0000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+.+. ...+.+ +..++..|+. .+|.+||++.+++..
T Consensus 219 ~~~~-~~~~~~---~~~~i~~~l~-~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLE-GNYSKP---LKEFVEACLN-KEPSFRPTAKELLKH 253 (277)
T ss_pred CCCC-cccCHH---HHHHHHHHcc-CChhhCcCHHHHHhC
Confidence 0000 112233 3344556766 889999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=287.10 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=187.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHH-hCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMAT-LGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|+..+.||+|+||.||++... +|..||+|+++... .....+..|+.. ++...|||++++++++..+...++|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999965 68999999987543 233455566665 666789999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|++ |+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6888887543333467899999999999999999999853 7999999999999999999999999999865321
Q ss_pred CCcccccccCCCCcccccCcccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART----LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
.. .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ... .......
T Consensus 158 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~~~-- 223 (283)
T cd06617 158 VA-----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQ-LKQVVEE-- 223 (283)
T ss_pred cc-----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------HHH-HHHHHhc--
Confidence 11 112347889999998864 45688999999999999999999998642211 111 1110000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..+.+.....++++. .++..|+. .+|++||++.++++
T Consensus 224 ----~~~~~~~~~~~~~l~---~li~~~l~-~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 ----PSPQLPAEKFSPEFQ---DFVNKCLK-KNYKERPNYPELLQ 260 (283)
T ss_pred ----CCCCCCccccCHHHH---HHHHHHcc-CChhhCcCHHHHhc
Confidence 000111111233333 44445666 89999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.18 Aligned_cols=190 Identities=23% Similarity=0.261 Sum_probs=159.0
Q ss_pred eeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC---CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV---KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
||+|+||.||+|+.. ++..||+|++.... .....+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 68999999986432 1223345566666554 699999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||+++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~- 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT- 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC-
Confidence 999999853 34688999999999999999999999 9999999999999999999999999999754322111
Q ss_pred cccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 153 ---TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ---ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 1233589999999998754 478999999999999999999999965
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=287.48 Aligned_cols=200 Identities=28% Similarity=0.383 Sum_probs=178.7
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.+.|+.-++||+|+||.||-...+ +|+.+|.|++.+.+ ..+...++|-.+|.++..+.||.+-..|++.+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999998855 68999999886543 4455678899999999999999999899999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+..|.||+|.-+|....+ ..+++..++.+|.+|+.||++||.+ +|+.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999976543 6799999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.... ..+++||.||||||++....|+...|.||+||+||||+.|+.||..
T Consensus 339 ~g~~-----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 339 EGKP-----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CCCc-----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 5433 3455799999999999999999999999999999999999999964
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.32 Aligned_cols=196 Identities=23% Similarity=0.340 Sum_probs=166.3
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------ 372 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 372 (623)
..++|...+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 356788999999999999999985 467899999986542 2345677899999999999999999887543
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 789998874 24589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++...... .+..||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCCc-------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 998654311 12347899999999876 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=283.73 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=190.2
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc-----------cHHHHHHHHHHhCCCCCCCCcceeEEEEeCC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR-----------SEKEFVAEMATLGSVKNRNLVPLLGFCMAKK 373 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 373 (623)
+|...+.||+|+||.||+|... ++..+++|.+..... ..+.+..|+.++.+++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3666789999999999999854 688999998753210 1245788999999999999999999999999
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++|+||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999643 4688999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV--ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
++........ .......++..|+|||.+.... ++.++||||||+++||+++|..||...... ......
T Consensus 155 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~- 224 (272)
T cd06629 155 SKKSDDIYDN--DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKL- 224 (272)
T ss_pred cccccccccc--cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHh-
Confidence 9865321111 1112234788999999987654 789999999999999999999998642211 111110
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
... .....+...... ....+ +..+...|+. .+|++||++++|++.
T Consensus 225 ~~~-~~~~~~~~~~~~-~~~~~---~~~li~~~l~-~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 GNK-RSAPPIPPDVSM-NLSPV---ALDFLNACFT-INPDNRPTARELLQH 269 (272)
T ss_pred hcc-ccCCcCCccccc-cCCHH---HHHHHHHHhc-CChhhCCCHHHHhhC
Confidence 000 000001111100 11233 3334456766 899999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=287.92 Aligned_cols=199 Identities=24% Similarity=0.366 Sum_probs=168.5
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|+..+.||+|++|.||+|+.. +++.|++|++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999865 68899999886432 2235788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++ ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68999886433 35689999999999999999999999 99999999999999999999999999998654322
Q ss_pred CcccccccCCCCcccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLV-ATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. .....++..|+|||++.+.. ++.++||||||+++|||+||+.||...
T Consensus 155 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 155 RT----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cc----cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 11 11223678899999886544 588999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.83 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=196.0
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+|+..+.||+|++|.||++... +++.+++|.+.... ...+.+.+|++.+++++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999975 68899999886543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++++|.+++.... ..+++.....++.|++.|++|||+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999996432 568889999999999999999999 7 99999999999999999999999999987653211
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
.. ...++..|+|||++.+..++.++||||||+++|||++|+.||...... .....+..........
T Consensus 156 ~~------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~----- 221 (265)
T cd06605 156 AK------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPP----- 221 (265)
T ss_pred hh------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCCC-----
Confidence 11 134788999999999889999999999999999999999999653221 1112222221111100
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+.+.....+.+ +.+++..|+. .+|++|||+.+++..
T Consensus 222 -~~~~~~~~~~~---~~~li~~~l~-~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 -PRLPSGKFSPD---FQDFVNLCLI-KDPRERPSYKELLEH 257 (265)
T ss_pred -CCCChhhcCHH---HHHHHHHHcC-CCchhCcCHHHHhhC
Confidence 00000002233 4445556776 899999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=286.23 Aligned_cols=201 Identities=21% Similarity=0.296 Sum_probs=167.9
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++++|...+.||+|+||.||+|... ++..|++|++.... .....+.+|++++++++|+||+++.+++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567888999999999999999854 68899999986542 23346788999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||++ +++.+++... ...+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6777776432 23577888899999999999999999 999999999999999999999999999976432
Q ss_pred CCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 156 PSQT----YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCCC----CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 2111 1223468899999998753 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=284.33 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=192.2
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc--cccHHHHHHHHHHhCCCC---CCCCcceeEEEEeCCeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS--QRSEKEFVAEMATLGSVK---NRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 379 (623)
.|+..+.||+|+||.||+|.. .++..+++|.+... ......+.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999996 57899999988643 234567888999988886 999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++++|.+++.. ..+++...+.++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999852 3688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... ....|+..|+|||++.+. .++.++||||||+++|||++|+.||...... .+..... .
T Consensus 154 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~~-~---- 216 (277)
T cd06917 154 NSSKR----STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMMLIP-K---- 216 (277)
T ss_pred Ccccc----ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhccc-c----
Confidence 32211 123478899999988654 4689999999999999999999999653221 1111000 0
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
...+.+.......+ +..++..|+. .+|++||++.|+++.
T Consensus 217 -~~~~~~~~~~~~~~---~~~~i~~~l~-~~p~~R~~~~~il~~ 255 (277)
T cd06917 217 -SKPPRLEDNGYSKL---LREFVAACLD-EEPKERLSAEELLKS 255 (277)
T ss_pred -CCCCCCCcccCCHH---HHHHHHHHcC-CCcccCcCHHHHhhC
Confidence 00111111112233 4445556776 899999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=282.26 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=193.5
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...+.||+|+||.||++..+ +|..+++|.+.... ...+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677899999999999999965 58889999986532 3445788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeecccccccCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFGLARLMNPI 460 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgla~~~~~~ 460 (623)
+++++|.+++.... +..+++..+..++.|++.|++|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999986432 24579999999999999999999998 999999999999999875 4699999999876432
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... .....|++.|+|||+..+..++.++||||||+++|||++|..||.... ..+++...... ....+
T Consensus 156 ~~~----~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~ 222 (257)
T cd08225 156 MEL----AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQG-YFAPI 222 (257)
T ss_pred ccc----ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcc-cCCCC
Confidence 211 112247889999999988889999999999999999999999986422 12222221111 10000
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
......+ +.++..+|+. .+|++|||+.|+++
T Consensus 223 ------~~~~~~~---~~~~i~~~l~-~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ------SPNFSRD---LRSLISQLFK-VSPRDRPSITSILK 253 (257)
T ss_pred ------CCCCCHH---HHHHHHHHhc-cChhhCcCHHHHhh
Confidence 0112233 4444456666 88999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=286.48 Aligned_cols=199 Identities=22% Similarity=0.346 Sum_probs=168.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|++|.||+|..+ +++.|++|.+.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999965 68899999986532 2234567899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++ +|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 9999886432 3688999999999999999999999 99999999999999999999999999987543211
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||...
T Consensus 158 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 158 KT----YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cc----ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 112236788999998865 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=289.90 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=188.4
Q ss_pred cceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 310 NNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
...||+|+||.||++... ++..|++|.+.... ...+.+.+|+..+++++|+|++++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999864 68899999886533 3345688999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.........
T Consensus 107 ~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~---- 174 (292)
T cd06658 107 TDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---- 174 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc----
Confidence 998842 3588999999999999999999999 9999999999999999999999999999765332111
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhc
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA 547 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 547 (623)
.....++..|+|||+..+..++.++||||||+++|||++|+.||....... .+ ... ...+.+.+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~----~~~------~~~~~~~~~~ 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AM----RRI------RDNLPPRVKD 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH----HHH------HhcCCCcccc
Confidence 122347889999999988889999999999999999999999986432210 01 000 0011111111
Q ss_pred -CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 548 -KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 548 -~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
....+.+..++ ..|+. .+|++|||++|+++.
T Consensus 241 ~~~~~~~~~~li---~~~l~-~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFL---DLMLV-REPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHH---HHHcc-CChhHCcCHHHHhhC
Confidence 11223333333 34544 899999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.22 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=193.9
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||++.. .++..|++|.+.... ...+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5688889999999999999985 467889999986433 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++++|.+++.. ..+++..+..++.+++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999852 3578999999999999999999999 999999999999999999999999999876544322
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.. ....+++.|+|||.+....++.++||||||+++||+++|+.||......+... ....... .. ..
T Consensus 171 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--------~~~~~~~-~~-~~ 236 (293)
T cd06647 171 KR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNGT-PE-LQ 236 (293)
T ss_pred cc----ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--------ehhcCCC-CC-CC
Confidence 11 12247889999999988888999999999999999999999997533211100 0000000 00 00
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
........ +..++..|+. .+|++||++.+++..
T Consensus 237 ---~~~~~~~~---l~~li~~~l~-~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 ---NPEKLSAI---FRDFLNRCLE-MDVEKRGSAKELLQH 269 (293)
T ss_pred ---CccccCHH---HHHHHHHHcc-CChhhCcCHHHHhcC
Confidence 00011222 3334456766 899999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=289.26 Aligned_cols=197 Identities=23% Similarity=0.346 Sum_probs=166.1
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...+.||+|+||.||+|... +|..+++|++.... .....+.+|++++++++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677889999999999999965 68899999986432 2235677899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++ ++|.+++... ...+++..++.++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 5888877532 24589999999999999999999999 99999999999999999999999999998654321
Q ss_pred CcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.. .....++..|+|||++.+. .++.++|||||||++|||+||+.|+..
T Consensus 154 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 154 RC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CC----cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 11 1223468899999988664 468999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.05 Aligned_cols=244 Identities=22% Similarity=0.325 Sum_probs=189.3
Q ss_pred ccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCC
Q 006982 309 KNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGS 386 (623)
Q Consensus 309 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 386 (623)
....||+|+||.||++... +++.|++|.+.... ...+.+.+|+.++..++|||++++++++...+..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999864 68999999986432 345668899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccc
Q 006982 387 LYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466 (623)
Q Consensus 387 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 466 (623)
|.+++. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..........
T Consensus 105 L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~-- 174 (297)
T cd06659 105 LTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-- 174 (297)
T ss_pred HHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc--
Confidence 999874 24588999999999999999999999 99999999999999999999999999997654321111
Q ss_pred cccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhh
Q 006982 467 FVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLV 546 (623)
Q Consensus 467 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 546 (623)
....++..|+|||++.+..++.++||||||+++|||++|+.||......+ -....... . ...+.
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~-~-----~~~~~ 238 (297)
T cd06659 175 --KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDS-P-----PPKLK 238 (297)
T ss_pred --cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcc-C-----CCCcc
Confidence 12347899999999998889999999999999999999999996432211 01111000 0 00000
Q ss_pred -cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 547 -AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 547 -~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
......++..+ +..|+. .+|++||++.++++.
T Consensus 239 ~~~~~~~~l~~~---i~~~l~-~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDF---LERMLT-REPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHH---HHHHhc-CCcccCcCHHHHhhC
Confidence 01122333333 344554 899999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=292.56 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=198.8
Q ss_pred ccCcccceeeccCccEEEEEEeCC-CcEEEEEEeccccc----cHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQR----SEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV 378 (623)
..|...+.||+|.||.||++..+. |+.+|+|.+.+... +...+.+|+++|.++. |||||.+.+.+++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 457777899999999999999664 99999999976542 3468899999999998 99999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC----CCeEEeecccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD----FEPKISDFGLA 454 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~----~~~kl~Dfgla 454 (623)
||++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++
T Consensus 115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999643 289999999999999999999998 99999999999999643 47999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
..... .. ...+.+||+.|+|||++....|+..+||||.||++|.|++|..||......+... .....
T Consensus 187 ~~~~~-~~----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~ 253 (382)
T KOG0032|consen 187 KFIKP-GE----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRG 253 (382)
T ss_pred eEccC-Cc----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcC
Confidence 98765 22 2334569999999999999999999999999999999999999998754322211 11111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.. ++-++.+. ...+.+..+++ .+...||..|+|+.++++.
T Consensus 254 -~~-~f~~~~w~--~is~~akd~i~----~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 -DF-DFTSEPWD--DISESAKDFIR----KLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CC-CCCCCCcc--ccCHHHHHHHH----HhcccCcccCCCHHHHhcC
Confidence 00 11111111 12344444443 3333889999999999984
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=280.29 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=197.9
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+|...+.||+|++|.||++... ++..|++|++.... .....+.+|++.+.+++|+|++++++++...+..++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5778899999999999999976 58999999987654 34567899999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++++|.+++... ..+++..++.++.|+++|++|||+ . +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999632 568999999999999999999999 8 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+........ .
T Consensus 155 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~-~----- 219 (264)
T cd06623 155 DQC----NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDG-P----- 219 (264)
T ss_pred Ccc----cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcC-C-----
Confidence 221 122367899999999988899999999999999999999999975432 0111111111111 0
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
...+.....++. +..++..|+. .+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~---l~~li~~~l~-~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PPSLPAEEFSPE---FRDFISACLQ-KDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCcccCCHH---HHHHHHHHcc-CChhhCCCHHHHHhC
Confidence 001111112333 3444445665 889999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=284.98 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=197.7
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.++.|+..+.||+|++|.||++... ++..+++|.+.........+.+|++.+++++|+|++++++++......++|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3456777889999999999999976 688999999976544566788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999996432 3789999999999999999999998 99999999999999999999999999987654322
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||...... ........ .......
T Consensus 171 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~ 237 (286)
T cd06614 171 SKR----NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITT-KGIPPLK 237 (286)
T ss_pred hhh----ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-cCCCCCc
Confidence 111 1223678999999998888999999999999999999999998642211 00111000 0000000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+ ....+.+ +..++..|+. .+|.+||++.++++.
T Consensus 238 ~----~~~~~~~---l~~li~~~l~-~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 N----PEKWSPE---FKDFLNKCLV-KDPEKRPSAEELLQH 270 (286)
T ss_pred c----hhhCCHH---HHHHHHHHhc-cChhhCcCHHHHhhC
Confidence 0 0112233 3344556766 899999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.01 Aligned_cols=242 Identities=25% Similarity=0.390 Sum_probs=190.8
Q ss_pred eeeccCccEEEEEEeC-CCcEEEEEEeccc-cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHhh
Q 006982 312 IIGSGRTGTMYKALLE-DGTSLMVKRLQDS-QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYD 389 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 389 (623)
+||+|.||+||-|+.. +...+|+|.+... .+..+-...|+...+.++|.|||+.+|.+.+++..-+.||.+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999955 4667899988654 3445667889999999999999999999999998899999999999999
Q ss_pred hccCCCCCCCcc--ChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeEEeecccccccCCCCCcccc
Q 006982 390 LLHPADDTGKSV--DWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLST 466 (623)
Q Consensus 390 ~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~ 466 (623)
+|..+.+ ++ ++.+.-.+..||.+||.|||++ .|+|||||-.||||+ ..|.+||+|||-++++.....-..+
T Consensus 662 LLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9976543 44 6778888999999999999999 999999999999995 7899999999999987643332222
Q ss_pred cccCCCCcccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 467 FVNGEFGDLGYVAPEYARTL--VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 467 ~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
+ .||..|||||++..+ .|..++|||||||.+.||.||++||.....+.. ..++- .+.+
T Consensus 736 F----TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFkV-----GmyK----- 795 (1226)
T KOG4279|consen 736 F----TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFKV-----GMYK----- 795 (1226)
T ss_pred c----ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhhh-----ccee-----
Confidence 2 389999999999765 478899999999999999999999975433211 00000 0000
Q ss_pred hhcCCCHHHHHHH-HHHHhhccCCCCCCCCCCHHHHHH
Q 006982 545 LVAKGVDNELFQF-LKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 545 l~~~~~~~~~~~~-~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.....++++.+- -..+++|-. +||.+||++.+++.
T Consensus 796 -vHP~iPeelsaeak~FilrcFe-pd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 -VHPPIPEELSAEAKNFILRCFE-PDPCDRPSAKDLLQ 831 (1226)
T ss_pred -cCCCCcHHHHHHHHHHHHHHcC-CCcccCccHHHhcc
Confidence 111234444443 345567877 99999999999875
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=302.16 Aligned_cols=196 Identities=26% Similarity=0.426 Sum_probs=165.8
Q ss_pred cceeeccCccEEEEEEeC-CCcEEEEEEec-----cccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe--eeEEEec
Q 006982 310 NNIIGSGRTGTMYKALLE-DGTSLMVKRLQ-----DSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE--RLLVYKH 381 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~ 381 (623)
..+||+|+|-+||||... +|..||---++ ......+.|..|+++|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 468999999999999964 57777743222 233445789999999999999999999999987665 6689999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeEEeecccccccCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~kl~Dfgla~~~~~~ 460 (623)
+..|+|..|++.. +.++.....+++.||.+||.|||++ .|+|+|||||..||+|+ .-|.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999744 4577788999999999999999997 67899999999999997 5689999999999987653
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAP 517 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~ 517 (623)
... ...|||.|||||... ..|++.+||||||+.++||+|+..||.....+
T Consensus 200 ~ak------svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~ 249 (632)
T KOG0584|consen 200 HAK------SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP 249 (632)
T ss_pred ccc------eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH
Confidence 221 235999999999987 67899999999999999999999999866554
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=285.61 Aligned_cols=256 Identities=17% Similarity=0.190 Sum_probs=193.7
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
+|...+.||+|+||.||++... .++.|++|.+.... .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999965 57889999886542 234567889999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++.. ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 82 YVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999953 24588999999999999999999998 9999999999999999999999999998742110
Q ss_pred CCc-----------ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHH
Q 006982 461 DTH-----------LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIA 529 (623)
Q Consensus 461 ~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~ 529 (623)
... .........++..|+|||++....++.++|+||||+++|||++|..||..... .++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~~ 226 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFG 226 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 000 00000112467899999999888899999999999999999999999964321 11111
Q ss_pred HHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
...... ...+.. ....+.++ ..++.+|+. .+|++||++.++.+.|+.
T Consensus 227 ~~~~~~----~~~~~~-~~~~~~~~---~~li~~~l~-~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 QVISDD----IEWPEG-DEALPADA---QDLISRLLR-QNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHhcc----cCCCCc-cccCCHHH---HHHHHHHhc-cChhhccCccCHHHHHhC
Confidence 111100 000000 01123333 444556766 999999998777766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=268.09 Aligned_cols=198 Identities=25% Similarity=0.428 Sum_probs=170.4
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc------c---cHHHHHHHHHHhCCC-CCCCCcceeEEEEeC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ------R---SEKEFVAEMATLGSV-KNRNLVPLLGFCMAK 372 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 372 (623)
.+.|...+++|.|..+.|.+..+ ++|...|+|++.... . -.+.-..|+.+|+++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677889999999999988875 468889999885321 1 123346799999999 799999999999999
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
...++|+|.|+.|.|+++|. ..-.+++....+|+.|+..|++|||.. .|+||||||+|||+|++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999995 335689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR------TLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
+++.+.+... ....+||++|+|||.+. ...|+..+|.|+.|||+|.++.|..||..
T Consensus 169 Fa~~l~~Gek-----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 169 FACQLEPGEK-----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred eeeccCCchh-----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 9998876432 33456999999999874 34578899999999999999999999963
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=279.58 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=196.5
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|+..+.||+|++|.||++... ++..+++|.+.... .....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677899999999999999854 67899999986532 3345678899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++.........+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999865433346789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...... .+...+ .......
T Consensus 157 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~----~~~~~~~-- 220 (256)
T cd08530 157 -----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYKV----QRGKYPP-- 220 (256)
T ss_pred -----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH----hcCCCCC--
Confidence 112234788999999999888999999999999999999999999643221 011110 1111000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
........+..++..|+. .+|++||++.|+++
T Consensus 221 -------~~~~~~~~~~~li~~~l~-~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 -------IPPIYSQDLQNFIRSMLQ-VKPKLRPNCDKILA 252 (256)
T ss_pred -------CchhhCHHHHHHHHHHcC-CCcccCCCHHHHhc
Confidence 011112335555667776 88999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=282.35 Aligned_cols=199 Identities=22% Similarity=0.280 Sum_probs=170.8
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|+..+.||+|++|.||+|... +++.|++|+++... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999975 57899999886532 3346788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++++.+..+... ...+++..+..++.+++.|++|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998777766532 24588999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... .....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 155 ASP---LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccc---ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 1123467889999999887 7899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=282.30 Aligned_cols=199 Identities=23% Similarity=0.342 Sum_probs=169.9
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...+.||+|++|.||+|... +++.|++|++.... .....+.+|+.++++++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999964 68999999986543 2346789999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+ +++|.+++.... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999986432 5689999999999999999999999 99999999999999999999999999998765422
Q ss_pred CcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
. .......++..|+|||.+.+. .++.++||||+|+++|||++|..||...
T Consensus 154 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 154 P---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred C---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 1 111223478899999998654 4689999999999999999998777543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=274.93 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=196.3
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc-cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR-SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
+|...+.||+|++|.||++... ++..+++|++..... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999975 688999999976543 55788999999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+++|.+++.... ..+++..+..++.+++.++.|||.. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999986432 4689999999999999999999998 999999999999999999999999999987654321
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
.....++..|+|||++....++.++||||||+++|||++|+.||...... ........ ........
T Consensus 154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~- 219 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------KALFKIAT-NGPPGLRN- 219 (253)
T ss_pred ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------HHHHHHHh-cCCCCcCc-
Confidence 11234788999999998888999999999999999999999998643211 11111000 00000000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
......+ +.+++..|+. .+|++|||+.|+++
T Consensus 220 ---~~~~~~~---~~~~i~~~l~-~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 ---PEKWSDE---FKDFLKKCLQ-KNPEKRPTAEQLLK 250 (253)
T ss_pred ---ccccCHH---HHHHHHHHcc-CChhhCCCHHHHhc
Confidence 0001233 4445557776 89999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=285.62 Aligned_cols=206 Identities=24% Similarity=0.330 Sum_probs=168.8
Q ss_pred cCcccceeeccCccEEEEEEeC---CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Ceee
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE---DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERL 376 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 376 (623)
+|...+.||+|++|.||+|... ++..||+|.+.... .....+.+|++++.+++|||++++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999965 47899999997632 2235678899999999999999999999988 7889
Q ss_pred EEEecCCCCCHhhhccCCCCC-CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC----CCCeEEeec
Q 006982 377 LVYKHMPNGSLYDLLHPADDT-GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD----DFEPKISDF 451 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~----~~~~kl~Df 451 (623)
+|+||+++ ++.+++...... ...+++.....++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677766433222 23688999999999999999999999 9999999999999999 999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
|+++........ .....+..++..|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 157 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999876432211 111223457889999998765 4578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=282.15 Aligned_cols=245 Identities=21% Similarity=0.337 Sum_probs=191.4
Q ss_pred CcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 307 FSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
|...+.||+|++|.||++.. .++..+++|++.... ...+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567999999999999985 478899999886433 3345688999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+.........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 999999853 4588999999999999999999999 9999999999999999999999999988765332111
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
.....|++.|+|||...+..++.++||||||+++|||++|+.||..... .......... . .+.
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~-~-----~~~ 234 (285)
T cd06648 172 ---RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRDN-L-----PPK 234 (285)
T ss_pred ---cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHhc-C-----CCC
Confidence 1123478899999999888899999999999999999999999864321 1111111111 0 000
Q ss_pred hhc-CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 545 LVA-KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 545 l~~-~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+.. ..... .+..++..|+. .+|++||++.++++
T Consensus 235 ~~~~~~~~~---~l~~li~~~l~-~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 LKNLHKVSP---RLRSFLDRMLV-RDPAQRATAAELLN 268 (285)
T ss_pred CcccccCCH---HHHHHHHHHcc-cChhhCcCHHHHcc
Confidence 100 01222 34455556776 89999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=284.66 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=188.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
..|...+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+++++.++|||++++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777899999999999999965 68899999885432 22356889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||++ |++.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5777776432 24589999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
.. ...++..|+|||++. ...++.++||||||+++|||++|+.||...... ......... .
T Consensus 168 ~~--------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~~~~-~ 230 (307)
T cd06607 168 AN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQN-D 230 (307)
T ss_pred CC--------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHHhcC-C
Confidence 21 123678899999874 456889999999999999999999998643211 101110000 0
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
. +.+......++ +..+...|+. .+|++||++.+++...
T Consensus 231 ~-----~~~~~~~~~~~---~~~li~~~l~-~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 S-----PTLSSNDWSDY---FRNFVDSCLQ-KIPQDRPSSEELLKHR 268 (307)
T ss_pred C-----CCCCchhhCHH---HHHHHHHHhc-CChhhCcCHHHHhcCh
Confidence 0 00001111223 4444556776 8999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=275.21 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=197.0
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 379 (623)
+|...+.||+|++|.||+|... ++..|++|++.... ...+.+.+|++.+++++|||++++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999976 78899999987654 3467789999999999999999999999988 8889999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++++|.+++... ..+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998632 3789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... .......++..|+|||......++.++||||||+++|||++|..||..... ................
T Consensus 154 ~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~ 224 (260)
T cd06606 154 IETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSSGEPPE 224 (260)
T ss_pred cccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccccCCCcC
Confidence 3221 011223478899999999888899999999999999999999999975431 1111111110001101
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+ ...... .+.+++.+|+. .+|++||++.|++.
T Consensus 225 ~------~~~~~~---~l~~~i~~~l~-~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 I------PEHLSE---EAKDFLRKCLR-RDPKKRPTADELLQ 256 (260)
T ss_pred C------CcccCH---HHHHHHHHhCc-CChhhCCCHHHHhh
Confidence 0 011122 34444557777 89999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=285.24 Aligned_cols=200 Identities=23% Similarity=0.284 Sum_probs=168.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 378 (623)
++|...+.||+|+||.||+|..+ +++.+++|.++.... ....+.+|++++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999976 588999999865432 234567899999999999999999999877 789999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++...
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 9999886432 3689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
..... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus 158 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 158 SPLKP----YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred CCccc----cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 42211 1223467889999988654 46889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=281.01 Aligned_cols=199 Identities=26% Similarity=0.347 Sum_probs=168.2
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeEEEe
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLLVYK 380 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 380 (623)
|...+.||+|++|.||+|... +++.+++|++.... .....+.+|++++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999966 58899999997652 3345688999999999999999999999888 78999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 899888543 24689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 154 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 154 NS---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred Cc---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11122346788999997754 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.04 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=191.1
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
|...+.||+|+||.||+++.. ++..+++|.+.... .....+.+|++++++++|||++++++++.+.+..++|+||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999964 68899999986432 2235688899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++ |++.+.+... ...++|.++..++.+++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 97 4888777432 24589999999999999999999999 9999999999999999999999999998764331
Q ss_pred CcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... .....+.. ...
T Consensus 179 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~----~~~-- 241 (317)
T cd06635 179 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQ----NES-- 241 (317)
T ss_pred -------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHh----ccC--
Confidence 1223788999999973 456889999999999999999999998642111 00111111 000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.........+. +..++..|+. .+|.+||++.+|++.+..+..
T Consensus 242 ----~~~~~~~~~~~---l~~li~~~l~-~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 242 ----PTLQSNEWSDY---FRNFVDSCLQ-KIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ----CCCCCccccHH---HHHHHHHHcc-CCcccCcCHHHHHhChhhhcc
Confidence 00001112223 3445556776 899999999999987765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=279.65 Aligned_cols=198 Identities=24% Similarity=0.347 Sum_probs=167.3
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
|+..+.||+|++|.||+|... +|..|++|++.... .....+.+|++++++++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 79999999986542 23356888999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
+ ++|.+++..... ..+++..++.++.|+++||+|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 699999864322 4689999999999999999999998 999999999999999999999999999976543211
Q ss_pred cccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 155 T----YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred c----cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1122367889999987654 5689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.00 Aligned_cols=202 Identities=21% Similarity=0.285 Sum_probs=166.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCe-----
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKE----- 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 374 (623)
++|+..+.||+|+||.||+|... +++.|++|.+..... ....+.+|+.++.+++ |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999965 689999998865432 2356788999999995 6999999999887665
Q ss_pred eeEEEecCCCCCHhhhccCCCCC-CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-CCCeEEeecc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDT-GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFG 452 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-~~~~kl~Dfg 452 (623)
.++||||+++ +|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898887643322 35689999999999999999999999 9999999999999998 8999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||...
T Consensus 157 ~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKS----YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccc----cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99865332111 112236788999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=280.17 Aligned_cols=258 Identities=16% Similarity=0.261 Sum_probs=178.1
Q ss_pred ccCcccceeeccCccEEEEEEeCCC----cEEEEEEecccccc------------HHHHHHHHHHhCCCCCCCCcceeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDG----TSLMVKRLQDSQRS------------EKEFVAEMATLGSVKNRNLVPLLGF 368 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~ 368 (623)
++|.+.++||+|+||.||+|...+. ..+++|........ ......+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5688899999999999999997543 45566643222111 1112334456777899999999997
Q ss_pred EEeCC----eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC
Q 006982 369 CMAKK----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF 444 (623)
Q Consensus 369 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~ 444 (623)
+.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 66543 34678887744 666666421 2356788899999999999999999 999999999999999999
Q ss_pred CeEEeecccccccCCCCCccc---ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccc-
Q 006982 445 EPKISDFGLARLMNPIDTHLS---TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETF- 520 (623)
Q Consensus 445 ~~kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~- 520 (623)
.++|+|||+++.......... .......||+.|+|||+..+..++.++|||||||++|||++|+.||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221111 1112235899999999999999999999999999999999999999764221110
Q ss_pred cccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 521 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.....++.... ..........++++.++++ ||++.+|++||+++++.+.+
T Consensus 244 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRL---------HEGKIKIKNANKFIYDFIE----CVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHh---------hhhhhccCCCCHHHHHHHH----HHHhCCCCCCCCHHHHHHhh
Confidence 00011111111 1111111122344444433 33348899999999999876
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=305.69 Aligned_cols=202 Identities=18% Similarity=0.252 Sum_probs=158.9
Q ss_pred hccCcccceeeccCccEEEEEEeCC--CcEEEE------------------EEeccccccHHHHHHHHHHhCCCCCCCCc
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED--GTSLMV------------------KRLQDSQRSEKEFVAEMATLGSVKNRNLV 363 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vav------------------K~~~~~~~~~~~~~~e~~~l~~l~h~niv 363 (623)
.++|...+.||+|+||.||++..+. +...+. |.+.........+.+|++++.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987532 111111 22222223345688999999999999999
Q ss_pred ceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCC-CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC
Q 006982 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDT-GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD 442 (623)
Q Consensus 364 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~ 442 (623)
++++++...+..++|+|++. ++|.+++...... ...........++.|++.||.|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 5777776432211 12233556778999999999999999 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006982 443 DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTN 512 (623)
Q Consensus 443 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~ 512 (623)
++.+||+|||+++.+...... ...+..||..|+|||++.+..++.++|||||||++|||++|..++.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA---FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCEEEEeCCCceecCccccc---ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 999999999999876432211 1123458999999999999999999999999999999999886543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=297.85 Aligned_cols=198 Identities=25% Similarity=0.349 Sum_probs=172.3
Q ss_pred cCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccccHHHHHHHHHHhCCCC-C-----CCCcceeEEEEeCCeeeEE
Q 006982 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-N-----RNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~lV 378 (623)
+|.+.++||+|.||.|-++. .++++.||+|+++....-..+...|+.+|..++ | -|+|++++||...++.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 78899999999999999999 456999999999987766677788999999887 4 3899999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC--CCCeEEeecccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD--DFEPKISDFGLARL 456 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~--~~~~kl~Dfgla~~ 456 (623)
+|.+.. +|.++++...- ..++......++.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.+..
T Consensus 267 fELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999965 99999986554 4588899999999999999999999 9999999999999964 44799999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
....-. + ..-+.-|+|||++.+.+|+.+.||||||||+.||++|.+-|.+...
T Consensus 341 ~~q~vy---t----YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 341 ESQRVY---T----YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCcce---e----eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 654221 2 2245679999999999999999999999999999999888876544
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=288.59 Aligned_cols=200 Identities=23% Similarity=0.377 Sum_probs=166.6
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----Cee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 375 (623)
.++|...+.||+|+||.||+|.. .+++.|++|.+... ......+.+|+.++.+++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46789999999999999999985 46899999998642 23345678899999999999999999987654 347
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||+++ +|.+.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 899999975 8888874 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.......... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 155 IADPEHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred eccccccccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7543222111 1223457889999998754 5678999999999999999999999965
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=283.23 Aligned_cols=203 Identities=23% Similarity=0.311 Sum_probs=166.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE------ 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 374 (623)
++|...+.||+|+||.||+|... ++..||+|.+.... .....+.+|++++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999965 68899999885432 223456789999999999999999999876543
Q ss_pred --eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 375 --RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 375 --~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
.++|+||+.+ +|.+.+... ...+++.+.+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4899999975 888887532 24689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++..................++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9987643222211122234478899999988654 4688999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=278.90 Aligned_cols=196 Identities=23% Similarity=0.328 Sum_probs=172.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|++|.||++... +++.+++|.+.... ...+.+.+|+++++++.||||+++++++.+....++|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35788899999999999999965 68899999986532 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998632 5688999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
. .....+++.|+|||.+.+...+.++||||||+++|||++|+.||...
T Consensus 154 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 154 R-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred C-------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 2 11224788999999998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.72 Aligned_cols=202 Identities=22% Similarity=0.354 Sum_probs=170.2
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+|+..+.||+|++|.||+|+.. +|..|++|.+.... .....+.+|++++++++|||++++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 68899999986543 23456778999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++ +|.+++..... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 89888754332 34689999999999999999999998 999999999999999999999999999976533211
Q ss_pred cccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 463 HLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
. .....++..|++||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 156 ~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 156 T----FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred c----cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 1 122346889999998865 4568899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.26 Aligned_cols=192 Identities=28% Similarity=0.364 Sum_probs=167.2
Q ss_pred CcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 307 FSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
|+..+.||+|+||.||-|+. .+...||+|++.-+. ..-..+..|+..|.+++|||.+.+.|+|......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56677899999999999994 577899999986542 2235688999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
|-| |-.|++... .+++.+..+..|..+...||+|||+. +.||||||+.|||+++.|.|||+|||.|....+..
T Consensus 108 ClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 954 877877533 25788889999999999999999999 99999999999999999999999999998876533
Q ss_pred CcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.-+|||.|||||++. .++|+-|+||||+|+...|+...++|+..
T Consensus 181 --------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 181 --------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred --------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 234999999999885 57899999999999999999999999754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=288.68 Aligned_cols=202 Identities=22% Similarity=0.342 Sum_probs=168.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe----CCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA----KKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 376 (623)
++|+..+.||+|++|.||+|... ++..|++|++.... ...+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999954 68999999986532 334567789999999999999999998764 34578
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||+. |+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 699999853 34589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
................++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 54322222222223457889999998765 46789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=274.26 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=198.3
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...+.||+|+||.||++... ++..+++|++.... ...+.+.+|++++++++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999965 68899999987543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++......+..+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999975443346799999999999999999999999 99999999999999999999999999998764432
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
. ......+++.|+|||......++.++||||+|+++|+|++|+.||..... .+........ ....+
T Consensus 158 ~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~- 223 (258)
T cd08215 158 D----LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKILKG-QYPPI- 223 (258)
T ss_pred c----eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHhcC-CCCCC-
Confidence 1 11223478899999999888899999999999999999999999864321 1111111111 01000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .....+ +..++..|+. .+|++||++.|+++
T Consensus 224 ----~-~~~~~~---~~~~i~~~l~-~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ----P-SQYSSE---LRNLVSSLLQ-KDPEERPSIAQILQ 254 (258)
T ss_pred ----C-CCCCHH---HHHHHHHHcC-CChhhCcCHHHHhc
Confidence 0 112233 3444556776 89999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=278.35 Aligned_cols=197 Identities=23% Similarity=0.286 Sum_probs=173.3
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
+|...+.||+|+||.||++... ++..+++|.+.... ...+.+.+|++++++++|||++++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777899999999999999975 58899999986532 345678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999532 4688999999999999999999999 9999999999999999999999999999876442
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 154 ~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 202 (258)
T cd05578 154 T-----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202 (258)
T ss_pred c-----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCC
Confidence 2 112334788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.60 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=192.9
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc--cHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEEecC
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR--SEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
|...+.||+|++|.||+|+.. ++..|++|++..... ......+|+..+.+++ |||++++++++..++..++|+||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556789999999999999975 478899999865433 2334567999999999 999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
+|+|.+++.... +..+++..++.++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999886433 24689999999999999999999998 999999999999999999999999999986543221
Q ss_pred cccccccCCCCcccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccccc--------HHHHHHHHhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR-TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN--------LVEWIAQLSS 533 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~--------l~~~~~~~~~ 533 (623)
. ....++..|+|||++. ...++.++|+||||+++|||++|+.||......+..... -..|......
T Consensus 155 ~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 Y-----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred c-----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 1 1234788899999874 455789999999999999999999998654332111000 0011111111
Q ss_pred cCchhhhhchhhh---cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 534 TGQLQDAIDKCLV---AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 534 ~~~~~~~~d~~l~---~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.......+..... ..........+..++..|+. .+|++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~-~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLR-WDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcc-cCcccCCCHHHHhh
Confidence 1011000000000 00000112346677778887 99999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=276.84 Aligned_cols=196 Identities=21% Similarity=0.283 Sum_probs=162.3
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeC--CeeeEEEe
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAK--KERLLVYK 380 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 380 (623)
|...+.||+|+||.||+|... ++..+++|+++... .......+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999954 68899999987542 22334557888888885 99999999999987 78899999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|++ |+|.+.+... ...++|.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888887532 24689999999999999999999999 9999999999999999 99999999999876432
Q ss_pred CCcccccccCCCCcccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYAR-TLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
... ....++..|+|||++. +..++.++|||||||++|||++|..||....
T Consensus 153 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 153 PPY-----TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred CCc-----CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 211 1123678999999764 4557889999999999999999999997543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.74 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=200.5
Q ss_pred CcccceeeccCccEEEEEEeC--------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 307 FSKNNIIGSGRTGTMYKALLE--------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
....+.+|+|.||.|++|... ....||||.++... ...+.+..|+++|..+ +|+|++.++|+|..++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 344559999999999999842 14579999998654 3467899999999999 699999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCC---C-------CC--CccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC
Q 006982 376 LLVYKHMPNGSLYDLLHPAD---D-------TG--KSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD 443 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~ 443 (623)
++|.||++.|+|.++|...+ . .. ..+.....+.++.|||.||+||++. +++||||.++|||++++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCC
Confidence 99999999999999997655 0 01 2388899999999999999999999 99999999999999999
Q ss_pred CCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccc
Q 006982 444 FEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKG 522 (623)
Q Consensus 444 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~ 522 (623)
..+||+|||+++.....+........++ -+..|||||.+....|+.|+|||||||+||||+| |..||.+.... .
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~----~ 529 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT----E 529 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH----H
Confidence 9999999999997655443322211111 3567999999999999999999999999999999 88888642111 1
Q ss_pred cHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 523 NLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 523 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
.+.+++ +++...+ ......+++. .++..|+. .+|++||++.++++.++...
T Consensus 530 ~l~~~l----~~G~r~~------~P~~c~~eiY---~iM~~CW~-~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 530 ELLEFL----KEGNRME------QPEHCSDEIY---DLMKSCWN-ADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHH----hcCCCCC------CCCCCCHHHH---HHHHHHhC-CCcccCCCHHHHHHHHHHHH
Confidence 112222 2211111 1223344444 44556875 89999999999999999853
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=278.95 Aligned_cols=241 Identities=22% Similarity=0.266 Sum_probs=179.3
Q ss_pred eeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHH---HhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 312 IIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMA---TLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
+||+|+||.||++... +++.+|+|.+.... .....+.+|.. .+...+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 68899999886532 11223344443 3444579999999999999899999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999999853 24689999999999999999999999 999999999999999999999999999975533211
Q ss_pred ccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
....|+..|+|||.... ..++.++|||||||++|||++|..||....... . ......... ..
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~-~~~~~~~~~------~~ 215 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----K-HEIDRMTLT------VN 215 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----H-HHHHHHhhc------CC
Confidence 12348899999998864 557899999999999999999999997543211 1 111111100 00
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERP-----TMFEVYQF 582 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-----s~~ev~~~ 582 (623)
..+ ......++.+++ ..|+. .||++|| +++|+++.
T Consensus 216 ~~~-~~~~~~~~~~li---~~~l~-~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VEL-PDSFSPELKSLL---EGLLQ-RDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCC-ccccCHHHHHHH---HHHhc-CCHHHhcCCCCCCHHHHHhC
Confidence 001 111234444444 45665 9999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.21 Aligned_cols=197 Identities=24% Similarity=0.332 Sum_probs=167.3
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-----
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----- 373 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 373 (623)
..++|...+.||+|+||.||+|... ++..||+|.+... ......+.+|+.++.+++|||++++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999954 7899999998643 223456778999999999999999999886442
Q ss_pred -eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 374 -ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 374 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
..++|+||++ ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 4689999996 488888742 278889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 164 LARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cceeCCCCCC-----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 9987543211 12234788999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.19 Aligned_cols=198 Identities=21% Similarity=0.237 Sum_probs=161.1
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
+.+|.|+++.||++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555555 6899999998654 33456789999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc---c
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH---L 464 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~---~ 464 (623)
.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+..+...... .
T Consensus 87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99996432 24578889999999999999999999 9999999999999999999999999998765332111 1
Q ss_pred cccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
........++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 111223346788999999865 35789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=282.68 Aligned_cols=200 Identities=23% Similarity=0.318 Sum_probs=165.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|++|.||+|... +++.|++|.+.... .....+.+|++++++++|||++++++++.+....++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999965 68899999886432 234568889999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-CCCeEEeecccccccCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFGLARLMNP 459 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-~~~~kl~Dfgla~~~~~ 459 (623)
|++ ++|.+++.... ...+++.....++.|++.||+|||+. +++|+||+|+||++++ ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 58888774322 23467888889999999999999999 9999999999999985 56799999999976543
Q ss_pred CCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.... .....+++.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 156 ~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 156 PVRT----FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred Cccc----cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2111 112346789999998865 45789999999999999999999999754
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=282.16 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=186.2
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...+.||+|+||.||++... +++.+++|.+.... .....+.+|+.++.++. ||||+++++++......++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3455678999999999999964 68999999986532 34557889999999996 99999999999998899999999
Q ss_pred CCCCCHhhhccCC-CCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 382 MPNGSLYDLLHPA-DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 382 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
++. ++.++.... ......+++....+++.+++.||+|||+.. +++||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 555443210 112356899999999999999999999743 8999999999999999999999999999765432
Q ss_pred CCcccccccCCCCcccccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTL---VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
... ....++..|+|||++... .++.++|||||||++|||++|+.||.... ...+-+.......
T Consensus 162 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~-- 227 (288)
T cd06616 162 IAK-----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD-- 227 (288)
T ss_pred Ccc-----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC--
Confidence 111 122378899999998765 68899999999999999999999986422 1111111111100
Q ss_pred hhhhchhhhcC---CCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 538 QDAIDKCLVAK---GVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 538 ~~~~d~~l~~~---~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+.+... ....+ +.+++..|+. .+|++|||+++|++.
T Consensus 228 ----~~~~~~~~~~~~~~~---l~~li~~~l~-~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ----PPILSNSEEREFSPS---FVNFINLCLI-KDESKRPKYKELLEH 267 (288)
T ss_pred ----CCcCCCcCCCccCHH---HHHHHHHHcc-CChhhCcCHHHHhcC
Confidence 0111111 12233 4444556766 999999999998864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=274.30 Aligned_cols=190 Identities=23% Similarity=0.289 Sum_probs=166.1
Q ss_pred eeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
||.|++|.||+++.. +++.+++|.+.... ...+.+.+|++++++++||||+++++++.+....++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 48899999986532 3346788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++........
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~---- 149 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---- 149 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc----
Confidence 9999642 3588999999999999999999998 9999999999999999999999999999876542211
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....++..|+|||.+....++.++|+||||+++|||++|..||...
T Consensus 150 -~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 150 -WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred -ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 1123688999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=270.77 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=194.3
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|+..+.||+|++|.||++... ++..|++|.+.... .....+.+|++++.+++|||++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999865 67899999997654 2456789999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998532 5689999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
.. .....++..|+|||...+..++.++||||+|+++|||++|+.||..... ...... .... ..
T Consensus 154 ~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~-~~~~-~~---- 216 (254)
T cd06627 154 KD----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFR-IVQD-DH---- 216 (254)
T ss_pred cc----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHH-Hhcc-CC----
Confidence 21 1223478899999999887889999999999999999999999864321 011000 0000 00
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..+ .....+++. .++.+|+. .+|++||++.|++.
T Consensus 217 -~~~-~~~~~~~~~---~~i~~~l~-~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -PPL-PEGISPELK---DFLMQCFQ-KDPNLRPTAKQLLK 250 (254)
T ss_pred -CCC-CCCCCHHHH---HHHHHHHh-CChhhCcCHHHHhc
Confidence 000 011233343 44456665 88999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=277.75 Aligned_cols=197 Identities=26% Similarity=0.358 Sum_probs=163.9
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCC---CCCCCcceeEEEEeCCe-----
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSV---KNRNLVPLLGFCMAKKE----- 374 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 374 (623)
|+..+.||+|+||.||+|+.+ +++.+++|++..... ....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999976 489999999964321 234566677665544 69999999999988776
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++++||+++ +|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8999886432 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
........ .....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 155 RIYSFEMA-----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred eeccCCcc-----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 87643221 11223678899999999888999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=281.77 Aligned_cols=194 Identities=23% Similarity=0.350 Sum_probs=163.6
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------ 373 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 373 (623)
.++|...+.||+|+||.||+|.. .++..||+|++.... .....+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788899999999999999995 468999999986532 22456789999999999999999999987543
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++|+||+.. +|.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 7777652 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 164 ARHADAEM-------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CcCCCCCC-------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 98653211 12246788999999876 46889999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=275.08 Aligned_cols=249 Identities=20% Similarity=0.266 Sum_probs=187.2
Q ss_pred cCcccceeeccCccEEEEEEeCC-CcEEEEEEeccc------cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDS------QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
+|...+.||+|+||.||++.... +..+++|.++.. ......+..|+.++++++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999998643 344555555431 12334567899999999999999999999988899999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+++++|.+++.........+++..++.++.|++.|+.|||+. +++|+||+|+||++++ +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998865433446799999999999999999999998 9999999999999986 569999999998764
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... .....++..|+|||+.....++.++|+||||+++|+|++|..||..... ......... ..
T Consensus 157 ~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~-~~-- 221 (260)
T cd08222 157 GSCDL----ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVE-GP-- 221 (260)
T ss_pred CCccc----ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHc-CC--
Confidence 32211 1123478899999999888889999999999999999999999863211 111111111 00
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+.+ ....+. .+..++.+|+. .+|++||++.|+++
T Consensus 222 ---~~~~-~~~~~~---~~~~li~~~l~-~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TPSL-PETYSR---QLNSIMQSMLN-KDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCC-cchhcH---HHHHHHHHHhc-CChhhCcCHHHHhh
Confidence 0000 011222 33445556666 89999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=280.18 Aligned_cols=201 Identities=26% Similarity=0.333 Sum_probs=167.1
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 377 (623)
.++|...+.||+|+||.||+|... +|..||+|.+..... ....+.+|++++.+++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 356888999999999999999964 689999999864321 233566899999999999999999998765 45789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+.+ +|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 888888543 25689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus 159 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 159 GLPAKP----MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred CCccCC----CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 542211 112235778999998865 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=281.73 Aligned_cols=203 Identities=23% Similarity=0.355 Sum_probs=166.8
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc---cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC--Ceee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS---QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK--KERL 376 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~ 376 (623)
.++|...+.||+|+||.||+|... ++..+++|++... ......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456888899999999999999965 5788999988542 22345577899999999 999999999998654 3578
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||++ ++|.+++.. ..++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 599998852 2678999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCcc-cccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 457 MNPIDTHL-STFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 457 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
........ ........++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 64322110 011122347889999998754 457889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=283.48 Aligned_cols=199 Identities=24% Similarity=0.246 Sum_probs=161.3
Q ss_pred ceeecc--CccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSG--RTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
..||+| +||+||+++. .+++.||+|.+.... ...+.+.+|+.++..++||||+++++++...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8999999996 478999999986533 2346688899999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|++.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999986542 24588999999999999999999998 99999999999999999999999998654332211110
Q ss_pred cc---cccCCCCcccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 465 ST---FVNGEFGDLGYVAPEYARTL--VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 465 ~~---~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. ......++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 00 00111245679999998763 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=278.97 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=186.9
Q ss_pred ccCcccceeeccCccEEEEEEeCC-CcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|++|.||+|...+ ++.|++|.++... .....+..|+.++.+. .||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457778999999999999999875 8899999987543 2345566777766666 49999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++ ++.+++... ...+++..+..++.|++.|++|||+.. +|+||||+|+||++++++.++|+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 777776432 246899999999999999999999732 8999999999999999999999999999765432
Q ss_pred CCcccccccCCCCcccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLV----ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+.........
T Consensus 169 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~- 235 (296)
T cd06618 169 KAK-----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE- 235 (296)
T ss_pred Ccc-----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC-
Confidence 211 1223678999999987553 788999999999999999999998642111 11111111110
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
...+-. .....++ +.+++.+|+. .+|++||++.++++.
T Consensus 236 ~~~~~~----~~~~~~~---l~~li~~~l~-~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 PPSLPP----NEGFSPD---FCSFVDLCLT-KDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCC----CCCCCHH---HHHHHHHHcc-CChhhCCCHHHHhcC
Confidence 000000 0012333 4444556776 899999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=277.93 Aligned_cols=242 Identities=23% Similarity=0.348 Sum_probs=187.9
Q ss_pred cceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 310 NNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
...||+|+||.||++.. .++..|++|++.... .....+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 478899999885433 3455688999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++.. ..+++.....++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++..........
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~--- 173 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--- 173 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc---
Confidence 998742 3578999999999999999999999 99999999999999999999999999987654321111
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhh-
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLV- 546 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~- 546 (623)
....++..|+|||+..+..++.++||||||+++|||++|..||......+ ........ ..+.+.
T Consensus 174 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-----~~~~~~~~---------~~~~~~~ 238 (292)
T cd06657 174 -KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDN---------LPPKLKN 238 (292)
T ss_pred -cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhh---------CCcccCC
Confidence 12347889999999988888999999999999999999999986422110 01111100 000100
Q ss_pred cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 547 AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 547 ~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
......++..+ ...|+. .+|.+||++.++++
T Consensus 239 ~~~~~~~l~~l---i~~~l~-~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHKVSPSLKGF---LDRLLV-RDPAQRATAAELLK 269 (292)
T ss_pred cccCCHHHHHH---HHHHHh-CCcccCcCHHHHhc
Confidence 01122333333 445665 88999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=271.91 Aligned_cols=201 Identities=22% Similarity=0.329 Sum_probs=168.4
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc------cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Cee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS------QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 375 (623)
.+|...+.||+|+||.||+|.. .++..|++|.+... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999995 46889999987432 12345788999999999999999999998764 357
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||+++++|.+++.. ...+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 799999999999999853 23478899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.......... ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 155 RIQTICMSGT-GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccccccccCc-cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 6543111111 11123478899999999888889999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=274.91 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=188.2
Q ss_pred eeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
||+|+||.||++... ++..+++|.+.... .....+.+|++++.+++|||++++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 48999999986543 2456788899999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc---
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL--- 464 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~--- 464 (623)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999632 3689999999999999999999999 99999999999999999999999999987643321100
Q ss_pred -cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 -STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 -~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
........++..|+|||.......+.++||||||+++||+++|..||..... .......... .. ....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~-~~~~- 222 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILNG-KI-EWPE- 222 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-Cc-CCCc-
Confidence 0011223467899999999888889999999999999999999999964321 1111111110 00 0000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
......++ ..+...|+. .+|++|||+.++.+.|+
T Consensus 223 ---~~~~~~~~---~~~i~~~l~-~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 ---DVEVSDEA---IDLISKLLV-PDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---cccCCHHH---HHHHHHHhc-CCHhhcCCCccHHHHhc
Confidence 00012333 344445665 88999999976666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=269.71 Aligned_cols=198 Identities=21% Similarity=0.263 Sum_probs=162.9
Q ss_pred HHHHHHhccCccccee--eccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCC-CCCCCCcceeEEEEeCC
Q 006982 298 SDLMKATNSFSKNNII--GSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGS-VKNRNLVPLLGFCMAKK 373 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~ 373 (623)
.+.....++|...+.+ |+|+||.||++.. .++..+++|.+........ |+..... .+|||++++++++...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3444455666666666 9999999999995 4678899998865432211 1211111 27999999999999999
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeecc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFG 452 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfg 452 (623)
..++||||+++|+|.+++... ..++|..+..++.|+++|+.|||+. +++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999532 3789999999999999999999999 999999999999999988 99999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 156 LCKIIGTPS--------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred cceecCCCc--------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 988654321 123788999999999888999999999999999999999999743
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-31 Score=277.57 Aligned_cols=201 Identities=21% Similarity=0.289 Sum_probs=163.5
Q ss_pred cCcccceeeccCccEEEEEEeC-C--CcEEEEEEecccc---ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC----Ce
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-D--GTSLMVKRLQDSQ---RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK----KE 374 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 374 (623)
+|...+.||+|+||.||++... . +..||+|++.... ...+.+.+|++++.++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3677889999999999999965 3 7789999886432 2345678899999999 599999999875432 34
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678888886 689998852 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+.................|+..|+|||+..+ ..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 8765322211111223458899999998765 46789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=278.12 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=188.6
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.|...+.||+|+||.||+|+.. ++..+++|.+... ......+.+|+++++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999964 6788999988532 1233567889999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+. |++.+.+... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 5888777432 24588999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
. ...++..|+|||++. ...++.++|||||||++|||++|+.||...... ......... ..
T Consensus 169 ~--------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~-~~ 231 (308)
T cd06634 169 N--------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQN-ES 231 (308)
T ss_pred c--------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHhhc-CC
Confidence 1 123678999999874 356788999999999999999999998642211 111111000 00
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
+.........+ +..++.+|+. .+|++||++.+++..-....
T Consensus 232 -----~~~~~~~~~~~---~~~li~~cl~-~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 -----PALQSGHWSEY---FRNFVDSCLQ-KIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -----CCcCcccccHH---HHHHHHHHhh-CCcccCCCHHHHhhCccccc
Confidence 00011112223 3344456766 89999999999987754433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=275.40 Aligned_cols=254 Identities=20% Similarity=0.241 Sum_probs=192.0
Q ss_pred cCcccceeeccCccEEEEEEe----CCCcEEEEEEecccc-----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 306 SFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
+|...+.||+|++|.||+++. .++..|++|.++... ...+.+..|++++.++ +|||++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999884 357889999986432 2345688999999999 599999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++|+|.+++.. ...+++.....++.|++++|.|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999853 24588999999999999999999998 99999999999999999999999999988
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhc
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV--ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 533 (623)
......... .....++..|+|||...+.. .+.++||||||+++|||++|..||...... ....+.......
T Consensus 154 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~ 226 (288)
T cd05583 154 EFLAEEEER---AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILK 226 (288)
T ss_pred ccccccccc---cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHc
Confidence 654322111 11224788999999987654 788999999999999999999998642211 111111111111
Q ss_pred cCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 534 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.. ... ......++. +++..|+. .+|++|||+.+|.+.|+.
T Consensus 227 ~~-------~~~-~~~~~~~l~---~li~~~l~-~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 SK-------PPF-PKTMSAEAR---DFIQKLLE-KDPKKRLGANGADEIKNH 266 (288)
T ss_pred cC-------CCC-CcccCHHHH---HHHHHHhc-CCHhhccCcchHHHHhcC
Confidence 00 000 011222333 34445665 999999999998887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=273.22 Aligned_cols=192 Identities=27% Similarity=0.374 Sum_probs=165.1
Q ss_pred eeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
||+|+||+||++... +|..+++|.+.... .....+..|++++++++|||++++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999986432 2244567899999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----~ 150 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----K 150 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----c
Confidence 999864332 4689999999999999999999999 99999999999999999999999999997654311 1
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 12234778999999998888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=278.86 Aligned_cols=199 Identities=22% Similarity=0.360 Sum_probs=167.7
Q ss_pred HHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe-CCe
Q 006982 300 LMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA-KKE 374 (623)
Q Consensus 300 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 374 (623)
+...+++|...+.||+|+||.||++... ++..|++|++.... ...+.+..|++++.+++|||++++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999854 78999999885432 234677889999999999999999999876 457
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++|+||+ +++|.+++.. ..+++.....++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 88999998 5699988842 3577888889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 156 RIQDPQM-------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cccCCCc-------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7543211 12246788999998765 56899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-34 Score=273.15 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=176.7
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
-|.+.++||+|+||.||+|.++ .|..+|+|.+.-. ...+++.+|+.+|.+...|++|+++|.+......++|||||..
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 3667789999999999999865 6999999988643 3567889999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|++.+.+.. .++++++.....++...+.||.|||.. .-+|||||+.|||++-+|.+|++|||.|-.+...-
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--- 183 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--- 183 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH---
Confidence 999999864 347899999999999999999999998 88999999999999999999999999998764321
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
..-++..||+-|||||++..-.|..++||||+|+...||..|++||.+..
T Consensus 184 -AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 184 -AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred -HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 12345569999999999999999999999999999999999999998654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=267.58 Aligned_cols=269 Identities=23% Similarity=0.362 Sum_probs=213.8
Q ss_pred CHHHHHHHhccCcccceeeccCccEEEEEEeC------CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeE
Q 006982 296 RLSDLMKATNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLG 367 (623)
Q Consensus 296 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~ 367 (623)
++.++.....+++...++-+|.||.||+|.|. +.+.|.+|.++.. +.....+..|.-.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 45566666667888888999999999999654 3456778877653 344567888999999999999999999
Q ss_pred EEEeC-CeeeEEEecCCCCCHhhhccC----CCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC
Q 006982 368 FCMAK-KERLLVYKHMPNGSLYDLLHP----ADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD 442 (623)
Q Consensus 368 ~~~~~-~~~~lV~e~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~ 442 (623)
++.+. ...+++|.++.-|+|..+|.. .....+.++-.+...++.|++.|++|||+. +++|.||.++|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 98765 466899999999999999962 122346678889999999999999999999 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 006982 443 DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFK 521 (623)
Q Consensus 443 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~ 521 (623)
...+||+|=.+++.+-+.+++ +..+....+..||+||.+....|+..+|||||||+||||+| |+.|+...++.|.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYh--cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-- 507 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYH--CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-- 507 (563)
T ss_pred heeEEeccchhccccCccccc--ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--
Confidence 999999999999999887765 34455667899999999999999999999999999999998 9999875444322
Q ss_pred ccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
..-..+..++. +....++|+..+ +.|||+..|++||++++++.-|.+...
T Consensus 508 ------~~ylkdGyRla-------QP~NCPDeLf~v----MacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 508 ------EHYLKDGYRLA-------QPFNCPDELFTV----MACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ------HHHHhccceec-------CCCCCcHHHHHH----HHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 11111111111 122356666655 467778999999999999999988653
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=271.63 Aligned_cols=190 Identities=23% Similarity=0.296 Sum_probs=157.7
Q ss_pred eeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHH---HHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 312 IIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEM---ATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
+||+|+||.||++... +++.||+|.+.... .....+..|. +.+....|||++.+++++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 58899999886532 1122233343 34555689999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999998853 24689999999999999999999998 999999999999999999999999999876533211
Q ss_pred ccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....|+..|+|||++.+. .++.++||||+|+++|||++|+.||...
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 -----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 123488999999998754 6889999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=273.56 Aligned_cols=198 Identities=22% Similarity=0.314 Sum_probs=167.0
Q ss_pred cCcccceeeccCccEEEEEEe----CCCcEEEEEEecccc-----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 306 SFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
+|+..+.||+|+||.||++.. .+|..||+|++.... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999985 368899999986532 2345678899999999 589999999999998899
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999853 24578889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL--VATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
........ ......|+..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 154 EFHEDEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred eccccccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 65432211 11123478899999998753 467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=278.92 Aligned_cols=198 Identities=21% Similarity=0.333 Sum_probs=166.2
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----Cee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 375 (623)
++|...+.||+|+||.||++.. .++..|++|.+... ......+.+|+.++..++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5688889999999999999995 46899999998653 23345677899999999999999999988654 347
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 89999996 689988853 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKGD----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCcc----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 7643221 1122346889999998764 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=274.65 Aligned_cols=243 Identities=27% Similarity=0.360 Sum_probs=185.5
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
|...+.||+|+||.||+|+.. ++..|++|++.... .....+.+|++++++++|||++++++++.+....++|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 455678999999999999964 68889999986432 2235678899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++ |++.+++... ...+++.++..++.|++.++.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 5787777532 24689999999999999999999999 9999999999999999999999999998653221
Q ss_pred CcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
....|+..|+|||++. ...++.++|||||||++|||++|..||...... .......... .
T Consensus 175 -------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~-~- 237 (313)
T cd06633 175 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQND-S- 237 (313)
T ss_pred -------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcC-C-
Confidence 1234788999999984 456888999999999999999999998653221 1111111100 0
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+.......... +..+...|+. .+|.+||++.+++..
T Consensus 238 ----~~~~~~~~~~~---l~~li~~~l~-~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 ----PTLQSNEWTDS---FRGFVDYCLQ-KIPQERPASAELLRH 273 (313)
T ss_pred ----CCCCccccCHH---HHHHHHHHcc-CChhhCcCHHHHhcC
Confidence 00011112222 3344456776 899999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=277.54 Aligned_cols=196 Identities=26% Similarity=0.362 Sum_probs=166.2
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-----
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----- 373 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 373 (623)
..++|...+.||+|+||.||++.. .++..||+|++.... .....+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456788999999999999999984 478999999986432 22356789999999999999999999987653
Q ss_pred -eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 374 -ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 374 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7799988842 4588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++....... ....++..|+|||.+.+ ..++.++|+||+|+++||+++|+.||...
T Consensus 164 ~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 164 LARQTDSEM-------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccCc-------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 998654311 12236788999998875 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=274.34 Aligned_cols=203 Identities=26% Similarity=0.343 Sum_probs=167.9
Q ss_pred HHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC----
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK---- 373 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 373 (623)
...++|+..+.||+|+||.||+|..+ +++.|++|+++... .....+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567889999999999999999975 58899999986432 23456778999999999999999999987654
Q ss_pred ------eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeE
Q 006982 374 ------ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPK 447 (623)
Q Consensus 374 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~k 447 (623)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 68899999986 777776532 24689999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 448 ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 448 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 l~dfg~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 157 LADFGLARLYNSEESR---PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred eCcccccccccCCccc---ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999876442211 1112235778999998764 45688999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=277.10 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=194.4
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
-|...+.||+|.|..|-.|++ -.|..||||++.+.. .+...+.+|++-|+.++|||||+++.+.......|+|+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 355567899999999999984 489999999997654 3456788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee-CCCCCeEEeecccccccCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL-DDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl-~~~~~~kl~Dfgla~~~~~~ 460 (623)
-.+|+|++++-+.. ..+.+....+++.||..|+.|+|.. +++||||||+||.+ .+-|-+||.|||++-...+.
T Consensus 99 GD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999996543 4588889999999999999999999 89999999999866 67788999999999877653
Q ss_pred CCcccccccCCCCcccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVAT-PKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. ..+.+|+..|-|||.+.+..|+ +++||||+|||||.++.|..||....+.+....
T Consensus 173 ~k-----L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----------------- 230 (864)
T KOG4717|consen 173 KK-----LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----------------- 230 (864)
T ss_pred ch-----hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh-----------------
Confidence 32 3344589999999999998886 589999999999999999999987665543211
Q ss_pred hhchhh-hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 540 AIDKCL-VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 540 ~~d~~l-~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
++|-.. .......+-..+++. |+..||++|.+.+||+..
T Consensus 231 ImDCKYtvPshvS~eCrdLI~s----MLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 231 IMDCKYTVPSHVSKECRDLIQS----MLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhcccccCchhhhHHHHHHHHH----HHhcCchhhccHHHHhcc
Confidence 111111 111122333333332 223789999998887653
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=270.25 Aligned_cols=198 Identities=23% Similarity=0.321 Sum_probs=168.9
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
|...+.||+|++|.||++... +++.+++|.+..... ....+.+|++++++++|+|++++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999965 688999999865432 3567888999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++ ++.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 888888542 24689999999999999999999999 999999999999999999999999999987654321
Q ss_pred cccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
. .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 154 ~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 154 P----YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred c----ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1123467889999998776 78999999999999999999999996543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=274.54 Aligned_cols=198 Identities=26% Similarity=0.349 Sum_probs=168.7
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
|+..+.||+|++|.||+|+.. +++.+++|.+... ....+.+..|++++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999966 5899999998764 233467788999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
+ ++|.+++.... ..+++..+..++.+++.||+|||+. +|+||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 59999996432 4689999999999999999999999 999999999999999999999999999986543221
Q ss_pred cccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 154 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 T----YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred c----cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 1122356789999998766 78999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=289.09 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=172.2
Q ss_pred CcccceeeccCccEEEEEE-eCCCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------eeeE
Q 006982 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------ERLL 377 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l 377 (623)
+...+.||+|+||.||+|+ .+.|..||||.++.. ....+...+|+++|++++|+|||++++.-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3446789999999999999 568999999999764 345677889999999999999999999865543 5679
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC--CCC--CeEEeeccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD--DDF--EPKISDFGL 453 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~--~~~--~~kl~Dfgl 453 (623)
|||||.+|||...|....+ ...+++.+.+.+..+++.||.|||+. +|+||||||.||++- .+| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999987654 46699999999999999999999998 999999999999984 323 469999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR-TLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
|+.++... .+...+||..|.+||... ...|+..+|.|||||++||..||..||.....
T Consensus 171 Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99886543 233456999999999998 58899999999999999999999999975433
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=283.40 Aligned_cols=201 Identities=23% Similarity=0.348 Sum_probs=175.7
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
...|.....||+|.|+.|..|++. .+..||+|.+.++.. ....+.+|+++|..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456788899999999999999965 689999999987653 2345889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+.+|.+++++... ..+....+..++.|+.++++|+|++ .|+|||||++|||++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999643 3455577888999999999999999 999999999999999999999999999998764
Q ss_pred CCCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
. ....+.+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++...
T Consensus 208 ~-----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 208 G-----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred c-----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 2 23344569999999999998776 5799999999999999999999986433
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=259.12 Aligned_cols=269 Identities=19% Similarity=0.282 Sum_probs=198.9
Q ss_pred cCHHHHHHHhccCcccceeeccCccEEEEEE-eCCCcEEEEEEecccc-ccHHHHHHHHHHhCCC-CCCCCcceeEEEEe
Q 006982 295 MRLSDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSV-KNRNLVPLLGFCMA 371 (623)
Q Consensus 295 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 371 (623)
.++.|+.+.| .+.||+|+|+.|..++ ..+|.++|||++.+.. ....+..+|++++.+. .|+||+.+++||++
T Consensus 73 g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3567777776 5889999999999988 7789999999997654 4567888999999988 59999999999999
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC---eEE
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE---PKI 448 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~---~kl 448 (623)
+...|+|||-|.||+|..+++. ...+++..+-++..+||.||.|||.+ +|+|||+||+|||..+-.. +||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999973 45689999999999999999999999 9999999999999976554 799
Q ss_pred eecccccccCC--CCCc-ccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccc-
Q 006982 449 SDFGLARLMNP--IDTH-LSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPET- 519 (623)
Q Consensus 449 ~Dfgla~~~~~--~~~~-~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~- 519 (623)
+||.+..-+.. .... ......+.+|+..|||||+.. ...|+.++|.||+|||||-|++|..||.+....+-
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 99988754321 1111 111233467899999999763 34688999999999999999999999976433221
Q ss_pred cc-ccHHHHHHHHhcc---CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 520 FK-GNLVEWIAQLSST---GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 520 ~~-~~l~~~~~~~~~~---~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+. +..-....+.+.+ +.-.++-|+.|.. ..++..+++...+. .+|.+|-++.+|+.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWah--IS~eakdlisnLlv----rda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAH--ISSEAKDLISNLLV----RDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHH--hhHHHHHHHHHHHh----ccHHhhhhhhhccC
Confidence 11 1111111111110 1112333333322 34445555544443 66888888887765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=301.71 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=180.3
Q ss_pred HHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK----- 372 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 372 (623)
.+-..+|+..++||+||||.|||++.+ ||+.||||++.-. ......+.+|+..+++++|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345578899999999999999999955 9999999999765 34456688999999999999999887322100
Q ss_pred --------------------------------------------------------------------------------
Q 006982 373 -------------------------------------------------------------------------------- 372 (623)
Q Consensus 373 -------------------------------------------------------------------------------- 372 (623)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeeEEEecCCCCCHhhhccCCCCCCCcc-ChHHHHHHHHHHHHHH
Q 006982 373 ----------------------------------KERLLVYKHMPNGSLYDLLHPADDTGKSV-DWPRRLKIAIGAARGF 417 (623)
Q Consensus 373 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~ia~~l 417 (623)
...||-||||+.-++.++++... .. .-...++++.+|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHH
Confidence 01357788888877777775322 11 3567789999999999
Q ss_pred HHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC----C---CC-------CcccccccCCCCcccccCcccc
Q 006982 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN----P---ID-------THLSTFVNGEFGDLGYVAPEYA 483 (623)
Q Consensus 418 ~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~----~---~~-------~~~~~~~~~~~gt~~y~aPE~~ 483 (623)
+|+|++ +||||||||.||++|++..+||+|||+|+... . .. ........+.+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 0 00 0001112345799999999999
Q ss_pred cCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh---hhchhhhcCCCHHHHHHH
Q 006982 484 RTL---VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD---AIDKCLVAKGVDNELFQF 557 (623)
Q Consensus 484 ~~~---~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~d~~l~~~~~~~~~~~~ 557 (623)
.+. .|+.|+|+||+|||++||+. ||..... + ..+-..++.+.+.. +.++. ..+-.++
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----R----a~iL~~LR~g~iP~~~~f~~~~------~~~e~sl 850 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----R----ASILTNLRKGSIPEPADFFDPE------HPEEASL 850 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHH----H----HHHHHhcccCCCCCCccccccc------chHHHHH
Confidence 765 49999999999999999996 6653211 1 11111122222211 12211 1112223
Q ss_pred HHHHhhccCCCCCCCCCCHHHHHH
Q 006982 558 LKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 558 ~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+.|+.++||.+|||+.|++.
T Consensus 851 ----I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 ----IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ----HHHHhcCCCccCCCHHHHhh
Confidence 34455599999999999874
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=277.51 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=193.1
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 380 (623)
..|++.+.||+||.+.||++...+.+.+|+|++.... .....|.+|+..|.++ .|.+|+.+++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4688889999999999999999988999998886543 3456799999999999 58999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|-+ .+|..+|..... ...+| .+..+..|++.++.+.|.+ ||||.||||.|+|+-+ |.+||+|||+|..+.+.
T Consensus 441 ~Gd-~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ccc-ccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 885 499999976543 34445 6788999999999999999 9999999999999876 57999999999988764
Q ss_pred CCcccccccCCCCcccccCcccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHH
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTL-----------VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIA 529 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~ 529 (623)
.+. ..-...+||+-||+||.+... +.+.++||||+|||||+|+.|+.||... ...|.
T Consensus 513 TTs--I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------~n~~a- 580 (677)
T KOG0596|consen 513 TTS--IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------INQIA- 580 (677)
T ss_pred ccc--eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------HHHHH-
Confidence 332 333456799999999988532 3567999999999999999999999631 11111
Q ss_pred HHhccCchhhhhchhhhcCC-CHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 530 QLSSTGQLQDAIDKCLVAKG-VDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
++..+.|+--.-.+ ...+-..++.++..|+. .||++||+..|+++
T Consensus 581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~-rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLA-RDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHhhcCCCccccccCCCCchHHHHHHHHHHh-cCcccCCCcHHHhc
Confidence 22233333211011 01111125555556665 99999999999876
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=268.43 Aligned_cols=243 Identities=21% Similarity=0.214 Sum_probs=180.8
Q ss_pred ceeeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHH-hCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMAT-LGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+|... +++.||+|.+..... ....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 688999999865321 12234445444 4556899999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 150 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---- 150 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence 9999999532 4578899999999999999999998 9999999999999999999999999998754321
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
....++..|+|||...+..++.++||||||+++|||++|..||...... ......... ... .+.
T Consensus 151 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~~---~~~ 214 (260)
T cd05611 151 ----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILSR-RIN---WPE 214 (260)
T ss_pred ----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhc-ccC---CCC
Confidence 1223678899999998888899999999999999999999999643221 111111000 000 000
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
-.....+.+ +..++..|+. .+|++||++.++.+.|.
T Consensus 215 ~~~~~~~~~---~~~~i~~~l~-~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPE---AVDLINRLLC-MDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHH---HHHHHHHHcc-CCHHHccCCCcHHHHHc
Confidence 000012233 3444456666 89999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=275.14 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=169.2
Q ss_pred HHHHHHHhccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC
Q 006982 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372 (623)
Q Consensus 297 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 372 (623)
..++...+++|...+.||+|+||.||++.. .++..||+|++.... ...+.+.+|++++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 456677788999999999999999999985 578899999986532 2245678899999999999999999988643
Q ss_pred ------CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 373 ------KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 373 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 2356777776 7899988842 3589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
||+|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 kl~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 160 KILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred EEecccccccccccc-------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998643211 12346889999998865 46788999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=272.60 Aligned_cols=203 Identities=25% Similarity=0.378 Sum_probs=173.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|++|.||++... ++..|++|++... ....+.+..|.+++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778899999999999999965 7899999998653 233466888999999998 99999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999963 24699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCccc----------------ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 459 PIDTHLS----------------TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 459 ~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....... .......++..|+|||......++.++||||||++++|+++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3221100 1112234688999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=278.79 Aligned_cols=201 Identities=20% Similarity=0.339 Sum_probs=164.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC----------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK---------- 372 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------- 372 (623)
.+|...+.||+|+||.||+|... ++..|++|.+.... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999964 68899999885543 3456788999999999999999999876543
Q ss_pred ----CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeE
Q 006982 373 ----KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPK 447 (623)
Q Consensus 373 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~k 447 (623)
...++|+||++ ++|.+++. ...+++.....++.|++.||.|||+. +|+||||||+||+++ +++.++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 34689999997 59988884 23588999999999999999999999 999999999999997 556789
Q ss_pred EeecccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 448 ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 448 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
++|||+++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 156 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 156 IGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred ECCcccceecCCccccc-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998654321111 11122346888999997654 567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.27 Aligned_cols=205 Identities=23% Similarity=0.297 Sum_probs=165.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------ 373 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 373 (623)
.++|...+.||+|+||.||+|... +++.+++|++.... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999965 68899999885432 22345678999999999999999999875543
Q ss_pred --eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 374 --ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 374 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
..++|+||+.+ ++...+... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999975 777776532 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccc-------ccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 452 GLARLMNPIDTHLS-------TFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 452 gla~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
|+++.......... .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 99986543211111 01112246788999998765 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=277.11 Aligned_cols=203 Identities=22% Similarity=0.255 Sum_probs=165.6
Q ss_pred ccCc-ccceeeccCccEEEEEEeC-CCcEEEEEEecccccc---------------HHHHHHHHHHhCCCCCCCCcceeE
Q 006982 305 NSFS-KNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRS---------------EKEFVAEMATLGSVKNRNLVPLLG 367 (623)
Q Consensus 305 ~~f~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~e~~~l~~l~h~niv~l~~ 367 (623)
++|. ..+.||+|+||.||+|... +++.||+|.+...... ...+.+|++++.+++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3577999999999999954 6899999988643221 124678999999999999999999
Q ss_pred EEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeE
Q 006982 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPK 447 (623)
Q Consensus 368 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~k 447 (623)
++...+..++|+||++ |+|.+++.. ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 699999853 34588999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCCc----------ccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 448 ISDFGLARLMNPIDTH----------LSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 448 l~Dfgla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
|+|||+++........ .........++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999865411100 00111123467889999998764 46899999999999999999999997543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=261.80 Aligned_cols=199 Identities=21% Similarity=0.246 Sum_probs=174.4
Q ss_pred ccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccc----cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQR----SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...++||+|.||.|-.++ ...++.+|+|++++... ....-..|-++|...+||.+..+...|+.++..++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 568888999999999999998 45789999999987542 2344567899999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||..||.|+-+|.. ...+++.....+-..|..||.|||++ +|+.||||.+|.|+|++|++||+|||+++.--.
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999953 45688888888999999999999999 999999999999999999999999999986433
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
..... .+-+||+.|+|||++....|...+|.|.+|||+|||+.|+.||+..
T Consensus 321 ~g~t~----kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 321 YGDTT----KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cccee----ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 22222 3345999999999999999999999999999999999999999863
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=276.09 Aligned_cols=201 Identities=23% Similarity=0.352 Sum_probs=170.7
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-----eee
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK-----ERL 376 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 376 (623)
+|...+.||+|++|.||+|+.. ++..+++|++.... ...+.+.+|++++++++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777899999999999999965 48899999987542 34567889999999999999999999988765 789
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||++ ++|.+++.. ...+++..++.++.+++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 489998853 23789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
....... ........++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 153 VDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 6543211 0112223478889999999877 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-33 Score=307.64 Aligned_cols=203 Identities=30% Similarity=0.416 Sum_probs=173.2
Q ss_pred hccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
+-++.....||.|.||.||.|. ..+|.-.|+|-++-. ....+...+|+.++..++|||+|+.+|+-.+++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3456777899999999999998 567888899977532 234456789999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
|||++|+|.+.+.. +...++.....+..|++.|++|||++ ||+||||||.||+++.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999963 34456666677889999999999999 999999999999999999999999999998876
Q ss_pred CCCcccccccCCCCcccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLV---ATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
..........+..||+-|||||++.+.. -..+.||||+|||++||+||++||..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 5333344556778999999999997643 34589999999999999999999974
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=277.77 Aligned_cols=195 Identities=25% Similarity=0.369 Sum_probs=165.8
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe-----
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE----- 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 374 (623)
.++|...+.||+|++|.||+|... ++..|++|++.... ...+.+.+|+.++++++|||++++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 567888999999999999999975 57899999986532 233567789999999999999999998766554
Q ss_pred -eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 375 -RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 375 -~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 78999998 6699999852 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+...... .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||...
T Consensus 165 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 165 ARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 112246788999998865 36789999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=301.19 Aligned_cols=214 Identities=22% Similarity=0.246 Sum_probs=183.9
Q ss_pred HHHHHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEe
Q 006982 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371 (623)
Q Consensus 297 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 371 (623)
+.++....++|.+.++||+|+||.|..++++ .++.||+|++.+. +....-|..|-++|.--+.+.|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4556666789999999999999999999975 5788999999763 2334568889999988899999999999999
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
..+.|+|||||+||+|-.++... ..+++..+..++..|+.||.-||+. |+|||||||.|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999533 2588888888999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccc
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETF 520 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~ 520 (623)
|-+..+...+.. .+...+|||.|++||++.. +.|...+|.||+||++|||+.|..||+.....+++
T Consensus 220 GsClkm~~dG~V---~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY 290 (1317)
T KOG0612|consen 220 GSCLKMDADGTV---RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY 290 (1317)
T ss_pred hhHHhcCCCCcE---EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH
Confidence 999888754432 2345579999999999852 57889999999999999999999999875554443
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=280.24 Aligned_cols=248 Identities=19% Similarity=0.336 Sum_probs=188.3
Q ss_pred CcccceeeccCccEEEEEEeCCCcE-EEEEEeccc-cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 307 FSKNNIIGSGRTGTMYKALLEDGTS-LMVKRLQDS-QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
|.+...||.|+||.||+|..++... .|.|++... ......|.-||++|....||+||++++.|+..+..++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4556779999999999999765443 456666443 34557899999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|-+...+-. .+..+.+.++..++++++.||.|||++ .|||||||+.|||++-+|.++|+|||.+-........
T Consensus 114 GAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk- 186 (1187)
T KOG0579|consen 114 GAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK- 186 (1187)
T ss_pred chHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhh-
Confidence 999998743 357899999999999999999999999 9999999999999999999999999998654321111
Q ss_pred cccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 465 STFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
-+.-.||+.|||||+.. ..+|+.++||||||+.|.||..+.+|-..... ++-.++....+++ -
T Consensus 187 ---RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSePP--T 254 (1187)
T KOG0579|consen 187 ---RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPP--T 254 (1187)
T ss_pred ---hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcCCC--c
Confidence 12335999999999864 56899999999999999999999988653221 1111111111111 1
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
++ ...........++ ..|+. .+|..||+++++++
T Consensus 255 Ll----qPS~Ws~~F~DfL---k~cL~-Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LL----QPSHWSRSFSDFL---KRCLV-KNPRNRPPAAQLLK 288 (1187)
T ss_pred cc----CcchhhhHHHHHH---HHHHh-cCCccCCCHHHHhh
Confidence 11 1112223333444 45666 88999999999875
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=249.95 Aligned_cols=246 Identities=21% Similarity=0.359 Sum_probs=185.5
Q ss_pred ccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 309 KNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 309 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
....||+|..|.|+++..+ .|..+|||.+.... ...+++...++++.+- ..|.||+.+|||..+...++.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3467999999999999965 58899999997654 4456788888886655 479999999999999999999999853
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
.+..++.... +++++.-.-++...+..||.||.+++ +|+|||+||+|||+|+.|++|++|||++-++.....+.
T Consensus 176 -C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 176 -CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred -HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 4555554322 45777778889999999999999886 99999999999999999999999999998775533332
Q ss_pred cccccCCCCcccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 465 STFVNGEFGDLGYVAPEYART---LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
...|-+.|||||.+.. ..|+.++||||||+.++|+.||..||....... +.......+.
T Consensus 250 -----rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-------e~ltkvln~e------ 311 (391)
T KOG0983|consen 250 -----RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-------EVLTKVLNEE------ 311 (391)
T ss_pred -----cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-------HHHHHHHhcC------
Confidence 2237789999999864 468899999999999999999999998654321 1111111111
Q ss_pred chhhhcC-CCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 542 DKCLVAK-GVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 542 d~~l~~~-~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
-++|... +.... +.+....|+. .|+.+||...++++.
T Consensus 312 PP~L~~~~gFSp~---F~~fv~~CL~-kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPD---FQSFVKDCLT-KDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHH---HHHHHHHHhh-cCcccCcchHHHhcC
Confidence 1333321 12333 3444456776 999999998887653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=294.16 Aligned_cols=144 Identities=24% Similarity=0.314 Sum_probs=129.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|.+.+.||+|+||.||+|... ++..||+|++.... .....+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999966 68899999986532 22356888999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
||+++++|.+++... ..+++..++.++.|++.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999632 4578889999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=259.50 Aligned_cols=190 Identities=25% Similarity=0.322 Sum_probs=165.7
Q ss_pred eeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 313 IGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
||+|+||.||++... +++.+++|.+..... ....+..|++++++++|||++++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 588999999865432 345788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
.+++... ..+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~ 149 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----R 149 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC----c
Confidence 9999632 3589999999999999999999998 999999999999999999999999999987643211 1
Q ss_pred ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.....++..|+|||...+...+.++|+||||+++||+++|..||..
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1223478899999999888889999999999999999999999964
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=252.63 Aligned_cols=253 Identities=20% Similarity=0.249 Sum_probs=191.4
Q ss_pred hccCccc-ceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC----Ceee
Q 006982 304 TNSFSKN-NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK----KERL 376 (623)
Q Consensus 304 ~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~~ 376 (623)
+++|++. ++||-|-.|.|-.+.++ ++..+|+|++.++..+ .+|++..-.. .|||||.+++++.+. .-.+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KA----RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKA----RREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHH----HhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 3445443 68999999999998854 7889999999776644 3566653333 799999999998653 3457
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC---CCCCeEEeeccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD---DDFEPKISDFGL 453 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~---~~~~~kl~Dfgl 453 (623)
+|||.|+||.|+..++.... ..+++.++-.|..||+.|+.|||+. .|+||||||+|+|.+ .+..+||+|||+
T Consensus 136 iVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 99999999999999976543 6799999999999999999999999 999999999999996 466799999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhc
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 533 (623)
|+.-... ....+.+-|+.|.|||++...+|+..+|+||+||++|-|+.|..||+..... .....+...+....
T Consensus 211 AK~t~~~-----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-aispgMk~rI~~gq- 283 (400)
T KOG0604|consen 211 AKETQEP-----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKRRIRTGQ- 283 (400)
T ss_pred ccccCCC-----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-cCChhHHhHhhccC-
Confidence 9975431 1223344689999999999999999999999999999999999999875442 11112222222111
Q ss_pred cCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 534 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.++-++.| .++.+..+-.++|++..+|++|.|+.|+...
T Consensus 284 ----y~FP~pEW------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 ----YEFPEPEW------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ----ccCCChhH------hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11222221 2344455556677777999999999998764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=253.37 Aligned_cols=205 Identities=24% Similarity=0.334 Sum_probs=169.2
Q ss_pred ccCcccceeeccCccEEEEEEeCC-----CcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe-CCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-----GTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA-KKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 375 (623)
..|+....||+|.||.||+|...+ ...+|+|+++... .-.....+|+..++.++|||++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 357888999999999999997432 2368999997653 223467789999999999999999999887 6678
Q ss_pred eEEEecCCCCCHhhhccCCCC-CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC----CCeEEee
Q 006982 376 LLVYKHMPNGSLYDLLHPADD-TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD----FEPKISD 450 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~----~~~kl~D 450 (623)
++++||.+. +|...++-.+. ....++......|+.||..|+.|||+. =|.||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 99888864432 236788889999999999999999999 69999999999999877 9999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+|+++.....-... ...++.+-|..|+|||++.+. .||.+.|||+.|||..||+|-.+-|...
T Consensus 180 lGlaR~~~~plkpl-~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPL-ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhcccccc-ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999876533222 123445578999999998764 6999999999999999999988887653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=253.45 Aligned_cols=180 Identities=23% Similarity=0.287 Sum_probs=153.0
Q ss_pred cCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCC
Q 006982 316 GRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPA 394 (623)
Q Consensus 316 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~ 394 (623)
|.+|.||++.. .+++.+++|++.... .+..|...+....|||++++++++.+.+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 88999999995 468899999986543 2334555555667999999999999999999999999999999998532
Q ss_pred CCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCc
Q 006982 395 DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474 (623)
Q Consensus 395 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt 474 (623)
..+++.....++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+....... .+..++
T Consensus 80 ----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~ 145 (237)
T cd05576 80 ----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------DGEAVE 145 (237)
T ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------ccCCcC
Confidence 3589999999999999999999998 99999999999999999999999999887654311 122356
Q ss_pred ccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 475 LGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 475 ~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
..|+|||......++.++||||+|+++|||++|+.|+..
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 789999999888889999999999999999999988753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=273.45 Aligned_cols=209 Identities=25% Similarity=0.401 Sum_probs=181.4
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEe----
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMA---- 371 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 371 (623)
+.+...++.|.+.++||+|.+|.||+++ .++++.+|+|+........++.+.|.++++.. .|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3344456778889999999999999999 56799999999988887788889999999888 69999999999864
Q ss_pred -CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEee
Q 006982 372 -KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450 (623)
Q Consensus 372 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~D 450 (623)
+++.|||||||.+||..|+++.-. +..+.|.....|+..+++|+.+||.. .++|||||-.|||+++++.+|+.|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 467899999999999999997654 67899999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
||++..+...... -++..||+-|||||++.- ..|+.++|+||+|++..||--|.+|+.+..
T Consensus 167 FGvSaQldsT~gr----RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 167 FGVSAQLDSTVGR----RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred eeeeeeeeccccc----ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 9999877643222 233459999999999853 357789999999999999999999987644
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=271.31 Aligned_cols=266 Identities=18% Similarity=0.215 Sum_probs=178.1
Q ss_pred HhccCcccceeeccCccEEEEEEe-----------------CCCcEEEEEEeccccc-cH--------------HHHHHH
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-----------------EDGTSLMVKRLQDSQR-SE--------------KEFVAE 350 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~-~~--------------~~~~~e 350 (623)
..++|...++||+|+||.||+|.. .+++.||||++..... .. +.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999964 2456799999864321 11 223446
Q ss_pred HHHhCCCCCCCC-----cceeEEEEe--------CCeeeEEEecCCCCCHhhhccCCCC--------------------C
Q 006982 351 MATLGSVKNRNL-----VPLLGFCMA--------KKERLLVYKHMPNGSLYDLLHPADD--------------------T 397 (623)
Q Consensus 351 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~ 397 (623)
+.++.+++|.++ ++++++|.. ....++||||+++|+|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 677787753 3567999999999999999874321 0
Q ss_pred CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccc
Q 006982 398 GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477 (623)
Q Consensus 398 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y 477 (623)
...++|..+..++.|++.+|.|||+. +|+||||||+||+++.++.+||+|||+++......... . ....+++.|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~--~~g~~tp~Y 376 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-P--LYGMLDPRY 376 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-c--cccCCCcce
Confidence 12357888999999999999999999 99999999999999999999999999997654321111 1 111247899
Q ss_pred cCcccccCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCCCc----ccccccHHHHHHH
Q 006982 478 VAPEYARTLVA----------------------TPKGDVYSFGTVLLELVTGER-PTNVAKAP----ETFKGNLVEWIAQ 530 (623)
Q Consensus 478 ~aPE~~~~~~~----------------------s~k~DV~sfGvil~elltg~~-P~~~~~~~----~~~~~~l~~~~~~ 530 (623)
+|||.+..... ..+.||||+||+++||++|.. |+...... ......+..|...
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 99998754221 235799999999999999875 66432110 0111223333221
Q ss_pred HhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.... .+-. ..+...+....++.-.+..-. .+|.+|+|++|+++.
T Consensus 457 ~~~~------~~~~-~~d~~s~~~~dLi~~LL~~~~-~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQK------YDFS-LLDRNKEAGWDLACKLITKRD-QANRGRLSVGQALSH 500 (507)
T ss_pred cccC------CCcc-cccccChHHHHHHHHHhccCC-CCcccCCCHHHHhCC
Confidence 1000 0000 011234555555554443221 345799999999753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.01 Aligned_cols=240 Identities=20% Similarity=0.211 Sum_probs=185.5
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEec
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++.|.....+|.|+|+.|-.+.. .+++..++|++.+.. ..-.+|+.++... .|||++++.+.+.+..+.|+|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 56777778899999999998884 468889999997652 2233567665555 799999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee-CCCCCeEEeecccccccCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL-DDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl-~~~~~~kl~Dfgla~~~~~~ 460 (623)
+.+|-+.+.+... +.+. ..+..|+.+++.++.|||++ |++||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988887532 2233 66778999999999999999 99999999999999 59999999999999987653
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
+.+.+-|..|.|||++....|++++|+||||++||||++|+.||...... ..+ ......+...
T Consensus 470 -------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei----~~~i~~~~~s-- 532 (612)
T KOG0603|consen 470 -------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEI----HTRIQMPKFS-- 532 (612)
T ss_pred -------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHH----HHhhcCCccc--
Confidence 22334588999999999999999999999999999999999999753221 011 1111111111
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+..+++...+++- +++.||.+||+|+++...
T Consensus 533 -------~~vS~~AKdLl~~----LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 -------ECVSDEAKDLLQQ----LLQVDPALRLGADEIGAH 563 (612)
T ss_pred -------cccCHHHHHHHHH----hccCChhhCcChhhhccC
Confidence 2244555555553 334899999999998654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-31 Score=246.26 Aligned_cols=267 Identities=21% Similarity=0.279 Sum_probs=194.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-------- 372 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 372 (623)
+.|....+||+|.||.||+|+.+ .|+.|++|+.-.. ..-.....+|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34666788999999999999955 5777888766331 22234567899999999999999999888542
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
...|+|+++|+. +|.-+|.. ....++..++.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 346899999987 89988853 235688899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHH--
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIA-- 529 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~-- 529 (623)
+++...............++-|..|++||.+.+ ..|+.+.|||+-|||+.||+||.+-+......... ..+.....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql-~~Is~LcGs~ 248 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL-HLISQLCGSI 248 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH-HHHHHHhccC
Confidence 998765443333333334556999999998876 56899999999999999999999887664332110 00000000
Q ss_pred --------------HHhcc----CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 530 --------------QLSST----GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 530 --------------~~~~~----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
+.... ..-...+...+..-..+++...+++..+. .||.+|+++++++..-
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~----~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLK----LDPTKRIDADQALNHD 316 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhc----cCcccCcchHhhhchh
Confidence 00000 01122223333322334566666666555 8999999999987654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=247.95 Aligned_cols=236 Identities=26% Similarity=0.317 Sum_probs=186.5
Q ss_pred CccEEEEEEeC-CCcEEEEEEeccccc-c-HHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHhhhccC
Q 006982 317 RTGTMYKALLE-DGTSLMVKRLQDSQR-S-EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHP 393 (623)
Q Consensus 317 ~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 393 (623)
+||.||+|... ++..+++|++..... . .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 489999999976432 2 57899999999999999999999999999999999999999999999863
Q ss_pred CCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCC
Q 006982 394 ADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFG 473 (623)
Q Consensus 394 ~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~g 473 (623)
. ..+++..++.++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+....... ......+
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~ 148 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFVG 148 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----ccccccC
Confidence 2 2388999999999999999999999 99999999999999999999999999998765432 1123347
Q ss_pred cccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHH-
Q 006982 474 DLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDN- 552 (623)
Q Consensus 474 t~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~- 552 (623)
+..|++||......++.++||||||++++||++|..||...... ....++.... .........
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~~~------------~~~~~~~~~~ 212 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIGKP------------KPPFPPPEWK 212 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhcc------------CCCCcccccc
Confidence 88999999998888899999999999999999999998652111 0111111100 000000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 553 ELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 553 ~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
....+.+++.+|+. .+|++||++.++++
T Consensus 213 ~~~~~~~~i~~~l~-~~p~~Rp~~~~~~~ 240 (244)
T smart00220 213 ISPEAKDLIRKLLV-KDPEKRLTAEEALQ 240 (244)
T ss_pred CCHHHHHHHHHHcc-CCchhccCHHHHhh
Confidence 11345666677887 89999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=255.08 Aligned_cols=202 Identities=22% Similarity=0.260 Sum_probs=170.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 378 (623)
.+|....+||+|+||.|-.|..+ ...-+|||++++... ..+--+.|-++|..- +-|.++.++.+++.-+..|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888899999999999999865 355689999977532 222234566677665 567899999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+.||+|--+++.. ..+.++.+..+|..||-||-|||++ +|+.||||..||++|.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999988643 4578888999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAP 517 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~ 517 (623)
-.+.. ..+-+||+.|+|||.+...+|...+|.|||||+||||+.|..||++.+..
T Consensus 502 ~~~~T----TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 502 FDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred cCCcc----eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 32222 23345999999999999999999999999999999999999999875543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=262.40 Aligned_cols=194 Identities=21% Similarity=0.374 Sum_probs=167.8
Q ss_pred cceeeccCccEEEEEEe-CCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 310 NNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
.++||+|.||+||-|++ ++|+.||||++.+. ...+..+.+|+.+|.++.||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 57999999999999995 57999999999764 34567889999999999999999999999999999999999965
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeecccccccCCCCC
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~ 462 (623)
+..+.+-..+ ...+++..-..+..||..||.|||.+ +|+|+||||+|||+.. --++||+|||+|+.+...
T Consensus 648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 5544443322 25688888888999999999999999 9999999999999953 457999999999998753
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.+-+..+||+.|+|||++....|...-|+||.|||+|--++|..||..+
T Consensus 721 ---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 721 ---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred ---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 3344567999999999999999999999999999999999999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=273.71 Aligned_cols=201 Identities=20% Similarity=0.226 Sum_probs=140.2
Q ss_pred HhccCcccceeeccCccEEEEEEeC-C----CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEE------EEe
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-D----GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGF------CMA 371 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~ 371 (623)
..++|...+.||+|+||.||+|++. + +..||+|++....... ....| .+....+.+++.++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-IWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-HHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4578999999999999999999975 4 6899999876433211 11111 1122222222222211 234
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCC----------------CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDT----------------GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISS 435 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~ 435 (623)
..+.++|+||+++++|.++++..... .....+..+..++.|++.||+|||+. +|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence 56789999999999999998643210 01112334567999999999999999 999999999
Q ss_pred CceeeCC-CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCC----------------------CCCcch
Q 006982 436 KCILLDD-DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL----------------------VATPKG 492 (623)
Q Consensus 436 ~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~ 492 (623)
+|||+++ ++.+||+|||+++.+....... .....++++|+|||.+... .++.++
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~---~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYI---PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccC---CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999985 6899999999998654322211 1223478999999965321 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCC
Q 006982 493 DVYSFGTVLLELVTGERPTN 512 (623)
Q Consensus 493 DV~sfGvil~elltg~~P~~ 512 (623)
|||||||++|||+++..|+.
T Consensus 361 DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc
Confidence 99999999999999776643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=260.04 Aligned_cols=208 Identities=25% Similarity=0.292 Sum_probs=172.8
Q ss_pred ccCcccceeeccCccEEEEEEeCC-CcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
..|.+.+.||-|+||.|.++...| ...+|+|.+.+.. ........|-++|.....+.||+|+..|++++..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 357778899999999999998655 4557889886542 33456778999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc--
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM-- 457 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~-- 457 (623)
||++||++-.+|-.. ..|.+..+..++.++.+|+++.|.. |+|||||||.|||||.+|++||+|||++.-.
T Consensus 709 dYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 999999999998532 4577887888888999999999999 9999999999999999999999999999532
Q ss_pred -------CCCCCcc-----------------------------cccccCCCCcccccCcccccCCCCCcchhHHHHHHHH
Q 006982 458 -------NPIDTHL-----------------------------STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVL 501 (623)
Q Consensus 458 -------~~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil 501 (623)
...+.+. .+.....+||+-|+|||++....|+.-+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 1100000 0111234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCccc
Q 006982 502 LELVTGERPTNVAKAPET 519 (623)
Q Consensus 502 ~elltg~~P~~~~~~~~~ 519 (623)
|||+.|+.||......+.
T Consensus 862 ~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHhhCCCCccCCCCCcc
Confidence 999999999988766544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-31 Score=247.00 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=181.8
Q ss_pred cceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHh-CCCCCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 310 NNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATL-GSVKNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
...||.|.||+|+|-.++ .|+.+|||++.... .+.+++..|.+.. +.-+.||||+++|.+...+..|+-||.|.-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 457999999999998854 79999999997643 4567788888875 444789999999999999999999999954
Q ss_pred CHhhhccCC-CCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 386 SLYDLLHPA-DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 386 sL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+..+-+.. ......+++.-.-+|..-...||.||-+.. .|+|||+||+|||+|..|.+||+|||++-.+..+
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---- 221 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---- 221 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH----
Confidence 766553211 112245777777788888899999999875 8999999999999999999999999999766431
Q ss_pred cccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC-chhhhh
Q 006982 465 STFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG-QLQDAI 541 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~ 541 (623)
.......|-..|||||.+.. ..|+.+|||||+|+.|+|+.||+.||..... ..+-+.+..... ++...-
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCCCCeecCc
Confidence 11112346678999999864 3488999999999999999999999864211 222222222221 111100
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.. ..+--..+.+..-.|+- .|-+.||..+++.++
T Consensus 294 ~~------~~~~s~~~~~fintCl~-Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KE------CVHYSFSMVRFINTCLI-KDRSDRPKYDDLKKF 327 (361)
T ss_pred cc------ccccCHHHHHHHHHHhh-cccccCcchhhhhcC
Confidence 00 11122344445556777 889999999887654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=223.75 Aligned_cols=198 Identities=23% Similarity=0.350 Sum_probs=165.3
Q ss_pred cCcccceeeccCccEEEEEE-eCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+|...++||+|.||+|++|+ +..+..||+|+++-.. .......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667889999999999999 4568889999986433 3346788999999999999999999999988899999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
|.. +|..+... -+..++......++.|+.+|+.|.|++ ++.|||+||+|.||+.+|+.|++|||+++-..-.-
T Consensus 83 cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 88888753 235688899999999999999999999 99999999999999999999999999998754321
Q ss_pred CcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVT-GERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~ellt-g~~P~~~~ 514 (623)
.++ ...+-|..|++|.++.+. -|+...|+||-|||+.|+.. |++-|.+.
T Consensus 156 ---rcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 156 ---RCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred ---Eee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 111 223468999999998765 47899999999999999997 55545543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=232.50 Aligned_cols=203 Identities=23% Similarity=0.326 Sum_probs=167.5
Q ss_pred CcccceeeccCccEEEEEEe-CCCcEEEEEEecccc--ccHHHHHHHHHHh-CCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 307 FSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ--RSEKEFVAEMATL-GSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
......||+|++|.|-+-++ .+|+..|+|++...- +..++..+|+++. +....|.+|.++|........++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34456799999999988875 479999999997643 4556788899884 4557899999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
.- ||..+-...-..+..+++.-.-+||..+.+||.|||++. .++|||+||+|||++.+|++|++|||.+-.+..+-.
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 65 888776554445678899999999999999999999986 899999999999999999999999999987653211
Q ss_pred cccccccCCCCcccccCccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAP 517 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~ 517 (623)
. . -..|-..|||||.+. ...|+-|+||||+|+.+.||.+++.||+....+
T Consensus 205 k---t--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 205 K---T--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred H---H--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 1 1 123667899999875 346899999999999999999999999865443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=254.91 Aligned_cols=204 Identities=22% Similarity=0.289 Sum_probs=166.7
Q ss_pred cCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccc--------cHHHHHHHHHHhCCCCCCCCcceeEEEEe-CCee
Q 006982 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQR--------SEKEFVAEMATLGSVKNRNLVPLLGFCMA-KKER 375 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 375 (623)
+|-..++||+|||+.||+|. +...+.||||+-..... -.+...+|.++...+.||.||++++|+.- .+..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 34445689999999999998 45677889997643221 23456789999999999999999999865 4567
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC---CCCCeEEeecc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD---DDFEPKISDFG 452 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~---~~~~~kl~Dfg 452 (623)
+-|+|||+|.+|.-+|+. ...+++..+..|+.||+.||.||.+. +|+|||-||||.|||+. .-|.+||+|||
T Consensus 544 CTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999963 45689999999999999999999886 67899999999999994 56789999999
Q ss_pred cccccCCCCCc-ccc--cccCCCCcccccCccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTH-LST--FVNGEFGDLGYVAPEYAR----TLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~-~~~--~~~~~~gt~~y~aPE~~~----~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++.+...... ... ......||++|++||.+. ..+.+.|+||||.|||+|..+.|+.||...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 99998654322 111 112235999999999874 346789999999999999999999999764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=257.73 Aligned_cols=198 Identities=22% Similarity=0.315 Sum_probs=172.1
Q ss_pred CcccceeeccCccEEEEEEeCCCc-EEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 307 FSKNNIIGSGRTGTMYKALLEDGT-SLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+.....||-|+||.|-.+..+... .+|+|.+++.. ...++...|-.+|...+.|.||+++..|.++...|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344567999999999998865433 47888886542 3455678899999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
|-||.|...|. ..+.++..+...++..+.+|++|||++ +|+.|||||+|.++|.+|.+||.|||+|+.+....
T Consensus 502 ClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 502 CLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999996 346788888899999999999999999 99999999999999999999999999999987654
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
... ++ +||+.|.|||.+.....+..+|.||+|+++||+++|.+||...+.
T Consensus 575 KTw-TF----cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 575 KTW-TF----CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred cee-ee----cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 432 22 499999999999998889999999999999999999999987554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=272.21 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=184.3
Q ss_pred cCcccceeeccCcc-EEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 306 SFSKNNIIGSGRTG-TMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 306 ~f~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
-|...+++|.|+.| .||+|..+ |+.||||++-... .+...+|+..|+.- +|||||++++.-.++...|+..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 35666789999987 56999995 7899999985443 23456899988777 79999999998888899999999995
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-----CCCeEEeecccccccC
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-----DFEPKISDFGLARLMN 458 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-----~~~~kl~Dfgla~~~~ 458 (623)
. +|.+++...........-...+.+..|++.|++|||+. +|+||||||+||||+. ...++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999976411111111134567889999999999998 9999999999999975 2578999999999987
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTG-ERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg-~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
........ ..+..||-||+|||.+....-+..+||||+|||+|+.++| .+||.+....+. ..+.....
T Consensus 663 ~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~~~ 731 (903)
T KOG1027|consen 663 GGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGNYT 731 (903)
T ss_pred CCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCccc
Confidence 65544444 5566799999999999988888899999999999999985 999976432110 11111000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.. +|... .+.+..+++...+. .+|..||++.+|+.
T Consensus 732 L~----~L~~~-~d~eA~dLI~~ml~----~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LV----HLEPL-PDCEAKDLISRMLN----PDPQLRPSATDVLN 766 (903)
T ss_pred ee----eeccC-chHHHHHHHHHhcC----CCcccCCCHHHHhC
Confidence 00 01111 11155555554443 89999999999964
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=245.98 Aligned_cols=202 Identities=21% Similarity=0.299 Sum_probs=170.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCC--C----CCcceeEEEEeCCeee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN--R----NLVPLLGFCMAKKERL 376 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~~~~ 376 (623)
+++|.+...+|+|.||.|-..... .+..||+|+++.-....+...-|++++.++.+ | -+|.+.+||...+..+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 567888999999999999999844 47899999998766666777789999999943 2 3677888899999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC--------------
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-------------- 442 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-------------- 442 (623)
+|+|.+ |-|+++++.... -.+++..+...|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 669999997543 36788899999999999999999999 9999999999999931
Q ss_pred ------CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 443 ------DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 443 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
+..+||+|||-|+...... +.. +.|..|+|||++.+-.++..+||||+||||.|+.||..-|...+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h---s~i----VsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH---STI----VSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc---cee----eeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3468999999998754422 222 357889999999999999999999999999999999999987654
Q ss_pred cc
Q 006982 517 PE 518 (623)
Q Consensus 517 ~~ 518 (623)
.|
T Consensus 315 ~E 316 (415)
T KOG0671|consen 315 LE 316 (415)
T ss_pred HH
Confidence 44
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=233.15 Aligned_cols=199 Identities=20% Similarity=0.275 Sum_probs=170.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 378 (623)
++|....+||+|+|..|..+.++ +.+.+|+|++++.- ...+-.+.|-.+..+. +||.+|-+..+|+.....++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 56888899999999999999865 57789999887542 3334456677777666 799999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
.||++||+|--+++. ...+++..+..+...|..||.|||++ ||+.||||..|||+|.+|++|++|||+++.--
T Consensus 330 ieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999888753 35688888889999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
......+++ +||+-|+|||.+.+..|...+|.|++||+++||+.|+.||+.-
T Consensus 403 ~~gd~tstf----cgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 403 GPGDTTSTF----CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred CCCcccccc----cCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 322223333 4999999999999999999999999999999999999999753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=222.84 Aligned_cols=209 Identities=28% Similarity=0.471 Sum_probs=177.1
Q ss_pred eeccCccEEEEEEeCC-CcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHhh
Q 006982 313 IGSGRTGTMYKALLED-GTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYD 389 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 389 (623)
||+|.+|.||++...+ +..+++|++..... ..+.+.+|++.+..++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 89999999976654 35779999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-CCCeEEeecccccccCCCCCcccccc
Q 006982 390 LLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFGLARLMNPIDTHLSTFV 468 (623)
Q Consensus 390 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 468 (623)
++.... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~ 150 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LL 150 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hh
Confidence 986331 3688999999999999999999999 9999999999999999 89999999999987654321 11
Q ss_pred cCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhc
Q 006982 469 NGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA 547 (623)
Q Consensus 469 ~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 547 (623)
....+...|++||..... .++.++|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 122367889999999877 788999999999999999
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 548 KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 548 ~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
..+.+++..|+. .+|++||++.++++.
T Consensus 188 -------~~~~~~l~~~l~-~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------PELKDLIRKMLQ-KDPEKRPSAKEILEH 214 (215)
T ss_pred -------HHHHHHHHHHhh-CCcccCcCHHHHhhC
Confidence 233444455655 789999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=245.02 Aligned_cols=197 Identities=21% Similarity=0.304 Sum_probs=167.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccH---------HHHHHHHHHhCCCC---CCCCcceeEEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSE---------KEFVAEMATLGSVK---NRNLVPLLGFCM 370 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~e~~~l~~l~---h~niv~l~~~~~ 370 (623)
..+|+..+.+|+|+||.|+.+.++ +...|++|.+.+++.-. ...-.|+++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356888899999999999999976 46678888887654221 22456999999997 999999999999
Q ss_pred eCCeeeEEEecC-CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEe
Q 006982 371 AKKERLLVYKHM-PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKIS 449 (623)
Q Consensus 371 ~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~ 449 (623)
+++..|++||-. ++-+|++++.. .+.+++..+..|+.||+.|+++||++ +|+|||||-+||.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 999999999966 67799999963 35689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT-PKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~sfGvil~elltg~~P~~~ 513 (623)
|||.+..... ...+.-+||.+|.|||++.+.+|- ..-|||++|++||.++....||+.
T Consensus 713 dfgsaa~~ks------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKS------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcC------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999976533 122333599999999999988775 457999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=224.47 Aligned_cols=198 Identities=27% Similarity=0.373 Sum_probs=170.0
Q ss_pred CcccceeeccCccEEEEEEeCC-CcEEEEEEeccccc--cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 307 FSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
|...+.||+|++|.||++...+ +..+++|.+..... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556889999999999999775 88999999976543 46788899999999999999999999999899999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+++|.+++.... ..+++.....++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999996432 1178999999999999999999999 9999999999999999999999999999876543200
Q ss_pred ccccccCCCCcccccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 464 LSTFVNGEFGDLGYVAPEYA-RTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11223467889999998 667778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=222.00 Aligned_cols=260 Identities=18% Similarity=0.312 Sum_probs=189.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEE-EEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGF-CMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~e~ 381 (623)
+.|.+.+.+|+|.||.+-.+.++ ..+.+++|.+.......++|.+|...--.+ .|.||+.-++. |+..+..++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 46888899999999999999976 567899999998888899999999885555 68999988765 5666777789999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC--CCCCeEEeecccccccCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD--DDFEPKISDFGLARLMNP 459 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~--~~~~~kl~Dfgla~~~~~ 459 (623)
+|.|+|.+-+.. ..+.+....+++.|++.|+.|+|++ .++|||||.+||||- +...+|++|||+.+..+.
T Consensus 104 aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998842 4467788899999999999999999 999999999999993 455899999999986543
Q ss_pred CCCcccccccCCCCcccccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTL-----VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
.- .....+..|.|||..... ...+.+|||.||++++.++||+.||......+.......+|.....
T Consensus 176 tV-------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~-- 246 (378)
T KOG1345|consen 176 TV-------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN-- 246 (378)
T ss_pred ee-------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--
Confidence 21 112245678999976532 3567899999999999999999999753332221122222322111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
..+.+.+. ...+.+.++++-.+. ++|++|--..++.++-.....+..
T Consensus 247 ~~~P~~F~------~fs~~a~r~Fkk~lt----~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 247 PALPKKFN------PFSEKALRLFKKSLT----PRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred ccCchhhc------ccCHHHHHHHHHhcC----CcccccchhHHHHHHHHHHHHHhh
Confidence 11111111 123444455544333 778888777777777665544443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-28 Score=225.33 Aligned_cols=198 Identities=24% Similarity=0.329 Sum_probs=163.5
Q ss_pred cccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----CeeeEE
Q 006982 308 SKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KERLLV 378 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV 378 (623)
+..+-||-|+||.||.... ++|+.|+.|++..-. .+.+.+-+|++++..++|.|++..++..+-. ++.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4467899999999999985 489999999986533 3567788999999999999999998877543 357889
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+|.|.. +|...+- ..+.++-....-+..||.+||.|||+. +|.||||||.|.|++.+...||+|||+++.-.
T Consensus 136 TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 999854 8888873 557788888888999999999999999 99999999999999999999999999999755
Q ss_pred CCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
..+... +...+-|..|+|||.+++ ..|+.+.||||.|||+.|++..+.-|.....
T Consensus 208 ~d~~~h---MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 208 QRDRLN---MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hhhhhh---hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 432211 111224778999999986 4689999999999999999998888865433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=207.55 Aligned_cols=194 Identities=16% Similarity=0.298 Sum_probs=162.5
Q ss_pred hccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCC--eeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKK--ERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lV~ 379 (623)
.++|++.+.+|+|.++.|+.|. ..+..++++|+++.- ..+.+.+|+.+|..++ ||||+++++...+.. ...+|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 3567888999999999999998 456788999999754 3567889999999997 999999999998765 456999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-CCCeEEeecccccccC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFGLARLMN 458 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-~~~~kl~Dfgla~~~~ 458 (623)
||+.+-+...+- +.++-........++..||.|+|+. ||.|||+||.|++||. .-..+|+|+|+|-+..
T Consensus 115 E~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 115 EYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999998888776 4567777888999999999999999 9999999999999985 5579999999999877
Q ss_pred CCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+.... +-++.+--|.-||.+-. ..|+..-|+|||||++.+|+..+.||-..
T Consensus 185 p~~eY-----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 185 PGKEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred CCcee-----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 64332 22335566788998865 45788999999999999999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=255.33 Aligned_cols=199 Identities=17% Similarity=0.166 Sum_probs=135.3
Q ss_pred CCCC-CCCcceeEEE-------EeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC
Q 006982 356 SVKN-RNLVPLLGFC-------MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427 (623)
Q Consensus 356 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 427 (623)
.++| +||++++++| ......+.++||+ +++|.++|... ...+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4456 6888888877 2233456778887 55999999632 35689999999999999999999999 9
Q ss_pred cEecCCCCCceeeCC-------------------CCCeEEeecccccccCCCCC----c--------ccccccCCCCccc
Q 006982 428 IIHRNISSKCILLDD-------------------DFEPKISDFGLARLMNPIDT----H--------LSTFVNGEFGDLG 476 (623)
Q Consensus 428 i~H~dlk~~NILl~~-------------------~~~~kl~Dfgla~~~~~~~~----~--------~~~~~~~~~gt~~ 476 (623)
|+||||||+||||+. ++.+|++|||+++....... . .........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965 44556666666654211000 0 0000011347888
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHH
Q 006982 477 YVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQ 556 (623)
Q Consensus 477 y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 556 (623)
|||||++.+..++.++|||||||+||||++|..|+.... ......... .+.+. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~---------~~~~~-----~~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR---------VLPPQ-----ILLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh---------hcChh-----hhhcCHH
Confidence 999999999999999999999999999999888764210 011111100 00110 0111223
Q ss_pred HHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 557 FLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 557 ~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
...++..|+. .+|.+||+|.|+++.
T Consensus 241 ~~~~~~~~L~-~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLH-PEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCC-CChhhCcChHHHhhc
Confidence 3455567776 999999999999763
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=214.35 Aligned_cols=131 Identities=19% Similarity=0.367 Sum_probs=114.1
Q ss_pred ccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccccHHHHHHHHHHhCCCC-----C---CCCcceeEEEEeC---
Q 006982 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-----N---RNLVPLLGFCMAK--- 372 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~--- 372 (623)
++|.+.++||=|.|++||++. ..+.+.||+|+.+..+.-.+....||++|.+++ | .+||+++++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 678899999999999999999 456788999999887777778889999999884 3 3799999999754
Q ss_pred -CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee
Q 006982 373 -KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440 (623)
Q Consensus 373 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl 440 (623)
.+.++|+|++ |-+|..+|....- +.++.....+|+.||+.||.|||.+| +|||.||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 5789999999 6689999876544 45778899999999999999999999 99999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=232.90 Aligned_cols=248 Identities=22% Similarity=0.302 Sum_probs=190.1
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|....++|.|.||.|||++. ..+...|+|+++... ...+...+|+-+++.-+|||||.++|.+...+..++.|||+
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 4577788999999999999994 468889999998654 34456778999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
.+|+|++.-+ ...++++.+.........+|++|||+. +-+|||||-.|||+++.+.+|++|||.+-.+...-.
T Consensus 95 gggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 95 GGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred CCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999886 336789999999999999999999999 889999999999999999999999999976643211
Q ss_pred cccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. ....||+.|||||+.. .+.|..++|||+.|+...|+-.-..|..+... .+-..-+...
T Consensus 168 Kr----ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr~l~LmTkS----- 230 (829)
T KOG0576|consen 168 KR----KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MRALFLMTKS----- 230 (829)
T ss_pred hh----hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------HHHHHHhhcc-----
Confidence 11 1234999999999873 56688999999999999999887777433211 1100000000
Q ss_pred hhch-hhhc-CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHH
Q 006982 540 AIDK-CLVA-KGVDNELFQFLKVACNCVLPTIPKERPTMFEVY 580 (623)
Q Consensus 540 ~~d~-~l~~-~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~ 580 (623)
.+++ .+.. ..-.+-+..+++.++. .+|++||++...+
T Consensus 231 ~~qpp~lkDk~kws~~fh~fvK~alt----knpKkRptaeklL 269 (829)
T KOG0576|consen 231 GFQPPTLKDKTKWSEFFHNFVKGALT----KNPKKRPTAEKLL 269 (829)
T ss_pred CCCCCcccCCccchHHHHHHHHHHhc----CCCccCCChhhhe
Confidence 0111 1111 1123445566666554 8899999988754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=211.51 Aligned_cols=193 Identities=25% Similarity=0.325 Sum_probs=158.4
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------Cee
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------KER 375 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 375 (623)
+|.....+|.|.- .|..+.. -.++.|++|++... ....++..+|...+..++|+|+++++.++.-. .+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555667888887 6666653 35788999988543 23456778899999999999999999988543 356
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
|+|||||. ++|...++ ..++-.+..+|..|+.+|+.|||+. +|+||||||+||++..+..+||.|||+|+
T Consensus 97 y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 89999995 49998886 3467778889999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.-... -.....+.|--|.|||++.+..+.+.+||||.||++.||++|+.-|.+.
T Consensus 167 ~e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 167 TEDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred ccCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 65432 1122234677899999999888999999999999999999999988753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=204.87 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=183.9
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
.+|.+...|..|+|+++ |..+++|++.-. .+..+.|..|.-.++-+.||||++++|.|.......++..|||.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 35778889999999997 556667777543 34456899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 467 (623)
+..||... +-..+-.++.+++.++|+|++|||+.. |-|.---|.+..|++|++.+++|+= +-++ .+..
T Consensus 275 ynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~k--------fsfq 342 (448)
T KOG0195|consen 275 YNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTK--------FSFQ 342 (448)
T ss_pred HHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccce--------eeee
Confidence 99998653 467788899999999999999999973 3344556889999999999998841 1111 1222
Q ss_pred ccCCCCcccccCcccccCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 468 VNGEFGDLGYVAPEYARTLVAT---PKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 468 ~~~~~gt~~y~aPE~~~~~~~s---~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
..++...+.||+||.++..+-+ ..+|+|||.+++||+.|...||.+...-+..-+. .+ +-+...
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------al------eglrv~ 409 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------AL------EGLRVH 409 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------hh------cccccc
Confidence 2344467899999999866533 5799999999999999999999865443211100 00 000111
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
+ ..+....+.+++. .|+. +||.+||.++.|+-.|+++.
T Consensus 410 i-ppgis~hm~klm~---icmn-edpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 I-PPGISRHMNKLMN---ICMN-EDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred C-CCCccHHHHHHHH---HHhc-CCCCcCCCcceehhhHHHhc
Confidence 1 1223444444444 5777 99999999999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=196.88 Aligned_cols=168 Identities=23% Similarity=0.241 Sum_probs=123.8
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.++++.. +..++|.+++.++.|++.||.|||+. + ||+|||+++++.+++ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 7899999632 35699999999999999999999998 5 999999999999999 99998754321
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...+..+..........
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~------- 127 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---SAILEILLNGMPADDPR------- 127 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---cHHHHHHHHHhccCCcc-------
Confidence 13789999999999999999999999999999999999998643221 11112221111110000
Q ss_pred hhcCCCHHHH---HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 545 LVAKGVDNEL---FQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 545 l~~~~~~~~~---~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
........ ..+.+++..|+. .+|++||++.|+++.+..+..
T Consensus 128 --~~~~~~~~~~~~~~~~~i~~cl~-~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 128 --DRSNLESVSAARSFADFMRVCAS-RLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred --ccccHHHHHhhhhHHHHHHHHHh-cccccccCHHHHHHHHHHHHH
Confidence 00011111 235666667777 999999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=220.33 Aligned_cols=209 Identities=20% Similarity=0.248 Sum_probs=174.3
Q ss_pred cCHHHHHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCC------CCCcceeE
Q 006982 295 MRLSDLMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN------RNLVPLLG 367 (623)
Q Consensus 295 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~ 367 (623)
+.+.|+. -..|.+....|+|-|++|.+|... .|..||||++.....-.+.-+.|+++|.+|+. -|+++++.
T Consensus 424 v~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 424 VRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred Eehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3444444 356888889999999999999954 58899999998887667777899999999953 48999999
Q ss_pred EEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-CCe
Q 006982 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-FEP 446 (623)
Q Consensus 368 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-~~~ 446 (623)
.|...++.+||+|-+. .+|.+.|+... ....|.......++.|+..||..|-.. +|+|.||||.||||++. ..+
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 9999999999999884 59999997654 345678888999999999999999887 99999999999999865 457
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
||||||.|.......... +. -+--|.|||.+.+..|+...|+||.||.|||+.||+.-|.+.+.
T Consensus 577 KLCDfGSA~~~~eneitP--YL----VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 577 KLCDFGSASFASENEITP--YL----VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred eeccCccccccccccccH--HH----HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 999999998775433221 11 23469999999999999999999999999999999999987544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=226.58 Aligned_cols=184 Identities=32% Similarity=0.513 Sum_probs=134.1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCcccCCCCCCCCCCCCCCcccceeecCCC-C--CcEEEEEecCCCceeeCCccccCCCC
Q 006982 29 YGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPD-E--NRVLNLRLTDMGLKGQFPRGIRNCSS 105 (623)
Q Consensus 29 ~~~~~d~~~Ll~~k~~~~~~~~~l~~sW~~~~~~~~~~c~w~gv~c~~~~-~--~~v~~l~l~~~~l~g~~p~~l~~l~~ 105 (623)
.+.++|..||+.+|+++.++.. .+|+++ ++....|.|.||.|.... . .+|+.|+|++|+|+|.+|+.|++|++
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~---~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR---FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc---CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 3467899999999999977642 389742 222223489999995321 1 35888999999999999999999999
Q ss_pred CCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccc
Q 006982 106 MTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVA 185 (623)
Q Consensus 106 L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~ 185 (623)
|+.|+|++|+|+|.+|..++.+.. |+.|||++|+|+|.+|..++++++|+.|+|++|+|+|.+|..++.+.
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~-L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~-------- 514 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITS-LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL-------- 514 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCC-CCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhcc--------
Confidence 999999999999999988888654 99999999999988888888888899999988888888888775431
Q ss_pred cccccccCCccccccccccccCCCCCCCCCCC-CCCCCCCCCCCccceeeehhhhHH
Q 006982 186 NNLLSGSIPTFVNLTLSADSVTNNQGLCGEPL-DACKGTSKGPHTGVIAGAAIGGVT 241 (623)
Q Consensus 186 ~N~l~g~ip~~~~~~~~~~~~~~n~~l~~~~~-~~c~~~~~~~~~~~i~~~~i~~v~ 241 (623)
.......+.+|+.+|+.|. ..|... .....++++++++++
T Consensus 515 -------------~~~~~l~~~~N~~lc~~p~l~~C~~~---~~~~~~i~~~~~~~~ 555 (623)
T PLN03150 515 -------------LHRASFNFTDNAGLCGIPGLRACGPH---LSVGAKIGIAFGVSV 555 (623)
T ss_pred -------------ccCceEEecCCccccCCCCCCCCccc---CCCceEEEEEhHHHH
Confidence 0112234667778888764 667532 123334444444443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=208.96 Aligned_cols=168 Identities=18% Similarity=0.146 Sum_probs=128.9
Q ss_pred HHhccCcccceeeccCccEEEEEEeC--CCcEEEEEEeccc------cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALLE--DGTSLMVKRLQDS------QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK 373 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 373 (623)
...+.|...+.||+|+||+||+|.+. +++.||+|++... ......+.+|++++.+++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34567999999999999999999864 5778899987532 1124568999999999999999864332 24
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCceeeCCCCCeEEeecc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNI-SSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dl-k~~NILl~~~~~~kl~Dfg 452 (623)
..++||||+++++|.... .. . ...++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~-~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PH-G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHhC----cc-c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 579999999999997321 00 1 145788999999999999 9999999 9999999999999999999
Q ss_pred cccccCCCCCccc----ccccCCCCcccccCcccccCC
Q 006982 453 LARLMNPIDTHLS----TFVNGEFGDLGYVAPEYARTL 486 (623)
Q Consensus 453 la~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 486 (623)
+++.......... .-.....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997654321111 011234578899999998643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-23 Score=208.45 Aligned_cols=203 Identities=24% Similarity=0.314 Sum_probs=164.6
Q ss_pred HHhccCcccceeeccCccEEEEEEeC----CCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeee
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 376 (623)
...+.|...++||+|.|++||++... ....||+|.+.... ......+|+++|..+ -+.||+++.+++..++...
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34467888999999999999999843 35779999886543 234588999999998 5899999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeEEeeccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLAR 455 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~kl~Dfgla~ 455 (623)
+|+||++.-+..++.. .++......+...+..||+|+|+. ||+||||||+|+|.+ ..+.-.|.|||+|.
T Consensus 112 ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999883 466788889999999999999999 999999999999997 45667999999997
Q ss_pred ccCCC-------C------Cc-----------------cccc----------ccCCCCcccccCcccccC-CCCCcchhH
Q 006982 456 LMNPI-------D------TH-----------------LSTF----------VNGEFGDLGYVAPEYART-LVATPKGDV 494 (623)
Q Consensus 456 ~~~~~-------~------~~-----------------~~~~----------~~~~~gt~~y~aPE~~~~-~~~s~k~DV 494 (623)
..... . .. .... ...+.||+||+|||++.. ...+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21100 0 00 0000 012469999999999865 456889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 006982 495 YSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 495 ~sfGvil~elltg~~P~~~~~ 515 (623)
||.|||++-+++++.||....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eeccceeehhhccccccccCc
Confidence 999999999999999996543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=233.19 Aligned_cols=158 Identities=37% Similarity=0.674 Sum_probs=120.1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCcccCCCCCCCCCCCCCCcccceeecCCCCCcEEEEEecCCCceeeCCccccCCCCCCE
Q 006982 29 YGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTG 108 (623)
Q Consensus 29 ~~~~~d~~~Ll~~k~~~~~~~~~l~~sW~~~~~~~~~~c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~ 108 (623)
...+.|+.||++||+++.+|...+ .+|+..+ +||.|.||+|++ .++|+.|+|++|+++|.+|+.+..+++|+.
T Consensus 25 ~~~~~~~~~l~~~~~~~~~~~~~~-~~w~~~~----~~c~w~gv~c~~--~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~ 97 (968)
T PLN00113 25 MLHAEELELLLSFKSSINDPLKYL-SNWNSSA----DVCLWQGITCNN--SSRVVSIDLSGKNISGKISSAIFRLPYIQT 97 (968)
T ss_pred CCCHHHHHHHHHHHHhCCCCcccC-CCCCCCC----CCCcCcceecCC--CCcEEEEEecCCCccccCChHHhCCCCCCE
Confidence 346789999999999998887666 5996433 599999999964 469999999999999999999999999999
Q ss_pred EEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccccccccccc
Q 006982 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNL 188 (623)
Q Consensus 109 L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~ 188 (623)
|+|++|+++|.+|..++...++|++|+|++|+++|.+|. +.+++|++|+|++|.++|.+|..++++++|+.|+|++|.
T Consensus 98 L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 175 (968)
T PLN00113 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175 (968)
T ss_pred EECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCc
Confidence 999999999999998873234588888888887776664 345555555555555555555555555555555555555
Q ss_pred ccccCCc
Q 006982 189 LSGSIPT 195 (623)
Q Consensus 189 l~g~ip~ 195 (623)
++|.+|.
T Consensus 176 l~~~~p~ 182 (968)
T PLN00113 176 LVGKIPN 182 (968)
T ss_pred ccccCCh
Confidence 5555554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-20 Score=193.46 Aligned_cols=264 Identities=18% Similarity=0.181 Sum_probs=191.6
Q ss_pred cCcccceeeccCccEEEEEEeCCC--cEEEEEEeccccc-cHHHHHHHHHHhCCCCC----CCCcceeEEE-EeCCeeeE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLEDG--TSLMVKRLQDSQR-SEKEFVAEMATLGSVKN----RNLVPLLGFC-MAKKERLL 377 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 377 (623)
.|.+.+.||+|+||.||.+...+. ..+|+|....... ....+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999996553 4788887755322 12267778888888763 5888888888 46778899
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-----CCeEEeecc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-----FEPKISDFG 452 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-----~~~kl~Dfg 452 (623)
||+.+ |.+|.++..... ...++..+.+.|+.|+..+|.+||+. |++||||||.|+.+... ..+.+.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 779999875443 46799999999999999999999999 99999999999999865 469999999
Q ss_pred ccc--ccCCCCC---ccccc-ccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHH
Q 006982 453 LAR--LMNPIDT---HLSTF-VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526 (623)
Q Consensus 453 la~--~~~~~~~---~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~ 526 (623)
+++ ....... ..... .....||..|.++....+...+.+.|+||++.++.|++.|..||........ ..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~~ 247 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----KS 247 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----HH
Confidence 999 3322111 01111 1234599999999999999999999999999999999999999965433211 00
Q ss_pred HHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 527 WIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
-+..... ...... .....+.++.++.+.... .+..++|....+...+++...+.
T Consensus 248 ~~~~~~~----~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 248 KFEKDPR----KLLTDR--FGDLKPEEFAKILEYIDS----LDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHhh----hhcccc--ccCCChHHHHHHHHHhhc----cCCcCCCCHHHHHHHHHHHHHhc
Confidence 0111000 000000 111234555555554433 56899999999999988765544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=186.13 Aligned_cols=202 Identities=30% Similarity=0.426 Sum_probs=167.9
Q ss_pred CcccceeeccCccEEEEEEeCCCcEEEEEEeccccc----cHHHHHHHHHHhCCCCCC-CCcceeEEEEeCCeeeEEEec
Q 006982 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR----SEKEFVAEMATLGSVKNR-NLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 381 (623)
|...+.||.|+||.||++... ..+++|.+..... ....+.+|+..+..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999987 7888898866432 366789999999999988 799999999777778999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeecccccccCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFGLARLMNPI 460 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgla~~~~~~ 460 (623)
+.++++.+++...... ..+.......+..+++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777532211 2688889999999999999999999 899999999999999988 7999999999865443
Q ss_pred CCccc--ccccCCCCcccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLS--TFVNGEFGDLGYVAPEYART---LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
..... .......|+..|+|||.+.. ..++...|+||+|++++++++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 22211 12344568999999999987 57889999999999999999999997643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.3e-21 Score=199.59 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=182.6
Q ss_pred hCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCc-EecC
Q 006982 354 LGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI-IHRN 432 (623)
Q Consensus 354 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i-~H~d 432 (623)
|+.+.|.|+.+++|.+.+....++|.+|+..|+|.+.+.. ....++|.....+..+++.||.|||+. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 4678999999999999999999999999999999999974 346799999999999999999999998 55 9999
Q ss_pred CCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCC-------CCCcchhHHHHHHHHHHHH
Q 006982 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-------VATPKGDVYSFGTVLLELV 505 (623)
Q Consensus 433 lk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DV~sfGvil~ell 505 (623)
++++|.++|....+|++|||+............. .......-|.|||.+... ..+.+.||||||++++|++
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~--~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAH--HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eccccceeeeeEEEEechhhhccccccccccccc--chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999999876421000000 001134679999998763 1467899999999999999
Q ss_pred hCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 506 TGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 506 tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
+.+.||+.....+.. ..+...+.. .-...+.+.+.... +....++.++..|+. .+|.+||++++|-..++.
T Consensus 153 ~r~~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~-e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWE-EIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred hccCccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcc-cChhhCccHHHHHhhhhh
Confidence 999999865443322 122222222 00111111111110 111256777778888 999999999999999998
Q ss_pred hhcccC-CCCCcccccCCCCCCchhhHHHHHhc
Q 006982 586 IGERYH-FTTEDEIMLPSDSGDADILEELIVAR 617 (623)
Q Consensus 586 i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (623)
+..... ..+..+.+.--...|++.+|.++..|
T Consensus 224 ~~~~~~~~~nl~D~m~~~le~Y~~nLe~~v~eR 256 (484)
T KOG1023|consen 224 INKGGSSKGNLMDSLFRMLESYADNLEKLVDER 256 (484)
T ss_pred hcccccccchhHHHHHHHHHHHHhhhHHHHHHH
Confidence 866542 34666666666778888888888876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-19 Score=174.25 Aligned_cols=269 Identities=18% Similarity=0.208 Sum_probs=204.5
Q ss_pred cCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.|.+.++||+|.||.++.|+ +-++..||+|.-.... ..-++..|.+..+.+ ..+.|...+.|-....+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 57889999999999999998 5679999999653322 233566677776666 4588888888877777888999998
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-----CCCeEEeecccccccC
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-----DFEPKISDFGLARLMN 458 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-----~~~~kl~Dfgla~~~~ 458 (623)
|-||.|+..- -+..++..+...+|.|+..-++|+|++ .+|.|||||+|.||.. ...+.++|||+|+.+.
T Consensus 107 GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 7799988742 346799999999999999999999999 9999999999999963 4458999999999886
Q ss_pred CCCCccccccc---CCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 459 PIDTHLSTFVN---GEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 459 ~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
...+......+ ...||.+||+-....+...+.+-|.=|+|-++.+.+-|..||.+......- .--+-+....+.-
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK--~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK--EKYEKIGETKRST 258 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH--HHHHHhccccccC
Confidence 65444333222 235999999999999999999999999999999999999999875543210 0011111222222
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCC
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTT 594 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 594 (623)
.+.++.+ +.++++..-++.+.. .+=.+-|..+-+...+.++.++...+.
T Consensus 259 ~i~~Lc~------g~P~efa~Yl~yvR~----L~F~E~PDYdylr~Lf~dvldr~g~t~ 307 (449)
T KOG1165|consen 259 PIEVLCE------GFPEEFATYLRYVRR----LDFFETPDYDYLRKLFDDVLDRLGETD 307 (449)
T ss_pred CHHHHHh------cCHHHHHHHHHHHHh----cCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence 3333322 467888888887766 567889999998888888877766554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-21 Score=211.05 Aligned_cols=254 Identities=20% Similarity=0.223 Sum_probs=183.7
Q ss_pred ccceeeccCccEEEEEEeC-CCcEEEEEEec----ccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 309 KNNIIGSGRTGTMYKALLE-DGTSLMVKRLQ----DSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 309 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
..+++|.|.+|.|+..... .......|.+. ... .....+..|+.+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999988777643 33333444332 111 111225678888899999999888887777666666699
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++ +|+.++.. ...+....+-.+..|+..|+.|+|+. +|.|||+|++|++++.++.+||+|||.+....-.
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99999953 23677788889999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATP-KGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.........+..|+-.|+|||.+....|.+ ..||||.|+++..|.+|+.||......+... .......+...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~~ 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRNI 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcccccccc
Confidence 222224455677999999999999988876 5899999999999999999997644332210 00000000000
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.. ........+..-.+.++.|+.+.+|.+|-|+++|++
T Consensus 547 -~~---~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 -FE---GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -cc---ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 000122344556677788888999999999999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=174.90 Aligned_cols=139 Identities=17% Similarity=0.179 Sum_probs=108.7
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccc---c-------H-----------------HHHHHHHHHhCCCCCCCC
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR---S-------E-----------------KEFVAEMATLGSVKNRNL 362 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-------~-----------------~~~~~e~~~l~~l~h~ni 362 (623)
...||+|++|.||+|...+|+.||+|+++.... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988999999999965421 1 0 122349999999988876
Q ss_pred cceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHH-HhcCCCCcEecCCCCCceeeC
Q 006982 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 363 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~i~H~dlk~~NILl~ 441 (623)
.....+.. ...++||||++++++..... ....+++.....++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333322 23489999999987765432 124678899999999999999999 577 999999999999998
Q ss_pred CCCCeEEeecccccccC
Q 006982 442 DDFEPKISDFGLARLMN 458 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~ 458 (623)
++.++|+|||++....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=170.96 Aligned_cols=139 Identities=19% Similarity=0.196 Sum_probs=111.2
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEecccccc---------------------------HHHHHHHHHHhCCCCCCCC
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRS---------------------------EKEFVAEMATLGSVKNRNL 362 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~ni 362 (623)
...||+|++|.||+|...+|+.||+|++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754210 1123578899999999987
Q ss_pred cceeEEEEeCCeeeEEEecCCCCCHhhh-ccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceee
Q 006982 363 VPLLGFCMAKKERLLVYKHMPNGSLYDL-LHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILL 440 (623)
Q Consensus 363 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl 440 (623)
.....+... ..++||||++++++... +. ...++......++.+++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655544333 34899999998865443 32 1346778889999999999999999 8 99999999999999
Q ss_pred CCCCCeEEeecccccccCC
Q 006982 441 DDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 441 ~~~~~~kl~Dfgla~~~~~ 459 (623)
+ ++.++|+|||++..+..
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-20 Score=203.21 Aligned_cols=197 Identities=24% Similarity=0.285 Sum_probs=155.6
Q ss_pred cCcccceeeccCccEEEEEEeCCCcEEEEEEecccc--ccHHHH---HHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 306 SFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ--RSEKEF---VAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++...+.+|++.|=.|.+|+..+|. |+||++.+.. ..-+.| ..|++ ...++|||++++.-+-..+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4566788999999999999999888 8889885432 333333 44555 566699999998888777777889999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC-C
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN-P 459 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~-~ 459 (623)
|+.+ +|+|.+. .++.+...+..-|+.|+..|+..+|+. +|.|||||.+||||+.-..+.|+||.-.+... +
T Consensus 102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 9999994 556788888999999999999999999 99999999999999999999999998776431 1
Q ss_pred CC--CcccccccCCCCcccccCcccccCC-----------CCCcchhHHHHHHHHHHHHh-CCCCCC
Q 006982 460 ID--THLSTFVNGEFGDLGYVAPEYARTL-----------VATPKGDVYSFGTVLLELVT-GERPTN 512 (623)
Q Consensus 460 ~~--~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DV~sfGvil~ellt-g~~P~~ 512 (623)
.+ .....+.++...-..|+|||.+-.. ..+++.||||.||++.|+++ |++||.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11 2233445555566789999976431 15678999999999999998 677774
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.1e-20 Score=176.20 Aligned_cols=169 Identities=10% Similarity=0.098 Sum_probs=131.8
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHH----------HHHHHHHHhCCCCCCCCcceeEEEEeC-
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEK----------EFVAEMATLGSVKNRNLVPLLGFCMAK- 372 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~e~~~l~~l~h~niv~l~~~~~~~- 372 (623)
.++|...+++|.|+||.||.+.. ++..+++|.+.......+ .+.+|++.+.+++|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999766 577899999975432222 268899999999999999999886643
Q ss_pred -------CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC
Q 006982 373 -------KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE 445 (623)
Q Consensus 373 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~ 445 (623)
...++||||++|.+|.++.. ++. ....+++.++..+|.. +++|||+||+||++++++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 34789999999999988742 121 2456899999999999 999999999999999988
Q ss_pred eEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 006982 446 PKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELV 505 (623)
Q Consensus 446 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ell 505 (623)
++++|||......... .. ..+.....+..++|+||||+.+.-..
T Consensus 173 i~liDfg~~~~~~e~~-a~---------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRK-AK---------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchh-hH---------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999999887543211 10 11334445667999999999887544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.7e-20 Score=169.43 Aligned_cols=204 Identities=21% Similarity=0.258 Sum_probs=165.7
Q ss_pred ccCcccceeeccCccEEEEEE-eCCCcEEEEEEeccccccHHHHHHHHHHhCCCCC-CCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN-RNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.+|.|. ..+|.+||+|.-.... ...+...|.++.+.++| ..|..+..|..+.....+|||..
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 578889999999999999998 6789999999865433 22356678888888876 56777777888888889999998
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeecccccccCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLARLMNP 459 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Dfgla~~~~~ 459 (623)
|.||.++..- -...++..+.+-+|.|+..-++|+|.+ +++||||||+|.|..- ...+.++|||+++....
T Consensus 94 -GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 94 -GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred -CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 7799998742 235688999999999999999999999 8999999999999964 44689999999998754
Q ss_pred CCCccc--c-cccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 460 IDTHLS--T-FVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 460 ~~~~~~--~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
..+... . .-....||.+|.+-....+...+.+-|+=|+|.+|.+.--|..||.+...
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 332222 1 12234589999998888877888999999999999999999999987544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=165.28 Aligned_cols=188 Identities=17% Similarity=0.141 Sum_probs=140.0
Q ss_pred cccceeeccCccEEEEEEeCCCcEEEEEEeccccccHH-----HHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEEec
Q 006982 308 SKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEK-----EFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.+...|++|+||+||.+.. .+.+++.+.+........ .+.+|+++|.++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 678888888876654333 5789999999995 4789888886 446899999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCceeeCCCCCeEEeecccccccCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNI-SSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dl-k~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
++|.+|.+.+.. . ...++.+++.++.++|+. +|+|||| ||+|||++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999999765421 1 134678899999999999 9999999 799999999999999999999865432
Q ss_pred CCcccccc---------cCCCCcccccCcccccCC-CCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFV---------NGEFGDLGYVAPEYARTL-VAT-PKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~---------~~~~gt~~y~aPE~~~~~-~~s-~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
........ .....+++|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.+
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 21100000 012256677777643321 223 5678889999999999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=165.32 Aligned_cols=197 Identities=20% Similarity=0.266 Sum_probs=131.2
Q ss_pred CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCC----------CCCcceeEEEE-
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKN----------RNLVPLLGFCM- 370 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~- 370 (623)
+...+.||.|+++.||.++.. +++++++|++.... ...+++.+|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344688999999999999976 48999999985432 334567777655555433 12222222221
Q ss_pred --------eCC--------eeeEEEecCCCCCHhhhccC---CCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 006982 371 --------AKK--------ERLLVYKHMPNGSLYDLLHP---ADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431 (623)
Q Consensus 371 --------~~~--------~~~lV~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~ 431 (623)
... ..+++|+-+ .+||.+++.. .......+....++.+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 235677777 5588887532 222234456677888889999999999999 99999
Q ss_pred CCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccC--------CCCCcchhHHHHHHHHHH
Q 006982 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART--------LVATPKGDVYSFGTVLLE 503 (623)
Q Consensus 432 dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DV~sfGvil~e 503 (623)
||+|+|++++.+|.+.|+||+.....+... .. ...+..|.+||.... ..++.+.|.|++|+++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee---ec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999998887654311 11 124577999997643 257889999999999999
Q ss_pred HHhCCCCCCCC
Q 006982 504 LVTGERPTNVA 514 (623)
Q Consensus 504 lltg~~P~~~~ 514 (623)
|.+|+.||...
T Consensus 243 lWC~~lPf~~~ 253 (288)
T PF14531_consen 243 LWCGRLPFGLS 253 (288)
T ss_dssp HHHSS-STCCC
T ss_pred HHHccCCCCCC
Confidence 99999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=157.87 Aligned_cols=136 Identities=16% Similarity=0.198 Sum_probs=104.8
Q ss_pred cccceeeccCccEEEEEEeCCCcEEEEEEeccc-cccHHHHHHHHHHhCCC-----CCCCCcceeEEEEeCC---eee-E
Q 006982 308 SKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDS-QRSEKEFVAEMATLGSV-----KNRNLVPLLGFCMAKK---ERL-L 377 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 377 (623)
+....||+|+||.||. .-.++.. ++|++... ....+.+.+|+++++.+ .||||++++++++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 3234444 68887643 23456789999999999 5799999999998874 333 7
Q ss_pred EEec--CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHH-HHHHhcCCCCcEecCCCCCceeeCC----CCCeEEee
Q 006982 378 VYKH--MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF-AWLHHNCNPRIIHRNISSKCILLDD----DFEPKISD 450 (623)
Q Consensus 378 V~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~i~H~dlk~~NILl~~----~~~~kl~D 450 (623)
|+|| +++|+|.+++.. ..+++. ..++.++..++ +|||+. +|+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 668999999953 224444 35577788777 999999 9999999999999974 34799999
Q ss_pred ccccc
Q 006982 451 FGLAR 455 (623)
Q Consensus 451 fgla~ 455 (623)
|+.+.
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 54443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.8e-18 Score=190.02 Aligned_cols=198 Identities=21% Similarity=0.215 Sum_probs=157.6
Q ss_pred HHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCC---CCCCcceeEEEEeCCeeeE
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK---NRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 377 (623)
......|.+...||+|+||+||+|...+|+.||+|+-+....+ +|.--.+++.+|+ -+-|..+...+...+.-++
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3344678888999999999999999888999999987765433 2222223333343 2345555555666778899
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-------CCCCeEEee
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-------DDFEPKISD 450 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-------~~~~~kl~D 450 (623)
|+||.+.|+|.+++. ..+.++|.-.+.++.|+++-+.+||.. +|||+||||+|.+|. +...++|+|
T Consensus 772 v~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence 999999999999996 457799999999999999999999999 999999999999993 345689999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGER 509 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~ 509 (623)
||.+-.+..- .......+.++|-++-++|...++..+.++|.|.+.-+++-|+.|+.
T Consensus 845 fG~siDm~lf--p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLF--PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEc--CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999765321 11123445568899999999999999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-18 Score=181.96 Aligned_cols=185 Identities=24% Similarity=0.275 Sum_probs=152.0
Q ss_pred eeeccCccEEEEEE----eCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEEecCC
Q 006982 312 IIGSGRTGTMYKAL----LEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
++|+|.||.|+... ...|.-+++|.+++.. ........|..++...+ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999998754 2346677888776532 11224456777788886 9999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|...+.. ...++..........++-++.++|+. +|+|||+|++||+++.+|++++.|||+.+..-.....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999999863 34466666677778899999999999 9999999999999999999999999999975432211
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 --------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 --------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 4899999999998 446789999999999999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=158.80 Aligned_cols=141 Identities=15% Similarity=0.147 Sum_probs=110.4
Q ss_pred cCcccceeeccCccEEEEEE--eCCCcEEEEEEeccccc-------------------------cHHHHHHHHHHhCCCC
Q 006982 306 SFSKNNIIGSGRTGTMYKAL--LEDGTSLMVKRLQDSQR-------------------------SEKEFVAEMATLGSVK 358 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~-------------------------~~~~~~~e~~~l~~l~ 358 (623)
-|...+.||+|++|.||+|. ..+|+.||+|++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778999999999999998 56899999999864321 0123568999999997
Q ss_pred CCC--CcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCC
Q 006982 359 NRN--LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR-IIHRNISS 435 (623)
Q Consensus 359 h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-i~H~dlk~ 435 (623)
+.. +.+++++ ...++||||+++++|...... ...+.......++.|++.++.|||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3333432 235899999999888776421 23345566788999999999999999 8 99999999
Q ss_pred CceeeCCCCCeEEeecccccccC
Q 006982 436 KCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 436 ~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999988644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=153.59 Aligned_cols=143 Identities=22% Similarity=0.192 Sum_probs=111.5
Q ss_pred HHHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccc-----------------------cHHHHHHHHHHhCC
Q 006982 300 LMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR-----------------------SEKEFVAEMATLGS 356 (623)
Q Consensus 300 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~e~~~l~~ 356 (623)
+......|...+.||+|+||.||++...+|+.|+||++..... ....+..|+..+.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333334777899999999999999988899999998754321 11235678888888
Q ss_pred CCCCC--CcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 006982 357 VKNRN--LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNIS 434 (623)
Q Consensus 357 l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk 434 (623)
+.|++ +...++ ....++||||+++++|.+.... .....++.+++.++.++|+. +++|||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 87774 444443 2456899999999999876421 23457889999999999998 99999999
Q ss_pred CCceeeCCCCCeEEeecccccccCC
Q 006982 435 SKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 435 ~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
|+||++++++.++|+|||.+.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=155.35 Aligned_cols=133 Identities=17% Similarity=0.267 Sum_probs=113.0
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccccc---------cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR---------SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+.||+|++|.||+|.. ++..+++|+...... ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999988 577888897653221 123577899999999999998888888778888999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
++|++|.+++... .+ .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998421 12 7889999999999999999 999999999999999 78999999998874
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=175.21 Aligned_cols=137 Identities=17% Similarity=0.248 Sum_probs=112.0
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc--------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ--------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
..|...+.||+|+||.||+|.+.+...++.++..... .....+.+|++++.+++|++++....++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3445678999999999999987654443333332211 12346789999999999999998888888877889
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+||||+++++|.+++. .+..++.+++++|.|||+. +++||||||+||++ +++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999883 3567899999999999999 99999999999999 678999999999975
Q ss_pred c
Q 006982 457 M 457 (623)
Q Consensus 457 ~ 457 (623)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=151.42 Aligned_cols=129 Identities=16% Similarity=0.280 Sum_probs=106.9
Q ss_pred eeeccCccEEEEEEeCCCcEEEEEEecccc--c-------cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 312 IIGSGRTGTMYKALLEDGTSLMVKRLQDSQ--R-------SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.||+|++|.||+|.+ ++..+++|...... . ....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999995 57788999864321 1 1245778999999999988766666666777789999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|++|.+++... .. .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999987421 11 7899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.1e-16 Score=153.05 Aligned_cols=146 Identities=25% Similarity=0.303 Sum_probs=108.5
Q ss_pred CCCCCcceeEEEEeC---------------------------CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHH
Q 006982 358 KNRNLVPLLGFCMAK---------------------------KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIA 410 (623)
Q Consensus 358 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 410 (623)
+|||||++.++|.+. ...|+||.-++. +|.+++.. ...+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 699999998877542 235788887765 89999842 345556677788
Q ss_pred HHHHHHHHHHHhcCCCCcEecCCCCCceee--CCCC--CeEEeecccccccCCCC---CcccccccCCCCcccccCcccc
Q 006982 411 IGAARGFAWLHHNCNPRIIHRNISSKCILL--DDDF--EPKISDFGLARLMNPID---THLSTFVNGEFGDLGYVAPEYA 483 (623)
Q Consensus 411 ~~ia~~l~yLH~~~~~~i~H~dlk~~NILl--~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~ 483 (623)
.|+.+|+.|||.+ +|.|||+|++|||+ |+|. ...|+|||++---.... ...+-.+ ..-|.-..||||+.
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~V-d~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEV-DLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccc-cCCCcceecchhhh
Confidence 9999999999999 99999999999999 4444 46889999985422211 1111111 12356678999988
Q ss_pred cCCC------CCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 484 RTLV------ATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 484 ~~~~------~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
...+ --.|+|.|+.|-+.||+++...||+.
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 6532 23589999999999999999999986
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.4e-16 Score=172.48 Aligned_cols=175 Identities=21% Similarity=0.285 Sum_probs=125.5
Q ss_pred ccCcccceeeccCccEEEEEEeCC-CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.+|...+.|..|+||.||..+++. .+..|+|+-+..- +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn--ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN--ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc--cccccCCccee--------------------
Confidence 578889999999999999998764 5566764322111 0000 23333334333
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC-
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT- 462 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~- 462 (623)
|+-.+.++.. +.++. +++.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+.+.......
T Consensus 136 -gDc~tllk~~----g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLKNI----GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhcccC----CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 5666666432 22221 227799999999 999999999999999999999999999986321100
Q ss_pred ---------ccccccc-CCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccc
Q 006982 463 ---------HLSTFVN-GEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG 522 (623)
Q Consensus 463 ---------~~~~~~~-~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~ 522 (623)
....+.+ ..+||+.|+|||++....|...+|.|++|+|+||.+.|+.||.+++.++.+..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~ 269 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 269 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh
Confidence 0011222 24799999999999999999999999999999999999999998766554443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-16 Score=164.78 Aligned_cols=126 Identities=27% Similarity=0.368 Sum_probs=107.3
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++.|+++...+|.++|.... .....+|...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 4679999999999999996544 34667889999999999999999 5 899999999999999999999999999
Q ss_pred ccccCCCCCc--ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 006982 454 ARLMNPIDTH--LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506 (623)
Q Consensus 454 a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt 506 (623)
.......... .........||..||+||.+.+..|+.|+||||+|+||+|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9876543311 1112234569999999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.3e-15 Score=133.56 Aligned_cols=135 Identities=19% Similarity=0.140 Sum_probs=114.6
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCC--CCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN--RNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++++....+..++++||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 4679999999999999865 7889998866543 5678899999999977 5888898888877889999999998777
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+...
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 544 45667788999999999999864457999999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.7e-15 Score=141.87 Aligned_cols=135 Identities=20% Similarity=0.214 Sum_probs=96.9
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccH---HH----------------------HHHHHHHhCCCCCCC--C
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSE---KE----------------------FVAEMATLGSVKNRN--L 362 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~----------------------~~~e~~~l~~l~h~n--i 362 (623)
.+.||+|+||.||+|...+++.||+|++....... .. ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999886532211 11 124555555554332 3
Q ss_pred cceeEEEEeCCeeeEEEecCCCCCHhhh-ccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceee
Q 006982 363 VPLLGFCMAKKERLLVYKHMPNGSLYDL-LHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILL 440 (623)
Q Consensus 363 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl 440 (623)
.+.+++ ...++||||++++++... +... ... .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 245899999999654321 1100 011 5567899999999999999 7 99999999999999
Q ss_pred CCCCCeEEeecccccccC
Q 006982 441 DDDFEPKISDFGLARLMN 458 (623)
Q Consensus 441 ~~~~~~kl~Dfgla~~~~ 458 (623)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.7e-14 Score=139.13 Aligned_cols=134 Identities=16% Similarity=0.229 Sum_probs=104.7
Q ss_pred cceee-ccCccEEEEEEeCCCcEEEEEEecccc--------------ccHHHHHHHHHHhCCCCCCCC--cceeEEEEeC
Q 006982 310 NNIIG-SGRTGTMYKALLEDGTSLMVKRLQDSQ--------------RSEKEFVAEMATLGSVKNRNL--VPLLGFCMAK 372 (623)
Q Consensus 310 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 372 (623)
..+|| .|+.|+||++... +..+++|++.... .....+.+|++++.+++|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999886 6778888774311 123457889999999998875 6677765433
Q ss_pred C----eeeEEEecCCC-CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeE
Q 006982 373 K----ERLLVYKHMPN-GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPK 447 (623)
Q Consensus 373 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~k 447 (623)
. ..++|+||+++ .+|.+++.. ..++.. .+.+++.++.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 699998853 223332 357899999999999 999999999999999999999
Q ss_pred Eeecccccc
Q 006982 448 ISDFGLARL 456 (623)
Q Consensus 448 l~Dfgla~~ 456 (623)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-14 Score=141.11 Aligned_cols=162 Identities=24% Similarity=0.316 Sum_probs=121.7
Q ss_pred HHHHHhCCCCCCCCcceeEEEEeCC-----eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhc
Q 006982 349 AEMATLGSVKNRNLVPLLGFCMAKK-----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423 (623)
Q Consensus 349 ~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~ 423 (623)
.-+.-+-++.|.|+|+++.|+.+.. +..+++|||..|++..+|+........+....-.++..||..||.|||+
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs- 194 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS- 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence 3445566678999999999987643 3578999999999999998765555667667778899999999999998
Q ss_pred CCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc-ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHH
Q 006982 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH-LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLL 502 (623)
Q Consensus 424 ~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ 502 (623)
|.|+|+|+++..+-|++..++-+|+.--... ...+.... ....-....+-++|.+||+-.....+..+|||+||...+
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 6889999999999999999998888532111 11110000 000001123568999999988888889999999999999
Q ss_pred HHHhCCCCCC
Q 006982 503 ELVTGERPTN 512 (623)
Q Consensus 503 elltg~~P~~ 512 (623)
||..+..-..
T Consensus 274 emailEiq~t 283 (458)
T KOG1266|consen 274 EMAILEIQST 283 (458)
T ss_pred HHHHheeccC
Confidence 9998876543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.8e-14 Score=156.68 Aligned_cols=93 Identities=42% Similarity=0.673 Sum_probs=89.1
Q ss_pred CCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccccccc
Q 006982 105 SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSV 184 (623)
Q Consensus 105 ~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l 184 (623)
.++.|+|++|.|+|.+|.+++.+.+ |+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..++++++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~-L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCC-CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 5889999999999999999999755 999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccc
Q 006982 185 ANNLLSGSIPTFVN 198 (623)
Q Consensus 185 ~~N~l~g~ip~~~~ 198 (623)
++|+|+|.+|..+.
T Consensus 498 s~N~l~g~iP~~l~ 511 (623)
T PLN03150 498 NGNSLSGRVPAALG 511 (623)
T ss_pred cCCcccccCChHHh
Confidence 99999999998765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-12 Score=140.63 Aligned_cols=144 Identities=20% Similarity=0.234 Sum_probs=100.9
Q ss_pred cCcccceeeccCccEEEEEEeCCCcEEEEEEecccccc-----------------------------------------H
Q 006982 306 SFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRS-----------------------------------------E 344 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------------------------~ 344 (623)
.|+ .+.||.|++|+||+|++++|+.||||+.+..... +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 444 3689999999999999999999999998543100 0
Q ss_pred HHHHHHHHHhCCC----CCCCCcceeEEE-EeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHH-HHH
Q 006982 345 KEFVAEMATLGSV----KNRNLVPLLGFC-MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR-GFA 418 (623)
Q Consensus 345 ~~~~~e~~~l~~l----~h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l~ 418 (623)
-.|..|.+.+.++ +|.+-+.+-.++ ......++||||++|++|.++...... .. .+.+++..++. .+.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLN 271 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHH
Confidence 0133444444444 233323332333 234567999999999999887642211 11 24556766666 467
Q ss_pred HHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 419 yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
.+|.. +++|+|++|.||++++++.++++|||++..+.+
T Consensus 272 ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 272 QVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88888 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.5e-13 Score=151.90 Aligned_cols=204 Identities=25% Similarity=0.326 Sum_probs=158.7
Q ss_pred cCcccceeeccCccEEEEEEeCC--CcEEEEEEeccccc---cHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLED--GTSLMVKRLQDSQR---SEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 379 (623)
.|...+-||+|.|+.|-...... ...+++|.+..... .......|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45556779999999998877533 34466666644332 2333445777766665 999999999999999999999
Q ss_pred ecCCCCCHhhhc-cCCCCCCCccChHHHHHHHHHHHHHHHHHH-hcCCCCcEecCCCCCceeeCCCC-CeEEeecccccc
Q 006982 380 KHMPNGSLYDLL-HPADDTGKSVDWPRRLKIAIGAARGFAWLH-HNCNPRIIHRNISSKCILLDDDF-EPKISDFGLARL 456 (623)
Q Consensus 380 e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgla~~ 456 (623)
+|..+|++.+.+ +... ...+-........|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999998 4221 13445566778899999999999 77 999999999999999999 999999999987
Q ss_pred cCCCCCcccccccCCCC-cccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFG-DLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
...... .........| ++.|+|||...+. ......|+||.|+++.-+++|..|+.....
T Consensus 175 ~~~~~g-~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNG-AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCC-cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 755211 1223344567 9999999999874 446789999999999999999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=115.18 Aligned_cols=130 Identities=15% Similarity=0.124 Sum_probs=97.0
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcc-eeEEEEeCCeeeEEEecCCCCCHhh
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP-LLGFCMAKKERLLVYKHMPNGSLYD 389 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~gsL~~ 389 (623)
+.++.|.++.||++... +..+++|...........+..|++++..+.+.++++ ++.+ .....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 56888999999999875 778999987655433345678899988886665554 4433 2334689999999988764
Q ss_pred hccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 390 LLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC--NPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 390 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
.- . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 31 0 11245678999999999982 22369999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.4e-13 Score=118.33 Aligned_cols=113 Identities=23% Similarity=0.353 Sum_probs=101.5
Q ss_pred CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 79 ~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
...++.|.|++|.++ .+|+.|..|.+|+.|+|++|++. .+|.+++++.+ |+.|+++-|++. .+|..||+++.|+.|
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~k-lr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPK-LRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchh-hhheecchhhhh-cCccccCCCchhhhh
Confidence 357889999999998 68889999999999999999999 89999999765 999999999999 899999999999999
Q ss_pred eccCCcCCC-CCCccccccccccccccccccccccCCc
Q 006982 159 KLDHNRFSG-QIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 159 ~l~~N~~~g-~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
||.+|+++- .+|..+..+..|+.|+|++|.|.-..|+
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~d 145 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPD 145 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcccCChh
Confidence 999999974 5788888899999999999998754443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.6e-12 Score=136.65 Aligned_cols=146 Identities=18% Similarity=0.241 Sum_probs=93.8
Q ss_pred hccCcccceeeccCccEEEEEEeCC-CcEEEEEEecccccc-----------------------------------HH--
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRS-----------------------------------EK-- 345 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----------------------------------~~-- 345 (623)
..+|+. +.||+|++|+||+|++++ |+.||||+....... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999987 999999998643100 01
Q ss_pred ----HHHHHHHHhCCCC----CCCCcceeEEEEe-CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHH
Q 006982 346 ----EFVAEMATLGSVK----NRNLVPLLGFCMA-KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416 (623)
Q Consensus 346 ----~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 416 (623)
++.+|...+.+++ +.+.+.+-.++.+ ....++||||++|+.+.+.-.... ...+ +..++...+..
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~---~g~d---~~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA---AGTD---MKLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---cCCC---HHHHHHHHHHH
Confidence 1333444433332 3333443333333 456789999999999987521111 1111 11222222221
Q ss_pred -HHHHHhcCCCCcEecCCCCCceeeCCCC----CeEEeecccccccCC
Q 006982 417 -FAWLHHNCNPRIIHRNISSKCILLDDDF----EPKISDFGLARLMNP 459 (623)
Q Consensus 417 -l~yLH~~~~~~i~H~dlk~~NILl~~~~----~~kl~Dfgla~~~~~ 459 (623)
+..+... +++|+|+||.||+++.++ .+++.|||++..+++
T Consensus 272 ~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2223345 999999999999999888 999999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.1e-11 Score=126.08 Aligned_cols=200 Identities=22% Similarity=0.231 Sum_probs=153.8
Q ss_pred cCcccceeec--cCccEEEEEEe---CCCcEEEEEEecccc---ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeee
Q 006982 306 SFSKNNIIGS--GRTGTMYKALL---EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 306 ~f~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 376 (623)
.|.....+|+ |.+|.||.+.. .++..+++|+-+... .....=.+|+....++ .|+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3566778999 99999999986 467888888743321 2233345677777777 5999999888888889999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHH----HHHHHHhcCCCCcEecCCCCCceeeCCC-CCeEEeec
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR----GFAWLHHNCNPRIIHRNISSKCILLDDD-FEPKISDF 451 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~i~H~dlk~~NILl~~~-~~~kl~Df 451 (623)
+-+|++. .+|.++-+... ..++....+.+..+... |+.++|+. .++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999885 68888876432 33555556666666666 99999999 99999999999999999 89999999
Q ss_pred ccccccCCCCCcccccccCC-CCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 452 GLARLMNPIDTHLSTFVNGE-FGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
|+...+.............+ .|...|++||...+ .++...|+|++|.+..|..++..+...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence 99998876543332222222 47788999998865 458899999999999999998777643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-12 Score=113.75 Aligned_cols=113 Identities=27% Similarity=0.463 Sum_probs=87.1
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCC-CCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYG-PLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g-~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
++..|++.=|.|. .+|..||.++.|+.|||+.|+++- .+|..++.+.. |+.|+|+.|.|. .+|+.++++++|+.|.
T Consensus 80 klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~t-lralyl~dndfe-~lp~dvg~lt~lqil~ 156 (264)
T KOG0617|consen 80 KLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTT-LRALYLGDNDFE-ILPPDVGKLTNLQILS 156 (264)
T ss_pred hhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHH-HHHHHhcCCCcc-cCChhhhhhcceeEEe
Confidence 3444455444443 567778888888888888877764 57777777665 888888888888 7888889999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
+..|.+- ++|.+++.++.|+.|++.+|.++-..|...
T Consensus 157 lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~ 193 (264)
T KOG0617|consen 157 LRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELA 193 (264)
T ss_pred eccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhh
Confidence 9888888 789999999999999999999886666543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2e-11 Score=121.94 Aligned_cols=109 Identities=33% Similarity=0.533 Sum_probs=90.6
Q ss_pred EEEEEecCCCc-----------------------eeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccC
Q 006982 82 VLNLRLTDMGL-----------------------KGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSS 138 (623)
Q Consensus 82 v~~l~l~~~~l-----------------------~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~ 138 (623)
|+.++++.|++ .+.+|..+..+++|..|+|++|-+. .+|.+++.+.. |+.||||+
T Consensus 390 Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~-Lq~LnlS~ 467 (565)
T KOG0472|consen 390 VTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVR-LQTLNLSF 467 (565)
T ss_pred eEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhh-hheecccc
Confidence 88888887754 3567788899999999999999999 89999999876 99999999
Q ss_pred ccCCCCCCC-----------------------C-CCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCC
Q 006982 139 NNFSGSIPS-----------------------N-LANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 139 N~l~g~ip~-----------------------~-~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
|+|. .+|. + +.++.+|.+|||.+|.+. +||+.+|+|++|++|.+++|.|+ .|
T Consensus 468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~P 543 (565)
T KOG0472|consen 468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QP 543 (565)
T ss_pred cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CC
Confidence 9887 4553 2 667888888888888888 78888888888888888888887 55
Q ss_pred cc
Q 006982 195 TF 196 (623)
Q Consensus 195 ~~ 196 (623)
+.
T Consensus 544 r~ 545 (565)
T KOG0472|consen 544 RH 545 (565)
T ss_pred HH
Confidence 43
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.5e-10 Score=109.07 Aligned_cols=141 Identities=19% Similarity=0.258 Sum_probs=110.5
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccccc--cHHHHHHHHHHhCCCCCC--CCcceeEEEEeCC---eeeEEEecCC
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR--SEKEFVAEMATLGSVKNR--NLVPLLGFCMAKK---ERLLVYKHMP 383 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~~ 383 (623)
+.|+.|..+.||++...+|..+++|....... ....+..|.+++..+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998765433 355788999999988763 4566777766542 5689999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC--------------------------------------- 424 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------- 424 (623)
+.++.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876531 34677778888889999999988531
Q ss_pred --------------CCCcEecCCCCCceeeCC--CCCeEEeecccccc
Q 006982 425 --------------NPRIIHRNISSKCILLDD--DFEPKISDFGLARL 456 (623)
Q Consensus 425 --------------~~~i~H~dlk~~NILl~~--~~~~kl~Dfgla~~ 456 (623)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.6e-12 Score=127.12 Aligned_cols=112 Identities=23% Similarity=0.313 Sum_probs=94.5
Q ss_pred eeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCC-CCCCCceeeccCCcCCCCCCcc
Q 006982 94 GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLA-NCTYLNSLKLDHNRFSGQIPPQ 172 (623)
Q Consensus 94 g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~-~l~~L~~l~l~~N~~~g~iP~~ 172 (623)
+++|+++|.+.+|.-|||..|++. .+| +|..+.. |..|+++.|++. .+|.+.+ ++++|.+|||.+|++. ++|++
T Consensus 196 ~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~-L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde 270 (565)
T KOG0472|consen 196 ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSL-LKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDE 270 (565)
T ss_pred hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHH-HHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchH
Confidence 578888888888888888888888 777 6766544 888888888888 7888766 8999999999999999 89999
Q ss_pred ccccccccccccccccccccCCccccccccccccCCCC
Q 006982 173 LGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210 (623)
Q Consensus 173 l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 210 (623)
+.-+.+|..||+|+|.+++-.|+.-++.+....+.|||
T Consensus 271 ~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 271 ICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNP 308 (565)
T ss_pred HHHhhhhhhhcccCCccccCCcccccceeeehhhcCCc
Confidence 99999999999999999988887666667777778876
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.8e-10 Score=118.71 Aligned_cols=165 Identities=15% Similarity=0.207 Sum_probs=121.4
Q ss_pred eCCCcEEEEEEeccccc-cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChH
Q 006982 326 LEDGTSLMVKRLQDSQR-SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP 404 (623)
Q Consensus 326 ~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~ 404 (623)
..++.+|.|...+.... ......+-++.|+.+|||||++++..++.....|+|+|-+. .|..+++. +.-.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 45778888877765443 23446678888999999999999999999999999999885 35555532 2233
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCccccc
Q 006982 405 RRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484 (623)
Q Consensus 405 ~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 484 (623)
.....+.||+.||.|||+.| +++|+++.-..|+|++.|+.||++|.++.......... ....--..|..|+.+.
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~----~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA----KSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc----ccchhhhcccChhhcC
Confidence 44557889999999999877 89999999999999999999999999887543322100 0001122455665443
Q ss_pred CCCCCcchhHHHHHHHHHHHHhC
Q 006982 485 TLVATPKGDVYSFGTVLLELVTG 507 (623)
Q Consensus 485 ~~~~s~k~DV~sfGvil~elltg 507 (623)
... -..|.|.||++++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 222 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=103.22 Aligned_cols=136 Identities=15% Similarity=0.127 Sum_probs=97.7
Q ss_pred cceeeccCccEEEEEEeCC-------CcEEEEEEecccc-----------------------ccHHHH----HHHHHHhC
Q 006982 310 NNIIGSGRTGTMYKALLED-------GTSLMVKRLQDSQ-----------------------RSEKEF----VAEMATLG 355 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-----------------------~~~~~~----~~e~~~l~ 355 (623)
...||.|.-+.||.|...+ +..+|+|+.+.+. ...+.+ ++|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 4789999874210 001122 37999998
Q ss_pred CCCC--CCCcceeEEEEeCCeeeEEEecCCCCCHhh-hccCCCCCCCccChHHHHHHHHHHHHHHHHH-HhcCCCCcEec
Q 006982 356 SVKN--RNLVPLLGFCMAKKERLLVYKHMPNGSLYD-LLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHNCNPRIIHR 431 (623)
Q Consensus 356 ~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~i~H~ 431 (623)
++.. -++..++++ ...++||||+.+..+.. .++. ..++..+...+..++..+|.+| |.. +++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8854 456666654 56789999997754422 2211 2234445667789999999999 677 99999
Q ss_pred CCCCCceeeCCCCCeEEeecccccccC
Q 006982 432 NISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 432 dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
||++.||++++ +.+.|+|||.+....
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-09 Score=99.24 Aligned_cols=130 Identities=20% Similarity=0.277 Sum_probs=99.4
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEE-eccccc--------cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKR-LQDSQR--------SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
..+++|+-+.+|.+.+.+.. +++|. +.+... ......+|++++.+++---|....-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876444 55553 333221 123467899999988766665566667778888999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
++|-.|.+.+... +..++..+-+-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888532 245666777777889999 999999999999998875 99999999975
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-10 Score=121.73 Aligned_cols=80 Identities=26% Similarity=0.394 Sum_probs=38.1
Q ss_pred EEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeecc
Q 006982 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~ 161 (623)
++.|||++|+|. ..|..+.+-.++-.|+||+|++. +||..++-.+..|-+||||+|++. .+|+++..|..|++|+|+
T Consensus 105 Lt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls 181 (1255)
T KOG0444|consen 105 LTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLS 181 (1255)
T ss_pred ceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcC
Confidence 445555555554 34444444444555555555554 444443321222445555555554 445555555555555555
Q ss_pred CCc
Q 006982 162 HNR 164 (623)
Q Consensus 162 ~N~ 164 (623)
+|.
T Consensus 182 ~NP 184 (1255)
T KOG0444|consen 182 NNP 184 (1255)
T ss_pred CCh
Confidence 544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.3e-10 Score=121.86 Aligned_cols=106 Identities=34% Similarity=0.487 Sum_probs=84.0
Q ss_pred cEEEEEecCCCcee-eCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCC-CCCCCCCcee
Q 006982 81 RVLNLRLTDMGLKG-QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSL 158 (623)
Q Consensus 81 ~v~~l~l~~~~l~g-~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~-~~~l~~L~~l 158 (623)
++.++.+.+|+|.. -||+.|-.|..|+.||||+|+|. ..|..+-.. +++-.|+||+|++. +||.. +.+|+-|-.|
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~A-Kn~iVLNLS~N~Ie-tIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYA-KNSIVLNLSYNNIE-TIPNSLFINLTDLLFL 155 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhh-cCcEEEEcccCccc-cCCchHHHhhHhHhhh
Confidence 45556666676653 47888888888888888888888 788888774 44888888888888 78876 4578888888
Q ss_pred eccCCcCCCCCCcccccccccccccccccccc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
|||+|++. .+|+++-.|..|++|.|++|.|.
T Consensus 156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred ccccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence 88888888 78888888888888888888764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.6e-08 Score=91.81 Aligned_cols=142 Identities=18% Similarity=0.255 Sum_probs=103.3
Q ss_pred ccceeeccCccEEEEEEeCCCcEEEEE-Eecccc--------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 309 KNNIIGSGRTGTMYKALLEDGTSLMVK-RLQDSQ--------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 309 ~~~~lG~G~~g~Vy~~~~~~~~~vavK-~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
...++-+|+-+.|+++.+. |+..++| ++.+.. -..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3578899999999999986 5555555 443322 12456778999999887666665566677777788999
Q ss_pred ecCCC-CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC---eEEeeccccc
Q 006982 380 KHMPN-GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE---PKISDFGLAR 455 (623)
Q Consensus 380 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~---~kl~Dfgla~ 455 (623)
||+++ -++.+++...-.. ...-......+..+-+.+.-||.. .|+|+||..+||++..++. +.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 4777777532211 111222256788888889999999 9999999999999965443 5899999986
Q ss_pred c
Q 006982 456 L 456 (623)
Q Consensus 456 ~ 456 (623)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-09 Score=116.16 Aligned_cols=195 Identities=17% Similarity=0.172 Sum_probs=145.7
Q ss_pred HHhccCcccceeeccCccEEEEEEe--CCCcEEEEEEecccccc---HHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALL--EDGTSLMVKRLQDSQRS---EKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
....+|.....||.|.|+.|++... .++..+++|.+...-.. ...-..|+.+...+ .|.+++.....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3345788888999999999999774 46788999987654321 11123455554444 588888877777777777
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-CCeEEeecccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-FEPKISDFGLA 454 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-~~~kl~Dfgla 454 (623)
++--||++++++...+. ....++...++++..+++.++.++|+. .++|+|+||+||++..+ +..++.|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 88899999999887762 335678888999999999999999988 99999999999999875 88999999999
Q ss_pred cccCCCCCcccccccCCCCccccc--CcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYV--APEYARTLVATPKGDVYSFGTVLLELVTGERP 510 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DV~sfGvil~elltg~~P 510 (623)
..+..... .. ...-++. +++......+..+.|+||||.-+.|.+++..-
T Consensus 415 t~~~~~~~---~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 415 TRLAFSSG---VF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccceecc---cc----cccccccccchhhccccccccccccccccccccccccCccc
Confidence 75321111 00 0222333 55555666778899999999999999988754
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-08 Score=113.90 Aligned_cols=156 Identities=27% Similarity=0.415 Sum_probs=104.2
Q ss_pred HHhhccCCCHHHHHHHHHHHHHcCCCCCc--ccCCCCCCCCCCCCCCcccc----------------eeecCCC------
Q 006982 23 LCFSLSYGTKEDLACLKSIKDSLEDPFNY--LNSSWNFNNDTEGFICKFTG----------------VECWHPD------ 78 (623)
Q Consensus 23 ~~~~~~~~~~~d~~~Ll~~k~~~~~~~~~--l~~sW~~~~~~~~~~c~w~g----------------v~c~~~~------ 78 (623)
+|......+.+|...++++.+.+..|... ....|++.++ +|.-.. |.|....
T Consensus 53 ~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~----fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~ 128 (754)
T PRK15370 53 LCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQ----YCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRV 128 (754)
T ss_pred HhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCc----ccccCCcchhhheeeecCCceEEecCCCccccccc
Confidence 34455567889999999999999887632 1123876554 564322 5663211
Q ss_pred ------------------------------------------------CCcEEEEEecCCCceeeCCccccCCCCCCEEE
Q 006982 79 ------------------------------------------------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLD 110 (623)
Q Consensus 79 ------------------------------------------------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~ 110 (623)
....+.|+|++++|+ .+|..+. ++|+.|+
T Consensus 129 ~g~~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~ 205 (754)
T PRK15370 129 TESEQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLI 205 (754)
T ss_pred ccccccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEE
Confidence 011457888888887 4676553 4788888
Q ss_pred cCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccccccccccccc
Q 006982 111 LSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 111 L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
|++|+|+ .+|..+. ++|+.|+|++|+|+ .||..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+
T Consensus 206 Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~ 275 (754)
T PRK15370 206 LDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS 275 (754)
T ss_pred ecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC
Confidence 8888888 6787664 24888888888888 6776543 36777777777777 6776653 46777777777777
Q ss_pred ccCCcc
Q 006982 191 GSIPTF 196 (623)
Q Consensus 191 g~ip~~ 196 (623)
.+|..
T Consensus 276 -~LP~~ 280 (754)
T PRK15370 276 -CLPEN 280 (754)
T ss_pred -ccccc
Confidence 35543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.6e-07 Score=95.28 Aligned_cols=267 Identities=15% Similarity=0.166 Sum_probs=155.1
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEE------EeCCe-eeEEEec
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFC------MAKKE-RLLVYKH 381 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~~~~-~~lV~e~ 381 (623)
..-||+|+-+.+|..---. ..+.|+........+. +.++.|.+. .||-+-.-+.+= -+... .-+.|..
T Consensus 16 gr~LgqGgea~ly~l~e~~--d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR--DQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchhh--chhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 5679999999999753211 1234666554322221 223344444 455433212221 11122 4467777
Q ss_pred CCCCC-HhhhccCC--CCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 382 MPNGS-LYDLLHPA--DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 382 ~~~gs-L~~~l~~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+++.. ..+++... +..-...+|+..++.+..+|.+.+-||.. |..-+|+.++|+|+.+++.+.+.|-.......
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeecc
Confidence 66542 22222211 11124579999999999999999999999 99999999999999999999998865443322
Q ss_pred CCCCcccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCcccccccHHHHHHHH-
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTG-ERPTNVAKAPETFKGNLVEWIAQL- 531 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg-~~P~~~~~~~~~~~~~l~~~~~~~- 531 (623)
. +. .....+|...|.+||... +..-+...|-|.+||++++++.| ++||.+.........-...-+...
T Consensus 169 n-g~----~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 169 N-GT----LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred C-Cc----eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 1 11 122345889999999765 33456789999999999999886 999976432211111111000000
Q ss_pred -hccCc--hhhhhc-hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 532 -SSTGQ--LQDAID-KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 532 -~~~~~--~~~~~d-~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
....+ ....-- ..+....-+..+..++..+..-- .++.-|||++-.+..|.+++.+.
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~--~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTES--GVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhccc--CCCCCCCCHHHHHHHHHHHHHhh
Confidence 00000 000000 00000112344555555544421 34779999999999998876653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.1e-10 Score=118.43 Aligned_cols=114 Identities=25% Similarity=0.211 Sum_probs=93.8
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|+|..|+++..-..++-+|++|+.||||+|.+...-++++.- +++|+.||||+|+++---|..|.-|..|+.|+|
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf-tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF-TQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh-cccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 4677888888888777778889999999999999999767777766 456999999999999444456888888999999
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
++|.++-.--..|-.+++|+.|||++|.+++.|.+
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 99998855555677788999999999999888875
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.1e-10 Score=123.44 Aligned_cols=127 Identities=26% Similarity=0.360 Sum_probs=95.2
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|.|.+|.|+...=+-|-+..+|+.|+|++|+|. ++|+....-...|+.|+||+|.|+ .||..+.++..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 4667788888888777777888888888888888888 788765444455888888888888 78888888888888888
Q ss_pred cCCcCCCCCCccccccccccccccccccccc-cCCcccc-ccccccccCCCCC
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSG-SIPTFVN-LTLSADSVTNNQG 211 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g-~ip~~~~-~~~~~~~~~~n~~ 211 (623)
.+|++. .+| ++.+++.|+.+|||.|+|+- .+|.... -++....++||.+
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 888888 677 78888888888888888864 3343222 2455566666664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=1e-07 Score=95.16 Aligned_cols=140 Identities=14% Similarity=0.101 Sum_probs=100.0
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccccc------------cHHHHHHHHHHhCCCCCC--CCcceeEEEEe-----
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR------------SEKEFVAEMATLGSVKNR--NLVPLLGFCMA----- 371 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~h~--niv~l~~~~~~----- 371 (623)
+.+-+-....|++..+ +|+.+.||+...... ....+.+|.+.+.++... ....++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444445667666 577899997743221 112477888888888443 34455666643
Q ss_pred CCeeeEEEecCCCC-CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-------C
Q 006982 372 KKERLLVYKHMPNG-SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-------D 443 (623)
Q Consensus 372 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-------~ 443 (623)
....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 8999874221 12345566778999999999999999 9999999999999975 5
Q ss_pred CCeEEeecccccc
Q 006982 444 FEPKISDFGLARL 456 (623)
Q Consensus 444 ~~~kl~Dfgla~~ 456 (623)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998864
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.6e-09 Score=72.62 Aligned_cols=41 Identities=37% Similarity=0.648 Sum_probs=28.1
Q ss_pred HHHHHHHHHHHHHcCC-CCCcccCCCCCCCCCCCCCCcccceeec
Q 006982 32 KEDLACLKSIKDSLED-PFNYLNSSWNFNNDTEGFICKFTGVECW 75 (623)
Q Consensus 32 ~~d~~~Ll~~k~~~~~-~~~~l~~sW~~~~~~~~~~c~w~gv~c~ 75 (623)
++|++||++||+++.+ |...+ .+|+.+. ..+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l-~~W~~~~--~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVL-SSWNPSS--DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCC-TT--TT----S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCccc-ccCCCcC--CCCCeeeccEEeC
Confidence 5799999999999985 54444 6998653 2469999999994
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.7e-08 Score=92.74 Aligned_cols=125 Identities=20% Similarity=0.234 Sum_probs=82.6
Q ss_pred EEEEEEeCCCcEEEEEEecccc--------------c-------------cHHHHHHHHHHhCCCCCC--CCcceeEEEE
Q 006982 320 TMYKALLEDGTSLMVKRLQDSQ--------------R-------------SEKEFVAEMATLGSVKNR--NLVPLLGFCM 370 (623)
Q Consensus 320 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------------~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 370 (623)
.||.|...+|..+|+|..+... . ......+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999874210 0 013356899999999765 45556544
Q ss_pred eCCeeeEEEecCC--CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHH-HhcCCCCcEecCCCCCceeeCCCCCeE
Q 006982 371 AKKERLLVYKHMP--NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPK 447 (623)
Q Consensus 371 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~i~H~dlk~~NILl~~~~~~k 447 (623)
....+||||++ |..+..+.. ..++......++.++...+..+ |.. +|+|+|+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24579999998 545544332 1111334566777888866665 566 99999999999999988 999
Q ss_pred EeecccccccC
Q 006982 448 ISDFGLARLMN 458 (623)
Q Consensus 448 l~Dfgla~~~~ 458 (623)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.7e-09 Score=118.16 Aligned_cols=56 Identities=32% Similarity=0.433 Sum_probs=27.1
Q ss_pred CCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 131 LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 131 L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|... .+|+.|+|++|+|+ .+|.
T Consensus 384 L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~ 439 (788)
T PRK15387 384 LKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPE 439 (788)
T ss_pred cceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccCh
Confidence 555555555555 34432 234555555555555 244321 23445555555554 3443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.2e-09 Score=96.96 Aligned_cols=104 Identities=29% Similarity=0.384 Sum_probs=31.3
Q ss_pred cEEEEEecCCCceeeCCcccc-CCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCC-CCCCCCcee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIR-NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYLNSL 158 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~-~~l~~L~~l 158 (623)
+...|+|.+|.++- | ..++ .|.+|+.|||++|.++ .++ .+..+. .|+.|+|++|+++ .++..+ ..+++|++|
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~-~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLP-RLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----T-T--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccChh-hhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 45667777776653 2 2455 4667777777777777 454 344443 3777777777777 454434 246777777
Q ss_pred eccCCcCCCCC-Ccccccccccccccccccccc
Q 006982 159 KLDHNRFSGQI-PPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 159 ~l~~N~~~g~i-P~~l~~l~~L~~l~l~~N~l~ 190 (623)
+|++|++...- =..+..+++|+.|+|.+|.++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 77777776311 124556666777777766654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.6e-08 Score=114.43 Aligned_cols=99 Identities=28% Similarity=0.484 Sum_probs=73.9
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .||..+.. .|+.|+|++|+++ .||..+. ++|+.|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~---~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~ 268 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLPD---TIQEMELSINRIT-ELPERLP--SALQSLD 268 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhhc---cccEEECcCCccC-cCChhHh--CCCCEEE
Confidence 35788999999988 5676654 58888888888888 67876543 4788888888887 6777654 4678888
Q ss_pred ccCCcCCCCCCccccccccccccccccccccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
|++|+|+ .+|..+. ++|+.|+|++|+|++
T Consensus 269 Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 269 LFHNKIS-CLPENLP--EELRYLSVYDNSIRT 297 (754)
T ss_pred CcCCccC-ccccccC--CCCcEEECCCCcccc
Confidence 8888887 5776654 467777788777774
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-07 Score=98.95 Aligned_cols=169 Identities=22% Similarity=0.309 Sum_probs=127.1
Q ss_pred ccEEEEEEe-CCCcEEEEEEeccccc-cHHHHHHHHHHhCCCCCCCCcceeEEEEe----CCeeeEEEecCCC-CCHhhh
Q 006982 318 TGTMYKALL-EDGTSLMVKRLQDSQR-SEKEFVAEMATLGSVKNRNLVPLLGFCMA----KKERLLVYKHMPN-GSLYDL 390 (623)
Q Consensus 318 ~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~ 390 (623)
..+.||+.. .||..|++|+++..+. .......-+++.+++.|+|+|++..++.. +...++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899984 4899999999954331 12233456788899999999999998863 4467899999986 577776
Q ss_pred ccCCC-----------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 391 LHPAD-----------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 391 l~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
-.... ..+...++...|.++.|+..||.++|+. |++-+-|.+++|+++.+..++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43221 1234567889999999999999999999 999999999999999999999988887766543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P 510 (623)
... |.+.. -.+-|.=.||.+++.+.||..-
T Consensus 446 d~~------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 2467888999999999999654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.3e-09 Score=111.89 Aligned_cols=111 Identities=32% Similarity=0.462 Sum_probs=96.7
Q ss_pred eCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccc
Q 006982 95 QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLG 174 (623)
Q Consensus 95 ~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~ 174 (623)
.||..+++|..|++|||+.|+++ .+|..+..| + |+.|-+++|+++ .+|.+++.+..|..||.+.|++. ++|++++
T Consensus 112 ~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-p-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~ 186 (722)
T KOG0532|consen 112 TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-P-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG 186 (722)
T ss_pred ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-c-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhh
Confidence 68899999999999999999999 899999985 6 999999999999 89999999999999999999999 8999999
Q ss_pred ccccccccccccccccccCCccccccccccccCCCC
Q 006982 175 QLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210 (623)
Q Consensus 175 ~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 210 (623)
.+.+|+.|++..|++.--.+....+.+..+.|+.|.
T Consensus 187 ~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNk 222 (722)
T KOG0532|consen 187 YLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNK 222 (722)
T ss_pred hHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCc
Confidence 999999999999998866665555555555665554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.2e-09 Score=115.59 Aligned_cols=208 Identities=18% Similarity=0.194 Sum_probs=135.8
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
..+.|.+.+-+-+|.++.+..+.-. .|...+.|...... ...+....+-.++-..+||-++....-+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455666667778889988877632 22112222221110 111122222223333344555544333334566789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|++|..+++|...|+... ..+..-.......+..+.+|||.. .+.|+|++|.|++...++..+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998543 233323334455677899999998 7999999999999999999999999844321
Q ss_pred CCC---CCc---------------------c---cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 006982 458 NPI---DTH---------------------L---STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510 (623)
Q Consensus 458 ~~~---~~~---------------------~---~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P 510 (623)
.-. ... . ...-....+|+.|.+||...+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 000 0 0001123589999999999999989999999999999999999999
Q ss_pred CCCCCCc
Q 006982 511 TNVAKAP 517 (623)
Q Consensus 511 ~~~~~~~ 517 (623)
|......
T Consensus 1035 ~na~tpq 1041 (1205)
T KOG0606|consen 1035 FNAETPQ 1041 (1205)
T ss_pred CCCcchh
Confidence 9875543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.9e-09 Score=107.76 Aligned_cols=110 Identities=21% Similarity=0.298 Sum_probs=84.0
Q ss_pred CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 79 ~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.|+++.|+|.+|-++..-..++..++.|++||||.|.++ .||..-+.-..++++|+|++|+++-.--..|.++.+|..|
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence 467888888888877777777888888888888888888 6765433323458888888888885445668888888888
Q ss_pred eccCCcCCCCCCc-ccccccccccccccccccc
Q 006982 159 KLDHNRFSGQIPP-QLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 159 ~l~~N~~~g~iP~-~l~~l~~L~~l~l~~N~l~ 190 (623)
.|+.|+++ ++|. .|.+|++|+.|+|..|++.
T Consensus 203 kLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 203 KLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred ecccCccc-ccCHHHhhhcchhhhhhcccccee
Confidence 88888888 5665 4555888888888888774
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=8e-08 Score=108.37 Aligned_cols=37 Identities=27% Similarity=0.432 Sum_probs=26.1
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCCh
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPD 122 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~ 122 (623)
.++.|+|.+|+|+. +|. .+++|++|+|++|+|+ .+|.
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~ 259 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV 259 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccC
Confidence 46777777777774 554 2567888888888887 5664
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.6e-08 Score=76.98 Aligned_cols=57 Identities=33% Similarity=0.554 Sum_probs=29.3
Q ss_pred CCEEEccCccCCCCCC-CCCCCCCCCceeeccCCcCCCCCCcccccccccccccccccc
Q 006982 131 LTSLDLSSNNFSGSIP-SNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNL 188 (623)
Q Consensus 131 L~~L~L~~N~l~g~ip-~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~ 188 (623)
|+.|+|++|+++ .|| ..|.++++|++|++++|+++..-|..+..+++|++|++++|+
T Consensus 3 L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 455555555555 233 344555555555555555554334445555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.7e-08 Score=76.83 Aligned_cols=61 Identities=36% Similarity=0.502 Sum_probs=52.0
Q ss_pred CCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcC
Q 006982 104 SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRF 165 (623)
Q Consensus 104 ~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~ 165 (623)
++|+.|+|++|+++ .||++...-.++|++|++++|+++..-|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57999999999999 67765443345699999999999966667899999999999999986
|
... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.4e-08 Score=101.72 Aligned_cols=144 Identities=21% Similarity=0.312 Sum_probs=113.0
Q ss_pred eeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCC
Q 006982 72 VECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143 (623)
Q Consensus 72 v~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g 143 (623)
|.|+..+ +...+.|+|..|+++-..|..|+.+.+|+.||||+|+++-.=|+.+..+.+-++-+++++|+++
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~- 129 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT- 129 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-
Confidence 8886643 2356899999999998777889999999999999999997668888887664555566679999
Q ss_pred CCCC-CCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCc-ccc-c-cccccccCCCCCCCCCCC
Q 006982 144 SIPS-NLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT-FVN-L-TLSADSVTNNQGLCGEPL 217 (623)
Q Consensus 144 ~ip~-~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~-~~~-~-~~~~~~~~~n~~l~~~~~ 217 (623)
.+|. .|++|.+|+.|.+.-|++.-.....+..|++|..|.+-+|.+.- |+. .+. + .....-+.-|+..|...+
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~-i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQS-ICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhh-hccccccchhccchHhhhcCcccccccc
Confidence 7776 58999999999999999998888889999999999999999863 332 222 1 223344556777775544
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.8e-08 Score=110.87 Aligned_cols=104 Identities=31% Similarity=0.406 Sum_probs=90.5
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|.|.-.-...+.+|..|+.|+||+|.|+ .||..+.++.. |++|...+|++. .+| ++.+++.|+.+|
T Consensus 383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~-L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGR-LHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh-hHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 46889999999997544456899999999999999999 99999999755 999999999999 889 999999999999
Q ss_pred ccCCcCCC-CCCcccccccccccccccccc
Q 006982 160 LDHNRFSG-QIPPQLGQLGRLKSFSVANNL 188 (623)
Q Consensus 160 l~~N~~~g-~iP~~l~~l~~L~~l~l~~N~ 188 (623)
||.|+|+- .+|..+-. ++|++|||++|.
T Consensus 459 lS~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred cccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 99999983 44544322 799999999996
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-06 Score=84.96 Aligned_cols=134 Identities=19% Similarity=0.170 Sum_probs=95.5
Q ss_pred CcccceeeccCccEEEEEEeCCCcEEEEEEecccc-----------------------ccHHHHHHHHHHhCCCCCC--C
Q 006982 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ-----------------------RSEKEFVAEMATLGSVKNR--N 361 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~--n 361 (623)
....+.||-|.-+.||.|..++|.++++|.=+... .+....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45568899999999999999999999999432110 1123457899999988654 5
Q ss_pred CcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 362 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
+.+.+++ +.-.+||||++|-.|...-- +....-.++..|.+-+.-+-.. ||+|+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 6666553 45679999999866554321 1122233445555555544466 999999999999999
Q ss_pred CCCCeEEeecccccc
Q 006982 442 DDFEPKISDFGLARL 456 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~ 456 (623)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999965543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.1e-08 Score=89.41 Aligned_cols=88 Identities=27% Similarity=0.412 Sum_probs=29.6
Q ss_pred cccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccc-cccc
Q 006982 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQL-GQLG 177 (623)
Q Consensus 99 ~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l-~~l~ 177 (623)
.+.+..+++.|+|++|.++ .|. .++....+|+.||||+|.++ .++ .+..+++|+.|+|++|+++ .+++.+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-T
T ss_pred ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 3567778999999999999 564 46532345999999999999 665 5888999999999999999 576655 4699
Q ss_pred cccccccccccccc
Q 006982 178 RLKSFSVANNLLSG 191 (623)
Q Consensus 178 ~L~~l~l~~N~l~g 191 (623)
+|+.|+|++|++..
T Consensus 89 ~L~~L~L~~N~I~~ 102 (175)
T PF14580_consen 89 NLQELYLSNNKISD 102 (175)
T ss_dssp T--EEE-TTS---S
T ss_pred cCCEEECcCCcCCC
Confidence 99999999999964
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=7.6e-08 Score=103.71 Aligned_cols=98 Identities=24% Similarity=0.420 Sum_probs=76.2
Q ss_pred HHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccC-----CCCcccccCcccccC
Q 006982 411 IGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNG-----EFGDLGYVAPEYART 485 (623)
Q Consensus 411 ~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~-----~~gt~~y~aPE~~~~ 485 (623)
.+++.|+.|+|... +++|++|.|++|.+++.+..||+.|+++..........-...+. ......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44558999999874 89999999999999999999999999987654421111111111 124568999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCC
Q 006982 486 LVATPKGDVYSFGTVLLELVTGERP 510 (623)
Q Consensus 486 ~~~s~k~DV~sfGvil~elltg~~P 510 (623)
...+.++|+||+||++|-+..|..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcc
Confidence 8889999999999999999955544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.8e-08 Score=102.29 Aligned_cols=103 Identities=24% Similarity=0.435 Sum_probs=65.9
Q ss_pred EEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeecc
Q 006982 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~ 161 (623)
+..|-+++|+++ .+|++|+.+..|..||.+.|.+. ++|+.++.+.+ |+.|.+..|++. .+|.+++.| .|..||+|
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~s-lr~l~vrRn~l~-~lp~El~~L-pLi~lDfS 219 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTS-LRDLNVRRNHLE-DLPEELCSL-PLIRLDFS 219 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHH-HHHHHHhhhhhh-hCCHHHhCC-ceeeeecc
Confidence 334455555554 56666666666666666666666 66666666554 666666666666 566666633 46667777
Q ss_pred CCcCCCCCCcccccccccccccccccccc
Q 006982 162 HNRFSGQIPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 162 ~N~~~g~iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
.|+++ .||..|.+|+.|++|.|.+|-|.
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 77766 66777777777777777777665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.39 E-value=8.8e-07 Score=106.89 Aligned_cols=111 Identities=23% Similarity=0.305 Sum_probs=65.8
Q ss_pred EEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeecc
Q 006982 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~ 161 (623)
+..|++.++.+ ..+|..+ .+.+|+.|+|++|++. .+|..+..+. +|+.|+|++|+..+.+| .++.+++|+.|+|+
T Consensus 591 Lr~L~~~~~~l-~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~-~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~ 665 (1153)
T PLN03210 591 LRLLRWDKYPL-RCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLT-GLRNIDLRGSKNLKEIP-DLSMATNLETLKLS 665 (1153)
T ss_pred cEEEEecCCCC-CCCCCcC-CccCCcEEECcCcccc-ccccccccCC-CCCEEECCCCCCcCcCC-ccccCCcccEEEec
Confidence 34444444433 2444444 3556666666666666 5666665543 36667776655444665 36666667777776
Q ss_pred CCcCCCCCCccccccccccccccccccccccCCccc
Q 006982 162 HNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 162 ~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
+|.....+|.+++++++|+.|++++|..-+.+|...
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i 701 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI 701 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC
Confidence 666555666666666777777776665555666543
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.3e-07 Score=107.60 Aligned_cols=113 Identities=19% Similarity=0.308 Sum_probs=93.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|.++.+. .+|..+..+++|+.|+|++|..-+.+|. ++.+ ++|+.|+|++|.....+|..++++++|+.|+
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l-~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMA-TNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccC-CcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 46888999999876 5788888999999999998776668884 6665 4599999999877778999999999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~ 196 (623)
|++|..-+.+|..+ ++++|+.|++++|...+.+|..
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~ 723 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI 723 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc
Confidence 99977666888876 7889999999998777777754
|
syringae 6; Provisional |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.1e-06 Score=82.82 Aligned_cols=107 Identities=22% Similarity=0.275 Sum_probs=83.6
Q ss_pred HHHHHHHHHHhCCCCC--CCCcceeEEEEeCC----eeeEEEecCCCC-CHhhhccCCCCCCCccChHHHHHHHHHHHHH
Q 006982 344 EKEFVAEMATLGSVKN--RNLVPLLGFCMAKK----ERLLVYKHMPNG-SLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416 (623)
Q Consensus 344 ~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 416 (623)
.....+|.+.+.+++. -...+.+++.+... ..++|+|++++. +|.+++.... ..+...+..++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 3456778887777743 34566777766532 347999999984 7999985321 25556678899999999
Q ss_pred HHHHHhcCCCCcEecCCCCCceeeCCCC---CeEEeeccccccc
Q 006982 417 FAWLHHNCNPRIIHRNISSKCILLDDDF---EPKISDFGLARLM 457 (623)
Q Consensus 417 l~yLH~~~~~~i~H~dlk~~NILl~~~~---~~kl~Dfgla~~~ 457 (623)
++-||.. +|+|+|++++|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=9.3e-06 Score=77.08 Aligned_cols=138 Identities=17% Similarity=0.102 Sum_probs=101.7
Q ss_pred eeccCccEEEEEEeCCCcEEEEEEecc----c---cccHHHHHHHHHHhCCCCCC--CCcceeEEEEeC----CeeeEEE
Q 006982 313 IGSGRTGTMYKALLEDGTSLMVKRLQD----S---QRSEKEFVAEMATLGSVKNR--NLVPLLGFCMAK----KERLLVY 379 (623)
Q Consensus 313 lG~G~~g~Vy~~~~~~~~~vavK~~~~----~---~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~~lV~ 379 (623)
-|+||-+.|++-.+. |..+.+|+-.. + ......|.+|+..+.++..- .+.++..+.... ...+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467889999998775 44688887642 1 23567899999999888543 344444222221 2357999
Q ss_pred ecCCC-CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC--eEEeecccccc
Q 006982 380 KHMPN-GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE--PKISDFGLARL 456 (623)
Q Consensus 380 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~--~kl~Dfgla~~ 456 (623)
|-+++ -+|.+++..... .+.+...+..+..+++..++-||.. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 589988853321 3456777889999999999999999 9999999999999986666 99999977764
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=9e-08 Score=99.00 Aligned_cols=114 Identities=22% Similarity=0.220 Sum_probs=80.0
Q ss_pred CCcEEEEEecCCCceeeCCccccCCCC---CCEEEcCCCCCCC----CCChhHhhhcCCCCEEEccCccCCCCC----CC
Q 006982 79 ENRVLNLRLTDMGLKGQFPRGIRNCSS---MTGLDLSSNKLYG----PLPDDISKLVGFLTSLDLSSNNFSGSI----PS 147 (623)
Q Consensus 79 ~~~v~~l~l~~~~l~g~~p~~l~~l~~---L~~L~L~~N~l~g----~ip~~~~~l~~~L~~L~L~~N~l~g~i----p~ 147 (623)
..+++.|+|+++.+.+..+..+..+.+ |+.|+|++|.+++ .+...+..+.++|+.|+|++|.+++.. +.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 357888888888887766666666655 8888888888874 233344443245888888888888532 33
Q ss_pred CCCCCCCCceeeccCCcCCCC----CCcccccccccccccccccccccc
Q 006982 148 NLANCTYLNSLKLDHNRFSGQ----IPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 148 ~~~~l~~L~~l~l~~N~~~g~----iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
.+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 456677888888888888853 344455566888888888887643
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.6e-07 Score=97.12 Aligned_cols=111 Identities=22% Similarity=0.396 Sum_probs=85.9
Q ss_pred CcEEEEEecCCCcee----eCCccccCC-CCCCEEEcCCCCCCCCCChh----HhhhcCCCCEEEccCccCCCC----CC
Q 006982 80 NRVLNLRLTDMGLKG----QFPRGIRNC-SSMTGLDLSSNKLYGPLPDD----ISKLVGFLTSLDLSSNNFSGS----IP 146 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g----~~p~~l~~l-~~L~~L~L~~N~l~g~ip~~----~~~l~~~L~~L~L~~N~l~g~----ip 146 (623)
.++..|++++|.+++ .+...+..+ ++|+.|+|++|.+++..+.. +..+ ..|+.|+|++|.+++. ++
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~l~ 186 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRAN-RDLKELNLANNGIGDAGIRALA 186 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhC-CCcCEEECcCCCCchHHHHHHH
Confidence 349999999999883 444566777 89999999999999654333 3333 3499999999999953 34
Q ss_pred CCCCCCCCCceeeccCCcCCCC----CCccccccccccccccccccccc
Q 006982 147 SNLANCTYLNSLKLDHNRFSGQ----IPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 147 ~~~~~l~~L~~l~l~~N~~~g~----iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
..+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 187 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 4556678999999999999854 34456678889999999999886
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.4e-07 Score=88.79 Aligned_cols=106 Identities=25% Similarity=0.370 Sum_probs=63.7
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.|..|+|+.|++.-. .++..|++|+.||||+|.|+ .+-..-.++ .+.+.|.|+.|.+. .+ +.++.+-+|..||+
T Consensus 308 kir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KL-GNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 308 KLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKL-GNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDL 381 (490)
T ss_pred ceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhh-cCEeeeehhhhhHh-hh-hhhHhhhhheeccc
Confidence 455666666665421 22556666666666666666 444333343 33666666666665 22 34666677777777
Q ss_pred cCCcCCCCCC--ccccccccccccccccccccccC
Q 006982 161 DHNRFSGQIP--PQLGQLGRLKSFSVANNLLSGSI 193 (623)
Q Consensus 161 ~~N~~~g~iP--~~l~~l~~L~~l~l~~N~l~g~i 193 (623)
++|++. .+- ..+|+|+.|+.+.|.+|.+++.+
T Consensus 382 ~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 382 SSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred cccchh-hHHHhcccccccHHHHHhhcCCCccccc
Confidence 777765 222 35677777777777777776553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.9e-06 Score=90.16 Aligned_cols=145 Identities=20% Similarity=0.280 Sum_probs=94.7
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccccc-------------------------------HHH-------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRS-------------------------------EKE------- 346 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------~~~------- 346 (623)
.+|+ .+-|+.++-|+||+|++++|+.||||+....-.. .++
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3454 3679999999999999999999999987532100 011
Q ss_pred ---HHHHHHHhCCCC-----CCCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHH-
Q 006982 347 ---FVAEMATLGSVK-----NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF- 417 (623)
Q Consensus 347 ---~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l- 417 (623)
+..|..-+.+++ .+++.-..=|.+-.....++|||++|-.+.+...... ..++ +..++..++++.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHH
Confidence 223444443332 2333222223334567899999999998888843221 2233 334444444432
Q ss_pred HHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 418 ~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
..+-.. +++|.|.+|.||+++.++...+.|||+...+.+
T Consensus 279 ~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 222233 899999999999999999999999999987654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.7e-07 Score=80.78 Aligned_cols=109 Identities=24% Similarity=0.318 Sum_probs=84.4
Q ss_pred EEEEEecCCCceeeCCcc---ccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 82 VLNLRLTDMGLKGQFPRG---IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~---l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
...++|++..| +.|+.. +.....|+..+|++|.|. .+|+.+....+.++.|+|++|.++ .+|.+++.++.|+.|
T Consensus 29 ~h~ldLssc~l-m~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQL-MYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchh-hHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 34456666554 234443 445566777799999998 788888776656899999999999 789999999999999
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+++.|.|+ ..|.-+..|.+|.+|+..+|... +||.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~ 140 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDV 140 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcH
Confidence 99999998 67888888889999998888765 4553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-07 Score=80.57 Aligned_cols=113 Identities=20% Similarity=0.240 Sum_probs=92.5
Q ss_pred CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 79 ~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
..+++.++|++|+|...-+..-...+.++.|+|++|.++ .+|.++..+.. |+.|++++|.|. ..|.-+..|.+|..|
T Consensus 52 ~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~a-Lr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPA-LRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHH-hhhcccccCccc-cchHHHHHHHhHHHh
Confidence 357889999999998654444456679999999999999 89999999765 999999999999 789999999999999
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+..+|..- +||-.+..-+..-..++.+|.+.+.-|.
T Consensus 129 ds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 129 DSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 99999988 7887754444444556677777776664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=77.10 Aligned_cols=139 Identities=12% Similarity=0.118 Sum_probs=85.2
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCC--CcceeEEEEeCCeeeEEEecCCCCC-H
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRN--LVPLLGFCMAKKERLLVYKHMPNGS-L 387 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs-L 387 (623)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999984 24567788776533 3445688999988886433 4667777777777789999999863 2
Q ss_pred hhh---------------------ccCCCCCCCccChHHHHH-HHH----------HHH-HHHHHHHhc-CCCCcEecCC
Q 006982 388 YDL---------------------LHPADDTGKSVDWPRRLK-IAI----------GAA-RGFAWLHHN-CNPRIIHRNI 433 (623)
Q Consensus 388 ~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~ia-~~l~yLH~~-~~~~i~H~dl 433 (623)
... +|........+ ..+.. +.. .+. ....+|... ..+.++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l--~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTF--QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcH--HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 111 12211111111 11000 000 000 112222211 1235789999
Q ss_pred CCCceeeCCCCCeEEeecccccc
Q 006982 434 SSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 434 k~~NILl~~~~~~kl~Dfgla~~ 456 (623)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999988763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.9e-07 Score=88.34 Aligned_cols=90 Identities=28% Similarity=0.329 Sum_probs=44.0
Q ss_pred eeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccc
Q 006982 94 GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQL 173 (623)
Q Consensus 94 g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l 173 (623)
|..-.++.....|+.||||+|.++ .|-.+.. +.+.++.|+||+|.+. .+- .+..+++|+.||||+|.++ .+-..-
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvK-L~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh 348 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVK-LAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWH 348 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhh-hccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhH
Confidence 333334444455566666666655 4444432 2344666666666655 332 2555566666666666555 232222
Q ss_pred ccccccccccccccc
Q 006982 174 GQLGRLKSFSVANNL 188 (623)
Q Consensus 174 ~~l~~L~~l~l~~N~ 188 (623)
..|.+++.|.|+.|.
T Consensus 349 ~KLGNIKtL~La~N~ 363 (490)
T KOG1259|consen 349 LKLGNIKTLKLAQNK 363 (490)
T ss_pred hhhcCEeeeehhhhh
Confidence 333344444444443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.4e-06 Score=93.12 Aligned_cols=107 Identities=32% Similarity=0.496 Sum_probs=70.2
Q ss_pred EEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCC
Q 006982 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHN 163 (623)
Q Consensus 84 ~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N 163 (623)
.+++.++.+...+. .+..++.++.|++.+|.++ .||+..+.+.++|+.|++++|++. .+|..++++++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~~-~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCch-hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 35566655533322 3445567777777777777 677666653213777777777777 66666777777777777777
Q ss_pred cCCCCCCccccccccccccccccccccccCCc
Q 006982 164 RFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 164 ~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+++ .+|...+.+++|+.|++++|+++ .+|.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~ 203 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCch
Confidence 777 66766667777777777777776 3443
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.1e-06 Score=60.09 Aligned_cols=35 Identities=40% Similarity=0.650 Sum_probs=21.5
Q ss_pred CCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCC
Q 006982 131 LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFS 166 (623)
Q Consensus 131 L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~ 166 (623)
|++|+|++|+|+ .||+.+++|++|+.|+|++|+++
T Consensus 3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 666666666666 56655666666666666666666
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.9e-05 Score=72.28 Aligned_cols=153 Identities=19% Similarity=0.197 Sum_probs=99.8
Q ss_pred ccCHHHHHHHhccCcccce---eeccCccEEEEEEeCCCcEEEEEEeccccccH--------------------H-----
Q 006982 294 KMRLSDLMKATNSFSKNNI---IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSE--------------------K----- 345 (623)
Q Consensus 294 ~~~~~~l~~~~~~f~~~~~---lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~----- 345 (623)
..++..+....+...+... |.+|.-..||+|...++..+|+|+++...... +
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3445555555555555554 45677779999998889999999986432110 1
Q ss_pred HHHHHHHHhCCCC--CCCCcceeEEEEeCCeeeEEEecCCCC-CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHh
Q 006982 346 EFVAEMATLGSVK--NRNLVPLLGFCMAKKERLLVYKHMPNG-SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422 (623)
Q Consensus 346 ~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~ 422 (623)
-..+|+.-|.++. +-.+.+.+++. ...|||||+... .-.-.|.. ..+.......+..++.+.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH
Confidence 1235666666663 33444444442 346999999653 11112211 122222456677788888888877
Q ss_pred cCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 423 ~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
.+ +++|+||..=|||+. ++.+.|+|||-+....
T Consensus 185 ~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 43 999999999999999 8899999999887654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.7e-05 Score=75.58 Aligned_cols=141 Identities=18% Similarity=0.179 Sum_probs=84.2
Q ss_pred eeccCc-cEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEEecCCCCCHhhh
Q 006982 313 IGSGRT-GTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDL 390 (623)
Q Consensus 313 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 390 (623)
|-.|.. ..||+.... +..+++|+..... .....+|++++..+. +--+.+++++....+..++|||+++|.++...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 789999865 4678888875543 334667888877773 33455667777666667899999999877643
Q ss_pred c-------------------cCCCCCCCccC--hHHHHHHHH--------------------HHHHHHHHHHhc----CC
Q 006982 391 L-------------------HPADDTGKSVD--WPRRLKIAI--------------------GAARGFAWLHHN----CN 425 (623)
Q Consensus 391 l-------------------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~~l~yLH~~----~~ 425 (623)
. |........+. +..++.... .+......|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 22111111111 001110000 011111222111 23
Q ss_pred CCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 426 PRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 426 ~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+.++|+|+.|.||+++++....|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4689999999999999988889999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.3e-05 Score=71.35 Aligned_cols=136 Identities=14% Similarity=0.197 Sum_probs=88.3
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccH-H---------HHHHHHHHhCCCCCC---CCcceeEEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSE-K---------EFVAEMATLGSVKNR---NLVPLLGFCM 370 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~---------~~~~e~~~l~~l~h~---niv~l~~~~~ 370 (623)
.++|...+++-......|.+-.. +|..+++|......... + ...+++..+.+++.. ..+.++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45677777777777677766666 47888899876532211 1 123344444444322 2223222222
Q ss_pred e-----CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC
Q 006982 371 A-----KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE 445 (623)
Q Consensus 371 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~ 445 (623)
. ....++++||++|..|.+... ++. .++..+..++.-||.. |+.|+|+.|.|+++++++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-
Confidence 2 234568999999988876642 221 2456677889999999 999999999999999665
Q ss_pred eEEeecccccc
Q 006982 446 PKISDFGLARL 456 (623)
Q Consensus 446 ~kl~Dfgla~~ 456 (623)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.6e-06 Score=91.10 Aligned_cols=104 Identities=34% Similarity=0.550 Sum_probs=92.4
Q ss_pred cEEEEEecCCCceeeCCccccCCC-CCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCS-SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~-~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+..|++.+|+++ .||+.++.+. +|+.|++++|.+. .+|..+..+.. |+.|++++|+++ .+|...+.+++|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~-L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPN-LKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhcccc-ccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 5888999999987 6787888885 9999999999999 88888888654 999999999999 8898888999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLL 189 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l 189 (623)
+++|+++ .+|..++.+..|+.|.+++|..
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~ 221 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSI 221 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcc
Confidence 9999999 8999887788899999999963
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.4e-06 Score=87.65 Aligned_cols=89 Identities=19% Similarity=0.225 Sum_probs=52.8
Q ss_pred ccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccc
Q 006982 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRL 179 (623)
Q Consensus 100 l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L 179 (623)
|..|++|+.|+|++|++++.-+..+..+.. ++.|+|..|++.-.--..|.++..|++|+|++|+++-.-|.+|..+.+|
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~-l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAE-LQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhh-hhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 556666666666666666555555555433 6666666666652222345556666666666666665556666666666
Q ss_pred cccccccccc
Q 006982 180 KSFSVANNLL 189 (623)
Q Consensus 180 ~~l~l~~N~l 189 (623)
..|+|-.|.|
T Consensus 349 ~~l~l~~Np~ 358 (498)
T KOG4237|consen 349 STLNLLSNPF 358 (498)
T ss_pred eeeehccCcc
Confidence 6666655544
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.3e-06 Score=97.49 Aligned_cols=105 Identities=30% Similarity=0.322 Sum_probs=73.2
Q ss_pred cEEEEEecCCCc-eeeCCc-cccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 81 RVLNLRLTDMGL-KGQFPR-GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 81 ~v~~l~l~~~~l-~g~~p~-~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.+++|-+.+|.. -..++. .|..++.|+.|||++|.=-+.+|.+|+.+.+ |++|+|+...++ .+|..+++|..|.+|
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~-LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH-LRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh-hhcccccCCCcc-ccchHHHHHHhhhee
Confidence 466666766652 223333 3666777888888877666677877777765 788888877777 777777777788888
Q ss_pred eccCCcCCCCCCccccccccccccccccc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANN 187 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N 187 (623)
++..+.....+|..+..|++|++|.+..-
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccccccccccchhhhcccccEEEeecc
Confidence 87777766566666666777777776443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=3.9e-05 Score=72.55 Aligned_cols=105 Identities=24% Similarity=0.248 Sum_probs=81.9
Q ss_pred HHHHHHhCCCCC-CCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCC
Q 006982 348 VAEMATLGSVKN-RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426 (623)
Q Consensus 348 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~ 426 (623)
..|.-++..+++ +++.+++|+|- .++|.||.+.+++...-.. -..-..-+|..|.+||.++.+.+.++++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357777888866 69999999994 4689999998766532100 00112468999999999999999999986544
Q ss_pred CcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 427 RIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 427 ~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
.+.-.|++++|+-+++++.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6888999999999999999999999777543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.91 E-value=7.3e-05 Score=73.24 Aligned_cols=145 Identities=19% Similarity=0.168 Sum_probs=84.6
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCC--CCcceeEEEEeC---CeeeEEEecCCC
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNR--NLVPLLGFCMAK---KERLLVYKHMPN 384 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~e~~~~ 384 (623)
.+.++.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+.... ...+++++++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 3578999999999999887 58899987655 4456677888887777433 345666654333 346899999999
Q ss_pred CCHhh----------------h---ccCCCCCCCccChHH---------HHHH------------HHHHHH-HHHHHHhc
Q 006982 385 GSLYD----------------L---LHPADDTGKSVDWPR---------RLKI------------AIGAAR-GFAWLHHN 423 (623)
Q Consensus 385 gsL~~----------------~---l~~~~~~~~~l~~~~---------~~~i------------~~~ia~-~l~yLH~~ 423 (623)
..+.. . +|........+.+.. .... ...+.+ .+..++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 1 111111111111110 0000 011222 23333321
Q ss_pred ----CCCCcEecCCCCCceeeC-CCCCeEEeecccccc
Q 006982 424 ----CNPRIIHRNISSKCILLD-DDFEPKISDFGLARL 456 (623)
Q Consensus 424 ----~~~~i~H~dlk~~NILl~-~~~~~kl~Dfgla~~ 456 (623)
....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 234799999999999999 556668999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.87 E-value=5.9e-06 Score=57.79 Aligned_cols=37 Identities=32% Similarity=0.658 Sum_probs=33.2
Q ss_pred CCCceeeccCCcCCCCCCcccccccccccccccccccc
Q 006982 153 TYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 153 ~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
++|++|+|++|+++ .+|+.+++|++|+.|++++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 57999999999999 79999999999999999999998
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 623 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-58 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-13 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-12 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-121
Identities = 123/307 (40%), Positives = 188/307 (61%), Gaps = 8/307 (2%)
Query: 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQD--SQRSEKEFVAEMATL 354
L +L A+++FS NI+G G G +YK L DGT + VKRL++ +Q E +F E+ +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 355 GSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA 414
+RNL+ L GFCM ERLLVY +M NGS+ L ++ +DWP+R +IA+G+A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
RG A+LH +C+P+IIHR++ + ILLD++FE + DFGLA+LM+ DTH++T V G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI-- 199
Query: 475 LGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534
G++APEY T ++ K DV+ +G +LLEL+TG+R ++A+ L++W+ L
Sbjct: 200 -GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG--ERYHF 592
+L+ +D L D E+ Q ++VA C + P ERP M EV + L G ER+
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS-PMERPKMSEVVRMLEGDGLAERWEE 317
Query: 593 TTEDEIM 599
++E+
Sbjct: 318 WQKEEMF 324
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-105
Identities = 117/314 (37%), Positives = 172/314 (54%), Gaps = 13/314 (4%)
Query: 270 GNKWAKSLTGTKGIKVSLFEKSITKMR--LSDLMKATNSFSKNNIIGSGRTGTMYKALLE 327
G+K++K+ S + R L DL +ATN+F +IG G G +YK +L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 328 DGTSLMVKRL-QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGS 386
DG + +KR +S + +EF E+ TL ++ +LV L+GFC + E +L+YK+M NG+
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 387 LYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446
L L+ +D S+ W +RL+I IGAARG +LH IIHR++ S ILLD++F P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 447 KISDFGLARLMNPID-THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELV 505
KI+DFG+++ +D THLST V G GY+ PEY T K DVYSFG VL E++
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTL---GYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 506 TGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCV 565
+ E NL EW + + GQL+ +D L K L +F A C+
Sbjct: 236 CARSAIVQSLPRE--MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 566 LPTIPKERPTMFEV 579
+ ++RP+M +V
Sbjct: 294 ALS-SEDRPSMGDV 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 6e-91
Identities = 102/301 (33%), Positives = 150/301 (49%), Gaps = 30/301 (9%)
Query: 297 LSDLMKATNSFSK------NNIIGSGRTGTMYKALLEDGTSLMVKRL-----QDSQRSEK 345
+L TN+F + N +G G G +YK + + T++ VK+L ++ ++
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 346 EFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPR 405
+F E+ + ++ NLV LLGF + LVY +MPNGSL D L D T + W
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSWHM 134
Query: 406 RLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID--TH 463
R KIA GAA G +LH N IHR+I S ILLD+ F KISDFGLAR T
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS-EKFAQTV 190
Query: 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN 523
+++ + G Y+APE R + TPK D+YSFG VLLE++TG + + P+
Sbjct: 191 MTSRIVGTT---AYMAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVDEHREPQ----L 242
Query: 524 LVEWIAQ-LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582
L++ + ++D IDK + + VA C+ +RP + +V Q
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEK-KNKRPDIKKVQQL 300
Query: 583 L 583
L
Sbjct: 301 L 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-69
Identities = 70/321 (21%), Positives = 117/321 (36%), Gaps = 41/321 (12%)
Query: 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGS 356
+L + + GR G ++KA L + VK + + E+ +L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74
Query: 357 VKNRNLVPLLGFCM----AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIG 412
+K+ N++ +G + L+ GSL D L V W IA
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAET 129
Query: 413 AARGFAWLHHN-------CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465
ARG A+LH + P I HR+I SK +LL ++ I+DFGLA +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 466 TFVNGEFGDLGYVAPEYARTLV-----ATPKGDVYSFGTVLLELVTGERPTNVAKAPETF 520
T +G+ G Y+APE + A + D+Y+ G VL EL + + + +
Sbjct: 190 T--HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD--GPVDEY 245
Query: 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNE----------LFQFLKVACNCVLPTIP 570
E I Q S +Q+ + V K + + C
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVV----VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD-A 300
Query: 571 KERPTMFEVYQFLRAIGERYH 591
+ R + V + + + +
Sbjct: 301 EARLSAGCVGERITQMQRLTN 321
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-49
Identities = 66/299 (22%), Positives = 113/299 (37%), Gaps = 63/299 (21%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
+ +G ++K G ++VK L S R ++F E L + N++P+LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 368 FCMAKKERLL--VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
C + + MP GSLY++LH + T VD + +K A+ ARG A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE---Y 482
P I ++S+ +++D+D +IS + S G +VAPE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKF---------SFQSPGRMYAPAWVAPEALQK 182
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG-NLVEWIAQLSSTG------ 535
D++SF +L ELVT E P F + +E +++ G
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVP---------FADLSNMEIGMKVALEGLRPTIP 233
Query: 536 -----QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589
+ + C+ P +RP + L + ++
Sbjct: 234 PGISPHVSKLMKICMNED---------------------PAKRPKFDMIVPILEKMQDK 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-48
Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 10/203 (4%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
IG+G GT+++A G+ + VK L EF+ E+A + +++ N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
+V +++ GSLY LLH + +D RRL +A A+G +LH N NP
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
I+HRN+ S +L+D + K+ DFGL+RL T LS+ G ++APE R
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSS--KSAAGTPEWMAPEVLRDEP 215
Query: 488 ATPKGDVYSFGTVLLELVTGERP 510
+ K DVYSFG +L EL T ++P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQP 238
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 9e-47
Identities = 64/342 (18%), Positives = 124/342 (36%), Gaps = 51/342 (14%)
Query: 298 SDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAE--MATLG 355
S+ ++ +IG GR G +YK L D + VK S + + F+ E + +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVP 62
Query: 356 SVKNRNLVPLLGFCM-----AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIA 410
+++ N+ + + E LLV ++ PNGSL L + DW ++A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLA 117
Query: 411 IGAARGFAWLH------HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464
RG A+LH + P I HR+++S+ +L+ +D ISDFGL+ +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 465 STFV----NGEFGDLGYVAPEYARTLV-------ATPKGDVYSFGTVLLELVTGERPTNV 513
E G + Y+APE V A + D+Y+ G + E+
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 514 AKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGV-----------DNELFQFLKVAC 562
++ ++ + + +Q + + + +
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLV----SREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 563 NCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDS 604
+C + R T + + + ++ + P+
Sbjct: 294 DCW-DQDAEARLTAQXAEERMAEL---MMIWERNKSVSPTAH 331
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-46
Identities = 66/314 (21%), Positives = 117/314 (37%), Gaps = 69/314 (21%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
++G G G + KA + +K++ +S+ K F+ E+ L V + N+V L G C+
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
LV ++ GSLY++LH + + + ++G A+LH +IH
Sbjct: 72 --NPVCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 431 RNISSKCILLDDDFE-PKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
R++ +LL KI DFG A + T G ++APE +
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-------NNKGSAAWMAPEVFEGSNYS 181
Query: 490 PKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKG 549
K DV+S+G +L E++T +P F
Sbjct: 182 EKCDVFSWGIILWEVITRRKP---------F---------------------------DE 205
Query: 550 VDNELFQFLKVACNCVLPTIPK-------------------ERPTMFEVYQFLRAIGERY 590
+ F+ + N P + K +RP+M E+ + + + RY
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL-MRY 264
Query: 591 HFTTEDEIMLPSDS 604
++ + P
Sbjct: 265 FPGADEPLQYPCQH 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 45/292 (15%)
Query: 311 NIIGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRSE--------KEFVAEMATLGSVKNRN 361
IG G G ++K L++D + + +K L +EF E+ + ++ + N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
+V L G +V + +P G LY L D + W +L++ + A G ++
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 422 HNCNPRIIHRNISSKCILLDDDFE-----PKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
N NP I+HR++ S I L E K++DFGL++ + G G+
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-------GLLGNFQ 191
Query: 477 YVAPE--YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534
++APE A T K D YSF +L ++TGE P + + +++I +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF------DEYSYGKIKFINMIREE 245
Query: 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
G + C + + C PK+RP + + L +
Sbjct: 246 GLRPTIPEDC-------PPRLRNVIELC---WSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 75/290 (25%), Positives = 114/290 (39%), Gaps = 45/290 (15%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRL-----QDSQRSEKEFVAEMATLGSVKNRNLVPL 365
IIG G G +Y+A G + VK +D ++ + E +K+ N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
G C+ + LV + G L +L GK + + A+ ARG +LH
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 426 PRIIHRNISSKCILLDDDFEP--------KISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
IIHR++ S IL+ E KI+DFGLAR + T G +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH------RTTKMSAAGAYAW 180
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG-NLVEWIAQLSSTGQ 536
+APE R + + DV+S+G +L EL+TGE P F+G + + ++
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP---------FRGIDGLAVAYGVAMNKL 231
Query: 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
C E F L C P RP+ + L I
Sbjct: 232 ALPIPSTC-------PEPFAKLMEDC---WNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-45
Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 37/283 (13%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
IGSG GT+YK + VK L + + + F E+ L ++ N++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHGDVA--VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 370 MAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
+L +V + SLY LH + + + + IA ARG +LH I
Sbjct: 90 T--APQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA 488
IHR++ S I L +D KI DFGLA + S G + ++APE R +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKS--RWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 489 TP---KGDVYSFGTVLLELVTGERPTNVAKAPETFKG--NLVEWIAQLSSTGQLQDAIDK 543
P + DVY+FG VL EL+TG+ P + N + I + G L + K
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLP---------YSNINNRDQIIEMVGR-GSLSPDLSK 249
Query: 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ + + C L ERP+ + + +
Sbjct: 250 V--RSNCPKRMKRLMA-EC---LKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-45
Identities = 60/302 (19%), Positives = 107/302 (35%), Gaps = 37/302 (12%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
IG GR G ++ G + VK ++ + E+ +++ N++ + +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 371 ----AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH----- 421
+ + L+ + NGSLYD L ++D LK+A + G LH
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
P I HR++ SK IL+ + I+D GLA + N G Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 482 ------YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535
+ D+YSFG +L E+ + + + +LV S
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP---SYE 273
Query: 536 QLQDA---------IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+++ + ++ + + C P R T V + L +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT-EC---WAHNPASRLTALRVKKTLAKM 329
Query: 587 GE 588
E
Sbjct: 330 SE 331
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 64/289 (22%), Positives = 114/289 (39%), Gaps = 40/289 (13%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
+IG GR G +Y G + ++ + +D++ K F E+ ++ N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
CM+ ++ +LY ++ D +D + +IA +G +LH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPID-THLSTFVNGEFGDLGYVAPEYARTL 486
I+H+++ SK + D+ + I+DFGL + + + + G L ++APE R L
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 487 VA---------TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537
+ DV++ GT+ EL E P FK E I TG
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---------FKTQPAEAIIWQMGTGMK 260
Query: 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ G+ E+ L +ERPT ++ L +
Sbjct: 261 PNLSQ-----IGMGKEISDILLFCWA----FEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 21/220 (9%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
+G GR G +++ G ++ VK E+ +++ N++ + M
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 371 AKK----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH----- 421
+ + L+ + GSLYD L ++D L+I + A G A LH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
P I HR++ SK IL+ + + I+D GLA + + L N G Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 482 ------YARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515
+ + D+++FG VL E+ + +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-43
Identities = 57/310 (18%), Positives = 109/310 (35%), Gaps = 49/310 (15%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
IG GR G +++ G + VK + AE+ +++ N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 371 ----AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH----- 421
+ LV + +GSL+D L+ +V +K+A+ A G A LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
P I HR++ SK IL+ + I+D GLA + + N G Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 482 ------YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535
+ + + D+Y+ G V E+ + E ++ + + S
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI---HEDYQLPYYDLVPSDPSVE 278
Query: 536 QLQDAIDKCLVAKG----VDNELFQFLKVACNCVLPTI-----------PKERPTMFEVY 580
+++ + + + N L + R T +
Sbjct: 279 EMRKVV----CEQKLRPNIPNRWQ------SCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 581 QFLRAIGERY 590
+ L + ++
Sbjct: 329 KTLSQLSQQE 338
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 59/291 (20%), Positives = 112/291 (38%), Gaps = 41/291 (14%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLM-VKRLQD-SQRSEKEFVAEMATLGSVKNRNLVPLLGF 368
++G G G K + +M +K L + +++ F+ E+ + +++ N++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
K + +++ G+L ++ W +R+ A A G A+LH I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF----------GDLGYV 478
IHR+++S L+ ++ ++DFGLARLM T + + G+ ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538
APE K DV+SFG VL E++ L T
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----------------DPDYLPRTMDFG 233
Query: 539 DAIDKCL---VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ L F C+ P++RP+ ++ +L +
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCD----LDPEKRPSFVKLEHWLETL 280
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 52/173 (30%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 33 EDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVEC-WHPDENRVLNLRLTDMG 91
+D L IK L +P SSW D + GV C RV NL L+ +
Sbjct: 6 QDKQALLQIKKDLGNP--TTLSSWLPTTDCCN--RTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 92 LKGQF--PRGIRNCSSMTGLDLSS-NKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN 148
L + P + N + L + N L GP+P I+KL L L ++ N SG+IP
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLYITHTNVSGAIPDF 120
Query: 149 LANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
L+ L +L +N SG +PP + L L + N +SG+IP ++ + +
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 38/141 (26%), Positives = 55/141 (39%), Gaps = 28/141 (19%)
Query: 83 LNLRLTDMG---LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSN 139
LNL D+ L+G + + + L+ N L L + L LDL +N
Sbjct: 197 LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKN-LNGLDLRNN 254
Query: 140 NFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL 199
G++P L +L+SL + N G+IP Q G L+ F
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP----QGGNLQRF----------------- 293
Query: 200 TLSADSVTNNQGLCGEPLDAC 220
+ NN+ LCG PL AC
Sbjct: 294 --DVSAYANNKCLCGSPLPAC 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 43/174 (24%), Positives = 66/174 (37%), Gaps = 26/174 (14%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
+ + + +G + S+ +++S G G + LD+S N
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN-GSMMFLDMSYNM 643
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP------ 194
SG IP + + YL L L HN SG IP ++G L L +++N L G IP
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 195 ---TFVNL----------------TLSADSVTNNQGLCGEPLDACKGTSKGPHT 229
T ++L T NN GLCG PL C ++ +
Sbjct: 704 TMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 38/106 (35%), Positives = 51/106 (48%), Gaps = 1/106 (0%)
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
G+ P + NCS + L LS N L G +P + L L L L N G IP L
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL-SKLRDLKLWLNMLEGEIPQELMY 464
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197
L +L LD N +G+IP L L S++NN L+G IP ++
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-30
Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 25 FSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLN 84
S S ++ L S KD L D N L W+ N + C F GV C +++V +
Sbjct: 4 ASPSQSLYREIHQLISFKDVLPDK-NLL-PDWSSNKN----PCTFDGVTC---RDDKVTS 54
Query: 85 LRLTDMGLK---GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNF 141
+ L+ L + + + + L LS++ + G + LTSLDLS N+
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCS-ASLTSLDLSRNSL 112
Query: 142 SGSIPS--NLANCTYLNSLKLDHNRFSGQIP-PQLGQLGRLKSFSVANNLLSGSIP 194
SG + + +L +C+ L L + N +L L+ ++ N +SG+
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-29
Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 84 NLRLTDMG---LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
LR + L+G+ P+ + ++ L L N L G +P +S L + LS+N
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-LNWISLSNNR 501
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT-FVNL 199
+G IP + L LKL +N FSG IP +LG L + NL +G+IP
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 200 TL 201
+
Sbjct: 562 SG 563
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 39/103 (37%), Positives = 59/103 (57%), Gaps = 1/103 (0%)
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
L G P + + S + L L N L G +P ++ + L +L L N+ +G IPS L+N
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV-KTLETLILDFNDLTGEIPSGLSN 488
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194
CT LN + L +NR +G+IP +G+L L ++NN SG+IP
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-28
Identities = 38/106 (35%), Positives = 62/106 (58%), Gaps = 5/106 (4%)
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
L G+ P G+ NC+++ + LS+N+L G +P I +L L L LS+N+FSG+IP+ L +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL-ENLAILKLSNNSFSGNIPAELGD 536
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197
C L L L+ N F+G IP + + S +A N ++G ++
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYI 578
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-28
Identities = 42/108 (38%), Positives = 58/108 (53%), Gaps = 2/108 (1%)
Query: 92 LKGQFPRGIRNCS-SMTGLDLSSNKLYGPLPDDISKLV-GFLTSLDLSSNNFSGSIPSNL 149
G+ P + N S S+ LDLSSN GP+ ++ + L L L +N F+G IP L
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 150 ANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197
+NC+ L SL L N SG IP LG L +L+ + N+L G IP +
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-28
Identities = 42/120 (35%), Positives = 62/120 (51%), Gaps = 4/120 (3%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L ++ G P S+ L L+ NK G +PD +S LT LDLS N+F G+
Sbjct: 252 LNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP-TFVNLTLS 202
+P +C+ L SL L N FSG++P L ++ LK ++ N SG +P + NL+ S
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
+L ++ L G F R I C+ + L++SSN+ GP+P K L L L+ N F+G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS---LQYLSLAENKFTG 283
Query: 144 SIPSNLA-NCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
IP L+ C L L L N F G +PP G L+S ++++N SG +P T + +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-27
Identities = 46/120 (38%), Positives = 64/120 (53%), Gaps = 4/120 (3%)
Query: 85 LRLTDMGLKGQFPRG-IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L L+ G+ P + + LDLS N+ G LP+ ++ L L +LDLSSNNFSG
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 144 SIPSNLANC--TYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
I NL L L L +N F+G+IPP L L S ++ N LSG+IP + +L+
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-26
Identities = 35/118 (29%), Positives = 54/118 (45%), Gaps = 6/118 (5%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L ++ + G + C ++ LD+SSN +P + L LD+S N SG
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDC-SALQHLDISGNKLSGD 238
Query: 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLS 202
++ CT L L + N+F G IPP L L+ S+A N +G IP F++
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACD 294
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 32/120 (26%), Positives = 52/120 (43%), Gaps = 10/120 (8%)
Query: 84 NLRLTDMG---LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
NL + L G+ P+ I ++ L LS+N G +P ++ L LDL++N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS-LIWLDLNTNL 549
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNL--LSGSIPTFVN 198
F+G+IP+ + S K+ N +G+ + G K A NL G +N
Sbjct: 550 FNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 605
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLV 363
+ + +G G+ G +Y+ + + ++ VK L++ +EF+ E A + +K+ NLV
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
LLG C + ++ + M G+L D L + + V L +A + +L
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
IHRN++++ L+ ++ K++DFGL+RLM DT+ + G + + APE
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAH--AGAKFPIKWTAPESL 391
Query: 484 RTLVATPKGDVYSFGTVLLELVT-GERP 510
+ K DV++FG +L E+ T G P
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLM-----VKRLQD--SQRSEKEFVAEMATLGSV 357
F K ++GSG GT+YK L + +K L++ S ++ KE + E + SV
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF 417
N ++ LLG C+ L+ + MP G L D + + ++ L + A+G
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+L R++HR+++++ +L+ KI+DFGLA+L+ + G+ + +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKV-PIKW 185
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+A E + T + DV+S+G + EL+T G +P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 31/253 (12%)
Query: 309 KNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKNRNLVP 364
+ IG G T+YK L E + LQD + ++ E F E L +++ N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 365 LLGFCM---AKKERLLVY-KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
K+ +++ + M +G+L L K + +G +L
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 145
Query: 421 HHNCNPRIIHRNISSKC--ILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
H P IIHR++ KC I + KI D GLA L + + G +
Sbjct: 146 H-TRTPPIIHRDL--KCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVI----GTPEF 196
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERP-TNVAKAPETFK----GNLVEWIAQLS 532
+APE DVY+FG +LE+ T E P + A + ++ G +++
Sbjct: 197 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255
Query: 533 STGQLQDAIDKCL 545
++++ I+ C+
Sbjct: 256 IP-EVKEIIEGCI 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
+G+G+ G ++ A T + VK ++ S + F+AE + ++++ LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
K+ ++ + M GSL D L D G P+ + + A G A++ IH
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 431 RNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATP 490
R++ + IL+ KI+DFGLAR++ D + +F + + APE T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKF-PIKWTAPEAINFGSFTI 364
Query: 491 KGDVYSFGTVLLELVT-GERP 510
K DV+SFG +L+E+VT G P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP 385
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-26
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
S +G G G ++ T + +K L+ S + F+ E + +++ LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L ++ +V ++M GSL D L +TGK + P+ + +A A G A++
Sbjct: 244 LYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM- 299
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+HR++ + IL+ ++ K++DFGLARL+ D + +F + + APE A
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKF-PIKWTAPEAAL 354
Query: 485 TLVATPKGDVYSFGTVLLELVT-GERP 510
T K DV+SFG +L EL T G P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
S +G G G ++ T + +K L+ S + F+ E + +++ LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L ++ +V ++M GSL D L +TGK + P+ + +A A G A++
Sbjct: 327 LYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM- 382
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+HR++ + IL+ ++ K++DFGLARL+ D + +F + + APE A
Sbjct: 383 --NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKF-PIKWTAPEAAL 437
Query: 485 TLVATPKGDVYSFGTVLLELVT-GERP 510
T K DV+SFG +L EL T G P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLM-----VKRLQD--SQRSEKEFVAEMATLGSV 357
F K ++GSG GT+YK L + +K L++ S ++ KE + E + SV
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF 417
N ++ LLG C+ L+ + MP G L D + + ++ L + A+G
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+L R++HR+++++ +L+ KI+DFGLA+L+ + G+ + +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKV-PIKW 185
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+A E + T + DV+S+G + EL+T G +P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 22/215 (10%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRN 361
IG G G ++ L D T + VK ++ + +F+ E L + N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
+V L+G C K+ +V + + G L G + L++ AA G +L
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
IHR+++++ L+ + KISDFG++R S G L V
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS-------GGLRQVPVK 280
Query: 479 --APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
APE + + DV+SFG +L E + G P
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
+ +G+G+ G ++ T + VK L+ S F+AE + ++++ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L ++ ++ ++M NGSL D L +G + + L +A A G A++
Sbjct: 73 LYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV---APE 481
IHR++ + IL+ D KI+DFGLARL+ D + +F + APE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFP----IKWTAPE 180
Query: 482 YARTLVATPKGDVYSFGTVLLELVT-GERP 510
T K DV+SFG +L E+VT G P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 312 IIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
+GSG+ G + + + VK +++ SE EF E T+ + + LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
+ +V +++ NG L + L GK ++ + L++ G A+L + + IHR
Sbjct: 75 EYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 432 NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV---APEYARTLVA 488
+++++ L+D D K+SDFG+ R + D + V +F V APE
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFP----VKWSAPEVFHYFKY 182
Query: 489 TPKGDVYSFGTVLLELVT-GERP 510
+ K DV++FG ++ E+ + G+ P
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 49/208 (23%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
+ + IGSG+ G ++ + + +K +++ SE++F+ E + + + LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHN 423
L G C+ + LV + M +G L D L L + + G A+L
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
IHR+++++ L+ ++ K+SDFG+ R + D ++ +F + + +PE
Sbjct: 125 V----IHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKF-PVKWASPEVF 177
Query: 484 RTLVATPKGDVYSFGTVLLELVT-GERP 510
+ K DV+SFG ++ E+ + G+ P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 17/214 (7%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLM-----VKRLQD--SQRSEKEFVAEMATLGSV 357
K ++GSG GT++K + + +K ++D ++S + M +GS+
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF 417
+ ++V LLG C LV +++P GSL D + ++ L + A+G
Sbjct: 73 DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGM 128
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+L + ++HRN++++ +LL + +++DFG+A L+ P D L + + +
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY-SEAKT-PIKW 183
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+A E T + DV+S+G + EL+T G P
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLE---DGTSLMV--KRLQ-DSQRSEKEFVAEMATLGSVK 358
+ +G G G++ + D T +V K+LQ +++F E+ L ++
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 359 NRNLVPLLGFCMAKKER--LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ +V G + LV +++P+G L D L +D R L + +G
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKG 139
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+L R +HR+++++ IL++ + KI+DFGLA+L+ + G+ +
Sbjct: 140 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-PIF 195
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ APE + + + DV+SFG VL EL T ++
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDG-TSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLV 363
+ + +G G+ G +Y+ + + ++ VK L++ +EF+ E A + +K+ NLV
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HH 422
LLG C + ++ + M G+L D L + + V L +A + +L
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY 482
N IHR+++++ L+ ++ K++DFGL+RLM DT+ + +F + + APE
Sbjct: 131 NF----IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAH-AGAKF-PIKWTAPES 183
Query: 483 ARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ K DV++FG +L E+ T G P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 45/211 (21%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
+ +G+G+ G + + +K +++ SE EF+ E + ++ + LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHN 423
L G C ++ ++ ++M NG L + L + + L++ +L
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV---AP 480
+HR+++++ L++D K+SDFGL+R + D ++ V +F V P
Sbjct: 141 F----LHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKFP----VRWSPP 190
Query: 481 EYARTLVATPKGDVYSFGTVLLELVT-GERP 510
E + K D+++FG ++ E+ + G+ P
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 23/230 (10%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLE---DGTSLMV--KRLQD--SQRSEKEFVAEMATLGSV 357
K +G G G + + DGT MV K L+ + + E+ L ++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 358 KNRNLVPLLGFCMAKKER--LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR 415
+ +++ G C LV +++P GSL D L S+ + L A
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICE 145
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G A+LH IHR+++++ +LLD+D KI DFGLA+ + + E GD
Sbjct: 146 GMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA---VPEGHEYYRVREDGDS 199
Query: 476 --GYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKG 522
+ APE + DV+SFG L EL+T + + G
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL---LEDGTSLMV--KRLQ-DSQRSEKEFVAEMATLGSVK 358
+G G G++ L+D T +V K+LQ ++ ++F E+ L S++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 359 NRNLVPLLGFCMAKKER--LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ N+V G C + R L+ +++P GSL D L + +D + L+ +G
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKG 126
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL- 475
+L R IHR+++++ IL++++ KI DFGL ++ + F E G+
Sbjct: 127 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV---LPQDKEFFKVKEPGESP 180
Query: 476 -GYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKG 522
+ APE + DV+SFG VL EL T E+ + G
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
IG G G + G + VK +++ + + F+AE + + +++ NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQ 250
Query: 365 LLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
LLG + +K L +V ++M GSL D L + LK ++ +L N
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+HR+++++ +L+ +D K+SDFGL + + G+ + + APE
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKL-PVKWTAPEAL 358
Query: 484 RTLVATPKGDVYSFGTVLLELVT-GERP 510
R + K DV+SFG +L E+ + G P
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 50/231 (21%), Positives = 95/231 (41%), Gaps = 21/231 (9%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLE---DGTSLMV--KRLQD--SQRSEKEFVAEMATLGSV 357
+ +G G G + + D T V K L+ + E+ L ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 358 KNRNLVPLLGFCMAKKER--LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR 415
+ N+V G C L+ + +P+GSL + L ++ ++LK A+ +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICK 137
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G +L + +HR+++++ +L++ + + KI DFGL + I+T + + D
Sbjct: 138 GMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA---IETDKEYYTVKDDRDS 191
Query: 476 --GYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGN 523
+ APE DV+SFG L EL+T + ++ G
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 20/229 (8%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLE---DGTSLMV--KRLQDSQRSE-KEFVAEMATLGSVK 358
+G G G++ + D T +V K+LQ S ++F E+ L S++
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 359 NRNLVPLLGFCMAKKER--LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ N+V G C + R L+ +++P GSL D L + +D + L+ +G
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKG 157
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL- 475
+L R IHR+++++ IL++++ KI DFGL ++ + + E G+
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV---LPQDKEYYKVKEPGESP 211
Query: 476 -GYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKG 522
+ APE + DV+SFG VL EL T E+ + G
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
IG G G + G + VK +++ + + F+AE + + +++ NLV LLG +
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 371 AKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHNCNPRI 428
+K L +V ++M GSL D L + LK ++ +L +N
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---- 138
Query: 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV---APEYART 485
+HR+++++ +L+ +D K+SDFGL + + + G+ V APE R
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQ-DTGKLP----VKWTAPEALRE 188
Query: 486 LVATPKGDVYSFGTVLLELVT-GERP 510
+ K DV+SFG +L E+ + G P
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL--EDGTSLMV--KRLQ----DSQRSEKEFVAEMATLGS 356
+G G G + + G ++ V K L+ + +F+ E+ + S
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ +RNL+ L G + +V + P GSL D L + A+ A G
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEG 133
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+L R IHR+++++ +LL KI DFGL R + D H + +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFA 189
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ APE +T + D + FG L E+ T G+ P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 312 IIGSGRTGTMYKALLEDGTSLM---VKRLQD---SQRSEKEFVAEMATLGSVKNRNLVPL 365
+GSG GT+ K + + VK L++ + E +AE + + N +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHNC 424
+G C + +LV + G L L + V +++ + G +L N
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+HR+++++ +LL KISDFGL++ + + + +G++ + + APE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW-PVKWYAPECIN 193
Query: 485 TLVATPKGDVYSFGTVLLELVT-GERP 510
+ K DV+SFG ++ E + G++P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 310 NNIIGSGRTGTMYKALLEDGTSL-------MVKRLQDSQRSEKEFVAEMATLGSVKNRNL 362
I+G G G++ + L+ +K SQR +EF++E A + + N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 363 VPLLGFC-----MAKKERLLVYKHMPNGSLYDLL--HPADDTGKSVDWPRRLKIAIGAAR 415
+ LLG C + +++ M G L+ L + K + LK + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G +L + +HR+++++ +L DD ++DFGL++ + D + G +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-------RQGRI 208
Query: 476 GYV-----APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ A E V T K DV++FG + E+ T G P
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 51/234 (21%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLM--------VKRL-QDSQRSEKEFVAEMATLG 355
N +G G ++K + + +K L + + + F + +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 356 SVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR 415
+ +++LV G C+ E +LV + + GSL L ++ +L++A A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAA 124
Query: 416 GFAWL-HHNCNPRIIHRNISSKCILLDDDFEP--------KISDFGLARLMNPIDTHLST 466
+L + IH N+ +K ILL + + K+SD G++ + P D
Sbjct: 125 AMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175
Query: 467 FVNGEFGDLGY------VAPE---YARTLVATPKGDVYSFGTVLLELVT-GERP 510
V PE + L D +SFGT L E+ + G++P
Sbjct: 176 ---------ILQERIPWVPPECIENPKNL--NLATDKWSFGTTLWEICSGGDKP 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 311 NIIGSGRTGTMYKALLEDG----TSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVP 364
+IG G G +Y D +K L + + F+ E + + + N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 365 LLGFCMAKKERLL-VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HH 422
L+G + + + +M +G L + ++ + + ARG +L
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID-THLSTFVNGEFGDLGYV--- 478
+HR+++++ +LD+ F K++DFGLAR + + + + V
Sbjct: 144 KF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP----VKWT 195
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
A E +T T K DV+SFG +L EL+T G P
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 45/205 (21%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 313 IGSGRTGTMYKALLEDGTSLM---VKRLQD--SQRSEKEFVAEMATLGSVKNRNLVPLLG 367
+G G G++ + + + +K L+ + +E + E + + N +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHNCNP 426
C + +LV + G L+ L + + ++ + G +L N
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKNF-- 457
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
+HRN++++ +LL + KISDFGL++ + D++ + G++ L + APE
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW-PLKWYAPECINFR 514
Query: 487 VATPKGDVYSFGTVLLELVT-GERP 510
+ + DV+S+G + E ++ G++P
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 44/205 (21%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 313 IGSGRTGTMYKALLEDGTSLM---VKRLQD--SQRSEKEFVAEMATLGSVKNRNLVPLLG 367
+G G G++ + + + +K L+ + +E + E + + N +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHNCNP 426
C + +LV + G L+ L + + ++ + G +L N
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKNF-- 131
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
+HR+++++ +LL + KISDFGL++ + D++ + G++ L + APE
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW-PLKWYAPECINFR 188
Query: 487 VATPKGDVYSFGTVLLELVT-GERP 510
+ + DV+S+G + E ++ G++P
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 311 NIIGSGRTGTMYKALLEDG----TSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVP 364
+IG G G +Y L D VK L +F+ E + + N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 365 LLGFCMAKKE-RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
LLG C+ + L+V +M +G L + + + + + + A+G +L
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV---AP 480
+ +HR+++++ +LD+ F K++DFGLAR M + + V+ + G V A
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS---VHNKTGAKLPVKWMAL 201
Query: 481 EYARTLVATPKGDVYSFGTVLLELVT-GERP 510
E +T T K DV+SFG +L EL+T G P
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 43/222 (19%), Positives = 90/222 (40%), Gaps = 31/222 (13%)
Query: 310 NNIIGSGRTGTMYKALLEDGTSL-------MVKRLQDSQRSEKEFVAEMATLGSVKNRNL 362
++G G G++ +A L+ M+K + +EF+ E A + + ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 363 VPLLGFC------MAKKERLLVYKHMPNGSLYDLL--HPADDTGKSVDWPRRLKIAIGAA 414
L+G +++ M +G L+ L + ++ ++ + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
G +L IHR+++++ +L +D ++DFGL+R + D + G
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-------RQGC 197
Query: 475 LGYV-----APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ A E + T DV++FG + E++T G+ P
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 55/215 (25%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLM-----VKRLQD--SQRSEKEFVAEMATLGSV 357
+ ++ +IG+G G +YK +L+ + +K L+ +++ +F+ E +G
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF 417
+ N++ L G K +++ ++M NG+L L + + + + G A G
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGM 160
Query: 418 AWL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+L + N +HR+++++ IL++ + K+SDFGL+R++ T G+ +
Sbjct: 161 KYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI-PIR 215
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ APE T DV+SFG V+ E++T GERP
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLM----VKRLQD--SQRSEKEFVAEMATLGSVKNRNLVP 364
+IG G G +Y L D VK L +F+ E + + N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 365 LLGFCMAKKE-RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
LLG C+ + L+V +M +G L + + + + + + A+G +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL--GYVAPE 481
+ +HR+++++ +LD+ F K++DFGLAR M + + N L ++A E
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--SVHNKTGAKLPVKWMALE 266
Query: 482 YARTLVATPKGDVYSFGTVLLELVT-GERP 510
+T T K DV+SFG +L EL+T G P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 30/220 (13%)
Query: 311 NIIGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNL 362
+G G G +Y+ + + VK L + S++ E +F+ E + ++N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLH---PADDTGKSVDWPRRLKIAIGAARGFAW 419
V +G + R ++ + M G L L P S+ L +A A G +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEP---KISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
L N IHR+I+++ LL KI DFG+AR + + G
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-------RKGGCA 205
Query: 477 YV-----APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ PE + T K D +SFG +L E+ + G P
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 46/214 (21%), Positives = 91/214 (42%), Gaps = 19/214 (8%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL--EDGTSLMV--KRLQD--SQRSEKEFVAEMATLGSVK 358
IG G+ G +++ + + +L V K ++ S ++F+ E T+
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
+ ++V L+G + ++ + G L L S+D + A + A
Sbjct: 75 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALA 130
Query: 419 WL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+L +HR+I+++ +L+ + K+ DFGL+R M D+ G+ + +
Sbjct: 131 YLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKL-PIKW 183
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+APE T DV+ FG + E++ G +P
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 44/207 (21%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 312 IIGSGRTGTMYKALL--EDGTSLMV--KRLQD--SQRSEKEFVAEMATLGSVKNRNLVPL 365
IG G+ G +++ + + ++ V K ++ S ++F+ E T+ + ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH-HNC 424
+G + ++ + G L L S+D + A + A+L
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKRF 512
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+HR+I+++ +L+ + K+ DFGL+R M + ++ G+ + ++APE
Sbjct: 513 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKL-PIKWMAPESIN 565
Query: 485 TLVATPKGDVYSFGTVLLELVT-GERP 510
T DV+ FG + E++ G +P
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 56/284 (19%), Positives = 103/284 (36%), Gaps = 36/284 (12%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKE---FVAEMATLGSVKNRN 361
F IG G+ +Y+A L DG + +K++Q K + E+ L + + N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
++ + E +V + G L ++ + + K + +H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
R++HR+I + + K+ D GL R + T + V G Y++PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSPE 206
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541
K D++S G +L E+ + P + + L I
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP----------------FYGDKMNLYSLCKKI 250
Query: 542 DKC----LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
++C L + EL Q + C + P++RP + VY
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVN-MC---INPDPEKRPDVTYVYD 290
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 53/232 (22%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLM---VKRLQD--SQRSEKEFVAEMATLGSV-KNRNLVP 364
++IG G G + KA ++ M +KR+++ S+ ++F E+ L + + N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLL------------HPADDTGKSVDWPRRLKIAIG 412
LLG C + L ++ P+G+L D L A+ T ++ + L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 413 AARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE 471
ARG +L IHR+++++ IL+ +++ KI+DFGL+R
Sbjct: 151 VARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR---------------- 190
Query: 472 FGDLGYV------------APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
G YV A E V T DV+S+G +L E+V+ G P
Sbjct: 191 -GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 310 NNIIGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRN 361
+ +G G G +Y+ + E T + +K + + S R EF+ E + + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLL------HPADDTGKSVDWPRRLKIAIGAAR 415
+V LLG + L++ + M G L L + + +++A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G A+L+ N + +HR+++++ ++ +DF KI DFG+ R + D + G
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-------RKGGK 199
Query: 476 GYV-----APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
G + +PE + V T DV+SFG VL E+ T E+P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 30/220 (13%)
Query: 311 NIIGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNL 362
+G G G +Y+ + + VK L + S++ E +F+ E + ++N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLH---PADDTGKSVDWPRRLKIAIGAARGFAW 419
V +G + R ++ + M G L L P S+ L +A A G +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEP---KISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
L N IHR+I+++ LL KI DFG+AR + + G
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-------RKGGCA 246
Query: 477 YV-----APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+ PE + T K D +SFG +L E+ + G P
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVK 358
+ S + ++G+G G + L + S+ +K L+ +++ ++F+ E + +G
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
+ N++ L G K ++V ++M NGSL L + + + G A G
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMK 161
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+L +HR+++++ IL++ + K+SDFGL R++ T G+ + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI-PIRWT 217
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+PE T DV+S+G VL E+++ GERP
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 311 NIIGSGRTGTMYKALL--EDGTSLMV--KRLQD--SQRSEKEFVAEMATLGSVKNRNLVP 364
IIGSG +G + L + V K L+ ++R ++F++E + +G + N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL-HHN 423
L G + ++V ++M NGSL L + + + G G +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+HR+++++ +L+D + K+SDFGL+R++ T G+ + + APE
Sbjct: 172 Y----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI-PIRWTAPEAI 226
Query: 484 RTLVATPKGDVYSFGTVLLELVT-GERP 510
+ DV+SFG V+ E++ GERP
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 42/225 (18%), Positives = 91/225 (40%), Gaps = 41/225 (18%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVK 358
N I+G G G +Y+ + + ++ VK + + ++++F++E + ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
+ ++V L+G ++ ++ + P G L L S+ + ++ + A
Sbjct: 72 HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMA 127
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+L +HR+I+ + IL+ K+ DFGL+R + D Y
Sbjct: 128 YLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---------------DEDYY 169
Query: 479 ------------APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+PE T DV+ F + E+++ G++P
Sbjct: 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 37/224 (16%)
Query: 313 IGSGRTGTMYKALLEDGTSLM------VKRLQD-SQRSEKEFVAEMATLGSVKNRNLVPL 365
+G G G ++ A + + VK L+D + + K+F E L ++++ ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLL------------HPADDTGKSVDWPRRLKIAIGA 413
G C ++V+++M +G L L + + L IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 414 ARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
A G +L + +HR+++++ L+ + KI DFG++R + D +
Sbjct: 143 ASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-------RV 191
Query: 473 GDLGYV-----APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
G + PE T + DV+SFG +L E+ T G++P
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 34/224 (15%)
Query: 311 NIIGSGRTGTMYKALL------EDGTSLMVKRLQD-SQRSEKEFVAEMATLGSVKNRNLV 363
+G G G ++ A +D + VK L++ S+ + ++F E L ++++++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLL-----------HPADDTGKSVDWPRRLKIAIG 412
G C + L+V+++M +G L L D + + L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 413 AARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
A G +L +HR+++++ L+ KI DFG++R + D +
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY-------RV 216
Query: 473 GDLGYV-----APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
G + PE T + DV+SFG VL E+ T G++P
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 15/127 (11%), Positives = 39/127 (30%), Gaps = 10/127 (7%)
Query: 83 LNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNF- 141
N N +T +++ + LP + L + ++++ N
Sbjct: 228 ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE-MQLINVACNRGI 286
Query: 142 -------SGSIPSNLANCTYLNSLKLDHNRF-SGQIPPQLGQLGRLKSFSVANNLLSGSI 193
++ + + + +N + + L ++ +L N L G +
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 194 PTFVNLT 200
P F +
Sbjct: 347 PAFGSEI 353
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-20
Identities = 31/214 (14%), Positives = 57/214 (26%), Gaps = 40/214 (18%)
Query: 25 FSLSYGTKEDLACLKSIKDSLEDPFNYLN-------SSWNFNNDTEGFICKFTGVECWHP 77
S + +D LK I D+L ++WNFN + + + GV
Sbjct: 22 LSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMW-GAQPGVSLN-- 78
Query: 78 DENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL--- 134
RV L L G G+ P I + + L L S+ K + S
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 135 DLSSNNFSGSIPSNLA--------------------------NCTYLNSLKLDHNRFSGQ 168
++ + + N +
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF- 197
Query: 169 IPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLS 202
+ + +L +L+ F + N+ +
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 22/125 (17%), Positives = 49/125 (39%), Gaps = 9/125 (7%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYG--PLPDDISKLVGF-----LTSLDL 136
++ + + + P ++ M ++++ N+ L DD L + + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 137 SSNNF-SGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195
NN + + ++L L L+ +N+ G P G +L S ++A N ++
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPAN 371
Query: 196 FVNLT 200
F T
Sbjct: 372 FCGFT 376
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 27/184 (14%), Positives = 50/184 (27%), Gaps = 19/184 (10%)
Query: 28 SYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHP---DENRVLN 84
+ + S + L W+ N G + N+ L+
Sbjct: 11 ALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKN---WSQQGFGTQPGANWNFNKELD 67
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG- 143
+ G+ + + +TGL L G +PD I +L L L L S+
Sbjct: 68 MWGAQPGV------SLNSNGRVTGLSLEGFGASGRVPDAIGQLT-ELEVLALGSHGEKVN 120
Query: 144 ---SIPSNLANCTYLNSLKLDHNRFSGQIPPQLG--QLGRLKSFSVANNLLSGSIPTFVN 198
P ++ + + L + ++ SI
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 199 LTLS 202
+TL
Sbjct: 181 ITLK 184
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-19
Identities = 25/127 (19%), Positives = 49/127 (38%), Gaps = 12/127 (9%)
Query: 81 RVLNLR------LTDMGLKGQFPRGIRNCSSMTGLDLSSNKL-YGPLPDDISKLVGFLTS 133
+++N+ + Q + + + N L P+ + K+ L
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK-LGM 334
Query: 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQL-GQLGRLKSFSVANNLLSGS 192
L+ N G +P+ + L SL L +N+ + IP G ++++ S A+N L
Sbjct: 335 LECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-Y 391
Query: 193 IPTFVNL 199
IP +
Sbjct: 392 IPNIFDA 398
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 24/118 (20%), Positives = 43/118 (36%), Gaps = 15/118 (12%)
Query: 99 GIRNCSSMTGLDLSSNKLYG-------PLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
++ S M+ +D S N++ PL K + ++S++LS+N S +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN-VSSINLSNNQISKFPKELFST 455
Query: 152 CTYLNSLKLDHNRFSG-------QIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLS 202
+ L+S+ L N + L S + N L+ F TL
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP 513
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 22/127 (17%), Positives = 44/127 (34%), Gaps = 13/127 (10%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
+ D +++ ++LS+N++ + S L+S++L N +
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS-PLSSINLMGNMLTE 471
Query: 144 -------SIPSNLANCTYLNSLKLDHNRFSGQIPP--QLGQLGRLKSFSVANNLLSGSIP 194
N N L S+ L N+ + + + L L ++ N S P
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FP 529
Query: 195 TFV-NLT 200
T N +
Sbjct: 530 TQPLNSS 536
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 15/115 (13%), Positives = 42/115 (36%), Gaps = 12/115 (10%)
Query: 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLA--NCT 153
+ + L+L+ N++ +P + + +L + N IP+ + +
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402
Query: 154 YLNSLKLDHNRFSG-------QIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
++++ +N + P + + S +++NN +S F +
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 18/125 (14%), Positives = 33/125 (26%), Gaps = 16/125 (12%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF-----LTSLDLSSNNFSGSIPSNLANCT 153
+ G+DLS N P D N P + C
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566
Query: 154 YLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV-------NLTLSADSV 206
L L++ N + ++ + + +N ++V L D
Sbjct: 567 SLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
Query: 207 TNNQG 211
+ +G
Sbjct: 624 QDIRG 628
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 15/139 (10%), Positives = 39/139 (28%), Gaps = 21/139 (15%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
++ + + + R T + SN + + + +L L + ++
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTK-LRQFYMGNSP 217
Query: 141 FSG-------------------SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKS 181
F + N L +++ + ++P L L ++
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 182 FSVANNLLSGSIPTFVNLT 200
+VA N +
Sbjct: 278 INVACNRGISGEQLKDDWQ 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 45/213 (21%), Positives = 82/213 (38%), Gaps = 20/213 (9%)
Query: 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKNR 360
+ + +G G G +++ + G VK RL+ + E + + +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE------LVACAGLSSP 110
Query: 361 NLVPLLGFCMAKKERLLVY-KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
+VPL G + + ++ + + GSL L+ + R L A G +
Sbjct: 111 RIVPLYGAVR-EGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEY 165
Query: 420 LHHNCNPRIIHRNISSKCILLDDD-FEPKISDFGLARLMNPIDTHLSTFVNGEF-GDLGY 477
LH RI+H ++ + +LL D + DFG A + P S G +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
+APE K D++S ++L ++ G P
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 49/234 (20%), Positives = 92/234 (39%), Gaps = 52/234 (22%)
Query: 311 NIIGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNL 362
+G R G +YK L E ++ +K L+D +EF E +++ N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLL------------HPADDTGKSVDWPRRLKIA 410
V LLG + +++ + +G L++ L +++ P + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 411 IGAARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVN 469
A G +L H+ +H++++++ +L+ D KISD GL R + D
Sbjct: 135 AQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADY------- 183
Query: 470 GEFGDLGYV------------APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
Y APE + D++S+G VL E+ + G +P
Sbjct: 184 -------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 64/305 (20%), Positives = 112/305 (36%), Gaps = 40/305 (13%)
Query: 301 MKAT-NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE---FVAEMATLG 355
M + + IG+G G K DG L+ K L +E E V+E+ L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 356 SVKNRNLVPLLGFCMAKKERLL--VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGA 413
+K+ N+V + + L V ++ G L ++ + +D L++
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 414 ARGFAWLH--HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE 471
H + ++HR++ + LD K+ DFGLAR++N + TFV
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--- 177
Query: 472 FGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531
G Y++PE + K D++S G +L EL P F
Sbjct: 178 -GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP---------FTAF-------- 219
Query: 532 SSTGQLQDAIDKCLVAK---GVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLRAI 586
S +L I + + +EL + + L RP++ E+ + +
Sbjct: 220 -SQKELAGKIREGKFRRIPYRYSDELNEIIT-RM---LNLKDYHRPSVEEILENPLILEH 274
Query: 587 GERYH 591
+H
Sbjct: 275 HHHHH 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 58/275 (21%), Positives = 99/275 (36%), Gaps = 38/275 (13%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKNRNLVPLLG 367
IG G G EDG ++K + S+ S KE E+A L ++K+ N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
+V + G L+ ++ G + L + +H +
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
I+HR+I S+ I L D ++ DFG+AR++N + G Y++PE
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI----GTPYYLSPEICENKP 201
Query: 488 ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVA 547
K D+++ G VL EL T + F+ S L I
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA---------FEAG---------SMKNLVLKIISGSFP 243
Query: 548 K---GVDNELFQFLKVACNCVLPTIPKERPTMFEV 579
+L + P++RP++ +
Sbjct: 244 PVSLHYSYDLRSLVS-QL---FKRNPRDRPSVNSI 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 53/237 (22%)
Query: 310 NNIIGSGRTGTMYKALL--------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKN 359
+G G G + A T + VK L+ +++ + ++EM + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 360 -RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL------------HPADDTGKSVDWPRR 406
+N++ LLG C ++ ++ G+L + L +P+ + + +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 407 LKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466
+ A ARG +L + IHR+++++ +L+ +D KI+DFGLAR ++ ID
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY---- 246
Query: 467 FVNGEFGDLGYV------------APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
Y APE + T + DV+SFG +L E+ T G P
Sbjct: 247 ----------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 53/236 (22%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLM--------VKRLQD--SQRSEKEFVAEMATLGSV-KN 359
+G G G + A VK L+D +++ + V+EM + + K+
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL------------HPADDTGKSVDWPRRL 407
+N++ LLG C ++ ++ G+L + L + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 408 KIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467
ARG +L + IHR+++++ +L+ ++ KI+DFGLAR +N ID
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY----- 212
Query: 468 VNGEFGDLGYV------------APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
Y APE V T + DV+SFG ++ E+ T G P
Sbjct: 213 ---------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 51/233 (21%)
Query: 311 NIIGSGRTGTMYKA----LLEDGTSLMV--KRLQD--SQRSEKEFVAEMATLGSVKN-RN 361
+G+G G + +A L ++ L V K L+ ++ ++E+ + + N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLL----------HPADDTGKSVDWPRRLKIAI 411
+V LLG C L++ ++ G L + L + L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 412 GAARGFAWL-HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNG 470
A+G A+L NC IHR+++++ +LL + KI DFGLAR +
Sbjct: 172 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-------- 219
Query: 471 EFGDLGYV------------APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
Y+ APE V T + DV+S+G +L E+ + G P
Sbjct: 220 ------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 1/116 (0%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L ++ + F SS+ L ++ N DI + LT LDLS
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNL 199
P+ + + L L + HN F L L+ + N + S +
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 19/107 (17%), Positives = 33/107 (30%), Gaps = 2/107 (1%)
Query: 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYL 155
+ LD + L + + L LD+S + + + L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 156 NSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
LK+ N F P +L L ++ L P F +L+
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 10/119 (8%)
Query: 83 LNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFS 142
+ L + P + S LDLS N L L LDLS
Sbjct: 15 MELNFY------KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQ 65
Query: 143 GSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
+ ++L++L L N L L+ L+ +L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 23/112 (20%), Positives = 37/112 (33%), Gaps = 3/112 (2%)
Query: 85 LRLTDMGLKGQFPRGI-RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L++ + F I ++T LDLS +L P + L L L++S NNF
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS-LQVLNMSHNNFFS 508
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGR-LKSFSVANNLLSGSIP 194
L L N +L L ++ N + +
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-18
Identities = 27/119 (22%), Positives = 43/119 (36%), Gaps = 3/119 (2%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
NL L+ L+ + + LDLS ++ L L++L L+ N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL-SHLSTLILTGNPIQS 90
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+ + L L + +G L LK +VA+NL+ F NLT
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 28/132 (21%), Positives = 47/132 (35%), Gaps = 7/132 (5%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNF-SG 143
L LT ++ SS+ L L I L L L+++ N S
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL-KTLKELNVAHNLIQSF 139
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSV----ANNLLSGSIP-TFVN 198
+P +N T L L L N+ L L ++ ++ + N ++ P F
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 199 LTLSADSVTNNQ 210
+ L ++ NN
Sbjct: 200 IRLHKLTLRNNF 211
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 30/131 (22%), Positives = 49/131 (37%), Gaps = 7/131 (5%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKL-YGPLPDDISKLVGFLTSLDLSSNNFSG 143
L + L I + ++ L+++ N + LP+ S L L LDLSSN
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQS 163
Query: 144 SIPSNLANCTYL----NSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL 199
++L + SL L N + I P + RL ++ NN S ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 200 TLSADSVTNNQ 210
L+ V
Sbjct: 223 GLAGLEVHRLV 233
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 16/92 (17%), Positives = 26/92 (28%), Gaps = 5/92 (5%)
Query: 110 DLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQI 169
Y +PD++ +LDLS N + + L L L
Sbjct: 13 QCMELNFYK-IPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 170 PPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
L L + + N + F L+
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLS 100
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 27/179 (15%), Positives = 43/179 (24%), Gaps = 30/179 (16%)
Query: 44 SLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLK-GQFPRGIRN 102
LE L N N + G+ + RL +
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLC-----NLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 103 CSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLN------ 156
++++ L S + S G L+L + F L + L
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFG-WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337
Query: 157 -------------SLKLDHNR--FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L L N F G LK ++ N + F+ L
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 5/105 (4%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
+VLN+ + +S+ LD S N + ++ L L+L+ N+
Sbjct: 497 QVLNMS--HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 141 FSGSIPSN--LANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFS 183
F+ + L L ++ R P + + S +
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 17/125 (13%), Positives = 30/125 (24%), Gaps = 9/125 (7%)
Query: 95 QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS------IPSN 148
G + L L +N + + + L L F S
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 149 LANCTYLNSLKLDHNR---FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADS 205
L L + + I L + SFS+ + + N
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 206 VTNNQ 210
+ N +
Sbjct: 311 LVNCK 315
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 38/235 (16%)
Query: 307 FSKNNI-----IGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMAT 353
F +N + +G+G G + +A + ++ VK L+ + ++E+
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 354 LGSVKN-RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL--------------HPADDTG 398
L + N N+V LLG C L++ ++ G L + L +D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 399 KSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458
++D L + A+G A+L IHR+++++ ILL KI DFGLAR +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 459 PIDTHLSTFVNGEFGDL--GYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
+V L ++APE V T + DV+S+G L EL + G P
Sbjct: 197 NDS----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 32/225 (14%)
Query: 311 NIIGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSV-KNRN 361
+G G G + +A ++ VK L++ + + ++E+ L + + N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 362 LVPLLGFCMAKKE-RLLVYKHMPNGSLYDLL------------HPADDTGKSVDWPRRLK 408
+V LLG C +++ + G+L L P D + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 409 IAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFV 468
+ A+G +L + IHR+++++ ILL + KI DFGLAR + +V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DYV 205
Query: 469 NGEFGDL--GYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
L ++APE V T + DV+SFG +L E+ + G P
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 53/236 (22%)
Query: 311 NIIGSGRTGTMYKALL------EDGTSLMV--KRLQD--SQRSEKEFVAEMATLGSV-KN 359
+G G G + A + ++ V K L+D +++ + V+EM + + K+
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL------------HPADDTGKSVDWPRRL 407
+N++ LLG C ++ ++ G+L + L + + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 408 KIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTF 467
ARG +L + IHR+++++ +L+ ++ KI+DFGLAR +N ID
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY----- 258
Query: 468 VNGEFGDLGYV------------APEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
Y APE V T + DV+SFG ++ E+ T G P
Sbjct: 259 ---------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 54/241 (22%), Positives = 97/241 (40%), Gaps = 58/241 (24%)
Query: 311 NIIGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNL 362
+G G G + KA T++ VK L++ S ++ ++E L V + ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLL--------------------HPADDTGKSVD 402
+ L G C LL+ ++ GSL L +++
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 403 WPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462
+ A ++G +L +++HR+++++ IL+ + + KISDFGL+R + D+
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 463 HLSTFVNGEFGDLGYV------------APEYARTLVATPKGDVYSFGTVLLELVT-GER 509
YV A E + T + DV+SFG +L E+VT G
Sbjct: 206 --------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 510 P 510
P
Sbjct: 252 P 252
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 4/110 (3%)
Query: 401 VDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460
+ R +++ A + + H N IIHR++ I++ K+ DFG+AR +
Sbjct: 113 MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
+ T G Y++PE AR + DVYS G VL E++TGE P
Sbjct: 170 GNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 48/369 (13%), Positives = 103/369 (27%), Gaps = 81/369 (21%)
Query: 256 RRMSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGS 315
+ R + + +++ +S + SL+ S+L + + + ++G
Sbjct: 25 EELFNRIPQANVRTTSEYMQSAA-DSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQ 83
Query: 316 GRTGTMYKAL-LEDGTSLMVKRL-------QDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
+A E G S V ++ + KE V + L +KN+ +
Sbjct: 84 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143
Query: 368 FCMAKKERLLVYKH-----------------------MPNGSLYDL---LHPADDTGKSV 401
+ + + + +L L T KS+
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 402 DWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461
RL++ + R A LHH ++H + I+LD ++ F D
Sbjct: 204 VHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR----D 256
Query: 462 THLSTFVNGEFGDLGYVAPEY-----------ARTLVATPKGDVYSFGTVLLELVTGERP 510
G+ PE R + T D ++ G V+ + + P
Sbjct: 257 GARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 511 TNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIP 570
A + + + ++ ++ L
Sbjct: 313 ITKDAALGGSE-WIFRSCKNIPQ--PVRALLEGFLR---YP------------------K 348
Query: 571 KERPTMFEV 579
++R +
Sbjct: 349 EDRLLPLQA 357
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 313 IGSGRTGTMYKALLED---GTSLMVKRLQDSQRSEKEFVA----EMATLGSVKNRNLVPL 365
+G G T+Y A ED + +K + R ++E + E+ + ++N+V +
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
+ LV +++ +L + + + + + G H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART 485
RI+HR+I + IL+D + KI DFG+A+ ++ +T L T N G + Y +PE A+
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSL-TQTNHVLGTVQYFSPEQAKG 186
Query: 486 LVATPKGDVYSFGTVLLELVTGERP 510
D+YS G VL E++ GE P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 56/299 (18%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFV-AEMATLGSVKNRNLVPLLGFCM 370
+G G + L DG +KR+ ++ ++E E + N++ L+ +C+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 371 ----AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
AK E L+ G+L++ + D G + + L + +G RG +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---K 153
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE-----FGDLGYVAPE 481
HR++ ILL D+ +P + D G + + + Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 482 ----YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI--------- 528
+ ++ + DV+S G VL ++ GE P + KG+ V
Sbjct: 214 LFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYD----MVFQKGDSVALAVQNQLSIPQ 268
Query: 529 -AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ SS L ++ + VD P +RP + + L A+
Sbjct: 269 SPRHSS--ALWQLLNSMMT---VD------------------PHQRPHIPLLLSQLEAL 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 309 KNNIIGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKNRNLVPL 365
++G G G +Y L + + +K +DS+ + E+A +K++N+V
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-YSQPLHEEIALHKHLKHKNIVQY 84
Query: 366 LGFCMAKKERLLVY-KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
LG + + ++ + +P GSL LL K + G +LH N
Sbjct: 85 LGSFS-ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDN- 141
Query: 425 NPRIIHRNISSKC--ILLDD-DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
+I+HR+I K +L++ KISDFG ++ + I+ TF G L Y+APE
Sbjct: 142 --QIVHRDI--KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT----GTLQYMAPE 193
Query: 482 YARTLV--ATPKGDVYSFGTVLLELVTGERP 510
D++S G ++E+ TG+ P
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 59/254 (23%), Positives = 91/254 (35%), Gaps = 36/254 (14%)
Query: 306 SFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSV-KNR 360
SF + + +G G G ++K EDG VKR R K+ +AE+ + V ++
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
V L + L + + SL G S+ + A L
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELCGPSLQQHCE---AWGASLPEAQVWGYLRDTLLALAHL 173
Query: 421 HHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
H ++H ++ K I L K+ DFGL + GD Y+
Sbjct: 174 HSQ---GLVHLDV--KPANIFLGPRGRCKLGDFGLLVELGT-AGAGEVQE----GDPRYM 223
Query: 479 APE-----YARTLVATPKGDVYSFGTVLLELVTGER-PTNVAKAPETFKGNL-VEWIAQL 531
APE Y DV+S G +LE+ P + +G L E+ A L
Sbjct: 224 APELLQGSY------GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL 277
Query: 532 SSTGQLQDAIDKCL 545
SS +L+ + L
Sbjct: 278 SS--ELRSVLVMML 289
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 24/260 (9%), Positives = 56/260 (21%), Gaps = 45/260 (17%)
Query: 286 SLFEKSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRS- 343
+++ ++ S L + + G ++ +E +K +
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102
Query: 344 ---EKEFVAEMATLGSVKNRNLVPLLGFC--------------------------MAKKE 374
+ + + A
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 375 RLLVYKHMP--NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432
LL+ L+ L + R A L ++H +
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY--ARTLVATP 490
+ + + D + D + T + Y E+ A T T
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW---KVGTRGPASS----VPVTYAPREFLNASTATFTH 272
Query: 491 KGDVYSFGTVLLELVTGERP 510
+ + G + + P
Sbjct: 273 ALNAWQLGLSIYRVWCLFLP 292
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 46/240 (19%), Positives = 82/240 (34%), Gaps = 24/240 (10%)
Query: 286 SLFEKSITKMRLSDLMKATNSFSKNNIIGSGRT--GTMYKAL-LEDGTSLMVKR--LQDS 340
+++ +S + + +IG G T+ A G + V+R L+
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65
Query: 341 QRSEKEFV-AEMATLGSVKNRNLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTG 398
F+ E+ + N+VP L +V M GS DL+ G
Sbjct: 66 SNEMVTFLQGELHVSKLFNHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDG 124
Query: 399 KSVDWPRRLKIAI---GAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455
+ IA G + ++HH +HR++ + IL+ D + +S
Sbjct: 125 MNELA-----IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 456 LMNPIDTHLSTFVNGEFGDLG---YVAPEYARTLVA--TPKGDVYSFGTVLLELVTGERP 510
M + + +++PE + + K D+YS G EL G P
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 34/159 (21%), Positives = 59/159 (37%), Gaps = 17/159 (10%)
Query: 81 RVLNL---RLTDM--GLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDI--SKLVGFLTS 133
+ L +T + +N +T +DL NKL L DD + L L++
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPY-LSN 757
Query: 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDH------NRFSGQIPPQLGQLGRLKSFSVANN 187
+D+S N FS S P+ N + L + + H NR Q P + L + +N
Sbjct: 758 MDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816
Query: 188 LLSGSIPTFVNLTLSADSVTNNQGLCGEPLDACKGTSKG 226
+ + + L + +N + + C G
Sbjct: 817 DIR-KVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAG 854
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 19/145 (13%), Positives = 39/145 (26%), Gaps = 18/145 (12%)
Query: 67 CKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISK 126
FT + N +T ++L + LPD +
Sbjct: 458 SPFTYD----NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
Query: 127 LVGFLTSLDLSSNNFSG---------SIPSNLANCTYLNSLKLDHNRFSGQIPP--QLGQ 175
L L SL+++ N + + + + +N P L +
Sbjct: 514 LPE-LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQK 571
Query: 176 LGRLKSFSVANNLLSGSIPTFVNLT 200
+ +L +N + + F
Sbjct: 572 MVKLGLLDCVHNKVR-HLEAFGTNV 595
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 4e-16
Identities = 34/217 (15%), Positives = 64/217 (29%), Gaps = 43/217 (19%)
Query: 25 FSLSYGTKEDLACLKSIKDSLEDPFNYLNS----------SWNFNNDTEGFICKFTGVEC 74
+ +D LK+I ++L+ S +WNFN + + GV+
Sbjct: 261 LKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELD-MWGDQPGVDL 319
Query: 75 WHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGP--------------- 119
+ RV L L G KG+ P I + + L ++
Sbjct: 320 --DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 120 -----LPDDISKLVGF----LTSLDLSSNNFS-----GSIPSNLANCTYLNSLKLDHNRF 165
+ K+ L DL + + I + + NR
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 166 SGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLS 202
+ I + +L +L+ AN+ + +
Sbjct: 438 TF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN 473
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-16
Identities = 18/137 (13%), Positives = 46/137 (33%), Gaps = 10/137 (7%)
Query: 80 NRVLNLRLTDMGLK----GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLD 135
+ ++L+ T +G + I+ + + + +++ + +
Sbjct: 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-DNIAV-----DWEDAN 473
Query: 136 LSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195
+ + +N L ++L + Q+P L L L+S ++A N +
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 196 FVNLTLSADSVTNNQGL 212
+ T AD +
Sbjct: 534 KADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 9e-14
Identities = 21/128 (16%), Positives = 38/128 (29%), Gaps = 19/128 (14%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKL-----VGFLTSLDLSSNNFSGSIPSNLANCT 153
++ +D+S N P G D N P+ + C
Sbjct: 748 RATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP 806
Query: 154 YLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANN-LLSGSIPTFVN------LTLSADSV 206
L L++ N + +L +L +A+N +S + + L D
Sbjct: 807 SLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD-- 861
Query: 207 TNNQGLCG 214
Q + G
Sbjct: 862 -KTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 17/108 (15%), Positives = 37/108 (34%), Gaps = 14/108 (12%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF-----LTSLDLSSNNFSGSIPSNLANCT 153
++ M +D S NK+ +IS + +++ LS N A +
Sbjct: 639 NAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 154 YLNSLKLDHNRFS-------GQIPPQLGQLGRLKSFSVANNLLSGSIP 194
++++ L +N + L + + N L+ S+
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS 744
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 20/133 (15%), Positives = 46/133 (34%), Gaps = 16/133 (12%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
++ ++ G + + + LS N++ + + ++++ LS
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS-PISTIILS 705
Query: 138 SNNFS-------GSIPSNLANCTYLNSLKLDHNRFSGQIPPQL--GQLGRLKSFSVANNL 188
+N + N N L ++ L N+ + + L L + V+ N
Sbjct: 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNC 764
Query: 189 LSGSIP-TFVNLT 200
S S P +N +
Sbjct: 765 FS-SFPTQPLNSS 776
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 22/115 (19%), Positives = 38/115 (33%), Gaps = 9/115 (7%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYL 155
++ + LD NK+ + V LT L L N IP + A +
Sbjct: 566 SASLQKMVKLGLLDCVHNKVRHL--EAFGTNVK-LTDLKLDYNQIE-EIPEDFCAFTDQV 621
Query: 156 NSLKLDHNRFSGQIPP--QLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTN 208
L HN+ IP + + S + N + S ++ ++ N
Sbjct: 622 EGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGIN 674
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 14/98 (14%), Positives = 30/98 (30%), Gaps = 8/98 (8%)
Query: 129 GFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSG--------QIPPQLGQLGRLK 180
G +T L L+ G +P + T L L + + ++ P + + + +
Sbjct: 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382
Query: 181 SFSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPLD 218
+ L D++ N + D
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 20/105 (19%), Positives = 40/105 (38%), Gaps = 2/105 (1%)
Query: 108 GLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSG 167
LD + + Y ++ + + + +L + + +L N + L L G
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWNFNKEL--DMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 168 QIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQGL 212
++P +GQL LK S + + S F + L+ D +
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 32/228 (14%), Positives = 66/228 (28%), Gaps = 28/228 (12%)
Query: 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRL----QDSQRSEKEF---VAEMATLGS 356
+ ++++G G +Y+A D K+ + EF M L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL-HPADDTGKSVDWPRRLKIAIGAAR 415
+ + + +LV + G+L + + + K + + A+
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEP-----------KISDFGLARLMN--PIDT 462
+H IIH +I +L + F + D G + M P T
Sbjct: 184 MIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
+ G+ E + D + + ++ G
Sbjct: 241 IFTAKC----ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 54/283 (19%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVAEMATLGSVKNRNLVP 364
+++ IG G +GT+Y A+ + G + ++++ Q ++ + E+ + KN N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 365 LLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLK---IAI---GAARGF 417
L + L +V +++ GSL D++ + IA +
Sbjct: 82 YLD-SYLVGDELWVVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQAL 129
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+LH N ++IHR+I S ILL D K++DFG + P + ST V G +
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYW 182
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERP---TNVAKA--------PETFKGNLVE 526
+APE PK D++S G + +E++ GE P N +A +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--- 239
Query: 527 WIAQLSSTGQLQDAIDKCLVAKGVDN-----ELFQ--FLKVAC 562
+LS+ +D +++CL V+ EL Q FLK+A
Sbjct: 240 --EKLSA--IFRDFLNRCLE-MDVEKRGSAKELLQHQFLKIAK 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 32/107 (29%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 404 PRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463
PR + I H HR++ + IL+ D + DFG+A D
Sbjct: 134 PRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEK 188
Query: 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
L T + G L Y+APE AT + D+Y+ VL E +TG P
Sbjct: 189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 34/280 (12%), Positives = 77/280 (27%), Gaps = 60/280 (21%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAE-------MATLGSVKNRNLV 363
++G +A E G S V ++R + + + L +KN+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 364 PLLGFCMAKKERLLVYKH---------------------MP-----NGSLYDLLHPADDT 397
+ + + + + P + ++L T
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 398 GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457
KS+ RL++ + R A LHH ++H + I+LD ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 458 NPIDTHLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTN 512
+ + F A + T D ++ G + + + P
Sbjct: 260 -RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-- 316
Query: 513 VAKAPETFKGNLVEWIAQLSSTG------QLQDAIDKCLV 546
+ ++ ++ ++ L
Sbjct: 317 -------NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLR 349
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 43/240 (17%)
Query: 307 FSKNNI-----IGSGRTGTMYKA----LLEDGTSLMV--KRLQD--SQRSEKEFVAEMAT 353
F + N+ +GSG G + A + + G S+ V K L++ + ++E+
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 354 LGSV-KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL-------------------HP 393
+ + + N+V LLG C L++++ G L + L
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 394 ADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453
++ + + L A A+G +L +HR+++++ +L+ KI DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 454 ARLMNPIDTHLSTFVNGEFGDL--GYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERP 510
AR + +V L ++APE + T K DV+S+G +L E+ + G P
Sbjct: 219 ARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 65/251 (25%)
Query: 307 FSKNNI-----IGSGRTGTMYKA----LLEDGTSLMV--KRLQD--SQRSEKEFVAEMAT 353
+ +NNI IG G G +++A LL MV K L++ S + +F E A
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 354 LGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL--------------------HP 393
+ N N+V LLG C K L++++M G L + L
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 394 ADDTGKSVDWPRRLKIAIGAARGFAWLH-HNCNPRIIHRNISSKCILLDDDFEPKISDFG 452
+ + +L IA A G A+L +HR+++++ L+ ++ KI+DFG
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFG 219
Query: 453 LARLMNPIDTHLSTFVNGEFGDLGYV------------APEYARTLVATPKGDVYSFGTV 500
L+R + D Y PE T + DV+++G V
Sbjct: 220 LSRNIYSADY--------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265
Query: 501 LLELVT-GERP 510
L E+ + G +P
Sbjct: 266 LWEIFSYGLQP 276
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 52/283 (18%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVAEMATLGSVKNRNLVP 364
IG G TG + A G + VK + Q+ + E+ + ++ N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLK---IAI---GAARGFA 418
+ + +E ++ + + G+L D++ RL IA + A
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALA 155
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+LH +IHR+I S ILL D K+SDFG ++ + V G ++
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWM 208
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERP---TNVAKA--------PETFKGNLVEW 527
APE + + D++S G +++E+V GE P + +A P K +
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS---- 264
Query: 528 IAQLSSTGQLQDAIDKCLVAKGVDN-----ELFQ--FLKVACN 563
++S L+D +++ LV + EL FL
Sbjct: 265 -HKVSP--VLRDFLERMLV-RDPQERATAQELLDHPFLLQTGL 303
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPL 365
F +G G G++YKA+ E G + +K++ + +E + E++ + + ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 366 LGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLK---IAI---GAARGFA 418
G K L +V ++ GS+ D++ + L IA +G
Sbjct: 90 YG-SYFKNTDLWIVMEYCGAGSVSDIIRLR---------NKTLTEDEIATILQSTLKGLE 139
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+LH R IHR+I + ILL+ + K++DFG+A + +T + F ++
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF----WM 192
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERP 510
APE + + D++S G +E+ G+ P
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKR--LQDSQRSEKEFVAEMATLGSVKNRNLV 363
F+K IG G G ++K + + +K L++++ ++ E+ L + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 364 PLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLK---IAI---GAARG 416
G K +L ++ +++ GS DLL P L IA +G
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKG 131
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+LH + IHR+I + +LL + E K++DFG+A + +TFV G
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPF 184
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
++APE + K D++S G +EL GE P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 6e-17
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKNRNLVPLL-- 366
+G+G G + + + + G + +K R + S ++ + + E+ + + + N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 367 ----GFCMAKKERLLVYKHMPNGSLYDLLH-PADDTGKSVDWPRRLKIAIGAARGFAWLH 421
LL ++ G L L+ + G R L I +A +LH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLH 138
Query: 422 HNCNPRIIHRNISSKCILLDDDFEP---KISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
N RIIHR++ + I+L + KI D G A+ ++ + FV G L Y+
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFV----GTLQYL 190
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL 524
APE T D +SFGT+ E +TG RP P + G +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 57/309 (18%), Positives = 106/309 (34%), Gaps = 80/309 (25%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVK--NRN 361
+S IGSG + +++ L E +K + + + + E+A L ++ +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR------ 415
++ L + + + + + N L L ++ I +
Sbjct: 118 IIRLYDYEI-TDQYIYMVMECGNIDLNSWLK------------KKKSIDPWERKSYWKNM 164
Query: 416 --GFAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMNPIDT--HLSTFVN 469
+H + I+H ++ K L+ D K+ DFG+A M P T + V
Sbjct: 165 LEAVHTIHQH---GIVHSDL--KPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV- 217
Query: 470 GEFGDLGYVAPE-----------YARTLVATPKGDVYSFGTVLLELVTGERP-----TNV 513
G + Y+ PE +PK DV+S G +L + G+ P +
Sbjct: 218 ---GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 514 AKAPETFKGNL-VEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKE 572
+K N +E+ LQD + CL D PK+
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLK---RD------------------PKQ 311
Query: 573 RPTMFEVYQ 581
R ++ E+
Sbjct: 312 RISIPELLA 320
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 65/270 (24%), Positives = 103/270 (38%), Gaps = 39/270 (14%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKR--LQDSQRSEKEFVAEMATLGSVKNRN 361
+ + +IGSG T + A + +KR L+ Q S E + E+ + + N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 362 LVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWP-RRLKIAI---GAARG 416
+V K+ L LV K + GS+ D++ G+ IA G
Sbjct: 75 IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL-ARLMNPIDTHLS----TFVNGE 471
+LH N IHR++ + ILL +D +I+DFG+ A L D + TFV
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 472 FGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERP--------------TNVAKA 516
++APE + K D++SFG +EL TG P N
Sbjct: 191 C----WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN---D 243
Query: 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLV 546
P + + + + + I CL
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQ 273
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 60/303 (19%), Positives = 108/303 (35%), Gaps = 68/303 (22%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVK--NRN 361
+S IGSG + +++ L E +K + + + + E+A L ++ +
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 362 LVPLLGFCMAKKERLLVYKHM--PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
++ L + + + +V M N L L KS+D R
Sbjct: 90 IIRLYDYEITDQYIYMV---MECGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 142
Query: 420 LHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMNPIDT--HLSTFVNGEFGDL 475
+H + I+H ++ K L+ D K+ DFG+A M P T + V G +
Sbjct: 143 IHQH---GIVHSDL--KPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV----GTV 192
Query: 476 GYVAPE-----------YARTLVATPKGDVYSFGTVLLELVTGERP--TNVAKAPETFK- 521
Y+ PE +PK DV+S G +L + G+ P + + +
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 522 ---GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFE 578
+ +E+ LQD + CL D PK+R ++ E
Sbjct: 253 IDPNHEIEFPDIPEK--DLQDVLKCCLK---RD------------------PKQRISIPE 289
Query: 579 VYQ 581
+
Sbjct: 290 LLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 62/303 (20%), Positives = 108/303 (35%), Gaps = 68/303 (22%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVK--NRN 361
+S IGSG + +++ L E +K + + + + E+A L ++ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 362 LVPLLGFCMAKKERLLVYKHM--PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
++ L + + + +V M N L L KS+D R
Sbjct: 71 IIRLYDYEITDQYIYMV---MECGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 123
Query: 420 LHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMNPIDT--HLSTFVNGEFGDL 475
+H + I+H ++ K L+ D K+ DFG+A M P T + V G +
Sbjct: 124 IHQH---GIVHSDL--KPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV----GTV 173
Query: 476 GYVAPE-----------YARTLVATPKGDVYSFGTVLLELVTGERP-----TNVAKAPET 519
Y+ PE +PK DV+S G +L + G+ P ++K
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 520 FKGNL-VEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFE 578
N +E+ LQD + CL D PK+R ++ E
Sbjct: 234 IDPNHEIEFPDIPEK--DLQDVLKCCLK---RD------------------PKQRISIPE 270
Query: 579 VYQ 581
+
Sbjct: 271 LLA 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 58/294 (19%), Positives = 111/294 (37%), Gaps = 62/294 (21%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLV-- 363
F + +IGSG G ++KA DG + ++KR++ + + E+ L + + N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKLDHVNIVHY 69
Query: 364 -----------PLLGFCMAKKERLLVYKHM---PNGSLYDLLHPADDTGKSVDWPRRLKI 409
++ + ++ M G+L + G+ +D L++
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALEL 127
Query: 410 AIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVN 469
+G ++H ++I+R++ I L D + KI DFGL + D +
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRSK- 182
Query: 470 GEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI- 528
G L Y++PE + + D+Y+ G +L EL+ A ET +
Sbjct: 183 ---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFET--SKFFTDLR 232
Query: 529 -AQLSS--TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEV 579
+S + + + K L K P++RP E+
Sbjct: 233 DGIISDIFDKKEKTLLQKLLSKK---------------------PEDRPNTSEI 265
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-16
Identities = 27/123 (21%), Positives = 45/123 (36%), Gaps = 7/123 (5%)
Query: 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSS 138
+ V + + + L Q P + +++T L+L+ N+L + ++ LTSLD+
Sbjct: 5 SHEVADC--SHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYS-QLTSLDVGF 58
Query: 139 NNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFV 197
N S P L L L HN S L + +N + FV
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 198 NLT 200
Sbjct: 119 KQK 121
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-16
Identities = 24/119 (20%), Positives = 38/119 (31%), Gaps = 2/119 (1%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L + + P + + L+L N+L + LT L L SN+
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN-LTELHLMSNSIQKI 112
Query: 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLTLS 202
+ L +L L HN S QL L+ ++NN + S
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 26/153 (16%), Positives = 47/153 (30%), Gaps = 8/153 (5%)
Query: 51 YLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLD 110
YL+ S +F + + T + + L LT + + LD
Sbjct: 357 YLSLSNSFTS-----LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 111 LSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSG--Q 168
L N++ L + + + + LS N + ++ A L L L
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 169 IPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
P L L ++NN ++ L
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 27/123 (21%), Positives = 50/123 (40%), Gaps = 5/123 (4%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF-LTSLDLSSNNFSG 143
L L+ GL ++ L LS+NK+ +++ L L+LSSN
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLG---QLGRLKSFSVANNLLSGSIP-TFVNL 199
P L L L++ + + +L +++ S++N+ LS + TF+ L
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 200 TLS 202
+
Sbjct: 246 KWT 248
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-14
Identities = 23/126 (18%), Positives = 37/126 (29%), Gaps = 9/126 (7%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKL--------YGPLPDDISKLVGFLTSLDL 136
L L++ + + + LDL N L G + L L L+L
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH-LHILNL 543
Query: 137 SSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196
SN F + L + L N + LKS ++ NL++
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 197 VNLTLS 202
Sbjct: 604 FGPAFR 609
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-14
Identities = 28/127 (22%), Positives = 38/127 (29%), Gaps = 12/127 (9%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYG--PLPDDISKLVGFLTSLDLSSNNFS 142
+ L+ S+ L L L P L LT LDLS+NN +
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN-LTILDLSNNNIA 493
Query: 143 GSIPSNLANCTYLNSLKLDHNRFS--------GQIPPQLGQLGRLKSFSVANNLLSGSIP 194
L L L L HN + G L L L ++ +N
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
Query: 195 -TFVNLT 200
F +L
Sbjct: 554 EVFKDLF 560
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 27/132 (20%), Positives = 46/132 (34%), Gaps = 4/132 (3%)
Query: 85 LRLTDMGLKGQFPRGIR---NCSSMTGLDLSSNKLYGPLPDDISKLVGF-LTSLDLSSNN 140
L L ++ L + +S+ L LS+++L L LT LDLS NN
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
+ + A L L++N L L ++ ++ + SI
Sbjct: 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
Query: 201 LSADSVTNNQGL 212
+ S + L
Sbjct: 320 IDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 20/121 (16%), Positives = 40/121 (33%), Gaps = 5/121 (4%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKL-YGPLPDDISKLVGF--LTSLDLSSNNF 141
L + D + G ++ L LS++ L ++ + L L+L+ N
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 142 SGSIPSNLANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP-TFVNL 199
S + +L L L N ++ Q L + ++ N +F +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 200 T 200
Sbjct: 454 P 454
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 23/129 (17%), Positives = 36/129 (27%), Gaps = 11/129 (8%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--------LTSLDL 136
L L+ L + L N + + L T +
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 137 SSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-- 194
S + + L L ++ N G L LK S++N+ S
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372
Query: 195 -TFVNLTLS 202
TFV+L S
Sbjct: 373 ETFVSLAHS 381
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 21/124 (16%), Positives = 41/124 (33%), Gaps = 7/124 (5%)
Query: 83 LNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFS 142
++ L + + L++ N + G + + L L L LS++ S
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTS 366
Query: 143 GSIPSNLA----NCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TF 196
+N + L+ L L N+ S LG L+ + N + + +
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 197 VNLT 200
L
Sbjct: 427 RGLE 430
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 19/124 (15%), Positives = 34/124 (27%), Gaps = 7/124 (5%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L L G ++ + +DL N L + V L SL+L N +
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS-LKSLNLQKNLITSV 599
Query: 145 IPSNLA-NCTYLNSLKLDHNRFSGQIPPQLG-----QLGRLKSFSVANNLLSGSIPTFVN 198
L L + N F ++++ L + P +
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG 659
Query: 199 LTLS 202
+
Sbjct: 660 FPVR 663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 6/97 (6%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
++++L L N S+ L+L N + LT LD+ N
Sbjct: 563 KIIDLG--LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQI----PPQL 173
F + S ++N + S PP
Sbjct: 621 FDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHY 657
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 56/313 (17%), Positives = 108/313 (34%), Gaps = 69/313 (22%)
Query: 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL 362
+ F + ++G G G + KA D +K+++ ++ ++E+ L S+ ++ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 363 VPLLGFCMAKKERLLVYKHM-------------PNGSLYDLLHPADDTGKSVDWPRRLKI 409
V + ++ + + NG+LYDL+H + ++
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRL 121
Query: 410 AIGAARGFAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN--------- 458
+++H IIHR++ K I +D+ KI DFGLA+ ++
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDL--KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 459 -----PIDTHLSTFVNGEFGDLGYVAPE-YARTLVATPKGDVYSFGTVLLELV----TGE 508
+L++ + G YVA E T K D+YS G + E++ TG
Sbjct: 177 SQNLPGSSDNLTSAI----GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
Query: 509 RPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPT 568
N+ K + + I + D
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMK-VEKKIIRLLID---HD----------------- 271
Query: 569 IPKERPTMFEVYQ 581
P +RP +
Sbjct: 272 -PNKRPGARTLLN 283
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 54/303 (17%), Positives = 95/303 (31%), Gaps = 61/303 (20%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVAEMATLGSVKN-RNLVPLLGFC 369
+ G +Y+A + G +KRL + + + + E+ + + N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 370 MAKKER-------LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
KE L+ + G L + L + G + LKI R +H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHR 154
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNG--------EFGD 474
P IIHR++ + +LL + K+ DFG A ++ + +
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 475 LGYVAPE---YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLV------ 525
Y PE K D+++ G +L L + P F+
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---------FEDGAKLRIVNG 264
Query: 526 --EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583
+ I L V+ P+ER ++ EV L
Sbjct: 265 KYSIPPHDTQYTVFHSLIRAMLQ---VN------------------PEERLSIAEVVHQL 303
Query: 584 RAI 586
+ I
Sbjct: 304 QEI 306
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 37/283 (13%)
Query: 307 FSKNNIIGSGRTGTMYKALL-EDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKNRNLV 363
F K + +G+G G ++K G + K L+ + + E+ L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 364 PLLG---------FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA 414
G CM +HM GSL +L + K++I
Sbjct: 95 GFYGAFYSDGEISICM---------EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVI 141
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
+G +L I+HR++ IL++ E K+ DFG++ + ID+ ++FV G
Sbjct: 142 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV----GT 193
Query: 475 LGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534
Y++PE + + + D++S G L+E+ G P A E + + T
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253
Query: 535 GQLQDAIDKCLVAKGVDNE----LFQFLKVACNCVLPTIPKER 573
+ L G+D+ +F+ L N P +P
Sbjct: 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 63/359 (17%), Positives = 122/359 (33%), Gaps = 70/359 (19%)
Query: 296 RLSDLMKATNSFSK----NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEM 351
R++++ S I+G G +GT+ G + VKR+ + E+
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEI 59
Query: 352 ATLGSVKN-RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLL---HPADDTGKSVDWPRRL 407
L + N++ + + + N +L DL+ + +D+ K +
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 408 KIAIGAARGFAWLHHNCNPRIIHR-----NI--------SSKCILLDDDFEPKISDFGLA 454
+ A G A LH +IIHR NI ++ ++ ISDFGL
Sbjct: 119 SLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 455 RLMNPIDTHLSTFVNGEFGDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTG 507
+ ++ + T +N G G+ APE T D++S G V +++
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 508 ---------ERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFL 558
R +N+ + + L + D I + + D
Sbjct: 236 GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEA--TDLISQMID---HD------- 283
Query: 559 KVACNCVLPTIPKERPTMFEVYQ--FLRAIGERYHFTTE--DEIMLPSDSGDADILEEL 613
P +RPT +V + ++ F + D + + + + +L +
Sbjct: 284 -----------PLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKF 331
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 44/245 (17%), Positives = 86/245 (35%), Gaps = 38/245 (15%)
Query: 313 IGSGRTGTMYKA--LLEDGTSLMVKRLQDSQRSE--KEFVAEMATLGSVKNRNLVPLL-- 366
I G G +Y A +G +++K L S +E +AE L V + ++V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 367 GFCMAKKERLLVYKHM---PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
+ + Y M SL G+ + + + ++LH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+++ ++ + I+L ++ + K+ D G + G G+ APE
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY----GTPGFQAPEIV 249
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543
RT T D+Y+ G L L G V+ + + + D+ +
Sbjct: 250 RTG-PTVATDIYTVGRTLAALTLDLPT---------RNGRYVDGLPEDDPVLKTYDSYGR 299
Query: 544 CLVAK 548
L+ +
Sbjct: 300 -LLRR 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 57/309 (18%), Positives = 107/309 (34%), Gaps = 51/309 (16%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLV 363
+ ++I+G G T +++ + G +K + R + E L + ++N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 364 PLLGF--CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP----RRLKIAIGAARGF 417
L + ++L+ + P GSLY +L + + P + +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVLRDVVGG--M 125
Query: 418 AWLHHNCNPRIIHRNISSKCILL----DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFG 473
L N I+HRNI I+ D K++DFG AR + D + G
Sbjct: 126 NHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY----G 177
Query: 474 DLGYVAPE-YARTLVA-------TPKGDVYSFGTVLLELVTGERPTNVAKAPETF----- 520
Y+ P+ Y R ++ D++S G TG P + P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 521 -----KGNLVEWIAQLSSTGQLQ---DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKE 572
K + Q + G + D C +++G+ L L +L ++
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA----NILEADQEK 293
Query: 573 RPTMFEVYQ 581
+ +
Sbjct: 294 CWGFDQFFA 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 41/217 (18%), Positives = 83/217 (38%), Gaps = 27/217 (12%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKNRNLV------ 363
+G G G +++A D + +K RL + + + ++ + E+ L +++ +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 364 ---PLLGFCMAKKERLLVYKHM---PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF 417
++ +Y M +L D ++ T + + L I + A
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFLQIAEAV 131
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG- 476
+LH ++HR++ I D K+ DFGL M+ + +
Sbjct: 132 EFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 477 -------YVAPEYARTLVATPKGDVYSFGTVLLELVT 506
Y++PE + K D++S G +L EL+
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 59/317 (18%), Positives = 109/317 (34%), Gaps = 51/317 (16%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLV 363
+ ++I+G G T +++ + G +K + R + E L + ++N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 364 PLLGF--CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWP----RRLKIAIGAARGF 417
L + ++L+ + P GSLY +L + + P + +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVLRDVVGG--M 125
Query: 418 AWLHHNCNPRIIHRNISSKCILL----DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFG 473
L N I+HRNI I+ D K++DFG AR + D + G
Sbjct: 126 NHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY----G 177
Query: 474 DLGYVAPE-YARTLVA-------TPKGDVYSFGTVLLELVTGERPTNVAKAPETF----- 520
Y+ P+ Y R ++ D++S G TG P + P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 521 -----KGNLVEWIAQLSSTGQLQ---DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKE 572
K + Q + G + D C +++G+ L L +L ++
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA----NILEADQEK 293
Query: 573 RPTMFEVYQFLRAIGER 589
+ + I R
Sbjct: 294 CWGFDQFFAETSDILHR 310
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 45/218 (20%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVAEMATLGSVKNRNLVP 364
+ +G G G +YKA E G K ++ S+ ++++ E+ L + + +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 365 LLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLK---IAI---GAARGF 417
LLG +L ++ + P G++ ++ R L I +
Sbjct: 81 LLG-AYYHDGKLWIMIEFCPGGAVDAIMLEL---------DRGLTEPQIQVVCRQMLEAL 130
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+LH RIIHR++ + +L+ + + +++DFG++ +F+ + +
Sbjct: 131 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY----W 183
Query: 478 VAPEYARTLVAT-----PKGDVYSFGTVLLELVTGERP 510
+APE K D++S G L+E+ E P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 21/115 (18%), Positives = 34/115 (29%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L ++ K F +S+ L ++ N ++ LT LDLS
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL 199
L L + HN QL L + + N + S +
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 19/107 (17%), Positives = 27/107 (25%), Gaps = 2/107 (1%)
Query: 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYL 155
+ LD + L + L LD+S N T L
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 156 NSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
N+LK+ N F L ++ L F L
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 19/118 (16%), Positives = 36/118 (30%), Gaps = 3/118 (2%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L L+ ++ + ++ L L+ N + P S L L +L +
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS-LENLVAVETKLASL 119
Query: 145 IPSNLANCTYLNSLKLDHNRFSG-QIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
+ L L + HN ++P L L ++ N + L
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 24/108 (22%), Positives = 36/108 (33%), Gaps = 6/108 (5%)
Query: 94 GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCT 153
G I ++T KL +PDDI ++DLS N + +N +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIPS---STKNIDLSFNPLKILKSYSFSNFS 56
Query: 154 YLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
L L L L L + + N + P +F LT
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLT 104
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 26/113 (23%), Positives = 40/113 (35%), Gaps = 8/113 (7%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
L + D L F N +++T LDLS +L L L L++S
Sbjct: 451 NTLKMAGNSFKDNTLSNVF----ANTTNLTFLDLSKCQLEQISWGVFDTLHR-LQLLNMS 505
Query: 138 SNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
NN S+ L++L NR L F++ NN ++
Sbjct: 506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 27/106 (25%), Positives = 42/106 (39%), Gaps = 3/106 (2%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLN 156
N S + LDLS ++ L L++L L+ N P + + T L
Sbjct: 49 SYSFSNFSELQWLDLSRCEIETIEDKAWHGL-HHLSNLILTGNPIQSFSPGSFSGLTSLE 107
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+L + + +GQL LK +VA+N + F NLT
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 7/124 (5%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
NL LT ++ P +S+ L KL I +L+ L L+++ N
Sbjct: 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT-LKKLNVAHNFIHS 142
Query: 144 -SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSV----ANNLLSGSIP-TFV 197
+P+ +N T L + L +N L L ++ + N + F
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQ 202
Query: 198 NLTL 201
+ L
Sbjct: 203 GIKL 206
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 36/207 (17%), Positives = 58/207 (28%), Gaps = 23/207 (11%)
Query: 9 LKSRSLVGVSVCLLLCFSLSYGT-----KEDLACLKSIKD-SLEDPFNYLNSSWNFNNDT 62
+ + G+ + F L+Y CL ++ SL + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG--VSIKYLEDVPKHF 307
Query: 63 EGFI-----CKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLY 117
+ C+ + L L KG S++ LDLS N L
Sbjct: 308 KWQSLSIIRCQLKQFPTLDLPFLKSLTLT----MNKGSISFKKVALPSLSYLDLSRNALS 363
Query: 118 GPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQ-LG 174
+G L LDLS N + +N L L H+
Sbjct: 364 F-SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
Query: 175 QLGRLKSFSVANNLLSGSIP-TFVNLT 200
L +L ++ F+ LT
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLT 448
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 26/121 (21%), Positives = 39/121 (32%), Gaps = 12/121 (9%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVG---FLTSL 134
+ LN+ + L F N +++ +DLS N + +D+ L SL
Sbjct: 131 KKLNVAHNFIHSCKLPAYF----SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQ-LGRLKSFSVANNLLSGSI 193
D+S N I L+ L L N S I Q L L +
Sbjct: 187 DMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245
Query: 194 P 194
Sbjct: 246 N 246
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 16/125 (12%), Positives = 31/125 (24%), Gaps = 10/125 (8%)
Query: 95 QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG---------SI 145
+ L L N + + + L L F SI
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 146 PSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADS 205
L + T +L + + L + + S+A + + + S
Sbjct: 255 MEGLCDVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLS 313
Query: 206 VTNNQ 210
+ Q
Sbjct: 314 IIRCQ 318
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 70/336 (20%), Positives = 126/336 (37%), Gaps = 72/336 (21%)
Query: 290 KSITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFV 348
+S+ ++ LS L F ++G+G G +YK ++ G +K + + E+E
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 349 AEMATLGSVKN-RNLVPLLGFCMAKKERL-------LVYKHMPNGSLYDLLHPADDTGKS 400
E+ L + RN+ G KK LV + GS+ DL+
Sbjct: 69 QEINMLKKYSHHRNIATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127
Query: 401 VDWPRRLKIAI---GAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457
+W IA RG + LH + ++IHR+I + +LL ++ E K+ DFG++ +
Sbjct: 128 EEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT-----PKGDVYSFGTVLLELVTGERP-- 510
+ +TF+ G ++APE K D++S G +E+ G P
Sbjct: 180 DRTVGRRNTFI----GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235
Query: 511 -TNVAKA--------PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVA 561
+ +A K +W + + Q I+ CLV +
Sbjct: 236 DMHPMRALFLIPRNPAPRLKSK--KW------SKKFQSFIESCLV---KN---------- 274
Query: 562 CNCVLPTIPKERPTMFEVYQ--FLRAIGERYHFTTE 595
+RP ++ + F+R +
Sbjct: 275 --------HSQRPATEQLMKHPFIRDQPNERQVRIQ 302
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 26/118 (22%), Positives = 43/118 (36%), Gaps = 6/118 (5%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
LRL G++ P I N ++ L + ++ L L I L L LDL +
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK-LEELDLRGCTALRN 244
Query: 145 IPSNLANCTYLNSLKL-DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
P L L L D + +P + +L +L+ + + +P L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 18/96 (18%), Positives = 30/96 (31%), Gaps = 1/96 (1%)
Query: 95 QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTY 154
I + + LDL P L L L + ++P ++ T
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAP-LKRLILKDCSNLLTLPLDIHRLTQ 278
Query: 155 LNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
L L L ++P + QL V +L +
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 25/108 (23%), Positives = 43/108 (39%), Gaps = 6/108 (5%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
L LR + L QFP S + + + + L LPD + + G L +L L+ N
Sbjct: 84 VALELR--SVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAG-LETLTLARNP 138
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNL 188
++P+++A+ L L + ++P L NL
Sbjct: 139 LR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 15/82 (18%), Positives = 26/82 (31%), Gaps = 1/82 (1%)
Query: 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYL 155
+P + + L L LP DI +L L LDL +PS +A
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ-LEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 156 NSLKLDHNRFSGQIPPQLGQLG 177
+ + + + +
Sbjct: 304 CIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 17/125 (13%), Positives = 33/125 (26%), Gaps = 23/125 (18%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKL----------------VGFLTSLDLSSNN 140
+ S L + P D +S+ + + +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRT 64
Query: 141 FSG--SIPSNLANCTYLN--SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-T 195
+ L + T +L+L Q P Q +L L+ ++ L +P T
Sbjct: 65 GRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122
Query: 196 FVNLT 200
Sbjct: 123 MQQFA 127
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 53/314 (16%), Positives = 105/314 (33%), Gaps = 68/314 (21%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ---DSQRSEKEFVAEMATLGSV-KNRN 361
F + IGSG G+++K + DG +KR + E+ + E+ + ++ +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 362 LVPLLGFCMAKKERLLVY-KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
+V A+ + +L+ ++ GSL D + + + RG ++
Sbjct: 73 VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 421 HHNCNPRIIHRNISSKC--ILLDDDFEP-------------------KISDFGLARLMNP 459
H ++H +I K I + P KI D G ++
Sbjct: 132 HSM---SLVHMDI--KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGER-PTNVAKAP 517
E GD ++A E + PK D+++ ++ E P N +
Sbjct: 187 PQV--------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 518 ETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMF 577
E +G L LS + + + + D P+ RP+
Sbjct: 239 EIRQGRLPRIPQVLSQ--EFTELLKVMIH---PD------------------PERRPSAM 275
Query: 578 EVYQ--FLRAIGER 589
+ + L + +
Sbjct: 276 ALVKHSVLLSASRK 289
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 27/128 (21%), Positives = 42/128 (32%), Gaps = 7/128 (5%)
Query: 74 CWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133
C + N+ N ++GL + P + +S L+ S N L S+L+ LT
Sbjct: 8 CIEKEVNKTYNCE--NLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLI-NLTF 61
Query: 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSI 193
LDL+ + L++L L N L LK +S
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121
Query: 194 P-TFVNLT 200
N
Sbjct: 122 FIPLHNQK 129
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 22/105 (20%), Positives = 32/105 (30%), Gaps = 2/105 (1%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLN 156
++ + L L++N L +S L L S L N L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKA-LKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
SL L N S P+ +LK NN + +L
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 27/120 (22%), Positives = 40/120 (33%), Gaps = 4/120 (3%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L L+ + C + LDL+ +L + + L L+LS + S
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 145 IPSNLANCTYLNSLKLDHNRFSG---QIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
L L L N F Q L LGRL+ ++ LS F +L
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 27/126 (21%), Positives = 46/126 (36%), Gaps = 6/126 (4%)
Query: 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSS 138
E V ++ L S + LDL++ L LP + L L L LS+
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGL-STLKKLVLSA 310
Query: 139 NNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--- 194
N F + +N L L + N ++ L L L+ ++++ + S
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 195 TFVNLT 200
NL+
Sbjct: 371 QLRNLS 376
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 25/125 (20%), Positives = 39/125 (31%), Gaps = 6/125 (4%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
R L+L D+ +RN S + L+LS N+ + + L LDL+
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ-LELLDLAFTR 411
Query: 141 FSGSIP-SNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP----T 195
S N L L L H+ L L+ ++ N +
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 196 FVNLT 200
L
Sbjct: 472 LQTLG 476
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 24/119 (20%), Positives = 42/119 (35%), Gaps = 4/119 (3%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFS 142
L L+ L + ++ L+L N + L L L LS + S
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 143 GSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
+ +N + L HNR + L L + ++A+N +S +P L+
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILS 547
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 27/121 (22%), Positives = 43/121 (35%), Gaps = 6/121 (4%)
Query: 85 LRLTDMGLKGQFPRG-IRNCSSMTGLDLSSNKLY--GPLPDDISKLVGFLTSLDLSSNNF 141
L + + + G + N ++ LDLS + + + L L SL+LS N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL-SHLQSLNLSYNEP 388
Query: 142 SGSIPSNLANCTYLNSLKLDHNRFSGQIPP-QLGQLGRLKSFSVANNLLSGSIP-TFVNL 199
C L L L R + L LK +++++LL S F L
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448
Query: 200 T 200
Sbjct: 449 P 449
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 24/115 (20%), Positives = 42/115 (36%), Gaps = 7/115 (6%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
+ LNL Q ++ + L LS L + L + +DLS
Sbjct: 452 QHLNLQGNHFP--KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM-MNHVDLS 508
Query: 138 SNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192
N + S L++ + L L N S +P L L + ++ ++ N L +
Sbjct: 509 HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 18/117 (15%), Positives = 34/117 (29%), Gaps = 4/117 (3%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLN 156
+ ++ L + + L SL L SN+ S L
Sbjct: 98 ETALSGPKALKHLFFIQTGISSIDFIPLHNQKT-LESLYLGSNHISSIKLPKGFPTEKLK 156
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLK--SFSVANNLLSGSIP-TFVNLTLSADSVTNNQ 210
L +N + L + S ++ N ++G P F + + + Q
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 16/123 (13%), Positives = 34/123 (27%), Gaps = 4/123 (3%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKL-VGFLTSLDLSSN 139
L+L L + G G + + L+ + + + + L
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 140 NFSGSIPSNLANCTYLN--SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197
+ P+ ++ S+ L + F L+ + LS V
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLV 298
Query: 198 NLT 200
L+
Sbjct: 299 GLS 301
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 21/122 (17%), Positives = 36/122 (29%), Gaps = 5/122 (4%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS-SNNFSG 143
L L + + LD +N ++ +D+S L T+L L+ + N
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ-ATNLSLNLNGNDIA 192
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLG--QLGRLKSFSVANNLLSGSIP-TFVNLT 200
I + SL + I L + L + + P F L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 201 LS 202
Sbjct: 253 EM 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 1e-13
Identities = 45/220 (20%), Positives = 79/220 (35%), Gaps = 27/220 (12%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLG 367
+G G +Y+A + G + +K + + E+ +K+ +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 368 FCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
+ LV + NG + L K G +LH +
Sbjct: 79 -YFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH--- 131
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
I+HR+++ +LL + KI+DFGLA + T G Y++PE
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPE----- 182
Query: 487 VATPKG-----DVYSFGTVLLELVTGERPTNVAKAPETFK 521
+AT DV+S G + L+ G P + T
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 35/167 (20%), Positives = 66/167 (39%), Gaps = 14/167 (8%)
Query: 350 EMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKI 409
E+ + +KN + G E ++Y++M N S+ K+ +++
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 410 AIGAAR----GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465
+ F+++H+ N I HR++ IL+D + K+SDFG + M D +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIK 208
Query: 466 TFVNGEFGDLGYVAPE--YARTLVATPKGDVYSFGTVLLELVTGERP 510
G ++ PE + K D++S G L + P
Sbjct: 209 GSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 53/292 (18%), Positives = 106/292 (36%), Gaps = 53/292 (18%)
Query: 306 SFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATL-GSVKNRNLVP 364
SF +++G G GT+ + D + VKR+ S + E+ L S ++ N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIR 82
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
++ + + + +L + + D ++ + + G A LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL- 137
Query: 425 NPRIIHRNISSKCILLDDDFE-----PKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
I+HR++ IL+ ISDFGL + + H + +G G G++A
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRHSFSRRSGVPGTEGWIA 194
Query: 480 PEYARTLV---ATPKGDVYSFGTVLLELVTG---------ERPTNVAKAPETFKGNLVEW 527
PE T D++S G V +++ +R N+ + + +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL--DCLHP 252
Query: 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEV 579
++ I+K + +D P++RP+ V
Sbjct: 253 EKHEDV--IARELIEKMIA---MD------------------PQKRPSAKHV 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 20/215 (9%)
Query: 313 IGSGRTGTMYKA-LLEDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLG 367
+G G+ G +Y A + L +K L +Q E + E+ +++ N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 368 FCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
+ R+ L+ ++ P G++Y L D R A ++ H
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK--- 128
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
R+IHR+I + +LL E KI+DFG + + + G L Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLC----GTLDYLPPEMIEGR 182
Query: 487 VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521
+ K D++S G + E + G+ P ET+K
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 217
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 40/239 (16%), Positives = 79/239 (33%), Gaps = 19/239 (7%)
Query: 284 KVSLFEKSITKMRLSDLMKATNSFSKNNIIGS----GRTGTMYKALLEDGTSLMVKRLQD 339
++ L + + + ++ +KA I+ T D L +
Sbjct: 38 RIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDW 97
Query: 340 SQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM---PNGSLYDLLHPADD 396
S A + + + +G ++ +Y M +L D ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN-RRC 156
Query: 397 TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456
+ + + L I I A +LH ++HR++ I D K+ DFGL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 457 MNPIDTHLSTFVNGEFGDLG--------YVAPEYARTLVATPKGDVYSFGTVLLELVTG 507
M+ + + Y++PE + K D++S G +L EL+
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 62/274 (22%), Positives = 107/274 (39%), Gaps = 43/274 (15%)
Query: 258 MSMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNS------FSKNN 311
MS ++L + ++ D+ + FS
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVK----RLQDSQRSEKEFVAEMATLGSVKNRNLVPLL 366
IG G G +Y A + + + +K + S ++ + E+ L +++ N +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 367 GFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLK---IAI---GAARGFAW 419
G C ++ LV ++ GS DLL + L+ IA GA +G A+
Sbjct: 121 G-CYLREHTAWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAY 169
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
LH + +IHR++ + ILL + K+ DFG A +M P + +FV G ++A
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFV----GTPYWMA 218
Query: 480 PEYARTLVAT---PKGDVYSFGTVLLELVTGERP 510
PE + K DV+S G +EL + P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 27/147 (18%), Positives = 54/147 (36%), Gaps = 15/147 (10%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
+ L+L + + F + ++ L+L N +Y + + L +LDLS
Sbjct: 147 QYLDLKLNEIDTV----NFAELAASSDTLEHLNLQYNFIYD-VKGQVVF--AKLKTLDLS 199
Query: 138 SNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS-GSIPTF 196
SN + + + + + L +N+ I L L+ F + N G++ F
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 197 VNLTLSADSVTNNQ--GLCGEPLDACK 221
+ +V L G+ + C
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECT 284
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 4/101 (3%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+N + ++ + L + + + LDLS N S ++LA T L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L N L L L++ + NN + + ++
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIE 102
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 11/123 (8%)
Query: 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSN 139
NR ++TD LK ++ ++ LDLS N L D++ L L+LSSN
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK-LELLNLSSN 68
Query: 140 NFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFV 197
L + + L +L L++N +L +++ ANN +S +
Sbjct: 69 VLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ 120
Query: 198 NLT 200
Sbjct: 121 GKK 123
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 11/103 (10%), Positives = 32/103 (31%), Gaps = 8/103 (7%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ S+ L ++N + + + ++ L++N + + + + L
Sbjct: 95 LLVGPSIETLHAANNNI-SRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 160 LDHNRFSGQIPPQ--LGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L N + L+ ++ N + + V
Sbjct: 151 LKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFA 191
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 11/78 (14%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 123 DISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSF 182
+I + ++ ++ ++ S + + L L N S L +L+
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 183 SVANNLLSGSIPTFVNLT 200
++++N+L +L+
Sbjct: 64 NLSSNVLY-ETLDLESLS 80
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 24/125 (19%), Positives = 48/125 (38%), Gaps = 8/125 (6%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ ++ L+L N +Y + + + L +LDLSSN + + + + +
Sbjct: 165 AASSDTLEHLNLQYNFIYD-VKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLS-GSIPTFVNLTLSADSVTNNQ--GLCGEP 216
L +N+ I L L+ F + N G++ F + +V L G+
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 217 LDACK 221
+ C
Sbjct: 280 EEECT 284
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 4/101 (3%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+N + ++ + L + + + LDLS N S ++LA T L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L N L L L++ + NN + + ++
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIE 102
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 9/122 (7%)
Query: 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSN 139
NR ++TD LK ++ ++ LDLS N L D++ L L+LSSN
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK-LELLNLSSN 68
Query: 140 NFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG-SIPTFVN 198
+L + + L +L L++N +L +++ ANN +S S
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQG 121
Query: 199 LT 200
Sbjct: 122 KK 123
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 11/78 (14%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 123 DISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSF 182
+I + ++ ++ ++ S + + L L N S L +L+
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 183 SVANNLLSGSIPTFVNLT 200
++++N+L +L+
Sbjct: 64 NLSSNVLY-ETLDLESLS 80
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 12/102 (11%), Positives = 33/102 (32%), Gaps = 6/102 (5%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ S+ L ++N + + + ++ L++N + + + + L
Sbjct: 95 LLVGPSIETLHAANNNI-SRVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 160 LDHNRFSGQIPPQL-GQLGRLKSFSVANNLLSGSIPTFVNLT 200
L N +L L+ ++ N + + V
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFA 191
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 17/126 (13%), Positives = 29/126 (23%), Gaps = 11/126 (8%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
++L +L + +R ++ DL N + D ++
Sbjct: 217 TWISLRNNKLVL------IEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVA 268
Query: 138 SNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197
N CT P +L LK A GS +
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERL 328
Query: 198 NLTLSA 203
Sbjct: 329 ECEREN 334
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 47/215 (21%), Positives = 88/215 (40%), Gaps = 20/215 (9%)
Query: 313 IGSGRTGTMYKA-LLEDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLG 367
+G G+ G +Y A ++ + +K L SQ E + E+ +++ N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 368 FCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
+ ++R+ L+ + P G LY L G+ + + A + H
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFME-ELADALHYCHER--- 133
Query: 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL 486
++IHR+I + +L+ E KI+DFG + + T G L Y+ PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--TM----CGTLDYLPPEMIEGK 187
Query: 487 VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521
K D++ G + E + G P + ET +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR 222
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 3e-12
Identities = 89/604 (14%), Positives = 169/604 (27%), Gaps = 207/604 (34%)
Query: 41 IKDSLEDPFNYLNSSWNFNN-----DTEGFICK----FTGVECWHPDE-NR---VLNLR- 86
+++ L + +L S T +I + + + + +R L LR
Sbjct: 83 VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ 142
Query: 87 -LTDM---------GLKG------------------QFPRGI-----RNCSSMTGLDLSS 113
L ++ G+ G + I +NC+S +
Sbjct: 143 ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 114 NKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK-LDHNRFSGQIPPQ 172
KL + + + +++ L ++ + L + Y N L L + + + +
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ-NAKA--- 258
Query: 173 LGQLGRLKSF-------------SVANNLLSGSIPTFVNLTLSADSVTNNQ--GLCGE-- 215
+F V + LS + T ++L + ++T ++ L +
Sbjct: 259 ------WNAFNLSCKILLTTRFKQVT-DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 216 -------PLDACKGTSKGP-HTGVIAGAAIGGVTFAALVVGIVMFFYFRRMSMRKKKD-- 265
P + P +IA ++ G+ + ++ ++ K
Sbjct: 312 DCRPQDLPREVLTT---NPRRLSIIA---------ESIRDGLATWDNWKHVNCDKLTTII 359
Query: 266 -------DDPEGNKWAKSLTGTKGIKVSLFEKS--ITKMRLS---------DLMKATNSF 307
+ E K L S+F S I + LS D+M N
Sbjct: 360 ESSLNVLEPAEYRKMFDRL--------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 308 SKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
K +L+E + K + L +R++V
Sbjct: 412 HK-------------YSLVEKQPKESTISIPSIYLELKVKLENEYAL----HRSIV---- 450
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG-FAWL--HHNC 424
+ Y DL+ P D F HH
Sbjct: 451 ------DH---YNIPKTFDSDDLIPPYLD-------------------QYFYSHIGHHLK 482
Query: 425 NPRIIHRNISSKCILLDDDF-EPKISDFGLARLMNPIDTHLSTFVNGEFGDL----GYVA 479
N R + + LD F E KI A N + L+T L Y+
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW--NASGSILNT-----LQQLKFYKPYIC 535
Query: 480 ---PEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536
P+Y R + + F L E N+ + T +L+
Sbjct: 536 DNDPKYERLV-----NAILDF------LPKIE--ENLICSKYT---DLLRIALMAEDEAI 579
Query: 537 LQDA 540
++A
Sbjct: 580 FEEA 583
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 56/256 (21%), Positives = 93/256 (36%), Gaps = 49/256 (19%)
Query: 335 KRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHP 393
K L ++ E++ S+ ++++V G + + +V + SL +L
Sbjct: 50 KSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH-- 106
Query: 394 ADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453
K++ P G +LH N R+IHR++ + L++D E KI DFGL
Sbjct: 107 --KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG-----DVYSFGTVLLELVTGE 508
A + G Y+APE V + KG DV+S G ++ L+ G+
Sbjct: 162 ATKVEYDGERKKVLC----GTPNYIAPE-----VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
Query: 509 RPTNVAKAPETFK---GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCV 565
P + ET+ N ++ I K L
Sbjct: 213 PPFETSCLKETYLRIKKNEYSIPKHINP--VAASLIQKMLQTD----------------- 253
Query: 566 LPTIPKERPTMFEVYQ 581
P RPT+ E+
Sbjct: 254 ----PTARPTINELLN 265
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
LH+ +IIHR+I +L+ +D KI+DFG++ D LS V G ++A
Sbjct: 153 LHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV----GTPAFMA 205
Query: 480 PE---YARTLVATPKGDVYSFGTVLLELVTGERP 510
PE R + + DV++ G L V G+ P
Sbjct: 206 PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 56/256 (21%), Positives = 93/256 (36%), Gaps = 49/256 (19%)
Query: 335 KRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHP 393
K L ++ E++ S+ ++++V G + + +V + SL +L
Sbjct: 76 KSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH-- 132
Query: 394 ADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453
K++ P G +LH N R+IHR++ + L++D E KI DFGL
Sbjct: 133 --KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG-----DVYSFGTVLLELVTGE 508
A + G Y+APE V + KG DV+S G ++ L+ G+
Sbjct: 188 ATKVEYDGERKKVLC----GTPNYIAPE-----VLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 509 RPTNVAKAPETFK---GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCV 565
P + ET+ N ++ I K L
Sbjct: 239 PPFETSCLKETYLRIKKNEYSIPKHINP--VAASLIQKMLQTD----------------- 279
Query: 566 LPTIPKERPTMFEVYQ 581
P RPT+ E+
Sbjct: 280 ----PTARPTINELLN 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 43/207 (20%), Positives = 85/207 (41%), Gaps = 18/207 (8%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMA-TLGSVKNRNLVPLLGF 368
+G G G + K + G + VK R + + +K + ++ ++ +V V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
+ + + + M + SL D G+++ KIA+ + LH + +
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 429 IHRNISSKCILLDDDFEPKISDFGL-ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
IHR++ +L++ + K+ DFG+ L++ + G Y+APE +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDA----GCKPYMAPERINPEL 185
Query: 488 ATP----KGDVYSFGTVLLELVTGERP 510
K D++S G ++EL P
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 55/270 (20%), Positives = 94/270 (34%), Gaps = 72/270 (26%)
Query: 311 NIIGSGRTGTMYKALL------EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSV-KNRN 361
+G G G + +A ++ VK L++ + + ++E+ L + + N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 362 LVPLLGFCMAKKERLLV-YKHMPNGSLYDLLHPADDTGK-------------------SV 401
+V LLG C L+V + G+L L + V
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 402 DWPRRLKIAIGA----------ARGFAWLHHNCNPRIIHRNI------------------ 433
D RRL + + + + P ++++
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 434 ---SSKCI---------LLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
S KCI LL + KI DFGLAR + ++ + L ++APE
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDARL-PLKWMAPE 265
Query: 482 YARTLVATPKGDVYSFGTVLLELVT-GERP 510
V T + DV+SFG +L E+ + G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 19/115 (16%), Positives = 43/115 (37%), Gaps = 8/115 (6%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
GI ++ L +++ + + + G L L + + + NL+ T L
Sbjct: 61 GIEYAHNIKDLTINNIHA-----TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
L + H+ I ++ L ++ S ++ N I L L + ++ +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 4/108 (3%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
LR+ + + +S+T LD+S + + I+ L + S+DLS N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK-VNSIDLSYNGAIT 150
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG 191
I L L SL + + + +L + + G
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 12/71 (16%), Positives = 29/71 (40%), Gaps = 5/71 (7%)
Query: 131 LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
LT + L++ N + + + + + L +++ + P + L L+ + ++
Sbjct: 46 LTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN-YNP-ISGLSNLERLRIMGKDVT 101
Query: 191 GS-IPTFVNLT 200
IP LT
Sbjct: 102 SDKIPNLSGLT 112
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 27/104 (25%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+ N S +T L++ +N++ DI+ + L L++ SN S S L N + LN
Sbjct: 238 PLANLSQLTWLEIGTNQI-----SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
SL L++N+ + +G L L + ++ N ++ I +L+
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPLASLS 333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 21/92 (22%), Positives = 41/92 (44%), Gaps = 5/92 (5%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158
+++ + + L++ SN++ ++ L L SL L++N + T L +L
Sbjct: 260 AVKDLTKLKMLNVGSNQISDI--SVLNNLSQ-LNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
L N + I P L L ++ S AN ++
Sbjct: 317 FLSQNHITD-IRP-LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 7/102 (6%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158
++N +++ L L+ + + P ++ L + SL+L +N+ S S L+N T LN L
Sbjct: 105 ALQNLTNLRELYLNEDNISDISP--LANLTK-MYSLNLGANHNL-SDLSPLSNMTGLNYL 160
Query: 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
+ ++ + P + L L S S+ N + I +LT
Sbjct: 161 TVTESKVKD-VTP-IANLTDLYSLSLNYNQIE-DISPLASLT 199
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 11/104 (10%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
GI +++ L+L+ N++ DIS L LT+L + +N + S L N T L
Sbjct: 61 GIEYLTNLEYLNLNGNQI-----TDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLR 113
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L L+ + S I P L L ++ S ++ N + N+T
Sbjct: 114 ELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMT 155
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 9e-11
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 8/102 (7%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158
I N + + L L+ N++ P ++ L L N + P +AN T LNSL
Sbjct: 172 PIANLTDLYSLSLNYNQIEDISP--LASLTS-LHYFTAYVNQITDITP--VANMTRLNSL 226
Query: 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
K+ +N+ + + P L L +L + N +S I +LT
Sbjct: 227 KIGNNKITD-LSP-LANLSQLTWLEIGTNQIS-DINAVKDLT 265
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 27/126 (21%), Positives = 46/126 (36%), Gaps = 12/126 (9%)
Query: 77 PDEN--RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134
PD + + L + S+T L ++ K+ I L L L
Sbjct: 17 PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIEYLTN-LEYL 71
Query: 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194
+L+ N + P L+N L +L + N+ + L L L+ + + +S I
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNIS-DIS 126
Query: 195 TFVNLT 200
NLT
Sbjct: 127 PLANLT 132
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 13/107 (12%), Positives = 31/107 (28%), Gaps = 13/107 (12%)
Query: 107 TGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNR 164
L + + I L + + + + L + +
Sbjct: 3 ATLATLPAPI-----NQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK 55
Query: 165 FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
+ I + L L+ ++ N ++ I NL L+ + N+
Sbjct: 56 VA-SIQG-IEYLTNLEYLNLNGNQIT-DISPLSNLVKLTNLYIGTNK 99
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 11/70 (15%), Positives = 20/70 (28%), Gaps = 5/70 (7%)
Query: 131 LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
+L + P A+ L + + +L + VA ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 191 GSIPTFVNLT 200
SI LT
Sbjct: 58 -SIQGIEYLT 66
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 32/106 (30%), Positives = 45/106 (42%), Gaps = 17/106 (16%)
Query: 414 ARGFAW--------LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS 465
AR H I+HR++ ++ +LLD D KI+DFG + L
Sbjct: 116 ARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLD 171
Query: 466 TFVNGEFGDLGYVAPE-YARTLVATPKGDVYSFGTVLLELVTGERP 510
F G Y APE + P+ DV+S G +L LV+G P
Sbjct: 172 AFC----GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 27/130 (20%), Positives = 48/130 (36%), Gaps = 20/130 (15%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
N RLT P S + L +S N+L LP S+L L +S N
Sbjct: 207 WAYNNRLT------SLPALP---SGLKELIVSGNRL-TSLPVLPSEL----KELMVSGNR 252
Query: 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
+ S+P + L+ + N+ + ++P L L + ++ N LS
Sbjct: 253 LT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALRE 306
Query: 201 LSADSVTNNQ 210
+++ +
Sbjct: 307 ITSAPGYSGP 316
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 33/155 (21%), Positives = 53/155 (34%), Gaps = 35/155 (22%)
Query: 73 ECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLT 132
C + N VLN+ + GL P + + +T L + N L LP +L
Sbjct: 36 ACL-NNGNAVLNVG--ESGLT-TLPDCL--PAHITTLVIPDNNL-TSLPALPPEL----R 84
Query: 133 SLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQL--------------GR 178
+L++S N + S+P L+ +P L +L
Sbjct: 85 TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPG 142
Query: 179 LKSFSVANNLLS---GSIPTFVNLTLSADSVTNNQ 210
L+ SV++N L+ L NNQ
Sbjct: 143 LQELSVSDNQLASLPALPSELCKLWAY-----NNQ 172
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 23/127 (18%), Positives = 42/127 (33%), Gaps = 19/127 (14%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L + L P L +S N+L + L L L +N +
Sbjct: 125 KLWIFGNQLT-SLPVLPPGLQE---LSVSDNQL-----ASLPALPSELCKLWAYNNQLT- 174
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSA 203
S+P + L L + N+ + +P +L +L +++ L L +S
Sbjct: 175 SLPMLPSG---LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVS- 229
Query: 204 DSVTNNQ 210
N+
Sbjct: 230 ----GNR 232
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 18/112 (16%), Positives = 32/112 (28%), Gaps = 11/112 (9%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L ++ L P S L + N+L LP+ + L T+++L N S
Sbjct: 245 ELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLTR-LPESLIHLSS-ETTVNLEGNPLS- 297
Query: 144 SIPSNLANCTYLNSLKLDHNRFS--GQIPPQLGQLGRLKSFSVANNLLSGSI 193
+ S + R + A+ L+
Sbjct: 298 ERTLQ--ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE 347
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 18/108 (16%), Positives = 33/108 (30%), Gaps = 4/108 (3%)
Query: 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYL 155
+ LD + L + + L LD+S + + + L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 156 NSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
LK+ N F P +L L ++ L + F +L+
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 494
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 22/118 (18%), Positives = 32/118 (27%), Gaps = 10/118 (8%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L + P + S LDLS N L L LDLS
Sbjct: 16 ELNFY------KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQT 66
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT 200
+ ++L++L L N L L+ L+ +L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 24/124 (19%), Positives = 39/124 (31%), Gaps = 7/124 (5%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140
L+L + KG + +S+ LDLS N + + + L L LD +N
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQ-LEHLDFQHSN 407
Query: 141 FSGSIPSN-LANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TF 196
+ + L L + H L L+ +A N + F
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 197 VNLT 200
L
Sbjct: 467 TELR 470
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 28/120 (23%), Positives = 44/120 (36%), Gaps = 5/120 (4%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
NL L+ L+ + + LDLS ++ L L++L L+ N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH-LSTLILTGNPIQS 90
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP---TFVNLT 200
+ + L L + +G L LK +VA+NL+ S F NLT
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 29/123 (23%), Positives = 48/123 (39%), Gaps = 7/123 (5%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKL-YGPLPDDISKLVGFLTSLDLSSNNFSG 143
L + L I + ++ L+++ N + LP+ S L L LDLSSN
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQS 163
Query: 144 SIPSNLANCTYL----NSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL 199
++L + SL L N + I P + RL ++ NN S ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 200 TLS 202
L+
Sbjct: 223 GLA 225
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 23/112 (20%), Positives = 39/112 (34%), Gaps = 4/112 (3%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L ++ + F SS+ L ++ N DI + LT LDLS
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-Q 484
Query: 145 IPSN-LANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP 194
+ + + L L + N+ +P +L L+ + N S P
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 18/94 (19%), Positives = 29/94 (30%), Gaps = 9/94 (9%)
Query: 110 DLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQI 169
Y +PD++ +LDLS N + + L L L I
Sbjct: 13 QCMELNFYK-IPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TI 67
Query: 170 PPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L L + + N + S+ F L+
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLS 100
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 32/134 (23%), Positives = 46/134 (34%), Gaps = 19/134 (14%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVG---FLTSL 134
+ LN+ + L P N +++ LDLSSNK+ D+ L SL
Sbjct: 127 KELNVAHNLIQSFKL----PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLK-------SFSVAN 186
DLS N + I L+ L L +N S + + L L+ F
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 187 NLLSGSIPTFVNLT 200
NL L
Sbjct: 242 NLEKFDKSALEGLC 255
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 26/111 (23%), Positives = 49/111 (44%), Gaps = 17/111 (15%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L+L + L P + +T L+++ N L LP+ + L LD N S
Sbjct: 63 ELQLNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELPASL----EYLDACDNRLS- 113
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194
++P A+ +L+ +D+N+ + +P L + + NN L+ +P
Sbjct: 114 TLPELPASLKHLD---VDNNQLT-MLPELPALLEYI---NADNNQLT-MLP 156
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 24/121 (19%), Positives = 44/121 (36%), Gaps = 12/121 (9%)
Query: 103 CSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNS----L 158
+S+ L + +N+L LP+ L +LD+S+N S+P+ +
Sbjct: 159 PTSLEVLSVRNNQL-TFLPELPESL----EALDVSTNLLE-SLPAVPVRNHHSEETEIFF 212
Query: 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-LTLSADSVTNNQGLCGEPL 217
+ NR + IP + L + + +N LS I ++ T D
Sbjct: 213 RCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
Query: 218 D 218
Sbjct: 272 Q 272
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 22/105 (20%), Positives = 37/105 (35%), Gaps = 18/105 (17%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQ 168
+ N+ L + + + L L+ N S S+P NL + L++ N
Sbjct: 42 PGENRNEAVSLLKE--CLINQ-FSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-S 94
Query: 169 IPPQLGQLGRLKSFSVANNLLS---GSIPTFVNLTLSADSVTNNQ 210
+P L L +N LS + +L + NNQ
Sbjct: 95 LPELPASLEYL---DACDNRLSTLPELPASLKHLDVD-----NNQ 131
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 29/113 (25%), Positives = 51/113 (45%), Gaps = 9/113 (7%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158
+ + +T L L +N++ ++ L LT+L+L+ N P ++N L L
Sbjct: 260 PLSGLTKLTELKLGANQISNI--SPLAGLTA-LTNLELNENQLEDISP--ISNLKNLTYL 314
Query: 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
L N S P + L +L+ NN +S + + NLT ++ S +NQ
Sbjct: 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQ 364
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 33/104 (31%), Positives = 45/104 (43%), Gaps = 9/104 (8%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLN 156
+ +S+ L N++ P ++ L L LD+SSN S S LA T L
Sbjct: 149 ISALSGLTSLQQLSFG-NQVTDLKP--LANLTT-LERLDISSNKVSD--ISVLAKLTNLE 202
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
SL +N+ S P LG L L S+ N L I T +LT
Sbjct: 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIGTLASLT 243
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 9/101 (8%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
++N + + + +++N++ P ++ L LT L L +N + P L N T LN L+
Sbjct: 86 LKNLTKLVDILMNNNQIADITP--LANLTN-LTGLTLFNNQITDIDP--LKNLTNLNRLE 140
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L N S L L L+ S N + + NLT
Sbjct: 141 LSSNTISD--ISALSGLTSLQQLSFGNQVT--DLKPLANLT 177
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 26/137 (18%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
+L+ G + + + N +++ LD+SSNK+ ++KL L SL ++N S
Sbjct: 157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTN-LESLIATNNQISD 213
Query: 144 SIP--------------------SNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFS 183
P LA+ T L L L +N+ S + P L L +L
Sbjct: 214 ITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISN-LAP-LSGLTKLTELK 271
Query: 184 VANNLLSGSIPTFVNLT 200
+ N +S +I LT
Sbjct: 272 LGANQIS-NISPLAGLT 287
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 17/102 (16%), Positives = 32/102 (31%), Gaps = 8/102 (7%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158
+ L + + + L +T+L + L +
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQ-VTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
+N+ + I P L L +L + NN ++ I NLT
Sbjct: 74 NFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITPLANLT 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 19/95 (20%), Positives = 38/95 (40%), Gaps = 7/95 (7%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLN 156
+ N +++ L N++ P ++ L +T L L+ ++ + + AN + N
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTR-ITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 157 SLKLDHNRFSGQIPP-QLGQLGRLKSFSVANNLLS 190
++K N I P + G + NL S
Sbjct: 403 TVK---NVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 22/120 (18%), Positives = 37/120 (30%), Gaps = 17/120 (14%)
Query: 95 QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF------------LTSLDLSSNNFS 142
+ P N S T + ++ P + L+L++ S
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 143 GSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLS 202
S+P + L SL N + ++P L L + LS P L +S
Sbjct: 85 -SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVS 139
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 26/124 (20%), Positives = 44/124 (35%), Gaps = 28/124 (22%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
++N S + +D+ +N L LPD L + +N +P L N +L ++
Sbjct: 149 LQNSSFLKIIDVDNNSL-KKLPDLPPSL----EFIAAGNNQLE-ELP-ELQNLPFLTAIY 201
Query: 160 LDHNRFSG------------------QIPPQLGQLGRLKSFSVANNLLS---GSIPTFVN 198
D+N + P+L L L + NNLL P+
Sbjct: 202 ADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEA 261
Query: 199 LTLS 202
L +
Sbjct: 262 LNVR 265
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 20/132 (15%), Positives = 43/132 (32%), Gaps = 23/132 (17%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLP---------------DDISKLV 128
+L + L + P ++ S+ + + L P ++
Sbjct: 95 SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSS 153
Query: 129 GFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNL 188
L +D+ +N+ +P + L + +N+ P+L L L + NN
Sbjct: 154 F-LKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE--ELPELQNLPFLTAIYADNNS 206
Query: 189 LSGSIPTFVNLT 200
L ++L
Sbjct: 207 LKKLPDLPLSLE 218
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 14/92 (15%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQ 168
L+L++ L LP+ L SL S N+ + +P + L + S
Sbjct: 76 LELNNLGL-SSLPELPPHL----ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-D 128
Query: 169 IPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
+PP L L V+NN L +P N +
Sbjct: 129 LPPLLEYL------GVSNNQLE-KLPELQNSS 153
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 22/112 (19%), Positives = 46/112 (41%), Gaps = 17/112 (15%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
++N +T + +N L + L L +L++ N + +P + T+L+
Sbjct: 233 LQNLPFLTTIYADNNLL-----KTLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLD--- 283
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
+ N FS + L L + ++N + +L L +V+NN+
Sbjct: 284 VSENIFS-GLSELPPNLYYL---NASSNEIRSLCDLPPSLEEL---NVSNNK 328
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 21/151 (13%), Positives = 39/151 (25%), Gaps = 40/151 (26%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
LN+ +L + P + L S N L +P+ L L +
Sbjct: 320 EELNVSNNKLI------ELPALPPR---LERLIASFNHLAE-VPELPQNL----KQLHVE 365
Query: 138 SNNFSGSIPSNLANCTYLN----------------SLKLDHNRFSGQIPPQLGQLGRLKS 181
N P + L L ++ N + P + L+
Sbjct: 366 YNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDLR- 422
Query: 182 FSVANNLLSGSIPTFVNLT--LSADSVTNNQ 210
+ + + T L D ++
Sbjct: 423 --MNSERVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 14/111 (12%), Positives = 29/111 (26%), Gaps = 23/111 (20%)
Query: 95 QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKL---------------VGFLTSLDLSSN 139
+ P +N L + N L PD + L L + +N
Sbjct: 351 EVPELPQNLKQ---LHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN 406
Query: 140 NFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
P + + L+++ R +L+ ++
Sbjct: 407 PLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 12/71 (16%), Positives = 23/71 (32%), Gaps = 3/71 (4%)
Query: 121 PDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLK 180
P ++S FL S+N + +P N + + PP G+ +
Sbjct: 5 PRNVSNT--FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 181 SFSVANNLLSG 191
+ + L
Sbjct: 62 VSRLRDCLDRQ 72
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 9/92 (9%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
L IIHR+I + I++ +DF K+ DFG A + TF G + Y A
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFC----GTIEYCA 197
Query: 480 PE-YARTLVATPKGDVYSFGTVLLELVTGERP 510
PE P+ +++S G L LV E P
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 56/323 (17%), Positives = 96/323 (29%), Gaps = 80/323 (24%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVK-----RLQDSQRSEKEFVA-EMATLGSVKNRNLVPL 365
IG G G + A+ + +K +++ + E + E+ + + + N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
++ LV + G L D L+ D +K I N +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 426 PR---------------------------------IIHRNISSKCILL--DDDFEPKISD 450
I HR+I + L + FE K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA--TPKGDVYSFGTVLLELVTGE 508
FGL++ ++ + + G +VAPE T PK D +S G +L L+ G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 509 RP----------TNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFL 558
P + V F+ + LS +D + L +
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENP--NY-NVLSP--LARDLLSNLLN---RN------- 318
Query: 559 KVACNCVLPTIPKERPTMFEVYQ 581
ER Q
Sbjct: 319 -----------VDERFDAMRALQ 330
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 31/144 (21%), Positives = 47/144 (32%), Gaps = 7/144 (4%)
Query: 49 FNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTG 108
+ L+ S N G I ++ + N + G + G
Sbjct: 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET--PSGVCSALAAARVQLQG 232
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQ 168
LDLS N L L SL+LS +P L L+ L L +NR
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR- 288
Query: 169 IPPQLGQLGRLKSFSVANNLLSGS 192
P +L ++ + S+ N S
Sbjct: 289 -NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 22/123 (17%), Positives = 42/123 (34%), Gaps = 10/123 (8%)
Query: 81 RVLNLRLTDMGLKGQFPRGIRNCS--SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSS 138
+LNLR + + ++ + L ++ + ++ L++LDLS
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN-FSCEQVRVFPALSTLDLSD 182
Query: 139 NNFSGSIPSNLANC----TYLNSLKLDHNRF---SGQIPPQLGQLGRLKSFSVANNLLSG 191
N G A C L L L + SG +L+ +++N L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 192 SIP 194
+
Sbjct: 243 AAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 17/120 (14%), Positives = 40/120 (33%), Gaps = 9/120 (7%)
Query: 80 NRVLNLRLTDMGLKGQFPRGIRNCS--SMTGLDLSSNKLYGP---LPDDISKLVGFLTSL 134
+ + L L ++ + G P + + + L+L + L + L L L
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIP----PQLGQLGRLKSFSVANNLLS 190
++ + + L++L L N G+ + L+ ++ N +
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 45/231 (19%)
Query: 302 KATNSFSKNNIIGSGRTGTMYKA-LLEDGTSLMVKR-LQDSQRSEKEFVAEMATLGSVKN 359
K + F + G G GT+ G S+ +K+ +QD + +E + M L + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHH 78
Query: 360 RNLVPLLGFCMAKKER-------LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI- 411
N+V L + ER +V +++P+ +L+ + P +K+ +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFLF 136
Query: 412 GAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNG 470
R LH + HR+I +L++ D K+ DFG A+ ++P + +++
Sbjct: 137 QLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA----- 190
Query: 471 EFGDLGYV------APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
Y+ APE Y T D++S G + E++ GE
Sbjct: 191 ------YICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 44/223 (19%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-----EMATLGSVK 358
+ ++G G G + K + G + +K+ +S + + V E+ L ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLR 82
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
+ NLV LL C KK LV++ + + +L + +D+ K G
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 419 WLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PID--THL-STFVNGEF 472
+ H + IIHR+I K IL+ K+ DFG AR + P + +T
Sbjct: 139 FCHSH---NIIHRDI--KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT------ 187
Query: 473 GDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
Y APE Y DV++ G ++ E+ GE
Sbjct: 188 --RWYRAPELLVGDVKY------GKAVDVWAIGCLVTEMFMGE 222
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 41/307 (13%)
Query: 261 RKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNI---IGSGR 317
R+ D D +G T + +F+ +K + +I +G+G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 318 TGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-EMATLGSVKNRNLVPLLGFCMAKKER 375
G +++ G + K + S+KE V E+ T+ +++ LV L E
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229
Query: 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR----GFAWLHHNCNPRIIHR 431
+++Y+ M G L++ + AD+ K + A+ R G +H N +H
Sbjct: 230 VMIYEFMSGGELFEKV--ADEHNKMSE-----DEAVEYMRQVCKGLCHMHEN---NYVHL 279
Query: 432 NISSKCILLDDDFEP--KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
++ + I+ K+ DFGL ++P V G + APE A
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDP-----KQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 490 PKGDVYSFGTVLLELVTGERP----------TNVAKAPETFKGNLVEWIAQLSSTGQLQD 539
D++S G + L++G P NV + + + +S G +D
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS--AF-SGISEDG--KD 389
Query: 540 AIDKCLV 546
I K L+
Sbjct: 390 FIRKLLL 396
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 9e-10
Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-----EMATLGSVK 358
+ K IG G G ++K + G + +K+ +S+ + + E+ L +K
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLK 60
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
+ NLV LL K+ LV+++ + +LH D + V I +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 419 WLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PID--THL-STFVNGEF 472
+ H + IHR++ K IL+ K+ DFG ARL+ P D +T
Sbjct: 117 FCHKH---NCIHRDV--KPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT------ 165
Query: 473 GDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
Y +PE Y P DV++ G V EL++G
Sbjct: 166 --RWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 63/287 (21%), Positives = 110/287 (38%), Gaps = 62/287 (21%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-------EMATLGSVKNR--NL 362
+GSG G++Y + + D + +K ++ + S+ + E+ L V + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 363 VPLLGFCMAKKERLLVYKH-MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW-- 419
+ LL + +L+ + P L+D + R + AR F W
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFIT------------ERGALQEELARSFFWQV 158
Query: 420 ---LHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
+ H N ++HR+I + IL+D + E K+ DFG L+ DT + F G
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFD----GTR 212
Query: 476 GYVAPEY-ARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534
Y PE+ V+S G +L ++V G+ P + E +G + + Q S+
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQV--FFRQRVSS 268
Query: 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
Q I CL + P +RPT E+
Sbjct: 269 E-CQHLIRWCLA---LR------------------PSDRPTFEEIQN 293
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 9/102 (8%)
Query: 102 NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161
+C + D S +P ++ + SLDLS N + +L C L L L
Sbjct: 3 SCDASGVCDGRSRSFTS-IPSGLTA---AMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 162 HNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+R + I LG L+ +++N LS S+ F L+
Sbjct: 59 SSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLS 98
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 24/197 (12%), Positives = 60/197 (30%), Gaps = 13/197 (6%)
Query: 12 RSLVGVSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTG 71
S+ + + + +K + S+N +I + +
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255
Query: 72 VECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFL 131
VE N + + ++ + + + ++ L + L+ L S L +
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYLFYDLSTVYSLLEK-V 312
Query: 132 TSLDLSSNNFSGSIPSN-LANCTYLNSLKLDHNRFSGQIPPQ---LGQLGRLKSFSVANN 187
+ + ++ +P + + L L L N + G L++ ++ N
Sbjct: 313 KRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 188 LLSGSIP----TFVNLT 200
L S+ + L
Sbjct: 372 HLR-SMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 27/108 (25%), Positives = 45/108 (41%), Gaps = 6/108 (5%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYL 155
+R C+++ L L S+++ + D +G L LDLS N+ S S+ S+ + L
Sbjct: 43 HGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSL 100
Query: 156 NSLKLDHNRFSG-QIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L L N + + L L++ + N I F LT
Sbjct: 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 19/108 (17%), Positives = 34/108 (31%), Gaps = 3/108 (2%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYG-PLPDDISKLVGFLTSLDLSSNNFSG 143
L L+D L SS+ L+L N + L L +L + +
Sbjct: 79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLRIGNVETFS 137
Query: 144 SIPSN-LANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
I A T LN L++ L + + ++ + +
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 31/126 (24%), Positives = 45/126 (35%), Gaps = 14/126 (11%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLY--GPLPDDISKLVGFLTSLD 135
L+L + + LK +G S+ L LS N L + + L LTSLD
Sbjct: 337 EFLDLSENLMVEEYLKNSACKG--AWPSLQTLVLSQNHLRSMQKTGEILLTLKN-LTSLD 393
Query: 136 LSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195
+S N F +P + + L L + L+ V+NN L S
Sbjct: 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSL 448
Query: 196 F-VNLT 200
F L
Sbjct: 449 FLPRLQ 454
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 14/114 (12%), Positives = 42/114 (36%), Gaps = 7/114 (6%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
+ LNL +G+ F N +++ L + + + + + + L L++
Sbjct: 101 KYLNLMGNPYQTLGVTSLF----PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 138 SNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG 191
+ + +L + ++ L L + + + L ++ + + L+
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 18/165 (10%), Positives = 47/165 (28%), Gaps = 13/165 (7%)
Query: 38 LKSIKDSLEDPFNYLNSSWNFNNDTEGF----ICKFTGVECWHPDENRVLNLRLTDMGLK 93
+ + D + + + + F + R L
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 94 GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF-------LTSLDLSSNNFSGSIP 146
+ R I S + D + N L P + + + L + +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 147 SNLANCTYLNSLKLDHNRFSGQIPPQLGQ-LGRLKSFSVANNLLS 190
+ + + + +++++ +P Q L L+ ++ NL+
Sbjct: 304 TVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 13/64 (20%), Positives = 20/64 (31%), Gaps = 7/64 (10%)
Query: 104 SSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161
+ L +S NKL + F L + +S N T L + L
Sbjct: 451 PRLQELYISRNKL-----KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 162 HNRF 165
N +
Sbjct: 506 TNPW 509
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 13/104 (12%)
Query: 414 ARGFAW-----LHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTF 467
+R F + H + ++HR+I + IL+D K+ DFG L++ D + F
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDF 198
Query: 468 VNGEFGDLGYVAPEY-ARTLVATPKGDVYSFGTVLLELVTGERP 510
G Y PE+ +R V+S G +L ++V G+ P
Sbjct: 199 D----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 34/194 (17%), Positives = 63/194 (32%), Gaps = 14/194 (7%)
Query: 11 SRSLVGVSVCLLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDT-----EGF 65
S + + C L + E +C + + E+ + L +
Sbjct: 345 SATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET 404
Query: 66 ICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDIS 125
+ F+ ++ D R L + + + L L+ L + +
Sbjct: 405 LQYFSTLKAV--DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLE 460
Query: 126 KLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVA 185
+L+ +T LDLS N ++P LA L L+ N + + L RL+ +
Sbjct: 461 QLL-LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLC 516
Query: 186 NNLLSGSIPTFVNL 199
NN L L
Sbjct: 517 NNRLQ-QSAAIQPL 529
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 38/115 (33%), Positives = 53/115 (46%), Gaps = 13/115 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
GI+ ++T L L+ NKL DI L L L L N + S+L + L
Sbjct: 60 GIQYLPNVTKLFLNGNKL-----TDIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLK 112
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
SL L+HN S I L L +L+S + NN ++ I LT L S+ +NQ
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQ 164
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+++ + L L N + DI+ LV L SL L +N + I + L+ T L+
Sbjct: 104 SLKDLKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLD 156
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
+L L+ N+ S I P L L +L++ ++ N +S + L
Sbjct: 157 TLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLK 197
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 9e-07
Identities = 13/104 (12%), Positives = 33/104 (31%), Gaps = 12/104 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+ +L + D + + ++++ S+ + +
Sbjct: 16 PDDAFAETIKDNLKKKSV-----TDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVT 68
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L L+ N+ + I P L L L + N + + + +L
Sbjct: 69 KLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSSLKDLK 109
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 17/88 (19%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLD 135
L+L +++D+ + + + L LS N + D+ L G L L+
Sbjct: 156 DTLSLEDNQISDI-------VPLAGLTKLQNLYLSKNHI-----SDLRALAGLKNLDVLE 203
Query: 136 LSSNNFSGSIPSNLANCTYLNSLKLDHN 163
L S ++ +N N++K
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDG 231
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 13/115 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+ S++ L L N++ +IS L G L L + + S + + LAN + L
Sbjct: 124 PLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLT 176
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
+LK D N+ S I P L L L + NN +S + N + L ++TN
Sbjct: 177 TLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 28/115 (24%), Positives = 53/115 (46%), Gaps = 13/115 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
G++ +++ GL+L N++ D++ L +T L+LS N ++ S +A +
Sbjct: 58 GVQYLNNLIGLELKDNQI-----TDLAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIK 110
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
+L L + + P L L L+ + N ++ +I LT L S+ N Q
Sbjct: 111 TLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQ 162
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 23/115 (20%), Positives = 46/115 (40%), Gaps = 11/115 (9%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+ +++ L + + ++ D++ L LT+L N S I S LA+ L
Sbjct: 146 PLAGLTNLQYLSIGNAQV-----SDLTPLANLSKLTTLKADDNKIS-DI-SPLASLPNLI 198
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQG 211
+ L +N+ S + P L L ++ N ++ + N + + V G
Sbjct: 199 EVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 16/115 (13%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
++ + + + D +T+L + +I + L
Sbjct: 14 PDPALANAIKIAAGKSNV-----TDTVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLI 66
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
L+L N+ + + P L L ++ ++ N L ++ L + +T+ Q
Sbjct: 67 GLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQ 118
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 63/304 (20%), Positives = 101/304 (33%), Gaps = 88/304 (28%)
Query: 311 NIIGSGRTGTMYKAL-LEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNLVPLL 366
+GSG G + +K + S S + + E+A L + + N++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 367 GFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIG------AAR----- 415
F K+ LV + G L+D + I AA
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEI-----------------IHRMKFNEVDAAVIIKQV 145
Query: 416 --GFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNG 470
G +LH + I+HR++ + +LL + D KI DFGL+ + + +
Sbjct: 146 LSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-QKKMKERL-- 199
Query: 471 EFGDLGYVAPE-----YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETF----K 521
G Y+APE Y K DV+S G +L L+ G P E K
Sbjct: 200 --GTAYYIAPEVLRKKY------DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251
Query: 522 GNL----VEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMF 577
G EW +S +D I + L D + R +
Sbjct: 252 GKYTFDSPEW-KNVSE--GAKDLIKQMLQ---FD------------------SQRRISAQ 287
Query: 578 EVYQ 581
+ +
Sbjct: 288 QALE 291
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 46/230 (20%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE-----FVA--EMATLGS 356
+ + K IG G G ++KA + G + +K++ E E A E+ L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQL 72
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLY--------DLLHPADDTGKSVDWPRRLK 408
+K+ N+V L+ C K K GS+Y DL + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCK----GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 409 IAIGAARGFAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PIDTHLS 465
+ G ++H N +I+HR++ K +L+ D K++DFGLAR + ++ +
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDM--KAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 466 TFVNGEFGDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
+ N L Y PE Y P D++ G ++ E+ T
Sbjct: 184 RYTN-RVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
+ H + +I+HR++ + +LLDD+ KI+DFGL+ +M L T G
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSC----GSP 171
Query: 476 GYVAPE-YARTLVATPKGDVYSFGTVLLELVTGERP 510
Y APE L A P+ DV+S G VL ++ G P
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 28/262 (10%)
Query: 259 SMRKKKDDDPEGNKWAKSLTGTKGIKVSLFEKSITKMRLSDLMKATNSFSKNNIIGSGRT 318
S + P +K +L + F+ I + + + + SK I+G GR
Sbjct: 44 SNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAV-NSFYTVSKTEILGGGRF 102
Query: 319 GTMYKAL-LEDGTSLMVKRLQDSQRSEKEFV-AEMATLGSVKNRNLVPLLGFCMAKKERL 376
G ++K G L K ++ +KE V E++ + + + NL+ L +K + +
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162
Query: 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--KIAIGAAR----GFAWLHHNCNPRIIH 430
LV +++ G L+D + +D L I + G +H I+H
Sbjct: 163 LVMEYVDGGELFDRI---------IDESYNLTELDTILFMKQICEGIRHMHQM---YILH 210
Query: 431 RNISSKCILLDDDFEP--KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA 488
++ + IL + KI DFGLAR P L FG ++APE
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVN----FGTPEFLAPEVVNYDFV 265
Query: 489 TPKGDVYSFGTVLLELVTGERP 510
+ D++S G + L++G P
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSP 287
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 49/208 (23%), Positives = 81/208 (38%), Gaps = 19/208 (9%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKN-RNLVPLLGF 368
IG G G++ K + G + VK R ++ +K+ + ++ + + +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPA-DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
+ + + + M + S + KI + + L N
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 428 IIHRNISSKCILLDDDFEPKISDFGL-ARLMNPIDTHLSTFVNGEFGDLGYVAPE----Y 482
IIHR+I ILLD K+ DFG+ +L++ I + G Y+APE
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDA----GCRPYMAPERIDPS 200
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERP 510
A + DV+S G L EL TG P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 6e-09
Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
+ H + ++HR++ + +LLD KI+DFGL+ +M+ L T G
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC----GSP 174
Query: 476 GYVAPE-YARTLVATPKGDVYSFGTVLLELVTGERP 510
Y APE + L A P+ D++S G +L L+ G P
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 67/322 (20%), Positives = 107/322 (33%), Gaps = 97/322 (30%)
Query: 300 LMKATNSFSKN----NIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA----E 350
+ +T FS ++G G G + G VK + Q +K E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 351 MATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIA 410
+ L + + N++ L F K LV + G L+D + I+
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----------------IS 119
Query: 411 IG------AAR-------GFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLA 454
AAR G ++H N +I+HR++ + +LL D +I DFGL+
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 455 RLMNPIDTHLSTFVNGEFGDLGYVAPE-----YARTLVATPKGDVYSFGTVLLELVTGER 509
+ + G Y+APE Y K DV+S G +L L++G
Sbjct: 177 THFEA-SKKMKDKI----GTAYYIAPEVLHGTY------DEKCDVWSTGVILYILLSGCP 225
Query: 510 P----------TNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLK 559
P V K TF+ +W ++S +D I K L
Sbjct: 226 PFNGANEYDILKKVEKGKYTFELP--QW-KKVSE--SAKDLIRKMLT---YV-------- 269
Query: 560 VACNCVLPTIPKERPTMFEVYQ 581
P R + +
Sbjct: 270 ----------PSMRISARDALD 281
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 45/223 (20%)
Query: 313 IGSGRTGTMYKA---LLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC 369
+G G G +YKA +D +K+++ + S E+A L +K+ N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-SACREIALLRELKHPNVISLQKVF 87
Query: 370 MAKKERL--LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA--------RGFAW 419
++ +R L++ + +DL H S + +++ G G +
Sbjct: 88 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 420 LHHNCNPRIIHRNISSKC--ILLDDDFEP----KISDFGLARLMN-PIDTHLSTFVNGEF 472
LH N ++HR++ K IL+ + KI+D G ARL N P+ ++
Sbjct: 144 LHAN---WVLHRDL--KPANILVMGEGPERGRVKIADMGFARLFNSPLKPL--ADLDPVV 196
Query: 473 GDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
Y APE Y T D+++ G + EL+T E
Sbjct: 197 VTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 41/174 (23%), Positives = 63/174 (36%), Gaps = 49/174 (28%)
Query: 422 HNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
H N I+HR+I + ILL + KI DFGL+ + D L + G Y+
Sbjct: 163 HKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRDRL----GTAYYI 215
Query: 479 APE-----YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533
APE Y K DV+S G ++ L+ G P F G +
Sbjct: 216 APEVLKKKY------NEKCDVWSCGVIMYILLCGYPP---------FGGQ---------N 251
Query: 534 TGQLQDAIDKCLVA------KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+ ++K K + +E + +K +L +R T E
Sbjct: 252 DQDIIKKVEKGKYYFDFNDWKNISDEAKELIK----LMLTYDYNKRCTAEEALN 301
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 31/180 (17%), Positives = 62/180 (34%), Gaps = 23/180 (12%)
Query: 29 YGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNL--- 85
Y K K I +L Y ++ + D + + G E + +++
Sbjct: 1 YNVKPRQPEYKCIDSNL----QYDCVFYDVHIDMQTQD-VYFGFEDITLNNQKIVTFKNS 55
Query: 86 RLTDMGLKGQFPRGI-RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
+ + P + + + L+L+ ++ + + L + N
Sbjct: 56 TMR------KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-Y 107
Query: 145 IPSN-LANCTYLNSLKLDHNRFSGQIPPQL-GQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+P + N L L L+ N S +P + +L + S++NN L I TF T
Sbjct: 108 LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 165
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 23/116 (19%), Positives = 43/116 (37%), Gaps = 6/116 (5%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160
+ L +S+N+L L + L LDLS N+ + N L +L L
Sbjct: 269 VKMQRLERLYISNNRLVA-LNLYGQPI-PTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEP 216
DHN + LK+ ++++N + + ++ +V + C
Sbjct: 326 DHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 11/95 (11%)
Query: 103 CSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
+T L L N L D + L+ + L +DLS N I + L L
Sbjct: 225 NVELTILKLQHNNL-----TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLY 278
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194
+ +NR + + LK +++N L +
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 7/101 (6%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
+N +T L L N L LP I LT+L +S+NN I + T L +L+
Sbjct: 114 QNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQ 171
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L NR + + + L +V+ NLLS ++ + +
Sbjct: 172 LSSNRLT-HVDL--SLIPSLFHANVSYNLLS-TLAIPIAVE 208
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 32/141 (22%), Positives = 48/141 (34%), Gaps = 33/141 (23%)
Query: 81 RVLNL---RLTDMGLKGQFPRGI-RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDL 136
VL L L+ PRGI N +T L +S+N L + DD + L +L L
Sbjct: 120 TVLVLERNDLS------SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQL 172
Query: 137 SSNNFSGSIP-----------------SNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRL 179
SSN + + S LA + L HN + + L
Sbjct: 173 SSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVEL 228
Query: 180 KSFSVANNLLSGSIPTFVNLT 200
+ +N L+ +N
Sbjct: 229 TILKLQHNNLT-DTAWLLNYP 248
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 21/99 (21%), Positives = 36/99 (36%), Gaps = 14/99 (14%)
Query: 104 SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHN 163
S+ ++S N L ++ + + LD S N+ + + + L LKL HN
Sbjct: 186 PSLFHANVSYNLL-----STLAIPI-AVEELDASHNSIN-VVRGPV--NVELTILKLQHN 236
Query: 164 RFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+ L L ++ N L I FV +
Sbjct: 237 NLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQ 272
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 18/108 (16%), Positives = 33/108 (30%), Gaps = 6/108 (5%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYL 155
+ LD + L + + L LD+S + + + L
Sbjct: 94 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSL 152
Query: 156 NSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
LK+ N F P +L L ++ L + F +L+
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 199
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 32/152 (21%), Positives = 45/152 (29%), Gaps = 26/152 (17%)
Query: 67 CKFTGVECWH----------PDENRVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSS 113
C T + C P L L +L + G F + +T L LSS
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLP-HGVF----DKLTQLTKLSLSS 61
Query: 114 NKLY-GPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQ 172
N L L LDLS N ++ SN L L H+ Q+
Sbjct: 62 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 119
Query: 173 --LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L L +++ F L+
Sbjct: 120 SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 150
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 23/107 (21%), Positives = 36/107 (33%), Gaps = 7/107 (6%)
Query: 85 LRLTDMGLKGQFPRGI-RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L++ + F I ++T LDLS +L L + L L++S NNF
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFF- 212
Query: 144 SIPSN-LANCTYLNSLKLDHNRFSGQIPPQL--GQLGRLKSFSVANN 187
S+ + L L N Q L ++ N
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 22/208 (10%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVK--RLQDSQRSEKEFVAEMATLGSVKN-RNLVPLLGF 368
+GSG G ++K + G + VK R ++ K + ++ + + +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428
+ + + + M + + K+ + + +L +
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEKHG--V 146
Query: 429 IHRNISSKCILLDDDFEPKISDFGL-ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV 487
IHR++ ILLD+ + K+ DFG+ RL++ G Y+APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSA----GCAAYMAPERIDPPD 200
Query: 488 ATPKG-----DVYSFGTVLLELVTGERP 510
T DV+S G L+EL TG+ P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 9e-09
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 45/223 (20%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMV--KRLQDSQRSEKE-----FVA--EMATLG 355
+ K +G G G +YKA +D +V KR+ R + E A E++ L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKA--KDSQGRIVALKRI----RLDAEDEGIPSTAIREISLLK 74
Query: 356 SVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR 415
+ + N+V L+ +++ LV++ M DL D+ + + R
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 416 GFAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEF 472
G A H + RI+HR++ K +L++ D K++DFGLAR P+ ++ V
Sbjct: 131 GVAHCHQH---RILHRDL--KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT--- 182
Query: 473 GDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
L Y AP+ Y + D++S G + E++TG+
Sbjct: 183 --LWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 11/109 (10%)
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEP--KISDFGLARLMNPIDTHLSTFVNGEFG 473
G ++ H +I HR++ + LLD P KI DFG ++ + + V G
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV----G 179
Query: 474 DLGYVAPE-YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521
Y+APE R DV+S G L ++ G P + P ++
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 38/115 (33%), Positives = 53/115 (46%), Gaps = 13/115 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
GI+ ++T L L+ NKL DI L L L L N + S+L + L
Sbjct: 63 GIQYLPNVTKLFLNGNKL-----TDIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLK 115
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
SL L+HN S I L L +L+S + NN ++ I LT L S+ +NQ
Sbjct: 116 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQ 167
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 29/115 (25%), Positives = 53/115 (46%), Gaps = 13/115 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+++ + L L N + DI+ LV L SL L +N + I + L+ T L+
Sbjct: 107 SLKDLKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLD 159
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
+L L+ N+ S I P L L +L++ ++ N +S + L L + + +
Sbjct: 160 TLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQE 211
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 16/115 (13%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+ +L + D + + ++++ S+ + +
Sbjct: 19 SDDAFAETIKDNLKKKSV-----TDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVT 71
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
L L+ N+ + I P L L L + N + + + +L L + S+ +N
Sbjct: 72 KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNG 123
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 21/115 (18%), Positives = 41/115 (35%), Gaps = 19/115 (16%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLD 135
L+L +++D+ + + + L LS N + D+ L G L L+
Sbjct: 159 DTLSLEDNQISDI-------VPLAGLTKLQNLYLSKNHI-----SDLRALAGLKNLDVLE 206
Query: 136 LSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
L S ++ +N N++K P + G + +V +L
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 35/94 (37%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI--DTHLSTFVNGEFGDLGY 477
LH I HR+I + +LLD+ KISDFGLA + + L+ G L Y
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPY 173
Query: 478 VAPE-YARTLVATPKGDVYSFGTVLLELVTGERP 510
VAPE R DV+S G VL ++ GE P
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G + H + ++HR++ + +LLD KI+DFGL+ +M+ L T G
Sbjct: 128 GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC----GSP 179
Query: 476 GYVAPE-YARTLVATPKGDVYSFGTVLLELVTGERP 510
Y APE + L A P+ D++S G +L L+ G P
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 307 FSKNNIIGSGRTGTMYKALLEDGTSLMV--KRLQDSQRSEKEFVA-----EMATLGSVKN 359
+ IG G G +YKA ++ K+++ E E + E++ L +K+
Sbjct: 4 YHGLEKIGEGTYGVVYKA--QNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
N+V L KK +LV++H+ DL D ++ + G A+
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 420 LHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFGDLG 476
H R++HR++ K +L++ + E KI+DFGLAR P+ + V L
Sbjct: 116 CHDR---RVLHRDL--KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT-----LW 165
Query: 477 YVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
Y AP+ Y + D++S G + E+V G
Sbjct: 166 YRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 48/231 (20%)
Query: 301 MKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE----FVA--EMAT 353
M +++ F + +G+G T+YK L G + +K + + + E A E++
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISL 56
Query: 354 LGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGA 413
+ +K+ N+V L + + LV++ M N L + D+ + PR L++ +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM----DSRTVGNTPRGLELNLVK 111
Query: 414 A------RGFAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PIDTHL 464
+G A+ H N +I+HR++ K +L++ + K+ DFGLAR P++T
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDL--KPQNLLINKRGQLKLGDFGLARAFGIPVNTFS 166
Query: 465 STFVNGEFGDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
S V L Y AP+ Y + D++S G +L E++TG+
Sbjct: 167 SEVVT-----LWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 42/222 (18%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-----EMATLGSVKNR 360
+ K IG G GT++KA E + +KR++ + E V E+ L +K++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHK 61
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
N+V L + K+ LV++ DL D +D +G +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 421 HHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PID--THLSTFVNGEFGDL 475
H ++HR++ K +L++ + E K+++FGLAR P+ + E L
Sbjct: 118 HSR---NVLHRDL--KPQNLLINRNGELKLANFGLARAFGIPVRCYSA-------EVVTL 165
Query: 476 GYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGERP 510
Y P+ Y + D++S G + EL RP
Sbjct: 166 WYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP 201
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 35/94 (37%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI--DTHLSTFVNGEFGDLGY 477
LH I HR+I + +LLD+ KISDFGLA + + L+ G L Y
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPY 173
Query: 478 VAPE-YARTLVATPKGDVYSFGTVLLELVTGERP 510
VAPE R DV+S G VL ++ GE P
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 42/178 (23%), Positives = 62/178 (34%), Gaps = 57/178 (32%)
Query: 422 HNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
H N I+HR++ + ILL + D + KI DFGL+ +T + + G Y+
Sbjct: 138 HKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI----GTAYYI 190
Query: 479 APE-----YARTLVATPKGDVYSFGTVLLELVTGERP----------TNVAKAPETFKGN 523
APE Y K DV+S G +L L++G P V F
Sbjct: 191 APEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244
Query: 524 LVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+W +S +D I K L P R T + +
Sbjct: 245 --QW-RTISD--DAKDLIRKMLT---FH------------------PSLRITATQCLE 276
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 23/114 (20%), Positives = 45/114 (39%), Gaps = 12/114 (10%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
++ +L + D+ + + + ++N S+ + + T L
Sbjct: 14 PDPGLANAVKQNLGKQSV-----TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLK 66
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210
L L HN+ S + P L L +L+ SV N L ++ + LS + NN+
Sbjct: 67 ELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNE 117
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 24/115 (20%), Positives = 45/115 (39%), Gaps = 14/115 (12%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+ S + + ++ + ++ + F L L LS N S + S L + T L
Sbjct: 36 SQKELSGVQNFNGDNSNI-----QSLAGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLE 88
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
L ++ NR + + L + NN L + ++L L S+ NN+
Sbjct: 89 ELSVNRNRLK-NLNG-IPSA-CLSRLFLDNNELR-DTDSLIHLKNLEILSIRNNK 139
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 18/120 (15%), Positives = 36/120 (30%), Gaps = 21/120 (17%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLN 156
+ + ++ L + +NKL I L L LDL N + + L +N
Sbjct: 123 SLIHLKNLEILSIRNNKL-----KSIVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVN 175
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNL--LSGSI--PTFV--NLTLSADSVTNNQ 210
+ L + + + + N + G P ++ + V
Sbjct: 176 WIDLTGQKCVNE------PVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 9/80 (11%), Positives = 28/80 (35%), Gaps = 7/80 (8%)
Query: 123 DISKLVGF--LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLK 180
+ G +L + + + + + + + D++ + + LK
Sbjct: 11 QVFPDPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLK 66
Query: 181 SFSVANNLLSGSIPTFVNLT 200
+++N +S + +LT
Sbjct: 67 ELHLSHNQIS-DLSPLKDLT 85
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 23/117 (19%), Positives = 43/117 (36%), Gaps = 6/117 (5%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160
+ L +S+N+L L + L LDLS N+ + N L +L L
Sbjct: 275 VKMQRLERLYISNNRLVA-LNLYGQPIPT-LKVLDLSHNHLL-HVERNQPQFDRLENLYL 331
Query: 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPL 217
DHN + LK+ ++++N + + ++ +V + C
Sbjct: 332 DHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDY 385
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 11/95 (11%)
Query: 103 CSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
+T L L N L D + L+ + L +DLS N I + L L
Sbjct: 231 NVELTILKLQHNNL-----TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLY 284
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194
+ +NR + + LK +++N L +
Sbjct: 285 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 317
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 20/122 (16%), Positives = 41/122 (33%), Gaps = 8/122 (6%)
Query: 83 LNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFS 142
++ + F ++ + ++ + LP + + L+L+
Sbjct: 30 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE 88
Query: 143 GSIPSN-LANCTYLNSLKLDHNRFSGQIPPQLGQ-LGRLKSFSVANNLLSGSIP--TFVN 198
I + A + L + N +PP + Q + L + N LS S+P F N
Sbjct: 89 -EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
Query: 199 LT 200
Sbjct: 146 TP 147
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 32/141 (22%), Positives = 48/141 (34%), Gaps = 33/141 (23%)
Query: 81 RVLNL---RLTDMGLKGQFPRGI-RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDL 136
VL L L+ PRGI N +T L +S+N L + DD + L +L L
Sbjct: 126 TVLVLERNDLS------SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQL 178
Query: 137 SSNNFSGSIP-----------------SNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRL 179
SSN + + S LA + L HN + + L
Sbjct: 179 SSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVEL 234
Query: 180 KSFSVANNLLSGSIPTFVNLT 200
+ +N L+ +N
Sbjct: 235 TILKLQHNNLT-DTAWLLNYP 254
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 27/127 (21%), Positives = 42/127 (33%), Gaps = 13/127 (10%)
Query: 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSS 138
+ R+ R L Q P+ + ++ L LS N + L L L+L S
Sbjct: 5 DGRIAFYR--FCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQ-LQLLELGS 57
Query: 139 NNFSGSIPSN-LANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP-- 194
+I N L L L ++ + P L L + LS ++
Sbjct: 58 QYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKD 116
Query: 195 -TFVNLT 200
F NL
Sbjct: 117 GYFRNLK 123
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 18/105 (17%), Positives = 34/105 (32%), Gaps = 6/105 (5%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
+ L+L S + + + + L LDL S+ + + +L L+
Sbjct: 45 PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELR 103
Query: 160 LDHNRFSGQIPPQ--LGQLGRLKSFSVANNLLS--GSIPTFVNLT 200
L S + L L ++ N + P+F L
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLN 148
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 33/129 (25%), Positives = 48/129 (37%), Gaps = 8/129 (6%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSI--PSNLANCTY 154
RN ++ LDL S+K+Y PD L L L L S ++ N
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFH-LFELRLYFCGLSDAVLKDGYFRNLKA 124
Query: 155 LNSLKLDHNRFSG-QIPPQLGQLGRLKSFSVANNLLS----GSIPTFVNLTLSADSVTNN 209
L L L N+ + P G+L LKS ++N + + TLS S+ N
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184
Query: 210 QGLCGEPLD 218
+D
Sbjct: 185 SLYSRVSVD 193
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 23/116 (19%), Positives = 40/116 (34%), Gaps = 5/116 (4%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL-----ANCTY 154
+ + L L+ N+ D L L L N + + L ++
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 155 LNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210
L L L+HN + P L L+ S+ +N L+ + L ++ NQ
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 33/191 (17%), Positives = 66/191 (34%), Gaps = 14/191 (7%)
Query: 36 ACLKSIKDSLEDPFNYLNS----SWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMG 91
+I S + + F+N + F G+ + V +L L+
Sbjct: 223 NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA-----RSSVRHLDLSHGF 277
Query: 92 LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151
+ R + L+L+ NK+ + D+ + L L+LS N SN
Sbjct: 278 VFSLNSRVFETLKDLKVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336
Query: 152 CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS--GSIPTFVNLTLSADSVTN- 208
+ + L N + L +L++ + +N L+ IP+ ++ LS + +
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTL 396
Query: 209 -NQGLCGEPLD 218
L +
Sbjct: 397 PKINLTANLIH 407
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 33/144 (22%), Positives = 50/144 (34%), Gaps = 16/144 (11%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYG-PLPDDISKLVGFLTSLDL 136
L L L+D LK + RN ++T LDLS N++ L KL L S+D
Sbjct: 100 FELRLYFCGLSDAVLKDGY---FRNLKALTRLDLSKNQIRSLYLHPSFGKLNS-LKSIDF 155
Query: 137 SSNNFSGSIPSNLANCT--YLNSLKLDHNRFSGQIPPQLGQLG------RLKSFSVANNL 188
SSN L L+ L N ++ G+ L+ V+ N
Sbjct: 156 SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNG 215
Query: 189 LSGSIPTFVNLTLSADSVTNNQGL 212
+ I + +S +
Sbjct: 216 WTVDITGNFSNAISKSQAFSLILA 239
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 33/204 (16%), Positives = 55/204 (26%), Gaps = 25/204 (12%)
Query: 74 CWHPDENRVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF 130
L L L S + L L+ N L LP + +
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS-LPPGVFSHLTA 505
Query: 131 LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
L L L+SN + + N L L + N+ P L + +N
Sbjct: 506 LRGLSLNSNRLT-VLSHN-DLPANLEILDISRNQLL-APNPD--VFVSLSVLDITHNKFI 560
Query: 191 GSIP--TFVNLTLSADSVT--NNQGLCGEPLDACKGTS------------KGPHTGVIAG 234
TF+N + + D+ G S + + +
Sbjct: 561 CECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSL 620
Query: 235 AAIGGVTFAALVVGIVMFFYFRRM 258
+ VT ++ I+ FR
Sbjct: 621 FIVCTVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 25/101 (24%), Positives = 38/101 (37%), Gaps = 7/101 (6%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG-SIPSNLANCTYLNSL 158
I S+ + LS NKL + K+ + LS N I L +L L
Sbjct: 377 IHFIPSIPDIFLSGNKL-----VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQIL 431
Query: 159 KLDHNRFSGQIPPQL-GQLGRLKSFSVANNLLSGSIPTFVN 198
L+ NRFS Q + L+ + N+L + T +
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC 472
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 21/139 (15%), Positives = 36/139 (25%), Gaps = 22/139 (15%)
Query: 83 LNLRLTDMGLKGQFPRGIRNCS------SMTGLDLSSNKLYGPLPDDISKLVGF------ 130
L L + C + LD+S N + + S +
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236
Query: 131 -----LTSLDLSSNNFSGSIPSNLAN--CTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFS 183
+ +N + A + + L L H L LK +
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 184 VANNLLSGSIP--TFVNLT 200
+A N ++ I F L
Sbjct: 297 LAYNKIN-KIADEAFYGLD 314
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 23/102 (22%), Positives = 35/102 (34%), Gaps = 5/102 (4%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
+S+ L+L N L +P + + L L L +N SIPS L L
Sbjct: 120 NGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLD 177
Query: 160 LDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L + I L LK ++ + +P L
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLV 218
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 24/103 (23%), Positives = 39/103 (37%), Gaps = 12/103 (11%)
Query: 103 CSSMTG-LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLKL 160
CS+ + + L +P I L+L NN I ++ + +L L+L
Sbjct: 52 CSNQFSKVVCTRRGLSE-VPQGIPS---NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQL 106
Query: 161 DHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
N QI L L + + +N L+ IP F L+
Sbjct: 107 GRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLS 147
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 24/106 (22%), Positives = 41/106 (38%), Gaps = 14/106 (13%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVG--FLTSLDLSSNNFSGSIPSN-LANCTYLNS 157
++ L+L + D+ L L L++S N+F I + L
Sbjct: 193 EGLFNLKYLNLGMCNI-----KDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKK 246
Query: 158 LKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L + +++ S I L L ++A+N LS S+P F L
Sbjct: 247 LWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLR 290
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKR-LQDSQRSEKEFVAEMATLGSVKNRNL 362
+++ +IG+G G +++A L + + +K+ LQD + +E + + VK+ N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNV 94
Query: 363 VPLLGFCMAKKERL------LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI-GAAR 415
V L F + ++ LV +++P ++Y +++ +K+ + R
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLR 152
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
A++H I HR+I + +LLD K+ DFG A+++ + ++S
Sbjct: 153 SLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS--------- 200
Query: 475 LGYV------APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
Y+ APE Y T D++S G V+ EL+ G+
Sbjct: 201 --YICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI--DTHLSTFVNGEFG 473
G +LH I+H++I +LL KIS G+A ++P D T G
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ----G 173
Query: 474 DLGYVAPEYARTLV--ATPKGDVYSFGTVLLELVTGERP 510
+ PE A L + K D++S G L + TG P
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 24/102 (23%), Positives = 37/102 (36%), Gaps = 5/102 (4%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYLNSLK 159
+++ L+L N+L +P+ + L L L +N SIPS L L
Sbjct: 109 NGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166
Query: 160 LDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIPTFVNLT 200
L + I L L+ ++A L IP L
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLI 207
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 10/104 (9%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
S++ L+L+ L +P+ ++ L+ L LDLS N+ S +I +L L
Sbjct: 182 EGLSNLRYLNLAMCNLRE-IPN-LTPLIK-LDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 160 LDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+ ++ I L L ++A+N L+ +P F L
Sbjct: 238 MIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLH 279
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 26/103 (25%), Positives = 40/103 (38%), Gaps = 12/103 (11%)
Query: 103 CSS-MTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLKL 160
CS+ + + L +PD IS L+L N I N + +L L+L
Sbjct: 41 CSNQFSKVICVRKNLRE-VPDGIST---NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQL 95
Query: 161 DHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
N I L L + + +N L+ +IP FV L+
Sbjct: 96 SRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLS 136
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMV--KRLQDSQRSEKE----FVA--EMATLGS 356
++ K + +G G T+YK + T +V K + R E E A E++ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKL-TDNLVALKEI----RLEHEEGAPCTAIREVSLLKD 56
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+K+ N+V L +K LV++++ DL DD G ++ RG
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 417 FAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PIDTHLSTFVNGEFG 473
A+ H +++HR++ K +L+++ E K++DFGLAR + P T+ + V
Sbjct: 113 LAYCHRQ---KVLHRDL--KPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT---- 163
Query: 474 DLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
L Y P+ Y + + D++ G + E+ TG
Sbjct: 164 -LWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 23/206 (11%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFV-AEMATLGSVKNRNLVPLLGFCM 370
+GSG G +++ + G + K + +K V E++ + + + L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR----GFAWLHHNCNP 426
K E +L+ + + G L+D + D + I R G +H +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAE-------VINYMRQACEGLKHMHEH--- 168
Query: 427 RIIHRNISSKCILL--DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
I+H +I + I+ KI DFGLA +NP V + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-----DEIVKVTTATAEFAAPEIVD 223
Query: 485 TLVATPKGDVYSFGTVLLELVTGERP 510
D+++ G + L++G P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 22/120 (18%), Positives = 48/120 (40%), Gaps = 8/120 (6%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L ++ ++T L ++ L +P + + +L L+LS N S +
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 145 IPSN-LANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
I + L L ++L + + + P L L+ +V+ N L+ ++ F ++
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVG 320
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 22/103 (21%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
+S+ L L L + +S L G L L L N + +I L L+
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHG-LIVLRLRHLNIN-AIRDYSFKRLYRLKVLE 206
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+ H + + P L S S+ + L+ ++P +L
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 8/120 (6%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
L L +K + + L+L+ N + + + L +L L SN
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRLK-L 94
Query: 145 IPSN-LANCTYLNSLKLDHNRFSGQIPPQL-GQLGRLKSFSVANNLLSGSIP--TFVNLT 200
IP + L L + N+ + + L LKS V +N L I F L
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 25/104 (24%), Positives = 43/104 (41%), Gaps = 8/104 (7%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYLNSLK 159
N ++ L L SN+L +P + + LT LD+S N + + + L SL+
Sbjct: 77 NNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLE 134
Query: 160 LDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+ N I + L L+ ++ L+ SIP +L
Sbjct: 135 VGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLH 176
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 23/102 (22%), Positives = 37/102 (36%), Gaps = 10/102 (9%)
Query: 103 CS-SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161
CS + + +P+ I LDL N A+ +L L+L+
Sbjct: 9 CSAQDRAVLCHRKRFVA-VPEGIPT---ETRLLDLGKNRIKTLNQDEFASFPHLEELELN 64
Query: 162 HNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
N S + P L L++ + +N L IP F L+
Sbjct: 65 ENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLS 104
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 47/181 (25%)
Query: 416 GFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
+LH N IIHR++ + +LL ++D KI+DFG ++++ + + T
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLC---- 302
Query: 473 GDLGYVAPEYARTLVA---TPKGDVYSFGTVLLELVTGERPTNVAKAPETF-----KGNL 524
G Y+APE ++ D +S G +L ++G P + + + G
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 525 V----EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVY 580
W A++S D + K LV VD PK R T E
Sbjct: 363 NFIPEVW-AEVSEKA--LDLVKKLLV---VD------------------PKARFTTEEAL 398
Query: 581 Q 581
+
Sbjct: 399 R 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 23/111 (20%), Positives = 42/111 (37%), Gaps = 11/111 (9%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ + +T LD S NK+ D+S+ L L+ +NN + + L L L
Sbjct: 166 VTPQTQLTTLDCSFNKITE---LDVSQNKL-LNRLNCDTNNIT-KLD--LNQNIQLTFLD 218
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210
N+ + +I + L +L F + N L+ + L+
Sbjct: 219 CSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTD 265
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 20/121 (16%), Positives = 47/121 (38%), Gaps = 12/121 (9%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ + + + LD + + D+S+ L L L++ + + +++ T L SL
Sbjct: 293 VTHNTQLYLLDCQAAGI---TELDLSQNPK-LVYLYLNNTELT-ELD--VSHNTKLKSLS 345
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLTLSADSVTNNQGLCGEPL 217
+ +G++ L + A ++P T N +L+ + G P+
Sbjct: 346 CVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPM 402
Query: 218 D 218
+
Sbjct: 403 N 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/123 (21%), Positives = 48/123 (39%), Gaps = 11/123 (8%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158
GI + +T L +SN + D+S+ LT L SN + ++ + T L L
Sbjct: 59 GIEKLTGLTKLICTSNNITTL---DLSQNTN-LTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQGLCGEPLD 218
D N+ + ++ + Q L + A N L+ I N L+ N+ + +
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVSHNTQLTELDCHLNKKITKLDVT 167
Query: 219 ACK 221
Sbjct: 168 PQT 170
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 16/112 (14%), Positives = 39/112 (34%), Gaps = 11/112 (9%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ + + + + L D++ L LD + + + L+ L L
Sbjct: 271 LTHNTQLIYFQAEGCRKIKEL--DVTHNTQ-LYLLDCQAAGIT-ELD--LSQNPKLVYLY 324
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
L++ + ++ + +LKS S N + + + L+ + Q
Sbjct: 325 LNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQ 372
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 21/111 (18%), Positives = 43/111 (38%), Gaps = 10/111 (9%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ +T L+ + N L D+S LT LD N + + T L +L
Sbjct: 123 VSQNPLLTYLNCARNTLT---EIDVSHNTQ-LTELDCHLNKKITKLD--VTPQTQLTTLD 176
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210
N+ + ++ + Q L + N ++ + N+ L+ ++N+
Sbjct: 177 CSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNK 223
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 23/111 (20%), Positives = 35/111 (31%), Gaps = 10/111 (9%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ +T LD SSNKL D++ L LT D S N + + + + L +L
Sbjct: 208 LNQNIQLTFLDCSSNKLTEI---DVTPLTQ-LTYFDCSVNPLT-ELDVS--TLSKLTTLH 260
Query: 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210
+I L +L F + N L
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAG 308
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 50/230 (21%)
Query: 304 TNSFSKNNIIGSGRTGTMYKA-LLEDGTSLMVKR-LQDSQRSEKEFVAEMATLGSVKNRN 361
S++ +IG+G G +Y+A L + G + +K+ LQD + +E + + + + N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 362 LVPLLGFCMAKKERL------LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI-GAA 414
+V L F + E+ LV ++P ++Y + +++ +K+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLF 166
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEP-KISDFGLARLMNPIDTHLSTFVNGEFG 473
R A++H I HR+I + +LLD D K+ DFG A+ + + ++S
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-------- 215
Query: 474 DLGYV------APE-------YARTLVATPKGDVYSFGTVLLELVTGERP 510
Y+ APE Y T DV+S G VL EL+ G +P
Sbjct: 216 ---YICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLG-QP 255
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 19/98 (19%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
L + RIIHR++ ILLD+ I+DF +A ++ +T ++T G Y+A
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMA----GTKPYMA 182
Query: 480 PEYARTLVATPKGDVY-------SFGTVLLELVTGERP 510
PE + ++ KG Y S G EL+ G RP
Sbjct: 183 PE----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 31/212 (14%)
Query: 313 IGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRSEKE--FVAEMATLGSVKNRNLVPLLGFC 369
+GSG G ++ G ++K + + AE+ L S+ + N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKS---VDWPRRLKIAIGAARGFAWLHHNCNP 426
+V + G L + + A GK+ +K + A A+ H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL---AYFHSQ--- 143
Query: 427 RIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE-- 481
++H+++ + IL KI DFGLA L D H + G Y+APE
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAA----GTALYMAPEVF 198
Query: 482 ---YARTLVATPKGDVYSFGTVLLELVTGERP 510
T K D++S G V+ L+TG P
Sbjct: 199 KRDV------TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 35/204 (17%)
Query: 318 TGTMY--KALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375
TG +Y K L + L ++ EK+ L V +R +V L + K
Sbjct: 209 TGKLYACKKLNKK--RLKKRKGYQGAMVEKK------ILAKVHSRFIVSLA-YAFETKTD 259
Query: 376 L-LVYKHMPNGSLYDLLHPADDTGKSVDWPR-RLKIA-IGAARGFAWLHHNCNPRIIHRN 432
L LV M G + ++ D+ PR A I + LH II+R+
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH--LHQR---NIIYRD 314
Query: 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE------YARTL 486
+ + +LLDDD +ISD GLA + T + G G++APE Y ++
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA----GTPGFMAPELLLGEEYDFSV 370
Query: 487 VATPKGDVYSFGTVLLELVTGERP 510
D ++ G L E++ P
Sbjct: 371 ------DYFALGVTLYEMIAARGP 388
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 29/104 (27%), Positives = 43/104 (41%), Gaps = 7/104 (6%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
R C ++T L L SN L + L L LDLS N S+ L++L
Sbjct: 53 RACRNLTILWLHSNVLARIDAAAFTGLAL-LEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111
Query: 160 LDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
LD ++ P L L+ + +N L ++P TF +L
Sbjct: 112 LDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG 153
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 22/105 (20%), Positives = 35/105 (33%), Gaps = 10/105 (9%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSL 158
+ L L L L + L L L L N ++P + + L L
Sbjct: 102 HGLGRLHTLHLDRCGL-QELGPGLFRGLAA-LQYLYLQDNALQ-ALPDDTFRDLGNLTHL 158
Query: 159 KLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L NR S +P + L L + N ++ + F +L
Sbjct: 159 FLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLG 201
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 21/104 (20%), Positives = 34/104 (32%), Gaps = 12/104 (11%)
Query: 103 CSSMTGL--DLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159
C + + L +P I + L N S +P+ C L L
Sbjct: 8 CYNEPKVTTSCPQQGLQA-VPVGIPA---ASQRIFLHGNRIS-HVPAASFRACRNLTILW 62
Query: 160 LDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L N + +I L L+ +++N S+ TF L
Sbjct: 63 LHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG 105
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 33/105 (31%), Positives = 44/105 (41%), Gaps = 10/105 (9%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSL 158
R +++ L L N L LPDD L LT L L N S S+P L+ L
Sbjct: 126 RGLAALQYLYLQDNAL-QALPDDTFRDLGN-LTHLFLHGNRIS-SVPERAFRGLHSLDRL 182
Query: 159 KLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L NR + + P LGRL + + N LS ++P L
Sbjct: 183 LLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLR 225
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 14/97 (14%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
LH I+HR++ + ILLDDD K++DFG + ++P L G Y+A
Sbjct: 140 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC----GTPSYLA 191
Query: 480 PE-YARTLVATPKG-----DVYSFGTVLLELVTGERP 510
PE ++ G D++S G ++ L+ G P
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 21/110 (19%), Positives = 40/110 (36%), Gaps = 13/110 (11%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160
+ +++ L LS N + + + L L L++N +P LA+ Y+ + L
Sbjct: 213 KGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270
Query: 161 DHNRFSGQIPPQ-------LGQLGRLKSFSVANN-LLSGSIP--TFVNLT 200
+N S I + S+ +N + I TF +
Sbjct: 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 5/92 (5%)
Query: 104 SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLKLDH 162
S+T L L NK+ + L L L LS N+ S ++ + LAN +L L L++
Sbjct: 192 PSLTELHLDGNKITKVDAASLKGLNN-LAKLGLSFNSIS-AVDNGSLANTPHLRELHLNN 249
Query: 163 NRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194
N+ ++P L ++ + NN +S +I
Sbjct: 250 NKLV-KVPGGLADHKYIQVVYLHNNNIS-AIG 279
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 12/105 (11%)
Query: 101 RNCS-SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSL 158
C + + S L +P D+ LDL +N + I N L++L
Sbjct: 27 FRCQCHLRVVQCSDLGL-EKVPKDLPP---DTALLDLQNNKIT-EIKDGDFKNLKNLHTL 81
Query: 159 KLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L +N+ S +I P L +L+ ++ N L +P L
Sbjct: 82 ILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQ 124
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 20/107 (18%), Positives = 39/107 (36%), Gaps = 15/107 (14%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGF--LTSLDLSSNNFSGSIPSN-LANCTYLNS 157
+ L LS N+L LP+ + L L + N + + + +
Sbjct: 97 APLVKLERLYLSKNQLKE-LPEKM-----PKTLQELRVHENEIT-KVRKSVFNGLNQMIV 149
Query: 158 LKLDHNRF-SGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
++L N S I + +L +A+ ++ +IP +LT
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLT 195
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 19/100 (19%), Positives = 37/100 (37%), Gaps = 12/100 (12%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-------L 149
+ N + L L++NKL +P ++ ++ + L +NN S +I SN
Sbjct: 233 NGSLANTPHLRELHLNNNKLVK-VPGGLADH-KYIQVVYLHNNNIS-AIGSNDFCPPGYN 289
Query: 150 ANCTYLNSLKLDHNRFS-GQIPPQL-GQLGRLKSFSVANN 187
+ + L N +I P + + + N
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 50/237 (21%), Positives = 89/237 (37%), Gaps = 57/237 (24%)
Query: 299 DLMKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVA-----EM 351
D+ + K + +G G+ T+YKA + +K+++ + K+ + E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 352 ATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAI 411
L + + N++ LL K LV+ M DL D + +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYML 119
Query: 412 GAARGFAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMNPIDTHLSTFVN 469
+G +LH + I+HR++ K +LLD++ K++DFGLA+
Sbjct: 120 MTLQGLEYLHQH---WILHRDL--KPNNLLLDENGVLKLADFGLAK-------------- 160
Query: 470 GEFGD-----------LGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
FG Y APE Y D+++ G +L EL+
Sbjct: 161 -SFGSPNRAYTHQVVTRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 23/205 (11%), Positives = 50/205 (24%), Gaps = 49/205 (23%)
Query: 313 IGSGRTGTMYKALLEDGT-------SLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPL 365
G ++A D + + + +E ++ L + + +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
L + L+V + + GSL ++ + ++ A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART 485
+ + + D G L +
Sbjct: 149 -GVALSIDHPSRVRVSID--------GDVVL----------------AYPATMPD----- 178
Query: 486 LVATPKGDVYSFGTVLLELVTGERP 510
A P+ D+ G L L+ P
Sbjct: 179 --ANPQDDIRGIGASLYALLVNRWP 201
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 18/100 (18%)
Query: 416 GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL 475
G +H+ +++R++ ILLD+ +ISD GLA + H V G
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV----GTH 354
Query: 476 GYVAPEYARTLVATPKG-----DVYSFGTVLLELVTGERP 510
GY+APE ++ D +S G +L +L+ G P
Sbjct: 355 GYMAPE----VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 30/102 (29%), Positives = 44/102 (43%), Gaps = 24/102 (23%)
Query: 420 LHHNCNPRIIHR-----NISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
LH N I+HR NI LLDD+ + ++SDFG + + P L G
Sbjct: 216 LHAN---NIVHRDLKPENI-----LLDDNMQIRLSDFGFSCHLEP-GEKLRELC----GT 262
Query: 475 LGYVAPE------YARTLVATPKGDVYSFGTVLLELVTGERP 510
GY+APE + D+++ G +L L+ G P
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 38/207 (18%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
+G G G +++ + + M K ++ + E++ L ++RN++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--KIAIGAAR----GFAWLHHNCN 425
+E +++++ + +++ + L + + +LH +
Sbjct: 73 MEELVMIFEFISGLDIFERI---------NTSAFELNEREIVSYVHQVCEALQFLHSH-- 121
Query: 426 PRIIHRNISSKCILL--DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
I H +I + I+ KI +FG AR + P + F Y APE
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLL----FTAPEYYAPEVH 175
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERP 510
+ V + D++S GT++ L++G P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 28/138 (20%), Positives = 45/138 (32%), Gaps = 23/138 (16%)
Query: 67 CKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISK 126
C + C +L ++ P+ + S LDLS N L +
Sbjct: 18 CASNILSCS--------KQQLPNV------PQSLP--SYTALLDLSHNNLSRLRAEWTPT 61
Query: 127 LVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSV 184
+ L SL LS N+ + I S L L L N + L L+ +
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 185 ANNLLSGSIP--TFVNLT 200
NN + + F ++
Sbjct: 120 YNNHIV-VVDRNAFEDMA 136
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 27/108 (25%), Positives = 44/108 (40%), Gaps = 13/108 (12%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSL 158
++ LDLSSN L L + + S L L L L +N+ + N + L L
Sbjct: 85 VPVPNLRYLDLSSNHL-HTLDEFLFSDLQA-LEVLLLYNNHIV-VVDRNAFEDMAQLQKL 141
Query: 159 KLDHNRFSGQIPPQ----LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L N+ S + P + +L +L +++N L +P L
Sbjct: 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLP 187
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 22/196 (11%)
Query: 318 TGTMY--KALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375
TG MY K L + + ++ + +EK+ L V +R +V L + K+
Sbjct: 208 TGKMYACKKLEKK--RIKKRKGEAMALNEKQ------ILEKVNSRFVVSL-AYAYETKDA 258
Query: 376 L-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNIS 434
L LV M G L ++ G I LH RI++R++
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED--LHRE---RIVYRDLK 313
Query: 435 SKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDV 494
+ ILLDD +ISD GLA + T + V G +GY+APE + T D
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV----GTVGYMAPEVVKNERYTFSPDW 368
Query: 495 YSFGTVLLELVTGERP 510
++ G +L E++ G+ P
Sbjct: 369 WALGCLLYEMIAGQSP 384
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 27/102 (26%), Positives = 44/102 (43%), Gaps = 11/102 (10%)
Query: 103 CSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLKLD 161
C SS L +P +++ + SLDLS+N + I ++ L C L +L L
Sbjct: 30 CDRNGICKGSSGSLNS-IPSGLTE---AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLT 84
Query: 162 HNRFSGQIPPQL-GQLGRLKSFSVANNLLSGSIP--TFVNLT 200
N + I LG L+ ++ N LS ++ F L+
Sbjct: 85 SNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS 124
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 10/106 (9%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYLNSL 158
+ C ++ L L+SN + + +D S L L LDLS N S ++ S+ + L L
Sbjct: 73 QRCVNLQALVLTSNGINT-IEEDSFSSLGS-LEHLDLSYNYLS-NLSSSWFKPLSSLTFL 129
Query: 159 KLDHNRFSGQIPPQ--LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L N + + L +L+ V N I F LT
Sbjct: 130 NLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 16/109 (14%), Positives = 34/109 (31%), Gaps = 7/109 (6%)
Query: 97 PRGI-RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTY 154
+ SS+T L+L N + + L L + + + I A T+
Sbjct: 116 SSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF 175
Query: 155 LNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L L++D + P+ L + + + + +
Sbjct: 176 LEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTS 222
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 19/146 (13%), Positives = 45/146 (30%), Gaps = 15/146 (10%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
LNL +G F + + + L + + + + + FL L++
Sbjct: 127 TFLNLLGNPYKTLGETSLF----SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 138 SNNFSGSIPSN-LANCTYLNSLKLDHNRFSGQIPPQL-GQLGRLKSFSVANNLLSG---- 191
+++ S L + ++ L L + + ++ + + L
Sbjct: 183 ASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 192 SIPTFVNLTLSADSVTNNQGLCGEPL 217
+ T +L N + E L
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESL 266
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 30/99 (30%), Positives = 45/99 (45%), Gaps = 6/99 (6%)
Query: 104 SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHN 163
S+ LD+S N + L SL++SSN + +I L + L L N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN 431
Query: 164 RFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+ IP Q+ +L L+ +VA+N L S+P F LT
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 25/111 (22%), Positives = 38/111 (34%), Gaps = 9/111 (8%)
Query: 104 SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHN 163
T L++S N + DI L L L +S N S L L L HN
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSK-LRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 164 RFSGQIPPQLGQLGRLKSFSVANNLLSGSIP---TFVNLT-LSADSVTNNQ 210
+ I LK ++ N ++P F N++ L ++
Sbjct: 80 KLVK-ISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTH 126
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 9/95 (9%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQ 168
+D S N L +P D+S+ T L++S N S S++ + + L L + HNR
Sbjct: 5 VDRSKNGLIH-VPKDLSQKT---TILNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 169 IPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+ L+ +++N L I VNL
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLK 93
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 24/191 (12%), Positives = 57/191 (29%), Gaps = 15/191 (7%)
Query: 21 LLLCFSLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDEN 80
L + + L +++ +S + + + K G + +
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN--VKLQGQLDFRDFDY 270
Query: 81 RVLNLR------LTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134
+L+ + S+M + + + SK+ L
Sbjct: 271 SGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP-FLHL 329
Query: 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLG---QLGRLKSFSVANNLLSG 191
D S+N + ++ N + T L +L L N+ ++ Q+ L+ ++ N +S
Sbjct: 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 192 SIP--TFVNLT 200
Sbjct: 389 DEKKGDCSWTK 399
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 27/116 (23%), Positives = 45/116 (38%), Gaps = 6/116 (5%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
I + S + L +S N++ L + K L LDLS N I + L L
Sbjct: 41 ILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96
Query: 160 LDHNRF-SGQIPPQLGQLGRLKSFSVANN-LLSGSIPTFVNLTLSADSVTNNQGLC 213
L N F + I + G + +LK ++ L S+ +L +S + +
Sbjct: 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 7/83 (8%)
Query: 87 LTDMGLKG-QFPRGIRNC--SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L + + I C + LDL SNK+ +P + KL L L+++SN
Sbjct: 401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKS-IPKQVVKLE-ALQELNVASNQLK- 457
Query: 144 SIPSN-LANCTYLNSLKLDHNRF 165
S+P T L + L N +
Sbjct: 458 SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 22/121 (18%), Positives = 42/121 (34%), Gaps = 14/121 (11%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160
S + L L N++ + + + L L L +N S +P+ L + L + L
Sbjct: 214 LRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271
Query: 161 DHNRFSGQIPPQ-------LGQLGRLKSFSVANNLLS-GSIP--TFVNLT-LSADSVTNN 209
N + ++ + S+ NN + + TF +T A N
Sbjct: 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
Query: 210 Q 210
+
Sbjct: 331 K 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 25/105 (23%), Positives = 44/105 (41%), Gaps = 12/105 (11%)
Query: 101 RNCS-SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSL 158
C + + S L +P +IS T LDL +N+ S + + +L +L
Sbjct: 29 FGCHCHLRVVQCSDLGL-KAVPKEISP---DTTLLDLQNNDIS-ELRKDDFKGLQHLYAL 83
Query: 159 KLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L +N+ S +I + L +L+ ++ N L IP +L
Sbjct: 84 VLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLV 126
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 32/126 (25%), Positives = 46/126 (36%), Gaps = 17/126 (13%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLS 137
+ + L + G G + + L +S KL G +P D L L L L
Sbjct: 150 NCIEMGGNPLENSGF----EPGAFDGLKLNYLRISEAKLTG-IPKD---LPETLNELHLD 201
Query: 138 SNNFSGSIPSN-LANCTYLNSLKLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP- 194
N +I L + L L L HN+ I L L L+ + NN LS +P
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPA 258
Query: 195 TFVNLT 200
+L
Sbjct: 259 GLPDLK 264
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 17/108 (15%), Positives = 35/108 (32%), Gaps = 10/108 (9%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYL 155
+ + L +S N L +P ++ L L + N +P + +
Sbjct: 95 EKAFSPLRKLQKLYISKNHLVE-IPPNLPS---SLVELRIHDNRIR-KVPKGVFSGLRNM 149
Query: 156 NSLKLDHNRF-SGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
N +++ N + P +L ++ L+ IP L
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLN 196
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 22/99 (22%)
Query: 420 LHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
H + HR++ + L D K+ DFGLA P + T V G
Sbjct: 122 CHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKMMRTKV----GTPY 173
Query: 477 YVAPE-----YARTLVATPKGDVYSFGTVLLELVTGERP 510
YV+P+ Y P+ D +S G ++ L+ G P
Sbjct: 174 YVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL--STFVNGEFGDLGYVA 479
H IIHR++ + ILL++D +I+DFG A++++P ++FV G YV+
Sbjct: 147 HGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVS 200
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERP 510
PE A D+++ G ++ +LV G P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 28/108 (25%), Positives = 46/108 (42%), Gaps = 34/108 (31%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFG 473
R ++H I HR+I + +L++ D K+ DFG A+ + P + ++
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA-------- 200
Query: 474 DLGYV------APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
Y+ APE Y TP D++S G V EL+ G+
Sbjct: 201 ---YICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELILGK 239
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 26/106 (24%), Positives = 42/106 (39%), Gaps = 11/106 (10%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYLNSL 158
+ + LDLS ++ + D L L++L L+ N S+ + + L L
Sbjct: 49 FSFPELQVLDLSRCEI-QTIEDGAYQSLS-HLSTLILTGNPIQ-SLALGAFSGLSSLQKL 105
Query: 159 KLDHNRFSGQIPPQL-GQLGRLKSFSVANNLLSGSIP---TFVNLT 200
+ + G L LK +VA+NL+ S F NLT
Sbjct: 106 VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 26/93 (27%), Positives = 40/93 (43%), Gaps = 19/93 (20%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
H+ IIHR++ I++ D KI DFGLAR + + T YV
Sbjct: 144 HSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMT---------PYVVTR 190
Query: 479 ---APEYARTLVATPKGDVYSFGTVLLELVTGE 508
APE + D++S G ++ E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 21/97 (21%)
Query: 422 HNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
H N I+HR++ + ILL + D + KI DFGL+ +T + + G Y+
Sbjct: 138 HKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI----GTAYYI 190
Query: 479 APE-----YARTLVATPKGDVYSFGTVLLELVTGERP 510
APE Y K DV+S G +L L++G P
Sbjct: 191 APEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 23/212 (10%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVK-----RLQDSQRSEKEFVA-EMATLGSVKNRNLVP 364
+IG G + + + E G VK + S E + E + +K+ ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKS---VDWPRRLKIAIGAARGFAWLH 421
LL + +V++ M L + D G ++ + A R + H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR---YCH 147
Query: 422 HNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
N IIHR++ C+LL ++ K+ FG+A + V G ++
Sbjct: 148 DN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV----GTPHFM 200
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERP 510
APE + DV+ G +L L++G P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 10/85 (11%)
Query: 420 LHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
H ++HRN+ + +LL K++DFGLA + F G G
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA----GTPG 178
Query: 477 YVAPEYARTLVATPKGDVYSFGTVL 501
Y++PE R D+++ G +L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 9/83 (10%)
Query: 422 HNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
H+ ++HR++ + +L +D+ E KI DFG ARL P + L T L Y
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC----FTLHYA 176
Query: 479 APEYARTLVATPKGDVYSFGTVL 501
APE D++S G +L
Sbjct: 177 APELLNQNGYDESCDLWSLGVIL 199
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 27/100 (27%), Positives = 45/100 (45%), Gaps = 21/100 (21%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
H N +IHR++ +L++ + + K+ DFGLAR+++ S + G + +V
Sbjct: 129 HGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 479 ---APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
APE Y + DV+S G +L EL
Sbjct: 187 WYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 45/233 (19%), Positives = 76/233 (32%), Gaps = 66/233 (28%)
Query: 300 LMKATNSFSKN----NIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATL 354
L + + F+ IG G + + VK + S+R E + +
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRY 72
Query: 355 GSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA 414
++ N++ L K +V + M G L D KI
Sbjct: 73 --GQHPNIITLKDVYDDGKYVYVVTELMKGGELLD------------------KIL---R 109
Query: 415 RGF-----------------AWLHHNCNPRIIHRNISSKCILL---DDDFEP-KISDFGL 453
+ F +LH ++HR++ IL + E +I DFG
Sbjct: 110 QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKG-----DVYSFGTVL 501
A+ + + L T +VAPE V +G D++S G +L
Sbjct: 167 AKQLRAENGLLMTPC----YTANFVAPE-----VLERQGYDAACDIWSLGVLL 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 14/88 (15%)
Query: 420 LHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
LH N IIHR++ + +LL ++D KI+DFG ++++ + + T G
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLC----GTPT 181
Query: 477 YVAPEYARTLVATPKG---DVYSFGTVL 501
Y+APE ++ D +S G +L
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 26/93 (27%), Positives = 40/93 (43%), Gaps = 19/93 (20%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
H+ IIHR++ I++ D KI DFGLAR + + T YV
Sbjct: 181 HSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMT---------PYVVTR 227
Query: 479 ---APEYARTLVATPKGDVYSFGTVLLELVTGE 508
APE + D++S G ++ E+V +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 40/223 (17%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-----EMATLGSVK 358
+ + + +G G G +YKA+ ++ +KR++ E+E V E++ L ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 359 NRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
+RN++ L L++++ N L + D V G
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM----DKNPDVSMRVIKSFLYQLINGVN 146
Query: 419 WLHHNCNPRIIHRNISSKCILLDDDFEP-----KISDFGLARLMN-PIDTHLSTFVNGEF 472
+ H R +HR++ + +LL KI DFGLAR PI +
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT--- 200
Query: 473 GDLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
L Y PE Y + D++S + E++
Sbjct: 201 --LWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 34/100 (34%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
H+ ++HR++ + +++D E KI DFGLAR + T GYV
Sbjct: 143 HSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-------------GYVVTR 187
Query: 479 ---APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
APE Y D++S G ++ E++TG+
Sbjct: 188 WYRAPEVILSWMHY------NQTVDIWSVGCIMAEMLTGK 221
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 52/241 (21%)
Query: 295 MRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMV--KRLQDSQRSEKEFVA--- 349
M L +A + IG G G ++KA V KR++ ++ +E +
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLST 58
Query: 350 --EMATLGSVKNR---NLVPLLGFCMAKKERL-----LVYKHMPNGSLYDLLHPADDTGK 399
E+A L ++ N+V L C + LV++H+ DL D +
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPE 114
Query: 400 SVDWPRRLK-IAIGAARGFAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARL 456
+K + RG +LH + R++HR++ K IL+ + K++DFGLAR+
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDL--KPQNILVTSSGQIKLADFGLARI 169
Query: 457 MN-PID-THL-STFVNGEFGDLGYVAPE------YARTLVATPKGDVYSFGTVLLELVTG 507
+ + T + T L Y APE Y D++S G + E+
Sbjct: 170 YSFQMALTSVVVT--------LWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRR 215
Query: 508 E 508
+
Sbjct: 216 K 216
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 29/129 (22%), Positives = 54/129 (41%), Gaps = 17/129 (13%)
Query: 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE 445
+L L+ + G + + + +I+ G ++H C IIH +I + +L++
Sbjct: 115 NLLALIKKYEHRGIPLIYVK--QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 170
Query: 446 P------KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGT 499
P KI+D G A D H + + Y +PE D++S
Sbjct: 171 PENLIQIKIADLGNACW---YDEHYTNSIQTRE----YRSPEVLLGAPWGCGADIWSTAC 223
Query: 500 VLLELVTGE 508
++ EL+TG+
Sbjct: 224 LIFELITGD 232
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 30/100 (30%), Positives = 44/100 (44%), Gaps = 34/100 (34%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
H IIHR++ + +++D E KI DFGLAR + T GYV
Sbjct: 145 HAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-------------GYVVTR 189
Query: 479 ---APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
APE Y T D++S G ++ E++TG+
Sbjct: 190 WYRAPEVILNWMRY------TQTVDIWSVGCIMAEMITGK 223
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 33/134 (24%), Positives = 50/134 (37%), Gaps = 16/134 (11%)
Query: 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143
L L++ L + + +T L+L +L D L L +LDLS N
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPV-LGTLDLSHNQLQ- 90
Query: 144 SIPSNLANCTYLNSLKLDHNRFSGQIPP----QLGQLGRLKSFSVANNLLSGSIP--TFV 197
S+P L L + NR + +P LG+L L + N L ++P
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQEL---YLKGNELK-TLPPGLLT 145
Query: 198 NLT-LSADSVTNNQ 210
L S+ NN
Sbjct: 146 PTPKLEKLSLANNN 159
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 28/112 (25%), Positives = 41/112 (36%), Gaps = 9/112 (8%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160
+S ++ L LP D+ K T L LS N + L T L L L
Sbjct: 7 SKVASHLEVNCDKRNL-TALPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP-TFVNLT-LSADSVTNNQ 210
D G L L + +++N L S+P L L+ V+ N+
Sbjct: 63 DRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR 111
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 24/85 (28%), Positives = 39/85 (45%), Gaps = 11/85 (12%)
Query: 420 LHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
H N I+HRN+ + +LL K++DFGLA +N F G G
Sbjct: 144 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFA----GTPG 195
Query: 477 YVAPEYARTLVATPKGDVYSFGTVL 501
Y++PE + + D+++ G +L
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 20/104 (19%), Positives = 43/104 (41%), Gaps = 22/104 (21%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFG 473
+ + H I+HR++ +++D + + ++ D+GLA +P + N
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-----NVRVA 192
Query: 474 DLGYVAPE-------YARTLVATPKGDVYSFGTVLLELVTGERP 510
+ PE Y +L D++S G +L ++ + P
Sbjct: 193 SRYFKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 11/94 (11%)
Query: 420 LHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
H N I+HRN+ + +LL K++DFGLA +N F G G
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFA----GTPG 172
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
Y++PE + + D+++ G +L L+ G P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 12/95 (12%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLA-RLMNPIDTHLSTFVNGEFGDLGYVAP 480
H + +HR+I IL+D + +++DFG +LM S V G Y++P
Sbjct: 192 HQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV----GTPDYISP 245
Query: 481 EYARTLVATPKG-----DVYSFGTVLLELVTGERP 510
E + + D +S G + E++ GE P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 30/100 (30%), Positives = 43/100 (43%), Gaps = 34/100 (34%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
H+ + IIHR++ + +++D E KI DFGLAR T GYV
Sbjct: 149 HSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-------------GYVATR 193
Query: 479 ---APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
APE Y D++S G ++ EL+TG
Sbjct: 194 WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGR 227
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 31/133 (23%), Positives = 52/133 (39%), Gaps = 12/133 (9%)
Query: 74 CWHPDENRVLNLRLTDMGLKGQFPRGI-RNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFL 131
+ + V L+ + + + + + + L L+ N++ + D+ L L
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTH-L 325
Query: 132 TSLDLSSNNFSGSIPSNL-ANCTYLNSLKLDHNRFSGQIPPQL-GQLGRLKSFSVANNLL 189
L+LS N SI S + N L L L +N + Q L LK ++ N L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL 383
Query: 190 SGSIP--TFVNLT 200
S+P F LT
Sbjct: 384 K-SVPDGIFDRLT 395
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 20/147 (13%), Positives = 39/147 (26%), Gaps = 15/147 (10%)
Query: 67 CKFTGVECWH------PDE-NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGP 119
C + P+ V + L+ + + L +
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 120 LPDDI-SKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLKLDHNRF-SGQIPPQL-GQ 175
+ ++ L L L L N F + + L L L +
Sbjct: 70 IRNNTFRGLSS-LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
Query: 176 LGRLKSFSVANNLLSGSIP--TFVNLT 200
L L+ + +N + P F+N+
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMR 154
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 26/158 (16%), Positives = 47/158 (29%), Gaps = 45/158 (28%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF-------------- 130
+ + L + +S+T LDLS N + +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 131 ------------------------LTSLDLSSNNFSGSIPSNL-ANCTYLNSLKLDHNRF 165
+ + DLS + ++ ++ ++ T L L L N
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311
Query: 166 SGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+ +I L L +++ N L SI F NL
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD 347
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 46/224 (20%), Positives = 82/224 (36%), Gaps = 50/224 (22%)
Query: 312 IIGSGRTGTMYKALLEDGTSLMV--------KRLQDSQRSEKEFVA-EMATLGSVKNRNL 362
+GSG+ + K E T L + + +E + E++ L V + N+
Sbjct: 19 ELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--------KIAIGAA 414
+ L + + +L+ + + G L+D L + A
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFD----------------FLAQKESLSEEEATSFI 121
Query: 415 R----GFAWLHHNCNPRIIHRNISSKCILLDDDFEP----KISDFGLARLMNPIDTHLST 466
+ G +LH +I H ++ + I+L D P K+ DFGLA +
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-----GV 173
Query: 467 FVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
FG +VAPE + D++S G + L++G P
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 11/85 (12%)
Query: 420 LHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
LH N I+HR++ + +L D KI+DFGL++++ + T G G
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTVC----GTPG 215
Query: 477 YVAPEYARTLVATPKGDVYSFGTVL 501
Y APE R P+ D++S G +
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 6/91 (6%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
LH N +++R++ + ++LD D KI+DFGL + + TF G Y+A
Sbjct: 264 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC----GTPEYLA 317
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERP 510
PE D + G V+ E++ G P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 40/184 (21%), Positives = 65/184 (35%), Gaps = 29/184 (15%)
Query: 341 QRSEKEFV-AEMATLGSVKNRNLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTG 398
+R E E L + R + L F + L LV ++ G L LL +
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGER- 158
Query: 399 KSVDWPR----RLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454
+ R + +AI + +H +HR+I ILLD +++DFG
Sbjct: 159 IPAEMARFYLAEIVMAIDS------VHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC 209
Query: 455 -RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVY-------SFGTVLLELVT 506
+L V G Y++PE + + P Y + G E+
Sbjct: 210 LKLRADGTVRSLVAV----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 507 GERP 510
G+ P
Sbjct: 266 GQTP 269
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 30/149 (20%), Positives = 60/149 (40%), Gaps = 24/149 (16%)
Query: 67 CKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISK 126
C+ T V+C N +L + P I L L++N+ I K
Sbjct: 11 CEGTTVDCS--------NQKLNKI------PEHIP--QYTAELRLNNNEFTVLEATGIFK 54
Query: 127 LVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLKLDHNRFSGQIPPQL-GQLGRLKSFSV 184
+ L ++ S+N + I + +N + L NR + ++ L LK+ +
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLML 112
Query: 185 ANNLLSGSIP--TFVNLT-LSADSVTNNQ 210
+N ++ + +F+ L+ + S+ +NQ
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 30/105 (28%)
Query: 415 RGFAWLHHNCNPRIIHRNISSKC--ILLDDDFEPKISDFGLARLMN-PID-THL-STFVN 469
RG +LH N I+HR++ K IL+ K++DFGLAR+ + + T + T
Sbjct: 131 RGLDFLHAN---CIVHRDL--KPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT--- 182
Query: 470 GEFGDLGYVAPE------YARTLVATPKGDVYSFGTVLLELVTGE 508
L Y APE Y D++S G + E+ +
Sbjct: 183 -----LWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 27/103 (26%), Positives = 41/103 (39%), Gaps = 13/103 (12%)
Query: 84 NLRLTDMGLKGQFPRGIRNC-----SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSS 138
+L D+ L + S+ L+LSSN L G + L + LDL +
Sbjct: 404 SLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR---CLPPKVKVLDLHN 459
Query: 139 NNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKS 181
N SIP ++ + L L + N+ +P G RL S
Sbjct: 460 NRIM-SIPKDVTHLQALQELNVASNQLKS-VPD--GVFDRLTS 498
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 6/94 (6%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQ 168
LD+S N L D + L+LSSN +GS+ L + L L +NR
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-S 464
Query: 169 IPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
IP + L L+ +VA+N L S+P F LT
Sbjct: 465 IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 15/104 (14%)
Query: 103 CSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDH 162
+ +D S+ L +P D+ +L LS N+ S +++ + L L+L H
Sbjct: 30 NELESMVDYSNRNLTH-VPKDLPPRT---KALSLSQNSISELRMPDISFLSELRVLRLSH 85
Query: 163 NRFSGQIPP----QLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
NR + L L V++N L +I +L
Sbjct: 86 NRIR-SLDFHVFLFNQDLEYL---DVSHNRLQ-NISCCPMASLR 124
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 24/106 (22%), Positives = 41/106 (38%), Gaps = 10/106 (9%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPS-NLANCTYLNSL 158
I S + L LS N++ L + L LD+S N +I +A+ +L+
Sbjct: 72 ISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLD-- 127
Query: 159 KLDHNRFSGQIPP--QLGQLGRLKSFSVANN-LLSGSIPTFVNLTL 201
L N F +P + G L +L ++ + +L L
Sbjct: 128 -LSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHL 171
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 30/144 (20%), Positives = 45/144 (31%), Gaps = 25/144 (17%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
H IIHR++ LL+ D K+ DFGLAR +N E + G
Sbjct: 146 HESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 482 YARTL---VAT----------------PKGDVYSFGTVLLELVTGERPTNVAKAPET--F 520
+ L V T D++S G + EL+ + F
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
Query: 521 KGN--LVEWIAQLSSTGQLQDAID 542
G+ + S + D
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 45/212 (21%), Positives = 80/212 (37%), Gaps = 52/212 (24%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFV-AEMATLGSVKNRNLVPLLGFC 369
++GSG ++ G +K ++ S + E+A L +K+ N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF------------ 417
+ LV + + G L+D +I RG
Sbjct: 76 ESTTHYYLVMQLVSGGELFD------------------RIL---ERGVYTEKDASLVIQQ 114
Query: 418 -----AWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVN 469
+LH N I+HR++ + +L +++ + I+DFGL+++ +ST
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTAC- 168
Query: 470 GEFGDLGYVAPEYARTLVATPKGDVYSFGTVL 501
G GYVAPE + D +S G +
Sbjct: 169 ---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 42/188 (22%), Positives = 66/188 (35%), Gaps = 42/188 (22%)
Query: 341 QRSEKEFV-AEMATLGSVKNRNLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTG 398
+RS+ F E + + +V L + L +V ++MP G L +L+
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM------- 160
Query: 399 KSVDWPRRLKIAIGAAR--------GFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450
+ AR +H IHR++ +LLD K++D
Sbjct: 161 ------SNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 451 FGLARLMNPIDTHLS-TFVNGEFGDLGYVAPEYARTLVATPKGDVY-------SFGTVLL 502
FG MN T V G Y++PE L + Y S G L
Sbjct: 212 FGTCMKMNKEGMVRCDTAV----GTPDYISPE---VLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 503 ELVTGERP 510
E++ G+ P
Sbjct: 265 EMLVGDTP 272
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 104 SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYLNSLKLDH 162
S L L L S L ++ + +S + + S+ N + + +++ +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPN-ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 163 NRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIPTFVNLTL 201
R I P L +L LK + N L P +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 21/107 (19%), Positives = 37/107 (34%), Gaps = 11/107 (10%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDIS-KLVGFLTSLDLSSNNFSGSIPSN----LANCTYL 155
+ + L + + L PD L+++ N + SIP N L N
Sbjct: 102 KELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN--ET 158
Query: 156 NSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
+LKL +N F+ + +L + + N I F +
Sbjct: 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 45/222 (20%), Positives = 77/222 (34%), Gaps = 48/222 (21%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVK-------RLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
+GSG+ + K G K S +E E+ L +++ N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--------KIAIGAAR- 415
L K + +L+ + + G L+D L A +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFD----------------FLAEKESLTEDEATQFLKQ 116
Query: 416 ---GFAWLHHNCNPRIIHRNISSKCILLDDDFEP----KISDFGLARLMNPIDTHLSTFV 468
G +LH RI H ++ + I+L D P K+ DFG+A +
Sbjct: 117 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIF 172
Query: 469 NGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
G +VAPE + D++S G + L++G P
Sbjct: 173 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 48/238 (20%), Positives = 77/238 (32%), Gaps = 62/238 (26%)
Query: 303 ATNSFSKN---------NIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-EM 351
+T+SFS +++G G + + L VK ++ + V E+
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 352 ATLGSVKN-RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHP--------ADDTGKSVD 402
L + RN++ L+ F + LV++ M GS+ +H A + V
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV- 120
Query: 403 WPRRLKIAIGAARGFAWLHHNCNPRIIHR-----NI--SSKCILLDDDFEPKISDFGLAR 455
A +LH+ I HR NI + KI DF L
Sbjct: 121 -----------ASALDFLHNK---GIAHRDLKPENILCEHP----NQVSPVKICDFDLGS 162
Query: 456 LMNPIDTH-------LSTFVNGEFGDLGYVAPEYARTLVATPKG-----DVYSFGTVL 501
+ L T G Y+APE D++S G +L
Sbjct: 163 GIKLNGDCSPISTPELLTPC----GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 25/100 (25%), Positives = 39/100 (39%), Gaps = 32/100 (32%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
H ++HR++ ILL D+ + I DF LAR D + + YV
Sbjct: 151 HEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTA-DANKT----------HYVTHR 197
Query: 479 ---APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
APE + T D++S G V+ E+ +
Sbjct: 198 WYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 45/216 (20%), Positives = 77/216 (35%), Gaps = 38/216 (17%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVK-NRNLVPLLG 367
+G G+ + + + G K L + Q E + E+A L K ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--KIAIGAAR----GFAWLH 421
E +L+ ++ G ++ L + + I + G +LH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC-LPELAE-------MVSENDVIRLIKQILEGVYYLH 148
Query: 422 HNCNPRIIHR-----NI--SSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
N I+H NI SS + KI DFG++R + L + G
Sbjct: 149 QN---NIVHLDLKPQNILLSSI----YPLGDIKIVDFGMSRKIGH-ACELREIM----GT 196
Query: 475 LGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
Y+APE T D+++ G + L+T P
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 45/222 (20%), Positives = 79/222 (35%), Gaps = 48/222 (21%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVA-------EMATLGSVKNRNLVP 364
+GSG+ + K G K ++ Q E++ L V + N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--------KIAIGAAR- 415
L + + +L+ + + G L+D L + A +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFD----------------FLAQKESLSEEEATSFIKQ 123
Query: 416 ---GFAWLHHNCNPRIIHRNISSKCILLDDDFEP----KISDFGLARLMNPIDTHLSTFV 468
G +LH +I H ++ + I+L D P K+ DFGLA +
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-----GVEF 175
Query: 469 NGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
FG +VAPE + D++S G + L++G P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 28/100 (28%)
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV--- 478
H+ N ++HR++ +LL+ + KI DFGLAR+ +P H YV
Sbjct: 145 HSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-------EYVATR 195
Query: 479 ---APE-------YARTLVATPKGDVYSFGTVLLELVTGE 508
APE Y T D++S G +L E+++
Sbjct: 196 WYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR 229
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 23/120 (19%), Positives = 39/120 (32%), Gaps = 13/120 (10%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYL 155
I +CS+ +K+ +P D+ + L I + L
Sbjct: 3 HHRICHCSNRV-FLCQESKV-TEIPSDLPR---NAIELRFVLTKLR-VIQKGAFSGFGDL 56
Query: 156 NSLKLDHNRFSGQIPPQ----LGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
+++ N I L +L + ANNLL + F NL L ++N
Sbjct: 57 EKIEISQNDVLEVIEADVFSNLPKLHEI-RIEKANNLLYINPEAFQNLPNLQYLLISNTG 115
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 20/105 (19%), Positives = 35/105 (33%), Gaps = 8/105 (7%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTY-LNSL 158
+N ++ L +S+ + LPD LD+ N +I N ++ L
Sbjct: 101 QNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159
Query: 159 KLDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIP--TFVNLT 200
L+ N +I + NN L +P F +
Sbjct: 160 WLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGAS 202
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 21/97 (21%)
Query: 422 HNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
H+ N I HR++ + +L + D K++DFG A+ L T YV
Sbjct: 145 HSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPC----YTPYYV 196
Query: 479 APEYARTLVATPKG-----DVYSFGTVLLELVTGERP 510
APE V P+ D++S G ++ L+ G P
Sbjct: 197 APE-----VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 18/92 (19%), Positives = 32/92 (34%), Gaps = 4/92 (4%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158
N LDL K+ P+ +++ + ++D S N + L +L
Sbjct: 14 QYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
+++NR L L + NN L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 2/90 (2%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160
R +++ L L + K + ++ L L L + S+ SNL L L+L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLEL 78
Query: 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
NR G + +L L +++ N L
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 28/101 (27%)
Query: 422 HNCNPRIIHR-----NI--SSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
H+ N I HR N+ +SK + K++DFG A+ L+T
Sbjct: 178 HSIN--IAHRDVKPENLLYTSK----RPNAILKLTDFGFAKETTS-HNSLTTPC----YT 226
Query: 475 LGYVAPEYARTLVATPKG-----DVYSFGTVLLELVTGERP 510
YVAPE V P+ D++S G ++ L+ G P
Sbjct: 227 PYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 44/223 (19%), Positives = 81/223 (36%), Gaps = 50/223 (22%)
Query: 313 IGSGRTGTMYKALLEDGTSLMV--------KRLQDSQRSEKEFVA-EMATLGSVKNRNLV 363
+GSG+ + K E T L + + +E + E++ L +++ N++
Sbjct: 19 LGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRL--------KIAIGAAR 415
L K + +L+ + + G L+D L + A +
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFD----------------FLAEKESLTEEEATEFLK 121
Query: 416 ----GFAWLHHNCNPRIIHRNISSKCILL----DDDFEPKISDFGLARLMNPIDTHLSTF 467
G +LH +I H ++ + I+L KI DFGLA ++
Sbjct: 122 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI 177
Query: 468 VNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510
G +VAPE + D++S G + L++G P
Sbjct: 178 F----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 23/123 (18%), Positives = 42/123 (34%), Gaps = 22/123 (17%)
Query: 79 ENRVLNLRLTDMGLKGQFPR------GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF-- 130
V+ + L G P + + L LS+N I K+
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNN--------IEKISSLSG 68
Query: 131 ---LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANN 187
L L L N I + A L L + +N+ + + + +L L+ ++NN
Sbjct: 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNN 125
Query: 188 LLS 190
++
Sbjct: 126 KIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 19/91 (20%), Positives = 39/91 (42%), Gaps = 7/91 (7%)
Query: 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158
+ ++ L L N + +++ + L L +S N + S+ S + L L
Sbjct: 65 SLSGMENLRILSLGRNLIKKI--ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVL 120
Query: 159 KLDHNRFS--GQIPPQLGQLGRLKSFSVANN 187
+ +N+ + G+I L L +L+ +A N
Sbjct: 121 YMSNNKITNWGEIDK-LAALDKLEDLLLAGN 150
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 13/92 (14%), Positives = 32/92 (34%), Gaps = 3/92 (3%)
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYL 155
+ ++T L + + + L + +G L +L + + + + L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 156 NSLKLDHNRFSGQIPPQLGQLGRLKSFSVANN 187
+ L L N + + Q L+ ++ N
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 29/111 (26%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYV 478
LH II+R++ +LLD + K++D+G+ + + P DT STF G Y+
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC----GTPNYI 177
Query: 479 APE------YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN 523
APE Y ++ D ++ G ++ E++ G P ++ + + N
Sbjct: 178 APEILRGEDYGFSV------DWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 30/103 (29%)
Query: 422 HNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV-- 478
H+ N ++HR++ + ++ +D KI DFGLAR+M+P +H +
Sbjct: 137 HSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS-------EGLVT 187
Query: 479 ----APE-------YARTLVATPKGDVYSFGTVLLELVTGERP 510
+P Y T D+++ G + E++TG +
Sbjct: 188 KWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTG-KT 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 26/107 (24%), Positives = 43/107 (40%), Gaps = 31/107 (28%)
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDL-----------G 476
++HR++ ILL+ + K++DFGL+R I + +
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 477 YV------APE-------YARTLVATPKGDVYSFGTVLLELVTGERP 510
YV APE Y T D++S G +L E++ G +P
Sbjct: 190 YVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCG-KP 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 29/111 (26%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYV 478
LH II+R++ +LLD + K++D+G+ + + P DT STF G Y+
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC----GTPNYI 220
Query: 479 APE------YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN 523
APE Y ++ D ++ G ++ E++ G P ++ + + N
Sbjct: 221 APEILRGEDYGFSV------DWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 2/90 (2%)
Query: 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160
R S + L L +++ + ++ L L + + SI +NL L L+L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLEL 71
Query: 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190
NR SG + + L +++ N +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 7e-04
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 9/92 (9%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYV 478
LH I++R++ ILLD D KI+DFG+ + M +TF G Y+
Sbjct: 134 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFC----GTPDYI 185
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERP 510
APE D +SFG +L E++ G+ P
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 16/97 (16%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYV 478
LH II+R+I + ILLD + ++DFGL++ + F G + Y+
Sbjct: 175 LHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC----GTIEYM 227
Query: 479 APEYARTLVATPKG-----DVYSFGTVLLELVTGERP 510
AP+ + G D +S G ++ EL+TG P
Sbjct: 228 APD---IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 21/98 (21%)
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL-MNPIDTHLSTFVNGEFGDLGYV 478
LH +++R+I + ++LD D KI+DFGL + ++ T + TF G Y+
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFC----GTPEYL 172
Query: 479 APE------YARTLVATPKGDVYSFGTVLLELVTGERP 510
APE Y R + D + G V+ E++ G P
Sbjct: 173 APEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 623 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.82 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.74 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.59 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.59 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.58 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.58 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.57 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.57 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.57 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.55 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.54 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.53 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.53 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.51 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.5 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.5 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.5 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.49 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.49 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.49 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.49 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.49 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.49 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.49 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.48 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.48 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.48 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.47 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.47 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.47 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.46 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.46 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.45 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.44 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.44 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.44 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.44 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.44 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.44 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.43 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.42 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.42 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.41 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.4 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.4 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.4 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.39 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.39 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.38 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.37 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.37 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.37 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.36 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.36 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.36 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.36 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.35 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.35 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.35 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.35 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.33 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.32 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.32 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.31 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.31 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.3 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.3 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.3 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.29 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.28 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.27 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.27 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.25 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.24 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.24 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.22 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.22 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.19 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.17 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.14 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.11 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.1 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.09 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.09 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.08 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.07 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.06 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.04 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.01 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.0 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.0 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.93 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.92 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.86 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.71 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.63 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.57 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.55 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.22 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.21 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.99 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.89 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.85 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.77 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.64 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.57 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.54 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.5 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.24 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.15 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.03 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.73 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.65 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.54 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.35 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.32 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.15 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.74 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.67 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.59 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.12 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.2 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.68 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 91.6 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 89.77 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 89.49 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 88.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.85 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.69 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 87.69 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.06 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.75 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.54 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 83.21 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=426.44 Aligned_cols=261 Identities=22% Similarity=0.378 Sum_probs=206.7
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|++. ++..||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777889999999999999864 47789999997643 445789999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCC---------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 378 VYKHMPNGSLYDLLHPAD---------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
||||+++|+|.++|+... .....++|.++++|+.|+|+||+|||++ +|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2345799999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~ 527 (623)
+|||+++.....+... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.
T Consensus 170 ~DFGla~~~~~~~~~~--~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~ 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV 239 (299)
T ss_dssp CCCSCHHHHTGGGCEE--ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHH
T ss_pred CCcccceecCCCCcee--ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 9999998765432211 1122348999999999999999999999999999999999 8999975322 111
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
+...... .... .....++++ .+++..|+. .||++||||+||++.|+++.+.
T Consensus 240 ~~~i~~~-~~~~------~p~~~~~~~---~~li~~cl~-~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 240 IECITQG-RVLQ------RPRTCPQEV---YELMLGCWQ-REPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHT-CCCC------CCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcC-CCCC------CCccchHHH---HHHHHHHcC-CChhHCcCHHHHHHHHHHHHhc
Confidence 1111111 1000 011233444 455567877 9999999999999999998653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=427.97 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=201.6
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 47889999997643 345789999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCC-----------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 378 VYKHMPNGSLYDLLHPADD-----------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
||||+++|+|.++++.... ....++|.++++|+.|+|+||+|||+. +|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999975432 124699999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~ 525 (623)
||+|||+++.....+.. .......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 198 Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-------- 267 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------- 267 (329)
T ss_dssp EECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--------
T ss_pred EEcccccceeccCCCcc--eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--------
Confidence 99999999976543221 11223458999999999999999999999999999999999 89999753221
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
+.+......... . .....++++ .+++..|+. .||++||||+||++.|+.+.+.
T Consensus 268 ~~~~~i~~g~~~-~------~p~~~~~~~---~~li~~cl~-~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 268 EAIDCITQGREL-E------RPRACPPEV---YAIMRGCWQ-REPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHHTCCC-C------CCTTCCHHH---HHHHHHHCC-SSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCCCC-C------CcccccHHH---HHHHHHHcC-cChhHCcCHHHHHHHHHHHhhC
Confidence 111111111110 0 111234444 445567877 9999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=425.19 Aligned_cols=256 Identities=22% Similarity=0.359 Sum_probs=203.5
Q ss_pred CcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 307 FSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
+...+.||+|+||.||+|.+. +++.||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445678999999999999863 46789999997543 3467899999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 379 YKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
|||+++|+|.++|+.... ....++|..+++|+.|+|+||+|||+. +|+||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 999999999999964321 124689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~ 525 (623)
||+|||+++.+...+.. .......||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .+.
T Consensus 185 Ki~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-----~~~ 257 (308)
T 4gt4_A 185 KISDLGLFREVYAADYY--KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVV 257 (308)
T ss_dssp EECCSCCBCGGGGGGCB--CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-----HHH
T ss_pred EECCcccceeccCCCce--eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-----HHH
Confidence 99999999876443221 12234468999999999999999999999999999999999 89999753221 111
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
..+. .+..... .+..+++ +.+++..|+. .||++||||+||++.|+.+
T Consensus 258 ~~i~----~~~~~~~------p~~~~~~---~~~li~~C~~-~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMIR----NRQVLPC------PDDCPAW---VYALMIECWN-EFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH----TTCCCCC------CTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHTS
T ss_pred HHHH----cCCCCCC------cccchHH---HHHHHHHHcC-CChhHCcCHHHHHHHHHhc
Confidence 1111 1111111 1123333 4455667887 9999999999999999865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=419.13 Aligned_cols=274 Identities=21% Similarity=0.279 Sum_probs=205.9
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC----eeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----ERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e 380 (623)
++|...+.||+|+||+||+|++ +|+.||||++.........++.|+..+.+++|||||+++++|.+++ ..++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 3566778999999999999998 5899999999766544445566778888999999999999998754 5789999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN-----CNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
|+++|+|.++++. ..++|..+++++.|+++||+|||++ ..++|+||||||+|||+++++++||+|||+++
T Consensus 82 y~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999963 4589999999999999999999986 35689999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccc-------c
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTL------VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK-------G 522 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~-------~ 522 (623)
.................||+.|||||++.+. .++.++|||||||++|||+||+.||.......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7654333222223345699999999998754 46789999999999999999998875432211100 1
Q ss_pred cHHHHHHHHhccCchhhhhchhhhcC-CCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 523 NLVEWIAQLSSTGQLQDAIDKCLVAK-GVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 523 ~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
......... .... .++.+... ...+....+.+++..|+. .||++||||.||++.|+++.++.
T Consensus 237 ~~~~~~~~~-~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~-~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 237 SVEEMRKVV-CEQK----LRPNIPNRWQSCEALRVMAKIMRECWY-ANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHH-TTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCC-SSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHH-hccc----CCCCCCccccchHHHHHHHHHHHHHcc-cCHhHCcCHHHHHHHHHHHHHHc
Confidence 111111111 1111 11111110 122445567788889988 99999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=414.65 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=198.6
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+++...+.||+|+||+||+|++++ .||||+++... ...+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456778899999999999999764 58999986432 345679999999999999999999998864 568999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.++|+.. ...++|.+++.|+.|+|.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999643 24699999999999999999999999 99999999999999999999999999998764322
Q ss_pred CcccccccCCCCcccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART---LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.. .......||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... .+...+..........
T Consensus 187 ~~--~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 187 GS--QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QIIFMVGRGYASPDLS 260 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHTTCCCCCST
T ss_pred cc--eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCCCCCcc
Confidence 11 12233469999999999853 468999999999999999999999997543211 1111111111111111
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.+ ....+++ +.+++..|+. .||++||||+||++.|+.++...
T Consensus 261 ~~------~~~~~~~---l~~li~~cl~-~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 261 KL------YKNCPKA---MKRLVADCVK-KVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TS------CTTSCHH---HHHHHHHHTC-SSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cc------cccchHH---HHHHHHHHcC-CCHhHCcCHHHHHHHHHHHhccC
Confidence 11 1112334 4445567887 99999999999999999887543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=400.91 Aligned_cols=258 Identities=19% Similarity=0.199 Sum_probs=201.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
+.|...++||+|+||.||+|+.+ +|+.||||+++.... ..+|++++++++|||||++++++.+.+..|+||||++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 46777889999999999999964 689999999975432 2469999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeecccccccCCCCC
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFGLARLMNPIDT 462 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~ 462 (623)
+|+|.++++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.+.....
T Consensus 134 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 134 GGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999963 24699999999999999999999999 999999999999999887 699999999998754322
Q ss_pred ccc-ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 463 HLS-TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 463 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+. ...... ......++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~---~~~~~~~~- 278 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----CLKIAS---EPPPIREI- 278 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----HHHHHH---SCCGGGGS-
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHHc---CCCCchhc-
Confidence 211 112234699999999999999999999999999999999999999976433221 111111 01111111
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
....++++.+++ ..|+. .||++|||+.|+++.|....++.
T Consensus 279 -----~~~~s~~~~~li---~~~L~-~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 279 -----PPSCAPLTAQAI---QEGLR-KEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -----CTTSCHHHHHHH---HHHTC-SSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----CccCCHHHHHHH---HHHcc-CCHhHCcCHHHHHHHHHHHHhhh
Confidence 112344444444 45665 99999999999999998765543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=412.25 Aligned_cols=269 Identities=23% Similarity=0.339 Sum_probs=209.4
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEEeCC------CcEEEEEEecccc--ccHHHHHHHHHHhCCCCC-CCCcceeEE
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKN-RNLVPLLGF 368 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h-~niv~l~~~ 368 (623)
+++....++|...+.||+|+||.||+|.+.. ++.||||++.... ...+.|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444445788999999999999999998542 3579999997643 335679999999999976 899999999
Q ss_pred EEeC-CeeeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 006982 369 CMAK-KERLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISS 435 (623)
Q Consensus 369 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~ 435 (623)
|.+. +..++|||||++|+|.++|+.... ....++|.+++.++.|||+||+|||++ +|+||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCc
Confidence 9765 568999999999999999964321 124589999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 006982 436 KCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVA 514 (623)
Q Consensus 436 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~ 514 (623)
+|||+++++.+||+|||+|+.+....... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~--~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCce--eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999765433221 1123358999999999999999999999999999999998 99999764
Q ss_pred CCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 515 KAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 515 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
...+ .+...+.. +.... ..+..++++. +++..|+. .||++||||+||++.|+++.+.
T Consensus 292 ~~~~----~~~~~i~~----g~~~~------~p~~~~~~~~---~li~~c~~-~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KIDE----EFCRRLKE----GTRMR------APDYTTPEMY---QTMLDCWH-GEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSH----HHHHHHHH----TCCCC------CCTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH----HHHHHHHc----CCCCC------CCccCCHHHH---HHHHHHcC-cChhHCcCHHHHHHHHHHHHHH
Confidence 3321 11111111 10000 1122334444 45567877 9999999999999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=407.84 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=195.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999964 69999999996543 334678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++|+|.+++.... +..+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999996432 35678999999999999999999999 9999999999999999999999999999976532
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+.+....... ..
T Consensus 179 ~~----~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~-~~-- 243 (350)
T 4b9d_A 179 VE----LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKIISGS-FP-- 243 (350)
T ss_dssp HH----HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC-CC--
T ss_pred cc----cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCC-CC--
Confidence 11 11223499999999999999999999999999999999999999975322 12122211111 00
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+ .....++++.+++ ..|+. .||++|||++|+++
T Consensus 244 --~--~~~~~s~~~~~li---~~~L~-~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --P--VSLHYSYDLRSLV---SQLFK-RNPRDRPSVNSILE 276 (350)
T ss_dssp --C--CCTTSCHHHHHHH---HHHTC-SSGGGSCCHHHHHT
T ss_pred --C--CCccCCHHHHHHH---HHHcc-CChhHCcCHHHHhc
Confidence 0 0112344555444 45665 99999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=404.07 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=199.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+.|+..+.||+|+||.||+|+.. +|+.||+|++.... ...+.+.+|+++|++++|||||++++++.+.+..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999965 69999999996543 34456889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999953 3589999999999999999999999 999999999999999999999999999998754332
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
. ..+.+||+.|||||++.+..|+.++||||+||++|||++|+.||...... +........ ..
T Consensus 226 ~----~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~------~~ 287 (346)
T 4fih_A 226 R----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDN------LP 287 (346)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHS------SC
T ss_pred c----ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcC------CC
Confidence 2 22346999999999999999999999999999999999999999753221 111111110 00
Q ss_pred hhhh-cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLV-AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~-~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+.+. ....++++.+++ ..|+. .||++|||++|+++
T Consensus 288 ~~~~~~~~~s~~~~dli---~~~L~-~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 288 PRLKNLHKVSPSLKGFL---DRLLV-RDPAQRATAAELLK 323 (346)
T ss_dssp CCCSCGGGSCHHHHHHH---HHHSC-SSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHH---HHHcC-CChhHCcCHHHHhc
Confidence 0000 011234444444 45665 99999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=387.97 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=189.3
Q ss_pred cccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe----CCeeeEEE
Q 006982 308 SKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA----KKERLLVY 379 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 379 (623)
...+.||+|+||.||+|... ++..||+|++.... ...+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999965 68899999996543 334678999999999999999999999875 24578999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeEEeecccccccC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMN 458 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~kl~Dfgla~~~~ 458 (623)
||+++|+|.++++. ...+++..+..++.|++.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999963 35689999999999999999999998 12399999999999998 47999999999998643
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.. ...+..||+.|||||++.+ .|+.++|||||||++|||+||+.||...... .......... ..
T Consensus 184 ~~------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~-~~- 247 (290)
T 3fpq_A 184 AS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSG-VK- 247 (290)
T ss_dssp TT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTT-CC-
T ss_pred CC------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcC-CC-
Confidence 31 1223469999999998865 6999999999999999999999999653221 1111111111 00
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+........+++. .++..|+. .||++|||++|+++
T Consensus 248 ----~~~~~~~~~~~~~---~li~~~L~-~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 ----PASFDKVAIPEVK---EIIEGCIR-QNKDERYSIKDLLN 282 (290)
T ss_dssp ----CGGGGGCCCHHHH---HHHHHHSC-SSGGGSCCHHHHHT
T ss_pred ----CCCCCccCCHHHH---HHHHHHcc-CChhHCcCHHHHhc
Confidence 0001111233444 34456776 99999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=391.97 Aligned_cols=249 Identities=19% Similarity=0.262 Sum_probs=201.6
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||+||+|+. .+++.||+|++... ....+.+.+|++++++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999996 47899999999653 234577899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999963 35699999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... ....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.. +......... .
T Consensus 185 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~-~-- 251 (311)
T 4aw0_A 185 ESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------LIFAKIIKLE-Y-- 251 (311)
T ss_dssp TTTC--CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC-C--
T ss_pred CCCc--ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC-C--
Confidence 3221 1223456999999999999999999999999999999999999999753221 1111111110 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+ .....+++..++ ..|+. .||++|||++|+...
T Consensus 252 ----~~-p~~~s~~~~dli---~~lL~-~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 252 ----DF-PEKFFPKARDLV---EKLLV-LDATKRLGCEEMEGY 285 (311)
T ss_dssp ----CC-CTTCCHHHHHHH---HHHSC-SSGGGSTTSGGGTCH
T ss_pred ----CC-CcccCHHHHHHH---HHHcc-CCHhHCcChHHHcCC
Confidence 00 112334444444 45555 999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=400.80 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=199.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+.|...+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888999999999999999965 69999999996543 34456889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999953 3589999999999999999999999 999999999999999999999999999998754332
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.. .+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +........ ..
T Consensus 303 ~~----~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~------~~ 364 (423)
T 4fie_A 303 RR----KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDN------LP 364 (423)
T ss_dssp CB----CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHS------CC
T ss_pred cc----cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcC------CC
Confidence 22 2345999999999999999999999999999999999999999753221 111111100 00
Q ss_pred hhhh-cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLV-AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~-~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+.+. ....++++..++ ..|+. .||++|||++|+++
T Consensus 365 ~~~~~~~~~s~~~~dli---~~~L~-~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 PRLKNLHKVSPSLKGFL---DRLLV-RDPAQRATAAELLK 400 (423)
T ss_dssp CCCSCTTSSCHHHHHHH---HHHSC-SSTTTSCCHHHHTT
T ss_pred CCCcccccCCHHHHHHH---HHHcC-CChhHCcCHHHHhc
Confidence 0111 112344555444 45665 99999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=378.09 Aligned_cols=244 Identities=20% Similarity=0.338 Sum_probs=185.4
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||+||+|.. .+|+.||+|++.... .....+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999995 479999999996532 33567899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+ +|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999863 34699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.. ...+..||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ............
T Consensus 165 ~~-----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~~-- 229 (275)
T 3hyh_A 165 GN-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGVY-- 229 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC--
T ss_pred CC-----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 22 1223469999999999988776 5799999999999999999999975321 111121111100
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+ ....++++.+++ .+|+. .||++|||++|+++
T Consensus 230 -----~~-p~~~s~~~~~li---~~~L~-~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----TL-PKFLSPGAAGLI---KRMLI-VNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CC-CTTSCHHHHHHH---HHHSC-SSGGGSCCHHHHHH
T ss_pred -----CC-CCCCCHHHHHHH---HHHcc-CChhHCcCHHHHHc
Confidence 00 112344444444 45665 99999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=386.73 Aligned_cols=199 Identities=23% Similarity=0.288 Sum_probs=168.8
Q ss_pred ccCcccceeeccCccEEEEEEeC----CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|+..+.||+|+||.||+|+.. .++.||+|+++... .....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999852 46789999996532 233468889999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999963 24689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
...... ..+..||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 177 ~~~~~~----~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 177 IDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp ----CC----CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCcc----ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 432221 23346999999999999999999999999999999999999999753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=378.45 Aligned_cols=252 Identities=19% Similarity=0.299 Sum_probs=182.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC--------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK-------- 373 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 373 (623)
++|+..+.||+|+||.||+|+.. +|+.||+|+++... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46888999999999999999964 78999999986433 34567899999999999999999999987644
Q ss_pred ----eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEe
Q 006982 374 ----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKIS 449 (623)
Q Consensus 374 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~ 449 (623)
..|+||||+++|+|.+++..... ....++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999975432 23456777899999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccc--------ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccc
Q 006982 450 DFGLARLMNPIDTHLS--------TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~ 521 (623)
|||+|+.+........ ....+.+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 9999997654322111 11223469999999999999999999999999999999996 774310
Q ss_pred ccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.....+... ......... .+.......+...|+. .||++|||+.|+++
T Consensus 232 -~~~~~~~~~-~~~~~p~~~---------~~~~~~~~~li~~~L~-~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -ERVRTLTDV-RNLKFPPLF---------TQKYPCEYVMVQDMLS-PSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHHH-HTTCCCHHH---------HHHCHHHHHHHHHHTC-SSGGGSCCHHHHHT
T ss_pred -HHHHHHHHH-hcCCCCCCC---------cccCHHHHHHHHHHcC-CChhHCcCHHHHhc
Confidence 000001110 111110100 0111122344556666 99999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=380.90 Aligned_cols=292 Identities=40% Similarity=0.704 Sum_probs=251.6
Q ss_pred cccccCHHHHHHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEE
Q 006982 291 SITKMRLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGF 368 (623)
Q Consensus 291 ~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~ 368 (623)
....+++.++....++|...+.||+|+||.||+|...+++.||+|++.... .....+.+|++++.+++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 345688899999999999999999999999999998889999999997643 223468999999999999999999999
Q ss_pred EEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 369 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
+.+....++||||+++|+|.+++.........++|..+..++.|++.||+|||+.+.++|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999876555567999999999999999999999988889999999999999999999999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~ 528 (623)
+|||+++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..............+|+
T Consensus 176 ~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp CCCSSCEECCSSSSCE---ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred ccCccccccCcccccc---cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999998765432221 2233489999999999888899999999999999999999999964322223345677888
Q ss_pred HHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 529 AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
........+..+.+..+......+....+.+++..|+. .||++|||+.||+++|++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~-~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQ-SSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTC-SCGGGSCCHHHHHHHHHTS
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhC-cCCccCCCHHHHHHHhcCc
Confidence 87777777888888887777778888889999999998 9999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=368.95 Aligned_cols=285 Identities=38% Similarity=0.595 Sum_probs=237.4
Q ss_pred CHHHHHHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe
Q 006982 296 RLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 296 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 374 (623)
++.++...+++|...+.||+|+||.||+|..+++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3444556778999999999999999999999889999999987643 345678999999999999999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++||||+++|+|.+++.........++|..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999976554445799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......|.......
T Consensus 187 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 187 KKGTELDQT--HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNN 262 (321)
T ss_dssp EECSSSSCC--CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHHTHHHHTT
T ss_pred ccccccccc--ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHHhhhcccc
Confidence 865432211 11122347899999999988899999999999999999999999997654432 23455665555555
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
..+.+.+++.+......+....+..++..|+. .||++|||+.||++.|+.+.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLA-LSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcC-CCcccCcCHHHHHHHHHHHhh
Confidence 55666666666555566677778888889988 999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.07 Aligned_cols=203 Identities=21% Similarity=0.348 Sum_probs=171.7
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------Ce
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------KE 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 374 (623)
++|...+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4688999999999999999996 479999999997543 2345688999999999999999999997643 56
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.|+||||++ |+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 799999996 689999963 35799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
+.+............+.+||+.|||||++.+. .++.++||||+||++|||++|+.||.+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 87654322222333455799999999998765 56899999999999999999999997643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.74 Aligned_cols=202 Identities=21% Similarity=0.317 Sum_probs=171.3
Q ss_pred HhccCcccceeeccCccEEEEEEeC----CCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 377 (623)
..+.|...+.||+|+||+||+|+.+ .++.||+|++.... ....+.+|++++.++ +|||||++++++.+.+..++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 4578999999999999999999853 46789999986543 345678999999988 69999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-CCeEEeecccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-FEPKISDFGLARL 456 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-~~~kl~Dfgla~~ 456 (623)
||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999993 488999999999999999999999 99999999999999876 7999999999986
Q ss_pred cCCCCCccc------------------------ccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 006982 457 MNPIDTHLS------------------------TFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPT 511 (623)
Q Consensus 457 ~~~~~~~~~------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~ 511 (623)
......... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543221110 112234699999999999775 5899999999999999999999999
Q ss_pred CCCC
Q 006982 512 NVAK 515 (623)
Q Consensus 512 ~~~~ 515 (623)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=375.03 Aligned_cols=197 Identities=23% Similarity=0.308 Sum_probs=171.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHH---HHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEF---VAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...++||+|+||.||+|+.+ +|+.||+|++.+.. ...... ..++.++..++|||||++++++++.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999965 68999999996532 222333 34467788999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+||||++||+|.++|.. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.+|++||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999963 24689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
...... .+.+||+.|||||++.. ..|+.++||||+||++|||++|+.||...
T Consensus 342 ~~~~~~------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 342 FSKKKP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CSSCCC------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred cCCCCC------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 654221 23469999999999964 57899999999999999999999999753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.82 Aligned_cols=274 Identities=23% Similarity=0.280 Sum_probs=209.4
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC----eeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----ERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 379 (623)
.++|...+.||+|+||.||+|+.. ++.||+|++.........+..|+.++.+++||||+++++++.... ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 357888999999999999999986 789999999876666667778999999999999999999998754 368999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhc-------CCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN-------CNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-------~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
||+++|+|.++++. ..++|..++.++.|++.||+|||+. +.++|+||||||+|||++.++.+||+|||
T Consensus 102 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 102 AFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999953 3489999999999999999999986 23479999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccc-----
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG----- 522 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~----- 522 (623)
+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........
T Consensus 177 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 177 LALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp TCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred cccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 99876543221 11223458999999999876 3556789999999999999999999976543221110
Q ss_pred ---cHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 523 ---NLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 523 ---~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
....+...... ......+...+. .......+.+++..|+. .||++|||+.||++.|+++.+..
T Consensus 255 ~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~cl~-~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVH-KKKRPVLRDYWQ---KHAGMAMLCETIEECWD-HDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTT-SCCCCCCCGGGG---SSHHHHHHHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhc-ccCCCCcccccc---ccchHHHHHHHHHHHcc-CChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111111 111111111111 12334456677778887 99999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.41 Aligned_cols=284 Identities=35% Similarity=0.575 Sum_probs=227.2
Q ss_pred cccccCHHHHHHHhccCccc------ceeeccCccEEEEEEeCCCcEEEEEEeccc-----cccHHHHHHHHHHhCCCCC
Q 006982 291 SITKMRLSDLMKATNSFSKN------NIIGSGRTGTMYKALLEDGTSLMVKRLQDS-----QRSEKEFVAEMATLGSVKN 359 (623)
Q Consensus 291 ~~~~~~~~~l~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~h 359 (623)
....+++.++..+++.|... +.||+|+||.||+|.. +++.||+|++... ....+.+.+|++++.+++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34578899999999999888 8999999999999997 5889999998643 2235678999999999999
Q ss_pred CCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCcee
Q 006982 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCIL 439 (623)
Q Consensus 360 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NIL 439 (623)
|||+++++++.+.+..++||||+++|+|.+++.... ....++|..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999986432 235689999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 006982 440 LDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPET 519 (623)
Q Consensus 440 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~ 519 (623)
+++++.+||+|||+++........ .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~- 241 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQT--VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ- 241 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSC--EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-
T ss_pred EcCCCcEEEeeccccccccccccc--ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-
Confidence 999999999999999876532211 11223458999999998865 57899999999999999999999997644322
Q ss_pred ccccHHHHHHHHhc-cCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 520 FKGNLVEWIAQLSS-TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 520 ~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.+..+...... ...+.+.+++.+.. ........+.+++..|+. .+|++|||+.+|++.|+++..
T Consensus 242 ---~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~-~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 ---LLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLH-EKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp ---BTTHHHHHHHTTSCCHHHHSCSSCSC-CCHHHHHHHHHHHHHHTC-SSTTTSCCHHHHHHHHHHHC-
T ss_pred ---HHHHHHHHhhhhhhhhhhhccccccc-cchHHHHHHHHHHHHHcC-CCcccCcCHHHHHHHHHHHhc
Confidence 12222222211 22344555544422 244555667778888887 999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.96 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=209.5
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|...++..||+|++.......+.+.+|++++.+++||||+++++++.+....++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 56888899999999999999998899999999988777778899999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 160 (269)
T 4hcu_A 90 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 160 (269)
T ss_dssp CBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc---
Confidence 9999999643 24689999999999999999999999 99999999999999999999999999998764321
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
.....+..+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .+.......... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~------~ 226 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFR------L 226 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC------C
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCcc------C
Confidence 112233446788999999998899999999999999999999 9999865322 111111111100 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
......+++ +.+++..|+. .+|++||+++|+++.|+++.++
T Consensus 227 -~~~~~~~~~---~~~li~~~l~-~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 -YKPRLASTH---VYQIMNHCWR-ERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCCcCCHH---HHHHHHHHcc-CCcccCcCHHHHHHHHHHHHHc
Confidence 001112333 3444556776 9999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=346.50 Aligned_cols=262 Identities=22% Similarity=0.377 Sum_probs=207.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc-cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS-QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56888999999999999999965 6899999988653 345677999999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++... ...++|..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999643 35689999999999999999999999 999999999999999999999999999987644322
Q ss_pred cccc----------cccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccc-cccHHHHHHHH
Q 006982 463 HLST----------FVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETF-KGNLVEWIAQL 531 (623)
Q Consensus 463 ~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~-~~~l~~~~~~~ 531 (623)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..|+......... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 1110 011345899999999999999999999999999999999999998754332221 11122221111
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.. ...+++ +..++..|+. .||++|||+.|+++.|++++...
T Consensus 244 -------------~~-~~~~~~---l~~li~~~l~-~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 244 -------------CP-PNCPPS---FFPITVRCCD-LDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -------------CC-TTCCTT---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------CC-CCCCHH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHHhc
Confidence 11 112222 3445556776 99999999999999999997654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=373.55 Aligned_cols=250 Identities=19% Similarity=0.329 Sum_probs=199.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|..+ +|+.||+|++.... ...+.+.+|+++|++++|||||++++++.+....++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57899999999999999999964 68999999986543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC--CCeEEeecccccccCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD--FEPKISDFGLARLMNPI 460 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~--~~~kl~Dfgla~~~~~~ 460 (623)
++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 237 ~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998532 24689999999999999999999999 99999999999999854 89999999999987653
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... ....||+.|||||++.+..|+.++||||+||++|||++|+.||...... +.......... .+
T Consensus 311 ~~~-----~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~~~--~~ 375 (573)
T 3uto_A 311 QSV-----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDW--NM 375 (573)
T ss_dssp SEE-----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCC--CC
T ss_pred Cce-----eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhCCC--CC
Confidence 221 2235999999999999999999999999999999999999999753321 11111111100 00
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
-+.. ....+++...+ +..|+. .||++|||+.|+++
T Consensus 376 ~~~~--~~~~s~~~~dl---i~~~L~-~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSA--FSGISEDGKDF---IRKLLL-ADPNTRMTIHQALE 410 (573)
T ss_dssp CSGG--GTTSCHHHHHH---HHTTSC-SSGGGSCCHHHHHH
T ss_pred Cccc--ccCCCHHHHHH---HHHHcc-CChhHCcCHHHHhc
Confidence 0111 11233444444 345665 99999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.18 Aligned_cols=260 Identities=23% Similarity=0.383 Sum_probs=203.9
Q ss_pred ccCcccceeeccCccEEEEEEeC----CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|... .+..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999974 45569999997642 3456799999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999643 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... +...........
T Consensus 203 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~~~~ 273 (325)
T 3kul_A 203 DDPDAA-YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEEGYRL 273 (325)
T ss_dssp ----CC-EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCCC
T ss_pred cCccce-eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCCC
Confidence 432221 11223346788999999998899999999999999999999 99999653221 111111111000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
. .....+++ +.+++..|+. .||++|||+.||++.|+.+.+..
T Consensus 274 ------~-~~~~~~~~---l~~li~~~l~-~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 274 ------P-APMGCPHA---LHQLMLDCWH-KDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ------C-CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ------C-CCCCcCHH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHhCc
Confidence 0 01112333 4445567776 99999999999999999987644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=342.59 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=197.3
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeC----CeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK----KERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~lV~ 379 (623)
.++|...+.||+|+||.||+|+. +++.||+|++..........+.|+....+++||||+++++++... ...++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 46788999999999999999998 689999999976543222233344445558999999999997653 4578999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH--------HNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
||+++|+|.++++ ...+++..+++++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 86 e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp CCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999994 246899999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL------VATPKGDVYSFGTVLLELVTG----------ERPTNVAK 515 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~sfGvil~elltg----------~~P~~~~~ 515 (623)
|+++.................||+.|+|||++.+. .++.++||||||+++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99987654333222222334689999999999876 455799999999999999999 77776433
Q ss_pred CcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 516 APETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 516 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
.... .................+ .... ........+.+++..|+. .||++|||+.||++.|+++
T Consensus 238 ~~~~---~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~-~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDP---SFEDMRKVVCVDQQRPNI-PNRW---FSDPTLTSLAKLMKECWY-QNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSC---CHHHHHHHHTTSCCCCCC-CGGG---GGSHHHHHHHHHHHHHCC-SSGGGSCCHHHHHHHHHHH
T ss_pred CCCc---chhhhhHHHhccCCCCCC-Chhh---ccCccHHHHHHHHHHHhh-cChhhCCCHHHHHHHHhcc
Confidence 2211 111111111111110000 0000 012234456677778887 9999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.48 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=205.3
Q ss_pred ccCcccceeeccCccEEEEEEe--------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL--------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKK 373 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 373 (623)
++|...+.||+|+||.||+|.. .++..||+|+++... ...+.+.+|++++.++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 5788889999999999999985 245679999997643 3346789999999999 8999999999999999
Q ss_pred eeeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 99999999999999999975432 124589999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 006982 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETF 520 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~ 520 (623)
.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--- 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCT--TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred CCCCEEEccccCCcccCcccceec--ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 999999999999987654322111 122346889999999999999999999999999999999 99999753221
Q ss_pred cccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 521 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.+...+..... .. ......++ +.+++..|+. .||++||++.|+++.|+++..
T Consensus 313 --~~~~~~~~~~~----~~------~~~~~~~~---l~~li~~~l~-~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 --ELFKLLKEGHR----MD------KPANCTNE---LYMMMRDCWH-AVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp --GHHHHHHTTCC----CC------CCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCC----CC------CCCCCCHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHH
Confidence 11111111100 00 01112333 4445556777 999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=339.38 Aligned_cols=259 Identities=23% Similarity=0.402 Sum_probs=209.8
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.++|...+.||+|+||.||+|...++..||+|++.......+.+.+|++++.+++||||+++++++.+....++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 35788899999999999999999988899999998877777889999999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++... +..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 87 NGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp TCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred CCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 99999999642 24689999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
....+..+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...........
T Consensus 160 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~------ 223 (268)
T 3sxs_A 160 --VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHR------ 223 (268)
T ss_dssp --EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCC------
T ss_pred --hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCC------
Confidence 11233446788999999998889999999999999999999 99998643221 11111111100
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.......+++ +.+++..|+. .+|++|||+.|+++.|+.++++.
T Consensus 224 -~~~~~~~~~~---l~~li~~~l~-~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 224 -LYRPHLASDT---IYQIMYSCWH-ELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp -CCCCTTSCHH---HHHHHHHTTC-SSGGGSCCHHHHHHHHGGGCC--
T ss_pred -CCCCCcChHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHhhhcc
Confidence 0001112333 4445556776 99999999999999999997653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=355.51 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=194.5
Q ss_pred ccCcccceeeccCccEEEEEEeC----CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|+.. ++..||+|+++... ...+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999864 57789999997542 3456799999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.++++.. +..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999643 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+......
T Consensus 199 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~----- 264 (373)
T 2qol_A 199 DDPEAA-YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVD----- 264 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHH-----
T ss_pred cCCccc-eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-----
Confidence 422111 11122235778999999999999999999999999999998 9999964321 11111111
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
..............+.+++..|+. .||++||++.||++.|+++....
T Consensus 265 -----~~~~~~~~~~~~~~l~~li~~cl~-~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 265 -----EGYRLPPPMDCPAALYQLMLDCWQ-KDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -----TTEECCCCTTCBHHHHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -----cCCCCCCCccccHHHHHHHHHHhC-cChhhCcCHHHHHHHHHHHHhCc
Confidence 110000011112235556667877 99999999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=345.83 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=197.4
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|.. +++.||+|++.... ...+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46788899999999999999987 58899999987643 234578899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR--IIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 115 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 115 YLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp CCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred cCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999996432 123489999999999999999999998 7 9999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +............
T Consensus 191 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~ 258 (309)
T 3p86_A 191 STFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVVAAVGFKCKRL 258 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHHSCCCC
T ss_pred cccc----ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCCCC
Confidence 3211 112345899999999999999999999999999999999999999753221 1111110000000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
. .....+.++ ..++..|+. .||++|||++|+++.|+.+.+..
T Consensus 259 ~------~~~~~~~~l---~~li~~~l~-~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 E------IPRNLNPQV---AAIIEGCWT-NEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp C------CCTTSCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHC--
T ss_pred C------CCccCCHHH---HHHHHHHcc-CChhhCcCHHHHHHHHHHHHHhC
Confidence 0 011123333 344556776 99999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=339.11 Aligned_cols=258 Identities=19% Similarity=0.327 Sum_probs=207.0
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.++|...+.||+|+||.||++...++..||+|++.......+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 35788889999999999999999988899999998877777889999999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 174 (283)
T 3gen_A 103 NGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-- 174 (283)
T ss_dssp TCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH--
T ss_pred CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc--
Confidence 99999999642 24689999999999999999999999 99999999999999999999999999998764321
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .......... .
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~------~ 239 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGL------R 239 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTC------C
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhccc------C
Confidence 111223446788999999998889999999999999999998 99999753221 1111111100 0
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
. ......+++ +.+++..|+. .+|++|||++|+++.|+++.++
T Consensus 240 ~-~~~~~~~~~---l~~li~~~l~-~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 L-YRPHLASEK---VYTIMYSCWH-EKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp C-CCCTTCCHH---HHHHHHHTTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-CCCCcCCHH---HHHHHHHHcc-CChhHCcCHHHHHHHHHHHhhc
Confidence 0 001112333 4455566777 9999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=363.00 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=207.4
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.++|...+.||+|+||.||+|.+.++..||||+++......+.|.+|++++.+++||||+++++++. .+..++||||++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 4568888999999999999999988999999999877777889999999999999999999999986 567899999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 266 ~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-- 338 (454)
T 1qcf_A 266 KGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-- 338 (454)
T ss_dssp TCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH--
T ss_pred CCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc--
Confidence 999999996432 23578999999999999999999999 99999999999999999999999999998764321
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.....+..+|+.|+|||++....++.++|||||||++|||+| |+.||...... .....+.. ....
T Consensus 339 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~---~~~~----- 404 (454)
T 1qcf_A 339 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALER---GYRM----- 404 (454)
T ss_dssp -HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHH---TCCC-----
T ss_pred -eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc---CCCC-----
Confidence 111223346789999999998899999999999999999999 99999753221 11111111 1000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
......+++ +.+++..|+. .||++|||+++|++.|+++...
T Consensus 405 --~~~~~~~~~---l~~li~~cl~-~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 --PRPENCPEE---LYNIMMRCWK-NRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp --CCCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHTSSSS
T ss_pred --CCCCCCCHH---HHHHHHHHcc-CChhHCcCHHHHHHHHHHHHhc
Confidence 001122333 4445567777 9999999999999999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.94 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=205.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|.+. +++.||+|.++... .....+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356888899999999999999976 78999999987542 233468899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++|+|.+++... +..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999632 24689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. ........+++.|+|||.+....++.++|||||||++|||+| |..||...... ...+.+.. ....
T Consensus 267 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----~~~~~~~~---~~~~-- 334 (377)
T 3cbl_A 267 VY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----QTREFVEK---GGRL-- 334 (377)
T ss_dssp EE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----HHHHHHHT---TCCC--
T ss_pred ce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc---CCCC--
Confidence 11 111111225678999999998889999999999999999998 99998753211 11111111 1000
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
-.....++++. +++..|+. .||++|||++++++.|++++++.
T Consensus 335 -----~~~~~~~~~l~---~li~~cl~-~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 335 -----PCPELCPDAVF---RLMEQCWA-YEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp -----CCCTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCCCCCCHHHH---HHHHHHcC-CCchhCcCHHHHHHHHHHHHhhc
Confidence 00112334444 45556777 99999999999999999997654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.42 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=206.0
Q ss_pred ccCHHHHHHHhcc----------CcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCC
Q 006982 294 KMRLSDLMKATNS----------FSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRN 361 (623)
Q Consensus 294 ~~~~~~l~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~n 361 (623)
.++.+++..+++. |...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4677888777764 666779999999999999976 79999999986543 44677899999999999999
Q ss_pred CcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 362 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
|+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 99999999999999999999999999999852 4589999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccc
Q 006982 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~ 521 (623)
.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----- 246 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----- 246 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred CCCcEEEeeeeeeeecccCccc----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 9999999999999876543221 1234589999999999999999999999999999999999999975321
Q ss_pred ccHHHHHHHHhccCchhhhhchhhh-cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLV-AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.......... ..+.+. ....++++.+ ++..|+. .||++|||+.|+++.
T Consensus 247 ---~~~~~~~~~~------~~~~~~~~~~~~~~l~~---li~~~l~-~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 ---VQAMKRLRDS------PPPKLKNSHKVSPVLRD---FLERMLV-RDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHHHHHHHS------SCCCCTTGGGSCHHHHH---HHHHHSC-SSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHhcC------CCCCcCccccCCHHHHH---HHHHHcc-CChhhCcCHHHHhcC
Confidence 1111111110 000000 0112333443 4446666 999999999999763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.31 Aligned_cols=275 Identities=16% Similarity=0.234 Sum_probs=214.0
Q ss_pred hccCcccceeeccCccEEEEEEeCC------CcEEEEEEecccccc------------HHHHHHHHHHhCCCCCCCCcce
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQRS------------EKEFVAEMATLGSVKNRNLVPL 365 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~l 365 (623)
.++|...+.||+|+||.||+|.+.+ ++.||+|++...... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999999764 478999998654311 1234456778889999999999
Q ss_pred eEEEEeC----CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 366 LGFCMAK----KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 366 ~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
++++... ...++||||+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 9998775 4478999999 99999999642 35699999999999999999999999 999999999999999
Q ss_pred --CCCCeEEeecccccccCCCCCccc---ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 442 --DDFEPKISDFGLARLMNPIDTHLS---TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 442 --~~~~~kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
.++.+||+|||+++.+........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 899999999999987654322111 111233489999999999999999999999999999999999999975322
Q ss_pred cccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCC
Q 006982 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTT 594 (623)
Q Consensus 517 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 594 (623)
. ......... .....+.+++++|+.....++++..+++ .|+. .+|++||+++++++.|+++.++.....
T Consensus 267 ~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~---~cl~-~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 267 D----PKYVRDSKI-RYRENIASLMDKCFPAANAPGEIAKYME---TVKL-LDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp C----HHHHHHHHH-HHHHCHHHHHHHHSCTTCCCHHHHHHHH---HHHT-CCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred C----HHHHHHHHH-HhhhhHHHHHHHhcccccCHHHHHHHHH---HHhc-CCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 1 111111111 1223567778888765556666666655 5666 999999999999999999877765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.29 Aligned_cols=257 Identities=25% Similarity=0.441 Sum_probs=197.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCc----EEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGT----SLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|.+. ++. +|++|.+... ....+.+.+|++++.+++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999954 344 3688887543 245678999999999999999999999998754 789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999643 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+....
T Consensus 168 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~~~---- 236 (327)
T 3poz_A 168 GAEEKEYH--AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGE---- 236 (327)
T ss_dssp TTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHTTC----
T ss_pred cCCccccc--ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----HHHHHHHcCC----
Confidence 54322211 123346889999999999999999999999999999999 99999753321 1222111110
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
...........+..++..|+. .+|++||++.|+++.|+.+...
T Consensus 237 ---------~~~~~~~~~~~~~~li~~~l~-~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 ---------RLPQPPICTIDVYMIMVKCWM-IDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTC-SCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCCCCccCCHHHHHHHHHHcC-CChhhCCCHHHHHHHHHHHHhh
Confidence 000011112245556667887 9999999999999999988654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.69 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=198.9
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35789999999999999999995 578999999986543 4466789999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999953 3588999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ....
T Consensus 171 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~-~~~~ 237 (297)
T 3fxz_A 171 SKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGT-PELQ 237 (297)
T ss_dssp CCB----CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCS-CCCS
T ss_pred ccc----CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-CCCC
Confidence 221 2345899999999999999999999999999999999999999653221 11111100000 0000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. ....++++ ..++..|+. .||++|||++|+++
T Consensus 238 ~----~~~~~~~~---~~li~~~l~-~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 N----PEKLSAIF---RDFLNRCLE-MDVEKRGSAKELLQ 269 (297)
T ss_dssp C----GGGSCHHH---HHHHHHHSC-SSTTTSCCHHHHTT
T ss_pred C----ccccCHHH---HHHHHHHcc-CChhHCcCHHHHhh
Confidence 0 01122333 344456776 99999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=364.98 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=209.6
Q ss_pred hccCcccceeeccCccEEEEEEeCC-CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
..+|...+.||+|+||.||+|.+.. +..||+|.++......+.|.+|++++.+++||||++++++|.+....++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 3567888999999999999999764 889999999877667888999999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 299 TYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp TTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999996532 25689999999999999999999999 999999999999999999999999999987643221
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
....+..+++.|+|||++....++.++|||||||++|||++ |+.||...... .+.+.+..... .
T Consensus 374 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~---~---- 438 (495)
T 1opk_A 374 ---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYR---M---- 438 (495)
T ss_dssp ---ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHHTTCC---C----
T ss_pred ---eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCC---C----
Confidence 11223346789999999998899999999999999999999 99998754321 11221111000 0
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
-.....++++. +++..|+. .||++|||+.+|++.|+.+.+.
T Consensus 439 ---~~~~~~~~~l~---~li~~cl~-~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 439 ---ERPEGCPEKVY---ELMRACWQ-WNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ---CCCTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHTSCSS
T ss_pred ---CCCCCCCHHHH---HHHHHHcC-cChhHCcCHHHHHHHHHHHHhc
Confidence 00112334444 44556777 9999999999999999987543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=331.22 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=208.8
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||++...++..||+|++.......+.+.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 56788899999999999999998899999999988777778899999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 158 (267)
T 3t9t_A 88 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 158 (267)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc---
Confidence 9999999643 24689999999999999999999999 99999999999999999999999999998764311
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.......... .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~------~ 224 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFR------L 224 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC------C
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCc------C
Confidence 111223447789999999998889999999999999999999 8999865321 111111111100 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
......+++ +.+++..|+. .||++||++.|+++.|+++.++
T Consensus 225 -~~~~~~~~~---l~~li~~~l~-~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 -YKPRLASTH---VYQIMNHCWR-ERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCccCcHH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHhc
Confidence 001112333 3445556776 9999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=338.42 Aligned_cols=262 Identities=22% Similarity=0.355 Sum_probs=206.4
Q ss_pred hccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
.++|...+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788889999999999999985 345789999997543 3346788999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCC--------------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 006982 376 LLVYKHMPNGSLYDLLHPADD--------------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISS 435 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~ 435 (623)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999975432 123589999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 006982 436 KCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVA 514 (623)
Q Consensus 436 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~ 514 (623)
+||++++++.+||+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYV--KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEE--CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred heEEEcCCCCEEEccccccccccccccce--eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998765432211 1122347889999999998889999999999999999999 99999753
Q ss_pred CCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 515 KAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 515 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
... .+...+...... . .....++++ ..++..|+. .||++||++.|+++.|+++.++
T Consensus 257 ~~~-----~~~~~~~~~~~~---------~-~~~~~~~~~---~~li~~~l~-~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPE-----RLFNLLKTGHRM---------E-RPDNCSEEM---YRLMLQCWK-QEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGG-----GHHHHHHTTCCC---------C-CCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHH-----HHHHHhhcCCcC---------C-CCccCCHHH---HHHHHHHcc-CChhhCcCHHHHHHHHHHHHhh
Confidence 321 122211111000 0 011223344 444556776 9999999999999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.78 Aligned_cols=275 Identities=23% Similarity=0.313 Sum_probs=200.0
Q ss_pred HHhccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeC----CeeeE
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK----KERLL 377 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~l 377 (623)
...++|...+.||+|+||.||+|+.. ++.||+|++..........+.|+.....++||||+++++++... ...++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 34568999999999999999999986 89999999865543333333444444455999999999999887 67899
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC-----NPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
||||+++|+|.++++. ..+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 9999999999999953 35899999999999999999999762 3489999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPK------GDVYSFGTVLLELVTG----------ERPTNVAKA 516 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k------~DV~sfGvil~elltg----------~~P~~~~~~ 516 (623)
+++.................||+.|+|||++.+...+.+ +|||||||++|||+|| ..||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 998765433322222234568999999999987766655 9999999999999999 555543222
Q ss_pred cccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 517 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
... ........ .........+...+.. .+....+.+++..|+. .||++|||+.||++.|+++.+..
T Consensus 268 ~~~---~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~-~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 268 SDP---SYEDMREI-VCIKKLRPSFPNRWSS---DECLRQMGKLMTECWA-HNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SSC---CHHHHHHH-HTTSCCCCCCCGGGGG---SHHHHHHHHHHHHHSC-SSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCC---chhhhHHH-HhhhccCccccccchh---hHHHHHHHHHHHHhhh-hChhhCCCHHHHHHHHHHHHhhc
Confidence 111 11111111 1111111111111111 1334456667778887 99999999999999999987754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=348.54 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=208.2
Q ss_pred hccCcccceeeccCccEEEEEEeC--------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE--------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK 372 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 372 (623)
.++|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888899999999999999852 34679999997643 3346788999999999 999999999999999
Q ss_pred CeeeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl 440 (623)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999965432 124689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 006982 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPET 519 (623)
Q Consensus 441 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~ 519 (623)
++++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTC--CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred cCCCcEEEcccCcccccccccccc--cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999998765432211 1122347889999999999999999999999999999999 9999864321
Q ss_pred ccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCC
Q 006982 520 FKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFT 593 (623)
Q Consensus 520 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~ 593 (623)
.+........... . ......++ +.+++..|+. .||++|||++||++.|+++.......
T Consensus 300 -----~~~~~~~~~~~~~-~------~~~~~~~~---l~~li~~~l~-~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 300 -----EELFKLLKEGHRM-D------KPSNCTNE---LYMMMRDCWH-AVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp -----HHHHHHHHTTCCC-C------CCSSCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred -----HHHHHHHHcCCCC-C------CCccCCHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 1111111111000 0 01123334 4444556776 99999999999999999987655433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=344.35 Aligned_cols=265 Identities=25% Similarity=0.399 Sum_probs=206.8
Q ss_pred HhccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 374 (623)
..++|...+.||+|+||.||+|... +++.||+|+++... ...+.+.+|++++.+++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999974 34789999997543 335678999999999999999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCC--------------------CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDT--------------------GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNIS 434 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk 434 (623)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999999653211 25689999999999999999999999 99999999
Q ss_pred CCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 006982 435 SKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNV 513 (623)
Q Consensus 435 ~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~ 513 (623)
|+||+++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEEECCCCeEEEeecCCCcccccCccc--cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999876432211 11223457899999999998889999999999999999999 9999975
Q ss_pred CCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 514 AKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 514 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
... .+...... ...... .....+.+ +..++..|+. .||++||++.|+++.|+++.+++.
T Consensus 280 ~~~--------~~~~~~~~-~~~~~~------~~~~~~~~---l~~li~~~l~-~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 280 MAH--------EEVIYYVR-DGNILA------CPENCPLE---LYNLMRLCWS-KLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp SCH--------HHHHHHHH-TTCCCC------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCh--------HHHHHHHh-CCCcCC------CCCCCCHH---HHHHHHHHcc-cCcccCCCHHHHHHHHHHHHhhhh
Confidence 321 11111111 111100 01122334 4444556776 999999999999999999987664
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.12 Aligned_cols=266 Identities=23% Similarity=0.388 Sum_probs=199.8
Q ss_pred ccCcccceeeccCccEEEEEEe-----CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Ceee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-----EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 376 (623)
++|...+.||+|+||.||++++ .+++.||+|++.... ...+.+.+|++++.+++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688889999999999999984 368899999997643 3446789999999999999999999998654 4578
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999643 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC-
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG- 535 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~- 535 (623)
........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... .+........
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~ 233 (295)
T 3ugc_A 164 LPQDKEFF-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---------EFMRMIGNDKQ 233 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH---------HHHHHHCTTCC
T ss_pred ccCCccee-eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH---------HHHhhhcCccc
Confidence 65432211 112233467889999999999999999999999999999999999864211 0000000000
Q ss_pred ------chhhhhchhhh---cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 536 ------QLQDAIDKCLV---AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 536 ------~~~~~~d~~l~---~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.+.+.+..... ....+++ +.+++..|+. .||++|||+.|+++.|+++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---l~~li~~~l~-~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 234 GQMIVFHLIELLKNNGRLPRPDGCPDE---IYMIMTECWN-NNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp THHHHHHHHHHHHTTCCCCCCTTCCHH---HHHHHHHHSC-SSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cchhHHHHHHHHhccCcCCCCcCcCHH---HHHHHHHHcC-CChhhCCCHHHHHHHHHHHHHhc
Confidence 00001110000 1122334 4445556777 99999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.64 Aligned_cols=271 Identities=23% Similarity=0.325 Sum_probs=208.6
Q ss_pred CHHHHHHHhccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCccee
Q 006982 296 RLSDLMKATNSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLL 366 (623)
Q Consensus 296 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~ 366 (623)
...++....++|...+.||+|+||.||+|.+ .+++.||+|++.... ...+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444555567899999999999999999973 346789999997643 2345789999999999 789999999
Q ss_pred EEEEeCCe-eeEEEecCCCCCHhhhccCCCCC------------------------------------------------
Q 006982 367 GFCMAKKE-RLLVYKHMPNGSLYDLLHPADDT------------------------------------------------ 397 (623)
Q Consensus 367 ~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------ 397 (623)
+++.+.+. .++||||+++|+|.++++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 88999999999999999754321
Q ss_pred --------------CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 398 --------------GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 398 --------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12289999999999999999999999 9999999999999999999999999999876432221
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.......||+.|+|||++.+..++.++||||||+++|||+| |+.||......+ .....+..... ..
T Consensus 250 --~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~~~-~~------ 316 (359)
T 3vhe_A 250 --VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGTR-MR------ 316 (359)
T ss_dssp --EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHHHHHHTCC-CC------
T ss_pred --hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----HHHHHHHcCCC-CC------
Confidence 11223447889999999999999999999999999999998 999997543321 11111111000 00
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
......+++ .+++..|+. .||++|||+.|++++|+++.+.
T Consensus 317 ---~~~~~~~~l---~~li~~~l~-~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 ---APDYTTPEM---YQTMLDCWH-GEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ---CCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHH---HHHHHHHcc-CChhhCCCHHHHHHHHHHHHHH
Confidence 011123344 444556777 9999999999999999998653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=358.07 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=202.3
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.++|...+.||+|+||.||+|.+.++..||+|+++......+.|.+|++++++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 35678889999999999999999888899999998766667889999999999999999999999876 67899999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.... +..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999996321 24589999999999999999999999 9999999999999999999999999999876432211
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
...+..+++.|+|||.+....++.++|||||||++|||++ |+.||..... .+...........
T Consensus 337 ---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~----- 400 (452)
T 1fmk_A 337 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRM----- 400 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCC-----
T ss_pred ---cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCC-----
Confidence 1122346789999999998899999999999999999999 9999865322 1111111111000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
-.....+++ +.+++..|+. .||++|||++++++.|+++....
T Consensus 401 --~~~~~~~~~---l~~li~~cl~-~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 401 --PCPPECPES---LHDLMCQCWR-KEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp --CCCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --CCCCCCCHH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHhccC
Confidence 001122333 3445567777 99999999999999999886543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=339.38 Aligned_cols=247 Identities=20% Similarity=0.293 Sum_probs=197.8
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999996 579999999996543 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999998532 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVAT-PKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
... .....||+.|+|||++.+..++ .++||||+||++|||++|+.||..... ............
T Consensus 167 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~-- 231 (328)
T 3fe3_A 167 GGK-----LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLRGKY-- 231 (328)
T ss_dssp SCG-----GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC--
T ss_pred CCc-----cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC--
Confidence 221 2334589999999999887765 799999999999999999999975321 111111111100
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
. .....+.++..+ ...|+. .||.+|||++|+++.
T Consensus 232 -----~-~p~~~s~~~~~l---i~~~L~-~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -----R-IPFYMSTDCENL---LKRFLV-LNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----C-CCTTSCHHHHHH---HHHHCC-SSTTTSCCHHHHTTC
T ss_pred -----C-CCCCCCHHHHHH---HHHHCC-CChhHCcCHHHHhcC
Confidence 0 011123344443 445655 999999999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=353.49 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=202.5
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-eeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK-ERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~ 382 (623)
.++|...+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|++++.+++||||+++++++.+.. ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 356888899999999999999986 7899999997654 4567999999999999999999999987765 689999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp TTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999999997432 23478999999999999999999999 99999999999999999999999999998643211
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
....+++.|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+.. ...+
T Consensus 344 ------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~---~~~~---- 405 (450)
T 1k9a_A 344 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEK---GYKM---- 405 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----THHHHHHT---TCCC----
T ss_pred ------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc---CCCC----
Confidence 11236789999999999999999999999999999998 99999754322 11111111 1000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
-.....++++.+ ++..|+. .||++|||+.++++.|+++...
T Consensus 406 ---~~p~~~~~~l~~---li~~cl~-~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 ---DAPDGCPPAVYD---VMKNCWH-LDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---CCCTTCCHHHHH---HHHHHTC-SSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCcCCHHHHH---HHHHHcC-CChhHCcCHHHHHHHHHHHHHh
Confidence 011123444444 4456776 9999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.45 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=203.2
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||+|.+. ++..||+|++... ......+.+|+.++.+++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888899999999999999853 4668999999653 234557889999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCC---CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC---CeEEee
Q 006982 377 LVYKHMPNGSLYDLLHPADD---TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF---EPKISD 450 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~---~~kl~D 450 (623)
+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999965332 224689999999999999999999999 999999999999999554 599999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHH
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIA 529 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~ 529 (623)
||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 228 FG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~ 297 (367)
T 3l9p_A 228 FGMARDIYRAGYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE 297 (367)
T ss_dssp CHHHHHHHHHSSCT--TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH
T ss_pred Cccccccccccccc--cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 99998653211111 1112237889999999998899999999999999999998 9999975321 11111
Q ss_pred HHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
........ . .....+++ +.+++..|+. .||++|||+.||++.|+.+.+..
T Consensus 298 ~i~~~~~~-~------~~~~~~~~---l~~li~~~l~-~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 298 FVTSGGRM-D------PPKNCPGP---VYRIMTQCWQ-HQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHTTCCC-C------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHcCCCC-C------CCccCCHH---HHHHHHHHcC-CCHhHCcCHHHHHHHHHHHhhCh
Confidence 11111000 0 01112333 4455567777 99999999999999999886644
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=337.80 Aligned_cols=267 Identities=20% Similarity=0.346 Sum_probs=191.0
Q ss_pred hccCcccceeeccCccEEEEEEeCCC----cEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee-
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDG----TSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER- 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~- 375 (623)
.++|...+.||+|+||.||+|..... ..||+|++... ....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46789999999999999999996543 27999999754 23456789999999999999999999999887655
Q ss_pred -----eEEEecCCCCCHhhhccCCC--CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 376 -----LLVYKHMPNGSLYDLLHPAD--DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 376 -----~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
++|+||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 89999999999999985432 1223689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~ 527 (623)
+|||+++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....
T Consensus 179 ~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~ 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYR--QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----EIYNY 251 (323)
T ss_dssp CCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHH
T ss_pred eecccccccccccccc--ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-----HHHHH
Confidence 9999998764432211 1122346789999999999999999999999999999999 89998754322 11111
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCC
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTT 594 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 594 (623)
+. ..... . ......++ +..++..|+. .||++|||+.++++.|+++........
T Consensus 252 ~~---~~~~~------~-~~~~~~~~---l~~li~~~l~-~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 252 LI---GGNRL------K-QPPECMEE---VYDLMYQCWS-ADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp HH---TTCCC------C-CCTTCCHH---HHHHHHHTTC-SSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred Hh---cCCCC------C-CCCccCHH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 11 10000 0 00112233 4455566776 999999999999999999877654443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.49 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=200.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 56888999999999999999954 68999999985432 33467899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 91 EYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999963 24689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... ....
T Consensus 164 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------~~~~~~~~~-~~~~ 231 (294)
T 4eqm_A 164 TSLT---QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--------SIAIKHIQD-SVPN 231 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--------HHHHHHHSS-CCCC
T ss_pred cccc---ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhhc-cCCC
Confidence 2211 112235899999999999999999999999999999999999999753221 111111111 0000
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHhhccc
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-TMFEVYQFLRAIGERY 590 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-s~~ev~~~L~~i~~~~ 590 (623)
.. ... ....++++ ..+...|+. .||++|| +++++.+.|+.+..+.
T Consensus 232 ~~-~~~-~~~~~~~l---~~li~~~l~-~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 232 VT-TDV-RKDIPQSL---SNVILRATE-KDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HH-HHS-CTTSCHHH---HHHHHHHSC-SSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred cc-hhc-ccCCCHHH---HHHHHHHhc-CCHhHccccHHHHHHHHHHHHhhc
Confidence 00 000 11123333 444556776 9999998 9999999999876544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.47 Aligned_cols=252 Identities=19% Similarity=0.266 Sum_probs=200.9
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.++|...+.||+|+||.||++... ++..+|+|.+.........+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 357888999999999999999965 6889999999876666677899999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC--CCCeEEeecccccccCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD--DFEPKISDFGLARLMNPI 460 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~--~~~~kl~Dfgla~~~~~~ 460 (623)
++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 84 ~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999632 24689999999999999999999999 9999999999999987 789999999999877543
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... ....||+.|+|||++.+..++.++|||||||++|||++|..||..... .+...........
T Consensus 158 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~--- 221 (321)
T 1tki_A 158 DNF-----RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYT--- 221 (321)
T ss_dssp CEE-----EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCC---
T ss_pred Ccc-----ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCCCC---
Confidence 221 123489999999999988889999999999999999999999975322 1111111111000
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+... ....+++ +..++..|+. .||++|||+.|+++.
T Consensus 222 ~~~~~-~~~~s~~---~~~li~~~L~-~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 FDEEA-FKEISIE---AMDFVDRLLV-KERKSRMTASEALQH 258 (321)
T ss_dssp CCHHH-HTTSCHH---HHHHHHTTSC-SSGGGSCCHHHHHHS
T ss_pred CChhh-hccCCHH---HHHHHHHHcC-CChhHCcCHHHHhcC
Confidence 00000 0112233 3344556766 999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.83 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=193.2
Q ss_pred cCcccceeeccCccEEEEEEeC--CC--cEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEe-CCeeeEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE--DG--TSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMA-KKERLLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV 378 (623)
.|...+.||+|+||.||+|... ++ ..||+|.+.... ...+.+.+|+.++.+++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4666789999999999999863 22 368999886533 345679999999999999999999999765 4577899
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999643 34688999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...........+..+|+.|+|||.+.+..++.++||||||+++|||+| |..||...... .....+... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~~~~~~~~~---~~- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQG---RR- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----CHHHHHHTT---CC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----HHHHHHHcC---CC-
Confidence 432221112223447889999999999999999999999999999999 66666543221 122211111 00
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCC
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTT 594 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 594 (623)
.......++++ .+++..|+. .||++|||+.|+++.|+++...+....
T Consensus 315 ------~~~p~~~~~~l---~~li~~cl~-~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 315 ------LLQPEYCPDPL---YEVMLKCWH-PKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp ------CCCCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ------CCCCCCCCHHH---HHHHHHHcC-CChhhCcCHHHHHHHHHHHHHhccccc
Confidence 00111233343 444556776 999999999999999999987765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=333.42 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=209.9
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.++|...+.||+|+||.||+|... ++..||+|.+.......+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 467888899999999999999976 4888999999877767788999999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 92 TYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp TTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred CCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999999996532 35689999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+......
T Consensus 167 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~~~~~~~~~~~~------- 231 (288)
T 3kfa_A 167 T---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYRM------- 231 (288)
T ss_dssp E---EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHHTTCCC-------
T ss_pred c---cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHhccCCC-------
Confidence 1 1222346788999999998899999999999999999999 99998753221 111111111000
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
. .....++++ .+++..|+. .||++|||+.|+++.|+++.++.
T Consensus 232 --~-~~~~~~~~l---~~li~~~l~-~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 --E-RPEGCPEKV---YELMRACWQ-WNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp --C-CCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --C-CCCCCCHHH---HHHHHHHhC-CChhhCcCHHHHHHHHHHHHHhc
Confidence 0 011223344 444456766 99999999999999999876654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.85 Aligned_cols=274 Identities=20% Similarity=0.285 Sum_probs=206.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC--eeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK--ERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++.+++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999976 58999999997543 44677889999999999999999999998765 678999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee----CCCCCeEEeeccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL----DDDFEPKISDFGLAR 455 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl----~~~~~~kl~Dfgla~ 455 (623)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999975432 23489999999999999999999999 99999999999999 888889999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHH
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYAR--------TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~ 527 (623)
........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||............+...
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 165 ELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp ECCTTCCB-----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ecCCCCce-----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 76543221 2235899999999886 5678999999999999999999999997544433222222222
Q ss_pred HHHHhcc--Cchhhhhchhh------h-cCCCHHHHHH-HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 528 IAQLSST--GQLQDAIDKCL------V-AKGVDNELFQ-FLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 528 ~~~~~~~--~~~~~~~d~~l------~-~~~~~~~~~~-~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
....... ..+......++ . .......+.. +..+...|+. .||++|||++|+++...+...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~-~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE-ADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSC-CCTTTSCCHHHHHHHHHHHTC
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhcc-CChhhhccHHHhhhccHHHhh
Confidence 2211100 00001011110 0 0112233333 3344445555 999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.23 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=196.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999965 78999999986443 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999963 35689999999999999999999999 99999999999999999999999999998654221
Q ss_pred CcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
. ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|.......
T Consensus 160 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~------ 228 (323)
T 3tki_A 160 R--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEKKTYL------ 228 (323)
T ss_dssp E--ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHHTTCTTS------
T ss_pred c--ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhcccccC------
Confidence 1 112234468999999999987765 779999999999999999999997543321 1111221110000
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+ .....+++ ..++..|+. .||++|||+.|+++.
T Consensus 229 -~~---~~~~~~~~---~~li~~~L~-~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 -NP---WKKIDSAP---LALLHKILV-ENPSARITIPDIKKD 262 (323)
T ss_dssp -TT---GGGSCHHH---HHHHHHHSC-SSTTTSCCHHHHTTC
T ss_pred -Cc---cccCCHHH---HHHHHHHcc-CChhhCcCHHHHhhC
Confidence 00 01122333 344556666 999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.90 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=198.8
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 379 (623)
++|...+.||+|+||.||+|+.. ++.||+|++.... ...+.+.+|++++.+++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888999999999999999985 8899999997543 3346789999999999999999999999887 6779999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR--IIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+||++++++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999997532 24689999999999999999999998 7 999999999999999999999999987653
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATP---KGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
.. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||...... .........
T Consensus 164 ~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~ 226 (271)
T 3kmu_A 164 QS---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--------EIGMKVALE 226 (271)
T ss_dssp SC---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--------HHHHHHHHS
T ss_pred cc---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--------HHHHHHHhc
Confidence 22 1234789999999998765444 899999999999999999999753221 111111111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.. .+.+ ....++++. .++..|+. .||++|||++|+++.|+++.++
T Consensus 227 ~~-----~~~~-~~~~~~~~~---~li~~~l~-~~p~~Rps~~~il~~L~~l~~~ 271 (271)
T 3kmu_A 227 GL-----RPTI-PPGISPHVS---KLMKICMN-EDPAKRPKFDMIVPILEKMQDK 271 (271)
T ss_dssp CC-----CCCC-CTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHCC-
T ss_pred CC-----CCCC-CCCCCHHHH---HHHHHHcC-CChhhCcCHHHHHHHHHHhhcC
Confidence 00 0000 112334444 44445766 9999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=329.59 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=189.2
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc-----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56888899999999999999985 8899999986542 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC--------CCCeEEeec
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD--------DFEPKISDF 451 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~--------~~~~kl~Df 451 (623)
||+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+||+++. ++.+||+||
T Consensus 86 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999994 346899999999999999999999992222999999999999986 778999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
|+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......
T Consensus 161 g~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~ 226 (271)
T 3dtc_A 161 GLAREWHRTTK------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVAYGV 226 (271)
T ss_dssp CC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHH
T ss_pred Ccccccccccc------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHhh
Confidence 99986543221 1234899999999999888999999999999999999999999753211 111111
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
........ .....+++ +.+++..|+. .||++|||+.|+++.|+++
T Consensus 227 ~~~~~~~~------~~~~~~~~---~~~li~~~l~-~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLALP------IPSTCPEP---FAKLMEDCWN-PDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCCC------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCCC------CCcccCHH---HHHHHHHHhc-CCcccCcCHHHHHHHHhcC
Confidence 11100000 01112333 4444556776 9999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=330.70 Aligned_cols=258 Identities=28% Similarity=0.413 Sum_probs=206.2
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|...++..||+|.+.......+.+.+|++++.+++||||+++++++. .+..++|+||+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCC
Confidence 568888999999999999999988889999999877667788999999999999999999999986 4568999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... +..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 92 ~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 164 (279)
T 1qpc_A 92 GSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-- 164 (279)
T ss_dssp CBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--
T ss_pred CCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc--
Confidence 99999995321 13689999999999999999999999 999999999999999999999999999987654221
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +.......... .
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~------~ 229 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGYR------M 229 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC------C
T ss_pred -ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcccC------C
Confidence 11223346789999999988889999999999999999999 89998653221 11111111100 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
......++++. +++..|+. .+|++|||++++++.|+++....
T Consensus 230 -~~~~~~~~~l~---~li~~~l~-~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 230 -VRPDNCPEELY---QLMRLCWK-ERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -CCCTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCcccccHHHH---HHHHHHhc-cChhhCCCHHHHHHHHHHHHHhc
Confidence 01112334444 44556776 99999999999999999986543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=340.44 Aligned_cols=280 Identities=21% Similarity=0.281 Sum_probs=200.5
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEe-----CCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA-----KKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|+. +++.||+|++............|+..+..++||||+++++++.. ....++||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 5788899999999999999987 58999999997554333334455555667899999999986643 22468999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC------CCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC------NPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
||+++|+|.+++.. ...++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+
T Consensus 92 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 92 EYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 99999999999953 34589999999999999999999873 33899999999999999999999999999
Q ss_pred ccccCCCCCcc----cccccCCCCcccccCcccccC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccc
Q 006982 454 ARLMNPIDTHL----STFVNGEFGDLGYVAPEYART-------LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG 522 (623)
Q Consensus 454 a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~ 522 (623)
++.+....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 98765322111 111223458999999999976 4567799999999999999999888754433222221
Q ss_pred cHHHH---------HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCC
Q 006982 523 NLVEW---------IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFT 593 (623)
Q Consensus 523 ~l~~~---------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~ 593 (623)
..... ............-+...+. ........+.+++..|+. .||++|||++|+++.|+++...+..-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~-~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWD-QDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSC-SSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhc-CChhhCcchHHHHHHHHHHHHHHHhc
Confidence 11110 0000000000000000000 012233456677778887 99999999999999999998877533
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=334.17 Aligned_cols=247 Identities=20% Similarity=0.242 Sum_probs=198.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+++.. +++.||+|+++.. ......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999965 6899999999753 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999863 24689999999999999999999999 999999999999999999999999999986433
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ..
T Consensus 158 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~-~~-- 222 (337)
T 1o6l_A 158 DGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME-EI-- 222 (337)
T ss_dssp TTCC----BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC--
T ss_pred CCCc----ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcC-CC--
Confidence 2221 1233589999999999999999999999999999999999999975321 1111111111 00
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-----TMFEVYQF 582 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-----s~~ev~~~ 582 (623)
.+ ....++++..++ ..|+. .||++|| +++|+++.
T Consensus 223 ----~~-p~~~s~~~~~li---~~lL~-~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ----RF-PRTLSPEAKSLL---AGLLK-KDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CC-CTTSCHHHHHHH---HHHTC-SSTTTSTTCSTTTHHHHHTS
T ss_pred ----CC-CCCCCHHHHHHH---HHHhh-cCHHHhcCCCCCCHHHHHcC
Confidence 00 112344444444 35555 8999999 89998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.83 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=205.0
Q ss_pred hccCcccceeeccCccEEEEEEeC--------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE--------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAK 372 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 372 (623)
.++|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888999999999999999863 56789999997643 3356788999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCC------------CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDT------------GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL 440 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl 440 (623)
+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999754321 23489999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 006982 441 DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPET 519 (623)
Q Consensus 441 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~ 519 (623)
+.++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEE--CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred cCCCCEEEcccccccccccccccc--ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 999999999999998765432211 1122346789999999988889999999999999999999 9999865321
Q ss_pred ccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 520 FKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 520 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.+.......... .. .......+ +.+++..|+. .+|.+|||+.|+++.|+++....
T Consensus 266 -----~~~~~~~~~~~~------~~-~~~~~~~~---l~~li~~~l~-~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 266 -----EELFKLLKEGHR------MD-KPANCTNE---LYMMMRDCWH-AVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp -----HHHHHHHHHTCC------CC-CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHhcCCC------CC-CCccCCHH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHhcc
Confidence 111111111000 00 01112333 4445556776 99999999999999999986644
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.14 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=198.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc-------cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR-------SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
.+.|...+.||+|+||.||++... +|..||+|.+..... ..+.+.+|++++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888999999999999999965 689999999865421 357899999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC----CeEEeec
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF----EPKISDF 451 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~----~~kl~Df 451 (623)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999953 35689999999999999999999999 999999999999998877 7999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... +.....
T Consensus 164 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i 230 (361)
T 2yab_A 164 GLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANI 230 (361)
T ss_dssp SSCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHH
T ss_pred CCceEcCCCCc-----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 99987654221 12345899999999999989999999999999999999999999753221 111111
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..... . ++... ....++++..+ +..|+. .||++|||+.|+++
T Consensus 231 ~~~~~--~-~~~~~-~~~~s~~~~~l---i~~~L~-~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 TAVSY--D-FDEEF-FSQTSELAKDF---IRKLLV-KETRKRLTIQEALR 272 (361)
T ss_dssp HTTCC--C-CCHHH-HTTSCHHHHHH---HHHHSC-SSTTTSCCHHHHHT
T ss_pred HhcCC--C-CCchh-ccCCCHHHHHH---HHHHCC-CChhHCcCHHHHhc
Confidence 11000 0 00000 01123344444 445665 99999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.58 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=206.7
Q ss_pred ccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
++|...+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5688889999999999999984 356789999997543 3356789999999999 999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCC--------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 376 LLVYKHMPNGSLYDLLHPADD--------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 999999999999999965432 123589999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 006982 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETF 520 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~ 520 (623)
.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 255 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred CCCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence 9999999999999876543221 11223346789999999998899999999999999999999 999997543221
Q ss_pred cccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 521 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.....+..... . ......++++ ..++..|+. .||.+|||+.|+++.|+++.++.
T Consensus 256 --~~~~~~~~~~~---------~-~~~~~~~~~l---~~li~~~l~-~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 --KFYKMIKEGFR---------M-LSPEHAPAEM---YDIMKTCWD-ADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp --HHHHHHHHTCC---------C-CCCTTSCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --HHHHHhccCCC---------C-CCcccCCHHH---HHHHHHHcC-CCchhCcCHHHHHHHHHHHHHHh
Confidence 11111111100 0 0011223344 444556776 99999999999999999886654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=328.22 Aligned_cols=265 Identities=22% Similarity=0.319 Sum_probs=203.5
Q ss_pred cCcccceeeccCccEEEEEEeCC----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee-eEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER-LLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lV 378 (623)
.|...+.||+|+||.||+|...+ +..+|+|.+.... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35556899999999999998532 2379999987543 3356789999999999999999999999877665 899
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999642 35689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..............+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ......+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~--- 248 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFLAQGRRLP--- 248 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHHHHHTTCCCC---
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHHHhhcCCCCC---
Confidence 43222222223345789999999999999999999999999999999977765433221 11222111111000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCC
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTT 594 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 594 (623)
.....+++ +.+++..|+. .||.+|||+.++++.|+++.+......
T Consensus 249 -------~~~~~~~~---l~~li~~~l~-~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 249 -------QPEYCPDS---LYQVMQQCWE-ADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp -------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred -------CCccchHH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 01112333 3444556776 999999999999999999987764433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.17 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=191.2
Q ss_pred ccCcccceeeccCccEEEEEEeCC----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|.... +..|++|++.... ...+.+.+|+.++.+++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 568888999999999999998643 4579999987532 33567899999999999999999999974 5678899
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 94 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999643 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...... .....+|+.|+|||.+....++.++||||||+++|||++ |..||...... .....+.. ....
T Consensus 168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~~~~~i~~---~~~~ 236 (281)
T 1mp8_A 168 DSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIEN---GERL 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHT---TCCC
T ss_pred cccccc---cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----HHHHHHHc---CCCC
Confidence 422111 112236789999999998889999999999999999997 99999754321 11111111 0000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
. .....++++. .++..|+. .||++|||+.|+++.|+++.++
T Consensus 237 ------~-~~~~~~~~l~---~li~~~l~-~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 ------P-MPPNCPPTLY---SLMTKCWA-YDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------C-CCTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------C-CCCCCCHHHH---HHHHHHcc-CChhhCcCHHHHHHHHHHHHHH
Confidence 0 0112333444 44456776 9999999999999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.76 Aligned_cols=253 Identities=19% Similarity=0.280 Sum_probs=198.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
+.|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56889999999999999999964 68999999985421 246789999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC---eEEeecccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE---PKISDFGLA 454 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~---~kl~Dfgla 454 (623)
||||+++|+|.+++......+..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988754333345689999999999999999999999 9999999999999986655 999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .........
T Consensus 181 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~---~~~~~i~~~ 247 (351)
T 3c0i_A 181 IQLGESGLV----AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------E---RLFEGIIKG 247 (351)
T ss_dssp EECCTTSCB----CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------H---HHHHHHHHT
T ss_pred eEecCCCee----ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------H---HHHHHHHcC
Confidence 876543221 223458999999999999899999999999999999999999997521 0 111111110
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.. . ..+.. ....++++.+ ++..|+. .||++|||+.|+++
T Consensus 248 ~~--~-~~~~~-~~~~s~~~~~---li~~~L~-~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KY--K-MNPRQ-WSHISESAKD---LVRRMLM-LDPAERITVYEALN 286 (351)
T ss_dssp CC--C-CCHHH-HTTSCHHHHH---HHHHHTC-SSTTTSCCHHHHHT
T ss_pred CC--C-CCccc-cccCCHHHHH---HHHHHCC-CChhHCcCHHHHhc
Confidence 00 0 00000 0112334443 4445666 99999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=332.45 Aligned_cols=267 Identities=16% Similarity=0.166 Sum_probs=206.0
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+|++++.++ +||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 5688899999999999999995 578999999986543 234578999999999 9999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC-----eEEeeccccccc
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE-----PKISDFGLARLM 457 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~-----~kl~Dfgla~~~ 457 (623)
+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 88 -GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred -CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999999643 35799999999999999999999999 9999999999999998887 999999999876
Q ss_pred CCCCCccc---ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 458 NPIDTHLS---TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 458 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~~ 235 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKERYQKIGDT 235 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHHHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHHHHHHHHhh
Confidence 43222111 0123446899999999999999999999999999999999999999864322 111111111000
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCC
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHF 592 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~ 592 (623)
.. ......+ ....+ .+..++..|+. .+|.+||++++|.+.|+++.++...
T Consensus 236 -~~-~~~~~~~-~~~~p----~~~~li~~~l~-~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 236 -KR-ATPIEVL-CENFP----EMATYLRYVRR-LDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp -HH-HSCHHHH-TTTCH----HHHHHHHHHHH-CCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -hc-cCCHHHH-hccCh----HHHHHHHHHHh-CCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00 0000000 11122 34444556666 8999999999999999998776543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.73 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=197.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcE----EEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTS----LMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|... ++.. |++|.+.... .....+.+|+.++.+++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999964 4443 7888775432 23346778999999999999999999986 456889
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999643 25689999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+...... .
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~-~ 237 (325)
T 3kex_A 166 PPDDKQL--LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----EVPDLLEKGERL-A 237 (325)
T ss_dssp CCCTTCC--C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----HHHHHHHTTCBC-C
T ss_pred Ccccccc--cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----HHHHHHHcCCCC-C
Confidence 5432221 1123347889999999998899999999999999999999 99999754321 111211111000 0
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
. ...... .+..++..|+. .||++||++.|+++.|+++...
T Consensus 238 ~---------~~~~~~---~~~~li~~~l~-~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 238 Q---------PQICTI---DVYMVMVKCWM-IDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp C---------CTTBCT---TTTHHHHHHTC-SCTTTSCCHHHHHHHHHHHTTS
T ss_pred C---------CCcCcH---HHHHHHHHHcC-CChhhCcCHHHHHHHHHHHHhc
Confidence 0 000111 23445556776 9999999999999999998654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.09 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=196.1
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|+.. ++.||+|++... ...+.+.+|++++.+++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 46788899999999999999985 788999998654 34567899999999999999999999876 347899999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC-eEEeecccccccCCCCCc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE-PKISDFGLARLMNPIDTH 463 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~-~kl~Dfgla~~~~~~~~~ 463 (623)
|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999975431 235788999999999999999999932228999999999999998886 7999999997654311
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........... .. +
T Consensus 161 -----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~-----~ 223 (307)
T 2eva_A 161 -----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVHNG-TR-----P 223 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHHTT-CC-----C
T ss_pred -----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHhcC-CC-----C
Confidence 1234899999999999999999999999999999999999999753221 11111111110 00 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCC
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHF 592 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~ 592 (623)
... ...++++ .+++..|+. .||++|||++|+++.|+.+.+....
T Consensus 224 ~~~-~~~~~~l---~~li~~~l~-~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PLI-KNLPKPI---ESLMTRCWS-KDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CCB-TTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred Ccc-cccCHHH---HHHHHHHhc-CChhhCcCHHHHHHHHHHHHHhccC
Confidence 000 1123333 344556776 9999999999999999999776643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.96 Aligned_cols=264 Identities=21% Similarity=0.315 Sum_probs=202.9
Q ss_pred hccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 374 (623)
.++|...+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|++++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788899999999999999995 245689999997542 3346789999999999 89999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCC-------------------CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDT-------------------GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISS 435 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~ 435 (623)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 99999999999999999754321 13489999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 006982 436 KCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVA 514 (623)
Q Consensus 436 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~ 514 (623)
+||+++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999876432221 11222346889999999988899999999999999999998 99999764
Q ss_pred CCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 515 KAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 515 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.... .....+...... . .....++++ ..++..|+. .||.+|||+.|+++.|+.+....
T Consensus 279 ~~~~----~~~~~~~~~~~~---------~-~~~~~~~~l---~~li~~~l~-~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 279 PVDA----NFYKLIQNGFKM---------D-QPFYATEEI---YIIMQSCWA-FDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCSH----HHHHHHHTTCCC---------C-CCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHC---
T ss_pred CcHH----HHHHHHhcCCCC---------C-CCCCCCHHH---HHHHHHHcC-CCchhCcCHHHHHHHHHHHHHHH
Confidence 3321 111111111000 0 011123344 444556776 99999999999999999886543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=331.54 Aligned_cols=253 Identities=19% Similarity=0.280 Sum_probs=192.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC-------
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------- 373 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 373 (623)
.++|...+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888999999999999999976 7999999998643 334577999999999999999999999986643
Q ss_pred --------------------------------------------------eeeEEEecCCCCCHhhhccCCCCCCCccCh
Q 006982 374 --------------------------------------------------ERLLVYKHMPNGSLYDLLHPADDTGKSVDW 403 (623)
Q Consensus 374 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~ 403 (623)
..++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 27899999999999999975432 345677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCccc--------ccccCCCCcc
Q 006982 404 PRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLS--------TFVNGEFGDL 475 (623)
Q Consensus 404 ~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--------~~~~~~~gt~ 475 (623)
..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999999 999999999999999999999999999987754321111 1123345899
Q ss_pred cccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHH
Q 006982 476 GYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELF 555 (623)
Q Consensus 476 ~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 555 (623)
.|+|||++.+..++.++||||||+++|||++|..|+.. ........ ......... .....
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~-~~~~~~~~~---------~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDV-RNLKFPLLF---------TQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHH-HTTCCCHHH---------HHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHh-hccCCCccc---------ccCCh
Confidence 99999999999999999999999999999998766421 00101110 010110000 11112
Q ss_pred HHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 556 QFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 556 ~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+..++..|+. .||++|||++|+++
T Consensus 301 ~~~~li~~~l~-~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLS-PSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHC-SSGGGSCCHHHHHH
T ss_pred hHHHHHHHHcc-CCCCcCCCHHHHhh
Confidence 33445556766 99999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=327.79 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=199.4
Q ss_pred ccCcccceeeccCccEEEEEEeCC----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEe-CCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMA-KKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 377 (623)
..|...+.||+|+||.||+|...+ ...+++|.+.... ...+.+.+|++++++++||||+++++++.. .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998643 2358999987533 345678999999999999999999999754 457789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999642 35688999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGER-PTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~-P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
............+..+|+.|+|||.+.+..++.++||||||+++|||++|.. ||...... ...........
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~--- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRR--- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----THHHHHHTTCC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHHhcCCC---
Confidence 5433222222334457889999999998899999999999999999999554 55432221 11111111000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
.......+++ +.+++..|+. .+|++|||+.|+++.|+++...+.
T Consensus 251 -------~~~~~~~~~~---l~~li~~~l~-~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 -------LLQPEYCPDP---LYEVMLKCWH-PKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -------CCCCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -------CCCCccCCHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHHhhc
Confidence 0001112333 4445556776 999999999999999999877653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.76 Aligned_cols=269 Identities=16% Similarity=0.188 Sum_probs=207.0
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+|++++.++ +|+|++++++++.+....++|+||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 5688899999999999999995 578999999986443 234577899999998 7999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC-----eEEeeccccccc
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE-----PKISDFGLARLM 457 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~-----~kl~Dfgla~~~ 457 (623)
+++|.+++... +..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 89 -~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 89 -GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99999999643 24689999999999999999999999 9999999999999987776 999999999876
Q ss_pred CCCCCccc---ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 458 NPIDTHLS---TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 458 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~ 239 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGEKKQS 239 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHHHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH--HHHHHHHhhccC
Confidence 54322111 1123345899999999999999999999999999999999999999764332110 111111111111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCC
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFT 593 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~ 593 (623)
....+.. ...++++.++ +..|+. .||++||++++|++.|+++.++....
T Consensus 240 ~~~~~~~------~~~~~~l~~l---i~~~l~-~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 240 TPLRELC------AGFPEEFYKY---MHYARN-LAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp SCHHHHT------TTSCHHHHHH---HHHHHH-CCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ccHHHHH------hhCcHHHHHH---HHHHhc-CCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 1111111 1233444444 445665 89999999999999999998776543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.10 Aligned_cols=202 Identities=24% Similarity=0.353 Sum_probs=172.7
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|...+++.||+|++..... ....+.+|++++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 367888999999999999999998899999999975432 24678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 888887542 24589999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 173 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 173 VRS----YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp CC-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred ccc----ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 221 122357999999999876 5689999999999999999999999976443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=332.92 Aligned_cols=272 Identities=22% Similarity=0.319 Sum_probs=207.1
Q ss_pred HHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCC--CCCCCCcceeEEEEeCC----e
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGS--VKNRNLVPLLGFCMAKK----E 374 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~ 374 (623)
....++|...+.||+|+||.||+|+. +++.||+|++.... ...+.+|.+++.. ++||||+++++++.... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 44567899999999999999999998 48999999996543 4566777777665 79999999999998876 7
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCceeeCCCCCe
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH--------HNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
.++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred eEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence 8999999999999999953 35899999999999999999999 66 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCC------CCCcchhHHHHHHHHHHHHhC----------CCC
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL------VATPKGDVYSFGTVLLELVTG----------ERP 510 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~sfGvil~elltg----------~~P 510 (623)
||+|||+++.................||+.|+|||.+.+. .++.++||||||+++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 9999999987654332222223344689999999998765 234789999999999999999 667
Q ss_pred CCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 511 TNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 511 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
|....... .....+....... ....-+.... ...+....+.+++..|+. .||++|||+.||++.|+++.++.
T Consensus 267 ~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~cl~-~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 267 YYDLVPSD---PSVEEMRKVVCEQ-KLRPNIPNRW---QSCEALRVMAKIMRECWY-ANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTSCSS---CCHHHHHHHHTTS-CCCCCCCGGG---GTSHHHHHHHHHHHHHCC-SSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccCcCc---ccHHHHHHHHHHH-HhCCCCcccc---cchhHHHHHHHHHHHHhc-cChhhCCCHHHHHHHHHHHHHHh
Confidence 76433221 1222222221111 1100011111 012344556677778887 99999999999999999998765
Q ss_pred C
Q 006982 591 H 591 (623)
Q Consensus 591 ~ 591 (623)
.
T Consensus 339 ~ 339 (342)
T 1b6c_B 339 G 339 (342)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=329.37 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=189.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---------------------------cHHHHHHHHHHhCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---------------------------SEKEFVAEMATLGS 356 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~e~~~l~~ 356 (623)
++|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999964 688999999864321 12468899999999
Q ss_pred CCCCCCcceeEEEEe--CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 006982 357 VKNRNLVPLLGFCMA--KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNIS 434 (623)
Q Consensus 357 l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk 434 (623)
++||||+++++++.+ ....++||||+++|+|.+++. ...+++..++.++.|++.||+|||+. +|+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 999999999999987 467899999999999998763 35689999999999999999999999 99999999
Q ss_pred CCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCC
Q 006982 435 SKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV---ATPKGDVYSFGTVLLELVTGERPT 511 (623)
Q Consensus 435 ~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~sfGvil~elltg~~P~ 511 (623)
|+||+++.++.+||+|||+++........ .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE----ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc----ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 99999999999999999999876543221 22345899999999997654 478899999999999999999999
Q ss_pred CCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 512 NVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 512 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..... ..+....... .. .. + .....++++. .++..|+. .||++|||+.|+++
T Consensus 241 ~~~~~--------~~~~~~~~~~-~~-~~--~--~~~~~~~~l~---~li~~~l~-~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERI--------MCLHSKIKSQ-AL-EF--P--DQPDIAEDLK---DLITRMLD-KNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSH--------HHHHHHHHHC-CC-CC--C--SSSCCCHHHH---HHHHHHTC-SCTTTSCCHHHHTT
T ss_pred CCccH--------HHHHHHHhcc-cC-CC--C--CccccCHHHH---HHHHHHhh-cChhhCCCHHHHhc
Confidence 64211 1111111110 00 00 0 0112334444 44456666 99999999999865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.17 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=206.7
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.++|...+.||+|+||.||+|.+.++..||||+++......+.|.+|+++|++++||||+++++++.+ +..++||||++
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 45688889999999999999999888899999998766667889999999999999999999999876 67899999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.... +..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 345 ~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 417 (535)
T 2h8h_A 345 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 417 (535)
T ss_dssp TEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--
T ss_pred CCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--
Confidence 999999996321 24589999999999999999999999 99999999999999999999999999998764311
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.....+..++..|+|||++....++.++|||||||++|||++ |+.||..... .+..........+ .
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~-~--- 484 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRM-P--- 484 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCCC-C---
T ss_pred -eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCC-C---
Confidence 111223346789999999998899999999999999999999 9999865321 1111111111000 0
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
......+++ .+++..|+. .||++|||+++|++.|+++...
T Consensus 485 ---~~~~~~~~l---~~li~~cl~-~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 ---CPPECPESL---HDLMCQCWR-KEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---CCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---CCCCCCHHH---HHHHHHHcC-CChhHCcCHHHHHHHHHHHhhc
Confidence 011233334 445556777 9999999999999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.72 Aligned_cols=200 Identities=17% Similarity=0.240 Sum_probs=174.0
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 377 (623)
.++|...++||+|+||.||+++.+ +++.||+|+++.... ....+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357899999999999999999965 578899999976432 223577899988776 89999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999963 24689999999999999999999999 9999999999999999999999999999863
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 204 ~~~~~~----~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 204 LRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCTTCC----BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccCCCc----cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 322211 22345899999999999999999999999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=324.85 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=191.0
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|+..+ .||+|+++... ...+.+.+|++++++++||||+++++++ .....++|+|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 3568889999999999999998753 59999987543 3346789999999999999999999965 4566899999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999643 35689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||......+ .+...+.........
T Consensus 174 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 174 SGS--HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVGRGSLSPDL 247 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHHHTSCCCCT
T ss_pred ccc--ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhcccccCcch
Confidence 111 1122345899999999986 5678889999999999999999999997543321 111111111111111
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
..+ ....+++ +.+++..|+. .+|++|||+.|+++.|+++.++
T Consensus 248 ~~~------~~~~~~~---l~~li~~~l~-~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 248 SKV------RSNCPKR---MKRLMAECLK-KKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp TSS------CTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHTTCC
T ss_pred hhc------cccCCHH---HHHHHHHHcc-CChhhCCCHHHHHHHHHHHhhC
Confidence 110 0112333 4444556776 9999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.75 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=197.6
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
+.|...+.||+|+||.||++... ++..||+|.+.... ...+.+.+|++++.+++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999965 68999999986532 24678999999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC----CeEEeecc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF----EPKISDFG 452 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~----~~kl~Dfg 452 (623)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999953 35689999999999999999999999 999999999999999887 89999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHh
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLS 532 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~ 532 (623)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......
T Consensus 164 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~~~ 230 (326)
T 2y0a_A 164 LAHKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVS 230 (326)
T ss_dssp TCEECCTTSC-----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHH
T ss_pred CCeECCCCCc-----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHH
Confidence 9987653221 12345899999999999889999999999999999999999999753221 1111111
Q ss_pred ccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 533 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.... ...+... ...+.++. .++..|+. .||++|||+.|+++
T Consensus 231 ~~~~--~~~~~~~--~~~~~~~~---~li~~~L~-~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 AVNY--EFEDEYF--SNTSALAK---DFIRRLLV-KDPKKRMTIQDSLQ 271 (326)
T ss_dssp HTCC--CCCHHHH--TTSCHHHH---HHHHHHSC-SSGGGSCCHHHHHH
T ss_pred hcCC--CcCcccc--ccCCHHHH---HHHHHHcc-CChhhCCCHHHHhc
Confidence 0000 0000000 11233333 34446666 99999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=358.41 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=196.2
Q ss_pred eeeccCccEEEEEEeC---CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCCCC
Q 006982 312 IIGSGRTGTMYKALLE---DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGS 386 (623)
Q Consensus 312 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 386 (623)
.||+|+||.||+|.+. ++..||||+++... ...+.+.+|++++.+++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 56679999997642 456789999999999999999999999976 56899999999999
Q ss_pred HhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccc
Q 006982 387 LYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466 (623)
Q Consensus 387 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 466 (623)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999643 35689999999999999999999999 9999999999999999999999999999876543221111
Q ss_pred cccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhh
Q 006982 467 FVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCL 545 (623)
Q Consensus 467 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 545 (623)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ +...+.. ...+ .
T Consensus 496 -~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~~i~~---~~~~-~------ 559 (613)
T 2ozo_A 496 -RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIEQ---GKRM-E------ 559 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----HHHHHHT---TCCC-C------
T ss_pred -ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHc---CCCC-C------
Confidence 112235689999999998999999999999999999998 999997643321 1111111 1000 0
Q ss_pred hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 546 VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
.....+++ +.+++..|+. .+|++||++.+|++.|+.+.....
T Consensus 560 ~p~~~~~~---l~~li~~cl~-~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 560 CPPECPPE---LYALMSDCWI-YKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CCTTCCHH---HHHHHHHTTC-SSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCCcCCHH---HHHHHHHHcC-CChhHCcCHHHHHHHHHHHHHHhc
Confidence 01123334 4445567877 999999999999999998765543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=324.80 Aligned_cols=251 Identities=26% Similarity=0.440 Sum_probs=194.6
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc--c------HHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR--S------EKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
++|...+.||+|+||.||+|.. .+++.||+|++..... . .+.+.+|++++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5688889999999999999996 4789999999864321 1 167899999999999999999999986554
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCceeeCCCCC-----eEE
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR--IIHRNISSKCILLDDDFE-----PKI 448 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlk~~NILl~~~~~-----~kl 448 (623)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7999999999999988643 35689999999999999999999998 7 999999999999988776 999
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccc--cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA--RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~ 526 (623)
+|||+++..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||...... ...
T Consensus 171 ~Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~ 237 (287)
T 4f0f_A 171 ADFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIK 237 (287)
T ss_dssp CCCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------HHH
T ss_pred CCCCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------HHH
Confidence 999999854321 1234589999999998 4456789999999999999999999999754321 111
Q ss_pred HHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 527 WIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
........... +.+ ....++++ .+++..|+. .||++|||++|+++.|+++
T Consensus 238 ~~~~~~~~~~~-----~~~-~~~~~~~l---~~li~~~l~-~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 FINMIREEGLR-----PTI-PEDCPPRL---RNVIELCWS-GDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHSCCC-----CCC-CTTSCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHhccCCC-----CCC-CcccCHHH---HHHHHHHhc-CChhhCcCHHHHHHHHHhC
Confidence 11111111000 000 11123333 344456766 9999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.29 Aligned_cols=269 Identities=24% Similarity=0.343 Sum_probs=203.4
Q ss_pred CcccceeeccCccEEEEEEeC-----CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--CeeeE
Q 006982 307 FSKNNIIGSGRTGTMYKALLE-----DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KERLL 377 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 377 (623)
|...+.||+|+||.||++.+. +++.||+|++.... .....+.+|++++.+++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998642 68889999997653 3356789999999999999999999999884 56789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999953 3489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
....... .......+|..|+|||++.+..++.++||||||+++|||++|+.||........ ....+.........+
T Consensus 185 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 185 PEGHEYY-RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL---ELIGIAQGQMTVLRL 260 (318)
T ss_dssp CTTCSEE-EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH---HHHCSCCHHHHHHHH
T ss_pred ccccccc-ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh---hhhcccccchhHHHH
Confidence 5432211 122234478889999999988899999999999999999999999864211000 000000000000011
Q ss_pred hhhhchhhhc---CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 538 QDAIDKCLVA---KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 538 ~~~~d~~l~~---~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
.+.++..... ...+.+ +.+++..|+. .||++|||++|+++.|+++.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~---l~~li~~~l~-~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAE---VYHLMKNCWE-TEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHH---HHHHHHHHcC-CCcccCcCHHHHHHHHHHHHHhhc
Confidence 1111111111 112333 4455557777 999999999999999999987764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=332.23 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=195.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCc----EEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGT----SLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|... ++. +|++|.+... ....+.+.+|++++.+++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888999999999999999954 444 3577777543 345678999999999999999999999998754 789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999643 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+...... .
T Consensus 168 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~~~~~~~-~ 239 (327)
T 3lzb_A 168 GAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGERL-P 239 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHTTCCC-C
T ss_pred cCccccc--cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCCC-C
Confidence 5432211 1223346889999999999999999999999999999999 99999754321 121211111000 0
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.......+ +..++..|+. .||++||++.|+++.|+++...
T Consensus 240 ---------~~~~~~~~---l~~li~~~l~-~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 240 ---------QPPICTID---VYMIMRKCWM-IDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCTTBCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCccCCHH---HHHHHHHHcC-CChhHCcCHHHHHHHHHHHHhC
Confidence 01112233 4445556776 9999999999999999998654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=338.73 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=191.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.++|...+.||+|+||.||+++.. +++.||+|++.......+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 457888999999999999999975 7899999999776655677899999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC--eEEeecccccccCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE--PKISDFGLARLMNPI 460 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~--~kl~Dfgla~~~~~~ 460 (623)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999853 24589999999999999999999999 9999999999999987776 999999999854321
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPK-GDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. .....||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ....+.........
T Consensus 172 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~~~-- 240 (361)
T 3uc3_A 172 SQ-----PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVKYS-- 240 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTCCC--
T ss_pred CC-----CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCCCC--
Confidence 11 123358999999999988777665 8999999999999999999976443222 22222221111000
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+. .......++. .++..|+. .||++|||+.|+++.
T Consensus 241 -~~---~~~~~s~~~~---~li~~~L~-~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 -IP---DDIRISPECC---HLISRIFV-ADPATRISIPEIKTH 275 (361)
T ss_dssp -CC---TTSCCCHHHH---HHHHHHSC-SCTTTSCCHHHHHTS
T ss_pred -CC---CcCCCCHHHH---HHHHHHcc-CChhHCcCHHHHHhC
Confidence 00 0011233443 44456666 999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=324.89 Aligned_cols=258 Identities=22% Similarity=0.374 Sum_probs=201.8
Q ss_pred cCcccc-eeeccCccEEEEEEeC---CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 306 SFSKNN-IIGSGRTGTMYKALLE---DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 306 ~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
+|...+ .||+|+||.||+|... ++..||+|+++... ...+.+.+|++++.+++||||+++++++ ..+..++|+
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 444455 8999999999999853 57889999997643 3456789999999999999999999999 456689999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp ECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999632 35689999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.. ...
T Consensus 163 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~i~~---~~~-- 231 (287)
T 1u59_A 163 DDSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIEQ---GKR-- 231 (287)
T ss_dssp CSCEE-CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHHHHHHT---TCC--
T ss_pred Cccee-eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHhc---CCc--
Confidence 32221 11222346889999999988889999999999999999999 99999754321 11111111 100
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
... ....++++ .+++..|+. .+|++||++.|+++.|+++..+.
T Consensus 232 ----~~~-~~~~~~~l---~~li~~~l~-~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 232 ----MEC-PPECPPEL---YALMSDCWI-YKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ----CCC-CTTCCHHH---HHHHHHTTC-SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCC-CCCcCHHH---HHHHHHHcC-CChhhCcCHHHHHHHHHHHHHhc
Confidence 000 11223344 444556776 99999999999999999986554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.58 Aligned_cols=260 Identities=23% Similarity=0.392 Sum_probs=196.7
Q ss_pred ccCcccceeeccCccEEEEEEeCC-----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+.||+|+||.||+|.... +..||+|++.... .....+.+|++++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677999999999999998642 2459999997543 334578899999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999643 25689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..........
T Consensus 198 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~ 268 (333)
T 1mqb_A 198 EDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC
T ss_pred ccccccc-cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCCCc
Confidence 5422111 11122346788999999998899999999999999999999 9999964321 111111111100
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.. .....+++ +.+++..|+. .+|++||++.|+++.|+++....
T Consensus 269 ~~-------~~~~~~~~---l~~li~~~l~-~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 LP-------TPMDCPSA---IYQLMMQCWQ-QERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CC-------CCTTCBHH---HHHHHHHHTC-SSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CC-------CcccCCHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHhcc
Confidence 00 01112333 4445567777 99999999999999999976543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=322.33 Aligned_cols=199 Identities=25% Similarity=0.387 Sum_probs=170.6
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||+|...+++.||+|++.... .....+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999999889999999986543 2346788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 999988643 24689999999999999999999999 99999999999999999999999999998764321
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 155 RK----YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc----cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 122347999999999875 45899999999999999999999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=332.44 Aligned_cols=245 Identities=20% Similarity=0.331 Sum_probs=196.1
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+++++.++||||+++++++.+....++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 578999999986532 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+ +|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 7899998853 24689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.. ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......+...... .. ..
T Consensus 161 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~---------~~-~~ 225 (336)
T 3h4j_B 161 GN-----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN---------SC-VY 225 (336)
T ss_dssp SB-----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC---------SS-CC
T ss_pred Cc-----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH---------cC-CC
Confidence 22 1233458999999999988776 789999999999999999999997643332211100 00 00
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
. .....+.++. .++..|+. .||.+|||++|+++.
T Consensus 226 -----~-~p~~~s~~~~---~li~~~L~-~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 -----V-MPDFLSPGAQ---SLIRRMIV-ADPMQRITIQEIRRD 259 (336)
T ss_dssp -----C-CCTTSCHHHH---HHHHTTSC-SSGGGSCCHHHHTTC
T ss_pred -----C-CcccCCHHHH---HHHHHHcC-CChhHCcCHHHHHhC
Confidence 0 0111233333 34456666 999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.32 Aligned_cols=208 Identities=22% Similarity=0.252 Sum_probs=177.4
Q ss_pred hccCcccceeecc--CccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 304 TNSFSKNNIIGSG--RTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
.++|...+.||+| +||.||+|... +++.||+|++.... ...+.+.+|++++++++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578889999999 99999999976 79999999997543 234567889999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999996542 24589999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCC---cccccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 458 NPIDT---HLSTFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 458 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
..... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 32111 11111223458999999999987 6789999999999999999999999976544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=328.51 Aligned_cols=264 Identities=20% Similarity=0.316 Sum_probs=196.9
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||+|.. .++..||+|++... ......+.+|++++.+++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35788899999999999999996 57899999998742 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++.........+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864322345689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ..
T Consensus 188 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~- 255 (310)
T 2wqm_A 188 SKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQC-DY- 255 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHHHTT-CS-
T ss_pred CCCcc----ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHhhcc-cC-
Confidence 32211 1223488999999999998999999999999999999999999964321 111222111110 00
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
+.+.....++++. +++..|+. .||++|||+.+|++.|+++....
T Consensus 256 ----~~~~~~~~~~~l~---~li~~~l~-~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 256 ----PPLPSDHYSEELR---QLVNMCIN-PDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp ----CCCCTTTSCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCcccccCHHHH---HHHHHHcC-CChhhCCCHHHHHHHHHHHHHhh
Confidence 0011112334444 44456776 99999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.05 Aligned_cols=199 Identities=18% Similarity=0.248 Sum_probs=174.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+++.+ +++.||+|++.... .....+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999975 58899999997543 2345678899999887 899999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999963 24689999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 162 RPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp CTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred CCCCc----ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 22211 22345899999999999999999999999999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.75 Aligned_cols=267 Identities=18% Similarity=0.238 Sum_probs=196.7
Q ss_pred ccCcccceeeccCccEEEEEEeC----CCcEEEEEEeccccc------------cHHHHHHHHHHhCCCCCCCCcceeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQR------------SEKEFVAEMATLGSVKNRNLVPLLGF 368 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~~ 368 (623)
++|...+.||+|+||.||+|... ++..+|+|++..... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999975 577899999865421 12346678899999999999999999
Q ss_pred EEe----CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC
Q 006982 369 CMA----KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF 444 (623)
Q Consensus 369 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~ 444 (623)
+.. ....++||||+ +++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 988 67789999999 99999999632 3789999999999999999999999 999999999999999887
Q ss_pred --CeEEeecccccccCCCCCc---ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 006982 445 --EPKISDFGLARLMNPIDTH---LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPET 519 (623)
Q Consensus 445 --~~kl~Dfgla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~ 519 (623)
.+||+|||+++.+...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876432211 1111233468999999999999899999999999999999999999996421110
Q ss_pred ccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 520 FKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 520 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
........... ..+...+..+......++++.+++ ..|+. .||++||++++|++.|+++..
T Consensus 268 ---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li---~~~l~-~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 ---VAVQTAKTNLL-DELPQSVLKWAPSGSSCCEIAQFL---VCAHS-LAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp ---HHHHHHHHHHH-HTTTHHHHHHSCTTSCCHHHHHHH---HHHHT-CCTTCCCCHHHHHHHHCTTCC
T ss_pred ---HHHHHHHHhhc-ccccHHHHhhccccccHHHHHHHH---HHHhh-cCcccCCCHHHHHHHHhccCC
Confidence 01111111110 111222222222223444555554 45666 999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.70 Aligned_cols=200 Identities=22% Similarity=0.318 Sum_probs=172.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 377 (623)
.++|...+.||+|+||.||+|+.+ +++.||+|+++.. ......+..|.+++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999965 6899999999753 23456678899999887 79999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999963 24689999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 175 ICNGVT----TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp CC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCcc----ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 332211 22335899999999999888999999999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=330.62 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=201.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcE--EEEEEeccc--cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTS--LMVKRLQDS--QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|... ++.. +++|.+... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999964 5554 488988653 23445788999999999 999999999999999999999
Q ss_pred EecCCCCCHhhhccCCC------------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 379 YKHMPNGSLYDLLHPAD------------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997543 2235789999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~ 525 (623)
||+|||+++....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .
T Consensus 182 kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~ 248 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------A 248 (327)
T ss_dssp EECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------H
T ss_pred EEcccCcCcccccccc-----ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------H
Confidence 9999999975432111 112236789999999988889999999999999999998 9999965321 1
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccC
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYH 591 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~ 591 (623)
+........... . .....++++ ..++..|+. .||++|||+.|+++.|+++.++..
T Consensus 249 ~~~~~~~~~~~~------~-~~~~~~~~l---~~li~~~l~-~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 249 ELYEKLPQGYRL------E-KPLNCDDEV---YDLMRQCWR-EKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHHGGGTCCC------C-CCTTBCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHHhhcCCCC------C-CCCCCCHHH---HHHHHHHcc-CChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111111000 0 001123333 444556776 999999999999999999876653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.66 Aligned_cols=256 Identities=13% Similarity=0.147 Sum_probs=199.0
Q ss_pred hccCcccceeeccCccEEEEEE------eCCCcEEEEEEeccccccHHHHHHHHHHhCCCC---CCCCcceeEEEEeCCe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKAL------LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK---NRNLVPLLGFCMAKKE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~ 374 (623)
.++|...+.||+|+||.||+|. ..+++.||+|++... ...++..|++++.+++ |+|++++++++...+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 4678889999999999999994 456889999999754 3456667777766665 9999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCC-CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-----------
Q 006982 375 RLLVYKHMPNGSLYDLLHPADD-TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD----------- 442 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~----------- 442 (623)
.++||||+++|+|.+++..... ....++|..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999964221 235699999999999999999999999 9999999999999998
Q ss_pred CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccc
Q 006982 443 DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG 522 (623)
Q Consensus 443 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~ 522 (623)
++.+||+|||+++.+..... ........||++|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 89999999999976532111 1222345689999999999999999999999999999999999999854221100
Q ss_pred cHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCC-CCHHHHHHHHHHhhccc
Q 006982 523 NLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKER-PTMFEVYQFLRAIGERY 590 (623)
Q Consensus 523 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~R-Ps~~ev~~~L~~i~~~~ 590 (623)
. +...+......+.+..+++.++ . .+|.+| |+++++.+.|+++.++.
T Consensus 294 -------------~----~~~~~~~~~~~~~~~~~~~~~l---~-~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 -------------K----PEGLFRRLPHLDMWNEFFHVML---N-IPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------------E----ECSCCTTCSSHHHHHHHHHHHH---C-CCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------e----echhccccCcHHHHHHHHHHHc---C-CCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 1111111123445555555433 3 667777 78999999999876654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.18 Aligned_cols=265 Identities=23% Similarity=0.351 Sum_probs=194.8
Q ss_pred HHhccCcccceeeccCccEEEEEEeC----CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALLE----DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 374 (623)
...++|...+.||+|+||.||+|... .+..||+|++.... ...+.+.+|++++.+++||||+++++++.+...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888999999999999999854 34579999987543 234678899999999999999999999987653
Q ss_pred -----eeEEEecCCCCCHhhhccCCC--CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeE
Q 006982 375 -----RLLVYKHMPNGSLYDLLHPAD--DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPK 447 (623)
Q Consensus 375 -----~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~k 447 (623)
.++|+||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 489999999999999984322 2345699999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHH
Q 006982 448 ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVE 526 (623)
Q Consensus 448 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~ 526 (623)
|+|||+++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 188 l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~ 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-----EMYD 260 (313)
T ss_dssp ECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHH
T ss_pred EeecCcceecccccccC--cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHH
Confidence 99999998764422111 1122346889999999999999999999999999999999 88888653321 1111
Q ss_pred HHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 527 WIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.+...... . ......++ +.+++..|+. .||++|||+.++++.|+++.++.
T Consensus 261 ~~~~~~~~---------~-~~~~~~~~---l~~li~~~l~-~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 261 YLLHGHRL---------K-QPEDCLDE---LYEIMYSCWR-TDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHTTCCC---------C-CBTTCCHH---HHHHHHHTTC-SSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHcCCCC---------C-CCccccHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHHhc
Confidence 11110000 0 00112233 4455567777 99999999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=331.18 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=197.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
.++|...+.||+|+||.||++... ++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999965 68999999996543 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC---CCeEEeecccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD---FEPKISDFGLARL 456 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~---~~~kl~Dfgla~~ 456 (623)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 108 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999853 35689999999999999999999999 99999999999999865 4599999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 181 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~ 247 (362)
T 2bdw_A 181 VNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAY 247 (362)
T ss_dssp CTTCCS-----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC
T ss_pred ecCCcc-----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCC
Confidence 653221 1234589999999999998999999999999999999999999975321 111111111000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
....+.+ ...++++.+ ++..|+. .||++||++.|+++.
T Consensus 248 --~~~~~~~--~~~~~~~~~---li~~~L~-~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 --DYPSPEW--DTVTPEAKS---LIDSMLT-VNPKKRITADQALKV 285 (362)
T ss_dssp --CCCTTGG--GGSCHHHHH---HHHHHSC-SSGGGSCCHHHHTTS
T ss_pred --CCCcccc--cCCCHHHHH---HHHHHcC-CChhhCcCHHHHhcC
Confidence 0000000 112334444 4445665 999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.14 Aligned_cols=253 Identities=18% Similarity=0.220 Sum_probs=197.6
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
..++|...+.||+|+||.||++.. .+|+.+|+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356799999999999999999985 478999999986543 3345688999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC---CCCCeEEeeccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD---DDFEPKISDFGLAR 455 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~---~~~~~kl~Dfgla~ 455 (623)
|||+++|+|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++ +++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999863 34689999999999999999999999 999999999999998 56889999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ ..+..||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.........
T Consensus 162 ~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~ 229 (444)
T 3soa_A 162 EVEGEQQA----WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGA 229 (444)
T ss_dssp CCCTTCCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC
T ss_pred EecCCCce----eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCC
Confidence 76543221 1234589999999999998999999999999999999999999965321 11111111100
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
. +...+. ....++++.+++ ..|+. .||++|||+.|+++.
T Consensus 230 ~--~~~~~~--~~~~s~~~~~li---~~~L~-~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 230 Y--DFPSPE--WDTVTPEAKDLI---NKMLT-INPSKRITAAEALKH 268 (444)
T ss_dssp C--CCCTTT--TTTSCHHHHHHH---HHHSC-SSTTTSCCHHHHHHS
T ss_pred C--CCCccc--cccCCHHHHHHH---HHHcC-CChhHCCCHHHHhcC
Confidence 0 000010 012334444444 45665 999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=329.97 Aligned_cols=263 Identities=20% Similarity=0.208 Sum_probs=196.2
Q ss_pred HHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc------cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC
Q 006982 300 LMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS------QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372 (623)
Q Consensus 300 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 372 (623)
+....++|...+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++.+++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3455678999999999999999999964 6889999998643 23456789999999999999999999999999
Q ss_pred CeeeEEEecCCCCCHhhhccCCCC------------------------------------CCCccChHHHHHHHHHHHHH
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADD------------------------------------TGKSVDWPRRLKIAIGAARG 416 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~~ 416 (623)
+..++||||+++|+|.+++..... ....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852100 01234677788999999999
Q ss_pred HHHHHhcCCCCcEecCCCCCceeeCCCC--CeEEeecccccccCCCCCcccccccCCCCcccccCcccccC--CCCCcch
Q 006982 417 FAWLHHNCNPRIIHRNISSKCILLDDDF--EPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART--LVATPKG 492 (623)
Q Consensus 417 l~yLH~~~~~~i~H~dlk~~NILl~~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~ 492 (623)
|+|||+. +|+||||||+||+++.++ .+||+|||+++.................||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 89999999998764322222222234458999999999865 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCC
Q 006982 493 DVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKE 572 (623)
Q Consensus 493 DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~ 572 (623)
||||||+++|||++|+.||...... +........... ...+.. ...++++. .++..|+. .||++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~--~~~~~~--~~~~~~~~---~li~~~l~-~~p~~ 321 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLC--FENPNY--NVLSPLAR---DLLSNLLN-RNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC--TTSGGG--GGSCHHHH---HHHHHHSC-SCTTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcccc--cCCccc--ccCCHHHH---HHHHHHcC-CChhH
Confidence 9999999999999999999753221 111111111000 000000 01233333 44456666 99999
Q ss_pred CCCHHHHHH
Q 006982 573 RPTMFEVYQ 581 (623)
Q Consensus 573 RPs~~ev~~ 581 (623)
||++.|+++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.67 Aligned_cols=269 Identities=22% Similarity=0.335 Sum_probs=202.5
Q ss_pred ccCcccceeeccCccEEEEEEe-----CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-----EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 376 (623)
++|...+.||+|+||.||++.+ .++..||+|++.... ...+.+.+|++++.+++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688889999999999999984 468899999997653 345678999999999999999999999874 45678
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999632 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhc---
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS--- 533 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~--- 533 (623)
....... ........+|..|+|||++.+..++.++||||||+++|||++|+.||...... .......
T Consensus 177 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---------~~~~~~~~~~ 246 (327)
T 3lxl_A 177 LPLDKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE---------FLRMMGCERD 246 (327)
T ss_dssp CCTTCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---------HHHHCC----
T ss_pred cccCCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch---------hhhhcccccc
Confidence 6543221 11223345788899999999888999999999999999999999998642110 0000000
Q ss_pred cCc---hhhhhchhhh---cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCC
Q 006982 534 TGQ---LQDAIDKCLV---AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFT 593 (623)
Q Consensus 534 ~~~---~~~~~d~~l~---~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~ 593 (623)
... +.+.+..... ....++++ .+++..|+. .||++|||+.|+++.|+.+.......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~l---~~li~~~l~-~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 247 VPALSRLLELLEEGQRLPAPPACPAEV---HELMKLCWA-PSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp CCHHHHHHHHHHTTCCCCCCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHC-------
T ss_pred cccHHHHHHHhhcccCCCCCCcccHHH---HHHHHHHcC-CChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 000 1111111111 11123344 445556776 99999999999999999986655433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.44 Aligned_cols=273 Identities=16% Similarity=0.229 Sum_probs=207.4
Q ss_pred ccCcccceeeccCccEEEEEEeCC---------CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcc-----------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED---------GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP----------- 364 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~----------- 364 (623)
++|...+.||+|+||.||+|.... ++.||+|++... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 578889999999999999999763 788999998654 36778999999999999887
Q ss_pred ----eeEEEEe-CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCcee
Q 006982 365 ----LLGFCMA-KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCIL 439 (623)
Q Consensus 365 ----l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NIL 439 (623)
+++++.. ....++||||+ +|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 6777776 67889999999 999999997432 25699999999999999999999999 9999999999999
Q ss_pred eCCCC--CeEEeecccccccCCCCCccc---ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 440 LDDDF--EPKISDFGLARLMNPIDTHLS---TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 440 l~~~~--~~kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++.++ .+||+|||+++.......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 999999999987654222111 1112346899999999999989999999999999999999999999753
Q ss_pred CCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCC
Q 006982 515 KAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTT 594 (623)
Q Consensus 515 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 594 (623)
.... ..+........ .....+.+.+......++++.+++ ..|+. .||++||+++++++.|+++.++.....
T Consensus 272 ~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li---~~~l~-~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 272 LPNT---EDIMKQKQKFV--DKPGPFVGPCGHWIRPSETLQKYL---KVVMA-LTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp TTCH---HHHHHHHHHHH--HSCCCEECTTSCEECCCHHHHHHH---HHHHT-CCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred CcCH---HHHHHHHHhcc--CChhhhhhhccccCCCcHHHHHHH---HHHHh-CChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 3111 11111111111 111222222222223345555554 45666 999999999999999999988776554
Q ss_pred Cc
Q 006982 595 ED 596 (623)
Q Consensus 595 ~~ 596 (623)
.+
T Consensus 343 ~~ 344 (352)
T 2jii_A 343 YD 344 (352)
T ss_dssp TS
T ss_pred Cc
Confidence 33
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.13 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=195.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||++... +++.||+|++.... .....+.+|++++.+++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999965 58899999986532 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccCCCCcccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYART---LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ..............
T Consensus 168 ~~~-----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 168 ETQ-----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIVHTFETTVV 237 (384)
T ss_dssp TCC-----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHHHHHHHCCC
T ss_pred CCc-----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhhccc
Confidence 221 223458999999999874 45899999999999999999999999753321 11111111110000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCC-HHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPT-MFEVYQ 581 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs-~~ev~~ 581 (623)
. .....+.++..+ +..|+. .||++||+ ++++.+
T Consensus 238 -------~-~p~~~s~~~~~l---i~~lL~-~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -------T-YPSAWSQEMVSL---LKKLLE-PNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------C-CCTTSCHHHHHH---HHHHSC-SSGGGSCCSHHHHHT
T ss_pred -------C-CCCcCCHHHHHH---HHHHhc-CCHhHhcccHHHHHc
Confidence 0 011123344444 445665 99999998 666654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=329.40 Aligned_cols=267 Identities=19% Similarity=0.267 Sum_probs=199.9
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc-cccHHHHHHHHHHhCCCCCCCCcceeEEEEe----CCeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS-QRSEKEFVAEMATLGSVKNRNLVPLLGFCMA----KKERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 377 (623)
.++|...+.||+|+||.||++.. .+++.||+|++... ....+.+.+|++++.+++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788899999999999999996 57899999988653 3445678999999999999999999999873 346789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|+|.+++......+..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999865433446799999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCccc-----ccccCCCCcccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHH
Q 006982 458 NPIDTHLS-----TFVNGEFGDLGYVAPEYARTLV---ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIA 529 (623)
Q Consensus 458 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~ 529 (623)
........ .......||+.|+|||.+.... ++.++||||||+++|||++|+.||...... .........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~ 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALAVQ 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHHhh
Confidence 32111000 0011223689999999987543 689999999999999999999998531100 001111111
Q ss_pred HHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.... . + .....+.+ +.+++..|+. .||.+|||+.|+++.|+.+....
T Consensus 262 ~~~~------~--~--~~~~~~~~---l~~li~~~l~-~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 262 NQLS------I--P--QSPRHSSA---LWQLLNSMMT-VDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp CC--------C--C--CCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ccCC------C--C--ccccCCHH---HHHHHHHHhh-cChhhCCCHHHHHHHhhhcCCCC
Confidence 0000 0 0 00112333 4445556776 99999999999999999986544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=327.56 Aligned_cols=266 Identities=20% Similarity=0.326 Sum_probs=200.4
Q ss_pred ccCcccceeeccCccEEEEEEe-----CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--Cee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-----EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK--KER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 375 (623)
+.|...+.||+|+||.||+|.+ .+++.||+|++.... .....+.+|++++.+++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999983 468899999997543 3457889999999999999999999999876 567
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999532 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+..... .............
T Consensus 175 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 175 AIETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFLKMIGPTHGQM 247 (302)
T ss_dssp ECCTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHHCSCCGGG
T ss_pred cccCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHhhccCCccccc
Confidence 76543221 1222334578889999999988899999999999999999999998643110 0000000000000
Q ss_pred chhhhhchh---hh---cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 536 QLQDAIDKC---LV---AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 536 ~~~~~~d~~---l~---~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
....+.... .. ....+++ +.+++..|+. .||++|||+.|+++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~---l~~li~~~l~-~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDE---VYQLMRKCWE-FQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHH---HHHHHHHTTC-SSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHH---HHHHHHHHcC-CCCCCCCCHHHHHHHHHHHh
Confidence 000111000 00 0112333 4455556776 99999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.07 Aligned_cols=198 Identities=22% Similarity=0.328 Sum_probs=169.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|+||+||+|... +++.||+|++.... .....+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999965 68999999996533 234678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 55555532 235689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccCCCCcccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLV-ATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 155 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 155 VRC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSC----CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ccc----ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 221 12345899999999997765 79999999999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.50 Aligned_cols=274 Identities=20% Similarity=0.300 Sum_probs=206.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC--eeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK--ERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 379 (623)
++|...++||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888999999999999999976 58999999997543 44677889999999999999999999998765 678999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee----CCCCCeEEeeccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL----DDDFEPKISDFGLAR 455 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl----~~~~~~kl~Dfgla~ 455 (623)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999965432 23489999999999999999999999 99999999999999 788889999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHH
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYART--------LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~ 527 (623)
....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||............+...
T Consensus 165 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp ECCCGGG-----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred EccCCCc-----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 7654221 123458999999998864 567889999999999999999999997544332222222221
Q ss_pred HHHHhccCc---hhhhhchhh------h-cCCCHHHHHH-HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 528 IAQLSSTGQ---LQDAIDKCL------V-AKGVDNELFQ-FLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 528 ~~~~~~~~~---~~~~~d~~l------~-~~~~~~~~~~-~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.... .... .......++ . .......+.. +..+...|+. .||++||+++|+++.++++..+
T Consensus 240 ~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~-~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE-ADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSC-CCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhc-cChhhhccHHHHHHHHHHHhhc
Confidence 1110 0000 000000000 0 0011233333 3445555655 9999999999999999997665
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=331.07 Aligned_cols=266 Identities=24% Similarity=0.379 Sum_probs=205.9
Q ss_pred HHHhccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 372 (623)
....++|...+.||+|+||.||+|... ++..||+|.+.... .....+.+|++++.+++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344577899999999999999999854 36789999997543 3345688999999999999999999999999
Q ss_pred CeeeEEEecCCCCCHhhhccCCC------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 373 KERLLVYKHMPNGSLYDLLHPAD------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeE
Confidence 99999999999999999986421 1124578999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~ 525 (623)
||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 178 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~ 247 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------E 247 (322)
T ss_dssp EECCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------H
T ss_pred EECcCcccccccccccc--ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--------H
Confidence 99999999865432211 11222346889999999998889999999999999999999 8888864321 1
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
......... .... .....++++. +++..|+. .||++|||+.|+++.|+++.++.
T Consensus 248 ~~~~~~~~~-~~~~------~~~~~~~~l~---~li~~~l~-~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 248 QVLRFVMEG-GLLD------KPDNCPDMLF---ELMRMCWQ-YNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HHHHHHHTT-CCCC------CCTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHHHHHHcC-CcCC------CCCCCCHHHH---HHHHHHcC-CCcccCcCHHHHHHHHHHhhccC
Confidence 111111111 1000 0112333444 44456766 99999999999999999875543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.78 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=183.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.+.|...+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 457888999999999999999976 57899999997543 3456889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeecccccccCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLARLMNP 459 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Dfgla~~~~~ 459 (623)
++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 131 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 131 TGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999963 34689999999999999999999999 9999999999999975 88999999999987543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... .
T Consensus 204 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~~~~~--~ 269 (349)
T 2w4o_A 204 QVL-----MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRILNCEY--Y 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHHTTCC--C
T ss_pred ccc-----cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHHhCCC--c
Confidence 211 123358999999999999899999999999999999999999997533211 01111111100 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
...+.. ...+.++ ..++..|+. .||++|||+.|+++
T Consensus 270 ~~~~~~--~~~~~~~---~~li~~~L~-~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FISPWW--DEVSLNA---KDLVRKLIV-LDPKKRLTTFQALQ 305 (349)
T ss_dssp CCTTTT--TTSCHHH---HHHHHTTSC-SSGGGSCCHHHHHH
T ss_pred cCCchh--hhCCHHH---HHHHHHHcc-CChhhCcCHHHHhc
Confidence 000000 1123333 344556776 99999999999876
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=345.14 Aligned_cols=209 Identities=20% Similarity=0.227 Sum_probs=180.0
Q ss_pred HHHHHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEe
Q 006982 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371 (623)
Q Consensus 297 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 371 (623)
+.++....++|...++||+|+||.||+|+.. +++.||+|++.... .....+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455556789999999999999999999976 47889999996532 222347889999999999999999999999
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999642 35689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
|+++......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 220 Gla~~~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 220 GSCLKLMEDGTVQ---SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp TTCEECCTTSCEE---CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hhhhhcccCCCcc---cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 9998765432221 12345899999999987 567899999999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.69 Aligned_cols=252 Identities=19% Similarity=0.274 Sum_probs=198.4
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.+.|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357899999999999999999965 68899999986543 3445788999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC--CCCeEEeecccccccCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD--DFEPKISDFGLARLMNP 459 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~--~~~~kl~Dfgla~~~~~ 459 (623)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999632 24689999999999999999999999 9999999999999974 57899999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...........
T Consensus 204 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~~~~~~-- 268 (387)
T 1kob_A 204 DEIV-----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDWE-- 268 (387)
T ss_dssp TSCE-----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCCC--
T ss_pred Ccce-----eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCC--
Confidence 3221 122489999999999999999999999999999999999999975321 1111111111000
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+... ....++++ ..++..|+. .||++|||+.|+++.
T Consensus 269 -~~~~~-~~~~s~~~---~~li~~~L~-~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 -FDEDA-FSSVSPEA---KDFIKNLLQ-KEPRKRLTVHDALEH 305 (387)
T ss_dssp -CCSST-TTTSCHHH---HHHHHTTSC-SSGGGSCCHHHHHTS
T ss_pred -CCccc-cccCCHHH---HHHHHHHcC-CChhHCcCHHHHhhC
Confidence 00000 01123333 344556766 999999999999763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.75 Aligned_cols=259 Identities=18% Similarity=0.216 Sum_probs=201.0
Q ss_pred HHHHHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEe
Q 006982 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371 (623)
Q Consensus 297 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 371 (623)
+.++....++|...+.||+|+||.||+|+.. +++.||+|++.... .....+.+|++++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556788999999999999999999975 58899999986532 223457889999999999999999999999
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
....++||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999953 3588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV----ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~ 527 (623)
|+++....... .......||+.|+|||++.... ++.++|||||||++|||++|+.||...... ..
T Consensus 213 G~a~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~ 281 (410)
T 3v8s_A 213 GTCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GT 281 (410)
T ss_dssp TTCEECCTTSE---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HH
T ss_pred ceeEeeccCCc---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------hH
Confidence 99987654321 1123446999999999997655 789999999999999999999999753221 11
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCC--CCCHHHHHHH
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKE--RPTMFEVYQF 582 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~--RPs~~ev~~~ 582 (623)
........ ..+.-+ .....++++..+++ .|+. .+|.+ ||+++||++.
T Consensus 282 ~~~i~~~~--~~~~~p--~~~~~s~~~~~li~---~lL~-~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 282 YSKIMNHK--NSLTFP--DDNDISKEAKNLIC---AFLT-DREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHTHH--HHCCCC--TTCCCCHHHHHHHH---HHSS-CGGGCTTSSCHHHHHTS
T ss_pred HHHHHhcc--ccccCC--CcccccHHHHHHHH---HHcc-ChhhhCCCCCHHHHhcC
Confidence 11111000 000000 01123455555554 4554 67888 9999998864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=323.42 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=193.9
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-CeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-KERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~~ 383 (623)
++|...+.||+|+||.||++... ++.||+|++.... ..+.+.+|++++.+++||||+++++++.+. +..++|+||++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 57888999999999999999885 8899999997553 456789999999999999999999997655 46899999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 99 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999995321 12378999999999999999999999 99999999999999999999999999998654321
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ..... . .
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~---~~~~~-~-----~ 232 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVP---RVEKG-Y-----K 232 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHH---HHTTT-C-----C
T ss_pred -----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH---HHhcC-C-----C
Confidence 11236889999999998889999999999999999998 99998753221 1111 11110 0 0
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.. .....++++. +++..|+. .||++||++.|+++.|+++...
T Consensus 233 ~~-~~~~~~~~l~---~li~~~l~-~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MD-APDGCPPAVY---EVMKNCWH-LDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CC-CCTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC-CcccCCHHHH---HHHHHHhc-CChhhCCCHHHHHHHHHHHHhh
Confidence 00 0112334444 44456776 9999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=329.43 Aligned_cols=270 Identities=23% Similarity=0.325 Sum_probs=207.5
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEE
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGF 368 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~ 368 (623)
.......++|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++.++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34444457899999999999999999984 356889999997643 2345788999999999 78999999999
Q ss_pred EEeCC-eeeEEEecCCCCCHhhhccCCCCC------------CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 006982 369 CMAKK-ERLLVYKHMPNGSLYDLLHPADDT------------GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISS 435 (623)
Q Consensus 369 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~ 435 (623)
+...+ ..++|+||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCcc
Confidence 88765 488999999999999999754321 12388999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 006982 436 KCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVA 514 (623)
Q Consensus 436 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~ 514 (623)
+||+++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEECCCCCEEECCCccccccccCccc--eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999876442221 11122346889999999998899999999999999999998 99999754
Q ss_pred CCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 515 KAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 515 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
...+ .....+.... . .. .......+ +.+++..|+. .||.+|||+.|+++.|+++.+..
T Consensus 255 ~~~~----~~~~~~~~~~---~------~~-~~~~~~~~---l~~li~~~l~-~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDE----EFCRRLKEGT---R------MR-APDYTTPE---MYQTMLDCWH-GEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSH----HHHHHHHHTC---C------CC-CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhH----HHHHHhccCc---c------CC-CCCCCCHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHhhh
Confidence 3221 1111111100 0 00 01112333 4445556776 99999999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=324.23 Aligned_cols=203 Identities=23% Similarity=0.373 Sum_probs=160.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467888999999999999999964 68999999986532 334678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCC--CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 381 HMPNGSLYDLLHPAD--DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|++ |+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999885421 1224589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 160 IPVNT----FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp SCCCC----CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCccc----CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32211 123458999999999876 46899999999999999999999999754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.88 Aligned_cols=256 Identities=18% Similarity=0.300 Sum_probs=197.8
Q ss_pred hccCcccceeeccCccEEEEEEeCC----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
.++|...+.||+|+||.||+|...+ +..||+|.+.... ...+.+.+|++++.+++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3578889999999999999998543 3359999987642 345678999999999999999999999764 45689
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999642 24589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+...... .
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~~~~~-~ 234 (281)
T 3cc6_A 164 EDEDYYK---ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKGDRL-P 234 (281)
T ss_dssp ------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHHTCCC-C
T ss_pred ccccccc---cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhcCCCC-C
Confidence 5422111 122346889999999988889999999999999999998 99999753221 111111111000 0
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.....+++ +..++..|+. .||++||++.|+++.|+++.+
T Consensus 235 ---------~~~~~~~~---l~~li~~~l~-~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 235 ---------KPDLCPPV---LYTLMTRCWD-YDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCHH---HHHHHHHHcc-CCchhCcCHHHHHHHHHHHHH
Confidence 01112333 3444556776 999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.73 Aligned_cols=256 Identities=22% Similarity=0.367 Sum_probs=197.2
Q ss_pred ccCcccc-eeeccCccEEEEEEe---CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNN-IIGSGRTGTMYKALL---EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
++|...+ .||+|+||.||+|.. .++..||+|++.... ...+.+.+|++++.+++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566667 999999999999964 346789999997543 2356789999999999999999999999 5667889
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999964 24589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.. ..
T Consensus 168 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~----~~ 237 (291)
T 1xbb_A 168 RADENYYK-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLEK----GE 237 (291)
T ss_dssp CTTCSEEE-C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHT----TC
T ss_pred ccCCCccc-ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc----CC
Confidence 54332211 1122336789999999988888999999999999999999 99999753221 11111111 00
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
... .....++++. .++..|+. .||++||++.|+++.|+++-.
T Consensus 238 ~~~------~~~~~~~~l~---~li~~~l~-~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 RMG------CPAGCPREMY---DLMNLCWT-YDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCC------CCTTCCHHHH---HHHHHHTC-SSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC------CCCCCCHHHH---HHHHHHcC-CChhhCcCHHHHHHHHHHHHH
Confidence 000 0112233444 44456776 999999999999999998743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=335.29 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=204.3
Q ss_pred hccCcccceeeccCccEEEEEEeCC------CcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 374 (623)
.++|...+.||+|+||.||+|.... ...||+|.+.... ...+.+.+|++++.++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678889999999999999999642 2479999997643 3456789999999999 89999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCC----------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC
Q 006982 375 RLLVYKHMPNGSLYDLLHPADD----------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF 444 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~ 444 (623)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999854210 124579999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccccccc
Q 006982 445 EPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGN 523 (623)
Q Consensus 445 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~ 523 (623)
.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||....... .
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~ 275 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----K 275 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH----H
T ss_pred eEEECccccccccccccce--eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH----H
Confidence 9999999999865432211 11223346789999999998899999999999999999999 999987543221 1
Q ss_pred HHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 524 LVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 524 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
....+...... . .....+++ +..++..|+. .||.+|||+.||++.|+++.++
T Consensus 276 ~~~~~~~~~~~---------~-~~~~~~~~---l~~li~~~l~-~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 FYKLVKDGYQM---------A-QPAFAPKN---IYSIMQACWA-LEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHHTCCC---------C-CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC---------C-CCCCCCHH---HHHHHHHHhc-cChhhCcCHHHHHHHHHHHHHh
Confidence 11111111000 0 01112333 4445556776 9999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=323.49 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=199.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEe-----------
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA----------- 371 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------- 371 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... ..+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 457888999999999999999976 79999999986543 356789999999999999999998864
Q ss_pred -----CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 372 -----KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 372 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 344789999999999999996432 25689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~ 526 (623)
||+|||++......... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+... ..
T Consensus 162 kl~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~ 226 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK 226 (284)
T ss_dssp EECCCTTCEESSCCSCC-----CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH
T ss_pred EECcchhheeccccccc-----cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH
Confidence 99999999876543211 2234899999999999989999999999999999999999886420 11
Q ss_pred HHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 527 WIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
+.... ....+ ....+.++. .++..|+. .||++|||+.|+++.|+.+....
T Consensus 227 ~~~~~-~~~~~---------~~~~~~~~~---~li~~~l~-~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 227 FFTDL-RDGII---------SDIFDKKEK---TLLQKLLS-KKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHH-HTTCC---------CTTSCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHHHh-hcccc---------cccCCHHHH---HHHHHHcc-CChhhCcCHHHHHHHHHHHhhCC
Confidence 11111 11111 112233333 34456666 99999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=333.25 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=190.2
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCC--CCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKN--RNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~ 379 (623)
+.|...+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++.+++| |||+++++++.+....++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4688899999999999999999889999999986543 234678899999999987 99999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
| +.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 89 e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 89 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp C-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred e-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9 568899999964 34689999999999999999999999 999999999999997 57899999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHH
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYART-----------LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~ 528 (623)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .. ...
T Consensus 160 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~-~~~ 230 (343)
T 3dbq_A 160 DTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QI-SKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HH-HHH
T ss_pred cccc--ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HH-HHH
Confidence 2221 11223458999999999864 6788999999999999999999999964221 11 111
Q ss_pred HHHhccCchhhhhchhhhc---CCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 529 AQLSSTGQLQDAIDKCLVA---KGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~~---~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
. .++++.... ....+++ ..++..|+. .||++|||+.|+++.-
T Consensus 231 ~---------~~~~~~~~~~~~~~~~~~l---~~li~~~L~-~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 231 H---------AIIDPNHEIEFPDIPEKDL---QDVLKCCLK-RDPKQRISIPELLAHP 275 (343)
T ss_dssp H---------HHHCTTSCCCCCCCSCHHH---HHHHHHHTC-SSTTTSCCHHHHHTSH
T ss_pred H---------HHhcCCcccCCcccCCHHH---HHHHHHHcC-CChhHCCCHHHHHhCc
Confidence 1 111111111 1122333 444556766 9999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.01 Aligned_cols=204 Identities=23% Similarity=0.312 Sum_probs=177.4
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCC-----CCCCcceeEEEEe
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-----NRNLVPLLGFCMA 371 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~ 371 (623)
.+.....++|...+.||+|+||.||+|.. .+++.||+|++.........+..|++++.+++ ||||+++++++..
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 33334467899999999999999999997 46889999999866656667788998888886 9999999999999
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---------
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD--------- 442 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~--------- 442 (623)
.+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccc
Confidence 99999999999 9999999975432 4589999999999999999999999 9999999999999975
Q ss_pred ----------------CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 006982 443 ----------------DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506 (623)
Q Consensus 443 ----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt 506 (623)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCCC-------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 8899999999998654321 22358999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 006982 507 GERPTNVA 514 (623)
Q Consensus 507 g~~P~~~~ 514 (623)
|+.||...
T Consensus 255 g~~pf~~~ 262 (360)
T 3llt_A 255 GSLLFRTH 262 (360)
T ss_dssp SSCSCCCS
T ss_pred CCCCCCCC
Confidence 99999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=324.46 Aligned_cols=242 Identities=20% Similarity=0.293 Sum_probs=196.6
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+++.. +|+.||+|++.... ...+.+.+|..++..++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999965 68999999997542 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999963 34689999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 159 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~----- 218 (318)
T 1fot_A 159 VT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNA----- 218 (318)
T ss_dssp CB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHC-----
T ss_pred cc-------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-----
Confidence 11 223589999999999999999999999999999999999999975321 1111111111
Q ss_pred hhchhhh-cCCCHHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHH
Q 006982 540 AIDKCLV-AKGVDNELFQFLKVACNCVLPTIPKERP-----TMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~-~~~~~~~~~~~~~~~~~C~~~~~P~~RP-----s~~ev~~ 581 (623)
.+. ....++++..+++ .|+. .||++|| +++|+++
T Consensus 219 ----~~~~p~~~~~~~~~li~---~lL~-~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 ----ELRFPPFFNEDVKDLLS---RLIT-RDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----CCCCCTTSCHHHHHHHH---HHTC-SCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCCCHHHHHHHH---HHhc-cCHHHcCCCcCCCHHHHhc
Confidence 000 1123344444443 4555 8999999 8888764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=332.98 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=195.8
Q ss_pred HHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
...++|...+.||+|+||.||+|+.+ +++.||+|+++.. ......+..|.+++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 6889999999754 23456678899988876 999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999963 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.........
T Consensus 167 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~ 234 (345)
T 1xjd_A 167 ENMLGDAK----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDN 234 (345)
T ss_dssp CCCCTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC
T ss_pred hcccCCCc----ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCC
Confidence 64332221 22345899999999999999999999999999999999999999753221 1111111110
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHH-HHH
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMF-EVY 580 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~-ev~ 580 (623)
..+ ....++++..++ ..|+. .||++||++. |+.
T Consensus 235 -------~~~-p~~~s~~~~~li---~~lL~-~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -------PFY-PRWLEKEAKDLL---VKLFV-REPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCC-CTTSCHHHHHHH---HHHSC-SSGGGSBTTBSCGG
T ss_pred -------CCC-CcccCHHHHHHH---HHHhc-CCHhHcCCChHHHH
Confidence 000 111234444444 45665 8999999987 554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.86 Aligned_cols=243 Identities=24% Similarity=0.274 Sum_probs=186.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||+||+|... +++.||||++..... ....+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 799999999865432 233455566555555 8999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+ +|+|.+++... +..++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 67999988643 34699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
... .....||++|+|||++.+ .++.++|||||||++|||++|..|+.... .| .... ....
T Consensus 210 ~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~-~~~~-~~~~-- 269 (311)
T 3p1a_A 210 AGA-----GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GW-QQLR-QGYL-- 269 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HH-HHHT-TTCC--
T ss_pred CCC-----CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HH-HHHh-ccCC--
Confidence 221 122348999999999876 78999999999999999999987764310 11 1111 1111
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+.+.. ..+++ +.+++..|+. .||++|||++|+++
T Consensus 270 --~~~~~~-~~~~~---l~~li~~~L~-~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 --PPEFTA-GLSSE---LRSVLVMMLE-PDPKLRATAEALLA 304 (311)
T ss_dssp --CHHHHT-TSCHH---HHHHHHHHSC-SSTTTSCCHHHHHT
T ss_pred --Cccccc-CCCHH---HHHHHHHHcC-CChhhCcCHHHHHh
Confidence 111111 12333 3444456766 99999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=326.42 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=196.1
Q ss_pred ccCcccceeeccCccEEEEEEeCC-C-------cEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-G-------TSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
++|...+.||+|+||.||+|.... + ..|++|++.... ...+.+.+|++++.+++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568888999999999999998543 3 479999986543 4567899999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC--------eE
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE--------PK 447 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~--------~k 447 (623)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999643 24489999999999999999999999 9999999999999998887 99
Q ss_pred EeecccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHH
Q 006982 448 ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526 (623)
Q Consensus 448 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~ 526 (623)
|+|||++....... . ..+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+...... ..
T Consensus 162 l~Dfg~~~~~~~~~----~----~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~ 226 (289)
T 4fvq_A 162 LSDPGISITVLPKD----I----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QR 226 (289)
T ss_dssp ECCCCSCTTTSCHH----H----HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HH
T ss_pred eccCcccccccCcc----c----cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HH
Confidence 99999997653311 1 126788999999987 67899999999999999999976665432211 11
Q ss_pred HHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 527 WIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
........... .....++ +.+++..|+. .||++|||+.|+++.|+++...
T Consensus 227 ~~~~~~~~~~~---------~~~~~~~---l~~li~~~l~-~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 227 KLQFYEDRHQL---------PAPKAAE---LANLINNCMD-YEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHHHHTTCCC---------CCCSSCT---THHHHHHHSC-SSGGGSCCHHHHHHHHHTCC--
T ss_pred HHHHhhccCCC---------CCCCCHH---HHHHHHHHcC-CChhHCcCHHHHHHHHHHhcCC
Confidence 11111000000 0111222 3444556776 9999999999999999988653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=320.60 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=192.6
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||++... ++..+|+|++.... ...+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888999999999999999964 68899999986543 3467899999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee---CCCCCeEEeecccccccC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMN 458 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl---~~~~~~kl~Dfgla~~~~ 458 (623)
+++|+|.+++......+..+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999854322346689999999999999999999999 99999999999999 556889999999998754
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||..... .............
T Consensus 179 ~~~~-----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~- 243 (285)
T 3is5_A 179 SDEH-----STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYKEPN- 243 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC-
T ss_pred Cccc-----CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccCCcc-
Confidence 3221 12234899999999886 4679999999999999999999999975321 1111111100000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.........+++. .++..|+. .||++|||+.|+++
T Consensus 244 ----~~~~~~~~~~~~~---~li~~~L~-~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 ----YAVECRPLTPQAV---DLLKQMLT-KDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCC--CCCCHHHH---HHHHHHTC-SCTTTSCCHHHHHT
T ss_pred ----cccccCcCCHHHH---HHHHHHcc-CChhhCcCHHHHhc
Confidence 0000011233444 44456666 99999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=331.21 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=190.7
Q ss_pred CcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 307 FSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
|...+.||+|+||.||+|.. .+|..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 34467899999999999996 468999999997643 3456789999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee--CCCCCeEEeecccccccCCCCC
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL--DDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl--~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 171 ~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 171 GELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp CEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 9999988532 24689999999999999999999999 99999999999999 6778999999999987654322
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.....||+.|+|||++....++.++|||||||++|||++|+.||...... +.......... ....
T Consensus 245 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~--~~~~ 309 (373)
T 2x4f_A 245 -----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILACRW--DLED 309 (373)
T ss_dssp -----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCC--CSCS
T ss_pred -----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccC--CCCh
Confidence 12235899999999999889999999999999999999999999753221 11111111100 0000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
... ...++++ ..++..|+. .||++|||+.|+++
T Consensus 310 ~~~--~~~~~~~---~~li~~~L~-~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEF--QDISEEA---KEFISKLLI-KEKSWRISASEALK 342 (373)
T ss_dssp GGG--TTSCHHH---HHHHHTTSC-SSGGGSCCHHHHHH
T ss_pred hhh--ccCCHHH---HHHHHHHcC-CChhhCCCHHHHhc
Confidence 000 1123333 344456666 99999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.72 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=191.6
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee----
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER---- 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 375 (623)
++|...+.||+|+||.||++.. .+++.||+|++.... .....+.+|++++.+++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788899999999999999995 578999999997642 2235688999999999999999999998776543
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++|+|.++++. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 899999999999999963 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 165 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~ 235 (311)
T 3ork_A 165 AIADSGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCC
T ss_pred ccccccccc-ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCC
Confidence 765422211 112234589999999999999999999999999999999999999975322 11111111111
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHH-HHHHHHHhhc
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFE-VYQFLRAIGE 588 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~e-v~~~L~~i~~ 588 (623)
.. .+.......++++. .++..|+. .||++||++.+ +...+..+..
T Consensus 236 ~~----~~~~~~~~~~~~l~---~li~~~l~-~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 236 PI----PPSARHEGLSADLD---AVVLKALA-KNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CC----CHHHHSTTCCHHHH---HHHHHHTC-SSGGGSCSSHHHHHHHHHHHHT
T ss_pred CC----CcccccCCCCHHHH---HHHHHHHh-cCHhhChhhHHHHHHHHHHHhc
Confidence 10 01111112334444 44456766 99999996555 5556665543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.30 Aligned_cols=260 Identities=19% Similarity=0.241 Sum_probs=194.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999965 688999999975432 246788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
+||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999632 4589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 186 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~-- 251 (309)
T 2h34_A 186 DEKLT---QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQAI-- 251 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSCC--
T ss_pred ccccc---cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccCC--
Confidence 32211 12233589999999999998999999999999999999999999974211 11111111100
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHhhccc
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-TMFEVYQFLRAIGERY 590 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-s~~ev~~~L~~i~~~~ 590 (623)
..........+.++. .++..|+. .||++|| +++++++.|+++....
T Consensus 252 --~~~~~~~~~~~~~l~---~li~~~l~-~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 252 --PRPSTVRPGIPVAFD---AVIARGMA-KNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --CCGGGTSTTCCTHHH---HHHHHHTC-SSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --CCccccCCCCCHHHH---HHHHHhcc-CCHHHHHHhHHHHHHHHHHHHHhh
Confidence 000001112233344 34456666 9999999 9999999999876554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.45 Aligned_cols=272 Identities=19% Similarity=0.255 Sum_probs=206.4
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEE-EeCCeeeEEEec
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC-MAKKERLLVYKH 381 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e~ 381 (623)
.++|...+.||+|+||.||+|.. .+++.||+|++..... ...+.+|++++.+++|++++..+.++ ......++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 35788899999999999999996 5789999999865432 34688999999999998877776666 556677999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee---CCCCCeEEeecccccccC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMN 458 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl---~~~~~~kl~Dfgla~~~~ 458 (623)
+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 87 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9 99999999632 24689999999999999999999999 99999999999999 488999999999998765
Q ss_pred CCCCccc---ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 459 PIDTHLS---TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 459 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ............ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~-~~ 237 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKM-ST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHH-HS
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-hhhhhhhccccc-CC
Confidence 4322111 112234589999999999999999999999999999999999999986433211 111111111111 00
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCCC
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTE 595 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~~ 595 (623)
.... +. ...++++ .+++..|+. .||++|||+.+|++.|+++.++......
T Consensus 238 ~~~~-----~~-~~~~~~l---~~li~~~l~-~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 238 PIEV-----LC-KGYPSEF---ATYLNFCRS-LRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp CHHH-----HT-TTSCHHH---HHHHHHHHT-SCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred chHH-----HH-hhCCHHH---HHHHHHHHh-cCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 1100 00 1123344 444556766 9999999999999999999887765443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=315.18 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=198.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999975 78999999986543 345678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999953 35689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....|..... .
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~---~--- 227 (276)
T 2yex_A 159 NR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEKKT---Y--- 227 (276)
T ss_dssp TE--ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHHHHTTCT---T---
T ss_pred cc--hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHhhhccc---c---
Confidence 11 111233458999999999987665 779999999999999999999997543321 11122211100 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.. . ....++++. .++..|+. .||++|||++|+++
T Consensus 228 -~~-~--~~~~~~~~~---~li~~~l~-~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 -LN-P--WKKIDSAPL---ALLHKILV-ENPSARITIPDIKK 261 (276)
T ss_dssp -ST-T--GGGSCHHHH---HHHHHHSC-SSTTTSCCHHHHTT
T ss_pred -cC-c--hhhcCHHHH---HHHHHHCC-CCchhCCCHHHHhc
Confidence 00 0 011233333 44556666 99999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.68 Aligned_cols=198 Identities=21% Similarity=0.294 Sum_probs=165.9
Q ss_pred ccCcccceeeccCccEEEEEEe----CCCcEEEEEEecccc-----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
++|...+.||+|+||.||+++. .+++.||+|+++... .....+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788899999999999999996 478999999997542 2345678899999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999963 24588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 170 ESIHDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp -------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 6433211 12234589999999999998999999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.76 Aligned_cols=199 Identities=21% Similarity=0.250 Sum_probs=175.4
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 377 (623)
.++|...+.||+|+||.||+++.. +++.||+|++.... .....+..|.+++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467899999999999999999976 47889999997542 3456788999999988 89999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999632 4589999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 172 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 172 IWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCTTCC----BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCcc----cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 322211 2234589999999999999999999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.45 Aligned_cols=271 Identities=20% Similarity=0.247 Sum_probs=202.3
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEE-EeCCeeeEEEe
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC-MAKKERLLVYK 380 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e 380 (623)
..++|...+.||+|+||.||+|.. .+++.||+|++..... ...+.+|++++.+++|++++..+.++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 346799999999999999999996 5788999998654332 23577899999999998887777766 55677899999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee---CCCCCeEEeeccccccc
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLM 457 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl---~~~~~~kl~Dfgla~~~ 457 (623)
|+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 99999998632 24689999999999999999999999 99999999999999 78999999999999876
Q ss_pred CCCCCccc---ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 458 NPIDTHLS---TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 458 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ........... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~-~ 236 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKM-S 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHH-H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccc-c
Confidence 54322111 1122345899999999999999999999999999999999999999764432211 11111111111 0
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCC
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFT 593 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~ 593 (623)
..... + ....++++. .++..|+. .||++|||+++|++.|+++.++....
T Consensus 237 ~~~~~-----~-~~~~~~~l~---~li~~~l~-~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 237 TPIEV-----L-CKGYPSEFA---TYLNFCRS-LRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp SCHHH-----H-TTTSCHHHH---HHHHHHHT-SCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred chhhh-----h-hccCCHHHH---HHHHHHHh-cCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 01000 0 011233444 44456666 99999999999999999988776543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.42 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=174.2
Q ss_pred cceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEEecCCCCCH
Q 006982 310 NNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
.+.||+|+||.||++... +++.||+|++... ....+.+|++++.+++ ||||+++++++.+....++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999975 6899999998643 3567788999999997 99999999999999999999999999999
Q ss_pred hhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC---CeEEeecccccccCCCCCcc
Q 006982 388 YDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF---EPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 388 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~---~~kl~Dfgla~~~~~~~~~~ 464 (623)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 999964 35689999999999999999999999 999999999999997765 8999999999876543222
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....+......... . ......
T Consensus 166 ---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~-~-~~~~~~ 239 (325)
T 3kn6_A 166 ---LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGD-F-SFEGEA 239 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTC-C-CCCSHH
T ss_pred ---ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCC-C-CCCccc
Confidence 1233479999999999999999999999999999999999999976433211 111122222211110 0 000000
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+ ...++++.. ++..|+. .||++|||++|+++
T Consensus 240 ~--~~~s~~~~~---li~~~L~-~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 W--KNVSQEAKD---LIQGLLT-VDPNKRLKMSGLRY 270 (325)
T ss_dssp H--HTSCHHHHH---HHHHHHC-CCTTTCCCTTTSTT
T ss_pred c--cCCCHHHHH---HHHHHCC-CChhHCCCHHHHhc
Confidence 0 012334444 4445665 99999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=327.70 Aligned_cols=243 Identities=18% Similarity=0.241 Sum_probs=196.6
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|++++.+++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999965 68999999996532 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999632 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ ..
T Consensus 194 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~-~~-- 255 (350)
T 1rdq_E 194 RT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG-KV-- 255 (350)
T ss_dssp CB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC--
T ss_pred Cc-------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcC-CC--
Confidence 21 123489999999999999999999999999999999999999975321 1111111111 00
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPT-----MFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs-----~~ev~~ 581 (623)
.+ ....+.++..++ ..|+. .||++||+ ++|+++
T Consensus 256 ----~~-p~~~~~~~~~li---~~lL~-~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ----RF-PSHFSSDLKDLL---RNLLQ-VDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CC-CTTCCHHHHHHH---HHHSC-SCTTTCTTSSTTTTHHHHT
T ss_pred ----CC-CCCCCHHHHHHH---HHHhh-cCHHhccCCccCCHHHHHh
Confidence 00 112334444444 45655 99999998 777765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=316.32 Aligned_cols=247 Identities=20% Similarity=0.317 Sum_probs=178.2
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++|+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999996 578999999996532 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999642 25689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
..... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ..... +
T Consensus 165 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~----~ 228 (278)
T 3cok_A 165 PHEKH----YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN--------KVVLA----D 228 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSS----C
T ss_pred CCCcc----eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH--------HHhhc----c
Confidence 22111 12348899999999998889999999999999999999999997543321110 00000 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
... ....+.++. .++..|+. .||++|||++|+++
T Consensus 229 ---~~~-~~~~~~~~~---~li~~~l~-~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 ---YEM-PSFLSIEAK---DLIHQLLR-RNPADRLSLSSVLD 262 (278)
T ss_dssp ---CCC-CTTSCHHHH---HHHHHHSC-SSGGGSCCHHHHTT
T ss_pred ---cCC-ccccCHHHH---HHHHHHcc-cCHhhCCCHHHHhc
Confidence 000 111233333 44556666 99999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.94 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=190.9
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCC--CCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVK--NRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 379 (623)
..|...+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588899999999999999998889999999986543 33467899999999996 599999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
| +.+|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5688999999643 4688999999999999999999999 999999999999996 57899999999987653
Q ss_pred CCCcccccccCCCCcccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHH
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYART-----------LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~ 528 (623)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+
T Consensus 207 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~ 277 (390)
T 2zmd_A 207 DTTS--VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKL 277 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHH
T ss_pred CCcc--ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHH
Confidence 2211 11233458999999999865 36889999999999999999999999643211 1111
Q ss_pred HHHhccCchhhhhchhhh---cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 529 AQLSSTGQLQDAIDKCLV---AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~---~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.. +++.... .....++ +..++..|+. .||++|||+.|+++.-
T Consensus 278 ~~---------~~~~~~~~~~~~~~~~~---~~~li~~~L~-~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 278 HA---------IIDPNHEIEFPDIPEKD---LQDVLKCCLK-RDPKQRISIPELLAHP 322 (390)
T ss_dssp HH---------HHCTTSCCCCCCCSCHH---HHHHHHHHTC-SSTTTSCCHHHHHTSH
T ss_pred HH---------HhCccccCCCCccchHH---HHHHHHHHcc-cChhhCCCHHHHhhCc
Confidence 11 1111111 1112233 3444556776 9999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.18 Aligned_cols=247 Identities=19% Similarity=0.218 Sum_probs=188.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.+++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367899999999999999999964 68999999997532 2345678899999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999853 3468999999999999999999998 7 8999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 300 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-~ 366 (446)
T 4ejn_A 300 IKDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEE-I 366 (446)
T ss_dssp CC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-C
T ss_pred cCCCc----ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCC-C
Confidence 33221 12334589999999999999999999999999999999999999975321 11111111110 0
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-----TMFEVYQ 581 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-----s~~ev~~ 581 (623)
.. ....++++.++ +..|+. .||++|| +++|+++
T Consensus 367 ------~~-p~~~~~~~~~l---i~~~L~-~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ------RF-PRTLGPEAKSL---LSGLLK-KDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------CC-CTTSCHHHHHH---HHHHTC-SSTTTSTTCSTTTHHHHHT
T ss_pred ------CC-CccCCHHHHHH---HHHHcc-cCHHHhCCCCCCCHHHHHh
Confidence 00 11123344444 445655 9999999 9999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=356.44 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=193.1
Q ss_pred ceeeccCccEEEEEEeC---CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLE---DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||.||+|.+. .++.||||+++... ...+++.+|++++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999997643 335789999999999999999999999964 557899999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.......
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999963 35689999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
. ......+|+.|+|||++....++.++|||||||++|||++ |+.||...... +........ ....
T Consensus 527 ~-~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~-~~~~---- 592 (635)
T 4fl3_A 527 K-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKG-ERMG---- 592 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTT-CCCC----
T ss_pred c-cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-CCCC----
Confidence 1 1122336789999999999999999999999999999998 99999753221 111111111 0000
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.....++++. +++..|+. .||++||++++|++.|+++-.
T Consensus 593 --~p~~~~~~l~---~li~~cl~-~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 --CPAGCPREMY---DLMNLCWT-YDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --CCTTCCHHHH---HHHHHHTC-SSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHH---HHHHHHcC-CCHhHCcCHHHHHHHHHHHHH
Confidence 0112334444 44456776 999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.50 Aligned_cols=263 Identities=22% Similarity=0.365 Sum_probs=199.4
Q ss_pred hccCcccceeeccCccEEEEEEe------CCCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
.++|...+.||+|+||.||+|.. .++..||+|++... ......+.+|+.++.+++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35788899999999999999984 35678999999643 23456788999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCC---CCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEe
Q 006982 376 LLVYKHMPNGSLYDLLHPADDT---GKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKIS 449 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~ 449 (623)
++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999754321 24589999999999999999999999 9999999999999984 4569999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHH
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWI 528 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~ 528 (623)
|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+
T Consensus 186 Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLEFV 258 (327)
T ss_dssp CCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHH
T ss_pred ccccccccccccccc--cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----HHHHHH
Confidence 999998653321111 1112347889999999988899999999999999999998 99998653211 111111
Q ss_pred HHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 529 AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 529 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
. ..... . .....+++ +.+++..|+. .||++||++.|+++.|+.+....
T Consensus 259 ~---~~~~~-~------~~~~~~~~---l~~li~~~l~-~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 259 T---SGGRM-D------PPKNCPGP---VYRIMTQCWQ-HQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp H---TTCCC-C------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHCH
T ss_pred h---cCCCC-C------CCCCCCHH---HHHHHHHHhc-CChhhCcCHHHHHHHHHHHhcCH
Confidence 1 11000 0 01112333 3445556776 99999999999999999886543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=326.65 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=195.3
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc---------cHHHHHHHHHHhCCCCCCCCcceeEEEEeC
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR---------SEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 372 (623)
..++|...+.||+|+||.||+|.. .+++.||+|++..... ....+.+|++++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356799999999999999999995 4788999999865431 233567899999999999999999999999
Q ss_pred CeeeEEEecCCCC-CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 373 KERLLVYKHMPNG-SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 373 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
+..++||||+.+| +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 99999963 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQ 530 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~ 530 (623)
|+++........ ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 175 g~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------- 235 (335)
T 3dls_A 175 GSAAYLERGKLF-----YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------- 235 (335)
T ss_dssp TTCEECCTTCCB-----CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------
T ss_pred ccceECCCCCce-----eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------
Confidence 999876543221 12348999999999988776 7899999999999999999999964211
Q ss_pred HhccCchhhhhchhh-hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 531 LSSTGQLQDAIDKCL-VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l-~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
...... .....++++.++ +..|+. .||++|||+.|+++.
T Consensus 236 ---------~~~~~~~~~~~~~~~l~~l---i~~~L~-~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---------TVEAAIHPPYLVSKELMSL---VSGLLQ-PVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------GTTTCCCCSSCCCHHHHHH---HHHHTC-SSGGGSCCHHHHHHC
T ss_pred ---------HHhhccCCCcccCHHHHHH---HHHHcc-CChhhCcCHHHHhcC
Confidence 000000 011133444444 445666 999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.76 Aligned_cols=244 Identities=20% Similarity=0.377 Sum_probs=197.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +|+.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999975 79999999996532 23567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.. ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... .........
T Consensus 169 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~---- 231 (476)
T 2y94_A 169 GE-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDG---- 231 (476)
T ss_dssp TC-----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTT----
T ss_pred cc-----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC----
Confidence 22 1223458999999999988765 68999999999999999999999753321 111111110
Q ss_pred hhhchhh-hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCL-VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l-~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.. .....+.++..+ +..|+. .||++|||+.|+++
T Consensus 232 -----~~~~p~~~s~~~~~L---i~~~L~-~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 232 -----IFYTPQYLNPSVISL---LKHMLQ-VDPMKRATIKDIRE 266 (476)
T ss_dssp -----CCCCCTTCCHHHHHH---HHHHTC-SSTTTSCCHHHHHT
T ss_pred -----CcCCCccCCHHHHHH---HHHHcC-CCchhCcCHHHHHh
Confidence 00 011123444444 445665 99999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.44 Aligned_cols=199 Identities=25% Similarity=0.333 Sum_probs=169.6
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999975 589999999865432 24567899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998853 34589999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 156 SDY----YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccc----cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 221 123358999999999875 66899999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=320.19 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=198.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 375 (623)
.+.|...+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999965 68999999986532 1367899999999999999999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC----CeEEeec
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF----EPKISDF 451 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~----~~kl~Df 451 (623)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++++++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999963 35689999999999999999999999 999999999999999888 7999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.....
T Consensus 164 g~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i 230 (321)
T 2a2a_A 164 GLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANI 230 (321)
T ss_dssp TTCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHH
T ss_pred ccceecCcccc-----ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH
Confidence 99987654221 1233589999999999998999999999999999999999999965321 1111111
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..... -.++... ...+++ +..++..|+. .||++|||+.|+++
T Consensus 231 ~~~~~---~~~~~~~-~~~~~~---~~~li~~~l~-~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 231 TSVSY---DFDEEFF-SHTSEL---AKDFIRKLLV-KETRKRLTIQEALR 272 (321)
T ss_dssp HTTCC---CCCHHHH-TTCCHH---HHHHHHTTSC-SSTTTSCCHHHHHH
T ss_pred Hhccc---ccChhhh-cccCHH---HHHHHHHHcC-CChhhCcCHHHHhc
Confidence 11000 0001110 112233 3344556766 99999999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=324.06 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=197.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCeeeE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKERLL 377 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 377 (623)
.++|...+.||+|+||.||++... +++.|++|.+.... ...+.+.+|++++.+++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999975 68999999996543 334678899999999999999999998864 567899
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC-----cEecCCCCCceeeCCCCCeEEeecc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR-----IIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-----i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
||||+++|+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999965433345689999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHh
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLS 532 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~ 532 (623)
+++......... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+...+..
T Consensus 162 ~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~-- 230 (279)
T 2w5a_A 162 LARILNHDTSFA----KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIRE-- 230 (279)
T ss_dssp HHHHC---CHHH----HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH--
T ss_pred hheeeccccccc----cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHHHHHhh--
Confidence 998765422111 122378999999999988899999999999999999999999975321 111111111
Q ss_pred ccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 006982 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRA 585 (623)
Q Consensus 533 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~ 585 (623)
.... .+ ....++++. +++..|+. .||++||++.|+++.+..
T Consensus 231 --~~~~-----~~-~~~~~~~l~---~li~~~l~-~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 231 --GKFR-----RI-PYRYSDELN---EIITRMLN-LKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --TCCC-----CC-CTTSCHHHH---HHHHHHTC-SSGGGSCCHHHHHTSTTC
T ss_pred --cccc-----cC-CcccCHHHH---HHHHHHcC-CCcccCCCHHHHHhChhh
Confidence 1100 00 011233444 44456776 999999999999986643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=316.92 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=194.9
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.+++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 367888999999999999999865 57789999986532 3356788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999998532 4589999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 161 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~--- 223 (279)
T 3fdn_A 161 SSRR------TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVE--- 223 (279)
T ss_dssp -------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTC---
T ss_pred cccc------cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHHHhCC---
Confidence 3211 123489999999999999999999999999999999999999974321 11111111000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
... .....+++.+ ++..|+. .||++|||+.|+++.-
T Consensus 224 ----~~~-~~~~~~~~~~---li~~~l~-~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 224 ----FTF-PDFVTEGARD---LISRLLK-HNPSQRPMLREVLEHP 259 (279)
T ss_dssp ----CCC-CTTSCHHHHH---HHHHHCC-SSGGGSCCHHHHHHCH
T ss_pred ----CCC-CCcCCHHHHH---HHHHHhc-cChhhCCCHHHHhhCc
Confidence 000 1112334443 4445666 9999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=341.25 Aligned_cols=210 Identities=20% Similarity=0.226 Sum_probs=180.1
Q ss_pred CHHHHHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEE
Q 006982 296 RLSDLMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCM 370 (623)
Q Consensus 296 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 370 (623)
++.+.....++|...+.||+|+||.||+++.+ +++.||+|++.... .....+.+|.+++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556788999999999999999999975 68999999996532 22345788999999999999999999999
Q ss_pred eCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEee
Q 006982 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450 (623)
Q Consensus 371 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~D 450 (623)
+.+..++||||+++|+|.+++... +..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999632 24689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCccccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR-------TLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
||+++......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 206 FGla~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 206 FGSCLKLRADGTVR---SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp CTTCEECCTTSCEE---CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred chhheeccCCCccc---cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 99998765432211 12345899999999987 457899999999999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=325.44 Aligned_cols=266 Identities=23% Similarity=0.376 Sum_probs=203.1
Q ss_pred ccCcccceeeccCccEEEEEEe-----CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC--eee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-----EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK--ERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~ 376 (623)
++|...+.||+|+||.||++.+ .+++.||+|++.... ...+.+.+|++++.+++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5688889999999999999984 468899999997643 34567899999999999999999999987654 678
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 121 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999643 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC-
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG- 535 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~- 535 (623)
........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+.... ..+........
T Consensus 195 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~---------~~~~~~~~~~~~ 264 (326)
T 2w1i_A 195 LPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP---------AEFMRMIGNDKQ 264 (326)
T ss_dssp CCSSCSEE-ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH---------HHHHHHHCTTCC
T ss_pred cccccccc-ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH---------HHHHHhhccccc
Confidence 65432211 11122346788999999988889999999999999999999999875311 00000000000
Q ss_pred ------chhhhhchhh---hcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 536 ------QLQDAIDKCL---VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 536 ------~~~~~~d~~l---~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.+.+.+.... .....+++ +.+++..|+. .||++|||+.|+++.|++++++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---l~~li~~cl~-~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 265 GQMIVFHLIELLKNNGRLPRPDGCPDE---IYMIMTECWN-NNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp THHHHHHHHHHHHTTCCCCCCTTCCHH---HHHHHHHHSC-SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHhhcCCCCCCCCcccHH---HHHHHHHHcC-CChhhCcCHHHHHHHHHHHHHHh
Confidence 0011111100 01122334 4445556777 99999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=312.96 Aligned_cols=249 Identities=20% Similarity=0.283 Sum_probs=196.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc-cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS-QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.++|...+.||+|+||.||+|... ++..+++|++... ....+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 356888999999999999999965 5778999998654 34567899999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee---CCCCCeEEeecccccccC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMN 458 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl---~~~~~~kl~Dfgla~~~~ 458 (623)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999853 24589999999999999999999999 99999999999999 888999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.... .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||...... +..........
T Consensus 161 ~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~-- 224 (277)
T 3f3z_A 161 PGKM-----MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTF-- 224 (277)
T ss_dssp TTSC-----BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC--
T ss_pred Cccc-----hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCC--
Confidence 4322 2234589999999998654 899999999999999999999999753221 11111111000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
...... ....++++ ..++..|+. .||++|||+.|+++
T Consensus 225 ~~~~~~--~~~~~~~~---~~li~~~l~-~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TFPEKD--WLNVSPQA---ESLIRRLLT-KSPKQRITSLQALE 261 (277)
T ss_dssp CCCHHH--HTTSCHHH---HHHHHHHTC-SSTTTSCCHHHHTT
T ss_pred CCCchh--hhcCCHHH---HHHHHHHcc-CChhhCcCHHHHhc
Confidence 000000 00123333 344456666 99999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.74 Aligned_cols=203 Identities=25% Similarity=0.370 Sum_probs=179.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...++||+|+||.||+++.. +|+.||+|++.... .....+.+|++++.+++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999975 68999999996532 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.........+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999975543446799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 342 ~~~~----~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 342 GQTK----TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TCCC----BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCcc----cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 3221 12235899999999999999999999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.69 Aligned_cols=247 Identities=25% Similarity=0.344 Sum_probs=195.0
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
+.|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999995 578999999986432 22356889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6888887532 25689999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...........
T Consensus 207 ~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~- 269 (348)
T 1u5q_A 207 A--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNE- 269 (348)
T ss_dssp B--------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSC-
T ss_pred C--------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcC-
Confidence 2 1234899999999984 56789999999999999999999999965321 11111111110
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.+.+.....++++.. ++..|+. .||++|||++++++..-
T Consensus 270 -----~~~~~~~~~~~~l~~---li~~~l~-~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 270 -----SPALQSGHWSEYFRN---FVDSCLQ-KIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -----CCCCCCTTSCHHHHH---HHHHHTC-SSGGGSCCHHHHTTCHH
T ss_pred -----CCCCCCCCCCHHHHH---HHHHHcc-cChhhCcCHHHHhhChh
Confidence 011111223344444 4446776 99999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=330.70 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=187.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHH-hCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMAT-LGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+++.+ ++..||+|++.... .....+..|..+ +..++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57889999999999999999975 58889999997643 223456677776 5778999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999963 24688999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......
T Consensus 191 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~----- 253 (373)
T 2r5t_A 191 EHNST----TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILN----- 253 (373)
T ss_dssp CCCCC----CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHH-----
T ss_pred cCCCc----cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-----
Confidence 22111 2234589999999999999999999999999999999999999975321 111111111
Q ss_pred hhhchhhh-cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 539 DAIDKCLV-AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 539 ~~~d~~l~-~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
..+. ......++..++ ..|+. .||++||++.+.++.+
T Consensus 254 ----~~~~~~~~~~~~~~~li---~~lL~-~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 254 ----KPLQLKPNITNSARHLL---EGLLQ-KDRTKRLGAKDDFMEI 291 (373)
T ss_dssp ----SCCCCCSSSCHHHHHHH---HHHTC-SSGGGSTTTTTTHHHH
T ss_pred ----cccCCCCCCCHHHHHHH---HHHcc-cCHHhCCCCCCCHHHH
Confidence 1110 112334444444 34555 8999999986444333
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.41 Aligned_cols=201 Identities=26% Similarity=0.336 Sum_probs=168.3
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc------ccHHHHHHHHHHhCCCC---CCCCcceeEEEEeC
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ------RSEKEFVAEMATLGSVK---NRNLVPLLGFCMAK 372 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 372 (623)
..++|...+.||+|+||+||+|.. .+++.||+|++.... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999995 578999999986432 12345667777776664 99999999999876
Q ss_pred C-----eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeE
Q 006982 373 K-----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPK 447 (623)
Q Consensus 373 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~k 447 (623)
. ..++|+||++ |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 4689999997 599999975432 4489999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 448 ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 448 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
|+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 161 l~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 161 LADFGLARIYSYQMAL-----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp ECSCSCTTTSTTCCCS-----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred EeeCccccccCCCccc-----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999876432221 2234899999999999999999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.67 Aligned_cols=251 Identities=20% Similarity=0.272 Sum_probs=197.6
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
.++|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.+++||||+++++++.+....++|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999965 68999999996543 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC---eEEeecccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE---PKISDFGLARL 456 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~---~kl~Dfgla~~ 456 (623)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998853 24689999999999999999999999 9999999999999986655 99999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............
T Consensus 158 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~ 224 (284)
T 3kk8_A 158 VNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAY 224 (284)
T ss_dssp CCSSCB-----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC
T ss_pred cccCcc-----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHHHhccc
Confidence 654222 1234589999999999999999999999999999999999999965321 111111111000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
....+. ....++++. .++..|+. .||++|||+.|+++.
T Consensus 225 --~~~~~~--~~~~~~~~~---~li~~~l~-~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 225 --DYPSPE--WDTVTPEAK---SLIDSMLT-VNPKKRITADQALKV 262 (284)
T ss_dssp --CCCTTT--TTTSCHHHH---HHHHHHSC-SSTTTSCCHHHHTTS
T ss_pred --cCCchh--hcccCHHHH---HHHHHHcc-cChhhCCCHHHHhcC
Confidence 000000 011234444 44456666 999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=319.46 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=199.6
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+.|...+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4588889999999999999985 46899999998654 34467899999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999952 4689999999999999999999999 99999999999999999999999999998764322
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 541 (623)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......... .
T Consensus 174 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~----- 235 (303)
T 3a7i_A 174 IK----RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKN-N----- 235 (303)
T ss_dssp CC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS-C-----
T ss_pred cc----cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHhhcC-C-----
Confidence 11 1233589999999999999999999999999999999999999964321 1111111000 0
Q ss_pred chhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 542 d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
.+.+. ...+.++ ..++..|+. .||++|||+.|+++..-
T Consensus 236 ~~~~~-~~~~~~l---~~li~~~l~-~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 236 PPTLE-GNYSKPL---KEFVEACLN-KEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCCC-SSCCHHH---HHHHHHHCC-SSGGGSCCHHHHTTCHH
T ss_pred CCCCc-cccCHHH---HHHHHHHcC-CChhhCcCHHHHhhChh
Confidence 00111 1223333 344456776 99999999999988643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=311.97 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=200.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||++... +++.||+|.+.... ...+.+.+|++++.+++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999976 68999999986532 23678999999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC----CeEEeecc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF----EPKISDFG 452 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~----~~kl~Dfg 452 (623)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999953 24689999999999999999999999 999999999999999877 89999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHh
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLS 532 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~ 532 (623)
++........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||..... .+......
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~ 224 (283)
T 3bhy_A 158 IAHKIEAGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNIS 224 (283)
T ss_dssp TCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH
T ss_pred cceeccCCCc-----ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHhH
Confidence 9987643221 1223489999999999988999999999999999999999999975321 11111111
Q ss_pred ccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH--HHHHhhcc
Q 006982 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLRAIGER 589 (623)
Q Consensus 533 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~--~L~~i~~~ 589 (623)
.... . ...... ...+++ +..++..|+. .||++|||+.|+++ .++.++.+
T Consensus 225 ~~~~--~-~~~~~~-~~~~~~---~~~li~~~l~-~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 225 AVNY--D-FDEEYF-SNTSEL---AKDFIRRLLV-KDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp TTCC--C-CCHHHH-TTCCHH---HHHHHHTTSC-SSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred hccc--C-Ccchhc-ccCCHH---HHHHHHHHcc-CCHhHCcCHHHHHhCHHHHHHHHH
Confidence 1000 0 000000 112233 3445556776 99999999999997 45666544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.79 Aligned_cols=253 Identities=18% Similarity=0.246 Sum_probs=186.6
Q ss_pred ccCccc-ceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHh-CCCCCCCCcceeEEEEe----CCeeeE
Q 006982 305 NSFSKN-NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATL-GSVKNRNLVPLLGFCMA----KKERLL 377 (623)
Q Consensus 305 ~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~l 377 (623)
++|... ++||+|+||.||++... ++..||+|++... ..+.+|++++ +..+||||+++++++.. ....++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 345554 68999999999999965 6889999998643 3566788776 44589999999999876 456789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeecccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLA 454 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Dfgla 454 (623)
||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999997532 24689999999999999999999999 9999999999999997 789999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+......
T Consensus 212 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 212 KETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQYE 285 (400)
T ss_dssp EECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHHTCCC
T ss_pred cccCCCCc-----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHcCccc
Confidence 87543211 12345899999999999999999999999999999999999999765433211 1122211111000
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
...+. .....+++ ..++..|+. .||++|||+.|+++.-
T Consensus 286 -----~~~~~--~~~~s~~~---~~li~~~L~-~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 286 -----FPNPE--WSEVSEEV---KMLIRNLLK-TEPTQRMTITEFMNHP 323 (400)
T ss_dssp -----CCTTT--TTTSCHHH---HHHHHTTSC-SSGGGSCCHHHHHHSH
T ss_pred -----CCCcc--cccCCHHH---HHHHHHHCC-CChhHCcCHHHHhcCc
Confidence 00000 01123333 344456666 9999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=317.52 Aligned_cols=245 Identities=19% Similarity=0.288 Sum_probs=192.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc---cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS---QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||+|... +++.||+|++... ......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999975 7899999998753 23456788899999988 999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC----------------
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---------------- 442 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---------------- 442 (623)
|||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999964322235689999999999999999999999 9999999999999984
Q ss_pred ---CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 006982 443 ---DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAKAPE 518 (623)
Q Consensus 443 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~~~~ 518 (623)
...+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..|+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred cCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 4479999999998765422 12389999999999765 56689999999999999999998764310
Q ss_pred cccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 519 TFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 519 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
....+ ...... .+ ....++++.+ ++..|+. .||++|||+.|+++
T Consensus 236 -----~~~~~----~~~~~~-----~~-~~~~~~~~~~---li~~~l~-~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -----QWHEI----RQGRLP-----RI-PQVLSQEFTE---LLKVMIH-PDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHH----HTTCCC-----CC-SSCCCHHHHH---HHHHHTC-SSGGGSCCHHHHHT
T ss_pred -----HHHHH----HcCCCC-----CC-CcccCHHHHH---HHHHHhC-CCcccCCCHHHHhh
Confidence 00100 011110 01 1123344444 4446666 99999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=330.42 Aligned_cols=251 Identities=19% Similarity=0.288 Sum_probs=186.6
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---------cHHHHHHHHHHhCCCCCCCCcceeEEEEeC
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---------SEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 372 (623)
..++|...+.||+|+||.||+|... +++.||+|++..... ....+.+|++++.+++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999864 689999999865321 1224789999999999999999999975 4
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC---CCeEEe
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD---FEPKIS 449 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~---~~~kl~ 449 (623)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 567999999999999999863 35689999999999999999999999 99999999999999754 459999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHH
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART---LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~ 526 (623)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..
T Consensus 285 DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~ 355 (419)
T 3i6u_A 285 DFGHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKD 355 (419)
T ss_dssp CSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CCHHH
T ss_pred ecccceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HHHHH
Confidence 999998765321 1223458999999999853 56788999999999999999999999754322 12222
Q ss_pred HHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 527 WIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+...... ...+ .+ ....++ +..++..|+. .||++|||++|+++
T Consensus 356 ~i~~~~~~-~~~~----~~--~~~~~~---~~~li~~~L~-~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGKYN-FIPE----VW--AEVSEK---ALDLVKKLLV-VDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTCCC-CCHH----HH--TTSCHH---HHHHHHHHSC-SSTTTSCCHHHHHH
T ss_pred HHhcCCCC-CCch----hh--cccCHH---HHHHHHHHcc-CChhHCcCHHHHhC
Confidence 21111000 0000 00 112233 3444556666 99999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.03 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=190.1
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe----CCeeeE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA----KKERLL 377 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 377 (623)
.|...+.||+|+||.||+|... ++..|++|.+.... ...+.+.+|++++.+++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3666788999999999999964 67889999986543 334678899999999999999999999875 345789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCceeeC-CCCCeEEeecccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR--IIHRNISSKCILLD-DDFEPKISDFGLA 454 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlk~~NILl~-~~~~~kl~Dfgla 454 (623)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. + |+||||||+||+++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999963 24688999999999999999999998 7 99999999999998 8899999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
........ ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... ..........
T Consensus 180 ~~~~~~~~------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~ 245 (290)
T 1t4h_A 180 TLKRASFA------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSG 245 (290)
T ss_dssp GGCCTTSB------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTT
T ss_pred cccccccc------ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhcc
Confidence 76543211 12348999999998864 5899999999999999999999999753221 1111111111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.. .. .. .....++ +..++..|+. .||++|||+.|+++
T Consensus 246 ~~-~~----~~-~~~~~~~---l~~li~~~l~-~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VK-PA----SF-DKVAIPE---VKEIIEGCIR-QNKDERYSIKDLLN 282 (290)
T ss_dssp CC-CG----GG-GGCCCHH---HHHHHHHHSC-SSGGGSCCHHHHHT
T ss_pred CC-cc----cc-CCCCCHH---HHHHHHHHcc-CChhhCCCHHHHhh
Confidence 00 00 01 1112233 4455556776 99999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.37 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=199.6
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...++||+|+||.||++... +|+.||+|++... ......+.+|++++.+++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999975 7899999999653 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999986432 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...+... ...
T Consensus 338 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~~--~~~-- 407 (576)
T 2acx_A 338 EGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEV--PEE-- 407 (576)
T ss_dssp TTCC-----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHHC--CCC--
T ss_pred cCcc-----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhcc--ccc--
Confidence 4321 1234689999999999998999999999999999999999999976432111 00111111110 000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-----TMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-----s~~ev~~ 581 (623)
+ ....+.++..+++ .|+. .||++|| +++||++
T Consensus 408 ------~-p~~~s~~~~dLI~---~lL~-~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 408 ------Y-SERFSPQARSLCS---QLLC-KDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ------C-CTTSCHHHHHHHH---HHTC-SSGGGSTTCSSSHHHHHHT
T ss_pred ------C-CccCCHHHHHHHH---Hhcc-CCHHHcCCCCCCCHHHHHh
Confidence 0 1123444544444 4555 8999999 6788765
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=318.70 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=182.0
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc--c-HHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR--S-EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
.++|...+.||+|+||.||++.. .+++.||+|++..... . ...+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 36788899999999999999996 4789999999975432 2 233445555688899999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||++ |+|.+++.........+++..++.++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 5888877543223467999999999999999999999853 899999999999999999999999999987644
Q ss_pred CCCcccccccCCCCcccccCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYA----RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
.... ....||+.|+|||++ ....++.++||||||+++|||++|+.||...... . ..........
T Consensus 163 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~ 230 (290)
T 3fme_A 163 DVAK-----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------F-QQLKQVVEEP 230 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------H-HHHHHHHHSC
T ss_pred cccc-----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------H-HHHHHHhccC
Confidence 2211 123489999999996 5667899999999999999999999999743221 1 1111111110
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. +.......++++ .+++..|+. .||++|||+.|+++
T Consensus 231 ~------~~~~~~~~~~~~---~~li~~~l~-~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 S------PQLPADKFSAEF---VDFTSQCLK-KNSKERPTYPELMQ 266 (290)
T ss_dssp C------CCCCTTTSCHHH---HHHHHHHTC-SSGGGSCCHHHHTT
T ss_pred C------CCcccccCCHHH---HHHHHHHhh-cChhhCcCHHHHHh
Confidence 0 001111223333 444556776 99999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=322.18 Aligned_cols=253 Identities=20% Similarity=0.323 Sum_probs=197.1
Q ss_pred HHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---------cHHHHHHHHHHhCCC-CCCCCcceeEEE
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---------SEKEFVAEMATLGSV-KNRNLVPLLGFC 369 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l-~h~niv~l~~~~ 369 (623)
....++|...+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445577999999999999999999975 799999999864321 135678899999998 799999999999
Q ss_pred EeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEe
Q 006982 370 MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKIS 449 (623)
Q Consensus 370 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~ 449 (623)
......++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999963 24689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccccc
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART------LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN 523 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~ 523 (623)
|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 243 DfG~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-----~ 312 (365)
T 2y7j_A 243 DFGFSCHLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-----L 312 (365)
T ss_dssp CCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----H
T ss_pred ecCcccccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-----H
Confidence 9999987654322 123458999999998853 35789999999999999999999999653211 0
Q ss_pred HHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 524 LVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 524 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
....+...... ...+.+ ...+.+ +..++..|+. .||++|||+.|+++
T Consensus 313 ~~~~i~~~~~~-----~~~~~~--~~~~~~---~~~li~~~L~-~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLRMIMEGQYQ-----FSSPEW--DDRSST---VKDLISRLLQ-VDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHTCCC-----CCHHHH--SSSCHH---HHHHHHHHSC-SSTTTSCCHHHHHH
T ss_pred HHHHHHhCCCC-----CCCccc--ccCCHH---HHHHHHHHcC-CChhHCcCHHHHhc
Confidence 11111110000 000000 112233 3344456666 99999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=323.75 Aligned_cols=199 Identities=26% Similarity=0.368 Sum_probs=168.9
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888999999999999999975 589999999865432 24567899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988752 24589999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 178 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 178 GEV----YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccc----cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 211 2234589999999998765 7899999999999999999999999764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.78 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=182.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCC-CCCCcceeEEEEe--------CC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVK-NRNLVPLLGFCMA--------KK 373 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--------~~ 373 (623)
.+|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++.++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 46888999999999999999964 78999999885543 34567889999999996 9999999999942 33
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCceeeCCCCCeEEeec
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR--IIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
..++|+||++ |+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred eEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 4689999996 79999885422 224699999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccCCCCCccc--------ccccCCCCcccccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccc
Q 006982 452 GLARLMNPIDTHLS--------TFVNGEFGDLGYVAPEYA---RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETF 520 (623)
Q Consensus 452 gla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~ 520 (623)
|+++.......... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 99987654221110 001123489999999998 56678999999999999999999999996432210
Q ss_pred cccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 521 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
........ . .......+ +..++..|+. .||++|||+.|+++.|+++....
T Consensus 261 ------~~~~~~~~-~---------~~~~~~~~---~~~li~~~l~-~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 ------IVNGKYSI-P---------PHDTQYTV---FHSLIRAMLQ-VNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------CCC-C---------TTCCSSGG---GHHHHHHHSC-SSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------hhcCcccC-C---------cccccchH---HHHHHHHHcc-CChhhCcCHHHHHHHHHHHHhcc
Confidence 00000000 0 00111122 3344556666 99999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=325.69 Aligned_cols=252 Identities=20% Similarity=0.268 Sum_probs=192.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEec
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.++|...+.||+|+||.||++..+ +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 457899999999999999999965 6889999999765432 34678887777 799999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC----CCeEEeeccccccc
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD----FEPKISDFGLARLM 457 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~----~~~kl~Dfgla~~~ 457 (623)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999863 34689999999999999999999999 99999999999998543 34999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+........ ..
T Consensus 171 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~~-~~ 240 (342)
T 2qr7_A 171 RAENGL----LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----TPEEILARIGSG-KF 240 (342)
T ss_dssp BCTTCC----BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----CHHHHHHHHHHC-CC
T ss_pred cCCCCc----eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----CHHHHHHHHccC-Cc
Confidence 432221 22345899999999998888899999999999999999999999753211 111222211111 00
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
...... ....++++.+++ ..|+. .||++||++.|+++.
T Consensus 241 -~~~~~~--~~~~s~~~~~li---~~~L~-~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 -SLSGGY--WNSVSDTAKDLV---SKMLH-VDPHQRLTAALVLRH 278 (342)
T ss_dssp -CCCSTT--TTTSCHHHHHHH---HHHTC-SSTTTSCCHHHHTTS
T ss_pred -ccCccc--cccCCHHHHHHH---HHHCC-CChhHCcCHHHHhcC
Confidence 000000 012344444444 45655 999999999998864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.44 Aligned_cols=204 Identities=22% Similarity=0.330 Sum_probs=162.6
Q ss_pred HhccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCC--ee
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKK--ER 375 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~ 375 (623)
..++|...+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 346799999999999999999995 478999999986532 33456788999999997 999999999998654 67
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 599999853 4688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc-----------------ccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 456 LMNPIDTH-----------------LSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 456 ~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
........ .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 75331110 0111223468999999999876 678999999999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.87 Aligned_cols=198 Identities=23% Similarity=0.397 Sum_probs=173.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||++... ++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888999999999999999975 68999999987542 3356789999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++... ..+++..+..++.+++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999632 45889999999999999999999842 7999999999999999999999999999754321
Q ss_pred CcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp -----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred -----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 112235899999999999999999999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=320.87 Aligned_cols=203 Identities=23% Similarity=0.321 Sum_probs=172.1
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-------- 372 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 372 (623)
++|...+.||+|+||.||+|.. .+++.||+|++.... .....+.+|++++.+++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999997 578999999986533 2345788999999999999999999999874
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
+..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999985 777777532 24589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 998765433322233344568999999998876 45799999999999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=313.82 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=198.1
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999976 57889999986542 3356788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999853 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+......... .
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~- 232 (294)
T 2rku_A 167 YDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNE-Y- 232 (294)
T ss_dssp STTCC----BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTC-C-
T ss_pred cCccc----cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhhcc-C-
Confidence 32221 1223489999999999988899999999999999999999999975321 11111111100 0
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+ ....++++. .++..|+. .||++|||++|+++.
T Consensus 233 -----~~-~~~~~~~~~---~li~~~l~-~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -----SI-PKHINPVAA---SLIQKMLQ-TDPTARPTINELLND 266 (294)
T ss_dssp -----CC-CTTSCHHHH---HHHHHHTC-SSGGGSCCGGGGGGS
T ss_pred -----CC-ccccCHHHH---HHHHHHcc-cChhhCcCHHHHhhC
Confidence 00 111233333 44456666 999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.55 Aligned_cols=256 Identities=20% Similarity=0.270 Sum_probs=195.5
Q ss_pred HHHhccCccc-ceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCe
Q 006982 301 MKATNSFSKN-NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 301 ~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 374 (623)
....+.|... +.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ .||||+++++++.+...
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445566666 88999999999999965 68999999987532 3467889999999998 46999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeec
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDF 451 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Df 451 (623)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999986432 35689999999999999999999999 9999999999999998 789999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
|+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+...
T Consensus 179 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~ 248 (327)
T 3lm5_A 179 GMSRKIGHACE-----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-----TYLNISQV 248 (327)
T ss_dssp GGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHT
T ss_pred ccccccCCccc-----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHHHhc
Confidence 99987653221 122358999999999999999999999999999999999999996532211 00001110
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
... ... .. .....+++. .++..|+. .||++|||++|+++.
T Consensus 249 ~~~-~~~----~~--~~~~~~~~~---~li~~~L~-~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVD-YSE----ET--FSSVSQLAT---DFIQSLLV-KNPEKRPTAEICLSH 288 (327)
T ss_dssp CCC-CCT----TT--TTTSCHHHH---HHHHHHSC-SSGGGSCCHHHHTTC
T ss_pred ccc-cCc----hh--hcccCHHHH---HHHHHHcC-CChhhCcCHHHHhCC
Confidence 000 000 00 011233333 44456666 999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.83 Aligned_cols=248 Identities=17% Similarity=0.186 Sum_probs=188.6
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc----cccHHHHHHHH---HHhCCCCCCCCccee-------EE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS----QRSEKEFVAEM---ATLGSVKNRNLVPLL-------GF 368 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 368 (623)
.++|...+.||+|+||.||+|.. .+|+.||+|++... ....+.+.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788889999999999999995 56999999999642 23457788999 667777999999998 66
Q ss_pred EEeCCe-----------------eeEEEecCCCCCHhhhccCCC---CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCc
Q 006982 369 CMAKKE-----------------RLLVYKHMPNGSLYDLLHPAD---DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428 (623)
Q Consensus 369 ~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 428 (623)
+.+.+. .++||||+ +|+|.+++.... .....++|..++.++.|++.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 689999996421 1123455788999999999999999999 99
Q ss_pred EecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCC-----------CCCcchhHHHH
Q 006982 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-----------VATPKGDVYSF 497 (623)
Q Consensus 429 ~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DV~sf 497 (623)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 9999999999999999999999999986432 1123346 899999999877 89999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHH
Q 006982 498 GTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMF 577 (623)
Q Consensus 498 Gvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ 577 (623)
||++|||++|+.||......... ..+... ....++++.+ ++..|+. .||++|||+.
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~-----------------~~~~~~---~~~~~~~~~~---li~~~L~-~dp~~Rpt~~ 355 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGS-----------------EWIFRS---CKNIPQPVRA---LLEGFLR-YPKEDRLLPL 355 (377)
T ss_dssp HHHHHHHHHSSCCC------CCS-----------------GGGGSS---CCCCCHHHHH---HHHHHTC-SSGGGCCCHH
T ss_pred HHHHHHHHHCCCCCcccccccch-----------------hhhhhh---ccCCCHHHHH---HHHHHcC-CCchhCCCHH
Confidence 99999999999999754322111 111110 0123344444 4456766 9999999999
Q ss_pred HHHH--HHHHhh
Q 006982 578 EVYQ--FLRAIG 587 (623)
Q Consensus 578 ev~~--~L~~i~ 587 (623)
|+++ .++++.
T Consensus 356 e~l~hp~f~~~~ 367 (377)
T 3byv_A 356 QAMETPEYEQLR 367 (377)
T ss_dssp HHHTSHHHHHHH
T ss_pred HHhhChHHHHHH
Confidence 9986 445443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.49 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=191.0
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
+|....+||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++.+++||||+++++++...+..++|+||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355566999999999999995 468899999986543 345678999999999999999999999999999999999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-CCCeEEeecccccccCCCCC
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~ 462 (623)
+++|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999996543 224567889999999999999999999 9999999999999987 89999999999987643221
Q ss_pred cccccccCCCCcccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLV--ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
. .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ...........
T Consensus 179 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~------ 242 (295)
T 2clq_A 179 C----TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGMFK------ 242 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHHHC------
T ss_pred c----ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhcccc------
Confidence 1 12335899999999987643 789999999999999999999999642211 00111100000
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..+.+ ....++++. .++..|+. .||++||++.|+++
T Consensus 243 ~~~~~-~~~~~~~~~---~li~~~l~-~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEI-PESMSAEAK---AFILKCFE-PDPDKRACANDLLV 278 (295)
T ss_dssp CCCCC-CTTSCHHHH---HHHHHTTC-SSTTTSCCHHHHHT
T ss_pred ccccc-cccCCHHHH---HHHHHHcc-CChhhCCCHHHHhc
Confidence 00001 111233333 44456776 99999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.12 Aligned_cols=199 Identities=22% Similarity=0.351 Sum_probs=165.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccH--HHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSE--KEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||.||+|... +++.||+|++....... ..+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999975 78999999986543221 2455799999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++ |+|.+++... +..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5999988643 34689999999999999999999999 99999999999999999999999999998654322
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 155 KT----YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc----cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 223357999999999876 56899999999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=317.22 Aligned_cols=193 Identities=18% Similarity=0.332 Sum_probs=169.3
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCC-CCCCcceeEEEEe--CCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NRNLVPLLGFCMA--KKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~e 380 (623)
++|...+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|++++.+++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 5788899999999999999985 57899999998743 3567899999999997 9999999999988 556789999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeecccccccCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFGLARLMNP 459 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgla~~~~~ 459 (623)
|+++++|.+++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 114 ~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999983 488899999999999999999999 999999999999999776 899999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 184 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 184 GQE-----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TCC-----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCc-----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 322 123358899999999877 67899999999999999999999999643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=331.42 Aligned_cols=197 Identities=23% Similarity=0.308 Sum_probs=165.0
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------C
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------K 373 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 373 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 357888999999999999999854 68899999997542 3356788999999999999999999999654 3
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999976 5666663 2488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 211 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98764321 1223458999999999999999999999999999999999999997643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.16 Aligned_cols=202 Identities=22% Similarity=0.315 Sum_probs=167.1
Q ss_pred HHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccccc------HHHHHHHHHHhCCCCCCCCcceeEEEEeCCe
Q 006982 302 KATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRS------EKEFVAEMATLGSVKNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 302 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 374 (623)
...++|...+.||+|+||.||+|... +++.||+|++...... ...+.+|++++.+++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34567999999999999999999965 6899999999653211 2467899999999999999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 899888642 35688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 160 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 160 KSFGSPNRA----YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp STTTSCCCC----CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCCccc----CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 876432221 1234589999999998654 5789999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=317.12 Aligned_cols=262 Identities=18% Similarity=0.259 Sum_probs=190.3
Q ss_pred ccCcc-cceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSK-NNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 380 (623)
+.|.+ .+.||+|+||.||+|.. .+++.||+|++.... .....+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 37899999999999995 478999999996543 4467889999999885 79999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC---eEEeeccccccc
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE---PKISDFGLARLM 457 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~---~kl~Dfgla~~~ 457 (623)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999963 24689999999999999999999999 9999999999999998776 999999999865
Q ss_pred CCCCCc---ccccccCCCCcccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccccc------
Q 006982 458 NPIDTH---LSTFVNGEFGDLGYVAPEYART-----LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGN------ 523 (623)
Q Consensus 458 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~------ 523 (623)
...... .........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 422111 0111223458999999999875 55789999999999999999999999765432211000
Q ss_pred -HHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 524 -LVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 524 -l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
........... .. ...... ....+.+ +..++..|+. .||++|||++|+++
T Consensus 245 ~~~~~~~~i~~~-~~-~~~~~~--~~~~~~~---~~~li~~~L~-~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEG-KY-EFPDKD--WAHISCA---AKDLISKLLV-RDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHC-CC-CCCHHH--HTTSCHH---HHHHHHHHSC-SSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhcc-Cc-ccCchh--cccCCHH---HHHHHHHHhh-CChhhCCCHHHHhc
Confidence 00001111000 00 000000 0112233 3445556766 99999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.75 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=198.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||++... +++.+++|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999975 57889999986542 3356788999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999853 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+..........
T Consensus 193 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~-- 258 (335)
T 2owb_A 193 YDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNEY-- 258 (335)
T ss_dssp STTCC----BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCC--
T ss_pred cCccc----ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHhcCCC--
Confidence 32221 1223489999999999988899999999999999999999999965321 111111111000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.+ ......++. .++..|+. .||++|||+.|+++.
T Consensus 259 -----~~-~~~~~~~~~---~li~~~l~-~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 -----SI-PKHINPVAA---SLIQKMLQ-TDPTARPTINELLND 292 (335)
T ss_dssp -----CC-CTTSCHHHH---HHHHHHTC-SSGGGSCCGGGGGGS
T ss_pred -----CC-CccCCHHHH---HHHHHHcc-CChhHCcCHHHHhcC
Confidence 00 111233333 34456666 999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=325.95 Aligned_cols=265 Identities=19% Similarity=0.238 Sum_probs=198.6
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCC--------CCCCcceeEEEE----
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK--------NRNLVPLLGFCM---- 370 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~---- 370 (623)
.++|...+.||+|+||.||+|.. .+++.||+|++.......+.+.+|++++.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 36789999999999999999985 46889999999876666678889999998886 788999999987
Q ss_pred eCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC------
Q 006982 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF------ 444 (623)
Q Consensus 371 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~------ 444 (623)
+....++||||+ +|+|.+.+.... ...+++..++.++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 455789999999 556666664322 256899999999999999999999964 799999999999999775
Q ss_pred -------------------------------------------CeEEeecccccccCCCCCcccccccCCCCcccccCcc
Q 006982 445 -------------------------------------------EPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481 (623)
Q Consensus 445 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE 481 (623)
.+||+|||+++..... .....||+.|+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~aPE 263 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGCCHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcccCCh
Confidence 7999999999876432 12235899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccc-cHHHHHHHHhccCc---------hhhhhc---------
Q 006982 482 YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG-NLVEWIAQLSSTGQ---------LQDAID--------- 542 (623)
Q Consensus 482 ~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~-~l~~~~~~~~~~~~---------~~~~~d--------- 542 (623)
++.+..++.++|||||||++|||++|+.||......+.... .....+........ ..+.+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999999976543321110 01111111110000 000000
Q ss_pred ---------hhhh-cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 ---------KCLV-AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ---------~~l~-~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.... .....+....+..++..|+. .||++|||++|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE-LIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGC-SSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhc-cChhhcCCHHHHhh
Confidence 0000 01123444566777778887 99999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=325.13 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=194.8
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEe----
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMA---- 371 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 371 (623)
.++....++|...+.||+|+||.||+|.. .+++.||+|++.........+.+|++++.++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33344567899999999999999999996 4789999999976666667899999999998 89999999999987
Q ss_pred --CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEe
Q 006982 372 --KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKIS 449 (623)
Q Consensus 372 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~ 449 (623)
....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 457899999999999999996432 25688999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccH
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL 524 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l 524 (623)
|||++......... .....||+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 172 Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------- 240 (326)
T 2x7f_A 172 DFGVSAQLDRTVGR----RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------- 240 (326)
T ss_dssp CCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------
T ss_pred eCcCceecCcCccc----cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------
Confidence 99999876432111 12234899999999987 567899999999999999999999999643211
Q ss_pred HHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 525 VEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
......... . .+.+.....++++..+ +..|+. .||++||++.|+++
T Consensus 241 -~~~~~~~~~-~-----~~~~~~~~~~~~l~~l---i~~~l~-~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 -RALFLIPRN-P-----APRLKSKKWSKKFQSF---IESCLV-KNHSQRPATEQLMK 286 (326)
T ss_dssp -HHHHHHHHS-C-----CCCCSCSCSCHHHHHH---HHHHCC-SSGGGSCCHHHHHT
T ss_pred -HHHHHhhcC-c-----cccCCccccCHHHHHH---HHHHhc-cChhhCCCHHHHhh
Confidence 101111000 0 0111112233444444 446766 99999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.83 Aligned_cols=253 Identities=20% Similarity=0.262 Sum_probs=194.7
Q ss_pred ccCcccceeeccCccEEEEEEe----CCCcEEEEEEecccc-----ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKE 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 374 (623)
++|...+.||+|+||.||+++. .+++.||+|+++... .....+.+|++++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5789999999999999999997 478999999987532 2345677899999999 69999999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999963 24689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHh
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLS 532 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~ 532 (623)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 207 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~ 279 (355)
T 1vzo_A 207 KEFVADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRIL 279 (355)
T ss_dssp EECCGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHH
T ss_pred eecccCCCC---cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----hHHHHHHHHh
Confidence 876432211 1122348999999999985 357899999999999999999999997543221 1222221111
Q ss_pred ccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHHH
Q 006982 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-----TMFEVYQFL 583 (623)
Q Consensus 533 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-----s~~ev~~~L 583 (623)
.... .. ....... +..++..|+. .||++|| +++|+++..
T Consensus 280 ~~~~-------~~-~~~~~~~---~~~li~~~L~-~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 280 KSEP-------PY-PQEMSAL---AKDLIQRLLM-KDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HCCC-------CC-CTTSCHH---HHHHHHHHTC-SSGGGSTTSSTTTHHHHHTSG
T ss_pred ccCC-------CC-CcccCHH---HHHHHHHHhh-hCHHHhcCCCCCCHHHHHcCc
Confidence 1100 00 0112233 3344456666 9999999 899987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=310.73 Aligned_cols=246 Identities=18% Similarity=0.329 Sum_probs=189.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +++.|++|++.... ...+.+.+|++++.+++||||+++++++.+.+..++|+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56888999999999999999976 78999999986532 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999632 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
... .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ............
T Consensus 164 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-- 228 (276)
T 2h6d_A 164 GEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKKIRGGVF-- 228 (276)
T ss_dssp ------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC--
T ss_pred Ccc-----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHHhhcCcc--
Confidence 221 122347899999999987765 6899999999999999999999964221 111111110000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
. .....+.++ ..++..|+. .||++|||+.|+++.
T Consensus 229 -----~-~~~~~~~~l---~~li~~~l~-~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----Y-IPEYLNRSV---ATLLMHMLQ-VDPLKRATIKDIREH 262 (276)
T ss_dssp -----C-CCTTSCHHH---HHHHHHHTC-SSGGGSCCHHHHHHS
T ss_pred -----c-CchhcCHHH---HHHHHHHcc-CChhhCCCHHHHHhC
Confidence 0 011123333 344456666 999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=309.17 Aligned_cols=244 Identities=20% Similarity=0.317 Sum_probs=196.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.+++||||+++++++.+.+..++|+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 57889999986532 23567899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999998632 4589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... .
T Consensus 167 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~-~--- 228 (284)
T 2vgo_A 167 LR------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRRIVNV-D--- 228 (284)
T ss_dssp SC------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTT-C---
T ss_pred cc------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHHHhcc-c---
Confidence 21 12235899999999999989999999999999999999999999753211 111111110 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..+ ....++++. .++..|+. .||.+||+++|+++
T Consensus 229 ---~~~-~~~~~~~~~---~li~~~l~-~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ---LKF-PPFLSDGSK---DLISKLLR-YHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCC-CTTSCHHHH---HHHHHHSC-SSGGGSCCHHHHHT
T ss_pred ---cCC-CCcCCHHHH---HHHHHHhh-cCHhhCCCHHHHhh
Confidence 000 011233444 44456666 99999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.13 Aligned_cols=266 Identities=19% Similarity=0.246 Sum_probs=201.3
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCC-CCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNR-NLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|.. .+++.||||++..... ...+..|++++..++|+ ++..+..++...+..++||||+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 5788899999999999999996 5789999998764432 23578899999999874 5555666667778889999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee---CCCCCeEEeecccccccCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl---~~~~~~kl~Dfgla~~~~~ 459 (623)
+++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++....
T Consensus 86 -g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 86 -GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999999632 34699999999999999999999999 99999999999999 6889999999999987654
Q ss_pred CCCccc---ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 460 IDTHLS---TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 460 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.. +........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~-i~~~~~~~~ 236 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEK-ISEKKVATS 236 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-HHHHH-HHHHHHHSC
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-HHHHH-Hhhcccccc
Confidence 322211 1112345899999999999999999999999999999999999999764332111 11111 111100111
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
+..+. ...+++ +..++..|+. .+|++||++.+|++.|+++..+.
T Consensus 237 ~~~l~------~~~p~~---l~~li~~cl~-~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 237 IEALC------RGYPTE---FASYFHYCRS-LRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHH------TTSCHH---HHHHHHHHHT-CCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHh------cCCcHH---HHHHHHHHhc-CChhhCcCHHHHHHHHHHHHHHc
Confidence 11111 122334 4445556776 99999999999999999986544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=318.55 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=192.1
Q ss_pred ccCcccceeeccCccEEEEEEeC--CCc--EEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE--DGT--SLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||+|.+. ++. .||+|+++.. ....+.+.+|++++.+++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888999999999999999853 333 6899998653 234567899999999999999999999998754 88
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 999999999999999642 24689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 171 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~ 241 (291)
T 1u46_A 171 LPQNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEG 241 (291)
T ss_dssp CCC-CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSC
T ss_pred ccccccch-hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHccC
Confidence 65432211 11222347889999999988888999999999999999999 9999975321 11122111111
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.... .....+++ +.+++..|+. .||++|||+.++++.|+++...
T Consensus 242 ~~~~------~~~~~~~~---l~~li~~~l~-~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 ERLP------RPEDCPQD---IYNVMVQCWA-HKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCCC------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCC------CCcCcCHH---HHHHHHHHcc-CCcccCcCHHHHHHHHHHhCcc
Confidence 0000 01122333 4444556776 9999999999999999988654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.88 Aligned_cols=263 Identities=25% Similarity=0.376 Sum_probs=181.3
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46789999999999999999995 468999999986542 345678899999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCC----CCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 381 HMPNGSLYDLLHPA----DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 381 ~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
|+++|+|.+++... ......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999999998531 11235689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-ccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 457 MNPIDTH-LSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 457 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
....... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ... ......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~---~~~~~~ 243 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VLM---LTLQND 243 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHH---HHHTSS
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HHH---HHhccC
Confidence 6432211 1111223458999999999875 568999999999999999999999997543211 110 000000
Q ss_pred -Cchhh-hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 535 -GQLQD-AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 535 -~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..... ..+.... ....+++. +++..|+. .||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~---~li~~~l~-~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEML-KKYGKSFR---KMISLCLQ-KDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCC-CCCCHHHH---HHHHHHCC-SSGGGSCCHHHHHT
T ss_pred CCccccccccchhh-hhhhHHHH---HHHHHHcc-CChhhCcCHHHHhh
Confidence 00100 0111111 11233443 44556776 99999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=333.92 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=197.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||++... +++.||+|++... ......+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999975 7899999998543 34567899999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee---CCCCCeEEeeccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLAR 455 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl---~~~~~~kl~Dfgla~ 455 (623)
+||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999863 35689999999999999999999999 99999999999999 578899999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ ....||+.|+|||++.+ .++.++||||+||++|||++|+.||...... +.........
T Consensus 178 ~~~~~~~~-----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~ 243 (484)
T 3nyv_A 178 HFEASKKM-----KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEKGK 243 (484)
T ss_dssp HBCCCCSH-----HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC
T ss_pred Eccccccc-----ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCC
Confidence 76543221 12348999999999876 6899999999999999999999999753221 1111111110
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.. .-.+.+ ...++++.. ++..|+. .||++|||+.|+++.
T Consensus 244 ~~--~~~~~~--~~~s~~~~~---li~~~L~-~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 244 YT--FELPQW--KKVSESAKD---LIRKMLT-YVPSMRISARDALDH 282 (484)
T ss_dssp CC--CCSGGG--GGSCHHHHH---HHHHHTC-SSGGGSCCHHHHHTS
T ss_pred CC--CCCccc--ccCCHHHHH---HHHHHCC-CChhHCcCHHHHhhC
Confidence 00 000011 112334444 4445665 999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=333.78 Aligned_cols=195 Identities=22% Similarity=0.327 Sum_probs=153.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----Cee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 375 (623)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57899999999999999999855 78999999986532 3346788999999999999999999998543 467
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+ +|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 5799999863 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcc-----------------------cccccCCCCcccccCcccc-cCCCCCcchhHHHHHHHHHHHHhC
Q 006982 456 LMNPIDTHL-----------------------STFVNGEFGDLGYVAPEYA-RTLVATPKGDVYSFGTVLLELVTG 507 (623)
Q Consensus 456 ~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DV~sfGvil~elltg 507 (623)
......... .....+..||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 764321110 0122345689999999976 566799999999999999999994
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.55 Aligned_cols=200 Identities=20% Similarity=0.296 Sum_probs=164.6
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
..++|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3468999999999999999999854 788999999975432 245678999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee-----CCCCCeEEeeccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL-----DDDFEPKISDFGL 453 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl-----~~~~~~kl~Dfgl 453 (623)
|||+++ +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999984 999998633 4589999999999999999999999 99999999999999 4555699999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 184 a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 184 ARAFGIPIRQ----FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCcccc----cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 9876432211 1223479999999999774 4899999999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.66 Aligned_cols=202 Identities=22% Similarity=0.325 Sum_probs=166.4
Q ss_pred HHHhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-------
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------- 372 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 372 (623)
....++|...+.||+|+||.||+|.. .+++.||+|++..... ...+|++++++++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34567899999999999999999985 5789999999865432 223799999999999999999998543
Q ss_pred -------------------------------CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHH
Q 006982 373 -------------------------------KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421 (623)
Q Consensus 373 -------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH 421 (623)
...++||||++ |+|.+.+......+..+++..+..++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 23789999998 5888777542223467999999999999999999999
Q ss_pred hcCCCCcEecCCCCCceeeC-CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHH
Q 006982 422 HNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGT 499 (623)
Q Consensus 422 ~~~~~~i~H~dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGv 499 (623)
+. +|+||||||+||+++ +++.+||+|||+++........ ....+|..|+|||.+.+. .++.++||||+||
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-----VAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC-----CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC-----cCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99 999999999999997 6899999999999876543222 223478999999998764 4899999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 006982 500 VLLELVTGERPTNVA 514 (623)
Q Consensus 500 il~elltg~~P~~~~ 514 (623)
++|||++|+.||...
T Consensus 231 il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 231 VFGELILGKPLFSGE 245 (383)
T ss_dssp HHHHHHHSSCSSCCS
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=320.62 Aligned_cols=200 Identities=21% Similarity=0.314 Sum_probs=174.7
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEecccccc------------------HHHHHHHHHHhCCCCCCCCcce
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRS------------------EKEFVAEMATLGSVKNRNLVPL 365 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~e~~~l~~l~h~niv~l 365 (623)
.++|...+.||+|+||.||+|.. ++..||+|++...... .+.+.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788899999999999999999 8999999998653211 1789999999999999999999
Q ss_pred eEEEEeCCeeeEEEecCCCCCHhhh------ccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCce
Q 006982 366 LGFCMAKKERLLVYKHMPNGSLYDL------LHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCI 438 (623)
Q Consensus 366 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NI 438 (623)
++++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||.|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999999 5422 24679999999999999999999999 8 999999999999
Q ss_pred eeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 439 LLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATP-KGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 439 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
+++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999875432 12234589999999999877 5666 9999999999999999999997543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.80 Aligned_cols=207 Identities=21% Similarity=0.253 Sum_probs=171.1
Q ss_pred CHHHHHHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccc------------cHHHHHHHHHHhCCCCCCCCc
Q 006982 296 RLSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR------------SEKEFVAEMATLGSVKNRNLV 363 (623)
Q Consensus 296 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~h~niv 363 (623)
.+.++....++|...+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677888899999999999999999999988899999999864321 136789999999999999999
Q ss_pred ceeEEEEeC-----CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCce
Q 006982 364 PLLGFCMAK-----KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCI 438 (623)
Q Consensus 364 ~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NI 438 (623)
++++++... ...++||||++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998653 35689999998 6888888632 34689999999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 439 LLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 439 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADAN-----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp EECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEcCCCCEEEEecCcccccccccc-----cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999985443221 122347899999999876 67899999999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.08 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=193.8
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--------------ccHHHHHHHHHHhCCCCCCCCcceeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--------------RSEKEFVAEMATLGSVKNRNLVPLLGF 368 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 368 (623)
.++|...+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++.+++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467899999999999999999965 57899999986532 234678899999999999999999999
Q ss_pred EEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC---C
Q 006982 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF---E 445 (623)
Q Consensus 369 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~---~ 445 (623)
+.+....++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999853 24689999999999999999999999 999999999999998776 6
Q ss_pred eEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHH
Q 006982 446 PKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 446 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~ 525 (623)
+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||..... .
T Consensus 188 ~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~ 253 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND--------Q 253 (504)
T ss_dssp EEECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred EEEEECCCCEEcCCCCc-----cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence 99999999987654221 223458999999999874 689999999999999999999999975322 1
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
+............. .+. ....++++..+ +..|+. .||.+|||+.|+++.
T Consensus 254 ~~~~~i~~~~~~~~--~~~--~~~~s~~~~~l---i~~~L~-~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 254 DIIKKVEKGKYYFD--FND--WKNISDEAKEL---IKLMLT-YDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHHHHCCCCCC--HHH--HTTSCHHHHHH---HHHHTC-SSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCCCCC--ccc--cCCCCHHHHHH---HHHHcC-CChhHCCCHHHHhcC
Confidence 11111111100000 000 01223444444 445665 999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.55 Aligned_cols=197 Identities=23% Similarity=0.284 Sum_probs=171.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCC------CCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSV------KNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~l 377 (623)
.+|...+.||+|+||.||+|... +++.||+|++.........+.+|++++..+ .|+||+++++++......++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 46888999999999999999865 588999999987655556677777776665 67799999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC--eEEeeccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE--PKISDFGLAR 455 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~--~kl~Dfgla~ 455 (623)
||||+. |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 177 v~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 999996 699999865432 4589999999999999999999999 9999999999999999887 9999999997
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 251 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 65432 12235899999999999999999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.13 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=194.6
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.++|...+.||+|+||.||++... +++.||+|++.... .....+.+|++++.+++||||+++++++.+....++|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356888999999999999999965 78999999997543 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee---CCCCCeEEeecccccccC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMN 458 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl---~~~~~~kl~Dfgla~~~~ 458 (623)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999853 24588999999999999999999999 99999999999999 788999999999997644
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............
T Consensus 161 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~-- 224 (304)
T 2jam_A 161 NGIM------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGYY-- 224 (304)
T ss_dssp CBTT------HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCCC--
T ss_pred CCcc------ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 3211 112378999999999999999999999999999999999999975321 111111111100
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
....+ .....++++.+ ++..|+. .||++|||+.|+++.
T Consensus 225 ~~~~~--~~~~~~~~~~~---li~~~l~-~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 EFESP--FWDDISESAKD---FICHLLE-KDPNERYTCEKALSH 262 (304)
T ss_dssp CCCTT--TTTTSCHHHHH---HHHHHHC-SSTTTSCCHHHHHTS
T ss_pred CCCcc--ccccCCHHHHH---HHHHHcC-CChhHCcCHHHHhcC
Confidence 00000 00112344444 4445665 999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.05 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=195.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
.++|...+.||+|+||.||++... +++.||+|++... ......+.+|++++++++||||+++++++.+....++|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357899999999999999999965 7899999998643 245678899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC---CCCCeEEeecccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD---DDFEPKISDFGLARL 456 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~---~~~~~kl~Dfgla~~ 456 (623)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999998853 24689999999999999999999999 999999999999995 566799999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
...... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||...... +..........
T Consensus 174 ~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~ 239 (486)
T 3mwu_A 174 FQQNTK-----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGKY 239 (486)
T ss_dssp BCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC
T ss_pred CCCCCc-----cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC
Confidence 644221 223458999999999876 5899999999999999999999999753221 11111111100
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.. -.+.+ ...++++.. ++..|+. .||++|||+.|+++.
T Consensus 240 ~~--~~~~~--~~~s~~~~~---li~~~L~-~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 AF--DLPQW--RTISDDAKD---LIRKMLT-FHPSLRITATQCLEH 277 (486)
T ss_dssp CS--CSGGG--GGSCHHHHH---HHHHHTC-SSTTTSCCHHHHHHC
T ss_pred CC--CCccc--CCCCHHHHH---HHHHHcC-CChhhCcCHHHHhcC
Confidence 00 00000 112334443 4445665 999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.16 Aligned_cols=251 Identities=19% Similarity=0.283 Sum_probs=192.6
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-----ccHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 375 (623)
.++|...+.||+|+||.||++... ++..||+|++.... .....+.+|++++.+++||||+++++++.. ....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999964 68899999997542 345678999999999999999999999853 4577
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||++++ |.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999886 777765432 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhc
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV--ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 533 (623)
........ .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... .+.......
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~ 227 (305)
T 2wtk_C 158 ALHPFAAD--DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFENIGK 227 (305)
T ss_dssp ECCTTCSS--CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH
T ss_pred ccCccccc--cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHHHhc
Confidence 76532221 1123345899999999987643 47899999999999999999999975321 111111111
Q ss_pred cCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 534 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.. . .+ .....+++. .++..|+. .||++|||+.|+++.
T Consensus 228 ~~-~------~~-~~~~~~~l~---~li~~~l~-~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 GS-Y------AI-PGDCGPPLS---DLLKGMLE-YEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC-C------CC-CSSSCHHHH---HHHHHHTC-SSTTTSCCHHHHHHS
T ss_pred CC-C------CC-CCccCHHHH---HHHHHHcc-CChhhCCCHHHHhcC
Confidence 10 0 00 111233444 44456666 999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.46 Aligned_cols=250 Identities=21% Similarity=0.354 Sum_probs=193.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+|++++.+++||||+++++++...+..++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 467889999999999999999975 58999999987543 3467889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999998522 35689999999999999999999999 999999999999999999999999999987643221
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... .......
T Consensus 181 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~~~~~~ 247 (314)
T 3com_A 181 K----RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMIPTN-PPPTFRK 247 (314)
T ss_dssp C----BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHS-CCCCCSS
T ss_pred c----cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcC-CCcccCC
Confidence 1 12335899999999999989999999999999999999999999743211 101110000 0000000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
....+++ +..++..|+. .||.+|||+.++++
T Consensus 248 ----~~~~~~~---l~~li~~~l~-~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ----PELWSDN---FTDFVKQCLV-KSPEQRATATQLLQ 278 (314)
T ss_dssp ----GGGSCHH---HHHHHHHHTC-SCTTTSCCHHHHTT
T ss_pred ----cccCCHH---HHHHHHHHcc-CChhhCcCHHHHHh
Confidence 0112233 3444556776 99999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.49 Aligned_cols=208 Identities=21% Similarity=0.258 Sum_probs=161.9
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe--
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE-- 374 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 374 (623)
.......++|...+.||+|+||.||+|... ++..||+|++.........+.++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 455677789999999999999999999974 68999999987655545567788888888999999999999976443
Q ss_pred -----eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHH--hcCCCCcEecCCCCCceeeCC-CCCe
Q 006982 375 -----RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH--HNCNPRIIHRNISSKCILLDD-DFEP 446 (623)
Q Consensus 375 -----~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~i~H~dlk~~NILl~~-~~~~ 446 (623)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 6899999987 554443321123456889999999999999999999 77 9999999999999996 8999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 172 kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPN-----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp EECCCTTCBCCCTTSCC-----CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeeCCCceecCCCCCc-----ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 99999999876543221 223479999999998654 4899999999999999999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.71 Aligned_cols=260 Identities=23% Similarity=0.386 Sum_probs=193.4
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|...+.||+|+||.||+|...+ .+++|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++|+|
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678889999999999999999864 48999886432 233567789999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 110 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999642 24689999999999999999999999 999999999999998 679999999998765321
Q ss_pred CCc-ccccccCCCCcccccCcccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHH
Q 006982 461 DTH-LSTFVNGEFGDLGYVAPEYART---------LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQ 530 (623)
Q Consensus 461 ~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~ 530 (623)
... .........||+.|+|||.+.. ..++.++||||||+++|||++|+.||...... .....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~ 254 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--------AIIWQ 254 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--------HHHHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 111 1111223458899999999864 45788999999999999999999999753211 11111
Q ss_pred HhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.... ..+.+.....++++ ..++..|+. .||++|||+.+++++|+++.++.
T Consensus 255 ~~~~------~~~~~~~~~~~~~l---~~li~~~l~-~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 255 MGTG------MKPNLSQIGMGKEI---SDILLFCWA-FEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHTT------CCCCCCCSSCCTTH---HHHHHHHHC-SSTTTSCCHHHHHHHHTTC----
T ss_pred hccC------CCCCCCcCCCCHHH---HHHHHHHhc-CChhhCcCHHHHHHHHHHHHHhh
Confidence 1110 01111111122333 344456766 99999999999999999987765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=346.35 Aligned_cols=258 Identities=21% Similarity=0.340 Sum_probs=199.0
Q ss_pred HhccCcccceeeccCccEEEEEEeCC----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
..++|...+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.++.+++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678888999999999999998642 4679999986533 33467899999999999999999999984 45689
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 999999999999999643 24689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ .....+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .....+.. ..
T Consensus 541 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~~~i~~---~~ 609 (656)
T 2j0j_A 541 MEDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIEN---GE 609 (656)
T ss_dssp CCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHH---TC
T ss_pred cCCCccee---ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHc---CC
Confidence 65422211 112346789999999998899999999999999999997 99998753221 11111111 10
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.. . .....++++ ..++..|+. .||++|||+.|+++.|+++.++
T Consensus 610 ~~-~------~~~~~~~~l---~~li~~~l~-~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 RL-P------MPPNCPPTL---YSLMTKCWA-YDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CC-C------CCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC-C------CCccccHHH---HHHHHHHcC-CChhHCcCHHHHHHHHHHHHHH
Confidence 00 0 011123333 445556777 9999999999999999998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.64 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=191.6
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
.+.|...+.||+|+||.||+|... ++..||+|++.... .....+.+|++++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999965 68899999986542 33567899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeecccccc
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLARL 456 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Dfgla~~ 456 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998853 24689999999999999999999999 9999999999999976 45599999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
...... .....||+.|+|||++. ..++.++||||+||++|||++|+.||...... +..........
T Consensus 189 ~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~ 254 (494)
T 3lij_A 189 FENQKK-----MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGKY 254 (494)
T ss_dssp CBTTBC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC
T ss_pred CCCCcc-----ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC
Confidence 643221 22345899999999986 46899999999999999999999999753221 11111111100
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
....+.+ ...++++..+ +..|+. .||++|||+.|+++.
T Consensus 255 --~~~~~~~--~~~s~~~~~l---i~~~L~-~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 255 --TFDSPEW--KNVSEGAKDL---IKQMLQ-FDSQRRISAQQALEH 292 (494)
T ss_dssp --CCCSGGG--TTSCHHHHHH---HHHHTC-SSTTTSCCHHHHHTC
T ss_pred --CCCchhc--ccCCHHHHHH---HHHHCC-CChhhCccHHHHhcC
Confidence 0000111 1223444444 445665 999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.91 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=190.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK 373 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 373 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.+++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457899999999999999999965 57899999986532 12235789999999999999999999987654
Q ss_pred eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC---eEEee
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE---PKISD 450 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~---~kl~D 450 (623)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 8999999999999999863 35689999999999999999999999 9999999999999987665 99999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHH
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~ 527 (623)
||+++....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+...
T Consensus 161 fg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~ 231 (322)
T 2ycf_A 161 FGHSKILGETSL-----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQ 231 (322)
T ss_dssp CTTCEECCCCHH-----HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHH
T ss_pred Cccceecccccc-----cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHH
Confidence 999987643211 11223789999999873 5678899999999999999999999997543321 22222
Q ss_pred HHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+...... ...+ .. ....++ +.+++..|+. .||++||++.|+++
T Consensus 232 ~~~~~~~-~~~~-----~~-~~~~~~---~~~li~~~l~-~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYN-FIPE-----VW-AEVSEK---ALDLVKKLLV-VDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCC-CCHH-----HH-TTSCHH---HHHHHHHHSC-SSTTTSCCHHHHHT
T ss_pred HHhCccc-cCch-----hh-hhcCHH---HHHHHHHHcc-cCHhhCCCHHHHhh
Confidence 2111000 0000 00 112233 3445556776 99999999999884
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=313.05 Aligned_cols=251 Identities=18% Similarity=0.307 Sum_probs=191.5
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
.+.|...+.||+|+||.||+|... ++..|++|++.... ...+.+.+|++++.+++||||+++++++...+..++|+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 357888999999999999999976 58899999986543 4567889999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999998532 24589999999999999999999999 99999999999999999999999999976432110
Q ss_pred CcccccccCCCCcccccCcccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 462 THLSTFVNGEFGDLGYVAPEYA-----RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
.......||+.|+|||++ ....++.++||||||+++|||++|+.||..... ............
T Consensus 172 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 239 (302)
T 2j7t_A 172 ----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSDP 239 (302)
T ss_dssp ----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCC
T ss_pred ----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhccCC
Confidence 111223489999999998 466789999999999999999999999975321 111111111100
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .. ......+.++ ..++..|+. .||++|||+.|+++
T Consensus 240 ~-~~----~~~~~~~~~l---~~li~~~l~-~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 P-TL----LTPSKWSVEF---RDFLKIALD-KNPETRPSAAQLLE 275 (302)
T ss_dssp C-CC----SSGGGSCHHH---HHHHHHHSC-SCTTTSCCHHHHTT
T ss_pred c-cc----CCccccCHHH---HHHHHHHcc-cChhhCCCHHHHhc
Confidence 0 00 0011122333 344456766 99999999999865
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.33 Aligned_cols=197 Identities=20% Similarity=0.297 Sum_probs=172.1
Q ss_pred ccCcccceeeccCccEEEEEEe--CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCC------CcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL--EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRN------LVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||+|.. .++..||+|+++......+.+.+|++++..++|++ ++++++++.+.+..+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 5788899999999999999986 36889999999876656677888999988887654 999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC--------------
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-------------- 442 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-------------- 442 (623)
+||||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 999999 889999986542 24688999999999999999999999 9999999999999987
Q ss_pred -----CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 443 -----DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 443 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHH-------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCC-------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCcccc-------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 6789999999998654321 1235899999999999989999999999999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=344.41 Aligned_cols=201 Identities=21% Similarity=0.251 Sum_probs=175.7
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeee
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 376 (623)
..++|...++||+|+||.||+|... +++.||+|+++.. ......+..|.+++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999965 6888999999753 23445678899999888 7999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+||||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999632 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 492 ~~~~~~~----~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 492 NIWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CCCTTCC----BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCcc----cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 4332221 22345899999999999999999999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=309.08 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=187.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEe-----------
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA----------- 371 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------- 371 (623)
.++|...+.||+|+||.||+|... +++.||+|++.......+.+.+|++++.+++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 467899999999999999999964 78999999997665566788999999999999999999998865
Q ss_pred --CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEe
Q 006982 372 --KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKIS 449 (623)
Q Consensus 372 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~ 449 (623)
....++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 34578999999999999999642 34678899999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCc----------ccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 006982 450 DFGLARLMNPIDTH----------LSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAKAPE 518 (623)
Q Consensus 450 Dfgla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~~~~ 518 (623)
|||+++........ .........||+.|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--- 232 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--- 232 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence 99999876432100 01112234589999999998754 68999999999999999998 553210
Q ss_pred cccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 519 TFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 519 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
............. ..+.+.+. ....++ +.+++..|+. .||++|||+.|+++
T Consensus 233 ----~~~~~~~~~~~~~---~~~~~~~~-~~~~~~---~~~li~~~l~-~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ----ERVNILKKLRSVS---IEFPPDFD-DNKMKV---EKKIIRLLID-HDPNKRPGARTLLN 283 (303)
T ss_dssp ----HHHHHHHHHHSTT---CCCCTTCC-TTTSHH---HHHHHHHHTC-SSGGGSCCHHHHHH
T ss_pred ----hHHHHHHhccccc---cccCcccc-ccchHH---HHHHHHHHHh-cCcccCcCHHHHhC
Confidence 0111111111100 00000000 112223 3444556666 99999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.00 Aligned_cols=251 Identities=8% Similarity=-0.013 Sum_probs=174.6
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHHHH---HHHhCCCCCCCCccee-------EEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFVAE---MATLGSVKNRNLVPLL-------GFC 369 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e---~~~l~~l~h~niv~l~-------~~~ 369 (623)
.+|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+| ++.+.. +|||+++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45888899999999999999965 78999999997643 234556777 455666 799977754 454
Q ss_pred EeC-----------------CeeeEEEecCCCCCHhhhccCCCCCCCccChHHH------HHHHHHHHHHHHHHHhcCCC
Q 006982 370 MAK-----------------KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRR------LKIAIGAARGFAWLHHNCNP 426 (623)
Q Consensus 370 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~ 426 (623)
... ...++||||++ |+|.+++... +..+.+..+ +.++.|++.||+|||+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 433 23789999999 8999999643 234566666 78889999999999999
Q ss_pred CcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHH
Q 006982 427 RIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLEL 504 (623)
Q Consensus 427 ~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~el 504 (623)
+|+||||||+|||++.++.+||+|||+++...... . ...+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---P----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---E----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc---c----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 99999999999999999999999999998764311 0 2236799999999987 6789999999999999999
Q ss_pred HhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 505 VTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 505 ltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
++|+.||............ ..............+. ....++++..+ +..|+. .||++|||+.|+++
T Consensus 287 ltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~--~~~~~~~~~~l---i~~~L~-~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGSWK-----RPSLRVPGTDSLAFGS--CTPLPDFVKTL---IGRFLN-FDRRRRLLPLEAME 352 (371)
T ss_dssp HHSSCSTTBCCTTCTTCCC-----BCCTTSCCCCSCCCTT--SSCCCHHHHHH---HHHHTC-SSTTTCCCHHHHTT
T ss_pred HhCCCCCCCcCcccccchh-----hhhhhhccccccchhh--ccCCCHHHHHH---HHHHcC-CChhhCCCHHHHhc
Confidence 9999999765332110000 0000000000000000 01234444444 445666 99999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.27 Aligned_cols=201 Identities=22% Similarity=0.301 Sum_probs=166.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----Ce
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 374 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357889999999999999999965 68889999997542 3346788999999999999999999999776 56
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++||||++ |+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 599999963 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcc------------------cccccCCCCcccccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006982 455 RLMNPIDTHL------------------STFVNGEFGDLGYVAPEYA-RTLVATPKGDVYSFGTVLLELVTGERPTN 512 (623)
Q Consensus 455 ~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DV~sfGvil~elltg~~P~~ 512 (623)
+......... ........||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 9765322110 0112345689999999986 56679999999999999999998666554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.67 Aligned_cols=198 Identities=23% Similarity=0.296 Sum_probs=163.2
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe------eeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE------RLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lV 378 (623)
.+|...+.||+|+||.||+|+..++..+|+|++...... ..+|++++++++||||+++++++..... .++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 468889999999999999999887777999988543321 2369999999999999999999965443 6799
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeEEeeccccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLM 457 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~kl~Dfgla~~~ 457 (623)
|||++++.+....+. ......+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 117 ~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPETVYRASRHY-AKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEEHHHHHHHH-HHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCccHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999987544433221 11235789999999999999999999999 999999999999999 8999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 193 IAGEPN-----VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CTTCCC-----CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCCC-----cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 443222 123479999999998764 5899999999999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.29 Aligned_cols=198 Identities=25% Similarity=0.313 Sum_probs=163.0
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeC----C--eeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK----K--ERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~--~~~l 377 (623)
.+|...+.||+|+||.||+|+.. +++.||+|++..... ...+|++++++++||||+++++++... + ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 45888899999999999999975 689999999865432 234799999999999999999998642 1 2568
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-CCeEEeecccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-FEPKISDFGLARL 456 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-~~~kl~Dfgla~~ 456 (623)
||||+++ ++.+.+.........+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 66666543222346789999999999999999999999 99999999999999955 6789999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 207 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 207 LVRGEPN-----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp CCTTCCC-----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCCc-----eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 6543221 123589999999998764 7899999999999999999999999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=313.82 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=189.8
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCC--CCCCcceeEEEEeCCeeeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVK--NRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV 378 (623)
.++|...+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++.+++ ||||+++++++.+.+..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 46788899999999999999999889999999986533 33467889999999997 59999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|| +.+++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||++++ +.+||+|||+++...
T Consensus 107 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 107 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred Ee-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 99 668899999963 24689999999999999999999999 9999999999999975 899999999998764
Q ss_pred CCCCcccccccCCCCcccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHH
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYART-----------LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEW 527 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~ 527 (623)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...
T Consensus 178 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~ 248 (313)
T 3cek_A 178 PDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISK 248 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHH
T ss_pred Ccccc--ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HHH
Confidence 42211 11223458999999999865 46788999999999999999999999643221 111
Q ss_pred HHHHhccCchhhhhchhhh---cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 528 IAQLSSTGQLQDAIDKCLV---AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 528 ~~~~~~~~~~~~~~d~~l~---~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.... ++.... ....++++. .++..|+. .||++||++.|+++.-
T Consensus 249 ~~~~---------~~~~~~~~~~~~~~~~l~---~li~~~l~-~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 249 LHAI---------IDPNHEIEFPDIPEKDLQ---DVLKCCLK-RDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHH---------HCTTSCCCCCCCSCHHHH---HHHHHHTC-SSTTTSCCHHHHHTSH
T ss_pred HHHH---------HhcccccCCcccchHHHH---HHHHHHcc-CCcccCcCHHHHhcCc
Confidence 1111 111111 111233344 44456776 9999999999998743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=328.26 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=181.3
Q ss_pred CcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCCCC
Q 006982 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMPNG 385 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g 385 (623)
|...++||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +||||+++++++.+.+..++||||++ |
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 44568899999999987777789999999986532 45678899999876 89999999999999999999999996 6
Q ss_pred CHhhhccCCCCCCCc---cChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC-------------CCeEEe
Q 006982 386 SLYDLLHPADDTGKS---VDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD-------------FEPKIS 449 (623)
Q Consensus 386 sL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~-------------~~~kl~ 449 (623)
+|.+++......... .++..++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999754332221 24445688999999999999999 99999999999999754 489999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-------LVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFK 521 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~ 521 (623)
|||+++.................||++|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---- 246 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR---- 246 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----
Confidence 999999875433222222234468999999999865 568999999999999999999 99999643221
Q ss_pred ccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
............... . .........+..++..|+. .||++|||+.||++
T Consensus 247 --~~~i~~~~~~~~~~~-----~---~~~~~~~~~~~~li~~~L~-~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 --ESNIIRGIFSLDEMK-----C---LHDRSLIAEATDLISQMID-HDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHHTCCCCCCCT-----T---CCCHHHHHHHHHHHHHHTC-SSGGGSCCHHHHHT
T ss_pred --HHHHhcCCCCccccc-----c---cccccchHHHHHHHHHHhh-CChhhCCCHHHHHh
Confidence 011111111100110 0 0112222345556667776 99999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=318.54 Aligned_cols=194 Identities=25% Similarity=0.369 Sum_probs=163.7
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------e
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------E 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 374 (623)
++|...+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++++++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 5688899999999999999996 478999999996533 23467889999999999999999999997653 4
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 59999999 8899999853 4588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+..... .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 176 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 176 RQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp EECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 875432 123358999999999876 67899999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.23 Aligned_cols=195 Identities=24% Similarity=0.321 Sum_probs=161.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------e
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------E 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 374 (623)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57888999999999999999864 68899999986532 33456889999999999999999999997654 6
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7999999975 7888884 3488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 175 RTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp --------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 8654321 112335899999999999989999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.72 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=195.0
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----------ccHHHHHHHHHHhCCCC-CCCCcceeEEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----------RSEKEFVAEMATLGSVK-NRNLVPLLGFCMA 371 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 371 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++.+++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 68899999986432 12356789999999995 9999999999999
Q ss_pred CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeec
Q 006982 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDF 451 (623)
Q Consensus 372 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Df 451 (623)
....++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999963 24689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR------TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~ 525 (623)
|++........ .....+++.|+|||++. ...++.++||||||+++|||++|+.||..... .
T Consensus 169 g~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~ 235 (298)
T 1phk_A 169 GFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------M 235 (298)
T ss_dssp TTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred cchhhcCCCcc-----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------H
Confidence 99987654221 12335899999999885 45678999999999999999999999965321 1
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
........... ....+.. ...+++ +..++..|+. .||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~--~~~~~~~--~~~~~~---l~~li~~~l~-~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 LMLRMIMSGNY--QFGSPEW--DDYSDT---VKDLVSRFLV-VQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHTCC--CCCTTTG--GGSCHH---HHHHHHHHCC-SSGGGSCCHHHHTT
T ss_pred HHHHHHhcCCc--ccCcccc--cccCHH---HHHHHHHHcc-CCcccCCCHHHHHh
Confidence 11111111000 0000000 012233 3444556666 99999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.41 Aligned_cols=202 Identities=22% Similarity=0.352 Sum_probs=171.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----Cee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 375 (623)
.++|...+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357888999999999999999965 68889999997533 3346788999999999999999999999765 357
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 89999997 599999853 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 177 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 177 VADPDHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp ECCGGGCB-CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCCc-cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 76542221 111233468999999998654 458999999999999999999999997644
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=317.55 Aligned_cols=201 Identities=23% Similarity=0.278 Sum_probs=170.3
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCC-CC-----CCcceeEEEEeCCeee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NR-----NLVPLLGFCMAKKERL 376 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~ 376 (623)
.++|...+.||+|+||.||+|... +++.||+|++.........+..|++++..++ |+ +++++++++...+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 467899999999999999999965 6889999999866555567778888877774 44 4999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC--CCCCeEEeecccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD--DDFEPKISDFGLA 454 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~--~~~~~kl~Dfgla 454 (623)
+||||++ |+|.+++..... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||+|||++
T Consensus 133 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999996 599999865432 4589999999999999999999952 12899999999999994 5788999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 209 ~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQRI-------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccccc-------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8764321 22358999999999999999999999999999999999999998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.52 Aligned_cols=199 Identities=19% Similarity=0.282 Sum_probs=168.9
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCC-----------CCCCcceeEEEEeC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-----------NRNLVPLLGFCMAK 372 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~ 372 (623)
++|...+.||+|+||.||+|.. .+++.||+|++.........+.+|++++.+++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 5688899999999999999996 57899999999876656677889999988886 89999999998865
Q ss_pred C----eeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC------C
Q 006982 373 K----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD------D 442 (623)
Q Consensus 373 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~------~ 442 (623)
. ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++ +|+||||||+|||++ .
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 4 678999999 899999996543 245899999999999999999999953 799999999999994 4
Q ss_pred CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 443 DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 443 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
.+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 174 ~~~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cceEEEcccccccccCCCC-------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4589999999998764321 22358999999999999999999999999999999999999997543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.04 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=195.1
Q ss_pred HhccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
..++|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.+++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999975 78999999986532 3567889999999999999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCC---CCeEEeeccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDD---FEPKISDFGLAR 455 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~---~~~kl~Dfgla~ 455 (623)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999998853 24689999999999999999999999 99999999999999754 479999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ ....+|+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ...........
T Consensus 173 ~~~~~~~~-----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~ 238 (287)
T 2wei_A 173 CFQQNTKM-----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGK 238 (287)
T ss_dssp TBCCCSSC-----SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC
T ss_pred eecCCCcc-----ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC
Confidence 76542221 11237889999999876 489999999999999999999999975321 11111111110
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.... .+ .....++++. .++..|+. .||++|||+.|+++
T Consensus 239 ~~~~--~~--~~~~~~~~~~---~li~~~l~-~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAFD--LP--QWRTISDDAK---DLIRKMLT-FHPSLRITATQCLE 276 (287)
T ss_dssp CCCC--SG--GGTTSCHHHH---HHHHHHTC-SSGGGSCCHHHHHH
T ss_pred CCCC--ch--hhhhcCHHHH---HHHHHHcc-cChhhCcCHHHHhc
Confidence 0000 00 0012233444 44456666 99999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=315.62 Aligned_cols=201 Identities=24% Similarity=0.349 Sum_probs=168.8
Q ss_pred HhccCcccceeeccCccEEEEEEe--CCCcEEEEEEeccccc---cHHHHHHHHHHhCCC---CCCCCcceeEEEE----
Q 006982 303 ATNSFSKNNIIGSGRTGTMYKALL--EDGTSLMVKRLQDSQR---SEKEFVAEMATLGSV---KNRNLVPLLGFCM---- 370 (623)
Q Consensus 303 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 370 (623)
+.++|...+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4688999999864321 123455677666655 8999999999987
Q ss_pred -eCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEe
Q 006982 371 -AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKIS 449 (623)
Q Consensus 371 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~ 449 (623)
.....++|+||++ |+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4456789999998 69999986543 24589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 450 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 450 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 163 Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 163 DFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp SCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999998654321 122345899999999999989999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=315.91 Aligned_cols=194 Identities=22% Similarity=0.365 Sum_probs=166.0
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCee----
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKER---- 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 375 (623)
.++|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888999999999999999964 689999999976432 346788999999999999999999999877654
Q ss_pred --eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccc
Q 006982 376 --LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGL 453 (623)
Q Consensus 376 --~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgl 453 (623)
++||||++ |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68988873 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 454 ARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 454 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 191 a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 191 ARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp C---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 123357999999999877 67899999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.18 Aligned_cols=204 Identities=22% Similarity=0.312 Sum_probs=154.9
Q ss_pred cCcc-cceeeccCccEEEEEEeC---CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCeeeEEE
Q 006982 306 SFSK-NNIIGSGRTGTMYKALLE---DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKERLLVY 379 (623)
Q Consensus 306 ~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 379 (623)
.|.. .++||+|+||.||+|... ++..||+|++..... ...+.+|++++++++||||+++++++.. ....++||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 3444 458999999999999965 578899999975543 3467899999999999999999999965 56789999
Q ss_pred ecCCCCCHhhhccCCC-----CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee----CCCCCeEEee
Q 006982 380 KHMPNGSLYDLLHPAD-----DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL----DDDFEPKISD 450 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl----~~~~~~kl~D 450 (623)
||+++ +|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99974 8888774211 1223589999999999999999999999 99999999999999 7789999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 176 fg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999876432111 112233458999999999887 458999999999999999999999997543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.82 Aligned_cols=194 Identities=25% Similarity=0.371 Sum_probs=153.2
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------Ce
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------KE 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 374 (623)
++|...+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 5788899999999999999985 468999999996532 2346788999999999999999999998754 45
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 78999999 7899998852 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 180 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 180 RHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 865431 122358999999999876 67899999999999999999999999764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=311.33 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=167.7
Q ss_pred hccCccc-ceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEe----CCeeeE
Q 006982 304 TNSFSKN-NIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA----KKERLL 377 (623)
Q Consensus 304 ~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 377 (623)
.++|... ++||+|+||.||+|... +++.||+|++........++. ..+..++||||+++++++.. ....++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~---~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVD---HHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHH---HHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHH---HHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 4567774 57999999999999976 689999999966443333222 23455689999999999876 345789
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeecccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLA 454 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Dfgla 454 (623)
||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999997542 25689999999999999999999999 9999999999999976 455999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
+...... .....+|+.|+|||++....++.++||||||+++|||++|+.||........... ....+....
T Consensus 179 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~-- 249 (336)
T 3fhr_A 179 KETTQNA------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRRIRLGQ-- 249 (336)
T ss_dssp EEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred eeccccc------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHhhhccc--
Confidence 8654321 1223479999999999888899999999999999999999999975433211000 000000000
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.....+ .....++++.+ ++..|+. .||++|||++|+++.
T Consensus 250 ---~~~~~~--~~~~~~~~~~~---li~~~L~-~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 250 ---YGFPNP--EWSEVSEDAKQ---LIRLLLK-TDPTERLTITQFMNH 288 (336)
T ss_dssp ----CCCTT--TSTTCCHHHHH---HHHHHSC-SSGGGSCCHHHHHHS
T ss_pred ---cccCch--hhccCCHHHHH---HHHHHCC-CChhHCcCHHHHhcC
Confidence 000000 00123344444 4456666 999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.00 Aligned_cols=200 Identities=20% Similarity=0.331 Sum_probs=161.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEE------------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCM------------ 370 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~------------ 370 (623)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++.+++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56888999999999999999976 48999999986543 34567899999999999999999999874
Q ss_pred --eCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeE
Q 006982 371 --AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPK 447 (623)
Q Consensus 371 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~k 447 (623)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3356789999998 699999952 4588999999999999999999999 999999999999997 677999
Q ss_pred EeecccccccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 448 ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 448 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
|+|||+++......... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 162 l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp ECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EccCccccccCCCcccc-cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999998764321111 11122346889999998865 67899999999999999999999999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.85 Aligned_cols=202 Identities=20% Similarity=0.292 Sum_probs=168.6
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----Cee
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KER 375 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 375 (623)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357888999999999999999965 68899999996433 3345688999999999999999999998764 567
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++|+||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 599999853 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccc------cccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 456 LMNPIDTHLST------FVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 456 ~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
........... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 76532211110 1122358999999998754 67899999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=311.08 Aligned_cols=197 Identities=17% Similarity=0.295 Sum_probs=169.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CC-cEEEEEEeccccccHHHHHHHHHHhCCCCCCC------CcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DG-TSLMVKRLQDSQRSEKEFVAEMATLGSVKNRN------LVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||+|... ++ ..||+|++.........+.+|++++.+++|++ ++.+.+++......+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 57888999999999999999964 34 68999999876656677888999998887765 899999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceee----------------
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILL---------------- 440 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl---------------- 440 (623)
+||||+ ++++.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 999999 667777765432 24689999999999999999999999 99999999999999
Q ss_pred ---CCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 441 ---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 441 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH-------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCccccccccc-------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 568899999999998654321 1235899999999999999999999999999999999999999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=308.01 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=172.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHH-HhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMA-TLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|+||.||+|... +++.||+|++.... .....+..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 56888899999999999999975 78999999996543 23345556665 7888899999999999999999999999
Q ss_pred cCCCCCHhhhccCCC-CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 381 HMPNGSLYDLLHPAD-DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
|+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 8877764210 11356899999999999999999999853 799999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYA----RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ....... .
T Consensus 179 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~-~ 245 (327)
T 3aln_A 179 SIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVK-G 245 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCC-S
T ss_pred ccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HHHHHhc-C
Confidence 211 1122489999999998 456789999999999999999999999975322100 0000000 0
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
....+.. . ......++ +.+++..|+. .||++|||+.|+++.
T Consensus 246 ~~~~~~~-~-~~~~~~~~---l~~li~~~l~-~dp~~Rps~~ell~h 286 (327)
T 3aln_A 246 DPPQLSN-S-EEREFSPS---FINFVNLCLT-KDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCC-C-SSCCCCHH---HHHHHHHHTC-SSGGGSCCHHHHTTS
T ss_pred CCCCCCC-c-ccccCCHH---HHHHHHHHhh-CChhhCcCHHHHHhC
Confidence 0000000 0 00112333 4444556776 999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.34 Aligned_cols=239 Identities=21% Similarity=0.337 Sum_probs=190.5
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc-------cHHHHHHHHHHhCCCC--CCCCcceeEEEEeCC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR-------SEKEFVAEMATLGSVK--NRNLVPLLGFCMAKK 373 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 373 (623)
.++|...+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.++.+++ ||||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 46788999999999999999985 4788999999865431 2245667899998886 599999999999999
Q ss_pred eeeEEEecCCC-CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeEEeec
Q 006982 374 ERLLVYKHMPN-GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDF 451 (623)
Q Consensus 374 ~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~kl~Df 451 (623)
..++|+||+.+ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||+||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999976 899999863 24689999999999999999999999 999999999999999 7899999999
Q ss_pred ccccccCCCCCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHH
Q 006982 452 GLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQ 530 (623)
Q Consensus 452 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~ 530 (623)
|+++....... ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .....
T Consensus 195 g~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~~~~ 258 (320)
T 3a99_A 195 GSGALLKDTVY------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRG 258 (320)
T ss_dssp TTCEECCSSCB------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHC
T ss_pred ccccccccccc------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hhhcc
Confidence 99987653211 22348999999999877665 688999999999999999999996310 00000
Q ss_pred HhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 531 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .......++++. .++..|+. .||++|||++|+++
T Consensus 259 ---~---------~~~~~~~~~~~~---~li~~~l~-~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 ---Q---------VFFRQRVSSECQ---HLIRWCLA-LRPSDRPTFEEIQN 293 (320)
T ss_dssp ---C---------CCCSSCCCHHHH---HHHHHHTC-SSGGGSCCHHHHHT
T ss_pred ---c---------ccccccCCHHHH---HHHHHHcc-CChhhCcCHHHHhc
Confidence 0 001112334444 44456776 99999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.69 Aligned_cols=193 Identities=22% Similarity=0.363 Sum_probs=165.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE------ 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 374 (623)
++|...+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|+.++.+++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999964 689999999975432 34578899999999999999999999987654
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++||||++ |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 489999997 59988873 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 174 RHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp TC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred cCCCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 865431 122347999999999876 67899999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.09 Aligned_cols=242 Identities=19% Similarity=0.295 Sum_probs=183.4
Q ss_pred HHHhccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc-------cHHHHHHHHHHhCCC----CCCCCcceeEE
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR-------SEKEFVAEMATLGSV----KNRNLVPLLGF 368 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l----~h~niv~l~~~ 368 (623)
....++|...+.||+|+||.||+|.. .+++.||+|++..... ....+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33457899999999999999999986 4788999999965432 123355788888877 89999999999
Q ss_pred EEeCCeeeEEEec-CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCe
Q 006982 369 CMAKKERLLVYKH-MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEP 446 (623)
Q Consensus 369 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~ 446 (623)
+...+..++|+|| +++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++ +++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 799999999963 24589999999999999999999999 999999999999999 89999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT-PKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~ 525 (623)
||+|||+++....... ....||..|+|||++.+..+. .++||||||+++|||++|+.||... .
T Consensus 180 kl~dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----------~ 243 (312)
T 2iwi_A 180 KLIDFGSGALLHDEPY------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----------Q 243 (312)
T ss_dssp EECCCSSCEECCSSCB------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------H
T ss_pred EEEEcchhhhcccCcc------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----------H
Confidence 9999999987654221 223489999999998776654 5899999999999999999999631 0
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
+.... ... + ......++ .+++..|+. .||++|||++|+++
T Consensus 244 ~~~~~---~~~--------~-~~~~~~~~---~~li~~~l~-~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 EILEA---ELH--------F-PAHVSPDC---CALIRRCLA-PKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHT---CCC--------C-CTTSCHHH---HHHHHHHTC-SSTTTSCCHHHHHH
T ss_pred HHhhh---ccC--------C-cccCCHHH---HHHHHHHcc-CChhhCcCHHHHhc
Confidence 00000 000 0 11123333 344556776 99999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=315.65 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=180.3
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 383 (623)
.+|...++||+|+||+||.....+++.||||++...... .+.+|++++.++ +|||||++++++.+....++||||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~--~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS--FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE--ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH--HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 458888999999999976666668999999999654322 345799999988 89999999999999999999999996
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-----CCCeEEeecccccccC
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-----DFEPKISDFGLARLMN 458 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-----~~~~kl~Dfgla~~~~ 458 (623)
|+|.+++.... ..+.+..++.++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++...
T Consensus 102 -g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 102 -ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp -EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred -CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 59999996433 2345556789999999999999999 9999999999999943 3468899999998765
Q ss_pred CCCCcccccccCCCCcccccCccccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYAR---TLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
...... .......||++|+|||++. ...++.++|||||||++|||++ |..||...... ........
T Consensus 175 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~~~~ 244 (432)
T 3p23_A 175 VGRHSF-SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANILLGA 244 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHHTTC
T ss_pred CCCcce-eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHHhcc
Confidence 422111 1123345899999999997 4567889999999999999999 88888542211 01111111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
... . .+.. ....-..+..++..|+. .||++|||+.||++
T Consensus 245 ~~~-~----~~~~--~~~~~~~~~~li~~~L~-~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSL-D----CLHP--EKHEDVIARELIEKMIA-MDPQKRPSAKHVLK 283 (432)
T ss_dssp CCC-T----TSCT--TCHHHHHHHHHHHHHSC-SSGGGSCCHHHHHT
T ss_pred CCc-c----ccCc--cccccHHHHHHHHHHHh-CCHhhCCCHHHHHh
Confidence 000 0 0000 11112223455566776 99999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=299.74 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=173.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc--c-HHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR--S-EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|...+.||+|+||.||+|... +++.||+|++..... . .+.+..+..++..++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56888899999999999999975 789999999965432 2 2334445556888899999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
|+ ++.+..+.... ...+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 55555554321 2568999999999999999999998 5 899999999999999999999999999986543
Q ss_pred CCCcccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
... .....+|+.|+|||++. ...++.++||||||+++|||++|+.||...... ..........
T Consensus 178 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~ 245 (318)
T 2dyl_A 178 DKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQE 245 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHS
T ss_pred Ccc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhcc
Confidence 221 11234899999999984 456889999999999999999999999753221 1111111111
Q ss_pred Cchhhhhchhhh-cCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 535 GQLQDAIDKCLV-AKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 535 ~~~~~~~d~~l~-~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
.. +.+. ....+.++.. ++..|+. .||.+||+++|+++.
T Consensus 246 ~~------~~~~~~~~~~~~l~~---li~~~l~-~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 246 EP------PLLPGHMGFSGDFQS---FVKDCLT-KDHRKRPKYNKLLEH 284 (318)
T ss_dssp CC------CCCCSSSCCCHHHHH---HHHHHTC-SCTTTSCCHHHHTTS
T ss_pred CC------CCCCccCCCCHHHHH---HHHHHcc-CChhHCcCHHHHhhC
Confidence 00 0000 0112344444 4456776 999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=330.61 Aligned_cols=237 Identities=20% Similarity=0.272 Sum_probs=187.1
Q ss_pred ccCcccceeeccCccEEEEEEeC--CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCe-----e
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE--DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKE-----R 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~ 375 (623)
++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67899999999999999999975 68999999986532 334578899999999999999999999987665 6
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++++|.+++. ..++|..++.++.|++.||.|||+. +|+||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 99999999999998874 2689999999999999999999999 99999999999999986 89999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
..... ....||++|+|||++.+.. +.++|||||||++|||++|..||...........
T Consensus 230 ~~~~~--------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~------------- 287 (681)
T 2pzi_A 230 RINSF--------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------------- 287 (681)
T ss_dssp ETTCC--------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTT-------------
T ss_pred hcccC--------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccccc-------------
Confidence 76532 2234899999999987654 8999999999999999999988764211100000
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHh
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-TMFEVYQFLRAI 586 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-s~~ev~~~L~~i 586 (623)
.+. ......+..++..|+. .||++|| +++++...|..+
T Consensus 288 ------~~~------~~~~~~l~~li~~~l~-~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 ------DPV------LKTYDSYGRLLRRAID-PDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------CHH------HHHCHHHHHHHHHHTC-SSGGGSCSSHHHHHHHHHHH
T ss_pred ------ccc------cccCHHHHHHHhhhcc-CChhhCCCHHHHHHHHHHHH
Confidence 000 0001234455566776 9999999 567777777664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=288.77 Aligned_cols=232 Identities=12% Similarity=0.092 Sum_probs=178.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccc----cHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR----SEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++.+.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888999999999999999975 489999999976532 2367899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++++|.+++.. . ....+..+++.|++.||+|||+. +|+||||||+|||+++++.+||++++
T Consensus 111 e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999942 1 24456888999999999999999 99999999999999999999997432
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
|++| ++.++|||||||++|||+||+.||.............. .... .
T Consensus 175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-----~~~~-~--- 221 (286)
T 3uqc_A 175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-----DTAG-Q--- 221 (286)
T ss_dssp -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-----CTTS-C---
T ss_pred -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-----Hhcc-C---
Confidence 3333 58899999999999999999999986543221100000 0000 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.....-.....++++. .++.+|+. .||++| |+.|+++.|+++....
T Consensus 222 ~~~~~~~~~~~~~~l~---~li~~~l~-~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 222 PIEPADIDRDIPFQIS---AVAARSVQ-GDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp BCCHHHHCTTSCHHHH---HHHHHHHC-TTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCChhhcccCCCHHHH---HHHHHHcc-cCCccC-CHHHHHHHHHHHhccC
Confidence 0000000112333444 44456766 999999 9999999999987543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.55 Aligned_cols=201 Identities=22% Similarity=0.346 Sum_probs=171.8
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEe------CCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMA------KKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~ 375 (623)
++|...+.||+|+||.||+|.. .+|..||+|++... ....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999996 46899999998754 2345678999999999999999999998765 5677
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCC---eEEeecc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFE---PKISDFG 452 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~---~kl~Dfg 452 (623)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999975432 24689999999999999999999999 9999999999999997665 9999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++........ ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 170 ~a~~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 170 YAKELDQGELC-----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCBTTSCCCC-----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccc-----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 99876543221 2345899999999999999999999999999999999999999753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=284.76 Aligned_cols=231 Identities=18% Similarity=0.249 Sum_probs=171.5
Q ss_pred ccCccc-ceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHh-CCCCCCCCcceeEEEEe----CCeeeE
Q 006982 305 NSFSKN-NIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATL-GSVKNRNLVPLLGFCMA----KKERLL 377 (623)
Q Consensus 305 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~l 377 (623)
++|... ++||+|+||.||++.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. ....++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 456655 7899999999999996 47899999998643 3566788877 55699999999999887 567899
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeecccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLA 454 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Dfgla 454 (623)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999997542 24689999999999999999999999 9999999999999998 789999999998
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
..... ..++.++|||||||++|||++|+.||............ ...
T Consensus 168 ~~~~~--------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--------~~~ 213 (299)
T 3m2w_A 168 KETTG--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTR 213 (299)
T ss_dssp EECTT--------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--------CCS
T ss_pred ccccc--------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--------HHH
Confidence 75421 23578999999999999999999999754322110000 000
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
........+.......++++. .++..|+. .||++|||+.|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~---~li~~~l~-~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVK---MLIRNLLK-TEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHH---HHHHHHTC-SSTTTSCCHHHHHTS
T ss_pred HhhccccCCchhcccCCHHHH---HHHHHHcc-cChhhCCCHHHHhcC
Confidence 000000000000011233444 44446666 999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=305.05 Aligned_cols=242 Identities=17% Similarity=0.213 Sum_probs=174.8
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCC-CCC---------cceeEE
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKN-RNL---------VPLLGF 368 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h-~ni---------v~l~~~ 368 (623)
+..|...++||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++..++| +|. +.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999994 579999999987332 235678999999999987 221 111111
Q ss_pred ------------EEe-----CCeeeEEEecCCCCCHhhhccCC---CCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCc
Q 006982 369 ------------CMA-----KKERLLVYKHMPNGSLYDLLHPA---DDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRI 428 (623)
Q Consensus 369 ------------~~~-----~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 428 (623)
+.. ....+++|+++ +++|.+++... ......++|..++.++.|++.||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 111 11235566654 68999988411 12345688999999999999999999999 99
Q ss_pred EecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccc----------cCCCCCcchhHHHHH
Q 006982 429 IHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA----------RTLVATPKGDVYSFG 498 (623)
Q Consensus 429 ~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DV~sfG 498 (623)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 99999999999999999999999999865431 223347 999999999 566688999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHH
Q 006982 499 TVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFE 578 (623)
Q Consensus 499 vil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~e 578 (623)
|++|||++|+.||......+.. ..++..+ ...++++.+ ++..|+. .||++||++.|
T Consensus 305 vil~elltg~~Pf~~~~~~~~~-----------------~~~~~~~---~~~~~~~~~---li~~~l~-~dP~~Rpt~~~ 360 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGS-----------------EWIFRSC---KNIPQPVRA---LLEGFLR-YPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCS-----------------GGGGSSC---CCCCHHHHH---HHHHHTC-SSGGGSCCHHH
T ss_pred HHHHHHHHCCCCCCCcchhhhH-----------------HHHHhhc---ccCCHHHHH---HHHHHcc-CChhhCcCHHH
Confidence 9999999999999754322111 1111111 123344444 4446766 99999999777
Q ss_pred HHH
Q 006982 579 VYQ 581 (623)
Q Consensus 579 v~~ 581 (623)
+++
T Consensus 361 ~l~ 363 (413)
T 3dzo_A 361 AME 363 (413)
T ss_dssp HTT
T ss_pred HHh
Confidence 643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-33 Score=292.00 Aligned_cols=190 Identities=15% Similarity=0.125 Sum_probs=158.6
Q ss_pred hccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---------ccHHHHHHHHHHhCCCC---------CCCCcce
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---------RSEKEFVAEMATLGSVK---------NRNLVPL 365 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~---------h~niv~l 365 (623)
.++|...+.||+|+||.||+|+. +|+.||+|++.... ...+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999998 68999999996532 23467888888887775 7788777
Q ss_pred eEEEE------------------------------eCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHH
Q 006982 366 LGFCM------------------------------AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAAR 415 (623)
Q Consensus 366 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 415 (623)
.+.+. .....++||||+++|++.+.+.. ..+++..+..++.|++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 77643 25778999999999987777632 45899999999999999
Q ss_pred HHHHHH-hcCCCCcEecCCCCCceeeCCCC--------------------CeEEeecccccccCCCCCcccccccCCCCc
Q 006982 416 GFAWLH-HNCNPRIIHRNISSKCILLDDDF--------------------EPKISDFGLARLMNPIDTHLSTFVNGEFGD 474 (623)
Q Consensus 416 ~l~yLH-~~~~~~i~H~dlk~~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt 474 (623)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt 240 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFC 240 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECC
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEe
Confidence 999999 88 999999999999999887 8999999999876431 12489
Q ss_pred ccccCcccccCCCCCcchhHHHHHHH-HHHHHhCCCCCC
Q 006982 475 LGYVAPEYARTLVATPKGDVYSFGTV-LLELVTGERPTN 512 (623)
Q Consensus 475 ~~y~aPE~~~~~~~s~k~DV~sfGvi-l~elltg~~P~~ 512 (623)
+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999999998766 899999998766 778888999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-29 Score=275.74 Aligned_cols=183 Identities=16% Similarity=0.097 Sum_probs=127.7
Q ss_pred eeccCccEEEEEE-eCCCcEEEEEEeccc-----------cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEEE
Q 006982 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDS-----------QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 313 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 379 (623)
.+.|++|.++.++ .--|..+++|.+... ....++|.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666665544 234788999998543 12345689999999999 7999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||++||+|.++|... ..++.. +|+.||+.||+|+|++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999643 345543 5899999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERP 510 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P 510 (623)
....... ..||++|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 392 ~~~~~~t----~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSWPTN----LVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHH----HHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCccccC----ceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 3322222 348999999999875 457789999999998887766544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=232.24 Aligned_cols=163 Identities=33% Similarity=0.505 Sum_probs=148.3
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCcccCCCCCCCCCCCCCCc--ccceeecCCC-CCcEEEEEecCCCcee--eCCccccCC
Q 006982 29 YGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICK--FTGVECWHPD-ENRVLNLRLTDMGLKG--QFPRGIRNC 103 (623)
Q Consensus 29 ~~~~~d~~~Ll~~k~~~~~~~~~l~~sW~~~~~~~~~~c~--w~gv~c~~~~-~~~v~~l~l~~~~l~g--~~p~~l~~l 103 (623)
.|.++|++||++||+++.||. .+ .+|+.+. +||. |.||+|+... .++|+.|+|++++++| .+|+.++++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l-~~W~~~~----~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l 75 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TL-SSWLPTT----DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANL 75 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GG-TTCCTTS----CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGC
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cc-cCCCCCC----CCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCC
Confidence 578999999999999998876 44 5997533 4787 9999996422 2799999999999999 999999999
Q ss_pred CCCCEEEcCC-CCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccccc
Q 006982 104 SSMTGLDLSS-NKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSF 182 (623)
Q Consensus 104 ~~L~~L~L~~-N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l 182 (623)
++|++|+|++ |.+.|.+|..++++.+ |++|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++++++|+.|
T Consensus 76 ~~L~~L~L~~~n~l~~~~p~~l~~l~~-L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 154 (313)
T 1ogq_A 76 PYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTT-CSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CCCCeeeCCCCCcccccCChhHhcCCC-CCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeE
Confidence 9999999995 9999999999999755 9999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccc
Q 006982 183 SVANNLLSGSIPTFVN 198 (623)
Q Consensus 183 ~l~~N~l~g~ip~~~~ 198 (623)
+|++|+++|.+|..+.
T Consensus 155 ~L~~N~l~~~~p~~l~ 170 (313)
T 1ogq_A 155 TFDGNRISGAIPDSYG 170 (313)
T ss_dssp ECCSSCCEEECCGGGG
T ss_pred ECcCCcccCcCCHHHh
Confidence 9999999999997654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-26 Score=250.80 Aligned_cols=186 Identities=16% Similarity=0.166 Sum_probs=145.9
Q ss_pred ccceeeccCccEEEEEEeCCCcEEEEEEecccc---------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 309 KNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 309 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
..++||+|+||.||++.. .+..+++|+..... ...+.+.+|++++.+++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999955 47788888764321 11345889999999999999998777777888889999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. +..++.|++.||.|||++ +|+||||||+|||+++ .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999953 457999999999999999 9999999999999999 999999999998754
Q ss_pred CCCccc---ccccCCCCcccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006982 460 IDTHLS---TFVNGEFGDLGYVAPEYART--LVATPKGDVYSFGTVLLELVTGERPTN 512 (623)
Q Consensus 460 ~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~sfGvil~elltg~~P~~ 512 (623)
...... .......||+.|+|||++.. ..|+..+|+|+..+-.++-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221110 01112348999999999986 567888999999999999988887763
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-24 Score=245.47 Aligned_cols=160 Identities=22% Similarity=0.323 Sum_probs=140.8
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCcccCCCCCCC---CCCCCCCcc------------cceeecCCCCCcEEEEEecCCCce
Q 006982 29 YGTKEDLACLKSIKDSLEDPFNYLNSSWNFNN---DTEGFICKF------------TGVECWHPDENRVLNLRLTDMGLK 93 (623)
Q Consensus 29 ~~~~~d~~~Ll~~k~~~~~~~~~l~~sW~~~~---~~~~~~c~w------------~gv~c~~~~~~~v~~l~l~~~~l~ 93 (623)
++..+|+.||++||+++.+| +|+.+. ..+.++|+| .||+|+. .+||+.|+|++++|+
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN--NGRVTGLSLAGFGAK 336 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT--TSCEEEEECTTTCCE
T ss_pred ccchHHHHHHHHHHHHcCCC------CCCcCCCcccccCCccccccccccccccCcCceEecC--CCCEEEEECccCCCC
Confidence 33467999999999999776 786543 122234999 9999965 589999999999999
Q ss_pred eeCCccccCCCCCCEEEc-CCCCCCCC-----------------------------------------------------
Q 006982 94 GQFPRGIRNCSSMTGLDL-SSNKLYGP----------------------------------------------------- 119 (623)
Q Consensus 94 g~~p~~l~~l~~L~~L~L-~~N~l~g~----------------------------------------------------- 119 (623)
|.+|++|++|++|+.|+| ++|.++|.
T Consensus 337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 999999999999999999 77866555
Q ss_pred -----------------------CChhHhhhcCCCCEEEccCccCCC-----------------CCCCCCC--CCCCCce
Q 006982 120 -----------------------LPDDISKLVGFLTSLDLSSNNFSG-----------------SIPSNLA--NCTYLNS 157 (623)
Q Consensus 120 -----------------------ip~~~~~l~~~L~~L~L~~N~l~g-----------------~ip~~~~--~l~~L~~ 157 (623)
||.+++++.+ |++|+|++|+|+| .||..++ ++++|++
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~-L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITFISKAIQRLTK-LQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTT-CCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred cccccccchhhceeccccCcccchhHHHhcCCC-CCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 8999999755 9999999999999 4999998 9999999
Q ss_pred eeccCCcCCCCCCcccccccccccccccccc-ccc-cCCccc
Q 006982 158 LKLDHNRFSGQIPPQLGQLGRLKSFSVANNL-LSG-SIPTFV 197 (623)
Q Consensus 158 l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~-l~g-~ip~~~ 197 (623)
|+|++|++.|.+|..++++++|+.|+|++|+ |+| .+|..+
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i 537 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHH
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHH
Confidence 9999999999999999999999999999998 999 888644
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=237.29 Aligned_cols=159 Identities=23% Similarity=0.317 Sum_probs=142.0
Q ss_pred CHHHHHHHHHHHHHcCCCCCcccC-------CCCCCCCCCCCCCcc---cceeecCCCCCcEEEEEecCCCceeeCCccc
Q 006982 31 TKEDLACLKSIKDSLEDPFNYLNS-------SWNFNNDTEGFICKF---TGVECWHPDENRVLNLRLTDMGLKGQFPRGI 100 (623)
Q Consensus 31 ~~~d~~~Ll~~k~~~~~~~~~l~~-------sW~~~~~~~~~~c~w---~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~l 100 (623)
...|+.||.+||.++.++.+.... +|+.+. +||.| .||+|+. .+||+.|+|++++++|.+|++|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~----~~c~w~~~~GV~C~~--~~~V~~L~L~~~~l~g~lp~~l 101 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNK----ELDMWGAQPGVSLNS--NGRVTGLSLEGFGASGRVPDAI 101 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSS----CGGGTTCCTTEEECT--TCCEEEEECTTSCCEEEECGGG
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCC----CcccccCCCCeEEcC--CCCEEEEEecCcccCCcCChHH
Confidence 357999999999999877654332 797543 59999 9999965 3899999999999999999999
Q ss_pred cCCCCCCEEEcCCCC-----------------------------------------------------------------
Q 006982 101 RNCSSMTGLDLSSNK----------------------------------------------------------------- 115 (623)
Q Consensus 101 ~~l~~L~~L~L~~N~----------------------------------------------------------------- 115 (623)
++|++|++|+|++|.
T Consensus 102 ~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~ 181 (636)
T 4eco_A 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181 (636)
T ss_dssp GGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred hcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence 999999999999984
Q ss_pred -------------CCCCCChhHhhhcCCCCEEEccCccCCCC-----------------CCCCCC--CCCCCceeeccCC
Q 006982 116 -------------LYGPLPDDISKLVGFLTSLDLSSNNFSGS-----------------IPSNLA--NCTYLNSLKLDHN 163 (623)
Q Consensus 116 -------------l~g~ip~~~~~l~~~L~~L~L~~N~l~g~-----------------ip~~~~--~l~~L~~l~l~~N 163 (623)
|+| ||.+++++.+ |++|+|++|+|+|. +|..++ ++++|++|+|++|
T Consensus 182 ~l~~l~l~~~~n~l~~-ip~~l~~l~~-L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 182 TLKDTQIGQLSNNITF-VSKAVMRLTK-LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCTTTTTCCSCEEEE-ECGGGGGCTT-CCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred chhhhhhccccCCCcc-CCHHHhcccC-CCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 445 8999999755 99999999999996 999999 9999999999999
Q ss_pred cCCCCCCcccccccccccccccccc-ccc-cCCccc
Q 006982 164 RFSGQIPPQLGQLGRLKSFSVANNL-LSG-SIPTFV 197 (623)
Q Consensus 164 ~~~g~iP~~l~~l~~L~~l~l~~N~-l~g-~ip~~~ 197 (623)
+++|.+|..++++++|+.|+|++|+ ++| .+|..+
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~ 295 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHH
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHH
Confidence 9999999999999999999999998 999 899754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.1e-23 Score=237.02 Aligned_cols=160 Identities=30% Similarity=0.423 Sum_probs=125.4
Q ss_pred hccCCCHHHHHHHHHHHHHcCCCCCcccCCCCCCCCCCCCCCcccceeecCCCCCcEEEEEecCCCceee---CC-----
Q 006982 26 SLSYGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQ---FP----- 97 (623)
Q Consensus 26 ~~~~~~~~d~~~Ll~~k~~~~~~~~~l~~sW~~~~~~~~~~c~w~gv~c~~~~~~~v~~l~l~~~~l~g~---~p----- 97 (623)
+.+.+.++|++||++||+++.||. .+ ++|+.+ .+||+|.||+|+ .++|+.|+|+++++.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l-~~W~~~----~~~C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~ 75 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LL-PDWSSN----KNPCTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLS 75 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SS-TTCCTT----SCGGGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTT
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cc-cCCCCC----CCCcCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhc
Confidence 344557889999999999999887 55 699743 359999999996 58999999999999997 54
Q ss_pred ------------------ccccCCCCCCEEEcCCCCCCCCCCh--hHhhhcCCCCEEEccCccCCCCCCCCC-CCCCCCc
Q 006982 98 ------------------RGIRNCSSMTGLDLSSNKLYGPLPD--DISKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYLN 156 (623)
Q Consensus 98 ------------------~~l~~l~~L~~L~L~~N~l~g~ip~--~~~~l~~~L~~L~L~~N~l~g~ip~~~-~~l~~L~ 156 (623)
+.++++++|++|||++|.++|.+|. .++++.+ |++|||++|.++|.+|..+ +++++|+
T Consensus 76 L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~-L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 154 (768)
T 3rgz_A 76 LTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSG-LKFLNVSSNTLDFPGKVSGGLKLNSLE 154 (768)
T ss_dssp CTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTT-CCEEECCSSEEECCSSCCSCCCCTTCS
T ss_pred cCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCC-CCEEECcCCccCCcCCHHHhccCCCCC
Confidence 4677778888888888888888887 7887654 8888888888888888765 7788888
Q ss_pred eeeccCCcCCCCCCcc---ccccccccccccccccccccCCc
Q 006982 157 SLKLDHNRFSGQIPPQ---LGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 157 ~l~l~~N~~~g~iP~~---l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+|+|++|+++|.+|.. ++++++|+.|++++|.++|.+|.
T Consensus 155 ~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 196 (768)
T 3rgz_A 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV 196 (768)
T ss_dssp EEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC
T ss_pred EEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc
Confidence 8888888888777766 66667777777777777666654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.3e-23 Score=206.17 Aligned_cols=152 Identities=14% Similarity=0.131 Sum_probs=122.7
Q ss_pred HHHHHHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccc-------------------cHHHHHHHHHHhCCC
Q 006982 297 LSDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR-------------------SEKEFVAEMATLGSV 357 (623)
Q Consensus 297 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l 357 (623)
+..+......|...+.||+|+||.||+|...+|+.||+|.++.... ....+.+|++++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445555566778899999999999999997899999999964321 245688999999999
Q ss_pred CCCCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCc
Q 006982 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKC 437 (623)
Q Consensus 358 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~N 437 (623)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 8 5 666665543 55699999999999998 521 12347999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCccccc
Q 006982 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484 (623)
Q Consensus 438 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 484 (623)
||++ ++.+||+|||+++.. ..++|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~~-----------------~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV-----------------GEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET-----------------TSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeEC-----------------CCCCHHHHHH
Confidence 9999 999999999999743 3467888874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-21 Score=201.81 Aligned_cols=176 Identities=22% Similarity=0.318 Sum_probs=143.6
Q ss_pred CCCHHHHHHHHHHHHHc-CCCCCcccCCCCCCCCCCCCCCcccceeecC-------CCCCcEEEEEecCCCceeeCCccc
Q 006982 29 YGTKEDLACLKSIKDSL-EDPFNYLNSSWNFNNDTEGFICKFTGVECWH-------PDENRVLNLRLTDMGLKGQFPRGI 100 (623)
Q Consensus 29 ~~~~~d~~~Ll~~k~~~-~~~~~~l~~sW~~~~~~~~~~c~w~gv~c~~-------~~~~~v~~l~l~~~~l~g~~p~~l 100 (623)
.+..+|+.||++||.++ .|+...+ .+|........++|.|.|+.|.. ....+|+.|+|++|+++ .+|+.+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~-~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHH-HHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred ccCchHHHHHHHHHHhccCCchhhh-hhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 34568999999999998 4665554 58953333445799999999942 12468999999999998 889999
Q ss_pred cCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccc-----
Q 006982 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQ----- 175 (623)
Q Consensus 101 ~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~----- 175 (623)
+++++|++|+|++|.++ .+|..++.+.+ |++|+|++|+++ .+|..++++++|++|+|++|++.|.+|..++.
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~-L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~ 177 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAG-LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTT-CSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCC-CCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence 99999999999999999 99999998755 999999999999 89999999999999999999999999988765
Q ss_pred ----cccccccccccccccccCCcccc-c-cccccccCCCC
Q 006982 176 ----LGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQ 210 (623)
Q Consensus 176 ----l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~ 210 (623)
+++|+.|+|++|+++ .+|..+. + .+....+.+|.
T Consensus 178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~ 217 (328)
T 4fcg_A 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217 (328)
T ss_dssp CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSC
T ss_pred hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCC
Confidence 999999999999998 7886543 1 23334444443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=217.06 Aligned_cols=138 Identities=36% Similarity=0.549 Sum_probs=127.7
Q ss_pred EEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCc
Q 006982 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNR 164 (623)
Q Consensus 85 l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~ 164 (623)
+++..+.++|.+|..++++++|+.|||++|+++|.||.+++++.. |+.|+|++|+|+|.||..++++++|+.|||++|+
T Consensus 613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~-L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY-LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTT-CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccceecccCchhhhccccccEEECcCCcccccCCHHHhcccc-CCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 455668899999999999999999999999999999999999765 9999999999999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccccccCCccccc-cccccccCCCCCCCCCCCCCCCCC
Q 006982 165 FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQGLCGEPLDACKGT 223 (623)
Q Consensus 165 ~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~l~~~~~~~c~~~ 223 (623)
++|.||..++++++|+.|+|++|+|+|.||....+ ++...+|.||+++||.|...|...
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~ 751 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence 99999999999999999999999999999975433 677788999999999998888643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.9e-19 Score=174.40 Aligned_cols=137 Identities=16% Similarity=0.158 Sum_probs=107.5
Q ss_pred cCcccceeeccCccEEEEEEe-CCCcE--EEEEEecccccc-------------------------HHHHHHHHHHhCCC
Q 006982 306 SFSKNNIIGSGRTGTMYKALL-EDGTS--LMVKRLQDSQRS-------------------------EKEFVAEMATLGSV 357 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l 357 (623)
-|...+.||+|+||.||+|.. .+|+. ||+|+++..... ...+.+|++.+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999997 68988 999987543111 13578899999999
Q ss_pred CCCCC--cceeEEEEeCCeeeEEEecCCC-C----CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHH-hcCCCCcE
Q 006982 358 KNRNL--VPLLGFCMAKKERLLVYKHMPN-G----SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH-HNCNPRII 429 (623)
Q Consensus 358 ~h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~i~ 429 (623)
+|+++ ..++++ ...++||||+.+ | +|.++... .++.....++.|++.+|.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88864 333332 356899999942 4 67766521 234567889999999999999 87 999
Q ss_pred ecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 430 HRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 430 H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
||||||+|||+++ .++|+|||++....
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999998 99999999998653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-18 Score=167.47 Aligned_cols=149 Identities=23% Similarity=0.263 Sum_probs=125.9
Q ss_pred CCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-HhhhcCCCCEE
Q 006982 64 GFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLVGFLTSL 134 (623)
Q Consensus 64 ~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~~L~~L 134 (623)
.+.|+|++|.|.+.. ...++.|+|++|++++..|..++++++|+.|+|++|+|+ .+|.. +..+ ++|++|
T Consensus 16 ~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l-~~L~~L 93 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSL-TQLTVL 93 (229)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTC-TTCCEE
T ss_pred CCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccC-CCcCEE
Confidence 358999999997643 246889999999999999999999999999999999997 56655 4665 459999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCC
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGL 212 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l 212 (623)
+|++|+|++..|..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+. + .+....+.+|+..
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 99999999766666899999999999999999 8999999999999999999999977665443 1 4556677888877
Q ss_pred CCC
Q 006982 213 CGE 215 (623)
Q Consensus 213 ~~~ 215 (623)
|..
T Consensus 173 c~c 175 (229)
T 3e6j_A 173 CEC 175 (229)
T ss_dssp TTB
T ss_pred CCc
Confidence 753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.2e-18 Score=164.62 Aligned_cols=151 Identities=21% Similarity=0.275 Sum_probs=130.0
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L 134 (623)
..|.|.|..|.|.+.. ...++.|+|++|++++..+..+..+++|+.|+|++|.+++..|..+..+. +|++|
T Consensus 7 ~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~-~L~~L 85 (220)
T 2v9t_B 7 AACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR-SLNSL 85 (220)
T ss_dssp TTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCS-SCCEE
T ss_pred CCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCc-CCCEE
Confidence 4567899999997532 23689999999999998888999999999999999999988898998875 49999
Q ss_pred EccCccCCCCCCC-CCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCC
Q 006982 135 DLSSNNFSGSIPS-NLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQG 211 (623)
Q Consensus 135 ~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~ 211 (623)
+|++|+|++ +|. .+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+. + .+....+.+|+.
T Consensus 86 ~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 86 VLYGNKITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp ECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred ECCCCcCCc-cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 999999994 555 578999999999999999998899999999999999999999998876544 2 455667888988
Q ss_pred CCCC
Q 006982 212 LCGE 215 (623)
Q Consensus 212 l~~~ 215 (623)
.|..
T Consensus 165 ~c~c 168 (220)
T 2v9t_B 165 ICDC 168 (220)
T ss_dssp ECSG
T ss_pred CCCC
Confidence 7753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.9e-18 Score=165.53 Aligned_cols=152 Identities=18% Similarity=0.195 Sum_probs=129.9
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCc-cccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPR-GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~-~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~ 133 (623)
..|.|.|..+.|++.. ...++.|+|++|++++..|. .++++++|+.|+|++|.+++..|..+..+. +|++
T Consensus 7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~-~L~~ 85 (220)
T 2v70_A 7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS-GVNE 85 (220)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCT-TCCE
T ss_pred CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCC-CCCE
Confidence 4577899999997643 23567999999999998764 589999999999999999976666888865 4999
Q ss_pred EEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCC
Q 006982 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQG 211 (623)
Q Consensus 134 L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~ 211 (623)
|+|++|++++..|..+.++++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+. + .+....+.+|+.
T Consensus 86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 99999999987777799999999999999999998899999999999999999999999887654 2 455667888887
Q ss_pred CCCC
Q 006982 212 LCGE 215 (623)
Q Consensus 212 l~~~ 215 (623)
.|..
T Consensus 166 ~c~c 169 (220)
T 2v70_A 166 NCNC 169 (220)
T ss_dssp ECSG
T ss_pred cCCC
Confidence 7753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-17 Score=160.05 Aligned_cols=152 Identities=25% Similarity=0.246 Sum_probs=124.0
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L 134 (623)
..|.|.|.+|.|+..+ ..+++.|+|++|++++..+..++++++|++|+|++|++++..+..+..+ ++|++|
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L 81 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL-TSLTYL 81 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTC-TTCCEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCC-CCcCEE
Confidence 3467999999997543 2468999999999998777778999999999999999995444445665 459999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCC
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGL 212 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l 212 (623)
+|++|++++..|..+.++++|++|+|++|++++..|..+.++++|+.|++++|++++..+..+. + ++....+.+|+..
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 9999999966556689999999999999999977677789999999999999999987665433 2 4556677888776
Q ss_pred CCC
Q 006982 213 CGE 215 (623)
Q Consensus 213 ~~~ 215 (623)
|..
T Consensus 162 ~~~ 164 (208)
T 2o6s_A 162 CTC 164 (208)
T ss_dssp CCT
T ss_pred cCC
Confidence 654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.3e-18 Score=163.46 Aligned_cols=153 Identities=22% Similarity=0.249 Sum_probs=125.3
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCc-cccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPR-GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~-~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~ 133 (623)
..|.|.|+.+.|++.. ...++.|+|++|.+++..+. .++++++|++|+|++|+|++..|..+..+.+ |++
T Consensus 4 ~~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~ 82 (192)
T 1w8a_A 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH-IQE 82 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTT-CCE
T ss_pred CCCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCccc-CCE
Confidence 3467899999997643 23788999999999887775 4899999999999999999888999988754 999
Q ss_pred EEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCCCC
Q 006982 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQGL 212 (623)
Q Consensus 134 L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~l 212 (623)
|+|++|+|++..|..+.++++|++|+|++|+|++.+|..+..+++|+.|+|++|.|++..|-..-. .+....+.++...
T Consensus 83 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~ 162 (192)
T 1w8a_A 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAAR 162 (192)
T ss_dssp EECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCB
T ss_pred EECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCC
Confidence 999999999888888999999999999999999999999999999999999999999987742111 1222344455555
Q ss_pred CCCC
Q 006982 213 CGEP 216 (623)
Q Consensus 213 ~~~~ 216 (623)
|+.|
T Consensus 163 C~~P 166 (192)
T 1w8a_A 163 CGAP 166 (192)
T ss_dssp BCSS
T ss_pred CCCC
Confidence 6544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-18 Score=174.84 Aligned_cols=136 Identities=31% Similarity=0.438 Sum_probs=94.1
Q ss_pred EEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeecc
Q 006982 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~ 161 (623)
++.|+|++|.++|.+|..++.++ |+.|+|++|.+++.+|..+..+. +|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus 176 L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDK-NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp CCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTS-CCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred CcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCC-CCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 34444444444444444444443 44444444444444444444443 366666666666655554 6777888888888
Q ss_pred CCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCCCCCCCCCCCC
Q 006982 162 HNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQGLCGEPLDAC 220 (623)
Q Consensus 162 ~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~l~~~~~~~c 220 (623)
+|+++|.+|..++++++|+.|+|++|+++|.+|....+ ++....+.+|+.+||.|.+.|
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCCCC
Confidence 89998899999999999999999999999999986433 466778899999999988777
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.1e-17 Score=151.34 Aligned_cols=132 Identities=22% Similarity=0.212 Sum_probs=109.4
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L 134 (623)
..|.|+|++|.|.+.. ...++.|+|++|++++..+..++++++|++|+|++|.+++..|..+..+. +|++|
T Consensus 3 ~~C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L 81 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLT-KLTIL 81 (177)
T ss_dssp TTCEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT-TCCEE
T ss_pred CCCEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCC-ccCEE
Confidence 3467899999997533 24688999999999987777789999999999999999954444456654 59999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+|++|++++..|..+.++++|++|+|++|++++..+..+..+++|+.|+|++|.+++..|.
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 9999999976666789999999999999999965555568899999999999999998874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=8.7e-16 Score=145.63 Aligned_cols=134 Identities=31% Similarity=0.377 Sum_probs=93.5
Q ss_pred CCCCcccceeecCCCCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCC
Q 006982 64 GFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG 143 (623)
Q Consensus 64 ~~~c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g 143 (623)
.|.|.|..|.|+ +++++ .+|..+. ++|+.|+|++|+++ .+|..+..+.. |+.|+|++|++++
T Consensus 7 ~C~C~~~~l~~~-------------~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~-L~~L~Ls~N~i~~ 68 (193)
T 2wfh_A 7 ECTCLDTVVRCS-------------NKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKH-LTLIDLSNNRIST 68 (193)
T ss_dssp TCEEETTEEECT-------------TSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTT-CCEEECCSSCCCC
T ss_pred CCEeCCCEEEcC-------------CCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccC-CCEEECCCCcCCE
Confidence 355666666663 44444 4565543 57888888888887 77777777544 8888888888886
Q ss_pred CCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCCC
Q 006982 144 SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCGE 215 (623)
Q Consensus 144 ~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~~ 215 (623)
..|..|.++++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+. + .+....+.+|+..|..
T Consensus 69 i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 69 LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred eCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 6666788888888888888888876667788888888888888888765554332 2 3455567777776653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.2e-15 Score=149.11 Aligned_cols=130 Identities=23% Similarity=0.240 Sum_probs=103.9
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|++++..|..++++++|++|+|++|.+++..|..+..+. +|++|+|++|++++..|..+..+++|++|+
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT-ELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCC-cCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 3578899999999998888899999999999999999977776677764 499999999999976667788899999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~ 210 (623)
|++|++++..|..+..+++|+.|+|++|++++..|..+. + ++....+.+|.
T Consensus 114 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 114 LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence 999999966666678899999999999999877664433 1 34444555553
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.9e-15 Score=155.21 Aligned_cols=138 Identities=15% Similarity=0.164 Sum_probs=101.5
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccc---------------cHHH--------HHHHHHHhCCCCCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR---------------SEKE--------FVAEMATLGSVKNRN 361 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~e~~~l~~l~h~n 361 (623)
.-|.+.+.||+|++|.||+|...+|+.||+|+++.... .... ...|...|.++.+..
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999999999999998753210 0111 234666666665444
Q ss_pred CcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 362 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
+....-+.. ...++||||+++++|.++... .....++.|++.+|.|||+. +|+||||||.|||++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 322222222 234799999999998776521 12356789999999999998 999999999999998
Q ss_pred CCC----------CeEEeeccccccc
Q 006982 442 DDF----------EPKISDFGLARLM 457 (623)
Q Consensus 442 ~~~----------~~kl~Dfgla~~~ 457 (623)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 876 3899999977654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=142.31 Aligned_cols=128 Identities=25% Similarity=0.357 Sum_probs=110.0
Q ss_pred EEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-HhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeecc
Q 006982 83 LNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161 (623)
Q Consensus 83 ~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~ 161 (623)
..|+++++++ +.+|..+.. +|+.|+|++|++++..|.. +..+. +|++|+|++|+|++.+|..|+++++|++|+|+
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLP-HLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCT-TCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCC-CCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 4689999999 578887754 9999999999999655543 77764 59999999999999889999999999999999
Q ss_pred CCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCC
Q 006982 162 HNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCG 214 (623)
Q Consensus 162 ~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~ 214 (623)
+|+|++..|..+..+++|+.|+|++|++++.+|..+. + .+....+.+|+..|.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 9999998888899999999999999999999997654 2 455667788887664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.4e-15 Score=149.48 Aligned_cols=113 Identities=23% Similarity=0.260 Sum_probs=81.2
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhH-hhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~-~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++.|+|++|++++..+..++++++|++|+|++|.++ .+|..+ ..+ ++|++|+|++|++++..|..+.++++|++|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 115 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKEL-KNLETLWVTDNKLQALPIGVFDQLVNLAELR 115 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSC-TTCCEEECCSSCCCCCCTTTTTTCSSCCEEE
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCC-CCCCEEECCCCcCCcCCHhHcccccCCCEEE
Confidence 3567777777777666667778888888888888877 455554 444 4488888888888755455567778888888
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
|++|++++..|..++++++|+.|+|++|.+++..+.
T Consensus 116 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 151 (270)
T 2o6q_A 116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG 151 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh
Confidence 888888776666677778888888888877765544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.58 E-value=6.4e-15 Score=145.78 Aligned_cols=134 Identities=20% Similarity=0.206 Sum_probs=114.3
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|+|++|.+++..|..+.++++|++|+|++|++++..|..+..+ ++|++|+|++|++++..|..+.++++|++|+
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHL-TQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhccc-CCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 578999999999999888889999999999999999996555566675 4599999999999966556689999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCG 214 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~ 214 (623)
|++|++++..|..++.+++|+.|+|++|++++..|..+. + ++....+.+|+..|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999976666899999999999999999988775543 2 455667788887664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.58 E-value=7.6e-15 Score=147.08 Aligned_cols=135 Identities=21% Similarity=0.181 Sum_probs=91.0
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|.+++..+..++++++|++|+|++|++++..|..+..+. +|++|+|++|++++..|..++++++|++|+
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT-NLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCC-CCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 3567777777777766666677777777777777777755444455644 377777777777755555567777777777
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCGE 215 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~~ 215 (623)
|++|++++..|..++.+++|+.|++++|++++..|..+. + .+....+.+|+..|..
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 777777766566667777777777777777776665432 1 3445556666655543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.7e-15 Score=153.59 Aligned_cols=130 Identities=20% Similarity=0.272 Sum_probs=100.7
Q ss_pred CcEEEEEecCCCceeeCCccccC---------CCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCC
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRN---------CSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLA 150 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~---------l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~ 150 (623)
.++..|+|++|++.|.+|..++. +++|+.|+|++|.++ .+|..++.+.+ |++|+|++|++++ +|..++
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~-L~~L~L~~N~l~~-l~~~l~ 226 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN-LKSLKIRNSPLSA-LGPAIH 226 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTT-CCEEEEESSCCCC-CCGGGG
T ss_pred cCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCC-CCEEEccCCCCCc-Cchhhc
Confidence 46788888888888888887765 888888888888888 78888877654 8888888888884 677788
Q ss_pred CCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCC
Q 006982 151 NCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGL 212 (623)
Q Consensus 151 ~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l 212 (623)
++++|++|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+. + .+....+++|+.+
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 888888888888888888888888888888888888888888886543 1 3444556666543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=4.2e-15 Score=166.77 Aligned_cols=154 Identities=19% Similarity=0.196 Sum_probs=114.3
Q ss_pred CCCCCCCCCCCCCccc----ceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCCh
Q 006982 55 SWNFNNDTEGFICKFT----GVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPD 122 (623)
Q Consensus 55 sW~~~~~~~~~~c~w~----gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~ 122 (623)
+|+.+-+...++|.+. -|.|.+.. +..++.|+|++|+|++..|..|.+|++|++|||++|+|++..|.
T Consensus 15 ~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~ 94 (635)
T 4g8a_A 15 AANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 94 (635)
T ss_dssp ----------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred cccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChh
Confidence 6665544444466543 36786532 24689999999999998888999999999999999999965555
Q ss_pred hHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccc-cCCcccc-c-
Q 006982 123 DISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG-SIPTFVN-L- 199 (623)
Q Consensus 123 ~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g-~ip~~~~-~- 199 (623)
.|.++. +|++|+|++|+|++..|..|.++++|++|+|++|++++..|..++++++|+.|+|++|.+++ .+|..+. +
T Consensus 95 ~f~~L~-~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~ 173 (635)
T 4g8a_A 95 AYQSLS-HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 173 (635)
T ss_dssp TTTTCT-TCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred HhcCCC-CCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence 677765 49999999999996555678999999999999999997666779999999999999999976 5666543 1
Q ss_pred cccccccCCC
Q 006982 200 TLSADSVTNN 209 (623)
Q Consensus 200 ~~~~~~~~~n 209 (623)
.+....+.+|
T Consensus 174 ~L~~L~L~~N 183 (635)
T 4g8a_A 174 NLEHLDLSSN 183 (635)
T ss_dssp TCCEEECCSS
T ss_pred hhhhhcccCc
Confidence 2333444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.4e-15 Score=143.23 Aligned_cols=114 Identities=16% Similarity=0.166 Sum_probs=105.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|.+++..|..|+++++|+.|+|++|.+++..|..+..+. +|++|+|++|++++..|..+.++++|++|+
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLE-SLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCS-SCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCc-CCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 4689999999999999888999999999999999999976666677765 599999999999988899999999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
|++|++++..|..+..+++|+.|+|++|.+++..+
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999999889999999999999999999998776
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-15 Score=172.69 Aligned_cols=111 Identities=28% Similarity=0.416 Sum_probs=83.1
Q ss_pred EEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeecc
Q 006982 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~ 161 (623)
+..|+|++|.+. .+|+.+.+|++|++|+|++|.|+ .||..++++.+ |++|+|++|+|+ .||..|++|++|++|+|+
T Consensus 226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~-L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSN-LRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTT-CCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCC-CCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 345666666666 67777777777777777777777 77777777644 788888888877 777777777778888888
Q ss_pred CCcCCCCCCccccccccccccccccccccccCCccc
Q 006982 162 HNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 162 ~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
+|.|+ .||..|++|++|+.|+|++|.|+|.+|..+
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 87776 677777777788888888888877777654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-14 Score=134.62 Aligned_cols=107 Identities=22% Similarity=0.258 Sum_probs=90.5
Q ss_pred EEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCc
Q 006982 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNR 164 (623)
Q Consensus 85 l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~ 164 (623)
|++++|+|+. +|..+ .++|+.|+|++|+|++..|..+..+.+ |++|+|++|+|++..|..+.++++|++|+|++|+
T Consensus 14 l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~-L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 14 VDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQ-LTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTT-CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCccc-CCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 3445566664 77766 389999999999999877888888654 9999999999996655567999999999999999
Q ss_pred CCCCCCccccccccccccccccccccccCCc
Q 006982 165 FSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 165 ~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
|++..|..+.++++|+.|+|++|.+++..+.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 9976666799999999999999999987664
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.1e-14 Score=136.05 Aligned_cols=112 Identities=23% Similarity=0.251 Sum_probs=100.5
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|+++ .+|..+.++++|+.|+|++|.+++..|..+..+. +|++|+|++|+|++..|..|.++++|++|+
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~-~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 108 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT-QLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCC-CCCEEECCCCccCEeCHHHhCCCCCCCEEE
Confidence 46899999999998 7889999999999999999999976667788865 499999999999987777899999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSI 193 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~i 193 (623)
|++|+|++..+..+..+++|+.|+|++|.+...-
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 109 LHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 9999999655557899999999999999998643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-14 Score=150.63 Aligned_cols=132 Identities=18% Similarity=0.132 Sum_probs=112.0
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCcccc-CCCCCCEEEcCCCCCCCCCChhHhhhcCCCCE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIR-NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~ 133 (623)
..|.|.|.-|.|.+.. ...++.|+|++|++++..+..+. ++++|+.|+|++|+|++..|..+..+. +|++
T Consensus 14 ~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~-~L~~ 92 (361)
T 2xot_A 14 ANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP-NLRY 92 (361)
T ss_dssp TTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCT-TCCE
T ss_pred CCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCC-CCCE
Confidence 4467889889997532 23477899999999998888887 999999999999999966666787765 4999
Q ss_pred EEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 134 L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
|+|++|+|++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..+.
T Consensus 93 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred EECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 99999999976666789999999999999999988888999999999999999999874433
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=157.06 Aligned_cols=145 Identities=15% Similarity=0.159 Sum_probs=119.7
Q ss_pred CCCcccc--eeecCCC-------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCCh-hHhhhcCCCCEE
Q 006982 65 FICKFTG--VECWHPD-------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPD-DISKLVGFLTSL 134 (623)
Q Consensus 65 ~~c~w~g--v~c~~~~-------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~-~~~~l~~~L~~L 134 (623)
..|.|.+ |.|++.. ..+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.+|+ .+..+ ++|++|
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l-~~L~~L 84 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL-SSLIIL 84 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTC-TTCCEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccccccc-ccCCEE
Confidence 3566666 8886543 25689999999999999999999999999999999999988865 46665 459999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcc--ccccccccccccccccccccCCcc-cc-c-cccccccCCC
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQ--LGQLGRLKSFSVANNLLSGSIPTF-VN-L-TLSADSVTNN 209 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~--l~~l~~L~~l~l~~N~l~g~ip~~-~~-~-~~~~~~~~~n 209 (623)
+|++|++++..|..++++++|++|+|++|++++.+|.. ++++++|+.|+|++|++++..|.. +. + ++....+++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99999999888999999999999999999999877665 899999999999999999988864 22 2 3344455555
Q ss_pred C
Q 006982 210 Q 210 (623)
Q Consensus 210 ~ 210 (623)
.
T Consensus 165 ~ 165 (455)
T 3v47_A 165 K 165 (455)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.51 E-value=5.1e-15 Score=133.98 Aligned_cols=112 Identities=23% Similarity=0.253 Sum_probs=99.1
Q ss_pred CcEEEEEecCCCce-eeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLK-GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~-g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.+++.|++++|+++ |.+|..++.+++|+.|+|++|.+++. ..++.+. +|++|+|++|++++.+|..++++++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLN-KLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCT-TCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCC-CCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 46889999999998 89999999999999999999999965 6677764 49999999999998888888889999999
Q ss_pred eccCCcCCCC-CCccccccccccccccccccccccCC
Q 006982 159 KLDHNRFSGQ-IPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 159 ~l~~N~~~g~-iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
+|++|++++. .|..++.+++|+.|++++|.+++..+
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 9999999972 45889999999999999999998765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.50 E-value=4.7e-14 Score=136.57 Aligned_cols=111 Identities=20% Similarity=0.251 Sum_probs=101.4
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhH-hhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~-~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.++..|+|++|.+++..|..|.++++|++|+|++|.|+ .+|..+ ..+ ++|++|+|++|++++..|..|.++++|++|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 133 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGL-FSLQLLLLNANKINCLRVDAFQDLHNLNLL 133 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCC-CCCCEEECCCCCCCEeCHHHcCCCCCCCEE
Confidence 57899999999999999999999999999999999999 677664 555 559999999999998888999999999999
Q ss_pred eccCCcCCCCCCcccccccccccccccccccccc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
+|++|+|++..|..+..+++|+.|+|++|.++..
T Consensus 134 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9999999987777899999999999999999764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.5e-14 Score=158.01 Aligned_cols=110 Identities=27% Similarity=0.271 Sum_probs=102.2
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|+|++|+|++ +|. +++|++|+.|+|++|.|+ .+|..++.+.+ |+.|+|++|+|++ +| .++++++|+.|+|
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~-L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRC-LEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTT-CCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCC-CCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 36789999999997 676 999999999999999999 99999999765 9999999999996 88 8999999999999
Q ss_pred cCCcCCCCC-CccccccccccccccccccccccCCcc
Q 006982 161 DHNRFSGQI-PPQLGQLGRLKSFSVANNLLSGSIPTF 196 (623)
Q Consensus 161 ~~N~~~g~i-P~~l~~l~~L~~l~l~~N~l~g~ip~~ 196 (623)
++|+|++.+ |..++.+++|+.|+|++|.|++.+|..
T Consensus 516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 999999887 999999999999999999999987753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=7.6e-14 Score=140.65 Aligned_cols=129 Identities=22% Similarity=0.219 Sum_probs=109.2
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCcc-CCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN-FSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~-l~g~ip~~~~~l~~L~~l 158 (623)
..++.|+|++|++++..+..++++++|++|+|++|.+++..|..+..+. +|++|+|++|. +++..|..+.++++|++|
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA-LLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT-TCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCcc-CCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 4688999999999998888899999999999999999987788888865 49999999998 775557889999999999
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCC
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNN 209 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n 209 (623)
+|++|++++..|..+.++++|+.|++++|.+++..+..+. + .+....+++|
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 163 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence 9999999988888899999999999999999977665443 1 3344445555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=6.3e-14 Score=156.79 Aligned_cols=118 Identities=24% Similarity=0.257 Sum_probs=99.3
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|+|++|.+++..|..|+++++|++|+|++|.+++..|..+.++.+ |++|+|++|++++..|..|+++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~-L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH-LSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTT-CCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhh-cCEeECCCCcccccChhhcCCcccCCEEE
Confidence 56889999999999888888999999999999999998777777877654 99999999999987788888899999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccc-cCCcccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG-SIPTFVN 198 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g-~ip~~~~ 198 (623)
|++|++++..|..++++++|++|+|++|.+++ .+|..+.
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~ 150 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGG
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHh
Confidence 99998887666788888888888888888876 6676543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.49 E-value=7.9e-14 Score=141.00 Aligned_cols=131 Identities=24% Similarity=0.227 Sum_probs=71.9
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|+|++|.++ .+|..+..+++|++|+|++|++++..|..+..+. +|++|+|++|++++..|..+..+++|+.|+|
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG-ELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCC-CCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 4555555555554 4555566666666666666666643334455543 3666666666666444444556666666666
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCC
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCG 214 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~ 214 (623)
++|+|++..+..+..+++|+.|+|++|+|+ .+|..+. . .+....+.+|++.|.
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 666666333333455666666666666666 3443221 1 233445566666554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=3e-14 Score=153.49 Aligned_cols=136 Identities=19% Similarity=0.171 Sum_probs=119.0
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|.+++.+|..++++++|+.|+|++|.+++..|..+..+.+ |++|+|++|++++..|..++++++|++|+
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH-LLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT-CCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc-CCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 36889999999999999999999999999999999999888888888654 99999999999987788899999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCGEP 216 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~~~ 216 (623)
|++|++++..|..+..+++|+.|+|++|++++..|..+. + .+....+.+|+..|..|
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999988899999999999999999999986665433 2 45667788888777655
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.8e-14 Score=135.83 Aligned_cols=118 Identities=21% Similarity=0.197 Sum_probs=101.4
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|++++..+..+.++++|++|+|++|++++..|..+..+. +|++|+|++|++++..|..+.++++|++|+
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLT-QLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCcc-CCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 5689999999999977667789999999999999999954444466754 599999999999976666689999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN 198 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~ 198 (623)
|++|++++..+..+..+++|+.|++++|.+++..|....
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l~~ 169 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY 169 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTTHH
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecCCCCHHH
Confidence 999999976666789999999999999999999886433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.49 E-value=1e-13 Score=138.55 Aligned_cols=114 Identities=22% Similarity=0.172 Sum_probs=70.2
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
+++.|+|++|.++...+..+.++++|++|+|++|.+++..|..+..+ ++|++|+|++|++++..|..++++++|++|+|
T Consensus 62 ~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 62 KLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQL-VNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTC-SSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccc-cCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 46677777777765444445667777777777777764333334443 33777777777776555555666666666666
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
++|++++..+..+..+++|+.|+|++|.+++..|.
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 175 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEeChh
Confidence 66666654444456666666666666666655443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=1.9e-14 Score=159.02 Aligned_cols=128 Identities=23% Similarity=0.253 Sum_probs=109.3
Q ss_pred CCcccceeecCCC----------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEE
Q 006982 66 ICKFTGVECWHPD----------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLD 135 (623)
Q Consensus 66 ~c~w~gv~c~~~~----------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~ 135 (623)
.|.|.|+ |+... ..+++.|+|++|++++..|..++++++|++|+|++|++++..|..++.+.+ |++|+
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~-L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS-LEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT-CCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc-CCEEE
Confidence 5899998 85421 246899999999999999999999999999999999999877788888654 99999
Q ss_pred ccCccCCCCCCCCCCCCCCCceeeccCCcCCC-CCCccccccccccccccccccccccCCc
Q 006982 136 LSSNNFSGSIPSNLANCTYLNSLKLDHNRFSG-QIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 136 L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g-~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
|++|++++..|..++++++|++|+|++|++++ .+|..++++++|+.|++++|.+.+.+|.
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~ 141 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCH
Confidence 99999997766669999999999999999987 5678889999999999999987777763
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.9e-14 Score=146.57 Aligned_cols=145 Identities=21% Similarity=0.214 Sum_probs=115.5
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCC--CCCChhHhhhcCCCC
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLY--GPLPDDISKLVGFLT 132 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~--g~ip~~~~~l~~~L~ 132 (623)
..|.|.|.+|.|++.. ...++.|+|++|+++...+..++++++|+.|+|++|.++ |.+|..+..+. +|+
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~-~L~ 81 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT-SLK 81 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCS-CCC
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccccccccc-ccC
Confidence 3467999999997633 247899999999998544445899999999999999998 34477777754 599
Q ss_pred EEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCC-ccccccccccccccccccccccCCcccc-c-cccccccCCC
Q 006982 133 SLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIP-PQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNN 209 (623)
Q Consensus 133 ~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP-~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n 209 (623)
+|+|++|.++ .+|..+.++++|++|+|++|++++..+ ..+..+++|+.|++++|.+++.+|..+. + .+....+.+|
T Consensus 82 ~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 82 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp EEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred EEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 9999999999 688889999999999999999996554 5788999999999999999988887543 1 3333444444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=3e-14 Score=143.63 Aligned_cols=117 Identities=21% Similarity=0.185 Sum_probs=77.5
Q ss_pred CcEEEEEecCCC-ceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMG-LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~-l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.++..|+|++|. +....|..+..+++|++|+|++|.+++..|..+..+.+ |++|+|++|++++..+..++++++|++|
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA-LQYLYLQDNALQALPDDTFRDLGNLTHL 158 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcC-CCEEECCCCcccccCHhHhccCCCccEE
Confidence 356677777776 55555666777777777777777777655666666443 7777777777775444456677777777
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCCccc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
+|++|++++..+..+..+++|+.|++++|.+++..|..+
T Consensus 159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 197 (285)
T 1ozn_A 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHc
Confidence 777777775444456667777777777777776666543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.48 E-value=4.4e-14 Score=141.46 Aligned_cols=117 Identities=22% Similarity=0.215 Sum_probs=104.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|++++..|..++++++|++|+|++|.+++..|..+..+. +|+.|+|++|++++..|..++++++|++|+
T Consensus 109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLT-NLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCc-cCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 5689999999999988888899999999999999999965555567764 599999999999977777789999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
|++|++++..|..++++++|+.|++++|.++|..|...
T Consensus 188 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l~ 225 (272)
T 3rfs_A 188 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIR 225 (272)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcHHH
Confidence 99999999888888999999999999999999998643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=138.93 Aligned_cols=129 Identities=21% Similarity=0.230 Sum_probs=106.5
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|++++..+..++++++|++|+|++|.+++..|..+..+. +|++|+|++|++++..|..+.++++|++|+
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCT-TCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCc-CCCEEECCCCccCccChhhhcCCccccEEE
Confidence 3588999999999988888899999999999999999965566777764 499999999999987778899999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccc-cCCcccc-c-cccccccCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG-SIPTFVN-L-TLSADSVTNN 209 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g-~ip~~~~-~-~~~~~~~~~n 209 (623)
+++|++++..+..++++++|+.|++++|++++ .+|..+. + .+....+++|
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N 159 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence 99999998777689999999999999999987 4676544 1 3334444444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=6.6e-14 Score=151.89 Aligned_cols=134 Identities=19% Similarity=0.185 Sum_probs=116.2
Q ss_pred CCCC--cccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCE
Q 006982 64 GFIC--KFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133 (623)
Q Consensus 64 ~~~c--~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~ 133 (623)
.|.| .|..|.|.+.. ...++.|+|++|++++..|..|.++++|++|+|++|.+++..|..+.++.+ |++
T Consensus 6 ~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~-L~~ 84 (477)
T 2id5_A 6 RCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN-LRT 84 (477)
T ss_dssp TCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT-CCE
T ss_pred CCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCcc-CCE
Confidence 3456 46789996532 246889999999999999999999999999999999999888989988755 999
Q ss_pred EEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc
Q 006982 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN 198 (623)
Q Consensus 134 L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~ 198 (623)
|+|++|++++..+..|+++++|++|+|++|++++..|..+.++++|+.|+|++|.+++..|..+.
T Consensus 85 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 149 (477)
T 2id5_A 85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS 149 (477)
T ss_dssp EECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSST
T ss_pred EECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhcc
Confidence 99999999954445689999999999999999998899999999999999999999988776543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=128.30 Aligned_cols=108 Identities=21% Similarity=0.249 Sum_probs=92.3
Q ss_pred EEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccC
Q 006982 83 LNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDH 162 (623)
Q Consensus 83 ~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~ 162 (623)
..+++++|+| +.+|..+. ++|+.|+|++|+|++..|..+..+.+ |++|+|++|+|++..|..+.++++|++|+|++
T Consensus 15 ~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVN-LQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcC-CCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 3578888888 47888775 89999999999999888888888755 99999999999964444578999999999999
Q ss_pred CcCCCCCCccccccccccccccccccccccCC
Q 006982 163 NRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 163 N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
|+|++..|..+..+++|+.|+|++|.++...+
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 99996555569999999999999999986654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.47 E-value=3.1e-14 Score=154.77 Aligned_cols=142 Identities=19% Similarity=0.154 Sum_probs=114.4
Q ss_pred CcccceeecCCCCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC
Q 006982 67 CKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP 146 (623)
Q Consensus 67 c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip 146 (623)
|.+.++.|.. ...+..|+|++|.+++..|..++++++|+.|+|++|.+++.+|..++...++|+.|+|++|.|++. |
T Consensus 109 N~l~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~ 185 (487)
T 3oja_A 109 NNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K 185 (487)
T ss_dssp SCCCCEEECC--CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred CcCCCCCccc--cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c
Confidence 5566777743 356899999999999999999999999999999999999988888873235599999999999965 4
Q ss_pred CCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCC
Q 006982 147 SNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCG 214 (623)
Q Consensus 147 ~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~ 214 (623)
. +..+++|+.|+|++|+|++ +|+.++.+++|+.|+|++|.|++ +|..+. + .+....+.+|+..|+
T Consensus 186 ~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 186 G-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp C-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred c-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 3 4469999999999999996 66679999999999999999997 565443 1 455667788887765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=4.5e-14 Score=143.86 Aligned_cols=113 Identities=17% Similarity=0.200 Sum_probs=60.1
Q ss_pred cEEEEEecCCCceeeCC-ccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCC-CCCCCCCCCCCCcee
Q 006982 81 RVLNLRLTDMGLKGQFP-RGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG-SIPSNLANCTYLNSL 158 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p-~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g-~ip~~~~~l~~L~~l 158 (623)
.+..|+|++|.+++..+ ..+.++++|++|+|++|.+.+..|..+..+. +|++|+|++|.+++ .+|..+..+++|++|
T Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 180 (306)
T 2z66_A 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNLTFL 180 (306)
T ss_dssp TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT-TCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCc-CCCEEECCCCccccccchhHHhhCcCCCEE
Confidence 34555555555554433 3455555555555555555555554444433 25555555555554 345555555555555
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCC
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
+|++|++++..|..+..+++|+.|+|++|.+++..+
T Consensus 181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCS
T ss_pred ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccCh
Confidence 555555555445555555555555555555554433
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.47 E-value=9.6e-15 Score=164.29 Aligned_cols=113 Identities=14% Similarity=0.296 Sum_probs=101.4
Q ss_pred CcEEEEEecCCCceee-----------------CCcccc--CCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCcc
Q 006982 80 NRVLNLRLTDMGLKGQ-----------------FPRGIR--NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~-----------------~p~~l~--~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~ 140 (623)
.+++.|+|++|.++|. +|++++ ++++|++|+|++|++.|.+|..++++.+ |++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE-MQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSS-CCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCC-CCEEECcCCC
Confidence 5688999999999996 999998 9999999999999999999999988754 9999999998
Q ss_pred -CCC-CCCCCCCCC------CCCceeeccCCcCCCCCCc--cccccccccccccccccccccCC
Q 006982 141 -FSG-SIPSNLANC------TYLNSLKLDHNRFSGQIPP--QLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 141 -l~g-~ip~~~~~l------~~L~~l~l~~N~~~g~iP~--~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
++| .+|..++++ ++|++|+|++|+++ .+|. .++++++|+.|++++|+++|.+|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip 347 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP 347 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh
Confidence 998 899888776 89999999999999 8998 89999999999999999999998
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=154.81 Aligned_cols=140 Identities=19% Similarity=0.109 Sum_probs=117.9
Q ss_pred ccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCcc
Q 006982 69 FTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140 (623)
Q Consensus 69 w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~ 140 (623)
+.-+.|.+.. ...++.|+|++|.+++..|..|+++++|++|+|++|.+.+..|..+.++.+ |++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~-L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR-LDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTT-CCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccc-cCeeeCCCCc
Confidence 4457886532 246899999999999999999999999999999999999888989998755 9999999999
Q ss_pred CCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccc-cCCccccc-cccccccCCC
Q 006982 141 FSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG-SIPTFVNL-TLSADSVTNN 209 (623)
Q Consensus 141 l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g-~ip~~~~~-~~~~~~~~~n 209 (623)
+++..|..++++++|++|+|++|++++..|..++++++|++|++++|++++ .+|....+ ++....+.+|
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 163 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSS
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccC
Confidence 998889999999999999999999997667889999999999999999998 55665442 2333334444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.1e-14 Score=132.65 Aligned_cols=112 Identities=22% Similarity=0.211 Sum_probs=79.2
Q ss_pred CcEEEEEecCCCce-eeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLK-GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~-g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
..++.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. ..+..+. +|++|+|++|++++.+|..+.++++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLP-KLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCS-SCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCC-CCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 45777777777777 67777777777777777777777754 5566643 37777777777776666666667777777
Q ss_pred eccCCcCCCC-CCccccccccccccccccccccccCC
Q 006982 159 KLDHNRFSGQ-IPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 159 ~l~~N~~~g~-iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
+|++|++++. .+..+..+++|+.|++++|.+++..+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 7777777742 12567777777777777777776554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=133.64 Aligned_cols=114 Identities=21% Similarity=0.206 Sum_probs=100.5
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|++++..+..+..+++|+.|+|++|+|++..|..+..+. +|++|+|++|+|+ .+|..+..+++|++|+
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~-~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLV-HLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcch-hhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 5689999999999766666789999999999999999955444456654 5999999999999 8999999999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
|++|+|++..+..+..+++|+.|+|++|.+++..+.
T Consensus 142 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 177 (229)
T 3e6j_A 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD 177 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGG
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcch
Confidence 999999976667799999999999999999988763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.44 E-value=7.2e-14 Score=145.96 Aligned_cols=135 Identities=24% Similarity=0.162 Sum_probs=111.2
Q ss_pred CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 79 ~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
..++..|+|++|++++..|..|.++++|+.|+|++|+|++..|..+..+. +|++|+|++|++++..|..|.++++|+.|
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQ-ALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCc-CCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 35789999999999999888999999999999999999965555677764 59999999999998878899999999999
Q ss_pred eccCCcCCCCCCccc----cccccccccccccccccccCCcccc-cc---ccccccCCCCCCCCC
Q 006982 159 KLDHNRFSGQIPPQL----GQLGRLKSFSVANNLLSGSIPTFVN-LT---LSADSVTNNQGLCGE 215 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l----~~l~~L~~l~l~~N~l~g~ip~~~~-~~---~~~~~~~~n~~l~~~ 215 (623)
+|++|+|++ +|..+ ..+++|+.|+|++|+|++..+..+. +. +....+.+|+..|..
T Consensus 142 ~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 142 YLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp ECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred ECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 999999995 77665 6799999999999999965443332 11 244678889888863
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.6e-13 Score=125.48 Aligned_cols=128 Identities=29% Similarity=0.318 Sum_probs=102.5
Q ss_pred EEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccC
Q 006982 83 LNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDH 162 (623)
Q Consensus 83 ~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~ 162 (623)
..+++++++++ .+|..+ .++|+.|+|++|++++..|..+..+. +|++|+|++|++++..|..++++++|++|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLT-QLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCT-TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcc-cccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 46889999987 466554 47999999999999965555566754 599999999999966556689999999999999
Q ss_pred CcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCC
Q 006982 163 NRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCG 214 (623)
Q Consensus 163 N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~ 214 (623)
|++++..|..+..+++|+.|++++|++++..+..+. + .+....+.+|+..|.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 999977777789999999999999999976665433 2 455667788876654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=6.4e-14 Score=156.71 Aligned_cols=134 Identities=20% Similarity=0.202 Sum_probs=69.0
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCC-CChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGP-LPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~-ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++.|++++|.+++.+|..++++++|+.|+|++|.+++. +|..+..+.+ |+.|+|++|++++.+|..++++++|++|+
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN-LTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT-CCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCC-CCEEECCCCcCCccChhhhcccccCCEEE
Confidence 344455555555555555555555555555555555542 4444444332 55555555555555555555555555555
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc-c--cccccccCCCCCCCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L--TLSADSVTNNQGLCGEP 216 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~--~~~~~~~~~n~~l~~~~ 216 (623)
|++|++++.+|..++++++|+.|+|++|+++ .+|..+. + .+....+.+|+..|..+
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 5555555555555555555555555555555 3333221 1 13344556666665443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=153.82 Aligned_cols=132 Identities=23% Similarity=0.220 Sum_probs=110.7
Q ss_pred CCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEc
Q 006982 65 FICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDL 136 (623)
Q Consensus 65 ~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L 136 (623)
|.|.++-|.|++.. ..+++.|+|++|++++..+..|+++++|++|+|++|.+++..|..++++.. |++|+|
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~L 80 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM-LKVLNL 80 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTT-CCEEEC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccC-cCEEEC
Confidence 34555567775421 357899999999999988888999999999999999999888888888754 999999
Q ss_pred cCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCccc
Q 006982 137 SSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 137 ~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
++|++++..+..|+++++|++|+|++|++++..|..++++++|++|+|++|.+++..|..+
T Consensus 81 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 141 (680)
T 1ziw_A 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSS
T ss_pred CCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhh
Confidence 9999995433469999999999999999997777889999999999999999999888654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=7.9e-14 Score=145.12 Aligned_cols=142 Identities=23% Similarity=0.282 Sum_probs=112.6
Q ss_pred CCCcccceeecCCC----------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEE
Q 006982 65 FICKFTGVECWHPD----------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134 (623)
Q Consensus 65 ~~c~w~gv~c~~~~----------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L 134 (623)
+.|.|.|+ |+... ...++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+.++. +|++|
T Consensus 28 ~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L 105 (353)
T 2z80_A 28 LSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG-SLEHL 105 (353)
T ss_dssp CEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT-TCCEE
T ss_pred CCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCC-CCCEE
Confidence 57999987 64321 23789999999999988777899999999999999999987777888865 49999
Q ss_pred EccCccCCCCCCCC-CCCCCCCceeeccCCcCCCCCCc--ccccccccccccccccc-ccccCCcccc-c-cccccccCC
Q 006982 135 DLSSNNFSGSIPSN-LANCTYLNSLKLDHNRFSGQIPP--QLGQLGRLKSFSVANNL-LSGSIPTFVN-L-TLSADSVTN 208 (623)
Q Consensus 135 ~L~~N~l~g~ip~~-~~~l~~L~~l~l~~N~~~g~iP~--~l~~l~~L~~l~l~~N~-l~g~ip~~~~-~-~~~~~~~~~ 208 (623)
+|++|++++ +|.. ++++++|++|+|++|+++ .+|. .+.++++|+.|++++|+ +++..|..+. + .+....+.+
T Consensus 106 ~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 106 DLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp ECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred ECCCCcCCc-CCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence 999999995 5554 899999999999999999 5665 78999999999999995 5555454433 1 233344444
Q ss_pred CC
Q 006982 209 NQ 210 (623)
Q Consensus 209 n~ 210 (623)
|.
T Consensus 184 n~ 185 (353)
T 2z80_A 184 SD 185 (353)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.8e-13 Score=138.70 Aligned_cols=143 Identities=22% Similarity=0.275 Sum_probs=117.6
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L 134 (623)
.+|.|.|+.+.|++.. ...++.|+|++|++++..|..++++++|++|+|++|.+++..|..+.++.+ |++|
T Consensus 29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L 107 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK-LQKL 107 (332)
T ss_dssp SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTT-CCEE
T ss_pred CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCC-CCEE
Confidence 3456899999997532 236889999999999988889999999999999999999877888988754 9999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccccccccccccc--ccCCcccc-ccccccccCCC
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS--GSIPTFVN-LTLSADSVTNN 209 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~--g~ip~~~~-~~~~~~~~~~n 209 (623)
+|++|+++ .+|..+. ++|++|+|++|++++..+..+.++++|+.|++++|.++ |..|..+. +++....+++|
T Consensus 108 ~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n 182 (332)
T 2ft3_A 108 YISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182 (332)
T ss_dssp ECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSS
T ss_pred ECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCC
Confidence 99999999 7898776 89999999999999766667899999999999999996 35565433 23344444444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-13 Score=153.45 Aligned_cols=116 Identities=14% Similarity=0.073 Sum_probs=80.6
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|+++++.+....+..++++++|++|+|++|.+++..|..++.+.. |++|+|++|.+++..|..|+++++|++|+|
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHT-IQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCC-CCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 3456777777776555555677777777777777777666666766543 777777777777766666777777777777
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCccc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
++|+|++..|..++++++|+.|+|++|.+++.+|..+
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 167 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence 7777774333345777777777777777777766544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=1.4e-13 Score=142.93 Aligned_cols=111 Identities=18% Similarity=0.208 Sum_probs=92.1
Q ss_pred CCcccceeecCCCCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCC-CCCCCCCChhHhhhcCCCCEEEccCccCCCC
Q 006982 66 ICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSS-NKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144 (623)
Q Consensus 66 ~c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~-N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ 144 (623)
.|.|..|.|++. |+|++ ||. |+.+++|+.|+|++ |.|++..|..+..+.+ |+.|+|++|+|+|.
T Consensus 7 ~C~~~~v~~~~~------------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~ 71 (347)
T 2ifg_A 7 PHGSSGLRCTRD------------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGE-LRNLTIVKSGLRFV 71 (347)
T ss_dssp CSSSSCEECCSS------------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCC-CSEEECCSSCCCEE
T ss_pred cccCCEEEcCCC------------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccC-CCEEECCCCcccee
Confidence 489988888431 15654 888 99999999999996 9999766677888654 99999999999998
Q ss_pred CCCCCCCCCCCceeeccCCcCCCCCCcccccccccccccccccccccc
Q 006982 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 145 ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
.|..|++|++|+.|+|++|+|++..|..+..++ |+.|+|++|.|...
T Consensus 72 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 888899999999999999999964444444454 99999999999864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.4e-13 Score=154.41 Aligned_cols=135 Identities=22% Similarity=0.244 Sum_probs=118.4
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCC-CCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLY-GPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~-g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
..+..++++.|.+.+..|..+..+++|+.|+|++|++. +.+|..+..+. +|++|||++|++++.+|..|+++++|++|
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~-~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR-NLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhcc-ccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 35678899999999999999999999999999999854 44677777764 59999999999999889999999999999
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCCcccc-c--cccccccCCCCCCCCC
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L--TLSADSVTNNQGLCGE 215 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~--~~~~~~~~~n~~l~~~ 215 (623)
+|++|+|++..|..+..+++|+.|+|++|+|++.+|..+. + ++....+.+|++.|.+
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 9999999998888999999999999999999999998654 2 4566788999999864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.42 E-value=3.8e-13 Score=136.00 Aligned_cols=113 Identities=26% Similarity=0.263 Sum_probs=86.5
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|.+++..|..+.++++|+.|+|++|.+++ +|.. +.+ ++|++|+|++|+++ .+|..+..+++|++|+
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l-~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 106 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTL-PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCC-TTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCC-CcCCEEECCCCcCC-cCchhhccCCCCCEEE
Confidence 467888999999988888888888888888888888884 4443 443 34888888888887 6777777788888888
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~ 196 (623)
|++|++++..|..+..+++|+.|+|++|++++..|..
T Consensus 107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 143 (290)
T 1p9a_G 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL 143 (290)
T ss_dssp CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhh
Confidence 8888888665667777888888888888887655543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.41 E-value=5e-14 Score=162.17 Aligned_cols=128 Identities=16% Similarity=0.246 Sum_probs=104.4
Q ss_pred CcEEEEEecCCCcee-----------------eCCcccc--CCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCcc
Q 006982 80 NRVLNLRLTDMGLKG-----------------QFPRGIR--NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN 140 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g-----------------~~p~~l~--~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~ 140 (623)
.+++.|+|++|.|+| .+|++++ +|++|++|+|++|++.|.+|..++++.+ |+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~-L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE-LQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSS-CCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCC-CCEEECcCCC
Confidence 568889999999998 4899988 9999999999999999999998988754 9999999998
Q ss_pred -CCC-CCCCCCCCCC-------CCceeeccCCcCCCCCCc--cccccccccccccccccccccCCccccc-cccccccCC
Q 006982 141 -FSG-SIPSNLANCT-------YLNSLKLDHNRFSGQIPP--QLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTN 208 (623)
Q Consensus 141 -l~g-~ip~~~~~l~-------~L~~l~l~~N~~~g~iP~--~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~ 208 (623)
|+| .+|..+++++ +|++|+|++|+++ .+|. .++++++|+.|+|++|+++ .||.+..+ .+....+.+
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 998 8887766665 8999999999999 8888 8899999999999999998 88833222 333444555
Q ss_pred CC
Q 006982 209 NQ 210 (623)
Q Consensus 209 n~ 210 (623)
|.
T Consensus 605 N~ 606 (876)
T 4ecn_A 605 NQ 606 (876)
T ss_dssp SC
T ss_pred Cc
Confidence 54
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.40 E-value=4.5e-13 Score=144.37 Aligned_cols=130 Identities=16% Similarity=0.154 Sum_probs=110.6
Q ss_pred CCCc--ccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEE
Q 006982 65 FICK--FTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134 (623)
Q Consensus 65 ~~c~--w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L 134 (623)
|.|. |..|.|.+.. ...++.|+|++|++++..|..|+++++|+.|+|++|.+++..|..+..+. +|++|
T Consensus 50 C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L 128 (452)
T 3zyi_A 50 CSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLA-SLNTL 128 (452)
T ss_dssp SEECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT-TCCEE
T ss_pred CEECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcc-cCCEE
Confidence 4454 5678886532 24689999999999999999999999999999999999987778888865 49999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+|++|++++..|..+.++++|++|+|++|++++..+..+.++++|+.|++++|+..+.+|.
T Consensus 129 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 189 (452)
T 3zyi_A 129 ELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE 189 (452)
T ss_dssp ECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred ECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh
Confidence 9999999966566699999999999999999966666889999999999999766666664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=5.9e-13 Score=142.88 Aligned_cols=130 Identities=16% Similarity=0.175 Sum_probs=109.4
Q ss_pred CCCc--ccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEE
Q 006982 65 FICK--FTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134 (623)
Q Consensus 65 ~~c~--w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L 134 (623)
|.|. |..|.|.+.. ...++.|+|++|++++..+..|.++++|+.|+|++|.+++..|..+..+. +|++|
T Consensus 39 C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~-~L~~L 117 (440)
T 3zyj_A 39 CSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLA-NLNTL 117 (440)
T ss_dssp SEECTTSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCS-SCCEE
T ss_pred CEeCCCCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCc-cCCEE
Confidence 4454 5678996532 24578899999999999999999999999999999999976667787765 59999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+|++|++++..+..+..+++|++|+|++|++++..+..+.++++|+.|+|++|+..+.+|.
T Consensus 118 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 178 (440)
T 3zyj_A 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE 178 (440)
T ss_dssp ECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred ECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc
Confidence 9999999965555799999999999999999976666889999999999999776666664
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=3e-13 Score=157.17 Aligned_cols=124 Identities=19% Similarity=0.138 Sum_probs=94.5
Q ss_pred CcccceeecCCCCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCC-ChhHhhhcCCCCEEEccCccCCCCC
Q 006982 67 CKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPL-PDDISKLVGFLTSLDLSSNNFSGSI 145 (623)
Q Consensus 67 c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~i-p~~~~~l~~~L~~L~L~~N~l~g~i 145 (623)
|+|..|.+ -..+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.| |..+.++. +|++|+|++|++++..
T Consensus 14 ~~L~~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~-~L~~L~Ls~N~l~~~~ 89 (844)
T 3j0a_A 14 CNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLP-NLRILDLGSSKIYFLH 89 (844)
T ss_dssp CCSSCCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCT-TCCEEECTTCCCCEEC
T ss_pred CCCCCCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCC-CCCEEECCCCcCcccC
Confidence 45666666 2457888999999888888888888888888888888777777 55566654 4888888888888777
Q ss_pred CCCCCCCCCCceeeccCCcCCCCCCcc--ccccccccccccccccccccCC
Q 006982 146 PSNLANCTYLNSLKLDHNRFSGQIPPQ--LGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 146 p~~~~~l~~L~~l~l~~N~~~g~iP~~--l~~l~~L~~l~l~~N~l~g~ip 194 (623)
|..|+++++|++|+|++|++++.+|.. ++++++|+.|+|++|.+++..|
T Consensus 90 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~ 140 (844)
T 3j0a_A 90 PDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140 (844)
T ss_dssp TTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC
T ss_pred HhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc
Confidence 778888888888888888888766665 7777788888888887777654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.2e-13 Score=149.94 Aligned_cols=122 Identities=30% Similarity=0.467 Sum_probs=97.7
Q ss_pred cccce-eecCCCCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC
Q 006982 68 KFTGV-ECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP 146 (623)
Q Consensus 68 ~w~gv-~c~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip 146 (623)
.|.|+ .|.. ++++.|+|++|+|++ +|+.+. ++|++|+|++|+|+ .|| . . .++|++|+|++|+|++ ||
T Consensus 49 ~~~~l~~C~~---~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip-~--~-l~~L~~L~Ls~N~l~~-ip 116 (571)
T 3cvr_A 49 AVSLLKECLI---NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP-E--L-PASLEYLDACDNRLST-LP 116 (571)
T ss_dssp HHHHHHHHHH---TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC-C--C-CTTCCEEECCSSCCSC-CC
T ss_pred hhhhcccccc---CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc-c--c-cCCCCEEEccCCCCCC-cc
Confidence 79999 7853 579999999999998 888774 88999999999999 788 2 2 3459999999999997 88
Q ss_pred CCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCccccccccccccCCCC
Q 006982 147 SNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210 (623)
Q Consensus 147 ~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 210 (623)
. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|.... ++....+++|.
T Consensus 117 ~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~-~L~~L~Ls~N~ 171 (571)
T 3cvr_A 117 E-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPT-SLEVLSVRNNQ 171 (571)
T ss_dssp C-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCT-TCCEEECCSSC
T ss_pred h-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCC-CcCEEECCCCC
Confidence 8 666 89999999999997 887 67889999999999987 666222 44445555553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=6.2e-13 Score=133.29 Aligned_cols=117 Identities=17% Similarity=0.182 Sum_probs=104.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|+|++|.+++..+..++++++|++|+|++|.+++..|..+.++. +|++|+|++|++++..+..++++++|++|+
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCT-TCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCc-cccEEECCCCCccccCchhcccCCCCCEEE
Confidence 5688999999999988888999999999999999999977777788865 499999999999977666899999999999
Q ss_pred ccCCcCCC-CCCccccccccccccccccccccccCCccc
Q 006982 160 LDHNRFSG-QIPPQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 160 l~~N~~~g-~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
|++|++++ .+|..++++++|+.|++++|++++..|..+
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 99999987 479999999999999999999998766544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=7.4e-13 Score=136.38 Aligned_cols=131 Identities=19% Similarity=0.235 Sum_probs=112.1
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSL 134 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L 134 (623)
..|.|.|+.+.|++.. ...++.|+|++|++++..+..++++++|++|+|++|.+++..|..+..+.+ |++|
T Consensus 27 ~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L 105 (330)
T 1xku_A 27 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK-LERL 105 (330)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTT-CCEE
T ss_pred CCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCC-CCEE
Confidence 3467899999997532 246789999999999988889999999999999999999877999988754 9999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccc--cCCccc
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG--SIPTFV 197 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g--~ip~~~ 197 (623)
+|++|+++ .+|..+. ++|++|++++|++++..|..+.++++|+.|++++|.++. ..|..+
T Consensus 106 ~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 167 (330)
T 1xku_A 106 YLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167 (330)
T ss_dssp ECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGG
T ss_pred ECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhc
Confidence 99999999 7888765 799999999999997777788999999999999999963 555433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=3.1e-13 Score=151.09 Aligned_cols=115 Identities=21% Similarity=0.153 Sum_probs=71.3
Q ss_pred cEEEEEecCCCceeeCCcc-ccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCC---CCCCCCCCCCCc
Q 006982 81 RVLNLRLTDMGLKGQFPRG-IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS---IPSNLANCTYLN 156 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~-l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~---ip~~~~~l~~L~ 156 (623)
.++.|+|++|.+++..|+. +.++++|+.|+|++|.+++..|..+..+. +|++|+|++|++++. .+..+..+++|+
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP-ALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCT-TCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCC-CCCEEECCCCCCCccccccchhhccCCCcc
Confidence 4666777777776665544 66666677777766666666666665543 366666666666652 223456666666
Q ss_pred eeeccCCcCCCCCCccccccccccccccccccccccCCcc
Q 006982 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196 (623)
Q Consensus 157 ~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~ 196 (623)
+|+|++|++++..|..++++++|+.|+|++|++++.+|..
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 519 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGG
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhH
Confidence 6666666666655666666666666666666666655543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=5e-13 Score=148.16 Aligned_cols=133 Identities=19% Similarity=0.219 Sum_probs=77.1
Q ss_pred EEEEEecCCCceeeCC-ccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCC-CCCCCCCCCCCCCceee
Q 006982 82 VLNLRLTDMGLKGQFP-RGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFS-GSIPSNLANCTYLNSLK 159 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p-~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~-g~ip~~~~~l~~L~~l~ 159 (623)
+..|++++|.+.+..| ..+.++++|++|+|++|.+.+.+|..+..+. +|+.|+|++|.++ |.+|..+..+++|++|+
T Consensus 398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT-TCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCC-cCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 3344444455544444 2455666666666666666655555555543 3666666666665 45666666666666666
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCGE 215 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~~ 215 (623)
|++|++++..|..++++++|+.|++++|++++.+|..+. + .+....+.+|+..|..
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 666666666566666666666666666666665554332 1 3334455566555543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.4e-13 Score=139.03 Aligned_cols=111 Identities=15% Similarity=0.161 Sum_probs=90.8
Q ss_pred CcEEEEEecCCCceeeCCccc--cCCCCCCEEEcCCCCCCCCCChhHhhhc----CCCCEEEccCccCCCCCCCCCCCCC
Q 006982 80 NRVLNLRLTDMGLKGQFPRGI--RNCSSMTGLDLSSNKLYGPLPDDISKLV----GFLTSLDLSSNNFSGSIPSNLANCT 153 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l--~~l~~L~~L~L~~N~l~g~ip~~~~~l~----~~L~~L~L~~N~l~g~ip~~~~~l~ 153 (623)
.+++.|+|++|+++|.+|..+ +.+++|++|+|++|++++. |..++.+. ++|++|+|++|++++..|..+++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 357788888888888888876 8888999999999998876 88887761 4589999999999877778888889
Q ss_pred CCceeeccCCcCCCC--CCccc--cccccccccccccccccc
Q 006982 154 YLNSLKLDHNRFSGQ--IPPQL--GQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 154 ~L~~l~l~~N~~~g~--iP~~l--~~l~~L~~l~l~~N~l~g 191 (623)
+|++|+|++|+++|. +|..+ +++++|+.|+|++|++++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 215 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcc
Confidence 999999999988876 34455 788888888888888883
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=146.44 Aligned_cols=114 Identities=18% Similarity=0.174 Sum_probs=102.0
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|+|++|.+++..|..|+++++|++|+|++|.+++..|..++.+. +|++|+|++|.|++..|..|+++++|++|+|
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP-LLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCC-CCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 578999999999999999999999999999999999987777778865 5999999999999544444699999999999
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
++|++++..|..++++++|+.|+|++|.+++..+.
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 189 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLS 189 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGG
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChh
Confidence 99999998898999999999999999999986433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.37 E-value=5e-13 Score=130.94 Aligned_cols=143 Identities=16% Similarity=0.195 Sum_probs=111.6
Q ss_pred CCCCcc-cc--eeecCC-----CCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCC-CCCCCCh-hHhhhcCCCCE
Q 006982 64 GFICKF-TG--VECWHP-----DENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNK-LYGPLPD-DISKLVGFLTS 133 (623)
Q Consensus 64 ~~~c~w-~g--v~c~~~-----~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~-l~g~ip~-~~~~l~~~L~~ 133 (623)
.|.|.+ .+ |.|.+. -...++.|+|++|++++..+..++++++|++|+|++|. ++ .+|+ .+..+. +|++
T Consensus 7 ~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~-~L~~ 84 (239)
T 2xwt_C 7 PCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLS-KVTH 84 (239)
T ss_dssp SCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCT-TCCE
T ss_pred CCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCc-CCcE
Confidence 345654 55 448541 12478999999999999888899999999999999997 87 4554 666754 5999
Q ss_pred EEccC-ccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccc---ccccccc-cccccCCcccc-c-ccc-ccc
Q 006982 134 LDLSS-NNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLK---SFSVANN-LLSGSIPTFVN-L-TLS-ADS 205 (623)
Q Consensus 134 L~L~~-N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~---~l~l~~N-~l~g~ip~~~~-~-~~~-~~~ 205 (623)
|+|++ |++++..|..+.++++|++|+|++|++++ +|. ++.+++|+ .|++++| ++++..|..+. + .+. ...
T Consensus 85 L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~ 162 (239)
T 2xwt_C 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162 (239)
T ss_dssp EEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEE
T ss_pred EECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEE
Confidence 99999 99996555678999999999999999996 887 88888888 9999999 88876665443 1 333 445
Q ss_pred cCCCC
Q 006982 206 VTNNQ 210 (623)
Q Consensus 206 ~~~n~ 210 (623)
+.+|.
T Consensus 163 l~~n~ 167 (239)
T 2xwt_C 163 LYNNG 167 (239)
T ss_dssp CCSCC
T ss_pred cCCCC
Confidence 55553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.36 E-value=4.6e-13 Score=127.17 Aligned_cols=110 Identities=18% Similarity=0.263 Sum_probs=77.8
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
+++.|++++|+++ .+| .+..+++|++|+|++|.++ .++.+..+. +|++|+|++|++++..|..++.+++|++|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCT-TCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCC-CCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 4667777777776 555 5777777777777777554 334566654 4777777777777767777777777777777
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
++|++++..|..++.+++|+.|++++|.+.+.+|.
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~ 154 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGG
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHh
Confidence 77777776777777777777777777774455553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.1e-13 Score=141.80 Aligned_cols=135 Identities=20% Similarity=0.224 Sum_probs=76.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-----------------------HhhhcCCCCEEEc
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-----------------------ISKLVGFLTSLDL 136 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-----------------------~~~l~~~L~~L~L 136 (623)
.++..|+|++|.+++..+..+.++++|+.|+|++|+..+.+|.. +..+. +|+.|+|
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~-~L~~L~L 214 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLI-KLDELDL 214 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCS-SCCEEEC
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccccccCCCc-ccCEEEC
Confidence 35778888888777655555555555555555553333333332 33332 3555566
Q ss_pred cCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCC
Q 006982 137 SSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCG 214 (623)
Q Consensus 137 ~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~ 214 (623)
++|++++..|..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|+|++..+..+. + .+....+.+|++.|.
T Consensus 215 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 66666655555566666666666666666655555666666666666666666654444332 1 334455667776665
Q ss_pred C
Q 006982 215 E 215 (623)
Q Consensus 215 ~ 215 (623)
+
T Consensus 295 C 295 (440)
T 3zyj_A 295 C 295 (440)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-13 Score=157.53 Aligned_cols=115 Identities=23% Similarity=0.293 Sum_probs=103.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|.|+ .+|..|++|++|++|+|++|.|+ .||.+++.+.+ |++|+|++|.|+ .||..|++|++|++|+
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~-L~~L~L~~N~l~-~lp~~~~~l~~L~~L~ 322 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQ-LKYFYFFDNMVT-TLPWEFGNLCNLQFLG 322 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTT-CSEEECCSSCCC-CCCSSTTSCTTCCCEE
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCC-CCEEECCCCCCC-ccChhhhcCCCccEEe
Confidence 46889999999999 89999999999999999999999 89999999765 999999999998 8999999999999999
Q ss_pred ccCCcCCCCCCccccccccc-cccccccccccccCCcccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRL-KSFSVANNLLSGSIPTFVN 198 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L-~~l~l~~N~l~g~ip~~~~ 198 (623)
|++|+|+|.+|..++.+... ..|+|++|.++|.+|..+.
T Consensus 323 L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~ 362 (727)
T 4b8c_D 323 VEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR 362 (727)
T ss_dssp CTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred CCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc
Confidence 99999999999988776443 4589999999999998654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.36 E-value=6.9e-13 Score=139.92 Aligned_cols=128 Identities=16% Similarity=0.140 Sum_probs=96.5
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+++++.++...+..+.++++|++|+|++|.+++..|..+..+. +|++|+|++|++++..|..++++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCC-CcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 3567788888887754444578889999999999998865566777764 499999999999877777788899999999
Q ss_pred ccCCcCCCCCCcc-ccccccccccccccccccccCCcccc-c-cccccccCCC
Q 006982 160 LDHNRFSGQIPPQ-LGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNN 209 (623)
Q Consensus 160 l~~N~~~g~iP~~-l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n 209 (623)
|++|+++ .+|.. ++++++|+.|++++|.+++..|..+. + ++....+++|
T Consensus 124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 175 (390)
T 3o6n_A 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175 (390)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSS
T ss_pred CCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCC
Confidence 9999988 56655 58888999999999998887776443 1 3333444444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-12 Score=120.82 Aligned_cols=108 Identities=24% Similarity=0.257 Sum_probs=95.9
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC--CCCCCCCCCce
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP--SNLANCTYLNS 157 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip--~~~~~l~~L~~ 157 (623)
..+..|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+. +|++|+|++|++++ +| ..++.+++|++
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~ 124 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLP-NLTHLNLSGNKLKD-ISTLEPLKKLECLKS 124 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCT-TCCEEECBSSSCCS-SGGGGGGSSCSCCCE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCC-CCCEEeccCCccCc-chhHHHHhcCCCCCE
Confidence 4688999999999986 7899999999999999999988888887765 59999999999995 44 78999999999
Q ss_pred eeccCCcCCCCCC---ccccccccccccccccccccc
Q 006982 158 LKLDHNRFSGQIP---PQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 158 l~l~~N~~~g~iP---~~l~~l~~L~~l~l~~N~l~g 191 (623)
|+|++|++++..+ ..+..+++|+.|++++|.+..
T Consensus 125 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 125 LDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp EECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred EEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 9999999996544 388999999999999998863
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.35 E-value=4.7e-13 Score=120.90 Aligned_cols=104 Identities=22% Similarity=0.217 Sum_probs=92.6
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCC-CCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS-IPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~-ip~~~~~l~~L~~l 158 (623)
.+++.|+|++|.+++. +.++++++|++|+|++|.+++.+|..+..+.+ |++|+|++|++++. .|..++++++|++|
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~-L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN-LTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTT-CCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCC-CCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 5789999999999987 78999999999999999999888888877654 99999999999972 45889999999999
Q ss_pred eccCCcCCCCCC---cccccccccccccccc
Q 006982 159 KLDHNRFSGQIP---PQLGQLGRLKSFSVAN 186 (623)
Q Consensus 159 ~l~~N~~~g~iP---~~l~~l~~L~~l~l~~ 186 (623)
+|++|++++..+ ..++.+++|+.|++++
T Consensus 119 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 119 DLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred eCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999997655 4789999999999874
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=2e-12 Score=131.88 Aligned_cols=127 Identities=20% Similarity=0.226 Sum_probs=82.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCC--CChh--HhhhcCCCCEEEccCccCCCCCCCC----CCC
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGP--LPDD--ISKLVGFLTSLDLSSNNFSGSIPSN----LAN 151 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~--ip~~--~~~l~~~L~~L~L~~N~l~g~ip~~----~~~ 151 (623)
.++..|+|++|.+++..|..++++++|++|+|++|++.|. +|.. ++.+ ++|++|+|++|+++ .+|.. +++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l-~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF-PAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS-CCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC-CCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 4678888999998888888888888999999998887652 2211 2343 33667777777665 33331 355
Q ss_pred CCCCceeeccCCcCCCCCCcccccc---ccccccccccccccccCCccccccccccccCCC
Q 006982 152 CTYLNSLKLDHNRFSGQIPPQLGQL---GRLKSFSVANNLLSGSIPTFVNLTLSADSVTNN 209 (623)
Q Consensus 152 l~~L~~l~l~~N~~~g~iP~~l~~l---~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n 209 (623)
+++|++|+|++|++++.+|+.++.+ ++|+.|+|++|+|+ .+|..+.-++....+++|
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N 282 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSN 282 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCC
Confidence 6777777777777776666666665 46777777777776 556544323444444444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=7.2e-13 Score=125.80 Aligned_cols=126 Identities=19% Similarity=0.204 Sum_probs=97.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|++++|.++ .++.+..+++|++|+|++|.+++..|..++.+. +|++|+|++|++++..|..++++++|++|+
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~-~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLT-SLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCT-TCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCC-CCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 36888999988554 455788899999999999999987888888865 499999999999988888889999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 210 (623)
|++|++.+.+| .+..+++|+.|++++|.+++ +|....+ ++....+.+|+
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC-
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCcc
Confidence 99998555777 68899999999999999887 3322222 34444555553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.33 E-value=2.6e-12 Score=118.92 Aligned_cols=106 Identities=25% Similarity=0.249 Sum_probs=90.6
Q ss_pred CCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccc
Q 006982 106 MTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVA 185 (623)
Q Consensus 106 L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~ 185 (623)
.+.|++++|.|+ .+|..+. +.|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..+..+++|+.|+|+
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 578999999999 6998774 459999999999998888899999999999999999997666667999999999999
Q ss_pred cccccccCCcccc-c-cccccccCCCCCCCCC
Q 006982 186 NNLLSGSIPTFVN-L-TLSADSVTNNQGLCGE 215 (623)
Q Consensus 186 ~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~~ 215 (623)
+|+|++..|..+. + .+....+.+|+..|..
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9999987776443 2 4566778889877754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.32 E-value=4.2e-13 Score=137.18 Aligned_cols=112 Identities=16% Similarity=0.171 Sum_probs=59.8
Q ss_pred cEEEEEecCCCceeeCCccccCC-----CCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCC--CCCCC--CC
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNC-----SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS--IPSNL--AN 151 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l-----~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~--ip~~~--~~ 151 (623)
+++.|+|++|.+++. |..++.+ ++|++|+|++|++++..|..++.+. +|++|+|++|+++|. +|..+ ++
T Consensus 122 ~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 122 DLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP-ALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS-SCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC-CCCEEECCCCCcCcchHHHHHHHhcc
Confidence 455666666666655 5555554 5666666666666654445555543 366666666665554 22233 55
Q ss_pred CCCCceeeccCCcCCC--CCCcc-ccccccccccccccccccccCC
Q 006982 152 CTYLNSLKLDHNRFSG--QIPPQ-LGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 152 l~~L~~l~l~~N~~~g--~iP~~-l~~l~~L~~l~l~~N~l~g~ip 194 (623)
+++|++|+|++|++++ .+|.. +.++++|+.|+|++|++++.+|
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 5556666666665552 22221 2344555555555555555543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.32 E-value=2.1e-12 Score=139.12 Aligned_cols=136 Identities=20% Similarity=0.202 Sum_probs=73.3
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-Hhhhc---------------------CCCCEEEcc
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLV---------------------GFLTSLDLS 137 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~---------------------~~L~~L~L~ 137 (623)
.++..|+|++|.+++..+..+.++++|+.|+|++|+.-+.+|.. +..+. ++|+.|+|+
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls 226 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMS 226 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECT
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECc
Confidence 46788888888888665555555555555555553333344432 22222 225555555
Q ss_pred CccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCCC
Q 006982 138 SNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCGE 215 (623)
Q Consensus 138 ~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~~ 215 (623)
+|+|++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..+..+. + ++....+.+|+..|.+
T Consensus 227 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 5555544455555555555555555555555555555555555555555555544443322 1 2334455666665543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.5e-12 Score=143.76 Aligned_cols=118 Identities=19% Similarity=0.183 Sum_probs=106.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCC-CCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG-SIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g-~ip~~~~~l~~L~~l 158 (623)
.+++.|+|++|.+++..|..|+++++|++|+|++|.+++..|..++.+. +|++|+|++|++++ .+|..++++++|++|
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLS-SLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCT-TCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCC-CCcEEECCCCcccccchhhhhhccCCccEE
Confidence 5789999999999999999999999999999999999976666688875 49999999999997 578899999999999
Q ss_pred eccCCcCCCCCC-ccccccccccccccccccccccCCcccc
Q 006982 159 KLDHNRFSGQIP-PQLGQLGRLKSFSVANNLLSGSIPTFVN 198 (623)
Q Consensus 159 ~l~~N~~~g~iP-~~l~~l~~L~~l~l~~N~l~g~ip~~~~ 198 (623)
+|++|++.+.+| ..++++++|+.|++++|++++.+|..+.
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 169 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTT
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhh
Confidence 999999777887 5799999999999999999999887654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.3e-12 Score=144.83 Aligned_cols=109 Identities=19% Similarity=0.185 Sum_probs=75.5
Q ss_pred CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCC--CCChhHhhhcCCCCEEEccCccCCCCCCCC-CCCCCCC
Q 006982 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYG--PLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYL 155 (623)
Q Consensus 79 ~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g--~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~-~~~l~~L 155 (623)
...++.|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..+..+. +|++|+|++|++++.+|.. +..+++|
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS-SLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCT-TCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCC-CCCEEECCCCcCCCccChhhhcCcccC
Confidence 3567888888888888888888888888888888888885 2345566654 4888888888888767754 5566666
Q ss_pred ceeeccCCcCCCCCCcccccccccccccccccccc
Q 006982 156 NSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 156 ~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
+.|+|++|+++|.+|..+. ++|+.|+|++|+++
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc
Confidence 6666666666655554433 45555555555555
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.5e-12 Score=144.35 Aligned_cols=108 Identities=19% Similarity=0.227 Sum_probs=84.1
Q ss_pred cCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCC--CCCCCCCCCCCCceeeccCCcCCCCCCcc-ccccc
Q 006982 101 RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG--SIPSNLANCTYLNSLKLDHNRFSGQIPPQ-LGQLG 177 (623)
Q Consensus 101 ~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g--~ip~~~~~l~~L~~l~l~~N~~~g~iP~~-l~~l~ 177 (623)
+.+++|++|+|++|.+++.+|..++.+.+ |+.|+|++|++++ .+|..++++++|++|+|++|++++.+|.. +..++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~ 428 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKR-LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSS-CCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCC-CCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcc
Confidence 67788888999999888888888887654 8999999998886 34567888888999999999988877764 67788
Q ss_pred cccccccccccccccCCccccccccccccCCC
Q 006982 178 RLKSFSVANNLLSGSIPTFVNLTLSADSVTNN 209 (623)
Q Consensus 178 ~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n 209 (623)
+|+.|++++|+++|.+|..+.-.+....+++|
T Consensus 429 ~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N 460 (562)
T 3a79_B 429 SILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460 (562)
T ss_dssp TCCEEECCSSCCCGGGGSSCCTTCSEEECCSS
T ss_pred cCCEEECCCCCCCcchhhhhcCcCCEEECCCC
Confidence 88899999998888887655323444445555
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=7.7e-13 Score=145.07 Aligned_cols=108 Identities=21% Similarity=0.236 Sum_probs=95.1
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..|..++++.+ |++|||++|+++ .||.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE-LEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTT-CCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccC-CCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 57888999999999888888999999999999999999777888888654 999999999999 68877 889999999
Q ss_pred ccCCcCCC-CCCccccccccccccccccccccc
Q 006982 160 LDHNRFSG-QIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 160 l~~N~~~g-~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
|++|++++ .+|..++++++|+.|++++|.+++
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~ 129 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccch
Confidence 99999987 688899999999999999999876
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.6e-12 Score=143.99 Aligned_cols=116 Identities=22% Similarity=0.276 Sum_probs=108.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCC-CCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLY-GPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~-g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.+++.|+|++|.+.+.+|..+.++++|+.|+|++|.+. +.+|..+..+.+ |+.|+|++|++++..|..++++++|++|
T Consensus 421 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN-LTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT-CCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC-CCEEECCCCccccCChhhhhcccCCCEE
Confidence 46889999999999999999999999999999999998 689998988754 9999999999999889999999999999
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCCcc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~ 196 (623)
+|++|++++..|..+.++++|+.|++++|.++|.+|..
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999999988888999999999999999999999863
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.6e-12 Score=132.92 Aligned_cols=111 Identities=20% Similarity=0.255 Sum_probs=100.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCC-CCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~-~~~l~~L~~l 158 (623)
.+++.|+|++|.+++..|..++++++|++|+|++|.+++..|..++.+. +|++|+|++|+++ .+|.. ++++++|++|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP-LLTVLVLERNDLS-SLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCC-CCCEEECCCCccC-cCCHHHhcCCCCCcEE
Confidence 3578999999999998888999999999999999999987777788865 4999999999999 66765 6899999999
Q ss_pred eccCCcCCCCCCcccccccccccccccccccccc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
+|++|++++..|..++.+++|+.|++++|++++.
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 9999999988888899999999999999999875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.5e-12 Score=149.41 Aligned_cols=117 Identities=25% Similarity=0.280 Sum_probs=85.4
Q ss_pred CcEEEEEecCCCceeeC-CccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCC--CCCCCCCc
Q 006982 80 NRVLNLRLTDMGLKGQF-PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN--LANCTYLN 156 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~-p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~--~~~l~~L~ 156 (623)
..++.|+|++|++.+.+ |..|++|++|++|+|++|.+++..|..+.++.+ |++|+|++|++++.+|.. ++++++|+
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFH-LFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSS-CCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcc-cCEeeCcCCCCCcccccCccccccCCCC
Confidence 45677777777666666 556777778888888888777766777777544 778888888777766655 77777788
Q ss_pred eeeccCCcCCCCCC-ccccccccccccccccccccccCCccc
Q 006982 157 SLKLDHNRFSGQIP-PQLGQLGRLKSFSVANNLLSGSIPTFV 197 (623)
Q Consensus 157 ~l~l~~N~~~g~iP-~~l~~l~~L~~l~l~~N~l~g~ip~~~ 197 (623)
+|+|++|++++..| ..++++++|+.|+|++|.+++..|..+
T Consensus 127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l 168 (844)
T 3j0a_A 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL 168 (844)
T ss_dssp EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGG
T ss_pred EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHc
Confidence 88888777776554 467777777777777777777766543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.3e-12 Score=143.23 Aligned_cols=114 Identities=22% Similarity=0.234 Sum_probs=90.1
Q ss_pred CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCC--CCChhHhhhcCCCCEEEccCccCCCCCCCC-CCCCCCC
Q 006982 79 ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYG--PLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYL 155 (623)
Q Consensus 79 ~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g--~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~-~~~l~~L 155 (623)
...++.|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..+..+.+ |++|+|++|++++.+|.. +..+++|
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~-L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS-LQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTT-CCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCC-CCEEECCCCcCCcccccchhccCccC
Confidence 3568899999999999999999999999999999999996 66777888654 999999999999878765 6777777
Q ss_pred ceeeccCCcCCCCCCccccccccccccccccccccccCCcc
Q 006982 156 NSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196 (623)
Q Consensus 156 ~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~ 196 (623)
+.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~ 439 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQ 439 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGG
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchh
Confidence 7777777777776666554 56777777777776 56653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.4e-12 Score=117.23 Aligned_cols=110 Identities=24% Similarity=0.261 Sum_probs=88.8
Q ss_pred CCCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-HhhhcCCCCEE
Q 006982 64 GFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLVGFLTSL 134 (623)
Q Consensus 64 ~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~~L~~L 134 (623)
.|.|...-+.|++.. ...+..|+|++|.+++..|..|+++++|+.|+|++|+|++ +|.. +..+. +|++|
T Consensus 9 ~C~C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~-~L~~L 86 (174)
T 2r9u_A 9 QCSCDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLT-QLTQL 86 (174)
T ss_dssp TSEECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCT-TCCEE
T ss_pred CCEECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcc-hhhEE
Confidence 355666678886532 2467899999999999999999999999999999999995 6665 46654 59999
Q ss_pred EccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccc
Q 006982 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQL 176 (623)
Q Consensus 135 ~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l 176 (623)
+|++|+|++..|..+.++++|++|+|++|.|.. .|..+..+
T Consensus 87 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c-~~~~~~~l 127 (174)
T 2r9u_A 87 DLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC-ECRDIMYL 127 (174)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT-TBGGGHHH
T ss_pred ECCCCccceeCHHHhccccCCCEEEeCCCCccc-ccccHHHH
Confidence 999999996544559999999999999999995 45444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.28 E-value=9.9e-13 Score=142.91 Aligned_cols=31 Identities=10% Similarity=-0.026 Sum_probs=25.7
Q ss_pred cHHHHHHHHHHhCCCCCCCCcceeEEEEeCC
Q 006982 343 SEKEFVAEMATLGSVKNRNLVPLLGFCMAKK 373 (623)
Q Consensus 343 ~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 373 (623)
+.++|..|++.+++++|+|+|+++|||....
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 4678999999999999999999999997653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.3e-12 Score=130.83 Aligned_cols=129 Identities=19% Similarity=0.130 Sum_probs=93.2
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|+|++|.+++..|..++.+++|+.|+|++|.+++..|..+....++|++|+|++|++++ +|. ...+++|++|+|
T Consensus 121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~L 198 (317)
T 3o53_A 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDL 198 (317)
T ss_dssp SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEEC
T ss_pred CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEEC
Confidence 467778888888777777788888888888888888876666665323458888888888884 343 345888888888
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCC
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLC 213 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~ 213 (623)
++|++++ +|+.+..+++|+.|+|++|++++ +|..+. + ++....+.+|+..|
T Consensus 199 s~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 199 SSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBH
T ss_pred CCCcCCc-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccC
Confidence 8888884 66668888888888888888884 555432 1 34455666676554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.8e-12 Score=132.34 Aligned_cols=116 Identities=22% Similarity=0.249 Sum_probs=102.5
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-HhhhcCCCCEEEccCccCCCCCCC--CCCCCCCCc
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLVGFLTSLDLSSNNFSGSIPS--NLANCTYLN 156 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~~L~~L~L~~N~l~g~ip~--~~~~l~~L~ 156 (623)
.+++.|+|++|++++..|..++++++|++|+|++|.++ .+|.. +..+. +|++|+|++|+++ .+|. .+.++++|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~-~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS-SLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCT-TCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCc-cCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 57899999999999999999999999999999999999 56666 66754 5999999999999 5776 789999999
Q ss_pred eeeccCCc-CCCCCCccccccccccccccccccccccCCcccc
Q 006982 157 SLKLDHNR-FSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN 198 (623)
Q Consensus 157 ~l~l~~N~-~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~ 198 (623)
+|+|++|+ +++..|..++++++|+.|++++|.+++.+|..+.
T Consensus 153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~ 195 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLK 195 (353)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTT
T ss_pred EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHh
Confidence 99999995 6655577899999999999999999998887654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.4e-12 Score=138.33 Aligned_cols=114 Identities=21% Similarity=0.223 Sum_probs=102.1
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-HhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.+++.|+|++|.+++..|..|+++++|++|+|++|.++ .+|.. +.++ ++|++|+|++|++++..|..+.++++|++|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGL-SNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTC-TTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCC-CCCCEEECCCCccccCChhHccccccCCEE
Confidence 57899999999999999999999999999999999999 45554 5665 459999999999998888899999999999
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+|++|++++..|..+.++++|+.|+|++|++++..+.
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 9999999988888999999999999999999876554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=4e-12 Score=144.11 Aligned_cols=128 Identities=21% Similarity=0.198 Sum_probs=108.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCCh-hHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPD-DISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~-~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.+++.|+|++|.+++..|..++++++|++|+|++|.++ .+|+ .++++. +|++|+|++|++++..|..++++++|++|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 126 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCT-NLTELHLMSNSIQKIKNNPFVKQKNLITL 126 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCT-TCSEEECCSSCCCCCCSCTTTTCTTCCEE
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCC-CCCEEECCCCccCccChhHccccCCCCEE
Confidence 46889999999999999999999999999999999999 4665 577765 49999999999997667789999999999
Q ss_pred eccCCcCCCCCCccccccccccccccccccccccCCcccc----ccccccccCCC
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN----LTLSADSVTNN 209 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~----~~~~~~~~~~n 209 (623)
+|++|++++..|..++++++|+.|++++|.+++..|..+. ..+....+.+|
T Consensus 127 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n 181 (680)
T 1ziw_A 127 DLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181 (680)
T ss_dssp ECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTC
T ss_pred ECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCC
Confidence 9999999999999999999999999999999988775432 13444455555
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.4e-11 Score=126.80 Aligned_cols=125 Identities=18% Similarity=0.305 Sum_probs=105.4
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|+|++|.+++..|..++++++|++|+|++|.++ .+|..+. ++|++|+|++|++++..+..++++++|++|+
T Consensus 78 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 153 (332)
T 2ft3_A 78 QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIE 153 (332)
T ss_dssp TTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEE
T ss_pred CCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEE
Confidence 56899999999999999999999999999999999999 8998876 4599999999999965555689999999999
Q ss_pred ccCCcCC--CCCCccccccccccccccccccccccCCccccccccccccCCCC
Q 006982 160 LDHNRFS--GQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~--g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 210 (623)
|++|+++ |..|..+..+ +|+.|++++|++++ +|..+.-.+....+++|.
T Consensus 154 l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~ 204 (332)
T 2ft3_A 154 MGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPETLNELHLDHNK 204 (332)
T ss_dssp CCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSCSSCSCCBCCSSC
T ss_pred CCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccccCCCCEEECCCCc
Confidence 9999996 5778888888 99999999999987 665443344455555553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.24 E-value=4.6e-12 Score=117.91 Aligned_cols=103 Identities=21% Similarity=0.275 Sum_probs=60.2
Q ss_pred cEEEEEecCCCceeeCCccccCCC-CCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCC-CCCCCCcee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCS-SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL-ANCTYLNSL 158 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~-~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~-~~l~~L~~l 158 (623)
.++.|+|++|+++. +|. +..+. +|++|+|++|.+++ + ..+..+. +|++|+|++|++++ +|+.+ +.+++|++|
T Consensus 20 ~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~-~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 20 RDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLR-RLKTLLVNNNRICR-IGEGLDQALPDLTEL 93 (176)
T ss_dssp SCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCS-SCCEEECCSSCCCE-ECSCHHHHCTTCCEE
T ss_pred CceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCc-c-cccccCC-CCCEEECCCCcccc-cCcchhhcCCCCCEE
Confidence 45666666666663 333 44433 66666666666664 2 3455543 36666666666663 44333 666666666
Q ss_pred eccCCcCCCCCCc--ccccccccccccccccccc
Q 006982 159 KLDHNRFSGQIPP--QLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 159 ~l~~N~~~g~iP~--~l~~l~~L~~l~l~~N~l~ 190 (623)
+|++|+++ .+|. .+..+++|+.|++++|.++
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 66666664 4555 5666666666666666665
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=127.15 Aligned_cols=126 Identities=20% Similarity=0.269 Sum_probs=94.9
Q ss_pred CcEEEEEecCCCce--eeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCce
Q 006982 80 NRVLNLRLTDMGLK--GQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNS 157 (623)
Q Consensus 80 ~~v~~l~l~~~~l~--g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~ 157 (623)
..+..|+|++|.+. |..+..+.++++|+.|+|++|.++ .+|..+. ++|+.|+|++|++++..|..+.++++|+.
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 220 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAK 220 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 46788899998885 477778888888888888888888 5777654 34888888888888777778888888888
Q ss_pred eeccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCC
Q 006982 158 LKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQ 210 (623)
Q Consensus 158 l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~ 210 (623)
|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+. + .+....+.+|.
T Consensus 221 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~ 274 (330)
T 1xku_A 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 274 (330)
T ss_dssp EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSC
T ss_pred EECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCc
Confidence 888888888776777888888888888888887 6665432 1 23334444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=5e-12 Score=128.97 Aligned_cols=109 Identities=16% Similarity=0.121 Sum_probs=92.6
Q ss_pred cEEEEEecCCCceeeCCccc--cCCCCCCEEEcCCCCCCCCCC----hhHhhhcCCCCEEEccCccCCCCCCCCCCCCCC
Q 006982 81 RVLNLRLTDMGLKGQFPRGI--RNCSSMTGLDLSSNKLYGPLP----DDISKLVGFLTSLDLSSNNFSGSIPSNLANCTY 154 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l--~~l~~L~~L~L~~N~l~g~ip----~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~ 154 (623)
+++.|+|++|.+++.+|..+ +.+++|++|+|++|.+++.+| ..+..+ ++|++|+|++|++++..|..++++++
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~-~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK-PGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC-SCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc-cCCCEEEeeCCCcchhhHHHhccCCC
Confidence 38899999999999999998 999999999999999998777 233444 45999999999999888889999999
Q ss_pred CceeeccCCcCCCC--CC--cccccccccccccccccccc
Q 006982 155 LNSLKLDHNRFSGQ--IP--PQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 155 L~~l~l~~N~~~g~--iP--~~l~~l~~L~~l~l~~N~l~ 190 (623)
|++|+|++|++.|. +| ..++++++|+.|+|++|+++
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 210 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME 210 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC
Confidence 99999999998763 32 23468889999999999986
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.22 E-value=5e-12 Score=117.66 Aligned_cols=104 Identities=15% Similarity=0.202 Sum_probs=78.9
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhH-hhhcCCCCEEEccCccCCCCCCC--CCCCCCCCce
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLDLSSNNFSGSIPS--NLANCTYLNS 157 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~-~~l~~~L~~L~L~~N~l~g~ip~--~~~~l~~L~~ 157 (623)
.+..|+|++|.+++. +.++.+++|++|+|++|.++ .+|+.+ ..+ ++|++|+|++|+++ .+|. .++.+++|+.
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l-~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~ 117 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQAL-PDLTELILTNNSLV-ELGDLDPLASLKSLTY 117 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHC-TTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcC-CCCCEEECCCCcCC-cchhhHhhhcCCCCCE
Confidence 577888888888875 56788888888888888888 455544 554 44888888888885 6776 6778888888
Q ss_pred eeccCCcCCCCCCcc----cccccccccccccccccc
Q 006982 158 LKLDHNRFSGQIPPQ----LGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 158 l~l~~N~~~g~iP~~----l~~l~~L~~l~l~~N~l~ 190 (623)
|+|++|.++ .+|.. +..+++|+.|++++|...
T Consensus 118 L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 118 LCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888887 56764 778888888888887764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3.7e-11 Score=119.28 Aligned_cols=145 Identities=13% Similarity=0.038 Sum_probs=112.5
Q ss_pred HHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc-ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEE
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV 378 (623)
......|.....++.|+.+.||++... +..+++|+..... .....+.+|++++..+. +.++.++++++.+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344456777778888888999999865 6789999986532 22335778888888774 67788899999888889999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN----------------------------------- 423 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------------------------------- 423 (623)
|||++|.+|.+.+.. ......++.+++++++.||+.
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999887421 122347888999999999981
Q ss_pred ---------------------CCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 424 ---------------------CNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 424 ---------------------~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
..+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999887667799998775
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.8e-11 Score=134.60 Aligned_cols=111 Identities=28% Similarity=0.402 Sum_probs=86.4
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|+|+ .+| +.+++|+.|+|++|+|++ ||. +.+ +|++|+|++|+|++ ||. .+++|+.|+
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~---~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 146 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA---SLKHLDVDNNQLTM-LPE---LPALLEYIN 146 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT---TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc---CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence 45888999999988 677 557899999999999986 887 554 48999999999986 777 678888888
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccccccccccCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNN 209 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n 209 (623)
|++|+|++ +|. .+++|+.|+|++|+|++ +|. +..++....+++|
T Consensus 147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~~~L~~L~Ls~N 190 (571)
T 3cvr_A 147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LPESLEALDVSTN 190 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSS
T ss_pred CCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hhCCCCEEECcCC
Confidence 88888886 776 56788888888888887 666 3334444455555
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.1e-13 Score=129.68 Aligned_cols=105 Identities=21% Similarity=0.300 Sum_probs=66.4
Q ss_pred cEEEEEecCCCceeeCCc------cccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCC
Q 006982 81 RVLNLRLTDMGLKGQFPR------GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTY 154 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~------~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~ 154 (623)
+++.++|+++.++|.+|+ .++++++|++|+|++|.+++ +| .+..+.+ |++|+|++|+++ .+|..+..+++
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~-L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMEN-LRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTT-CCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCC-CCEEECCCCCcc-cccchhhcCCc
Confidence 344555555566666555 66666666666666666664 66 5666433 666666666666 56665566666
Q ss_pred CceeeccCCcCCCCCCccccccccccccccccccccc
Q 006982 155 LNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 155 L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
|+.|+|++|++++ +| .++.+++|+.|++++|++++
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 6666666666664 44 46666666666666666664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=2e-11 Score=134.77 Aligned_cols=101 Identities=24% Similarity=0.261 Sum_probs=88.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCC-CCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSI-PSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~i-p~~~~~l~~L~~l 158 (623)
..++.|+|++|.|+ .+|..|++|++|+.|+|++|.|++ +| .++.+.+ |+.|+|++|+|++.+ |..++++++|+.|
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~-L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPR-LQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSS-CCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCC-CcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 46899999999999 899999999999999999999996 88 8888754 999999999999877 9999999999999
Q ss_pred eccCCcCCCCCCcc---cccccccccccc
Q 006982 159 KLDHNRFSGQIPPQ---LGQLGRLKSFSV 184 (623)
Q Consensus 159 ~l~~N~~~g~iP~~---l~~l~~L~~l~l 184 (623)
+|++|+|++..|.. +..+++|+.|++
T Consensus 539 ~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 539 NLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp ECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999999765532 234788888754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.17 E-value=4.6e-11 Score=120.69 Aligned_cols=106 Identities=30% Similarity=0.392 Sum_probs=85.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|+|++|.+++..| ++++++|+.|+|++|.+++ +| .+..+. +|++|+|++|++++ + +.+..+++|+.|+
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~-~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLK-KLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCT-TCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCC-CCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 468889999998887544 8889999999999999885 44 477754 49999999999885 4 4688888999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
|++|++++. +.++.+++|+.|++++|++++..|
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 999998864 578888899999999998887655
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.17 E-value=1.2e-11 Score=121.16 Aligned_cols=127 Identities=17% Similarity=0.205 Sum_probs=101.2
Q ss_pred CcEEEEEecCCC-ceeeCCccccCCCCCCEEEcCC-CCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCc-
Q 006982 80 NRVLNLRLTDMG-LKGQFPRGIRNCSSMTGLDLSS-NKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLN- 156 (623)
Q Consensus 80 ~~v~~l~l~~~~-l~g~~p~~l~~l~~L~~L~L~~-N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~- 156 (623)
.++..|+|++|. +++..+..+.++++|++|+|++ |.+++..|..+..+. +|++|+|++|++++ +|. ++.+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~-~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP-LLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCT-TCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCC-CCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 578999999997 8877777899999999999998 999954445566654 49999999999996 887 88888888
Q ss_pred --eeeccCC-cCCCCCCcccccccccc-ccccccccccccCCcc-cc-ccccccccCCCC
Q 006982 157 --SLKLDHN-RFSGQIPPQLGQLGRLK-SFSVANNLLSGSIPTF-VN-LTLSADSVTNNQ 210 (623)
Q Consensus 157 --~l~l~~N-~~~g~iP~~l~~l~~L~-~l~l~~N~l~g~ip~~-~~-~~~~~~~~~~n~ 210 (623)
+|+|++| ++++..|..+..+++|+ .|++++|+++ .+|.. +. .++....+.+|.
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 89866566789999999 9999999998 66653 22 134444555553
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=2.1e-11 Score=126.36 Aligned_cols=106 Identities=19% Similarity=0.172 Sum_probs=90.2
Q ss_pred CEEEcCCC-CCCCCCChhHhhhcCCCCEEEccC-ccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccccccc
Q 006982 107 TGLDLSSN-KLYGPLPDDISKLVGFLTSLDLSS-NNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSV 184 (623)
Q Consensus 107 ~~L~L~~N-~l~g~ip~~~~~l~~~L~~L~L~~-N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l 184 (623)
..+++++| +|+ .||. +..+. +|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|++|++|+.|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~-~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCS-CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCC-CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 35799998 899 6999 88865 499999996 9999777788999999999999999999988989999999999999
Q ss_pred ccccccccCCcccc-ccccccccCCCCCCCCC
Q 006982 185 ANNLLSGSIPTFVN-LTLSADSVTNNQGLCGE 215 (623)
Q Consensus 185 ~~N~l~g~ip~~~~-~~~~~~~~~~n~~l~~~ 215 (623)
++|+|++..|..+. +.+....+.+|+..|.+
T Consensus 88 ~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCccceeCHHHcccCCceEEEeeCCCccCCC
Confidence 99999987665543 34666677888877754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.16 E-value=3.2e-11 Score=119.96 Aligned_cols=103 Identities=21% Similarity=0.353 Sum_probs=74.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|.+++..| ++++++|+.|+|++|++++ +|.... .+|+.|+|++|++++ +| .++++++|+.|+
T Consensus 63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~---~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS---ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC---SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc---CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 457778888887776444 7778888888888888874 554332 348888888888875 44 577788888888
Q ss_pred ccCCcCCCCCCcccccccccccccccccccccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
|++|++++ +| .++.+++|+.|+|++|++++.
T Consensus 135 Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 135 IRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch
Confidence 88888875 44 577788888888888888766
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.15 E-value=4e-11 Score=121.13 Aligned_cols=121 Identities=22% Similarity=0.367 Sum_probs=97.9
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|.+++ + +.++.+++|+.|+|++|.+++ + +.+..+. +|+.|+|++|++++. ..++.+++|++|+
T Consensus 90 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 162 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLP-QLESLYLGNNKITDI--TVLSRLTKLDTLS 162 (291)
T ss_dssp TTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCC-C-GGGGGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCEEECCCCcCCC-C-hhhccCCCCCEEECCCCcCCC-C-hhhcCCC-CCCEEEccCCcCCcc--hhhccCCCCCEEE
Confidence 568999999999987 3 459999999999999999996 4 4677765 599999999999964 5789999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 210 (623)
|++|++++..| +..+++|+.|+|++|.+++ +|....+ .+....+.+|+
T Consensus 163 L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~ 211 (291)
T 1h6t_A 163 LEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQE 211 (291)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEE
T ss_pred ccCCccccchh--hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCc
Confidence 99999997544 8999999999999999986 4543222 33344445553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.14 E-value=8.8e-11 Score=126.32 Aligned_cols=102 Identities=25% Similarity=0.398 Sum_probs=72.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|.+++ +| +++++++|++|+|++|++++ +|..+ .+|++|+|++|++++ +| .++++++|++|+
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIY 201 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEE
Confidence 356777777777776 66 57888888888888888874 66543 247888888888885 66 577888888888
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+++|++++ +|... ++|+.|++++|.++ .+|.
T Consensus 202 l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~ 232 (454)
T 1jl5_A 202 ADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE 232 (454)
T ss_dssp CCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC
T ss_pred CCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc
Confidence 88888775 55432 46677777777776 5664
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.14 E-value=3.1e-13 Score=128.44 Aligned_cols=109 Identities=17% Similarity=0.222 Sum_probs=97.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|.+++ +| .++++++|++|+|++|.++ .+|..+..+.+ |++|+|++|++++ +| .++.+++|++|+
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~-L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT-LEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH-CSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc-CCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 468899999999998 77 8999999999999999999 79988877654 9999999999996 67 689999999999
Q ss_pred ccCCcCCCCCC--ccccccccccccccccccccccCCc
Q 006982 160 LDHNRFSGQIP--PQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 160 l~~N~~~g~iP--~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
|++|++++ +| ..+..+++|+.|++++|.+++.+|.
T Consensus 122 l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 122 MSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCCcCCc-hhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 99999995 44 4789999999999999999998775
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5.9e-11 Score=131.82 Aligned_cols=106 Identities=30% Similarity=0.396 Sum_probs=65.1
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|.+++..| +..|++|+.|+|++|.|++ +| .+..+. +|+.|+|++|++++ + +.+..+++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~-~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLK-KLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCT-TCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCC-CCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 356667777777665443 6666666666666666663 33 455543 36666666666664 3 2466666666666
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
|++|++++. +.++.+++|+.|+|++|.|++.+|
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 666666643 456666666666666666666555
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-11 Score=126.37 Aligned_cols=114 Identities=21% Similarity=0.306 Sum_probs=99.3
Q ss_pred CcEEEEEecCCCceeeCCccc-cCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCcee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGI-RNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSL 158 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l-~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l 158 (623)
.++..|+|++|.+++..|..+ ..+++|+.|+|++|.+++ +|... .+ ++|++|+|++|+++ .+|..+..+++|+.|
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~-~l-~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L 219 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EECCC-CC-TTCCEEECCSSCCC-EECGGGGGGTTCSEE
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccccc-cc-ccCCEEECCCCcCC-cchhhhcccCcccEE
Confidence 469999999999999888877 489999999999999995 45443 34 45999999999999 467779999999999
Q ss_pred eccCCcCCCCCCcccccccccccccccccccc-ccCCcccc
Q 006982 159 KLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS-GSIPTFVN 198 (623)
Q Consensus 159 ~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~-g~ip~~~~ 198 (623)
+|++|+++ .+|..+..+++|+.|++++|.++ +.+|..+.
T Consensus 220 ~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (317)
T ss_dssp ECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred ECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence 99999999 68999999999999999999999 77776543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.12 E-value=9.9e-11 Score=119.22 Aligned_cols=106 Identities=31% Similarity=0.482 Sum_probs=75.4
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|+|++|.+++..+ +..+++|++|+|++|.+++ +| .+..+. +|++|+|++|++++ +|. +..+++|++|+
T Consensus 63 ~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~-~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQ-SIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCT-TCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCC-CCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 457778888887776443 7778888888888888774 44 566654 48888888888875 443 77778888888
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
|++|++++. |+ ++.+++|+.|++++|.+++..|
T Consensus 136 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~ 168 (308)
T 1h6u_A 136 LDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTP 168 (308)
T ss_dssp CCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG
T ss_pred CCCCccCcC-cc-ccCCCCccEEEccCCcCCCChh
Confidence 888887753 33 7777778888888877776433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.4e-10 Score=115.30 Aligned_cols=120 Identities=23% Similarity=0.311 Sum_probs=95.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|++++|+++. +| .++.+++|+.|+|++|.+++ +|+ +..+. +|++|+|++|++++ +|.... ++|+.|+
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~-~L~~L~L~~N~l~~-l~~~~~--~~L~~L~ 112 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP-LKDLT-KLEELSVNRNRLKN-LNGIPS--ACLSRLF 112 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCS-SCCEEECCSSCCSC-CTTCCC--SSCCEEE
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh-hccCC-CCCEEECCCCccCC-cCcccc--CcccEEE
Confidence 458899999999984 56 79999999999999999995 565 77765 59999999999995 665433 9999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 210 (623)
|++|++++ +| .++.+++|+.|+|++|++++. |....+ .+....+.+|.
T Consensus 113 L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 113 LDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp CCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSC
T ss_pred ccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCc
Confidence 99999996 44 699999999999999999975 432222 33444555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.11 E-value=8.9e-11 Score=130.43 Aligned_cols=121 Identities=22% Similarity=0.348 Sum_probs=94.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|.+++ + +.++.|++|+.|+|++|.+++ +| .+..+. +|+.|+|++|++++. ..++.+++|+.|+
T Consensus 87 ~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~-~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISD-IN-GLVHLP-QLESLYLGNNKITDI--TVLSRLTKLDTLS 159 (605)
T ss_dssp TTCCEEECCSSCCCC-C-TTSTTCTTCCEEECTTSCCCC-CG-GGGGCT-TCSEEECCSSCCCCC--GGGGSCTTCSEEE
T ss_pred CCCCEEECcCCCCCC-C-hhhccCCCCCEEEecCCCCCC-Cc-cccCCC-ccCEEECCCCccCCc--hhhcccCCCCEEE
Confidence 468889999999986 3 378999999999999999995 44 577764 499999999999964 5788999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 210 (623)
|++|+|++..| +..+++|+.|+|++|+|++. |....+ .+....+.+|+
T Consensus 160 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEE
T ss_pred CcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCc
Confidence 99999997666 88999999999999999874 543222 33444455553
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.10 E-value=7.9e-11 Score=119.98 Aligned_cols=121 Identities=27% Similarity=0.398 Sum_probs=92.4
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|.+++. +.++.+++|+.|+|++|.+++ +|. +..+. +|++|+|++|++++. |. ++.+++|++|+
T Consensus 85 ~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~-~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~ 157 (308)
T 1h6u_A 85 TKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLS-NLQVLYLDLNQITNI-SP-LAGLTNLQYLS 157 (308)
T ss_dssp CSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCT-TCCEEECCSSCCCCC-GG-GGGCTTCCEEE
T ss_pred CCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCC-CCCEEECCCCccCcC-cc-ccCCCCccEEE
Confidence 5688999999998863 468899999999999999985 554 77754 499999999999854 43 88899999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 210 (623)
|++|++++ +|. +..+++|+.|++++|++++..| ...+ .+....+++|.
T Consensus 158 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 158 IGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSC
T ss_pred ccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCc
Confidence 99999985 554 8888999999999999887554 2111 33344455553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.5e-11 Score=135.05 Aligned_cols=134 Identities=24% Similarity=0.289 Sum_probs=92.4
Q ss_pred CCCCCCCCCCCCCCcccceeecCC-----CCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhc
Q 006982 54 SSWNFNNDTEGFICKFTGVECWHP-----DENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLV 128 (623)
Q Consensus 54 ~sW~~~~~~~~~~c~w~gv~c~~~-----~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~ 128 (623)
++|.... +||.|+|..|... ....++.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .||. . .
T Consensus 13 ~~W~~~~----~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~-l 80 (622)
T 3g06_A 13 SAWRRAA----PAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---L-P 80 (622)
T ss_dssp HHHHHTC----CGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---C-C
T ss_pred HHHHhcC----CcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---c-C
Confidence 4786433 4889977422100 1134788899999988 7887775 78999999999888 6777 2 3
Q ss_pred CCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCccccccccccccCC
Q 006982 129 GFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTN 208 (623)
Q Consensus 129 ~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~ 208 (623)
++|++|+|++|+|+ .||. .+++|++|+|++|++++ +|. .+++|+.|++++|++++ +|.... ++....+++
T Consensus 81 ~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~l~-~L~~L~Ls~ 150 (622)
T 3g06_A 81 PELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVLPP-GLQELSVSD 150 (622)
T ss_dssp TTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCCCT-TCCEEECCS
T ss_pred CCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCCCC-CCCEEECcC
Confidence 45888999999888 5776 67888888888888884 665 45677777788887775 454332 333444444
Q ss_pred C
Q 006982 209 N 209 (623)
Q Consensus 209 n 209 (623)
|
T Consensus 151 N 151 (622)
T 3g06_A 151 N 151 (622)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=7.9e-11 Score=116.44 Aligned_cols=129 Identities=14% Similarity=0.125 Sum_probs=96.6
Q ss_pred eccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCC--CcceeEEEEeCCeeeEEEecCCCCCHhhhc
Q 006982 314 GSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRN--LVPLLGFCMAKKERLLVYKHMPNGSLYDLL 391 (623)
Q Consensus 314 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 391 (623)
+.|..+.||++...+|..+++|..... ....+..|++++..+.+.+ +.+++++....+..++||||++|.++. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 455669999998877888999987654 2245678888888885544 455888888777889999999998884 2
Q ss_pred cCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 006982 392 HPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC----------------------------------------------- 424 (623)
Q Consensus 392 ~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------------- 424 (623)
.. .+ ...++.++++.++.||+..
T Consensus 105 ~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 105 SH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp SC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred Cc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 10 11 2356777888888888642
Q ss_pred --------CCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 425 --------NPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 425 --------~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998763
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-10 Score=125.32 Aligned_cols=121 Identities=17% Similarity=0.144 Sum_probs=89.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|++++ +| ++.+++|+.|+|++|.+++. + ++.+. +|++|+|++|+++| +| ++.+++|+.|+
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~-~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~ 239 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNI-QLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCT-TCSEEECCSSCCSC-CC--CTTCTTCSEEE
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCC-CCCEEECcCCcccc-cC--ccccCCCCEEE
Confidence 467889999999988 55 88889999999999999864 3 66654 49999999999997 77 78889999999
Q ss_pred ccCCcCCCCCCccccccc-------cccccccccccccccCCccccccccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLG-------RLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~-------~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 210 (623)
|++|+++|..+..+.++. +|+.|++++|.+.|.+|...--.+....+++|.
T Consensus 240 l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~ 297 (457)
T 3bz5_A 240 CSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNT 297 (457)
T ss_dssp CCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCT
T ss_pred eeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCc
Confidence 999999886555555555 566778888887777773211134444455554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.08 E-value=9.2e-11 Score=121.38 Aligned_cols=106 Identities=25% Similarity=0.339 Sum_probs=52.5
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|++++|.+++..+ +..+++|+.|+|++|.+++ +|. +..+. +|+.|+|++|.+++ + +.+..+++|++|+|
T Consensus 200 ~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~-~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLS-QLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCT-TCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred ccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCC-CCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 34555555555554333 4555555555555555552 332 43432 25555555555553 2 23455555555555
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
++|++++ + +.+..+++|+.|++++|.+++..|.
T Consensus 273 ~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 273 GSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp CSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred cCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChh
Confidence 5555553 2 2345555555555555555554443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.08 E-value=8e-11 Score=122.19 Aligned_cols=123 Identities=14% Similarity=0.124 Sum_probs=80.2
Q ss_pred CCCcccceeecCCC--------CCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhH-hhhcCCCCEEE
Q 006982 65 FICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDI-SKLVGFLTSLD 135 (623)
Q Consensus 65 ~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~-~~l~~~L~~L~ 135 (623)
|.|.|..|.|++.. ...++.|+|++|+|+...+..|.+|++|++|+|++|.+.+.+|... .++.+.++.++
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 55889999996532 1346677777777775444567777777777777777766666543 34433233466
Q ss_pred ccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccc
Q 006982 136 LSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANN 187 (623)
Q Consensus 136 L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N 187 (623)
++.|++++..|..|.++++|++|++++|++++..+..+....++..|++.+|
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~ 138 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc
Confidence 6677777555566777777777777777777555555555556666666553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.3e-10 Score=124.96 Aligned_cols=58 Identities=28% Similarity=0.394 Sum_probs=31.2
Q ss_pred CCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccc--cCCcc
Q 006982 131 LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG--SIPTF 196 (623)
Q Consensus 131 L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g--~ip~~ 196 (623)
|+.|+|++|++++ +|.. +++|++|+|++|+++ .+|. .+++|+.|++++|+++| .+|..
T Consensus 319 L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~ 378 (454)
T 1jl5_A 319 LEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPES 378 (454)
T ss_dssp CCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTT
T ss_pred CCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHH
Confidence 5555555555553 4433 355555555555555 3554 24555555555555555 45543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.1e-10 Score=122.08 Aligned_cols=105 Identities=22% Similarity=0.231 Sum_probs=93.0
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|++++|...|.+ .++.+++|+.|+|++|++++ +| ++.+. +|+.|+|++|++++. .++.+++|+.|+
T Consensus 148 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~-~L~~L~l~~N~l~~~---~l~~l~~L~~L~ 218 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNK-LLNRLNCDTNNITKL---DLNQNIQLTFLD 218 (457)
T ss_dssp TTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCT-TCCEEECCSSCCSCC---CCTTCTTCSEEE
T ss_pred CcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCC-CCCEEECcCCcCCee---ccccCCCCCEEE
Confidence 46889999999888888 48999999999999999996 77 66754 599999999999974 489999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~ 196 (623)
|++|++++ +| ++.+++|+.|++++|+++|..+..
T Consensus 219 Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~ 252 (457)
T 3bz5_A 219 CSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVST 252 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTT
T ss_pred CcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHH
Confidence 99999998 77 889999999999999999976543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.04 E-value=2.3e-10 Score=123.62 Aligned_cols=103 Identities=25% Similarity=0.394 Sum_probs=59.7
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
++..|+|++|.+++..| +..+++|+.|+|++|.+++ +|+ +..+. +|+.|+|++|++++..| ++.+++|+.|+|
T Consensus 244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~-~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLT-ALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCT-TCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCC-ccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 46666677666665443 6666666666666666664 333 44433 36666666666664332 555666666666
Q ss_pred cCCcCCCCCCcccccccccccccccccccccc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
++|++++..| +..+++|+.|++++|.+++.
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 6666665443 45555666666666655553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.01 E-value=2.3e-10 Score=118.37 Aligned_cols=124 Identities=23% Similarity=0.352 Sum_probs=102.2
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|.+++..+ +..+++|+.|+|++|.+++ + +.+..+. +|++|+|++|++++ +| .+..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~-~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~ 293 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLT-KLKMLNVGSNQISD-IS-VLNNLSQLNSLF 293 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCT-TCCEEECCSSCCCC-CG-GGGGCTTCSEEE
T ss_pred CcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCC-CcCEEEccCCccCC-Ch-hhcCCCCCCEEE
Confidence 468999999999987544 9999999999999999995 4 4577754 59999999999996 44 689999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccccccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 210 (623)
|++|++++..|..++.+++|+.|++++|.+++..|-..--++....+.+|+
T Consensus 294 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred CcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhc
Confidence 999999998899999999999999999999998772111144455566554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.00 E-value=5e-10 Score=120.90 Aligned_cols=121 Identities=28% Similarity=0.330 Sum_probs=94.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..|+|++|.+++. +.+..+++|+.|+|++|.+++..| +..+. +|+.|+|++|++++. |. +..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~ 293 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT-KLTELKLGANQISNI-SP-LAGLTALTNLE 293 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT-TCSEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCC-CCCEEECCCCccCcc-cc-ccCCCccCeEE
Confidence 4688999999998864 468899999999999999996544 66654 499999999999964 43 88999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccccccccccCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLTLSADSVTNN 209 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n 209 (623)
|++|++++..| ++.+++|+.|++++|++++..|-..--.+....+.+|
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNN 341 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSS
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCC
Confidence 99999997444 8899999999999999998876211113444445555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.6e-10 Score=126.90 Aligned_cols=83 Identities=28% Similarity=0.303 Sum_probs=49.3
Q ss_pred CCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccc
Q 006982 104 SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFS 183 (623)
Q Consensus 104 ~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~ 183 (623)
++|+.|+|++|+|++ +|. . .++|+.|+|++|+|+ .||. .+++|+.|+|++|+|+ .+|..++++++|+.|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp~---~-l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LPV---L-PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC---C-CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCEEEccCCccCc-CCC---C-CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 445555555555553 442 1 123666666666666 4554 4556666666666666 5666666666666666
Q ss_pred cccccccccCCcc
Q 006982 184 VANNLLSGSIPTF 196 (623)
Q Consensus 184 l~~N~l~g~ip~~ 196 (623)
|++|.++|.+|..
T Consensus 291 L~~N~l~~~~~~~ 303 (622)
T 3g06_A 291 LEGNPLSERTLQA 303 (622)
T ss_dssp CCSCCCCHHHHHH
T ss_pred ecCCCCCCcCHHH
Confidence 6666666666653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.98 E-value=2.1e-11 Score=128.29 Aligned_cols=130 Identities=16% Similarity=0.213 Sum_probs=103.6
Q ss_pred CcEEEEEecCCCce-eeCC---ccccCCCCCCEEEcCCCCCC--C---CCChhHhhhcCCCCEEEccCccCC----CCCC
Q 006982 80 NRVLNLRLTDMGLK-GQFP---RGIRNCSSMTGLDLSSNKLY--G---PLPDDISKLVGFLTSLDLSSNNFS----GSIP 146 (623)
Q Consensus 80 ~~v~~l~l~~~~l~-g~~p---~~l~~l~~L~~L~L~~N~l~--g---~ip~~~~~l~~~L~~L~L~~N~l~----g~ip 146 (623)
.++..|+|++|.++ +.+| ..+..+++|+.|+|++|.++ | .+|..+..+. +|+.|+|++|.++ +.+|
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~-~L~~L~Ls~n~l~~~g~~~l~ 237 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ-ELKVLDLQDNTFTHLGSSALA 237 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCT-TCCEEECCSSCCHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCC-CccEEECcCCCCCcHHHHHHH
Confidence 47899999999997 5555 56788999999999999998 3 3444666754 4999999999996 6788
Q ss_pred CCCCCCCCCceeeccCCcCCCC----CCccc--cccccccccccccccccc----cCCccc-c--ccccccccCCCC
Q 006982 147 SNLANCTYLNSLKLDHNRFSGQ----IPPQL--GQLGRLKSFSVANNLLSG----SIPTFV-N--LTLSADSVTNNQ 210 (623)
Q Consensus 147 ~~~~~l~~L~~l~l~~N~~~g~----iP~~l--~~l~~L~~l~l~~N~l~g----~ip~~~-~--~~~~~~~~~~n~ 210 (623)
..+..+++|++|+|++|++++. +|..+ +.+++|+.|+|++|.+++ .+|..+ . -++....+.+|.
T Consensus 238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 8899999999999999999976 67776 448999999999999998 577654 1 134455566664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.6e-09 Score=112.63 Aligned_cols=141 Identities=13% Similarity=0.189 Sum_probs=105.8
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEec--ccc--ccHHHHHHHHHHhCCCC--CCCCcceeEEEEeC---CeeeEEEe
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQ--DSQ--RSEKEFVAEMATLGSVK--NRNLVPLLGFCMAK---KERLLVYK 380 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~e 380 (623)
.+.++.|.++.||+....+ ..+++|+.. ... .....+.+|.+++..+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999998765 577888776 332 22446778998888886 45678888888766 34789999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC------------------------------------ 424 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------ 424 (623)
|++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99998775422 134677888899999999999999731
Q ss_pred -------------------CCCcEecCCCCCceeeCCCCC--eEEeeccccccc
Q 006982 425 -------------------NPRIIHRNISSKCILLDDDFE--PKISDFGLARLM 457 (623)
Q Consensus 425 -------------------~~~i~H~dlk~~NILl~~~~~--~kl~Dfgla~~~ 457 (623)
.+.++|+|+++.||++++++. +.|.||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997753 689999998753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.93 E-value=4.2e-11 Score=123.34 Aligned_cols=114 Identities=20% Similarity=0.394 Sum_probs=80.3
Q ss_pred CcEEEEEecCCCceee-CCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCc-cCCC-CCCCCCCCCCCCc
Q 006982 80 NRVLNLRLTDMGLKGQ-FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSN-NFSG-SIPSNLANCTYLN 156 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~-~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N-~l~g-~ip~~~~~l~~L~ 156 (623)
.+++.|+|++|.+++. +|..+..+++|++|+|++|.+++.+|..++.+ ++|++|+|++| .+++ .+|..+.++++|+
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~-~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN-SNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTC-TTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcC-CCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 4577788888877765 77777777888888888887777777777775 34788888777 5665 2565666777777
Q ss_pred eeeccCC-cCCCC-CCccccccc-cccccccccc--ccc-ccCC
Q 006982 157 SLKLDHN-RFSGQ-IPPQLGQLG-RLKSFSVANN--LLS-GSIP 194 (623)
Q Consensus 157 ~l~l~~N-~~~g~-iP~~l~~l~-~L~~l~l~~N--~l~-g~ip 194 (623)
+|+|++| ++++. +|..+..++ +|+.|++++| .++ +.+|
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~ 215 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 215 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHH
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHH
Confidence 7777777 77654 566667777 7777777777 444 3444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.92 E-value=6.7e-11 Score=121.76 Aligned_cols=109 Identities=20% Similarity=0.191 Sum_probs=71.1
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCC-CChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGP-LPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~-ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
++..|++++|.+.+.++. +.++++|+.|+|++|.+++. +|..+..+. +|++|+|++|++++.+|..++++++|++|+
T Consensus 71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~-~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCS-KLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBC-CCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCC-CCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 456666666666665544 45667777777777776654 665555543 477777777777666666666677777777
Q ss_pred ccCC-cCCC-CCCccccccccccccccccc-cccc
Q 006982 160 LDHN-RFSG-QIPPQLGQLGRLKSFSVANN-LLSG 191 (623)
Q Consensus 160 l~~N-~~~g-~iP~~l~~l~~L~~l~l~~N-~l~g 191 (623)
|++| .+++ .+|..+.++++|+.|++++| .+++
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence 7777 5664 25656666777777777777 6665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.92 E-value=2.7e-11 Score=127.47 Aligned_cols=110 Identities=19% Similarity=0.261 Sum_probs=55.8
Q ss_pred cEEEEEecCCCcee----eCCccccCCCCCCEEEcCCCCCCCCCChhHhhhc------------CCCCEEEccCccCC-C
Q 006982 81 RVLNLRLTDMGLKG----QFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLV------------GFLTSLDLSSNNFS-G 143 (623)
Q Consensus 81 ~v~~l~l~~~~l~g----~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~------------~~L~~L~L~~N~l~-g 143 (623)
+++.|+|++|.+++ .+|..+.++++|++|+|++|.+++..+..+.... ++|++|+|++|+++ +
T Consensus 95 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~ 174 (386)
T 2ca6_A 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 174 (386)
T ss_dssp TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred cccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcH
Confidence 45555555555555 3555555555555555555555433222222211 23555555555555 3
Q ss_pred CCC---CCCCCCCCCceeeccCCcCC--C---CCCcccccccccccccccccccc
Q 006982 144 SIP---SNLANCTYLNSLKLDHNRFS--G---QIPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 144 ~ip---~~~~~l~~L~~l~l~~N~~~--g---~iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
.+| ..+..+++|++|+|++|+++ | .+|..+..+++|+.|+|++|.++
T Consensus 175 ~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~ 229 (386)
T 2ca6_A 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229 (386)
T ss_dssp GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred HHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCC
Confidence 334 23445555555555555555 2 23334555555555666555554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.2e-10 Score=121.51 Aligned_cols=113 Identities=27% Similarity=0.261 Sum_probs=77.8
Q ss_pred cEEEEEecCCCceeeCC----ccccCCC-CCCEEEcCCCCCCCCCChhHhhh----cCCCCEEEccCccCCCCCCCCCCC
Q 006982 81 RVLNLRLTDMGLKGQFP----RGIRNCS-SMTGLDLSSNKLYGPLPDDISKL----VGFLTSLDLSSNNFSGSIPSNLAN 151 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p----~~l~~l~-~L~~L~L~~N~l~g~ip~~~~~l----~~~L~~L~L~~N~l~g~ip~~~~~ 151 (623)
.++.|+|++|.+++..+ ..+.+++ +|+.|+|++|.+++..+..+..+ .++|++|+|++|++++..+..++.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 47778888887776655 5666777 78888888888777667666664 134788888888877665554333
Q ss_pred ----C-CCCceeeccCCcCCCCCCccccc-----cccccccccccccccccC
Q 006982 152 ----C-TYLNSLKLDHNRFSGQIPPQLGQ-----LGRLKSFSVANNLLSGSI 193 (623)
Q Consensus 152 ----l-~~L~~l~l~~N~~~g~iP~~l~~-----l~~L~~l~l~~N~l~g~i 193 (623)
+ ++|++|+|++|++++..+..++. .++|+.|+|++|.+++.-
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 154 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKS 154 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSC
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHH
Confidence 3 67888888888877655555443 257778888888777543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.8e-10 Score=118.62 Aligned_cols=114 Identities=25% Similarity=0.257 Sum_probs=60.2
Q ss_pred cEEEEEecCCCceeeCCccccCC-----CCCCEEEcCCCCCCCCCChhHhhhc----CCCCEEEccCccCCCCCCCCCC-
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNC-----SSMTGLDLSSNKLYGPLPDDISKLV----GFLTSLDLSSNNFSGSIPSNLA- 150 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l-----~~L~~L~L~~N~l~g~ip~~~~~l~----~~L~~L~L~~N~l~g~ip~~~~- 150 (623)
+++.|+|++|.+++..+..+..+ ++|+.|+|++|.+++..+..++... ++|+.|+|++|++++..+..++
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 45666666666665555544443 5666666666666655555444421 2366666666666544333322
Q ss_pred ---C-CCCCceeeccCCcCCCCCCc----cccccc-cccccccccccccccCC
Q 006982 151 ---N-CTYLNSLKLDHNRFSGQIPP----QLGQLG-RLKSFSVANNLLSGSIP 194 (623)
Q Consensus 151 ---~-l~~L~~l~l~~N~~~g~iP~----~l~~l~-~L~~l~l~~N~l~g~ip 194 (623)
. .++|++|+|++|++++.-+. .+..++ +|+.|+|++|++++..+
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~ 184 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC 184 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence 2 24666666666666643222 223333 56666666666655444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.83 E-value=1.3e-10 Score=114.75 Aligned_cols=125 Identities=15% Similarity=0.216 Sum_probs=84.6
Q ss_pred CCcccceeecCCCCCcEEEEEecC---CCceeeCCcc------------------------ccCCCCCCE--EEcCCCCC
Q 006982 66 ICKFTGVECWHPDENRVLNLRLTD---MGLKGQFPRG------------------------IRNCSSMTG--LDLSSNKL 116 (623)
Q Consensus 66 ~c~w~gv~c~~~~~~~v~~l~l~~---~~l~g~~p~~------------------------l~~l~~L~~--L~L~~N~l 116 (623)
.|+|.|+.|+. ...+|+.+...+ ..+.|.++++ +...+.|.. ++++.|..
T Consensus 77 l~~~~g~i~~~-~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~ 155 (267)
T 3rw6_A 77 LKAVNYKILDR-ENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR 155 (267)
T ss_dssp HHHTTSSCBCT-TSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred HHhcCcEEECC-CCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHH
Confidence 68899999964 334666555544 3344444421 222223333 45566643
Q ss_pred CCCCChhH----hhhcCCCCEEEccCccCCC--CCCCCCCCCCCCceeeccCCcCCCCCCccccccc--ccccccccccc
Q 006982 117 YGPLPDDI----SKLVGFLTSLDLSSNNFSG--SIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLG--RLKSFSVANNL 188 (623)
Q Consensus 117 ~g~ip~~~----~~l~~~L~~L~L~~N~l~g--~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~--~L~~l~l~~N~ 188 (623)
. .++..+ .+ .++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.
T Consensus 156 ~-~~~~~l~i~~~~-l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Np 231 (267)
T 3rw6_A 156 S-CMAATLRIIEEN-IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNS 231 (267)
T ss_dssp H-HHHHHHHHHHHH-CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTST
T ss_pred H-HHHHHHHHHHhh-CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCc
Confidence 2 333222 23 3459999999999998 6677778899999999999999964 4566666 89999999999
Q ss_pred ccccCCc
Q 006982 189 LSGSIPT 195 (623)
Q Consensus 189 l~g~ip~ 195 (623)
+++.+|.
T Consensus 232 l~~~~~~ 238 (267)
T 3rw6_A 232 LCDTFRD 238 (267)
T ss_dssp TGGGCSS
T ss_pred CccccCc
Confidence 9998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=2.1e-09 Score=109.07 Aligned_cols=188 Identities=21% Similarity=0.252 Sum_probs=119.6
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCC-CCC--CcceeEEEEeCC---eeeEEEecCC
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NRN--LVPLLGFCMAKK---ERLLVYKHMP 383 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~~ 383 (623)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++.+....+ ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568999999999863 45788876433 33467888999987773 332 334444433332 3478999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN---------------------------------------- 423 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------------------------------------- 423 (623)
|.++.+... ..++..++..++.++++.++.||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988865331 2356667778888888888888861
Q ss_pred ---------------CCCCcEecCCCCCceeeCC--CCCeEEeecccccccCCCCCcccccccC--CCC---------cc
Q 006982 424 ---------------CNPRIIHRNISSKCILLDD--DFEPKISDFGLARLMNPIDTHLSTFVNG--EFG---------DL 475 (623)
Q Consensus 424 ---------------~~~~i~H~dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~--~~g---------t~ 475 (623)
..+.++|+|++|.||++++ +..+.|+||+.+..-.+.. ........ ..+ .+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHc
Confidence 1245899999999999998 5668899999987643311 00000000 000 01
Q ss_pred cccC-cccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 006982 476 GYVA-PEYARTLVATPKGDVYSFGTVLLELVTGERPT 511 (623)
Q Consensus 476 ~y~a-PE~~~~~~~s~k~DV~sfGvil~elltg~~P~ 511 (623)
+... |+.... .....+.|++|.++|++.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 222111 112368999999999999998765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.2e-08 Score=103.66 Aligned_cols=108 Identities=16% Similarity=0.037 Sum_probs=67.1
Q ss_pred EEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHh-------------------------hhcCCCCEEEccC
Q 006982 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDIS-------------------------KLVGFLTSLDLSS 138 (623)
Q Consensus 84 ~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~-------------------------~l~~~L~~L~L~~ 138 (623)
.+.+.+|+++...|..+..+++|++|++++|++.+..+..+. .+...|+.|+|++
T Consensus 84 ~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~ 163 (350)
T 4ay9_X 84 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163 (350)
T ss_dssp EEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred hhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccc
Confidence 344555666655566677777777777777777643222111 1122366677777
Q ss_pred ccCCCCCCCCCCCCCCCceeeccCCcCCCCCCc-ccccccccccccccccccccc
Q 006982 139 NNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPP-QLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 139 N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~-~l~~l~~L~~l~l~~N~l~g~ 192 (623)
|+|+ .||......++|+.|++++|+..+.||. .+..+++|+.|+|++|+|+.-
T Consensus 164 N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 164 NGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp SCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred cccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 7777 5666666666777777765444446664 457777777777777777743
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.63 E-value=4.5e-10 Score=120.88 Aligned_cols=113 Identities=19% Similarity=0.134 Sum_probs=68.7
Q ss_pred CcEEEEEecCCCceeeC-----CccccCCCCCCEEEcCCCCCCCC----CChhHhhhcCCCCEEEccCccCCCCCCCCCC
Q 006982 80 NRVLNLRLTDMGLKGQF-----PRGIRNCSSMTGLDLSSNKLYGP----LPDDISKLVGFLTSLDLSSNNFSGSIPSNLA 150 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~-----p~~l~~l~~L~~L~L~~N~l~g~----ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~ 150 (623)
..++.|+|++|.+++.- +..+..+++|+.|+|++|.+++. +|..+..+. +|++|+|++|.+++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~-~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE-SLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCT-TCCEEECTTCCCHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCC-CcceEECCCCCCchHHHHHHH
Confidence 35667777777766532 12223567777777777777643 555555543 377777777776643333332
Q ss_pred C-----CCCCceeeccCCcCCCC----CCccccccccccccccccccccccC
Q 006982 151 N-----CTYLNSLKLDHNRFSGQ----IPPQLGQLGRLKSFSVANNLLSGSI 193 (623)
Q Consensus 151 ~-----l~~L~~l~l~~N~~~g~----iP~~l~~l~~L~~l~l~~N~l~g~i 193 (623)
. .++|++|+|++|++++. +|..+..+++|+.|++++|.+++..
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 2 25677777777777654 4555666677777777777766543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.57 E-value=3.6e-08 Score=97.18 Aligned_cols=80 Identities=25% Similarity=0.345 Sum_probs=66.4
Q ss_pred cCCCCCCEEEcCCCCCCC--CCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCC--CCceeeccCCcCCCCCCc-----
Q 006982 101 RNCSSMTGLDLSSNKLYG--PLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCT--YLNSLKLDHNRFSGQIPP----- 171 (623)
Q Consensus 101 ~~l~~L~~L~L~~N~l~g--~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~--~L~~l~l~~N~~~g~iP~----- 171 (623)
.++++|+.|+|++|+|++ .+|..+..+. +|+.|+|++|+|++. .++..++ +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~-~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~ 243 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAP-NLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYI 243 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHST-TCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCC-CCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHH
Confidence 568999999999999998 6677777764 599999999999964 4455555 999999999999998884
Q ss_pred --cccccccccccc
Q 006982 172 --QLGQLGRLKSFS 183 (623)
Q Consensus 172 --~l~~l~~L~~l~ 183 (623)
.+..+++|+.||
T Consensus 244 ~~il~~~P~L~~LD 257 (267)
T 3rw6_A 244 SAIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHHCTTCCEES
T ss_pred HHHHHHCcccCeEC
Confidence 366788888765
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.55 E-value=1.5e-09 Score=116.73 Aligned_cols=131 Identities=24% Similarity=0.258 Sum_probs=102.3
Q ss_pred CcEEEEEecCCCceee----CCccccCCCCCCEEEcCCCCCCCCCChhHhhhc----CCCCEEEccCccCCCC----CCC
Q 006982 80 NRVLNLRLTDMGLKGQ----FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLV----GFLTSLDLSSNNFSGS----IPS 147 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~----~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~----~~L~~L~L~~N~l~g~----ip~ 147 (623)
.++..|+|++|++++. ++..+.++++|+.|+|++|.+++..+..+.... ++|+.|+|++|.+++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 5789999999999875 788888899999999999999865555555432 3599999999999976 566
Q ss_pred CCCCCCCCceeeccCCcCCCCCCccccc-----cccccccccccccccc----cCCcccc--ccccccccCCCC
Q 006982 148 NLANCTYLNSLKLDHNRFSGQIPPQLGQ-----LGRLKSFSVANNLLSG----SIPTFVN--LTLSADSVTNNQ 210 (623)
Q Consensus 148 ~~~~l~~L~~l~l~~N~~~g~iP~~l~~-----l~~L~~l~l~~N~l~g----~ip~~~~--~~~~~~~~~~n~ 210 (623)
.+..+++|++|+|++|++++..+..+.. .++|+.|++++|.+++ .+|..+. -++....+.+|.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 7778899999999999998766666654 6799999999999986 6665432 134445555553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.45 E-value=8.7e-09 Score=107.55 Aligned_cols=112 Identities=23% Similarity=0.215 Sum_probs=78.0
Q ss_pred CcEEEEEecCCCceeeCCccc-cCCCCCCEEEcCCCCCCCCCChhHhhh----cCCCCEEEccCccCCC----CCCCCCC
Q 006982 80 NRVLNLRLTDMGLKGQFPRGI-RNCSSMTGLDLSSNKLYGPLPDDISKL----VGFLTSLDLSSNNFSG----SIPSNLA 150 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l-~~l~~L~~L~L~~N~l~g~ip~~~~~l----~~~L~~L~L~~N~l~g----~ip~~~~ 150 (623)
..+..|+|++|.++..-...+ ..+++|+.|+|++|.|+..-...+... ...|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 468899999998865433333 235678888999888875433344322 2348888888888864 2344456
Q ss_pred CCCCCceeeccCCcCCC----CCCccccccccccccccccccccc
Q 006982 151 NCTYLNSLKLDHNRFSG----QIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 151 ~l~~L~~l~l~~N~~~g----~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
.+++|++|+|++|+++. .++..+...++|+.|+|++|.++.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 77888888888888874 235556677788888888888865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=3.4e-06 Score=83.51 Aligned_cols=135 Identities=18% Similarity=0.210 Sum_probs=96.2
Q ss_pred eeeccCcc-EEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCeeeEEEecCCCCCHh
Q 006982 312 IIGSGRTG-TMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKERLLVYKHMPNGSLY 388 (623)
Q Consensus 312 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 388 (623)
.+..|..| .||+.... ++..+++|+-... ....+.+|.+.|+.+. +-.+.++++++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 45556655 68988754 5667888886433 3446778888877663 334677889999989999999999998887
Q ss_pred hhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 006982 389 DLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC-------------------------------------------- 424 (623)
Q Consensus 389 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------------------------------------------- 424 (623)
+.... .......+..+++..|+-||...
T Consensus 109 ~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 75421 11233456666777777777431
Q ss_pred -----------CCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 425 -----------NPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 425 -----------~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999887778999988764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=3.7e-06 Score=85.09 Aligned_cols=136 Identities=17% Similarity=0.164 Sum_probs=92.1
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCC---CCcceeEEEE-eCCeeeEEEecCCCC
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNR---NLVPLLGFCM-AKKERLLVYKHMPNG 385 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~g 385 (623)
.+.++.|....||+. +..+++|+-.. ......+..|.+++..+.+. .+.+.+.+.. ..+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 356788888899988 56678887432 23346788999999888653 3556666664 345578999999998
Q ss_pred CHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 006982 386 SLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN------------------------------------------ 423 (623)
Q Consensus 386 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------ 423 (623)
++.+... ..++...+..++.++++.|+.||+.
T Consensus 99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8876321 1123344444555555555555532
Q ss_pred ---------------CCCCcEecCCCCCceeeCC---CCC-eEEeecccccc
Q 006982 424 ---------------CNPRIIHRNISSKCILLDD---DFE-PKISDFGLARL 456 (623)
Q Consensus 424 ---------------~~~~i~H~dlk~~NILl~~---~~~-~kl~Dfgla~~ 456 (623)
..+.++|+|+++.||++++ ++. ..|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999997 455 48999998864
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.22 E-value=1.8e-08 Score=105.06 Aligned_cols=112 Identities=13% Similarity=0.125 Sum_probs=84.5
Q ss_pred CcEEEEEecCCCceeeCCcccc-----CCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCC-----
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIR-----NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNL----- 149 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~-----~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~----- 149 (623)
..+..|+|++|.++..-...|. +.++|+.|+|++|.++..-...+....++|+.|+|++|+++..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 4588999999998864333332 237999999999999754444444434459999999999985433333
Q ss_pred CCCCCCceeeccCCcCCC----CCCccccccccccccccccccccc
Q 006982 150 ANCTYLNSLKLDHNRFSG----QIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 150 ~~l~~L~~l~l~~N~~~g----~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
...++|++|+|++|+|+. .++..+..+++|+.|+|++|.++.
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence 346889999999999974 355566778999999999999875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.8e-08 Score=108.46 Aligned_cols=112 Identities=7% Similarity=-0.001 Sum_probs=75.9
Q ss_pred CcEEEEEecCCCceeeCCccccC-CCCCCEEEcC----CCCCCCC-----CChhHhhhcCCCCEEEccCc--cCCCCCCC
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRN-CSSMTGLDLS----SNKLYGP-----LPDDISKLVGFLTSLDLSSN--NFSGSIPS 147 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~-l~~L~~L~L~----~N~l~g~-----ip~~~~~l~~~L~~L~L~~N--~l~g~ip~ 147 (623)
.++..|+|..+++++..+..++. +++|+.|+|+ .|.+++. ++..+..+ ++|+.|+|+++ .+++..+.
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~-~~L~~L~L~~~~~~l~~~~~~ 456 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGC-KKLRRFAFYLRQGGLTDLGLS 456 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHC-TTCCEEEEECCGGGCCHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhC-CCCCEEEEecCCCCccHHHHH
Confidence 35777888888888777777765 8888888885 6777753 33334454 34888888643 36655554
Q ss_pred CCCC-CCCCceeeccCCcCCC-CCCcccccccccccccccccccccc
Q 006982 148 NLAN-CTYLNSLKLDHNRFSG-QIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 148 ~~~~-l~~L~~l~l~~N~~~g-~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
.++. +++|+.|+|++|++++ .+|..+..+++|+.|++++|.+++.
T Consensus 457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence 4443 6778888888888775 3455556777788888888877654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.18 E-value=9.5e-08 Score=89.28 Aligned_cols=110 Identities=17% Similarity=0.244 Sum_probs=83.6
Q ss_pred CcEEEEEecCC-Ccee----eCCccccCCCCCCEEEcCCCCCCCC----CChhHhhhcCCCCEEEccCccCCCC----CC
Q 006982 80 NRVLNLRLTDM-GLKG----QFPRGIRNCSSMTGLDLSSNKLYGP----LPDDISKLVGFLTSLDLSSNNFSGS----IP 146 (623)
Q Consensus 80 ~~v~~l~l~~~-~l~g----~~p~~l~~l~~L~~L~L~~N~l~g~----ip~~~~~l~~~L~~L~L~~N~l~g~----ip 146 (623)
..++.|+|++| .+.. .+...+...++|++|+|++|.+... +...+... +.|++|+|++|.++.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n-~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVN-NTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHC-SSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhC-CCcCEEECcCCcCCHHHHHHHH
Confidence 46889999999 8764 2555677889999999999998743 23333333 3499999999999853 45
Q ss_pred CCCCCCCCCceeec--cCCcCCCC----CCcccccccccccccccccccc
Q 006982 147 SNLANCTYLNSLKL--DHNRFSGQ----IPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 147 ~~~~~l~~L~~l~l--~~N~~~g~----iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
..+...++|++|+| ++|.++.. +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 56777889999999 88999853 3344556689999999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=6.8e-06 Score=84.94 Aligned_cols=79 Identities=5% Similarity=-0.030 Sum_probs=54.2
Q ss_pred cee-eccCccEEEEEEeC-------CCcEEEEEEecccc---c-cHHHHHHHHHHhCCCCC---CCCcceeEEEEeC---
Q 006982 311 NII-GSGRTGTMYKALLE-------DGTSLMVKRLQDSQ---R-SEKEFVAEMATLGSVKN---RNLVPLLGFCMAK--- 372 (623)
Q Consensus 311 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~--- 372 (623)
+.| +.|....+|+.... ++..+++|+..... . ....+..|++++..+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999998764 26678888765432 1 12456778888777742 3566778777654
Q ss_pred CeeeEEEecCCCCCHhh
Q 006982 373 KERLLVYKHMPNGSLYD 389 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~ 389 (623)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.89 E-value=4.4e-06 Score=92.53 Aligned_cols=105 Identities=9% Similarity=0.028 Sum_probs=69.2
Q ss_pred CcEEEEEecCCCceee----CCccccCCCCCCEEEcCCCCCCC----CCChhHhhhcCCCCEEEccCccCCCCCCCCCCC
Q 006982 80 NRVLNLRLTDMGLKGQ----FPRGIRNCSSMTGLDLSSNKLYG----PLPDDISKLVGFLTSLDLSSNNFSGSIPSNLAN 151 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~----~p~~l~~l~~L~~L~L~~N~l~g----~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~ 151 (623)
..++.|+|++|.+++. ++..+.++++|+.|+|++|.+++ .++..+.++ ++|+.|+|++|.+.+ +|..+.+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~-~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC-RSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC-TTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC-CCCcEEeccCccHHH-HHHHHhh
Confidence 3578888988888766 44456678888888888888873 334444454 458888888888875 6666667
Q ss_pred CCCCceeeccCCcCC---CCCCcccccccccccccccc
Q 006982 152 CTYLNSLKLDHNRFS---GQIPPQLGQLGRLKSFSVAN 186 (623)
Q Consensus 152 l~~L~~l~l~~N~~~---g~iP~~l~~l~~L~~l~l~~ 186 (623)
+++|+.|+++++... +..+..+..+++|+.|++++
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~ 279 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETT
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccc
Confidence 777777777643222 23334455555555555554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.85 E-value=1.3e-05 Score=81.80 Aligned_cols=84 Identities=18% Similarity=0.262 Sum_probs=42.8
Q ss_pred CCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC-CCCCCCCCCc-eeeccCCcCCCCCCcccccccccc
Q 006982 103 CSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP-SNLANCTYLN-SLKLDHNRFSGQIPPQLGQLGRLK 180 (623)
Q Consensus 103 l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip-~~~~~l~~L~-~l~l~~N~~~g~iP~~l~~l~~L~ 180 (623)
+++|+.|+|++|+++ .||...+.-..+|+.|+|++| ++ .|+ ..|.+|++|+ .++|.+ +++..-+.+|.++++|+
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLR 300 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCC
Confidence 555555555555555 455443322333555555555 44 333 2355555555 555555 44422234555555555
Q ss_pred cccccccccc
Q 006982 181 SFSVANNLLS 190 (623)
Q Consensus 181 ~l~l~~N~l~ 190 (623)
.+++++|+++
T Consensus 301 ~l~l~~n~i~ 310 (329)
T 3sb4_A 301 YVLATGDKIT 310 (329)
T ss_dssp EEEECSSCCC
T ss_pred EEEeCCCccC
Confidence 5555555554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=4.9e-05 Score=77.68 Aligned_cols=141 Identities=16% Similarity=0.281 Sum_probs=78.7
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCC-----CCCCCccee-E--EEEeCCeeeEEEecC
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSV-----KNRNLVPLL-G--FCMAKKERLLVYKHM 382 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lV~e~~ 382 (623)
+.|+.|..+.||+....+| .+++|+..... .....|.+++..+ ..|.++... + +....+..++|++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3466677889999988655 48889887532 2333344444333 224433311 1 123456778999999
Q ss_pred CCCCHh--------------hhccCC---C--CCC-----CccChHHHH-------------------------------
Q 006982 383 PNGSLY--------------DLLHPA---D--DTG-----KSVDWPRRL------------------------------- 407 (623)
Q Consensus 383 ~~gsL~--------------~~l~~~---~--~~~-----~~l~~~~~~------------------------------- 407 (623)
+|.++. ..+|.. . ... ..-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 111210 0 000 112342211
Q ss_pred HHHHHHHHHHHHHHh----------cCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 408 KIAIGAARGFAWLHH----------NCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 408 ~i~~~ia~~l~yLH~----------~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
.+...+..++.+|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666763 124589999999999999888899999998775
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.77 E-value=7.5e-07 Score=98.77 Aligned_cols=111 Identities=13% Similarity=0.060 Sum_probs=76.7
Q ss_pred cEEEEEecCCCceeeCCcccc-CCCCCCEEEcC--C----CCCCCCCCh------hHhhhcCCCCEEEccCccCCCCCCC
Q 006982 81 RVLNLRLTDMGLKGQFPRGIR-NCSSMTGLDLS--S----NKLYGPLPD------DISKLVGFLTSLDLSSNNFSGSIPS 147 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~L~--~----N~l~g~ip~------~~~~l~~~L~~L~L~~N~l~g~ip~ 147 (623)
++..|.+..+++++..+..+. .+++|+.|+|+ + |.+++ .|. -+..+ ++|+.|+|++ ++++..+.
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~-~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHC-KDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHC-TTCCEEECCS-SCCHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhC-CCccEEeecC-cccHHHHH
Confidence 566777888888876666665 58888888888 4 55652 222 13343 4588888876 66655555
Q ss_pred CCCC-CCCCceeeccCCcCCCCCCccc-cccccccccccccccccccCC
Q 006982 148 NLAN-CTYLNSLKLDHNRFSGQIPPQL-GQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 148 ~~~~-l~~L~~l~l~~N~~~g~iP~~l-~~l~~L~~l~l~~N~l~g~ip 194 (623)
.++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~ 498 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKAL 498 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHH
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHH
Confidence 5555 7888888888888876555555 567888888888888855433
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=8.9e-05 Score=77.74 Aligned_cols=74 Identities=14% Similarity=0.147 Sum_probs=47.7
Q ss_pred cceeeccCccEEEEEEeC-CCcEEEEEEeccccc--------cHHHHHHHHHHhCCCCC--CCCc-ceeEEEEeCCeeeE
Q 006982 310 NNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQR--------SEKEFVAEMATLGSVKN--RNLV-PLLGFCMAKKERLL 377 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~l 377 (623)
.+.||.|..+.||++... ++..+++|....... ....+..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 467899997643211 22345678887776632 3333 44443 4455789
Q ss_pred EEecCCCC
Q 006982 378 VYKHMPNG 385 (623)
Q Consensus 378 V~e~~~~g 385 (623)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00023 Score=71.88 Aligned_cols=139 Identities=17% Similarity=0.198 Sum_probs=91.5
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCC---CCCCcceeEEEEeCCeeeEEEecCCCCC
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK---NRNLVPLLGFCMAKKERLLVYKHMPNGS 386 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~gs 386 (623)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+.+++++....+..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45789999999999986 4678888887543 3556888888887773 3567888888888888999999999886
Q ss_pred Hhh-----------hccCCCC-C-----------------CCccChHHHH---HHHH--H--------------HHHHH-
Q 006982 387 LYD-----------LLHPADD-T-----------------GKSVDWPRRL---KIAI--G--------------AARGF- 417 (623)
Q Consensus 387 L~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~--~--------------ia~~l- 417 (623)
+.. .||.... . ...-+|.... ++.. + +...+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 521 1232211 0 0012454321 1111 1 11111
Q ss_pred HHHHh-cCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 418 AWLHH-NCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 418 ~yLH~-~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
..|.. ...|.++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 2356899999999999999887 8888873
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.64 E-value=4.5e-06 Score=77.77 Aligned_cols=97 Identities=14% Similarity=0.220 Sum_probs=72.8
Q ss_pred eCCccccCCCCCCEEEcCCC-CCCCC----CChhHhhhcCCCCEEEccCccCCCC----CCCCCCCCCCCceeeccCCcC
Q 006982 95 QFPRGIRNCSSMTGLDLSSN-KLYGP----LPDDISKLVGFLTSLDLSSNNFSGS----IPSNLANCTYLNSLKLDHNRF 165 (623)
Q Consensus 95 ~~p~~l~~l~~L~~L~L~~N-~l~g~----ip~~~~~l~~~L~~L~L~~N~l~g~----ip~~~~~l~~L~~l~l~~N~~ 165 (623)
.+...+...++|+.|+|++| .+... +...+... +.|++|+|++|++... +...+...++|++|+|++|++
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~-~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTN-TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTC-CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhC-CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 44556778999999999999 88743 22333332 4599999999998742 233455668999999999999
Q ss_pred CCC----CCcccccccccccccc--cccccccc
Q 006982 166 SGQ----IPPQLGQLGRLKSFSV--ANNLLSGS 192 (623)
Q Consensus 166 ~g~----iP~~l~~l~~L~~l~l--~~N~l~g~ 192 (623)
+.. +...+...++|+.|+| ++|.++..
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 853 4566777889999999 88988643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00015 Score=72.43 Aligned_cols=77 Identities=23% Similarity=0.307 Sum_probs=54.7
Q ss_pred CcccceeeccCccEEEEEEeCCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCC---CCCcceeEEEEeCCeeeEEEecC
Q 006982 307 FSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKN---RNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 307 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
....+.+|.|..+.||+....||+.+++|+-.... .....|..|.+.|+.+.. -.+.+++++ +..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 34456789999999999999999999999875433 233457788888776632 234444443 2347899999
Q ss_pred CCCCH
Q 006982 383 PNGSL 387 (623)
Q Consensus 383 ~~gsL 387 (623)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.57 E-value=7.1e-05 Score=76.30 Aligned_cols=98 Identities=12% Similarity=0.122 Sum_probs=45.2
Q ss_pred EEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCC-EEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLT-SLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~-~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
++.|+|++|+++..-+..|.+|++|+.|+|++| +. .|+...+.-..+|+ .|+|++ +++-.-+..|.+|++|+.|+|
T Consensus 228 L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l 304 (329)
T 3sb4_A 228 LVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLA 304 (329)
T ss_dssp CCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEE
T ss_pred CeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEe
Confidence 445555555554333344555555555555554 33 34433222223355 555554 444111234555555555555
Q ss_pred cCCcCCCCCCcccccccccccc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSF 182 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l 182 (623)
++|+++..-+..|.++++|+.+
T Consensus 305 ~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 305 TGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCccCccchhhhcCCcchhhh
Confidence 5555553223344455555444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.54 E-value=8.5e-06 Score=90.21 Aligned_cols=105 Identities=20% Similarity=0.154 Sum_probs=69.6
Q ss_pred CcEEEEEecCCCceeeCCcccc-CCCCCCEEEcCCC-CCCCC-CChhHhhhcCCCCEEEccCccCCCCCCCCC----CCC
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIR-NCSSMTGLDLSSN-KLYGP-LPDDISKLVGFLTSLDLSSNNFSGSIPSNL----ANC 152 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~L~~N-~l~g~-ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~----~~l 152 (623)
.+++.|+|+++.+++..+..+. .+++|+.|+|++| .++.. ++..+.++ ++|++|+|++|.+++..+..+ ..+
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~-~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATC-RNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHC-TTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhC-CCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 3577888888887777666665 6788888888887 45432 33333344 458888888888776544333 356
Q ss_pred CCCceeeccCCcCCCCCCc-c----ccccccccccccccc
Q 006982 153 TYLNSLKLDHNRFSGQIPP-Q----LGQLGRLKSFSVANN 187 (623)
Q Consensus 153 ~~L~~l~l~~N~~~g~iP~-~----l~~l~~L~~l~l~~N 187 (623)
++|+.|+|++|. +.++. . +.++++|+.|++++|
T Consensus 184 ~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 184 TSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred CcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 688888888876 23331 2 244578888888877
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.50 E-value=5.2e-06 Score=85.90 Aligned_cols=108 Identities=16% Similarity=0.198 Sum_probs=74.8
Q ss_pred CcEEEEEecCCC-ceeeCCccccCCCCCCEEEcCCCCCCCCCChhHh--hhcCCCCEEEccC--ccCCCC--C---CCCC
Q 006982 80 NRVLNLRLTDMG-LKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDIS--KLVGFLTSLDLSS--NNFSGS--I---PSNL 149 (623)
Q Consensus 80 ~~v~~l~l~~~~-l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~--~l~~~L~~L~L~~--N~l~g~--i---p~~~ 149 (623)
.++..|+|+++. + .+++ +. +++|+.|+|..+.++...-..+. .+ ++|+.|+|+. |...|. + -..+
T Consensus 172 P~L~~L~L~g~~~l--~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~l-p~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDL-PNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBC-TTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCcEEEEeCCCCc--eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccC-CCCcEEEEeccccccccchhHHHHHHHH
Confidence 468899998873 3 3444 43 89999999998877643333343 33 5699999864 332222 1 1112
Q ss_pred --CCCCCCceeeccCCcCCCCCCcccc---cccccccccccccccccc
Q 006982 150 --ANCTYLNSLKLDHNRFSGQIPPQLG---QLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 150 --~~l~~L~~l~l~~N~~~g~iP~~l~---~l~~L~~l~l~~N~l~g~ 192 (623)
..+++|++|+|++|.+++..+..+. .+++|+.|+|+.|.+++.
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 3589999999999999865554454 478999999999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00051 Score=68.96 Aligned_cols=139 Identities=12% Similarity=0.037 Sum_probs=73.7
Q ss_pred cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCC-cceeEEEEeCCeeeEEEecC-CCCCH
Q 006982 310 NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL-VPLLGFCMAKKERLLVYKHM-PNGSL 387 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~gsL 387 (623)
.+.|+.|....+|+. ..+++|+.............|+.++..+....+ .+++++ +.+..++++||+ ++-++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 567888999999998 457788775432111123457766665543333 344443 444567999999 55444
Q ss_pred hh------------------hccCCCC-CCCccChHHHH-HHHH--------------HHHHHHH----HHHh-cCCCCc
Q 006982 388 YD------------------LLHPADD-TGKSVDWPRRL-KIAI--------------GAARGFA----WLHH-NCNPRI 428 (623)
Q Consensus 388 ~~------------------~l~~~~~-~~~~l~~~~~~-~i~~--------------~ia~~l~----yLH~-~~~~~i 428 (623)
.. .+|.... .....+....+ .+.. .+...+. .+.. ...+.+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 1122111 01111111111 0100 0111111 1111 123358
Q ss_pred EecCCCCCceeeCCCCCeEEeecccccc
Q 006982 429 IHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 429 ~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+|+.+.||+ .+++.+.++||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5566789999988864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.001 Score=70.11 Aligned_cols=80 Identities=11% Similarity=0.080 Sum_probs=48.6
Q ss_pred CCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCC---CCcchhHHHHHHHH
Q 006982 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV---ATPKGDVYSFGTVL 501 (623)
Q Consensus 425 ~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~sfGvil 501 (623)
.+.++|+|+++.||++++++ ++++||+.+..-.+. ......... -...|.+|+...... .....+++.....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 44799999999999999876 999999998754321 111111100 013456666553211 12235556778888
Q ss_pred HHHHhCC
Q 006982 502 LELVTGE 508 (623)
Q Consensus 502 ~elltg~ 508 (623)
|+.+++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0029 Score=64.00 Aligned_cols=143 Identities=14% Similarity=0.127 Sum_probs=81.7
Q ss_pred ceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCC--CCcceeEE-----EEeCCeeeEEEecCC
Q 006982 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNR--NLVPLLGF-----CMAKKERLLVYKHMP 383 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lV~e~~~ 383 (623)
..++ |....||+....+|..+++|...........+..|..++..+... .+++++.. ....+..+++++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 3466 788899998887787899999864433455666677776665321 23334332 122445678999998
Q ss_pred CCCHhh-----h---------ccC----CCC-CCCccChHHH----HHH---------------HHHHHHHHHHHHhc--
Q 006982 384 NGSLYD-----L---------LHP----ADD-TGKSVDWPRR----LKI---------------AIGAARGFAWLHHN-- 423 (623)
Q Consensus 384 ~gsL~~-----~---------l~~----~~~-~~~~l~~~~~----~~i---------------~~~ia~~l~yLH~~-- 423 (623)
|..+.. . +|. ... .....++... ..+ ...+...+..+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 854321 0 111 000 0112222211 000 11111223333322
Q ss_pred --CCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 424 --CNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 424 --~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
..+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0013 Score=66.57 Aligned_cols=159 Identities=10% Similarity=0.102 Sum_probs=85.7
Q ss_pred cCHHHHHHHhccCcc-----cceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCC--CcceeE
Q 006982 295 MRLSDLMKATNSFSK-----NNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRN--LVPLLG 367 (623)
Q Consensus 295 ~~~~~l~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~ 367 (623)
++.+++......|.. .+.|+.|....+|+....+| .+++|...... ....+..|.+++..+.... +.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 445555555555654 23466688889999987766 57788876521 1223445666555442211 222321
Q ss_pred ------EEEeCCeeeEEEecCCCCCHhh--------------hccCC----CCCC----CccChHHHHH-----------
Q 006982 368 ------FCMAKKERLLVYKHMPNGSLYD--------------LLHPA----DDTG----KSVDWPRRLK----------- 408 (623)
Q Consensus 368 ------~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~----~~~~----~~l~~~~~~~----------- 408 (623)
+....+..+++++|++|..+.. .+|.. .... ....|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1122456689999999865421 01211 0000 1112332111
Q ss_pred -HHHHHHHHHHHHHhc----CCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 409 -IAIGAARGFAWLHHN----CNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 409 -i~~~ia~~l~yLH~~----~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
+...+...+.++++. ..++++|+|+++.||+++++..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666543 23479999999999999987666899998775
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00083 Score=58.28 Aligned_cols=55 Identities=25% Similarity=0.310 Sum_probs=33.4
Q ss_pred EEEcCCCCCC-CCCChhHhhhcCCCCEEEccCccCCCCCCC-CCCCCCCCceeeccCCcCC
Q 006982 108 GLDLSSNKLY-GPLPDDISKLVGFLTSLDLSSNNFSGSIPS-NLANCTYLNSLKLDHNRFS 166 (623)
Q Consensus 108 ~L~L~~N~l~-g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~~~ 166 (623)
.++.++++|+ ..+|..+. .+|+.|+|++|+|+ .||. .|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp---~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP---VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC---TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC---cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 4455555554 34554432 23777777777777 4544 4566777777777777665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00017 Score=74.53 Aligned_cols=110 Identities=13% Similarity=0.165 Sum_probs=72.8
Q ss_pred CcEEEEEecCCCc---------eeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCC
Q 006982 80 NRVLNLRLTDMGL---------KGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLA 150 (623)
Q Consensus 80 ~~v~~l~l~~~~l---------~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~ 150 (623)
.++..|.+.++.. .+.+++.+..+++|+.|+|++|.-. .+|+ + . .++|+.|+|..+.++......++
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~-~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-P-RPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-B-CTTCSEEEEECSBCCHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-c-CCCCcEEEEecCCCChHHHHHHH
Confidence 3677888866533 2345566778899999999988311 3554 3 2 34599999998887643323343
Q ss_pred --CCCCCceeeccC--CcCCCCC-----Cccc--cccccccccccccccccccC
Q 006982 151 --NCTYLNSLKLDH--NRFSGQI-----PPQL--GQLGRLKSFSVANNLLSGSI 193 (623)
Q Consensus 151 --~l~~L~~l~l~~--N~~~g~i-----P~~l--~~l~~L~~l~l~~N~l~g~i 193 (623)
.+++|+.|+|+. |...|.. ...+ ..+++|+.|+|++|.++...
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~ 268 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVV 268 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHH
Confidence 789999999863 3332221 1122 35789999999999987543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0032 Score=63.97 Aligned_cols=33 Identities=21% Similarity=0.297 Sum_probs=28.1
Q ss_pred CCCcEecCCCCCceeeCCC----CCeEEeeccccccc
Q 006982 425 NPRIIHRNISSKCILLDDD----FEPKISDFGLARLM 457 (623)
Q Consensus 425 ~~~i~H~dlk~~NILl~~~----~~~kl~Dfgla~~~ 457 (623)
.+.++|||+.+.||+++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999875 67999999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0035 Score=66.21 Aligned_cols=73 Identities=18% Similarity=0.281 Sum_probs=48.6
Q ss_pred cceeeccCccEEEEEEeCC--------CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCC-cceeEEEEeCCeeeEEEe
Q 006982 310 NNIIGSGRTGTMYKALLED--------GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL-VPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 380 (623)
.+.|+.|....+|+....+ +..+++|+.... .....+..|..++..+...++ .++++.+. + .+|+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 3567778889999998753 578899988432 122455678888877743344 45666543 2 38999
Q ss_pred cCCCCCH
Q 006982 381 HMPNGSL 387 (623)
Q Consensus 381 ~~~~gsL 387 (623)
|++|-++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0027 Score=54.97 Aligned_cols=56 Identities=21% Similarity=0.302 Sum_probs=43.7
Q ss_pred CEEEccCccCC-CCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccc
Q 006982 132 TSLDLSSNNFS-GSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLL 189 (623)
Q Consensus 132 ~~L~L~~N~l~-g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l 189 (623)
..++.+++.|+ ..+|..+. ++|++|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 57999999997 46786543 3699999999999954445567888999888887765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0052 Score=65.32 Aligned_cols=74 Identities=15% Similarity=0.080 Sum_probs=45.9
Q ss_pred cceeeccCccEEEEEEeCC-CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCC-cceeEEEEeCCeeeEEEecCCCCCH
Q 006982 310 NNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL-VPLLGFCMAKKERLLVYKHMPNGSL 387 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL 387 (623)
.+.|+.|-...+|+....+ +..+++|+........-....|..++..+...++ .++++++. + ..|+||++|-+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 3567778889999998865 4778888874322111112477777777754445 45666552 2 359999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0021 Score=66.43 Aligned_cols=73 Identities=14% Similarity=0.160 Sum_probs=42.6
Q ss_pred ceeeccCccEEEEEEeCC---------CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCC-cceeEEEEeCCeeeEEEe
Q 006982 311 NIIGSGRTGTMYKALLED---------GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL-VPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 380 (623)
..++.|....+|+....+ +..+++|+.............|.+++..+....+ .++++.. . .++|+|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 456778888999998754 2678888875432221123567777766643333 3555443 2 378999
Q ss_pred cCCCCCH
Q 006982 381 HMPNGSL 387 (623)
Q Consensus 381 ~~~~gsL 387 (623)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0054 Score=63.48 Aligned_cols=142 Identities=14% Similarity=0.169 Sum_probs=81.9
Q ss_pred ceeeccCccEEEEEEeC--------CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCC-cceeEEEEeCCeeeEEEec
Q 006982 311 NIIGSGRTGTMYKALLE--------DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL-VPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 381 (623)
+.+..|-...+|+.... ++..+++|+..........+.+|.++++.+....+ .++++++.+ .+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45666778899998875 34788999864433345566789888877743333 455655432 299999
Q ss_pred CCCCCHhhh-----------------ccCCCC-CCCccC--hHHHHHHHHHHH-------------------HHHHHHHh
Q 006982 382 MPNGSLYDL-----------------LHPADD-TGKSVD--WPRRLKIAIGAA-------------------RGFAWLHH 422 (623)
Q Consensus 382 ~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~ia-------------------~~l~yLH~ 422 (623)
++|.+|..- ||.... .+.... |.+..++..++. ..+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998655311 122211 112222 344444443332 12333322
Q ss_pred ----c-CCCCcEecCCCCCceeeCCC----CCeEEeecccccc
Q 006982 423 ----N-CNPRIIHRNISSKCILLDDD----FEPKISDFGLARL 456 (623)
Q Consensus 423 ----~-~~~~i~H~dlk~~NILl~~~----~~~kl~Dfgla~~ 456 (623)
. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 22368999999999999876 7899999988763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0006 Score=62.22 Aligned_cols=85 Identities=12% Similarity=0.055 Sum_probs=57.6
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCC-CCCCCChhHhhh---cCCCCEEEccCcc-CCCCCCCCCCCCCC
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNK-LYGPLPDDISKL---VGFLTSLDLSSNN-FSGSIPSNLANCTY 154 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~-l~g~ip~~~~~l---~~~L~~L~L~~N~-l~g~ip~~~~~l~~ 154 (623)
-+++.|||+++.++..--..+..|++|+.|+|+++. ++..-=..++.+ .++|++|+|+++. +|..-=..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468999999988765434557889999999999974 664211223331 1248999998864 66322234677888
Q ss_pred CceeeccCCc
Q 006982 155 LNSLKLDHNR 164 (623)
Q Consensus 155 L~~l~l~~N~ 164 (623)
|++|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0051 Score=64.33 Aligned_cols=95 Identities=16% Similarity=0.228 Sum_probs=63.3
Q ss_pred EEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC-CCCCCCCCCceeec
Q 006982 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP-SNLANCTYLNSLKL 160 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip-~~~~~l~~L~~l~l 160 (623)
+..+.|.+ ++.-.-+..|.+|++|+.++|++|++. .||...+.. ..|+.+.|.+| ++ .|+ ..|.++++|+.++|
T Consensus 159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~-~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVY-AGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTT-CCCSEEECCTT-CC-EECTTTTTTCTTCCCEEC
T ss_pred ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEee-cccCEEEeCCc-hh-eehhhHhhCCCCCCEEec
Confidence 55666664 555555567888888888888888888 677776665 44888888744 66 444 45778888888888
Q ss_pred cCCcCCCCCCc-ccccccccccccc
Q 006982 161 DHNRFSGQIPP-QLGQLGRLKSFSV 184 (623)
Q Consensus 161 ~~N~~~g~iP~-~l~~l~~L~~l~l 184 (623)
..| ++ .|+. .+.+ .+|+.+.+
T Consensus 234 ~~~-l~-~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 234 PEN-VS-TIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp CTT-CC-EECTTTTTT-CCCSEEEE
T ss_pred CCC-cc-Ccccccccc-CCccEEEe
Confidence 765 33 3333 2323 55666665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0061 Score=63.74 Aligned_cols=102 Identities=14% Similarity=0.192 Sum_probs=50.1
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCC----CCC-CCCCCCCCC
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG----SIP-SNLANCTYL 155 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g----~ip-~~~~~l~~L 155 (623)
.+..|.|+++ ++-.-...|.+ .+|+.++| .|++. .|+...+.-..+|+.++|.+|.+.. .|+ ..|.+|++|
T Consensus 227 ~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 227 QLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 3555666542 33333333444 56666666 33344 3443333223346666666665541 122 345666666
Q ss_pred ceeeccCCcCCCCCCccccccccccccccccc
Q 006982 156 NSLKLDHNRFSGQIPPQLGQLGRLKSFSVANN 187 (623)
Q Consensus 156 ~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N 187 (623)
+.++|. |+++-.-...+.++++|+.+.|.+|
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 666666 3344222334555666666666443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.74 E-value=0.00076 Score=61.52 Aligned_cols=92 Identities=11% Similarity=0.136 Sum_probs=61.2
Q ss_pred CCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCcc-CCCCCCCCCCCC----CCCceeeccCCc-CCCCC
Q 006982 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN-FSGSIPSNLANC----TYLNSLKLDHNR-FSGQI 169 (623)
Q Consensus 96 ~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~-l~g~ip~~~~~l----~~L~~l~l~~N~-~~g~i 169 (623)
+|...-.--+|+.|||+++.++..=-..+..+ ++|+.|+|+++. ++..-=..++.+ ++|++|+|+++. +|..=
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~-~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGL-QYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTC-SCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCC-CCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 45433233479999999998764322345554 459999999985 653222234553 479999999974 66322
Q ss_pred Ccccccccccccccccccc
Q 006982 170 PPQLGQLGRLKSFSVANNL 188 (623)
Q Consensus 170 P~~l~~l~~L~~l~l~~N~ 188 (623)
=..+.++++|+.|+|++..
T Consensus 132 l~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHGGGCTTCCEEEEESCT
T ss_pred HHHHhcCCCCCEEECCCCC
Confidence 2356788999999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.67 E-value=0.029 Score=57.11 Aligned_cols=32 Identities=19% Similarity=0.229 Sum_probs=28.2
Q ss_pred CCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 426 ~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
..++|+|+.+.||++++++.+.|.||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0014 Score=60.95 Aligned_cols=83 Identities=13% Similarity=0.180 Sum_probs=47.0
Q ss_pred CcEEEEEecCC-Ccee----eCCccccCCCCCCEEEcCCCCCCCC----CChhHhhhcCCCCEEEccCccCCCCC----C
Q 006982 80 NRVLNLRLTDM-GLKG----QFPRGIRNCSSMTGLDLSSNKLYGP----LPDDISKLVGFLTSLDLSSNNFSGSI----P 146 (623)
Q Consensus 80 ~~v~~l~l~~~-~l~g----~~p~~l~~l~~L~~L~L~~N~l~g~----ip~~~~~l~~~L~~L~L~~N~l~g~i----p 146 (623)
..++.|+|+++ ++.. .+-..+..-+.|+.|+|++|.+... |-..+.... .|+.|+|++|+|+..- -
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~-tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSP-SLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCS-SCCEEECCSSBCCHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCC-ccCeEecCCCcCCHHHHHHHH
Confidence 45677777764 5432 2344556667777777777777632 222222322 3777777777776321 1
Q ss_pred CCCCCCCCCceeeccCC
Q 006982 147 SNLANCTYLNSLKLDHN 163 (623)
Q Consensus 147 ~~~~~l~~L~~l~l~~N 163 (623)
..+..-+.|+.|+|++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 12334455777777654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.12 E-value=0.22 Score=46.61 Aligned_cols=100 Identities=14% Similarity=0.109 Sum_probs=65.4
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
.-||.+.|.. .+.++++.++|.++.|.+.+|.-+-.+..+ ..+=+.|..|++..+|.+...+ ..+. .
T Consensus 32 ~vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------~- 98 (229)
T 2yle_A 32 ALSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------A- 98 (229)
T ss_dssp EEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------c-
Confidence 3478888864 347899999999999999988766221111 1233456889999999998764 1110 0
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT 506 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt 506 (623)
....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 99 ---------~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 99 ---------GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---------cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 122366888764 345788999999999999885
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.20 E-value=0.056 Score=56.62 Aligned_cols=73 Identities=11% Similarity=0.102 Sum_probs=45.8
Q ss_pred ceeeccCccEEEEEEeCC--------CcEEEEEEeccccccHHHHHHHHHHhCCCCCCCC-cceeEEEEeCCeeeEEEec
Q 006982 311 NIIGSGRTGTMYKALLED--------GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL-VPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 381 (623)
+.+..|-...+|+....+ +..+++|+........-...+|.+++..+....+ .++++.+ . .+.|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 456667788999998763 5788888865432211223567777766643233 4455432 2 3789999
Q ss_pred CCCCCH
Q 006982 382 MPNGSL 387 (623)
Q Consensus 382 ~~~gsL 387 (623)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.68 E-value=0.008 Score=55.77 Aligned_cols=88 Identities=10% Similarity=0.153 Sum_probs=58.4
Q ss_pred cccCCCCCCEEEcCCC-CCCCC----CChhHhhhcCCCCEEEccCccCCCCCCCC----CCCCCCCceeeccCCcCCCC-
Q 006982 99 GIRNCSSMTGLDLSSN-KLYGP----LPDDISKLVGFLTSLDLSSNNFSGSIPSN----LANCTYLNSLKLDHNRFSGQ- 168 (623)
Q Consensus 99 ~l~~l~~L~~L~L~~N-~l~g~----ip~~~~~l~~~L~~L~L~~N~l~g~ip~~----~~~l~~L~~l~l~~N~~~g~- 168 (623)
-+.+-+.|+.|+|++| .+... |-..+.... .|+.|+|++|++...--.. +..-+.|++|+|++|+|+..
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~-~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSK-HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCS-CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCC-CcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 3556788999999986 66521 222233323 4999999999998322222 33457899999999999842
Q ss_pred ---CCccccccccccccccccc
Q 006982 169 ---IPPQLGQLGRLKSFSVANN 187 (623)
Q Consensus 169 ---iP~~l~~l~~L~~l~l~~N 187 (623)
|-..+..-+.|+.|+|++|
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHhhCCceeEEECCCC
Confidence 1223334466899999865
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=91.60 E-value=0.3 Score=50.08 Aligned_cols=82 Identities=12% Similarity=0.244 Sum_probs=33.0
Q ss_pred cccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC-CCCCCCCCCceeeccCCcCCCCCCccccccc
Q 006982 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP-SNLANCTYLNSLKLDHNRFSGQIPPQLGQLG 177 (623)
Q Consensus 99 ~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip-~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~ 177 (623)
.+.++.+|+.+.+..+ +. .|+.....-...|+.+.+..+ ++ .|+ ..+.++++|+.+.+.+|.++-.=+..+.++.
T Consensus 235 ~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~ 310 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCV 310 (379)
T ss_dssp TTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCT
T ss_pred cccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCC
Confidence 3444555555555443 22 232222221223444444332 22 222 2344445555555544444411122344444
Q ss_pred ccccccc
Q 006982 178 RLKSFSV 184 (623)
Q Consensus 178 ~L~~l~l 184 (623)
+|+.+.|
T Consensus 311 ~L~~i~l 317 (379)
T 4h09_A 311 KLSSVTL 317 (379)
T ss_dssp TCCEEEC
T ss_pred CCCEEEc
Confidence 4544444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=89.77 E-value=0.27 Score=50.84 Aligned_cols=102 Identities=16% Similarity=0.337 Sum_probs=72.1
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC-CCCCCCCCCceee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP-SNLANCTYLNSLK 159 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip-~~~~~l~~L~~l~ 159 (623)
.+..+.+.++-. -.-...+.++++|+.+++. +.+. .|+...+.-..+|+.++|..| ++ .|. ..|.+|++|+.+.
T Consensus 266 ~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ 340 (394)
T 4gt6_A 266 YLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIA 340 (394)
T ss_dssp SCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEE
T ss_pred cccEEecccccc-eecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEE
Confidence 345566654332 2334467889999999996 4555 577665544456999999865 55 454 4688999999999
Q ss_pred ccCCcCCCCCC-ccccccccccccccccccc
Q 006982 160 LDHNRFSGQIP-PQLGQLGRLKSFSVANNLL 189 (623)
Q Consensus 160 l~~N~~~g~iP-~~l~~l~~L~~l~l~~N~l 189 (623)
|..| ++ .|+ .++.++++|+.+++.+|..
T Consensus 341 ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 341 IPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp ECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred ECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 9755 55 454 5788999999999988754
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=89.49 E-value=0.31 Score=50.40 Aligned_cols=84 Identities=19% Similarity=0.292 Sum_probs=62.3
Q ss_pred ccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC-CCCCCCCCCceeeccCCcCCCCC-Cccccc
Q 006982 98 RGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP-SNLANCTYLNSLKLDHNRFSGQI-PPQLGQ 175 (623)
Q Consensus 98 ~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip-~~~~~l~~L~~l~l~~N~~~g~i-P~~l~~ 175 (623)
..+..+.+|+.+.+..+ +. .|+...+.-..+|+.++|.++ ++ .|+ ..|.+|++|+.+.|..| ++ .| ..++.+
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~ 364 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQG 364 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTBTT
T ss_pred ccccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHHhhC
Confidence 35778999999999765 55 566554433345999999754 66 554 56889999999999877 55 34 457888
Q ss_pred cccccccccccc
Q 006982 176 LGRLKSFSVANN 187 (623)
Q Consensus 176 l~~L~~l~l~~N 187 (623)
+++|+.+++..|
T Consensus 365 C~~L~~i~lp~~ 376 (394)
T 4fs7_A 365 CINLKKVELPKR 376 (394)
T ss_dssp CTTCCEEEEEGG
T ss_pred CCCCCEEEECCC
Confidence 999999988655
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=88.97 E-value=0.67 Score=47.76 Aligned_cols=85 Identities=13% Similarity=0.338 Sum_probs=61.7
Q ss_pred CccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCC-CCCCCCCCceeeccCCcCCCCC-Ccccc
Q 006982 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPS-NLANCTYLNSLKLDHNRFSGQI-PPQLG 174 (623)
Q Consensus 97 p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~~~g~i-P~~l~ 174 (623)
...+.++.+|+.+.+..+... |+.....-...|+.+.+. +.++ .|+. .|.+|++|+.++|..| ++ .| ..++.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~--I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~ 331 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS--IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFA 331 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE--ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTT
T ss_pred cceeeecccccEEecccccce--ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhh
Confidence 446888999999999876543 444433334559999996 4566 4554 6889999999999865 54 34 45788
Q ss_pred ccccccccccccc
Q 006982 175 QLGRLKSFSVANN 187 (623)
Q Consensus 175 ~l~~L~~l~l~~N 187 (623)
++.+|+.+.+..+
T Consensus 332 ~C~~L~~i~ip~s 344 (394)
T 4gt6_A 332 GCEQLERIAIPSS 344 (394)
T ss_dssp TCTTCCEEEECTT
T ss_pred CCCCCCEEEECcc
Confidence 8999999988654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.85 E-value=1.1 Score=46.44 Aligned_cols=29 Identities=21% Similarity=0.326 Sum_probs=24.8
Q ss_pred cEecCCCCCceee------CCCCCeEEeecccccc
Q 006982 428 IIHRNISSKCILL------DDDFEPKISDFGLARL 456 (623)
Q Consensus 428 i~H~dlk~~NILl------~~~~~~kl~Dfgla~~ 456 (623)
++|+|+.+.||++ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.69 E-value=0.14 Score=34.39 Aligned_cols=31 Identities=23% Similarity=0.329 Sum_probs=16.2
Q ss_pred CCccceeeehhhhHHHHHHHHHHhheeeeeee
Q 006982 227 PHTGVIAGAAIGGVTFAALVVGIVMFFYFRRM 258 (623)
Q Consensus 227 ~~~~~i~~~~i~~v~~~~l~~~i~~~~~~~r~ 258 (623)
+.+..|++.+++++++.+++++. +++++||+
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~-~~~~~RRr 38 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALG-IGLFMRRR 38 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHH-HHHHHHTT
T ss_pred CCcceEEeehhHHHHHHHHHHHH-HHHHhhhh
Confidence 44555666666666655544433 33444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=87.69 E-value=0.48 Score=48.92 Aligned_cols=84 Identities=19% Similarity=0.175 Sum_probs=61.3
Q ss_pred CCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCC-CCCCCCCCCceeeccCCcCCCCC-Cccc
Q 006982 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIP-SNLANCTYLNSLKLDHNRFSGQI-PPQL 173 (623)
Q Consensus 96 ~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip-~~~~~l~~L~~l~l~~N~~~g~i-P~~l 173 (623)
-...+.++..|+.+.+..+. ||........+|+.+.+.+| ++ .|+ ..|.++++|+.++|.++ ++ .| ..++
T Consensus 268 ~~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF 339 (394)
T 4fs7_A 268 GGSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSF 339 (394)
T ss_dssp CSCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTT
T ss_pred eccccccccccceeccCcee----eccccccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhc
Confidence 34467889999999888764 44443333455999999765 55 454 46889999999999754 55 45 4578
Q ss_pred cccccccccccccc
Q 006982 174 GQLGRLKSFSVANN 187 (623)
Q Consensus 174 ~~l~~L~~l~l~~N 187 (623)
.++++|+.+.+..|
T Consensus 340 ~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 340 RGCTSLSNINFPLS 353 (394)
T ss_dssp TTCTTCCEECCCTT
T ss_pred cCCCCCCEEEECcc
Confidence 88999999988765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.06 E-value=1.2 Score=41.44 Aligned_cols=116 Identities=9% Similarity=0.098 Sum_probs=77.4
Q ss_pred CCCCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCc
Q 006982 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKC 437 (623)
Q Consensus 358 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~N 437 (623)
.||++++. .+-.+.+...+.|+.-+.+.=+..+ ..++...+++++..++.-..++++ -+|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 58888876 4555566555555544422222223 457788999999999887766654 3788899999
Q ss_pred eeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006982 438 ILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTN 512 (623)
Q Consensus 438 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~ 512 (623)
+++|.++.+++.-.|+-..+.+ . ..++..=.-.+=+++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P---------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDP---------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSC---------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCC---------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987776543322 1 01112223347788899999988874
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.75 E-value=0.22 Score=33.35 Aligned_cols=32 Identities=31% Similarity=0.414 Sum_probs=16.7
Q ss_pred CCCccceeeehhhhHHHHHHHHHHhheeeeeee
Q 006982 226 GPHTGVIAGAAIGGVTFAALVVGIVMFFYFRRM 258 (623)
Q Consensus 226 ~~~~~~i~~~~i~~v~~~~l~~~i~~~~~~~r~ 258 (623)
++.+..|++.+++++++.+++++. .++++||+
T Consensus 6 ~s~~~aIA~gVVgGv~~v~ii~~~-~~~~~RRR 37 (44)
T 2l2t_A 6 HARTPLIAAGVIGGLFILVIVGLT-FAVYVRRK 37 (44)
T ss_dssp SCSSHHHHHHHHHHHHHHHHHHHH-HHHHHHTT
T ss_pred CCCcceEEEeehHHHHHHHHHHHH-HHHHhhhh
Confidence 345555666666666655544433 33444443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.54 E-value=2 Score=40.17 Aligned_cols=114 Identities=13% Similarity=0.184 Sum_probs=75.9
Q ss_pred CCCCCcceeEEEEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHH-HHHhcCCCCcEecCCCCC
Q 006982 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA-WLHHNCNPRIIHRNISSK 436 (623)
Q Consensus 358 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~i~H~dlk~~ 436 (623)
.||++ -...-.+.+...+.|+.-+++.=...+ ..++...+++++..++.-.. +++ .-+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 57887 444446666766777766454333344 34677889999888887655 444 3578889999
Q ss_pred ceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHH-HHHHHHHHHHhCCCCCC
Q 006982 437 CILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVY-SFGTVLLELVTGERPTN 512 (623)
Q Consensus 437 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~-sfGvil~elltg~~P~~ 512 (623)
|+++|.++.+++.-.|+-..+ +|.-+ ...|.| .+=+++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l---------------------pP~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL---------------------PPDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB---------------------SSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC---------------------CCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877765433 22211 122333 46778888888887764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=83.21 E-value=1.6 Score=44.40 Aligned_cols=30 Identities=20% Similarity=0.424 Sum_probs=12.9
Q ss_pred CCEEEccCccCCCCCC-CCCCCCCCCceeecc
Q 006982 131 LTSLDLSSNNFSGSIP-SNLANCTYLNSLKLD 161 (623)
Q Consensus 131 L~~L~L~~N~l~g~ip-~~~~~l~~L~~l~l~ 161 (623)
|+.+++.+|.++ .|+ ..|.+|++|+.+.|.
T Consensus 288 L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 288 LTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp CCEEEECCTTCC-EECTTTTTTCTTCCEEECC
T ss_pred cccccccccccc-eehhhhhcCCCCCCEEEcC
Confidence 444444444444 222 234444444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 623 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 4e-53
Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 31/291 (10%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
+ +G+G+ G ++ T + VK L+ S F+AE + ++++ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L ++ ++ ++M NGSL D L +G + + L +A A G A++
Sbjct: 73 LYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
IHR++ + IL+ D KI+DFGLARL+ + + + APE
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK---FPIKWTAPEAIN 183
Query: 485 TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544
T K DV+SFG +L E+VT R + G + Q G D C
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI--------PYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTE 595
EL+Q ++ C P++RPT + L E + TE
Sbjct: 236 ------PEELYQLMR---LCWKER-PEDRPTFDYLRSVL----EDFFTATE 272
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-53
Identities = 68/287 (23%), Positives = 116/287 (40%), Gaps = 29/287 (10%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSL-MVKRLQDSQRSEKEFVAEMATLGSVKNRNLV 363
+ IGSG GT+YK ++ M+ + + + F E+ L ++ N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
+G+ + +V + SLY LH + + + IA A+G +LH
Sbjct: 68 LFMGYST-APQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
IIHR++ S I L +D KI DFGLA + + G + ++APE
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF--EQLSGSILWMAPEVI 178
Query: 484 RTLVA---TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG-NLVEWIAQLSSTGQLQD 539
R + + DVY+FG VL EL+TG+ P + N + I + G L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP---------YSNINNRDQIIFMVGRGYLSP 229
Query: 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ K V + + + C+ ERP ++ + +
Sbjct: 230 DLSK--VRSNCPKAMKRLMA---ECLKKK-RDERPLFPQILASIELL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-52
Identities = 56/284 (19%), Positives = 118/284 (41%), Gaps = 27/284 (9%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
+ + IGSG+ G ++ + + +K +++ SE++F+ E + + + LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L G C+ + LV++ M +G L D L L + + G + +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+IHR+++++ L+ ++ K+SDFG+ R + ST + + +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT---KFPVKWASPEVFS 175
Query: 485 TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544
+ K DV+SFG ++ E+ + + ++ +VE I+ +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTG----------FRL 221
Query: 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588
+ ++Q + +C P++RP + + L I E
Sbjct: 222 YKPRLASTHVYQIMN---HCWKER-PEDRPAFSRLLRQLAEIAE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-52
Identities = 70/300 (23%), Positives = 121/300 (40%), Gaps = 32/300 (10%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
S +G G G ++ T + +K L+ S + F+ E + +++ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L ++ +V ++M GSL D L +TGK + P+ + +A A G A++
Sbjct: 77 LYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+HR++ + IL+ ++ K++DFGLARL+ + G + + APE A
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ---GAKFPIKWTAPEAAL 187
Query: 485 TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544
T K DV+SFG +L EL T R ++ D +++
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------EVLDQVERG 230
Query: 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDEIMLPSDS 604
+ C C P+ERPT + FL FT+ + P ++
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKE-PEERPTFEYLQAFLEDY-----FTSTEPQYQPGEN 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-51
Identities = 58/292 (19%), Positives = 109/292 (37%), Gaps = 25/292 (8%)
Query: 313 IGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM-- 370
IG GR G +++ G + VK + AE+ +++ N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 371 --AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC---- 424
+ LV + +GSL+D L+ +V +K+A+ A G A LH
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 425 -NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
P I HR++ SK IL+ + I+D GLA + + N G Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 484 RTLV------ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLV--EWIAQLSSTG 535
+ + + D+Y+ G V E+ + + + +LV + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 536 QLQDAIDKCLVAKGVDNELFQFL-KVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ + + + E + + K+ C R T + + L +
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN-GAARLTALRIKKTLSQL 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-49
Identities = 48/282 (17%), Positives = 109/282 (38%), Gaps = 27/282 (9%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
+ +G+G+ G + + +K +++ SE EF+ E + ++ + LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L G C ++ ++ ++M NG L + L + L++ +L
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
+HR+++++ L++D K+SDFGL+R + + S G + + PE
Sbjct: 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLM 174
Query: 485 TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544
+ K D+++FG ++ E+ + + ++ + + + I +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKM--------PYER---------FTNSETAEHIAQG 217
Query: 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
L + + +C ERPT + + +
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEK-ADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 7e-49
Identities = 62/294 (21%), Positives = 124/294 (42%), Gaps = 27/294 (9%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLED-GTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLV 363
+ + +G G+ G +Y+ + + ++ VK L++ +EF+ E A + +K+ NLV
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
LLG C + ++ + M G+L D L + + V L +A + +L
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
IHR+++++ L+ ++ K++DFGL+RLM + + APE
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK---FPIKWTAPESL 188
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543
+ K DV++FG +L E+ T + G Q+ + ++K
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMS--------PYPGI---------DLSQVYELLEK 231
Query: 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTEDE 597
+ + + ++ C P +RP+ E++Q + + + E E
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWN-PSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 9e-49
Identities = 60/307 (19%), Positives = 125/307 (40%), Gaps = 42/307 (13%)
Query: 297 LSDLMKATNSFSKN---------NIIGSGRTGTMYKALL----EDGTSLMVKRLQD--SQ 341
D +A F+K +IG+G G + L + + +K L+ ++
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 342 RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSV 401
+ ++F++E + +G + N++ L G +++ + M NGSL L
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQF 125
Query: 402 DWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461
+ + + G A G +L +HR+++++ IL++ + K+SDFGL+R +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 462 THLS-TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPET 519
+ + T G + + APE + T DV+S+G V+ E+++ GERP
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--------- 233
Query: 520 FKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEV 579
+ + + +AI++ + ++ +C RP ++
Sbjct: 234 YWDM---------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKD-RNHRPKFGQI 283
Query: 580 YQFLRAI 586
L +
Sbjct: 284 VNTLDKM 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 2e-48
Identities = 67/321 (20%), Positives = 126/321 (39%), Gaps = 51/321 (15%)
Query: 296 RLSDLMKATNSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRL--QDSQRSEKEF 347
+L L N+ IG G G +++A E T + VK L + S + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 348 VAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLH--------------- 392
E A + N N+V LLG C K L++++M G L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 393 -----PADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPK 447
+ + +L IA A G A+L + +HR+++++ L+ ++ K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 448 ISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTG 507
I+DFGL+R + D + + + + ++ PE T + DV+++G VL E+ +
Sbjct: 181 IADFGLSRNIYSADYYKAD--GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 508 ERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLP 567
+ G E + G + + C + + + C
Sbjct: 239 GLQ--------PYYGMAHEEVIYYVRDGNILACPENCPL---------ELYNLMRLCWSK 281
Query: 568 TIPKERPTMFEVYQFLRAIGE 588
P +RP+ +++ L+ + E
Sbjct: 282 L-PADRPSFCSIHRILQRMCE 301
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-48
Identities = 60/306 (19%), Positives = 117/306 (38%), Gaps = 39/306 (12%)
Query: 303 ATNSFSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRL--QDSQRSEKEFVAEMATLGSVKN 359
+ F K + +G+G G ++K G + K + + + + E+ L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
+V G + E + +HM GSL +L + K++I +G +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTY 119
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
L +I+HR++ IL++ E K+ DFG++ + D+ ++FV G Y++
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV----GTRSYMS 171
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539
PE + + + D++S G L+E+ G P A E + + T
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 540 AIDKCLVAKGVDN----ELFQFLKVACNCVLPTI--------------------PKERPT 575
+ L + G+D+ +F+ L N P + P ER
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 576 MFEVYQ 581
+ ++
Sbjct: 292 LKQLMV 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 7e-48
Identities = 65/288 (22%), Positives = 118/288 (40%), Gaps = 31/288 (10%)
Query: 310 NNIIGSGRTGTMYKALLEDGTSLM----VKRLQD--SQRSEKEFVAEMATLGSVKNRNLV 363
N +IG G G +Y L D VK L +F+ E + + N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 364 PLLGFCM-AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
LLG C+ ++ L+V +M +G L + + + + + A+G +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKG---MKF 145
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY 482
+ + +HR+++++ +LD+ F K++DFGLAR M + G + ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542
+T T K DV+SFG +L EL+T P N + L +L
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDITVYLLQGRRLLQ--- 255
Query: 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590
+ + L++ + C P + RP+ E+ + AI +
Sbjct: 256 ----PEYCPDPLYEVML---KCWHPK-AEMRPSFSELVSRISAIFSTF 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-47
Identities = 56/289 (19%), Positives = 116/289 (40%), Gaps = 32/289 (11%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLM-----VKRLQD--SQRSEKEFVAEMATLGSV 357
+ ++ +IG+G G +YK +L+ + +K L+ +++ +F+ E +G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 358 KNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGF 417
+ N++ L G K +++ ++M NG+L L + + + + G A G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGM 123
Query: 418 AWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+ N +HR+++++ IL++ + K+SDFGL+R++ T G + +
Sbjct: 124 ---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-GGKIPIRW 179
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537
APE T DV+SFG V+ E++T + ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----------------EV 222
Query: 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
AI+ + ++ C RP ++ L +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQE-RARRPKFADIVSILDKL 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-47
Identities = 60/287 (20%), Positives = 104/287 (36%), Gaps = 39/287 (13%)
Query: 307 FSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKNRNL 362
+ IG+G G K DG L+ K L +E E V+E+ L +K+ N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 363 VPLLGFCMAKKERLL--VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
V + + L V ++ G L ++ + +D L++
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 421 H--HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
H + ++HR++ + LD K+ DFGLAR++N + F G Y+
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF----VGTPYYM 181
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETF----KGNLVEWIAQLSST 534
+PE + K D++S G +L EL P E +G + S
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD- 240
Query: 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+L + I + L K RP++ E+ +
Sbjct: 241 -ELNEIITRMLNLK---------------------DYHRPSVEEILE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-47
Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 33/283 (11%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
IG G G + G + VK +++ + + F+AE + + +++ NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQ 64
Query: 365 LLGFCMAKKERL-LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
LLG + +K L +V ++M GSL D L + LK ++ +L N
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
+HR+++++ +L+ +D K+SDFGL + + + + APE
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-------KLPVKWTAPEAL 172
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543
R + K DV+SFG +L E+ + R + ++ + G DA D
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV--------PYPRIPLKDVVPRVEKGYKMDAPDG 224
Query: 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
C +++ +K NC RP+ ++ + L I
Sbjct: 225 C------PPAVYEVMK---NCWHLD-AAMRPSFLQLREQLEHI 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-46
Identities = 58/283 (20%), Positives = 114/283 (40%), Gaps = 35/283 (12%)
Query: 309 KNNIIGSGRTGTMYKALLED---GTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNRNL 362
++ +GSG GT+ K + ++ VK L++ E +AE + + N +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
V ++G C + +LV + G L L + V +++ + G +L
Sbjct: 71 VRMIGICE-AESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY 482
+ +HR+++++ +LL KISDFGL++ + + + +G + + APE
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPEC 181
Query: 483 ARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAI 541
+ K DV+SFG ++ E + G++P ++G + + G+
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP---------YRGMKGSEVTAMLEKGERMGCP 232
Query: 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584
C E++ + C + RP V LR
Sbjct: 233 AGC------PREMYDLMN-LC---WTYDVENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-46
Identities = 60/299 (20%), Positives = 123/299 (41%), Gaps = 42/299 (14%)
Query: 299 DLMKATNSFSKNNI-IGSGRTGTMYKALL---EDGTSLMVKRLQD--SQRSEKEFVAEMA 352
L ++ +I +G G G++ + + + + +K L+ + +E + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 353 TLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIG 412
+ + N +V L+G C A+ +LV + G L+ L + + ++
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 117
Query: 413 AARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
+ G +L +HR+++++ +LL + KISDFGL++ + D++ + G+
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK- 173
Query: 473 GDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETF----KGNLVEW 527
L + APE + + DV+S+G + E ++ G++P K PE +G +E
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 528 IAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ +L + C + K ++RP V Q +RA
Sbjct: 234 PPECPP--ELYALMSDCWIYK---------------------WEDRPDFLTVEQRMRAC 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 66/300 (22%), Positives = 127/300 (42%), Gaps = 44/300 (14%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLM---VKRLQD--SQRSEKEFVAEMATLGSVKN 359
N ++IG G G + KA ++ M +KR+++ S+ ++F E+ L + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 360 -RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLH------------PADDTGKSVDWPRR 406
N++ LLG C + L ++ P+G+L D L A+ T ++ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 407 LKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLST 466
L A ARG + + + IHR+++++ IL+ +++ KI+DFGL+R
Sbjct: 130 LHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 467 FVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526
+ ++A E V T DV+S+G +L E+V+ + G
Sbjct: 187 -----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--------PYCGMTCA 233
Query: 527 WIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ + G + C D+E++ ++ C P ERP+ ++ L +
Sbjct: 234 ELYEKLPQGYRLEKPLNC------DDEVYDLMR---QCWREK-PYERPSFAQILVSLNRM 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 70/325 (21%), Positives = 129/325 (39%), Gaps = 38/325 (11%)
Query: 300 LMKATNSFSKNNIIGSGRTGTMYKA-LLEDGTSLMVK------RLQDSQRSEKEFVAEMA 352
++K T F K ++GSG GT+YK + +G + + R S ++ KE + E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 353 TLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIG 412
+ SV N ++ LLG C+ +L+ MP G L L + ++ L +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCL---LDYVREHKDNIGSQYLLNWCVQ 119
Query: 413 AARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEF 472
A+G +L R++HR+++++ +L+ KI+DFGLA+L+ + G
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGK 174
Query: 473 GDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLS 532
+ ++A E + T + DV+S+G + EL+T + G
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--------PYDGI--------- 217
Query: 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG---ER 589
++ ++K + C + RP E+ + +R
Sbjct: 218 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID-ADSRPKFRELIIEFSKMARDPQR 276
Query: 590 YHFTTEDEIMLPSDSGDADILEELI 614
Y DE M D++ L+
Sbjct: 277 YLVIQGDERMHLPSPTDSNFYRALM 301
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-43
Identities = 53/280 (18%), Positives = 102/280 (36%), Gaps = 42/280 (15%)
Query: 313 IGSGRTGTMYKA-LLEDGTSLMVKRLQ-DSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
+G G G +YKA E K + S+ ++++ E+ L S + N+V LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
+ ++ + G++ ++ + + + + + +LH N +IIH
Sbjct: 80 YENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 431 RNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA-- 488
R++ + IL D + K++DFG++ +F+ G ++APE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKD 189
Query: 489 ---TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS----TGQLQDAI 541
K DV+S G L+E+ E P + L+ + +D +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249
Query: 542 DKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
KCL R T ++ Q
Sbjct: 250 KKCLEKN---------------------VDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 9e-43
Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 40/281 (14%)
Query: 307 FSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRS----EKEFVAEMATLGSVKNRN 361
F +G G+ G +Y A + L +K L +Q E + E+ +++ N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
++ L G+ L+ ++ P G++Y L D R A ++ H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH 123
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
R+IHR+I + +LL E KI+DFG + + +T G L Y+ PE
Sbjct: 124 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLC----GTLDYLPPE 174
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL-VEWIAQLSSTGQLQDA 540
+ K D++S G + E + G+ P ET+K VE+ T +D
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234
Query: 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
I + L P +RP + EV +
Sbjct: 235 ISRLLKHN---------------------PSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 9e-43
Identities = 66/286 (23%), Positives = 123/286 (43%), Gaps = 41/286 (14%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE-FVAEMATLGSVKNRNLVP 364
+++ IG G +GT+Y A+ + G + ++++ Q+ +KE + E+ + KN N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L + E +V +++ GSL D++ +D + + + +LH N
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
++IHR+I S ILL D K++DFG + P + ST V G ++APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVT 189
Query: 485 TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS----TGQLQDA 540
PK D++S G + +E++ GE P +L + + +D
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLR 584
+++CL ++R + E+ Q FL+
Sbjct: 250 LNRCLDMD---------------------VEKRGSAKELLQHQFLK 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-42
Identities = 62/290 (21%), Positives = 106/290 (36%), Gaps = 48/290 (16%)
Query: 310 NNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKE---FVAEMATLGSVKNRNLVPL 365
+ IG G T+YK L E + LQD + ++ E F E L +++ N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 366 LGFCMA----KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
+ KK +LV + M +G+L L K + +G +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 422 HNCNPRIIHRNISSKCILLDD-DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
P IIHR++ I + KI D GLA L + + G ++AP
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVI----GTPEFMAP 182
Query: 481 EYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLS----STGQ 536
E DVY+FG +LE+ T E P + + + + S + +
Sbjct: 183 EMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLR 584
+++ I+ C+ ER ++ ++ F +
Sbjct: 242 VKEIIEGCIRQN---------------------KDERYSIKDLLNHAFFQ 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 9e-42
Identities = 64/294 (21%), Positives = 119/294 (40%), Gaps = 37/294 (12%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRL--QDSQRSEKEFVAEMATLGS 356
+ + +G G G +Y+ + E T + +K + S R EF+ E + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSV------DWPRRLKIA 410
++V LLG + L++ + M G L L + + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 411 IGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNG 470
A G A+L+ N + +HR+++++ ++ +DF KI DFG+ R + D +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--GK 194
Query: 471 EFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQ 530
+ +++PE + V T DV+SFG VL E+ T ++G E + +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--------PYQGLSNEQVLR 246
Query: 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584
G L D D C ++ C PK RP+ E+ ++
Sbjct: 247 FVMEGGLLDKPDNCPD---------MLFELMRMCWQYN-PKMRPSFLEIISSIK 290
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 2e-41
Identities = 59/286 (20%), Positives = 108/286 (37%), Gaps = 47/286 (16%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRL----QDSQRSEKEFVAEMATLGSVKNRN 361
FS IG G G +Y A + + + +K++ + S ++ + E+ L +++ N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
+ G + + LV ++ + L K + + GA +G A+LH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
+ +IHR++ + ILL + K+ DFG A +M P ++ + T ++APE
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT--------PYWMAPE 181
Query: 482 YARTL---VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG--- 535
+ K DV+S G +EL + P A L S
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
++ +D CL P++RPT + +
Sbjct: 242 YFRNFVDSCLQKI---------------------PQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-41
Identities = 62/302 (20%), Positives = 112/302 (37%), Gaps = 45/302 (14%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRL--QDSQRSEKEFVAEMATLGS 356
N S +G+G G + +A + ++ VK L + ++E+ L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 357 VKN-RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLH--------------PADDTGKSV 401
+ N N+V LLG C L++ ++ G L + L +D ++
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 402 DWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461
D L + A+G A+L IHR+++++ ILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521
++ + ++APE V T + DV+S+G L EL +
Sbjct: 200 NYVVK--GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----------- 246
Query: 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+ + I + ++ + + C P +RPT ++ Q
Sbjct: 247 -----PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDAD-PLKRPTFKQIVQ 300
Query: 582 FL 583
+
Sbjct: 301 LI 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 53/309 (17%), Positives = 107/309 (34%), Gaps = 50/309 (16%)
Query: 305 NSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQD--SQRSEKEFVAEMATLGS 356
+ ++GSG G + A + VK L++ + ++E+ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 357 VKN-RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLH-------------------PADD 396
+ + N+V LLG C L++++ G L + L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 397 TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456
+ + L A A+G +L +HR+++++ +L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKA 516
+ + + ++APE + T K DV+S+G +L E+ +
Sbjct: 214 IMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------ 265
Query: 517 PETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTM 576
+ G + I + + +C ++RP+
Sbjct: 266 --PYPG--------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD-SRKRPSF 314
Query: 577 FEVYQFLRA 585
+ FL
Sbjct: 315 PNLTSFLGC 323
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 54/289 (18%), Positives = 97/289 (33%), Gaps = 40/289 (13%)
Query: 302 KATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ----DSQRSEKEFVAEMATLGS 356
K F I+G G T+ A L +K L+ + E +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ + V L ++ + NG L + S D
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSA 120
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+LH IIHR++ + ILL++D +I+DFG A++++P N G
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ--ARANSFVGTAQ 175
Query: 477 YVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL---VEWIAQLSS 533
YV+PE A D+++ G ++ +LV G P F+ + ++ +
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582
+ +D ++K LV +R E+ +
Sbjct: 236 --KARDLVEKLLVLD---------------------ATKRLGCEEMEGY 261
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-39
Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 35/283 (12%)
Query: 313 IGSGRTGTMYKALLE----DGTSLMVKRLQ----DSQRSEKEFVAEMATLGSVKNRNLVP 364
+G G G + + + S+ VK L+ + +F+ E+ + S+ +RNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 365 LLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC 424
L G + ++ V + P GSL D L + A+ A G +L
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 425 NPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR 484
IHR+++++ +LL KI DFGL R + D H + APE +
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAPESLK 187
Query: 485 TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG-NLVEWIAQLSSTGQLQDAIDK 543
T + D + FG L E+ T + + G N + + ++ G+ +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQE--------PWIGLNGSQILHKIDKEGERLPRPED 239
Query: 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
C +++ + C P++RPT + FL
Sbjct: 240 C------PQDIYNVMV---QCWAHK-PEDRPTFVALRDFLLEA 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-39
Identities = 54/286 (18%), Positives = 104/286 (36%), Gaps = 44/286 (15%)
Query: 312 IIGSGRTGTMYKALL----EDGTSLMVKRLQD--SQRSEKEFVAEMATLGSVKNRNLVPL 365
IG G+ G +++ + ++ +K ++ S ++F+ E T+ + ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
+G + ++ + G L L S+D + A + A+L
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART 485
R +HR+I+++ +L+ + K+ DFGL+R M + ++ ++APE
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMAPESINF 183
Query: 486 LVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETF----KGNLVEWIAQLSSTGQLQDA 540
T DV+ FG + E++ G +P K + G + L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP--TLYSL 241
Query: 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586
+ KC P RP E+ L I
Sbjct: 242 MTKCWAYD---------------------PSRRPRFTELKAQLSTI 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-39
Identities = 59/283 (20%), Positives = 99/283 (34%), Gaps = 38/283 (13%)
Query: 307 FSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRL--QDSQRSEKEFVAEMATLGSVKNRNLV 363
+ +G G G + A ++ VK + + + + E+ + + N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
G + L ++ G L+D + P + P + G +LH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
I HR+I + +LLD+ KISDFGLA + + +N G L YVAPE
Sbjct: 123 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELL 177
Query: 484 RTL-VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS----TGQLQ 538
+ DV+S G VL ++ GE P + + E L+
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+ K LV P R T+ ++ +
Sbjct: 238 ALLHKILVEN---------------------PSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 4e-39
Identities = 54/291 (18%), Positives = 105/291 (36%), Gaps = 51/291 (17%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKE-FVAEMATLGSVKNRNL 362
+ + + +G+G G +++ G + K + S+KE E+ T+ +++ L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
V L E +++Y+ M G L++ + D + ++ +G +H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 423 NCNPRIIHRNISSKCILL--DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
N +H ++ + I+ E K+ DFGL ++P + T G + AP
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-----TGTAEFAAP 194
Query: 481 EYARTLVATPKGDVYSFGTVLLELVTGERP----------TNVAKAPETFKGNLVEWIAQ 530
E A D++S G + L++G P NV + I++
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 531 LSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+D I K L+A P R T+ + +
Sbjct: 255 -----DGKDFIRKLLLAD---------------------PNTRMTIHQALE 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-39
Identities = 68/305 (22%), Positives = 129/305 (42%), Gaps = 46/305 (15%)
Query: 305 NSFSKNNIIGSGRTGTMYKALL--------EDGTSLMVKRL--QDSQRSEKEFVAEMATL 354
+ +G G G + A T + VK L +++ + ++EM +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 355 GSVKN-RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLH------------PADDTGKSV 401
+ +N++ LLG C ++ ++ G+L + L P+ + + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 402 DWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461
+ A ARG + + + + IHR+++++ +L+ +D KI+DFGLAR ++ ID
Sbjct: 133 SSKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 462 THLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521
+ T + ++APE + T + DV+SFG +L E+ T +
Sbjct: 190 YYKKTTNG--RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--------PYP 239
Query: 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
G VE + +L G D C NEL+ ++ +C P +RPT ++ +
Sbjct: 240 GVPVEELFKLLKEGHRMDKPSNC------TNELYMMMR---DCWHAV-PSQRPTFKQLVE 289
Query: 582 FLRAI 586
L I
Sbjct: 290 DLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-36
Identities = 64/304 (21%), Positives = 115/304 (37%), Gaps = 44/304 (14%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL------LEDGTSLMVKRLQDS--QRSEKEFVAEMATLGS 356
+ +G G G + +A ++ VK L++ + ++E+ L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 357 VKNR-NLVPLLGFCMAKKERL-LVYKHMPNGSLYDLLH------------PADDTGKSVD 402
+ + N+V LLG C L ++ + G+L L P D +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 403 WPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462
+ + A+G +L + IHR+++++ ILL + KI DFGLAR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG 522
++ L ++APE V T + DV+SFG +L E+ +
Sbjct: 190 YVRK--GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------PGV 240
Query: 523 NLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582
+ E + G A D E++Q + +C P +RPT E+ +
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYT------TPEMYQTML---DCWHGE-PSQRPTFSELVEH 290
Query: 583 LRAI 586
L +
Sbjct: 291 LGNL 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (345), Expect = 3e-36
Identities = 49/283 (17%), Positives = 98/283 (34%), Gaps = 51/283 (18%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQ-DSQRSEKEFVAEMATLGSVKNRNLVPLLGFCM 370
+GSG G +++ + G + K + + E++ + + + L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 371 AKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIH 430
K E +L+ + + G L+D + + + A G +H + I+H
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 431 RNISSKCILLDDDFEP--KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA 488
+I + I+ + KI DFGLA +NP V + APE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNP-----DEIVKVTTATAEFAAPEIVDREPV 205
Query: 489 TPKGDVYSFGTVLLELVTGERP----------TNVAKAPETFKGNLVEWIAQLSSTGQLQ 538
D+++ G + L++G P NV + F + ++ + +
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP-----EAK 260
Query: 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
D I L + P++R T+ + +
Sbjct: 261 DFIKNLLQKE---------------------PRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 55/292 (18%), Positives = 111/292 (38%), Gaps = 52/292 (17%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
+G G G +++ + + M K ++ + E++ L ++RN++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
+E +++++ + +++ ++ + ++ + +LH + I H
Sbjct: 73 MEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHF 126
Query: 432 NISSKCILLDDDFEP--KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVAT 489
+I + I+ KI +FG AR + P D F Y APE + V +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-----FTAPEYYAPEVHQHDVVS 181
Query: 490 PKGDVYSFGTVLLELVTGERP----------TNVAKAPETFKGNLVEWIAQLSSTGQLQD 539
D++S GT++ L++G P N+ A TF + I+ + D
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI-----EAMD 236
Query: 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLRAIGER 589
+D+ LV + K R T E Q +L+ ER
Sbjct: 237 FVDRLLVKE---------------------RKSRMTASEALQHPWLKQKIER 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (327), Expect = 3e-34
Identities = 53/290 (18%), Positives = 108/290 (37%), Gaps = 46/290 (15%)
Query: 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRL--QDSQRSEKEFVAEMATLGSVKNR 360
+ + +++G+G + A + +K + + + E E+A L +K+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
N+V L + L+ + + G L+D + ++ +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDA---V 120
Query: 421 HHNCNPRIIHRNISSKCILL---DDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
+ + I+HR++ + +L D+D + ISDFGL+++ +P + LST G GY
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTAC----GTPGY 175
Query: 478 VAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS---- 533
VAPE + D +S G + L+ G P + F+ +++ + S
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-QILKAEYEFDSPYWD 234
Query: 534 --TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+ +D I + P++R T + Q
Sbjct: 235 DISDSAKDFIRHLMEKD---------------------PEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (313), Expect = 1e-32
Identities = 55/257 (21%), Positives = 101/257 (39%), Gaps = 22/257 (8%)
Query: 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ----DSQRSEKEFVAEMATLGSVK 358
++ + I+G G ++ A L + VK L+ F E ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 359 NRNLVPLLGFCMAKKERL----LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA 414
+ +V + A+ +V +++ +L D++H T + R +++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
+ L+ + IIHR++ I++ K+ DFG+AR + + T G
Sbjct: 122 QA---LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 177
Query: 475 LGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS- 533
Y++PE AR + DVYS G VL E++TGE P ++ E S+
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 534 ----TGQLQDAIDKCLV 546
+ L + K L
Sbjct: 238 HEGLSADLDAVVLKALA 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 50/301 (16%), Positives = 107/301 (35%), Gaps = 36/301 (11%)
Query: 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRL--QDSQRSEKEFVAEMATLGSVKNR 360
++ + IG G G + A + + +K++ + Q + + E+ L ++
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 361 NLVPLLGFCMAK----KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
N++ + A + + + H+ LY LL + + RG
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRG 121
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
++H ++HR++ +LL+ + KI DFGLAR+ +P H + F+
Sbjct: 122 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH-TGFLTEYVATRW 177
Query: 477 YVAPEYART-LVATPKGDVYSFGTVLLELVTGERP---------------TNVAKAPETF 520
Y APE T D++S G +L E+++ + + E
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVY 580
+ + ++ + + D++ L +L P +R + +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD----KMLTFNPHKRIEVEQAL 293
Query: 581 Q 581
Sbjct: 294 A 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 123 bits (309), Expect = 4e-32
Identities = 58/288 (20%), Positives = 109/288 (37%), Gaps = 32/288 (11%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNRNLVPLLG 367
IG G G +YKA G + +K+++ + E + E++ L +K+ N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 368 FCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPR 427
KK +LV++H+ L ++ + G A+ H R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 428 IIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE-YARTL 486
++HR++ + +L++ + E KI+DFGLAR + + L Y AP+ +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSK 176
Query: 487 VATPKGDVYSFGTVLLELVTGERP-------------TNVAKAPETFKGNLVEWIAQLSS 533
+ D++S G + E+V G + P + V + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+ + + KG+D L L P +R T + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLS---KM-LKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (309), Expect = 7e-32
Identities = 53/305 (17%), Positives = 99/305 (32%), Gaps = 26/305 (8%)
Query: 301 MKATNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN 359
++ N + IGSG G +Y + G + +K + + E ++
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQG 61
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
+P + +C A+ + ++ + SL DL + + L +A +
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEY 118
Query: 420 LHHNCNPRIIHRNISSKCIL---LDDDFEPKISDFGLARLMNPIDTHLSTFV---NGEFG 473
+H IHR++ L I DFGLA+ TH G
Sbjct: 119 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 474 DLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS 533
Y + + + + D+ S G VL+ G P KA + ++S
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 234
Query: 534 TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFT 593
++ KG +E +L ++P + Q R + R F+
Sbjct: 235 -------TPIEVLCKGYPSEFATYLN----FCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
Query: 594 TEDEI 598
+
Sbjct: 284 YDYVF 288
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 52/247 (21%), Positives = 91/247 (36%), Gaps = 18/247 (7%)
Query: 307 FSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRL-----QDSQRSEKEFVAEMATLGSVKNR 360
F + ++G G G ++ A + +K L E V + + ++
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
L + K+ V +++ G L + + D R A G L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILG---L 116
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
+ I++R++ ILLD D KI+DFG+ + D +TF G Y+AP
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC----GTPDYIAP 172
Query: 481 EYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSS-TGQLQD 539
E D +SFG +L E++ G+ P + E F ++ + +D
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
Query: 540 AIDKCLV 546
+ K V
Sbjct: 233 LLVKLFV 239
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 122 bits (306), Expect = 1e-31
Identities = 58/299 (19%), Positives = 104/299 (34%), Gaps = 58/299 (19%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRL----------QDSQRSEKEFVAEMATLG 355
+ I+G G + + + + VK + ++ Q + + E+ L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 356 SVKN-RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA 414
V N++ L LV+ M G L+D L ++ KI
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALL 120
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
LH I+HR++ + ILLDDD K++DFG + ++P L G
Sbjct: 121 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC----GT 172
Query: 475 LGYVAPEYARTLVA------TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWI 528
Y+APE + + D++S G ++ L+ G P K + ++
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-MIMSGN 231
Query: 529 AQLSS------TGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
Q S + ++D + + LV + P++R T E
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFLVVQ---------------------PQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 123 bits (310), Expect = 2e-31
Identities = 54/257 (21%), Positives = 91/257 (35%), Gaps = 30/257 (11%)
Query: 305 NSFSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRL-------QDSQRSEKEFVAEMATLGS 356
N FS + IIG G G +Y + G +K L + + ++ + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 357 VKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+V + + + M G L+ L A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
+H+ +++R++ ILLD+ +ISD GLA + H S G G
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTHG 170
Query: 477 YVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFK------GNLVEWIA 529
Y+APE + VA D +S G +L +L+ G P K + + VE
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230
Query: 530 QLSSTGQLQDAIDKCLV 546
S +L+ ++ L
Sbjct: 231 SFSP--ELRSLLEGLLQ 245
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (301), Expect = 6e-31
Identities = 43/293 (14%), Positives = 90/293 (30%), Gaps = 28/293 (9%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
IG G G +++ L + + +K + + E T + +P + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 372 KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHR 431
+ ++ + SL DLL G+ A +H +++R
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYR 125
Query: 432 NISSKCILLDDDFEP-----KISDFGLARLMNPIDTHLSTFV---NGEFGDLGYVAPEYA 483
+I L+ + DFG+ + T G Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543
+ + D+ + G V + + G P KA + ++ Q +
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERIGEKKQSTPLREL 240
Query: 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTTED 596
C G E ++++ A N P + + ER + T ++
Sbjct: 241 C---AGFPEEFYKYMHYARNLA----FDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (301), Expect = 1e-30
Identities = 47/244 (19%), Positives = 97/244 (39%), Gaps = 24/244 (9%)
Query: 311 NIIGSGRTGTMYKA-LLEDGTSLMVKRLQ----DSQRSEKEFVAEMATLGSVKNRNLVPL 365
+G+G G ++ +G +K L+ + + E L V + ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 366 LGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCN 425
G ++ ++ ++ G L+ LL + P A L + +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCL---ALEYLHS 122
Query: 426 PRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYART 485
II+R++ + ILLD + KI+DFG A+ + + L G Y+APE T
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-------GTPDYIAPEVVST 175
Query: 486 LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL---VEWIAQLSSTGQLQDAID 542
D +SFG ++ E++ G P + +T++ L + + + ++D +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE--DVKDLLS 233
Query: 543 KCLV 546
+ +
Sbjct: 234 RLIT 237
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-30
Identities = 54/293 (18%), Positives = 103/293 (35%), Gaps = 32/293 (10%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNL 362
F K IG G G +YKA G + +K++ +++ + E++ L + + N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
V LL + + LV++ + + + P +G A+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE- 481
+ ++HR++ + +L++ + K++DFGLAR + V L Y APE
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV----VTLWYRAPEI 173
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERP-------------TNVAKAPETFKGNLVEWI 528
+ D++S G + E+VT P+ V +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 529 AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+ D V +D + L +L P +R +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLS----QMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 59/298 (19%), Positives = 109/298 (36%), Gaps = 38/298 (12%)
Query: 306 SFSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVP 364
S++ +IG+G G +Y+A L + G + +K++ + ++ E+ + + + N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFKNRELQIMRKLDHCNIVR 77
Query: 365 LLGFCMAKKER------LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFA 418
L F + E+ LV ++P H +++ R A
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 419 WLHHNCNPRIIHRNISSKCILLDDD-FEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGY 477
++H I HR+I + +LLD D K+ DFG A+ + + ++S + Y
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-----YY 188
Query: 478 VAP-EYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL-------VEWIA 529
AP T DV+S G VL EL+ G+ + + E I
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 530 QLSST------GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+++ Q++ + E +L P R T E
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS----RLLEYTPTARLTPLEACA 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 5e-29
Identities = 52/291 (17%), Positives = 104/291 (35%), Gaps = 35/291 (12%)
Query: 311 NIIGSGRTGTMYKA-LLEDGTSLMVKRLQDSQRSE------KEFVAEMATLGSVKNRNLV 363
+ +G G+ T+YKA + +K+++ RSE + + E+ L + + N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 364 PLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHN 423
LL K LV+ M + + + +G +LH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 424 CNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
I+HR++ +LLD++ K++DFGLA+ + + V Y APE
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV----VTRWYRAPELL 172
Query: 484 RTL-VATPKGDVYSFGTVLLELVTGERP----------TNVAKAPETFKGNLVEWIAQLS 532
+ D+++ G +L EL+ T + + T + L
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 533 STGQLQDAIDKCL--VAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
+ L + ++L ++ + P R T + +
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQ----GLFLFNPCARITATQALK 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 7e-29
Identities = 61/310 (19%), Positives = 110/310 (35%), Gaps = 65/310 (20%)
Query: 307 FSKNNI---------IGSGRTGTMYKAL-LEDGTSLMVKRL-------QDSQRSEKEFVA 349
F + N+ +GSG+ + K G K + S ++
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 350 EMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKI 409
E++ L +++ N++ L K + +L+ + + G L+D L +S+ +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEF 118
Query: 410 AIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP----KISDFGLARLMNPIDTHLS 465
G +LH I H ++ + I+L D P KI DFGLA ++
Sbjct: 119 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-----G 170
Query: 466 TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL- 524
FG +VAPE + D++S G + L++G P ET
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 525 ------VEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFE 578
E+ + S+ +D I + LV PK+R T+ +
Sbjct: 231 VNYEFEDEYFSNTSA--LAKDFIRRLLVKD---------------------PKKRMTIQD 267
Query: 579 VYQ--FLRAI 586
Q +++
Sbjct: 268 SLQHPWIKPK 277
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 8e-29
Identities = 48/250 (19%), Positives = 85/250 (34%), Gaps = 21/250 (8%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ----DSQRSEKEFVAEMATLGSVKN 359
N F ++G G G + G +K L+ ++ V E L + ++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
L L V ++ G L+ L + R
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSA--- 117
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
L + + +++R+I + ++LD D KI+DFGL + + TF G Y+A
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC----GTPEYLA 173
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNL---VEWIAQLSSTGQ 536
PE D + G V+ E++ G P F+ L + + LS +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP--E 231
Query: 537 LQDAIDKCLV 546
+ + L
Sbjct: 232 AKSLLAGLLK 241
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 9e-29
Identities = 50/279 (17%), Positives = 96/279 (34%), Gaps = 35/279 (12%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFC- 369
++G G G + + +K LQD ++ +E + ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS---QCPHIVRIVDVYE 75
Query: 370 ---MAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNP 426
+K L+V + + G L+ + D ++ +I +LH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 427 RIIHRNISSKCILLDDDFEP---KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYA 483
I HR++ + +L K++DFG A+ ++ + YVAPE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVL 185
Query: 484 RTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID- 542
D++S G ++ L+ G P F N I+ T +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP---------FYSNHGLAISPGMKTRIRMGQYEF 236
Query: 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
V E+ ++ +L T P +R T+ E
Sbjct: 237 PNPEWSEVSEEVKMLIR----NLLKTEPTQRMTITEFMN 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 53/305 (17%), Positives = 104/305 (34%), Gaps = 29/305 (9%)
Query: 302 KATNSFSKNNIIGSGRTGTMYKA--LLEDGTSLMVKRL------QDSQRSEKEFVAEMAT 353
+A + IG G G ++KA L G + +KR+ + S VA +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 354 LGSVKNRNLVPLLGFCMAKKERLLVYKHMPNGSLY--DLLHPADDTGKSVDWPRRLKIAI 411
L + ++ N+V L C + + + + V +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 412 GAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGE 471
RG +LH + ++HR++ + IL+ + K++DFGLAR+ + S
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---- 176
Query: 472 FGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK--------GN 523
L Y APE D++S G + E+ + + +
Sbjct: 177 -VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 524 LVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ-- 581
+W ++ Q + + K V + + C L P +R + +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC-LTFNPAKRISAYSALSHP 294
Query: 582 FLRAI 586
+ + +
Sbjct: 295 YFQDL 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-28
Identities = 56/289 (19%), Positives = 105/289 (36%), Gaps = 52/289 (17%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE-------KEFVAEMATLGSVKN--RN 361
++GSG G++Y + + D + +K ++ + S+ E+ L V +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 362 LVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
++ LL + +L+ + ++ +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEA---VR 124
Query: 422 HNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
H N ++HR+I + IL+D + E K+ DFG L+ DT + F G Y P
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFD----GTRVYSPP 178
Query: 481 EYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539
E+ R V+S G +L ++V G+ P E V + ++SS + Q
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVSS--ECQH 233
Query: 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--FLRAI 586
I CL + P +RPT E+ +++ +
Sbjct: 234 LIRWCLALR---------------------PSDRPTFEEIQNHPWMQDV 261
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-27
Identities = 49/298 (16%), Positives = 99/298 (33%), Gaps = 24/298 (8%)
Query: 305 NSFSKNNIIGSGRTGTMYKA-LLEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNR 360
+ + K IG G G ++KA + G + +K++ + + + E+ L +K+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSL----YDLLHPADDTGKSVDWPRRLKIAIGAARG 416
N+V L+ C K K +DL + ++ G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
L++ +I+HR++ + +L+ D K++DFGLAR + L
Sbjct: 130 ---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 477 YVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFK------GNLVEWIA 529
Y PE P D++ G ++ E+ T G++ +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCV------LPTIPKERPTMFEVYQ 581
+L + ++ K + + + L P +R +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 51/293 (17%), Positives = 99/293 (33%), Gaps = 32/293 (10%)
Query: 307 FSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRL---QDSQRSEKEFVAEMATLGSVKNRNL 362
+ K IG G GT++KA E + +KR+ D + + E+ L +K++N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 363 VPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH 422
V L + K+ LV++ +D +G L
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKG---LGF 116
Query: 423 NCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEY 482
+ ++HR++ + +L++ + E K+++FGLAR S V +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW---YRPPDVL 173
Query: 483 ARTLVATPKGDVYSFGTVLLELVTGERP--------------TNVAKAPETFKGNLVEWI 528
+ + D++S G + EL RP + P + + +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 529 AQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581
V ++ L+ +L P +R + E Q
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQ----NLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (256), Expect = 2e-24
Identities = 47/249 (18%), Positives = 88/249 (35%), Gaps = 24/249 (9%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQ----DSQRSEKEFVAEMATLGSVKN 359
+ F + +G+G G + E G +K L + + + E L +V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
LV L +V +++ G ++ L P A F +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
LH +I+R++ + +L+D +++DFG A+ + L G +A
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-------CGTPEALA 206
Query: 480 PEYARTLVATPKGDVYSFGTVLLELVTGERP---TNVAKAPETFKGNLVEWIAQLSSTGQ 536
PE + D ++ G ++ E+ G P + E V + + SS
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS--D 264
Query: 537 LQDAIDKCL 545
L+D + L
Sbjct: 265 LKDLLRNLL 273
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-24
Identities = 58/330 (17%), Positives = 116/330 (35%), Gaps = 41/330 (12%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKNR 360
+ +GSG G + A+ G + +K+L +SE K E+ L +++
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 361 NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
N++ LL + + + R + +G ++
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 421 HHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAP 480
H HR++ + +++D E KI DFGLAR D+ ++ +V Y AP
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYV----VTRWYRAP 187
Query: 481 E-YARTLVATPKGDVYSFGTVLLELVTGERP----------TNVAKAPETFKGNLVEWIA 529
E + T D++S G ++ E++TG+ + K T V+ +
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 530 QLSSTGQLQ-----DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ--F 582
+ ++ + D + L+ +L ++R T E +
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE----KMLVLDAEQRVTAGEALAHPY 303
Query: 583 LRAIGERYHFTTEDEIMLPSDSGDADILEE 612
++ + TEDE + D ++
Sbjct: 304 FESLHD-----TEDEPQVQKYDDSFDDVDR 328
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 3e-22
Identities = 50/259 (19%), Positives = 98/259 (37%), Gaps = 31/259 (11%)
Query: 307 FSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQ-----DSQRSEKEFVAEMATLGSV 357
F ++G+G G ++ + G +K L+ ++ + E L +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 358 KNR-NLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARG 416
+ LV L + + L+ ++ G L+ L + ++ I
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-------QRERFTEHEVQIYVGEI 138
Query: 417 FAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLG 476
L H II+R+I + ILLD + ++DFGL++ +T G +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET---ERAYDFCGTIE 195
Query: 477 YVAPEYARTLVA--TPKGDVYSFGTVLLELVTGERPTNVAKAPETFK-------GNLVEW 527
Y+AP+ R + D +S G ++ EL+TG P V + + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 528 IAQLSSTGQLQDAIDKCLV 546
++S+ +D I + L+
Sbjct: 256 PQEMSA--LAKDLIQRLLM 272
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 91.8 bits (227), Expect = 7e-21
Identities = 43/246 (17%), Positives = 97/246 (39%), Gaps = 27/246 (10%)
Query: 305 NSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NRNL 362
+ + +G G+ +++A+ + + ++VK L+ ++ K+ E+ L +++ N+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 363 VPLLGFCMAKKERL--LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWL 420
+ L R LV++H+ N L +++ + +
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 145
Query: 421 HHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVA 479
H I+HR++ +++D + + ++ D+GLA +P + N +
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-----NVRVASRYFKG 197
Query: 480 PEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538
PE D++S G +L ++ + P + + IA++ T L
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF----FHGHDNYDQLVRIAKVLGTEDLY 253
Query: 539 DAIDKC 544
D IDK
Sbjct: 254 DYIDKY 259
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 6e-20
Identities = 47/209 (22%), Positives = 77/209 (36%), Gaps = 25/209 (11%)
Query: 312 IIGSGRTGTMYKAL-LEDGTSLMVKRLQ---DSQRSEKEFVAEMATLGSVKNRNLVPLLG 367
IGSG G + A ++ +K+L +Q K E+ + V ++N++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 368 FCMAKK------ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLH 421
+K + LV + M + +D R + G LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQME-------LDHERMSYLLYQMLCGIKHLH 136
Query: 422 HNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPE 481
IHR++ I++ D KI DFGLAR S + Y APE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPE 188
Query: 482 YARTLVATPKGDVYSFGTVLLELVTGERP 510
+ D++S G ++ E+V +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 3e-19
Identities = 57/303 (18%), Positives = 108/303 (35%), Gaps = 44/303 (14%)
Query: 304 TNSFSKNNIIGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSE---KEFVAEMATLGSVKN 359
+ + +GSG G++ A + G + VK+L +S K E+ L +K+
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 360 RNLVPLLGFCMAKK-----ERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAA 414
N++ LL + + + H+ L +++ + + +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQIL 131
Query: 415 RGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGD 474
RG ++H HR++ + +++D E KI DFGLAR + T
Sbjct: 132 RGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-------YVAT 181
Query: 475 LGYVAPE-YARTLVATPKGDVYSFGTVLLELVTGERP----------TNVAKAPETFKGN 523
Y APE + D++S G ++ EL+TG + + T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 524 LVEWIAQLSSTGQLQDAIDKC-----LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFE 578
L++ I+ S+ +Q V G + L+ +L +R T +
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE----KMLVLDSDKRITAAQ 297
Query: 579 VYQ 581
Sbjct: 298 ALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.4 bits (215), Expect = 4e-19
Identities = 36/212 (16%), Positives = 74/212 (34%), Gaps = 18/212 (8%)
Query: 313 IGSGRTGTMYKAL-LEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA 371
+G G T++ A + + T + +K ++ + + E+ L V + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 372 KKERLLVY--KHMPNGSLYDLLHPADDT----------GKSVDWPRRLKIAIGAARGFAW 419
+LL + PNG ++ + + +I+ G +
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 420 LHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYV 478
+H C IIH +I + +L++ D + +A L N Y
Sbjct: 141 MHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYR 196
Query: 479 APEYARTLVATPKGDVYSFGTVLLELVTGERP 510
+PE D++S ++ EL+TG+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.3 bits (186), Expect = 1e-15
Identities = 30/71 (42%), Positives = 36/71 (50%), Gaps = 1/71 (1%)
Query: 151 NCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNN 209
LN L L +NR G +P L QL L S +V+ N L G IP NL + NN
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 210 QGLCGEPLDAC 220
+ LCG PL AC
Sbjct: 302 KCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 24/115 (20%), Positives = 41/115 (35%), Gaps = 2/115 (1%)
Query: 56 WNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNK 115
+ G ++ + ++ GLDL +N+
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR 255
Query: 116 LYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIP 170
+YG LP +++L FL SL++S NN G IP N + +N+ P
Sbjct: 256 IYGTLPQGLTQLK-FLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.5 bits (119), Expect = 2e-07
Identities = 45/169 (26%), Positives = 65/169 (38%), Gaps = 31/169 (18%)
Query: 33 EDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGL 92
+D L IK L +P SSW D + GV C + R+
Sbjct: 6 QDKQALLQIKKDLGNPTTL--SSWLPTTDCCN--RTWLGVLC----DTDTQTYRVN---- 53
Query: 93 KGQFPRGIRNCSSMTGLDLSSNKLYG--PLPDDISKLVGFLTSLDLSSN-NFSGSIPSNL 149
LDLS L P+P ++ L +L L + N G IP +
Sbjct: 54 ---------------NLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAI 97
Query: 150 ANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN 198
A T L+ L + H SG IP L Q+ L + + N LSG++P ++
Sbjct: 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.0 bits (115), Expect = 7e-07
Identities = 17/98 (17%), Positives = 28/98 (28%), Gaps = 4/98 (4%)
Query: 56 WNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNK 115
+ L L + + G P+G+ + L++S N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 116 LYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCT 153
L G +P L ++N P L CT
Sbjct: 280 LCGEIP-QGGNLQR-FDVSAYANNKCLCGSP--LPACT 313
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.0 bits (173), Expect = 9e-15
Identities = 27/156 (17%), Positives = 48/156 (30%), Gaps = 22/156 (14%)
Query: 311 NIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEK-----------EFVAEMATLGSVKN 359
++G G+ ++ E +VK + S K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 360 RNLVPLLGFCMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAW 419
R L L G + K Y N L +L+ V ++ A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDA--KELYRVRVENPDEVLDMILEEVAK 118
Query: 420 LHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455
+H I+H ++S +L+ + I DF +
Sbjct: 119 FYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.6 bits (156), Expect = 1e-11
Identities = 33/144 (22%), Positives = 51/144 (35%), Gaps = 12/144 (8%)
Query: 64 GFICKFTGVECWHPDENRVLNL-------RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKL 116
G + T + N++ NL +LT++ L I + +T L
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294
Query: 117 YGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQL 176
+ LT L L NN S P +++ T L L +N+ S L L
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 177 GRLKSFSVANNLLSGSIPTFVNLT 200
+ S +N +S P NLT
Sbjct: 351 TNINWLSAGHNQISDLTP-LANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 1e-11
Identities = 26/86 (30%), Positives = 38/86 (44%), Gaps = 7/86 (8%)
Query: 102 NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161
N ++T L L N + P +S L L L ++N S S+LAN T +N L
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTK-LQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 162 HNRFSGQIPPQLGQLGRLKSFSVANN 187
HN+ S P L L R+ + +
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 23/89 (25%), Positives = 32/89 (35%), Gaps = 4/89 (4%)
Query: 133 SLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192
SL ++N S P T L+ L L+ N+ L L L +ANN +S
Sbjct: 201 SLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 193 IPTFVNLTLSADSVTNNQGLCGEPLDACK 221
P L+ + NQ PL
Sbjct: 257 APLSGLTKLTELKLGANQISNISPLAGLT 285
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 16/98 (16%), Positives = 30/98 (30%), Gaps = 19/98 (19%)
Query: 75 WHPDEN--RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF-- 130
D + L + + +T L I + G
Sbjct: 15 IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG--------IKSIDGVEY 64
Query: 131 ---LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRF 165
LT ++ S+N + P L N T L + +++N+
Sbjct: 65 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.9 bits (148), Expect = 1e-10
Identities = 24/141 (17%), Positives = 43/141 (30%), Gaps = 8/141 (5%)
Query: 48 PFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMT 107
L + E ++ N RL D G++ + S +
Sbjct: 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 372
Query: 108 GLDLSSNKLYGPLPDDISKLVGF---LTSLDLSSNNFSGSIPSNLA-----NCTYLNSLK 159
L L+ + ++ + L LDLS+N + L L L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 160 LDHNRFSGQIPPQLGQLGRLK 180
L +S ++ +L L + K
Sbjct: 433 LYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 15/87 (17%), Positives = 25/87 (28%), Gaps = 4/87 (4%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG----SIPSNLANCTYLNSLKLDHNR 164
LD+ +L ++ L+ + L + I S L L L L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 165 FSGQIPPQLGQLGRLKSFSVANNLLSG 191
+ Q + S + L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 17/98 (17%), Positives = 28/98 (28%), Gaps = 10/98 (10%)
Query: 81 RVLNL---RLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF---LTSL 134
+ L++ L+D P ++ C + L L DIS + L L
Sbjct: 5 QSLDIQCEELSDARWAELLP-LLQQCQV---VRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 135 DLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQ 172
+L SN + S K+
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 2e-04
Identities = 12/69 (17%), Positives = 21/69 (30%), Gaps = 5/69 (7%)
Query: 131 LTSLDLSSNNFSGS-IPSNLANCTYLNSLKLDHNRFSGQ----IPPQLGQLGRLKSFSVA 185
+ SLD+ S + L ++LD + I L L ++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 186 NNLLSGSIP 194
+N L
Sbjct: 64 SNELGDVGV 72
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.7 bits (140), Expect = 7e-10
Identities = 20/132 (15%), Positives = 42/132 (31%), Gaps = 10/132 (7%)
Query: 49 FNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTG 108
N ++ + + E + + + S+
Sbjct: 229 LNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEE 288
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQ 168
L++S+NKL LP + L L S N+ + +P N L+ +++N +
Sbjct: 289 LNVSNNKLIE-LPALPPR----LERLIASFNHLA-EVPELPQNLKQLH---VEYNPLR-E 338
Query: 169 IPPQLGQLGRLK 180
P + L+
Sbjct: 339 FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 11/70 (15%)
Query: 100 IRNC--SSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNS 157
+R+C L+L++ L LP+ L SL S N+ + +P + L S
Sbjct: 32 LRDCLDRQAHELELNNLGL-SSLPELPPHL----ESLVASCNSLT-ELPELPQS---LKS 82
Query: 158 LKLDHNRFSG 167
L +D+N
Sbjct: 83 LLVDNNNLKA 92
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 20/95 (21%), Positives = 34/95 (35%), Gaps = 5/95 (5%)
Query: 102 NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161
C + S L +P D+ LDL +N + + N L++L L
Sbjct: 9 QCHL-RVVQCSDLGLEK-VPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLILI 63
Query: 162 HNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTF 196
+N+ S P L +L+ ++ N L
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM 98
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 34/159 (21%), Positives = 51/159 (32%), Gaps = 17/159 (10%)
Query: 67 CKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISK 126
C V+C +L L + P+ + LDL +NK+ D
Sbjct: 10 CHLRVVQCS--------DLGLE------KVPKDLP--PDTALLDLQNNKITEIKDGDFKN 53
Query: 127 LVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVAN 186
L L +L L +N S P A L L L N+ L L+
Sbjct: 54 LK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEI 112
Query: 187 NLLSGSIPTFVNLTLSADSVTNNQGLCGEPLDACKGTSK 225
+ S+ +N + + TN G A +G K
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 28/175 (16%), Positives = 52/175 (29%), Gaps = 12/175 (6%)
Query: 37 CLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQF 96
LK + + + L N I K ++ V+ L + G
Sbjct: 90 QLKELPEKMPKTLQELRVHENE-------ITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 97 PRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLN 156
+ ++ + ++ + +P + LT L L N + ++L L
Sbjct: 143 NGAFQGMKKLSYIRIADTNI-TTIPQGLPPS---LTELHLDGNKITKVDAASLKGLNNLA 198
Query: 157 SLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNLT-LSADSVTNNQ 210
L L N S L L+ + NN L + + + NN
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 16/76 (21%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSG-SIPSNLANCTYLNSLKLDHNRFSG 167
+ + PL + S + +DLS++ ++ L+ C+ L +L L+ R S
Sbjct: 28 FRCPRSFMDQPLAEHFSPFR--VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSD 85
Query: 168 QIPPQLGQLGRLKSFS 183
I L + L +
Sbjct: 86 PIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 12/89 (13%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 107 TGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFS 166
LDL+ L+ + + + + + + + + + + L ++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59
Query: 167 G-QIPPQLGQLGRLKSFSVANNLLSGSIP 194
+ L Q +L++ S+ LS I
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 5e-06
Identities = 17/66 (25%), Positives = 23/66 (34%), Gaps = 4/66 (6%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ +S ++ L LP D+ K T L LS N + L T L L
Sbjct: 6 VSKVASHLEVNCDKRNLTA-LPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 160 LDHNRF 165
LD
Sbjct: 62 LDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 11/51 (21%), Positives = 17/51 (33%), Gaps = 1/51 (1%)
Query: 137 SSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANN 187
++NN + L L++L L N IP L + N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 1e-05
Identities = 22/135 (16%), Positives = 42/135 (31%), Gaps = 5/135 (3%)
Query: 85 LRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS 144
LR T G + ++T L + + + L + +G L +L + +
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 145 IPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLL--SGSIPTFVN-LTL 201
P L+ L L N + + Q L+ ++ N L S ++
Sbjct: 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEE 130
Query: 202 SADSVTNNQGLCGEP 216
V + C
Sbjct: 131 GLGGVPEQKLQCHGQ 145
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 3e-05
Identities = 22/105 (20%), Positives = 31/105 (29%), Gaps = 25/105 (23%)
Query: 109 LDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPS--NLANCTYLN---------- 156
L L+ L + +L+ +T LDLS N P+ L L
Sbjct: 3 LHLAHKDLTVL--CHLEQLL-LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 157 ---------SLKLDHNRF-SGQIPPQLGQLGRLKSFSVANNLLSG 191
L L +NR L RL ++ N L
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 14/66 (21%), Positives = 22/66 (33%), Gaps = 5/66 (7%)
Query: 102 NCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161
++ L L+ N L +L SS+ S+P LA + +L
Sbjct: 223 PLRALQYLRLNDNPWVCDC--RARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLA 277
Query: 162 HNRFSG 167
N G
Sbjct: 278 ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 24/184 (13%), Positives = 46/184 (25%), Gaps = 31/184 (16%)
Query: 35 LACLKSIKDSLEDPFNYLNSSWNFNNDTEGFICKFTGVECWHPDE----NRVLNLRLTDM 90
L L ++ + + + ++ D + +L L
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 91 GLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGF-------------------- 130
+ R R S+ L L N++ P L
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 131 ---LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANN 187
L L L+ N + +L + + +P +L LK + +
Sbjct: 224 LRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGR-DLKRLAAND- 280
Query: 188 LLSG 191
L G
Sbjct: 281 -LQG 283
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 18/139 (12%), Positives = 35/139 (25%), Gaps = 11/139 (7%)
Query: 53 NSSWNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLS 112
N G+ + L +++ ++ L L+
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 113 SNKLYGPLPDDISKLVGF-----LTSLDLSSNNFSGSIPSNLA-----NCTYLNSLKLDH 162
L + L +L L N L L L+L+
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 163 NRFSGQIPPQLGQLGRLKS 181
NRF + + ++ + S
Sbjct: 312 NRF-SEEDDVVDEIREVFS 329
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 9e-04
Identities = 19/116 (16%), Positives = 34/116 (29%), Gaps = 6/116 (5%)
Query: 56 WNFNNDTEGFICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNK 115
D E+ +L L + + N + + L+LS N
Sbjct: 131 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ---EIHNCAFNGTQLDELNLSDNN 187
Query: 116 LYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPP 171
LP+D+ LD+S L N L + + + ++P
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 10/73 (13%), Positives = 19/73 (26%), Gaps = 5/73 (6%)
Query: 101 RNCS-SMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
R C S +K+ +P D+ + L + L ++
Sbjct: 4 RICHCSNRVFLCQESKVTE-IPSDLPR---NAIELRFVLTKLRVIQKGAFSGFGDLEKIE 59
Query: 160 LDHNRFSGQIPPQ 172
+ N I
Sbjct: 60 ISQNDVLEVIEAD 72
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 5/63 (7%)
Query: 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159
+ N S +T L NK+ P ++ L L + L +N S P LAN + L +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPN-LIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 160 LDH 162
L +
Sbjct: 224 LTN 226
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 623 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.63 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.52 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.36 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.33 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.27 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.22 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.2 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.19 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.19 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.09 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.05 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.02 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.99 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.83 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.8 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.8 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.79 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.61 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.61 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.58 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.43 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.11 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.91 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.88 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.62 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.26 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.29 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.9 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.4 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=403.90 Aligned_cols=258 Identities=21% Similarity=0.362 Sum_probs=200.8
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||+||+|.+.++..||||++.......++|.+|++++++++|||||+++|+|.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 46777899999999999999999999999999988777788999999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++... ...++|..++.++.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 85 g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 85 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999998643 35689999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
.....||+.|+|||++.+..++.++|||||||++|||+|+..|+..... ..+.......... ..
T Consensus 159 ---~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~---~~--- 222 (263)
T d1sm2a_ 159 ---STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFR---LY--- 222 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCC---CC---
T ss_pred ---ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCC---CC---
Confidence 1234589999999999999999999999999999999996555543211 1111111111100 00
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.....+++ +.+++..|+. .||++||||+||++.|++|++.
T Consensus 223 -~p~~~~~~---l~~li~~cl~-~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 -KPRLASTH---VYQIMNHCWK-ERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -CCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CccccCHH---HHHHHHHHcc-CCHhHCcCHHHHHHHHHHHHhC
Confidence 01112333 4456667887 9999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=399.71 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=205.0
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|...+.||+|+||.||+|.+++++.||||+++......+.|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 5677889999999999999999988999999998877778899999999999999999999998754 567999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... ...++|..+++|+.|+++||+|||+. +|+||||||+||||++++.+||+|||+++.+......
T Consensus 92 g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 92 GSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp CBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc-
Confidence 99999885432 24589999999999999999999999 9999999999999999999999999999987543221
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
......||+.|+|||++.+..++.++|||||||++|||+||..|+...... .+.......... .
T Consensus 166 --~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~------~- 229 (272)
T d1qpca_ 166 --AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYR------M- 229 (272)
T ss_dssp --CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC------C-
T ss_pred --cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCC------C-
Confidence 122345899999999999899999999999999999999977766432221 111111111100 0
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
......++++ .+++..|+. .||++||||+||++.|+++
T Consensus 230 ~~p~~~~~~l---~~li~~cl~-~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNCPEEL---YQLMRLCWK-ERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHH
T ss_pred CCcccChHHH---HHHHHHHcC-CCHhHCcCHHHHHHHhhhh
Confidence 0112233444 445567877 9999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=402.86 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=192.3
Q ss_pred cCcccceeeccCccEEEEEEeCC-C---cEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLED-G---TSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
+|...++||+|+||+||+|.++. + ..||||.+.... ...+.|.+|+++|++++|||||++++++.+.+..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 45556899999999999999752 2 358899886542 34567999999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++... ...++|.+++.++.|+|+||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 107 Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp ECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999988643 34699999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCccc-ccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 460 IDTHLS-TFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 460 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...... ....+..||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+. .....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~~~~i~---~~~~~ 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DVINAIE---QDYRL 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHH---TTCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HHHHHHH---cCCCC
Confidence 322211 11223457899999999999999999999999999999998 89998753221 1111111 11100
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
. .....+++ +.+++..|+. .||++||||+||++.|+++.+
T Consensus 253 ~-------~~~~~~~~---l~~li~~cl~-~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 P-------PPMDCPSA---LHQLMLDCWQ-KDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C-------CCTTCCHH---HHHHHHHHTC-SSTTTSCCHHHHHHHHHHHHH
T ss_pred C-------CCccchHH---HHHHHHHHcC-CCHhHCcCHHHHHHHHHHHhc
Confidence 0 01112334 4445567877 999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=392.24 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=198.6
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccc---cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDS---QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||+||+|++++ .||||+++.. ....+.|.+|++++.+++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 568888999999999999998753 5999998643 3345789999999999999999999998754 568999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.++++.. ...++|..++.++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 85 CEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999643 24699999999999999999999999 99999999999999999999999999998765322
Q ss_pred CcccccccCCCCcccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART---LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...+..........
T Consensus 159 ~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 159 GS--HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRGYLSPDLS 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHHTSCCCCGG
T ss_pred Cc--ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCCCCcch
Confidence 21 12233458999999999864 357999999999999999999999997543211 1111111111111111
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
++ ....++++. +++..|+. .||++||||+||++.|+.+++.
T Consensus 233 ~~------~~~~~~~l~---~li~~cl~-~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 233 KV------RSNCPKAMK---RLMAECLK-KKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp GS------CTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHHHT
T ss_pred hc------cccchHHHH---HHHHHHcC-CCHhHCcCHHHHHHHHHHHHHc
Confidence 11 112334444 44567877 9999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-49 Score=400.01 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=210.4
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.++|...+.||+|+||+||+|.+. +++.||||+++......++|.+|++++++++|||||+++++|.+.+..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 356788899999999999999975 5889999999887777888999999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.... ...++|..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 96 ~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999986533 35789999999999999999999999 999999999999999999999999999997654322
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.. ..+..|++.|+|||++.+..++.++|||||||++|||++|+.||....... .+.+.+.. +..
T Consensus 171 ~~---~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----~~~~~i~~----~~~----- 234 (287)
T d1opja_ 171 TA---HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEK----DYR----- 234 (287)
T ss_dssp EE---ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHT----TCC-----
T ss_pred ee---eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH----HHHHHHhc----CCC-----
Confidence 21 123347899999999999999999999999999999999887765422211 11111111 000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.. .....++++ .+++..|+. .||++||||+||++.|+.+.++.
T Consensus 235 ~~-~~~~~~~~l---~~li~~cl~-~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 235 ME-RPEGCPEKV---YELMRACWQ-WNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CC-CCTTCCHHH---HHHHHHHTC-SSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CC-CCccchHHH---HHHHHHHcC-CCHhHCcCHHHHHHHHHHHHHhC
Confidence 00 011233444 445567777 99999999999999999886543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=389.04 Aligned_cols=254 Identities=19% Similarity=0.333 Sum_probs=209.0
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|+..+.||+|+||.||+|++++++.||||+++......++|.+|++++++++|||||+++|+|.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 57888999999999999999999899999999988777788999999999999999999999999999999999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++... ...+++..+++++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 84 g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 84 GCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999997533 35689999999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.......... ..
T Consensus 158 ---~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~---~~-- 221 (258)
T d1k2pa_ 158 ---SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLR---LY-- 221 (258)
T ss_dssp ---CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCC---CC--
T ss_pred ---ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCC---CC--
Confidence 223458999999999999999999999999999999998 89898753321 11111111100 00
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
.....+++ +..++..|+. .||++|||++|+++.|.+|
T Consensus 222 --~p~~~~~~---l~~li~~cl~-~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 --RPHLASEK---VYTIMYSCWH-EKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCTTCCHH---HHHHHHHTTC-SSGGGSCCHHHHHHHHHCC
T ss_pred --CcccccHH---HHHHHHHHcc-CCHhHCcCHHHHHHHhhCC
Confidence 11122333 4455567877 9999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=386.28 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=196.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|+..+.||+|+||+||+|+.. +|+.||+|++.... ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999964 68999999986543 3345689999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999963 35799999999999999999999999 99999999999999999999999999998764322
Q ss_pred CcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 462 THLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
. ........||+.|+|||++.+..+ +.++||||+||++|||+||+.||........ ....+. ......
T Consensus 158 ~--~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~~~~----~~~~~~-- 226 (271)
T d1nvra_ 158 R--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWK----EKKTYL-- 226 (271)
T ss_dssp E--ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HHHHHH----TTCTTS--
T ss_pred c--cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HHHHHh----cCCCCC--
Confidence 1 122334569999999999988776 5789999999999999999999975432111 111111 000000
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .....++++.++ ..+|+. .||++|||++|+++
T Consensus 227 --~--~~~~~s~~~~~l---i~~~L~-~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 --N--PWKKIDSAPLAL---LHKILV-ENPSARITIPDIKK 259 (271)
T ss_dssp --T--TGGGSCHHHHHH---HHHHSC-SSTTTSCCHHHHTT
T ss_pred --C--ccccCCHHHHHH---HHHHcC-CChhHCcCHHHHhc
Confidence 0 001123444444 446666 99999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=388.82 Aligned_cols=259 Identities=21% Similarity=0.357 Sum_probs=196.6
Q ss_pred ccCcccceeeccCccEEEEEEeCCC-----cEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDG-----TSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
+.|+..++||+|+||.||+|.+++. ..||||++.... ....+|.+|++++.+++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999997542 469999986543 334578999999999999999999999999999999
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
|+||+++|++.+++... ...++|.++++++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.+
T Consensus 87 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999987543 35699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...... .....+..||+.|+|||++.+..++.++|||||||++|||++|..|+...... ..+...+....+
T Consensus 161 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~~i~~~~~---- 231 (283)
T d1mqba_ 161 EDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDGFR---- 231 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTCC----
T ss_pred cCCCcc-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHHHHhccCC----
Confidence 543221 11222345899999999999999999999999999999999977776532221 111111111000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.. .....++ .+.+++.+|+. .||++||||.||++.|+++.+
T Consensus 232 -----~~-~~~~~~~---~l~~li~~cl~-~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -----LP-TPMDCPS---AIYQLMMQCWQ-QERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----CC-CCTTCBH---HHHHHHHHHTC-SSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CC-CchhhHH---HHHHHHHHHCc-CCHhHCcCHHHHHHHHHHHhh
Confidence 00 0111233 34556677887 999999999999999998765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=386.70 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=201.6
Q ss_pred ccCcccce-eeccCccEEEEEEeC---CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNI-IGSGRTGTMYKALLE---DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+. ||+|+||.||+|.++ ++..||||+++... ...+.|.+|++++.+++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 999999999999864 45579999997543 345679999999999999999999999865 567899
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++... ...+++..+++++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998532 35699999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+. .+..
T Consensus 161 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----~~~~~i~----~~~~ 230 (285)
T d1u59a_ 161 ADDSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIE----QGKR 230 (285)
T ss_dssp TCSCEE-CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHHHHHH----TTCC
T ss_pred cccccc-ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----cCCC
Confidence 533221 11223458999999999999999999999999999999998 89999754322 1111111 1110
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.+ .....++++. +++..|+. .||++||||.+|++.|+.+..
T Consensus 231 ~~------~p~~~~~~l~---~li~~cl~-~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 ME------CPPECPPELY---ALMSDCWI-YKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CC------CCTTCCHHHH---HHHHHTTC-SSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------CCCcCCHHHH---HHHHHHcC-CCHhHCcCHHHHHHHHHHHHH
Confidence 00 0112334444 45567887 999999999999999987643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=388.32 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=201.3
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
++|+..+.||+|+||.||+|.++++..||||+++......+.|.+|+.++.+++|||||++++++. .++.++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 568889999999999999999998889999999877777889999999999999999999999985 4568999999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.+++.... ...++|.+++.++.|++.||+|||+. +|+||||||+|||+|+++++||+|||+++.........
T Consensus 96 g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999986432 24699999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhchh
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKC 544 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 544 (623)
.....||+.|+|||++....++.++|||||||++|||++|+.|+..... ..+........... .
T Consensus 171 ---~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~~~~------~ 234 (285)
T d1fmka3 171 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRM------P 234 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCC------C
T ss_pred ---eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCC------C
Confidence 1224589999999999999999999999999999999998777654322 11111111111000 0
Q ss_pred hhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 545 LVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 545 l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
.....+++ +.+++.+|+. .||++||+|++|+++|++.-
T Consensus 235 -~~~~~~~~---l~~li~~cl~-~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 -CPPECPES---LHDLMCQCWR-KEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -CCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHTTT
T ss_pred -CCcccCHH---HHHHHHHHcc-cCHhHCcCHHHHHHHHhhhh
Confidence 01122333 4455667877 99999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=387.58 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=189.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe--CCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA--KKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV 378 (623)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ...+.+.+|++++++++|||||++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999964 68999999986543 234568899999999999999999999865 3457899
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC--NPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
|||+++|+|.+++.........+++..++.++.|++.||.|||++. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643333467999999999999999999999872 12499999999999999999999999999998
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+...... ...
T Consensus 164 ~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~-~~~ 230 (269)
T d2java1 164 LNHDTSF----AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIR-EGK 230 (269)
T ss_dssp C---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH-HTC
T ss_pred cccCCCc----cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHH-cCC
Confidence 6543221 2234589999999999999999999999999999999999999975321 11111111 111
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
... + ....++++..+ +.+|+. .||++|||++|+++
T Consensus 231 ~~~-----~-~~~~s~~l~~l---i~~~L~-~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FRR-----I-PYRYSDELNEI---ITRMLN-LKDYHRPSVEEILE 265 (269)
T ss_dssp CCC-----C-CTTSCHHHHHH---HHHHTC-SSGGGSCCHHHHHT
T ss_pred CCC-----C-CcccCHHHHHH---HHHHcC-CChhHCcCHHHHHh
Confidence 111 0 11234454444 446766 99999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=378.32 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=199.2
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|+.+ +++.||+|++... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999975 6889999998643 234677899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999963 24689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 159 ~~~------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~--- 221 (263)
T d2j4za1 159 SRR------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEF--- 221 (263)
T ss_dssp CCC------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCC---
T ss_pred Ccc------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC---
Confidence 221 123589999999999999999999999999999999999999975321 111111111100
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+ .+..++++.+++ ..|+. .||++|||++|+++
T Consensus 222 ----~~-p~~~s~~~~~li---~~~L~-~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----TF-PDFVTEGARDLI---SRLLK-HNPSQRPMLREVLE 254 (263)
T ss_dssp ----CC-CTTSCHHHHHHH---HHHTC-SSGGGSCCHHHHHT
T ss_pred ----CC-CccCCHHHHHHH---HHHcc-CCHhHCcCHHHHHc
Confidence 00 112344555444 45666 99999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=382.83 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=193.4
Q ss_pred ceeeccCccEEEEEEeCC---CcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecCCC
Q 006982 311 NIIGSGRTGTMYKALLED---GTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHMPN 384 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 384 (623)
+.||+|+||+||+|.+++ ++.||||+++... ...+.|.+|++++++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 4679999996532 235679999999999999999999999865 457899999999
Q ss_pred CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCcc
Q 006982 385 GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTHL 464 (623)
Q Consensus 385 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 464 (623)
|+|.++++. ...++|..+++++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999963 35699999999999999999999999 99999999999999999999999999999765433222
Q ss_pred cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhch
Q 006982 465 STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAIDK 543 (623)
Q Consensus 465 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 543 (623)
. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+. ..... .
T Consensus 165 ~-~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----~~~~~i~---~~~~~-~---- 230 (277)
T d1xbba_ 165 K-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLE---KGERM-G---- 230 (277)
T ss_dssp E-C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH---TTCCC-C----
T ss_pred c-cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----HHHHHHH---cCCCC-C----
Confidence 1 1223458999999999999999999999999999999998 89999753221 1111111 11000 0
Q ss_pred hhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 544 CLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 544 ~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
.....++++. +++..|+. .||++||||++|++.|+..
T Consensus 231 --~p~~~~~~~~---~li~~cl~-~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 --CPAGCPREMY---DLMNLCWT-YDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --CCTTCCHHHH---HHHHHHTC-SSTTTSCCHHHHHHHHHHH
T ss_pred --CCcccCHHHH---HHHHHHcC-CCHhHCcCHHHHHHHhhCH
Confidence 0112344444 45557877 9999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=380.87 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=199.1
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4689999999999999999995 579999999986543 45677999999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998853 3589999999999999999999999 999999999999999999999999999998754332
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||...... +........... .+-
T Consensus 172 ~----~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~~~~~~~-~~~- 237 (293)
T d1yhwa1 172 K----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTP-ELQ- 237 (293)
T ss_dssp C----BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCSC-CCS-
T ss_pred c----ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCCC-CCC-
Confidence 2 22345999999999999999999999999999999999999999753221 111111110000 000
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.....++++..+ ...|+. .||++|||++|+++
T Consensus 238 ---~~~~~s~~~~~l---i~~~L~-~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 ---NPEKLSAIFRDF---LNRCLD-MDVEKRGSAKELLQ 269 (293)
T ss_dssp ---SGGGSCHHHHHH---HHHHTC-SSTTTSCCHHHHTT
T ss_pred ---CcccCCHHHHHH---HHHHcc-CChhHCcCHHHHhc
Confidence 001123344444 445665 99999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=382.57 Aligned_cols=275 Identities=21% Similarity=0.283 Sum_probs=205.0
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC----eeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----ERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e 380 (623)
++|...+.||+|+||.||+|++ +|+.||||+++........++.|+..+.+++|||||++++++.+.+ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4566778999999999999997 5889999999765544444556677778899999999999998654 5689999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC-----NPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
|+++|+|.++++. ..++|..+++++.|+|.||+|||+.. .++|+||||||+||||++++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999963 35899999999999999999999741 3489999999999999999999999999999
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccc------c
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLV------ATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKG------N 523 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~------~ 523 (623)
.................||+.|+|||++.... ++.++|||||||++|||+||..||........... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 87554333333334566999999999987542 57799999999999999999988754332211100 0
Q ss_pred HHHHHHHHhccCchhhhhchhhhcCC-CHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 524 LVEWIAQLSSTGQLQDAIDKCLVAKG-VDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 524 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
.............. ++.+.... ..+....+.+++..|+. .||++||||.||++.|+++.++-
T Consensus 237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~-~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWY-ANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCC-SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcc-cCHhHCcCHHHHHHHHHHHHHhc
Confidence 11111111111111 11111110 12344557778888887 99999999999999999987654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=390.41 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=199.2
Q ss_pred ccCcccceeeccCccEEEEEEeCC------CcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED------GTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
++|...+.||+|+||+||+|++.. ...||+|.+.... .....+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568888999999999999998642 2368999986532 3346789999999998 899999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCC-------------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 006982 376 LLVYKHMPNGSLYDLLHPADD-------------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSK 436 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~ 436 (623)
++||||+++|+|.++++.... ....++|..++.++.|++.||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999965432 124589999999999999999999999 9999999999
Q ss_pred ceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 006982 437 CILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAK 515 (623)
Q Consensus 437 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~ 515 (623)
|||++.++.+||+|||+|+........ ....+..||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccccccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999876543221 11223347999999999999999999999999999999998 899997543
Q ss_pred CcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 006982 516 APETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLR 584 (623)
Q Consensus 516 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~ 584 (623)
... .+.+.+....+ . + .....++++. +++..|+. .||++||||+||+++|.
T Consensus 272 ~~~----~~~~~~~~~~~---~-~------~p~~~~~~l~---~li~~cl~-~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA----NFYKLIQNGFK---M-D------QPFYATEEIY---IIMQSCWA-FDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH----HHHHHHHTTCC---C-C------CCTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHH
T ss_pred HHH----HHHHHHhcCCC---C-C------CCCcCCHHHH---HHHHHHcC-CChhHCcCHHHHHHHHh
Confidence 321 12221111100 0 0 0112334444 44556777 99999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=379.62 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=204.7
Q ss_pred cceeeccCccEEEEEEeCCC----cEEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeC-CeeeEEEecC
Q 006982 310 NNIIGSGRTGTMYKALLEDG----TSLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-KERLLVYKHM 382 (623)
Q Consensus 310 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 382 (623)
.++||+|+||+||+|.+.++ ..||||+++.. ....++|.+|++++++++|||||+++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 35899999643 33457799999999999999999999998764 5789999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.++++.. ...+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998643 34678899999999999999999999 999999999999999999999999999998765443
Q ss_pred cccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 463 HLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
.......+..||+.|+|||++.+..++.++||||||+++|||+||+.||....... ....++.. ..+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----~~~~~i~~---g~~~----- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQ---GRRL----- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHT---TCCC-----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----HHHHHHHc---CCCC-----
Confidence 33333334568999999999999999999999999999999999888886432211 11121111 1100
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCC
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTT 594 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 594 (623)
......+++ +.+++..|+. .||++||+|.||++.|+++.+++....
T Consensus 254 --~~p~~~~~~---l~~li~~cl~-~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 254 --LQPEYCPDP---LYEVMLKCWH-PKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp --CCCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred --CCcccCcHH---HHHHHHHHcC-CCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 011123344 4455668888 999999999999999999988765543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-47 Score=384.49 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=206.1
Q ss_pred HHHhccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC
Q 006982 301 MKATNSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK 372 (623)
Q Consensus 301 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 372 (623)
+-..++|+..+.||+|+||.||+|+++ +++.||||+++... ...++|.+|++++++++||||++++++|.+.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334567999999999999999999864 45789999997543 3356799999999999999999999999999
Q ss_pred CeeeEEEecCCCCCHhhhccCCC--------------------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 006982 373 KERLLVYKHMPNGSLYDLLHPAD--------------------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRN 432 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~d 432 (623)
+..++|+||+++|+|.++++... .....++|..+++|+.|++.||+|||+. +|+|||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeE
Confidence 99999999999999999985422 1124589999999999999999999999 999999
Q ss_pred CCCCceeeCCCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CC
Q 006982 433 ISSKCILLDDDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGER-PT 511 (623)
Q Consensus 433 lk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~-P~ 511 (623)
|||+|||+|.++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCcccc--ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999998765432221 1223457899999999999999999999999999999999865 55
Q ss_pred CCCCCcccccccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 512 NVAKAPETFKGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 512 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
..... .+..... ..+..... ....++ .+.+++..|+. .+|++||||.||+++|++|.+
T Consensus 244 ~~~~~--------~e~~~~v-~~~~~~~~------p~~~~~---~~~~li~~cl~-~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMAH--------EEVIYYV-RDGNILAC------PENCPL---ELYNLMRLCWS-KLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSCH--------HHHHHHH-HTTCCCCC------CTTCCH---HHHHHHHHHTC-SSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCH--------HHHHHHH-HcCCCCCC------CccchH---HHHHHHHHHcC-CChhHCcCHHHHHHHHHHhcC
Confidence 53221 1111111 11111110 112233 34556667877 999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=387.61 Aligned_cols=200 Identities=23% Similarity=0.391 Sum_probs=176.2
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
.++|+..+.||+|+||+||+|... +|+.||+|+++... .....+.+|++++++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999964 78999999986542 335678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999963 246899999999999999999999732 7999999999999999999999999999865321
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
...+..||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 159 ------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1223469999999999999999999999999999999999999997644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=374.56 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=193.4
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEe-CCeeeEEEecCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMA-KKERLLVYKHMP 383 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~ 383 (623)
++|...+.||+|+||.||+|.++ |+.||||+++... ..+.+.+|++++++++|||||+++|+|.+ ++..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 45777889999999999999985 7899999997643 45679999999999999999999999865 456789999999
Q ss_pred CCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCCc
Q 006982 384 NGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDTH 463 (623)
Q Consensus 384 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 463 (623)
+|+|.++++... ...++|..+++++.|++.||.|||+. +|+||||||+|||++.++.+|++|||+++......
T Consensus 85 ~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 85 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 999999996432 23589999999999999999999999 99999999999999999999999999998754321
Q ss_pred ccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCchhhhhc
Q 006982 464 LSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDAID 542 (623)
Q Consensus 464 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 542 (623)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+..++....+ .++
T Consensus 158 -----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~~~i~~~~~----~~~-- 221 (262)
T d1byga_ 158 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYK----MDA-- 221 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTTTCC----CCC--
T ss_pred -----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCC----CCC--
Confidence 12237889999999999999999999999999999998 6777654322 122222221110 011
Q ss_pred hhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 543 KCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 543 ~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
....++++. +++..|+. .||++||||.|++++|++++.
T Consensus 222 ----~~~~~~~~~---~li~~cl~-~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 ----PDGCPPAVY---EVMKNCWH-LDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ----CTTCCHHHH---HHHHHHTC-SSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CccCCHHHH---HHHHHHcc-cCHhHCcCHHHHHHHHHHHHh
Confidence 111234444 44557777 999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=372.17 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=188.8
Q ss_pred cccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEe----CCeeeEEE
Q 006982 308 SKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMA----KKERLLVY 379 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 379 (623)
...+.||+|+||+||+|... ++..||+|++.... ...+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34568999999999999965 68899999986543 234578999999999999999999999875 34568999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC-CCCCeEEeecccccccC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD-DDFEPKISDFGLARLMN 458 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~-~~~~~kl~Dfgla~~~~ 458 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ .++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999963 35689999999999999999999998 12399999999999996 57899999999998654
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .............
T Consensus 167 ~~~------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~~~~~- 231 (270)
T d1t4ha_ 167 ASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVKP- 231 (270)
T ss_dssp TTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCCC-
T ss_pred CCc------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHcCCCC-
Confidence 321 123459999999999875 5899999999999999999999999643221 1111111111000
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..+ .....+++. +++..|+. .||++|||++|+++
T Consensus 232 ----~~~-~~~~~~~~~---~li~~~l~-~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ----ASF-DKVAIPEVK---EIIEGCIR-QNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGG-GGCCCHHHH---HHHHHHSC-SSGGGSCCHHHHHT
T ss_pred ----ccc-CccCCHHHH---HHHHHHcc-CCHhHCcCHHHHhC
Confidence 011 112333444 44556776 99999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=377.97 Aligned_cols=250 Identities=19% Similarity=0.269 Sum_probs=196.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc-cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS-QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
+.|+..+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35788899999999999999964 6899999998653 344567899999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPIDT 462 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 462 (623)
++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-- 163 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 163 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence 999999997532 24699999999999999999999999 9999999999999999999999999999765321
Q ss_pred cccccccCCCCcccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 463 HLSTFVNGEFGDLGYVAPEYAR-----TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 463 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
........||+.|+|||++. ...|+.++|||||||++|||+||+.||......+ .+.... ....
T Consensus 164 --~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~~i~----~~~~- 232 (288)
T d2jfla1 164 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLLKIA----KSEP- 232 (288)
T ss_dssp --HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHH----HSCC-
T ss_pred --cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHH----cCCC-
Confidence 11223456999999999984 4568899999999999999999999997543221 111111 1100
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
..+. .....++++.++ ...|+. .||++|||++|+++
T Consensus 233 ~~~~----~~~~~s~~~~~l---i~~~L~-~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PTLA----QPSRWSSNFKDF---LKKCLE-KNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCS----SGGGSCHHHHHH---HHHHSC-SSTTTSCCHHHHTT
T ss_pred CCCC----ccccCCHHHHHH---HHHHcc-CChhHCcCHHHHhc
Confidence 0000 001123444444 445666 99999999999865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=374.62 Aligned_cols=250 Identities=19% Similarity=0.247 Sum_probs=198.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56899999999999999999964 7899999998643 234567999999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999863 35689999999999999999999999 999999999999999999999999999997754
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ..
T Consensus 161 ~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~-~~-- 227 (288)
T d1uu3a_ 161 ESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------LIFQKIIKL-EY-- 227 (288)
T ss_dssp -----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTT-CC--
T ss_pred CCcc--cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--------HHHHHHHcC-CC--
Confidence 2221 1223346999999999999999999999999999999999999999753211 111111111 00
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFL 583 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L 583 (623)
.+ ....++++.+ +...|+. .||++|||++|++..-
T Consensus 228 ----~~-p~~~s~~~~~---li~~~L~-~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 228 ----DF-PEKFFPKARD---LVEKLLV-LDATKRLGCEEMEGYG 262 (288)
T ss_dssp ----CC-CTTCCHHHHH---HHHTTSC-SSGGGSTTSGGGTCHH
T ss_pred ----CC-CccCCHHHHH---HHHHHcc-CCHhHCcCHHHHcCCH
Confidence 00 1123344443 4446666 9999999999986543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=379.81 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=198.5
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCc----EEEEEEeccc--cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGT----SLMVKRLQDS--QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 377 (623)
.+|+..++||+|+||+||+|.+. +|+ +||+|+++.. ....++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999864 443 5899988643 34567899999999999999999999999865 5678
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
++||+.+|+|.+++... ...++|..+++++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988643 35789999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |..||...... .+...+....+..
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----~~~~~i~~~~~~~- 233 (317)
T d1xkka_ 162 GAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGERLP- 233 (317)
T ss_dssp TTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----GHHHHHHHTCCCC-
T ss_pred ccccccc--cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCCCC-
Confidence 5433222 1223358999999999999999999999999999999999 78887653221 1222221111000
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
.....+++ +.+++..|+. .||++|||+.||++.|+.+...
T Consensus 234 ---------~p~~~~~~---~~~li~~cl~-~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 234 ---------QPPICTID---VYMIMVKCWM-IDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---------CCTTBCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------CCcccCHH---HHHHHHHhCC-CChhhCcCHHHHHHHHHHHHhC
Confidence 01112333 4455567877 9999999999999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-46 Score=377.63 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=194.9
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
..|+..+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3488899999999999999995 478899999986543 23356889999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|..++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999877642 35689999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCcccccccCCCCcccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYART---LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
. ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... +........ .
T Consensus 168 ~--------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------~~~~~i~~~-~ 230 (309)
T d1u5ra_ 168 A--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQN-E 230 (309)
T ss_dssp B--------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHS-C
T ss_pred C--------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC-C
Confidence 2 12358999999999864 46899999999999999999999999753221 111111111 0
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.+.+.....++++..++ ..|+. .||++|||++|+++
T Consensus 231 -----~~~~~~~~~s~~~~~li---~~~L~-~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 -----SPALQSGHWSEYFRNFV---DSCLQ-KIPQDRPTSEVLLK 266 (309)
T ss_dssp -----CCCCSCTTSCHHHHHHH---HHHTC-SSGGGSCCHHHHTT
T ss_pred -----CCCCCCCCCCHHHHHHH---HHHCc-CChhHCcCHHHHHh
Confidence 01111122344555444 45666 99999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=371.62 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=192.4
Q ss_pred ccCcccceeeccCccEEEEEEeCC----CcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED----GTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||.||+|.+.. +..||+|.++... ...+.|.+|++++++++|||||++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 468888999999999999998642 4568999886532 33567999999999999999999999985 4678999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 86 ~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999987533 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccCch
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTGQL 537 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 537 (623)
....... ....||+.|+|||++.+..++.++|||||||++|||+| |..||...... .+...+.. ....
T Consensus 160 ~~~~~~~---~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----~~~~~i~~---~~~~ 228 (273)
T d1mp8a_ 160 DSTYYKA---SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIEN---GERL 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHT---TCCC
T ss_pred CCcceec---cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc---CCCC
Confidence 4322211 22347899999999999999999999999999999998 88888754332 12221111 1000
Q ss_pred hhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 538 QDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 538 ~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
. .....++++.+ ++..|+. .||++|||+.||++.|+++.++
T Consensus 229 -~------~~~~~~~~~~~---li~~cl~-~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 -P------MPPNCPPTLYS---LMTKCWA-YDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -C------CCTTCCHHHHH---HHHHHTC-SSGGGSCCHHHHHHHHHHHHHH
T ss_pred -C------CCCCCCHHHHH---HHHHHcC-CCHhHCcCHHHHHHHHHHHHHH
Confidence 0 01123444444 4457777 9999999999999999988654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-45 Score=373.10 Aligned_cols=249 Identities=20% Similarity=0.290 Sum_probs=183.3
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
+.|...+.||+|+||+||+|... +++.||+|++.... .....+.+|++++++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45888999999999999999965 68999999986543 3345688999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC---CCCCeEEeecccccccC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD---DDFEPKISDFGLARLMN 458 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~---~~~~~kl~Dfgla~~~~ 458 (623)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++...
T Consensus 89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999963 35699999999999999999999999 999999999999994 57899999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..........
T Consensus 162 ~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~-- 226 (307)
T d1a06a_ 162 PGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAEY-- 226 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTCC--
T ss_pred CCCe-----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCC--
Confidence 4221 22345999999999999999999999999999999999999999753221 11111111100
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
. .... .....++++.++ ...|+. .||++|||++|+++
T Consensus 227 ~-~~~~-~~~~~s~~~~~l---i~~~L~-~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 E-FDSP-YWDDISDSAKDF---IRHLME-KDPEKRFTCEQALQ 263 (307)
T ss_dssp C-CCTT-TTTTSCHHHHHH---HHHHSC-SSGGGSCCHHHHHH
T ss_pred C-CCCc-cccCCCHHHHHH---HHHHcc-CCHhHCcCHHHHhc
Confidence 0 0000 001123444444 445666 99999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=374.78 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=200.1
Q ss_pred ccCcccceeeccCccEEEEEEeCC-Cc--EEEEEEeccc--cccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLED-GT--SLMVKRLQDS--QRSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 378 (623)
++|+..+.||+|+||.||+|.+++ +. .||||++... ....+.|.+|++++.++ +|||||+++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568888999999999999999754 43 4778887543 23456799999999998 799999999999999999999
Q ss_pred EecCCCCCHhhhccCCC------------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCe
Q 006982 379 YKHMPNGSLYDLLHPAD------------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEP 446 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~ 446 (623)
|||+++|+|.++++... .....++|..+++++.|+|.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997542 2346799999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCcccccccHH
Q 006982 447 KISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGER-PTNVAKAPETFKGNLV 525 (623)
Q Consensus 447 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~-P~~~~~~~~~~~~~l~ 525 (623)
||+|||+++........ ....||..|+|||.+....++.++|||||||++|||++|.. ||.... ..
T Consensus 167 kl~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~ 233 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CA 233 (309)
T ss_dssp EECCTTCEESSCEECCC---------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred EEccccccccccccccc-----cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HH
Confidence 99999999865432211 12348999999999999999999999999999999999776 454321 11
Q ss_pred HHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 526 EWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
+.......... .. .....++++.. ++.+|+. .||++||||+||++.|+++.++.
T Consensus 234 ~~~~~i~~~~~------~~-~~~~~~~~~~~---li~~cl~-~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 234 ELYEKLPQGYR------LE-KPLNCDDEVYD---LMRQCWR-EKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHHGGGTCC------CC-CCTTBCHHHHH---HHHHHTC-SSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHhcCC------CC-CCccCCHHHHH---HHHHHcC-CChhHCcCHHHHHHHHHHHHhcC
Confidence 11111111100 00 01112344444 4456777 99999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-44 Score=373.76 Aligned_cols=251 Identities=19% Similarity=0.333 Sum_probs=199.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ...+.+.+|++++.+++|||||++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47899999999999999999964 78999999997643 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC--CCCCeEEeecccccccCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD--DDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~--~~~~~kl~Dfgla~~~~~~ 460 (623)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999998532 34699999999999999999999999 999999999999996 4678999999999987643
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.......... ..
T Consensus 180 ~~~-----~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~--~~ 244 (350)
T d1koaa2 180 QSV-----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDW--NM 244 (350)
T ss_dssp SCE-----EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC--CS
T ss_pred ccc-----ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC--CC
Confidence 322 2234899999999999999999999999999999999999999753221 11111111100 00
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
..... ...++++.++ +..|+. .||++|||++|+++.
T Consensus 245 ~~~~~--~~~s~~~~~l---i~~~L~-~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAF--SGISEDGKDF---IRKLLL-ADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGG--GGCCHHHHHH---HHHHCC-SSGGGSCCHHHHHHS
T ss_pred Ccccc--cCCCHHHHHH---HHHHcc-CChhHCcCHHHHhcC
Confidence 00000 1123444444 446666 999999999999763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-44 Score=375.14 Aligned_cols=250 Identities=19% Similarity=0.275 Sum_probs=199.3
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|...+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|++++++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4689999999999999999996 479999999986543 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC--CCCCeEEeecccccccCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD--DDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~--~~~~~kl~Dfgla~~~~~~ 460 (623)
++|+|.+++.. .+..+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999998753 234699999999999999999999999 999999999999998 6789999999999987653
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... +.......... ..
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~--~~ 247 (352)
T d1koba_ 183 EIV-----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDW--EF 247 (352)
T ss_dssp SCE-----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCC--CC
T ss_pred Cce-----eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC--CC
Confidence 222 2234899999999999999999999999999999999999999753221 11111111000 00
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
... .....++++. .++..|+. .||++|||++|+++
T Consensus 248 -~~~-~~~~~s~~~~---~li~~~L~-~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 -DED-AFSSVSPEAK---DFIKNLLQ-KEPRKRLTVHDALE 282 (352)
T ss_dssp -CSS-TTTTSCHHHH---HHHHTTSC-SSGGGSCCHHHHHT
T ss_pred -Ccc-cccCCCHHHH---HHHHHHcc-CChhHCcCHHHHhc
Confidence 000 0011234444 44456776 99999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=371.80 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=192.0
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCC-e
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKK-E 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~ 374 (623)
++|...+.||+|+||.||+|.+. +++.||||+++... ...+.+..|...+.++ +|+||+.+++++...+ .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57888999999999999999853 34689999997543 3356678888888777 6899999999987654 5
Q ss_pred eeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC
Q 006982 375 RLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD 442 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~ 442 (623)
.++||||+++|+|.++++.... ....++|.+++.++.|+++||+|||++ +|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 7899999999999999864321 124589999999999999999999999 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCccccc
Q 006982 443 DFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGER-PTNVAKAPETFK 521 (623)
Q Consensus 443 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~-P~~~~~~~~~~~ 521 (623)
++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+||.. ||......+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--- 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--- 244 (299)
T ss_dssp GGCEEECC------CCSCTTS--CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---
T ss_pred CCcEEEccCcchhhccccccc--cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999876543222 12223458999999999999999999999999999999999754 665432211
Q ss_pred ccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
.+...+.. +.... ..+..+++ +.+++..|+. .||++|||++||+++|+++.+
T Consensus 245 -~~~~~~~~----~~~~~------~~~~~~~~---l~~li~~cl~-~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 245 -EFCRRLKE----GTRMR------APDYTTPE---MYQTMLDCWH-GEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -HHHHHHHH----TCCCC------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhc----CCCCC------CCccCCHH---HHHHHHHHcC-CChhHCcCHHHHHHHHHHHHh
Confidence 11111111 11000 01122333 4455567877 999999999999999998865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=363.82 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=197.9
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc-------ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ-------RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
+.|...+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688899999999999999996 478999999985421 24678999999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC----CeEEeecc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF----EPKISDFG 452 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~----~~kl~Dfg 452 (623)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+|++|||
T Consensus 90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999963 24699999999999999999999999 999999999999998776 49999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHh
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLS 532 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~ 532 (623)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......
T Consensus 163 ~a~~~~~~~~-----~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~ 229 (293)
T d1jksa_ 163 LAHKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVS 229 (293)
T ss_dssp TCEECTTSCB-----CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred hhhhcCCCcc-----ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHH
Confidence 9987654322 12345899999999999999999999999999999999999999753221 1111111
Q ss_pred cc-CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 533 ST-GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 533 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.. ..... ... ...++++. .+...|+. .||++|||++|+++
T Consensus 230 ~~~~~~~~----~~~-~~~s~~~~---~li~~~L~-~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 AVNYEFED----EYF-SNTSALAK---DFIRRLLV-KDPKKRMTIQDSLQ 270 (293)
T ss_dssp TTCCCCCH----HHH-TTSCHHHH---HHHHTTSC-SSGGGSCCHHHHHH
T ss_pred hcCCCCCc----hhc-CCCCHHHH---HHHHHHcc-CChhHCcCHHHHhc
Confidence 11 00000 000 11233333 34456766 99999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=371.81 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=204.2
Q ss_pred ccCcccceeeccCccEEEEEEe------CCCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCCee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL------EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKKER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 375 (623)
++|...+.||+|+||.||+|++ .+++.||||+++... .....+.+|+.++.++ +|||||+++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677789999999999999985 346789999997543 3445789999999999 699999999999999999
Q ss_pred eEEEecCCCCCHhhhccCCCC--------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 376 LLVYKHMPNGSLYDLLHPADD--------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
++||||+++|+|.++++.... ....+++..++.++.|+++||+|||++ +|+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 999999999999999865431 224689999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccccc
Q 006982 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFK 521 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~ 521 (623)
.++.+|++|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+|+..|+...... .
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---~ 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---D 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---S
T ss_pred ccCcccccccchheeccCCCcc--eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---H
Confidence 9999999999999976543322 2223445899999999999999999999999999999999955554322211 1
Q ss_pred ccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhc
Q 006982 522 GNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGE 588 (623)
Q Consensus 522 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~ 588 (623)
..+.+.+....+. ......+++ +.+++.+|+. .||++||||+||+++|+++..
T Consensus 255 ~~~~~~i~~~~~~----------~~~~~~~~~---l~~Li~~cl~-~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 255 SKFYKMIKEGFRM----------LSPEHAPAE---MYDIMKTCWD-ADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHHHTCCC----------CCCTTSCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCC----------CCcccccHH---HHHHHHHHcC-CChhHCcCHHHHHHHHHHhhc
Confidence 1122222211100 001112333 4555667887 999999999999999997644
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=367.91 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=191.9
Q ss_pred ccCcccceeeccCccEEEEEEeC--C--CcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE--D--GTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|+..+.||+|+||.||+|++. + ...||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999853 2 236899998653 2334679999999999999999999999965 4678
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+|+||+++|++.+++... ...+++..++.++.|+|.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999987642 24699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ .......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...... +........+
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--------~~~~~i~~~~ 231 (273)
T d1u46a_ 161 LPQNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKEG 231 (273)
T ss_dssp CCC-CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTSC
T ss_pred cccCCCcc-eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--------HHHHHHHhCC
Confidence 75433221 12223347889999999999999999999999999999998 89999743221 1111211111
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAI 586 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i 586 (623)
...+ .....+.+ +.+++..|+. .||++||||.||.+.|++.
T Consensus 232 ~~~~------~~~~~~~~---l~~li~~cl~-~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ERLP------RPEDCPQD---IYNVMVQCWA-HKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC------CCTTCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHH
T ss_pred CCCC------CcccccHH---HHHHHHHHcC-CChhHCcCHHHHHHHHHhc
Confidence 1000 01122333 4455567877 9999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=369.62 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=199.1
Q ss_pred ccCcccceeeccCccEEEEEEeC--------CCcEEEEEEecccc--ccHHHHHHHHHHhCCC-CCCCCcceeEEEEeCC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE--------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSV-KNRNLVPLLGFCMAKK 373 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 373 (623)
++|...+.||+|+||.||+|+.. ++..||||+++... ....++.+|...+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 56788899999999999999853 23579999997644 3446788899998888 8999999999999999
Q ss_pred eeeEEEecCCCCCHhhhccCCCC------------CCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC
Q 006982 374 ERLLVYKHMPNGSLYDLLHPADD------------TGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD 441 (623)
Q Consensus 374 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~ 441 (623)
..++||||+++|+|.+++..... ....+++.++++++.|++.||+|||+. +|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999965431 235689999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 006982 442 DDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVT-GERPTNVAKAPETF 520 (623)
Q Consensus 442 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~ellt-g~~P~~~~~~~~~~ 520 (623)
.++.+||+|||+++........ .......+|+.|+|||.+.+..|+.++|||||||++|||++ |..||......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred CCCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 9999999999999976543222 11233458999999999999999999999999999999998 67777542211
Q ss_pred cccHHHHHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 006982 521 KGNLVEWIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIG 587 (623)
Q Consensus 521 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~ 587 (623)
.+...+. .+.... . ....+++ +.+++.+|+. .||++|||+.||++.|+++.
T Consensus 245 --~~~~~i~----~~~~~~-----~-p~~~~~~---l~~li~~cl~-~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 --ELFKLLK----EGHRMD-----K-PSNCTNE---LYMMMRDCWH-AVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp --HHHHHHH----TTCCCC-----C-CSSCCHH---HHHHHHHHTC-SSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHH----cCCCCC-----C-CccchHH---HHHHHHHHcc-CCHhHCcCHHHHHHHHHHHh
Confidence 1111111 110000 0 1122333 4556677887 99999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=370.32 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=205.0
Q ss_pred ccCcccceeeccCccEEEEEEeC------CCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE------DGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||+||+|.+. +++.||||+++... .....|.+|++++.+++|||||++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56778899999999999999863 35789999997543 33456899999999999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCC------CCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEee
Q 006982 377 LVYKHMPNGSLYDLLHPAD------DTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~D 450 (623)
+||||+++|+|.+++.... .....++|..+.+++.|+|+||.|||+. +|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 9999999999999885321 1224578999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCcccccccHHHHHH
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGE-RPTNVAKAPETFKGNLVEWIA 529 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~-~P~~~~~~~~~~~~~l~~~~~ 529 (623)
||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+||. .||... ...+...
T Consensus 177 FGla~~~~~~~~~--~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~~~~~ 246 (308)
T d1p4oa_ 177 FGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNEQVLR 246 (308)
T ss_dssp TTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHHHHHH
T ss_pred cccceeccCCcce--eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHHHHHH
Confidence 9999876543221 2223345899999999999999999999999999999999986 555432 1122222
Q ss_pred HHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhccc
Q 006982 530 QLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERY 590 (623)
Q Consensus 530 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~ 590 (623)
..... ...+. ....++ .+.+++..|+. .+|++||||.||+++|++..++.
T Consensus 247 ~i~~~-~~~~~------p~~~~~---~l~~li~~cl~-~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 247 FVMEG-GLLDK------PDNCPD---MLFELMRMCWQ-YNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp HHHTT-CCCCC------CTTCCH---HHHHHHHHHTC-SSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHHhC-CCCCC------cccchH---HHHHHHHHHcC-CChhHCcCHHHHHHHHHHhcCCC
Confidence 22211 11110 111223 35555667877 99999999999999998876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-44 Score=363.09 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=197.4
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc----ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC----ee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ----RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----ER 375 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 375 (623)
++|...+.||+|+||.||+|.. .+++.||+|+++... .....+.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5688999999999999999996 579999999996542 23457899999999999999999999987654 36
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||++.++..+++|||.++
T Consensus 87 ~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 899999999999998853 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 456 LMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 456 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.........
T Consensus 160 ~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~~~~~~ 230 (277)
T d1o6ya_ 160 AIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVRED 230 (277)
T ss_dssp ECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred hhcccccc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--------HHHHHHHhcC
Confidence 65432211 11223446899999999999999999999999999999999999999753221 1111111111
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHhh
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-TMFEVYQFLRAIG 587 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-s~~ev~~~L~~i~ 587 (623)
.. .+.......++++.+++ .+|+. .||++|| |++++...|.+++
T Consensus 231 ~~----~~~~~~~~~s~~l~~li---~~~L~-~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 PI----PPSARHEGLSADLDAVV---LKALA-KNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CC----CGGGTSSSCCHHHHHHH---HHHTC-SSGGGSCSSHHHHHHHHHHHH
T ss_pred CC----CCchhccCCCHHHHHHH---HHHcc-CCHhHCHhHHHHHHHHHHHHh
Confidence 11 01111122345555544 45666 9999999 8999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-44 Score=366.20 Aligned_cols=246 Identities=20% Similarity=0.242 Sum_probs=198.9
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||.||+|+. .+|+.||+|++... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5689999999999999999996 57999999999753 234577899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999863 35688999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...... +........ ..
T Consensus 158 ~~~~----~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~i~~~-~~-- 222 (337)
T d1o6la_ 158 DGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILME-EI-- 222 (337)
T ss_dssp TTCC----BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CC--
T ss_pred CCcc----cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHHHHHhcC-CC--
Confidence 2222 22345899999999999999999999999999999999999999753221 111111111 00
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPT-----MFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs-----~~ev~~ 581 (623)
.+ ....++++..++ ..|+. .||++||+ +.|+++
T Consensus 223 ----~~-p~~~s~~~~dli---~~~L~-~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ----RF-PRTLSPEAKSLL---AGLLK-KDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CC-CTTSCHHHHHHH---HHHTC-SSTTTSTTCSTTTHHHHHT
T ss_pred ----CC-CccCCHHHHHHH---Hhhcc-CCchhhcccccccHHHHHc
Confidence 00 112344444444 35555 99999995 777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.9e-44 Score=363.06 Aligned_cols=243 Identities=20% Similarity=0.290 Sum_probs=197.1
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|...+.||+|+||+||+|+. .+|+.||+|+++.. ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999996 46999999999643 234577899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999863 35678889999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. ....||+.|+|||++.+..++.++||||+||++|||+||+.||..... .+..........
T Consensus 157 ~~-------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~--- 218 (316)
T d1fota_ 157 VT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAEL--- 218 (316)
T ss_dssp CB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCC---
T ss_pred cc-------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcCCC---
Confidence 21 234599999999999999999999999999999999999999975322 111111111100
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERP-----TMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RP-----s~~ev~~ 581 (623)
.. ....++++..++ .+|+. .||.+|| |++|+++
T Consensus 219 ----~~-p~~~s~~~~~li---~~~L~-~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ----RF-PPFFNEDVKDLL---SRLIT-RDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CC-CTTSCHHHHHHH---HHHTC-SCTTTCTTSSTTTTHHHHT
T ss_pred ----CC-CCCCCHHHHHHH---HHHhh-hCHHhccccchhhHHHHHc
Confidence 00 112334444444 45555 8899995 8898876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=362.22 Aligned_cols=251 Identities=19% Similarity=0.268 Sum_probs=199.9
Q ss_pred hccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEecC
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
.++|...+.||+|+||+||+|... +++.||+|.++........+.+|+++|.+++|||||++++++.+++..|+||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 357889999999999999999965 6889999999877666677889999999999999999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC--CCCeEEeecccccccCCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD--DFEPKISDFGLARLMNPI 460 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~--~~~~kl~Dfgla~~~~~~ 460 (623)
++|+|.+++... +..+++.++..++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999642 24689999999999999999999999 9999999999999985 458999999999876543
Q ss_pred CCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhhh
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQDA 540 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 540 (623)
... ....+|+.|+|||...+..++.++||||+||++|||++|+.||...... +...........
T Consensus 158 ~~~-----~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~~~--- 221 (321)
T d1tkia_ 158 DNF-----RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYT--- 221 (321)
T ss_dssp CEE-----EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCC---
T ss_pred Ccc-----cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC---
Confidence 222 1224789999999999999999999999999999999999999753221 111111111000
Q ss_pred hchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 541 IDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 541 ~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
++... ....++++. .+...|+. .||++|||++|+++
T Consensus 222 ~~~~~-~~~~s~~~~---~li~~~L~-~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEA-FKEISIEAM---DFVDRLLV-KERKSRMTASEALQ 257 (321)
T ss_dssp CCHHH-HTTSCHHHH---HHHHTTSC-SSGGGSCCHHHHHH
T ss_pred CChhh-ccCCCHHHH---HHHHHHcc-CChhHCcCHHHHhc
Confidence 00000 001233333 34446666 99999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6e-44 Score=357.40 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=196.1
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc----------cHHHHHHHHHHhCCCC-CCCCcceeEEEEeC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR----------SEKEFVAEMATLGSVK-NRNLVPLLGFCMAK 372 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 372 (623)
++|...+.||+|+||+||+|+. .+++.||||++..... ..+.+.+|++++.+++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999996 4789999999864321 1245889999999997 99999999999999
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999963 34689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHH
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYAR------TLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVE 526 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~ 526 (623)
+++....... .....||+.|+|||++. ...++.++||||+||++|||++|+.||...... .
T Consensus 156 ~a~~~~~~~~-----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--------~ 222 (277)
T d1phka_ 156 FSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------L 222 (277)
T ss_dssp TCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H
T ss_pred heeEccCCCc-----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--------H
Confidence 9998754322 12345899999999885 345788999999999999999999999753221 1
Q ss_pred HHHHHhccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 527 WIAQLSSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
........ ... ...+ .....++++. .++.+|+. .||++|||++||++
T Consensus 223 ~~~~i~~~-~~~-~~~~--~~~~~s~~~~---~li~~~L~-~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 MLRMIMSG-NYQ-FGSP--EWDDYSDTVK---DLVSRFLV-VQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHT-CCC-CCTT--TGGGSCHHHH---HHHHHHCC-SSGGGSCCHHHHTT
T ss_pred HHHHHHhC-CCC-CCCc--ccccCCHHHH---HHHHHHcc-CChhHCcCHHHHHc
Confidence 11111111 000 0000 0011234444 44557777 99999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.1e-43 Score=365.03 Aligned_cols=247 Identities=22% Similarity=0.251 Sum_probs=193.1
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc----ccHHHHH---HHHHHhCCCCCCCCcceeEEEEeCCeee
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ----RSEKEFV---AEMATLGSVKNRNLVPLLGFCMAKKERL 376 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~ 376 (623)
++|...+.||+|+||.||+|+.. +|+.||+|++.... .....+. .|+++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999965 68999999986432 2223333 4577889999999999999999999999
Q ss_pred EEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 377 LVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 377 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999963 34678999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccC
Q 006982 457 MNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTG 535 (623)
Q Consensus 457 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 535 (623)
...... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+ ......... ..
T Consensus 157 ~~~~~~------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~-~~ 224 (364)
T d1omwa3 157 FSKKKP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTL-TM 224 (364)
T ss_dssp CSSSCC------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSS-SC
T ss_pred cCCCcc------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcc-cC
Confidence 654321 23459999999999865 568999999999999999999999997643321 111111111 00
Q ss_pred chhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHH
Q 006982 536 QLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPT-----MFEVYQ 581 (623)
Q Consensus 536 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs-----~~ev~~ 581 (623)
. .......++++..++ ..|+. .||++||| ++|+++
T Consensus 225 ~-------~~~~~~~s~~~~~li---~~~L~-~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 A-------VELPDSFSPELRSLL---EGLLQ-RDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C-------CCCCSSSCHHHHHHH---HHHTC-SSTTTSTTTSSSTHHHHHT
T ss_pred C-------CCCCCCCCHHHHHHH---HHHcc-cCHHHhCCCcccCHHHHHc
Confidence 0 000112344555444 45666 99999999 577764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-43 Score=361.50 Aligned_cols=243 Identities=18% Similarity=0.235 Sum_probs=197.7
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVY 379 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 379 (623)
++|.+.+.||+|+||.||+|..+ +|+.||+|++... ....+.+.+|++++++++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47899999999999999999964 7999999998643 234567899999999999999999999999999999999
Q ss_pred ecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCC
Q 006982 380 KHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNP 459 (623)
Q Consensus 380 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~ 459 (623)
||+.+|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999998632 4689999999999999999999999 999999999999999999999999999997653
Q ss_pred CCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchhh
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQD 539 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 539 (623)
.. ....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ........... .
T Consensus 194 ~~-------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~-~-- 255 (350)
T d1rdqe_ 194 RT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK-V-- 255 (350)
T ss_dssp CB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-C--
T ss_pred cc-------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCC-C--
Confidence 21 123489999999999999999999999999999999999999975321 11111111110 0
Q ss_pred hhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCC-----CCHHHHHH
Q 006982 540 AIDKCLVAKGVDNELFQFLKVACNCVLPTIPKER-----PTMFEVYQ 581 (623)
Q Consensus 540 ~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~R-----Ps~~ev~~ 581 (623)
. .....++++.+++ ..|+. .||.+| ||++|+++
T Consensus 256 ----~-~p~~~s~~~~~li---~~~L~-~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----R-FPSHFSSDLKDLL---RNLLQ-VDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----C-CCTTCCHHHHHHH---HHHSC-SCTTTCTTSSTTTTHHHHT
T ss_pred ----C-CCccCCHHHHHHH---HHHhh-hCHHhccccccccHHHHHc
Confidence 0 0112344454444 45666 999999 48999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=361.69 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=189.6
Q ss_pred ccCccc-ceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCC-CCCCCCcceeEEEEe----CCeeeE
Q 006982 305 NSFSKN-NIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGS-VKNRNLVPLLGFCMA----KKERLL 377 (623)
Q Consensus 305 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~l 377 (623)
++|.+. ++||+|+||.||+|+. .+++.||+|+++.. ..+.+|++++.+ .+|||||++++++.+ +...|+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 467765 4699999999999996 57899999998643 456788988655 489999999999876 356799
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC---CCCeEEeecccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD---DFEPKISDFGLA 454 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~---~~~~kl~Dfgla 454 (623)
||||++||+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+|||+++ ++.+||+|||++
T Consensus 87 vmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 999999999999996432 25699999999999999999999999 9999999999999985 567999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
+....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.......... .+......
T Consensus 162 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-----~~~~~i~~ 231 (335)
T d2ozaa1 162 KETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----GMKTRIRM 231 (335)
T ss_dssp EECCCCCC-----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCS
T ss_pred eeccCCCc-----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-----HHHHHHhc
Confidence 87654322 123458999999999999999999999999999999999999997543321110 01000000
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQF 582 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~ 582 (623)
... ++..+.. ...++++.+ ++..|+. .||++|||+.|+++.
T Consensus 232 ~~~-~~~~~~~--~~~s~~~~~---li~~~L~-~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 GQY-EFPNPEW--SEVSEEVKM---LIRNLLK-TEPTQRMTITEFMNH 272 (335)
T ss_dssp CSS-SCCTTHH--HHSCHHHHH---HHHHHSC-SSTTTSCCHHHHHHS
T ss_pred CCC-CCCCccc--ccCCHHHHH---HHHHHcc-CChhHCcCHHHHHcC
Confidence 000 0000000 012233333 4445665 999999999999873
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=359.70 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=195.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccc----cccHHHHHHHHHHhC-CCCCCCCcceeEEEEeCCeeeEE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDS----QRSEKEFVAEMATLG-SVKNRNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV 378 (623)
++|...+.||+|+||+||+|+.. +++.||||++... ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999965 6899999999643 234456677777665 68999999999999999999999
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccC
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMN 458 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~ 458 (623)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999963 34688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCchh
Q 006982 459 PIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQLQ 538 (623)
Q Consensus 459 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 538 (623)
..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +.........
T Consensus 155 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~--- 219 (320)
T d1xjda_ 155 LGDAK----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDN--- 219 (320)
T ss_dssp CTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC---
T ss_pred ccccc----ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC---
Confidence 43222 22345899999999999999999999999999999999999999753221 1111111110
Q ss_pred hhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHH-HHHH
Q 006982 539 DAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMF-EVYQ 581 (623)
Q Consensus 539 ~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~-ev~~ 581 (623)
+.. ....++++..++ ..|+. .||++||++. |+++
T Consensus 220 ----~~~-p~~~s~~~~dli---~~~L~-~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 ----PFY-PRWLEKEAKDLL---VKLFV-REPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCC-CTTSCHHHHHHH---HHHSC-SSGGGSBTTBSCGGG
T ss_pred ----CCC-CccCCHHHHHHH---HHhcc-cCCCCCcCHHHHHHh
Confidence 000 112344444444 46666 9999999985 6653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=351.65 Aligned_cols=195 Identities=22% Similarity=0.292 Sum_probs=165.9
Q ss_pred ccceeeccCccEEEEEEe-CCCcEEEEEEecccccc------HHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 309 KNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRS------EKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 309 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
..++||+|+||+||+|+. .+|+.||||+++..... .+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999996 46899999998654321 24688999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
++++++..+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99988877764 345688999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 155 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 155 RA----YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CC----CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc----ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 21 223458999999998865 45799999999999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=349.56 Aligned_cols=200 Identities=23% Similarity=0.350 Sum_probs=169.2
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|.+.+.||+|+||+||+|+. .+|+.||+|+++... .....+.+|++++++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788999999999999999996 579999999996543 234678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+.++.+ +++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~-~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLK-KFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHH-HHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchh-hhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976544 444322 235699999999999999999999999 9999999999999999999999999999876542
Q ss_pred CCcccccccCCCCcccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLV-ATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. ......||+.|+|||.+.... ++.++||||+||++|||++|+.||...
T Consensus 156 ~~----~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 156 VR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp SB----CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc----cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 22 222345899999999876655 578999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-42 Score=349.52 Aligned_cols=199 Identities=24% Similarity=0.349 Sum_probs=172.1
Q ss_pred ccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEec
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 381 (623)
++|...+.||+|+||+||+|+.++|+.||||++.... ...+.+.+|+.++++++|||||++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4788899999999999999999999999999996542 3357899999999999999999999999999999999999
Q ss_pred CCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCCC
Q 006982 382 MPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPID 461 (623)
Q Consensus 382 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 461 (623)
+.++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99887777764 235699999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 462 THLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 462 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
.. .....+++.|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 155 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 155 RK----YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc----cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 21 122347899999999865 45689999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=347.08 Aligned_cols=238 Identities=21% Similarity=0.336 Sum_probs=188.6
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc-------cHHHHHHHHHHhCCCC--CCCCcceeEEEEeCCe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR-------SEKEFVAEMATLGSVK--NRNLVPLLGFCMAKKE 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 374 (623)
++|...+.||+|+||.||+|.. .+++.||||++..... ....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788999999999999999996 4789999999864321 1234678999998886 8999999999999999
Q ss_pred eeEEEecCCC-CCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-CCCeEEeecc
Q 006982 375 RLLVYKHMPN-GSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-DFEPKISDFG 452 (623)
Q Consensus 375 ~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-~~~~kl~Dfg 452 (623)
.++||||+.+ +++.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 688888753 35689999999999999999999999 9999999999999985 5799999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHH
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVA-TPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQL 531 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 531 (623)
+++...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... + +
T Consensus 157 ~a~~~~~~~------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~-i--- 216 (273)
T d1xwsa_ 157 SGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E-I--- 216 (273)
T ss_dssp TCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H-H---
T ss_pred cceeccccc------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------H-H---
Confidence 998754321 123458999999999987665 567999999999999999999996411 0 0
Q ss_pred hccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 006982 532 SSTGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQ 581 (623)
Q Consensus 532 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~ 581 (623)
.... .......++++.+++ .+|+. .||++|||++|+++
T Consensus 217 ~~~~--------~~~~~~~s~~~~~li---~~~L~-~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 IRGQ--------VFFRQRVSSECQHLI---RWCLA-LRPSDRPTFEEIQN 254 (273)
T ss_dssp HHCC--------CCCSSCCCHHHHHHH---HHHTC-SSGGGSCCHHHHHT
T ss_pred hhcc--------cCCCCCCCHHHHHHH---HHHcc-CCHhHCcCHHHHhc
Confidence 0000 000112344555444 45666 99999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=348.96 Aligned_cols=200 Identities=23% Similarity=0.334 Sum_probs=165.6
Q ss_pred hccCcccceeeccCccEEEEEEe-CC-CcEEEEEEecccc---ccHHHHHHHHHHhCCC---CCCCCcceeEEEEe----
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-ED-GTSLMVKRLQDSQ---RSEKEFVAEMATLGSV---KNRNLVPLLGFCMA---- 371 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 371 (623)
.++|.+.+.||+|+||+||+|+. ++ ++.||+|+++... .....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 5679999986432 1223455677666554 89999999999864
Q ss_pred -CCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEee
Q 006982 372 -KKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISD 450 (623)
Q Consensus 372 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~D 450 (623)
....++++||++++++...... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 2357899999999877655432 235689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 451 FGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 451 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 160 fg~~~~~~~~-----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 160 FGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhhhhccc-----ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 9999865432 2233456999999999999999999999999999999999999999754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=339.69 Aligned_cols=203 Identities=22% Similarity=0.291 Sum_probs=168.0
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC--------
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK-------- 372 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 372 (623)
++|.+.+.||+|+||+||+|+. .+|+.||||++.... .....+.+|+++|++++|||++++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788999999999999999996 579999999985432 3346788999999999999999999998653
Q ss_pred CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecc
Q 006982 373 KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFG 452 (623)
Q Consensus 373 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfg 452 (623)
...++||||+.++.+..... ....++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 35789999999887776653 335688899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 453 LARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 453 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+++..............+..||+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 9987654333322333445699999999998755 6899999999999999999999999753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.8e-40 Score=332.41 Aligned_cols=270 Identities=16% Similarity=0.194 Sum_probs=204.4
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCC-CCCcceeEEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKN-RNLVPLLGFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~ 382 (623)
++|.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+|++.+..++| +|++.+++++......++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 46888999999999999999964 68999999875432 22346778888888865 89999999999999999999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCC-----CCCeEEeeccccccc
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDD-----DFEPKISDFGLARLM 457 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~-----~~~~kl~Dfgla~~~ 457 (623)
+|+|.+++... +..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 84 -~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 84 -GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 68999998643 34689999999999999999999999 9999999999999974 578999999999876
Q ss_pred CCCCCcc---cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhcc
Q 006982 458 NPIDTHL---STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSST 534 (623)
Q Consensus 458 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 534 (623)
....... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.......... ....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~~~~~~ 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEKKQS 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHHHHHhccCC
Confidence 4322111 112233469999999999999999999999999999999999999997543321110 11111111111
Q ss_pred CchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcccCCCC
Q 006982 535 GQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGERYHFTT 594 (623)
Q Consensus 535 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 594 (623)
....++. ...++++.++++ .|.. .+|++||+++.+.+.|+++.++.....
T Consensus 235 ~~~~~l~------~~~p~~l~~ii~---~~~~-~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 235 TPLRELC------AGFPEEFYKYMH---YARN-LAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp SCHHHHT------TTSCHHHHHHHH---HHHH-CCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred CChHHhc------CCCCHHHHHHHH---HHhc-CCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 1111211 123455555554 3444 789999999999999999877665443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-39 Score=330.32 Aligned_cols=265 Identities=20% Similarity=0.233 Sum_probs=194.3
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCccee-EEEEeCCeeeEEEecC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLL-GFCMAKKERLLVYKHM 382 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~lV~e~~ 382 (623)
++|+..+.||+|+||.||+|+. .+++.||||++.... ...++..|++++++++|+|++..+ ++..+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4688899999999999999996 468999999876543 234578899999999887766555 4556677888999999
Q ss_pred CCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeC---CCCCeEEeecccccccCC
Q 006982 383 PNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLD---DDFEPKISDFGLARLMNP 459 (623)
Q Consensus 383 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~---~~~~~kl~Dfgla~~~~~ 459 (623)
. |++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++....
T Consensus 86 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 G-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 4 566666543 235689999999999999999999999 999999999999985 456799999999998754
Q ss_pred CCCcc---cccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHhccCc
Q 006982 460 IDTHL---STFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLSSTGQ 536 (623)
Q Consensus 460 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 536 (623)
..... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.......... ....+...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~-~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS-TP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-SC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCC-CC
Confidence 32221 112233469999999999999999999999999999999999999997644322211 11111111100 01
Q ss_pred hhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcc
Q 006982 537 LQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPTMFEVYQFLRAIGER 589 (623)
Q Consensus 537 ~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs~~ev~~~L~~i~~~ 589 (623)
... + ....++++.++++ .|+. .+|++||+++++.+.|+++..+
T Consensus 237 ~~~-----~-~~~~p~~~~~li~---~cl~-~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 IEV-----L-CKGYPSEFATYLN---FCRS-LRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHH-----H-TTTSCHHHHHHHH---HHHH-SCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhH-----h-ccCCCHHHHHHHH---HHcc-CChhHCcCHHHHHHHHHHHHHH
Confidence 111 1 1123445555544 5555 8899999999999999987544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=341.36 Aligned_cols=201 Identities=21% Similarity=0.347 Sum_probs=167.4
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc--ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC----eeeE
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ--RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK----ERLL 377 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 377 (623)
.+|...+.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+++|.+++|||++++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688899999999999999985 589999999997543 33567889999999999999999999997653 2356
Q ss_pred EEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeeccccccc
Q 006982 378 VYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLM 457 (623)
Q Consensus 378 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~ 457 (623)
+++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 6677889999999953 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
....... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 160 DPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CGGGCBC-CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCCccc-eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 5432221 22334568999999999854 56789999999999999999999999754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-41 Score=347.00 Aligned_cols=198 Identities=25% Similarity=0.288 Sum_probs=163.0
Q ss_pred cCcccceeeccCccEEEEEEeC-CCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------eeeEE
Q 006982 306 SFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------ERLLV 378 (623)
Q Consensus 306 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV 378 (623)
+|...++||+|+||+||+|+.. +|+.||||++..... ...+|+++|++++||||+++++++.... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 5788899999999999999965 689999999965432 2347999999999999999999986532 46899
Q ss_pred EecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeeccccccc
Q 006982 379 YKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFGLARLM 457 (623)
Q Consensus 379 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgla~~~ 457 (623)
|||++++.+..+.+.. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999876544433211 1335799999999999999999999999 999999999999999765 8999999999876
Q ss_pred CCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 006982 458 NPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVAK 515 (623)
Q Consensus 458 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~~ 515 (623)
...... ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 174 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGEPN-----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTSCC-----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCCccc-----ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 543322 23458999999998764 578999999999999999999999997543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-40 Score=331.28 Aligned_cols=198 Identities=22% Similarity=0.303 Sum_probs=172.7
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCCeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKKERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 380 (623)
++|++.+.||+|+||+||+|+. .+++.||||+++... .....+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788999999999999999996 578999999986433 335678999999999999999999999999999999999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccccccCCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLARLMNPI 460 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 460 (623)
|+.++++..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999988853 35688999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCcccccccCCCCcccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCC
Q 006982 461 DTHLSTFVNGEFGDLGYVAPEYARTLV-ATPKGDVYSFGTVLLELVTGERPTNV 513 (623)
Q Consensus 461 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~sfGvil~elltg~~P~~~ 513 (623)
.... ....++..|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 155 ~~~~----~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 155 VRCY----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSCC----CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred Cccc----eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 3221 2234678899999987654 68999999999999999999999854
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-39 Score=333.62 Aligned_cols=195 Identities=17% Similarity=0.331 Sum_probs=167.9
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCC-CCCCcceeEEEEeC--CeeeEEEe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-NRNLVPLLGFCMAK--KERLLVYK 380 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 380 (623)
++|...+.||+|+||+||+|+. .+++.||+|+++.. ..+.+.+|+++|.+++ ||||+++++++... ...++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5799999999999999999996 57899999998654 3567889999999995 99999999999754 45789999
Q ss_pred cCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCC-CeEEeecccccccCC
Q 006982 381 HMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDF-EPKISDFGLARLMNP 459 (623)
Q Consensus 381 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~-~~kl~Dfgla~~~~~ 459 (623)
|+++|+|..+. +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999998765 3589999999999999999999999 999999999999998655 689999999987654
Q ss_pred CCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 006982 460 IDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVAKA 516 (623)
Q Consensus 460 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~~~ 516 (623)
... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.....
T Consensus 183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 183 GQE-----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp TCC-----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCc-----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 322 2234589999999998765 479999999999999999999999976443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=336.09 Aligned_cols=194 Identities=25% Similarity=0.361 Sum_probs=162.4
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeCC------e
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAKK------E 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 374 (623)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+++|++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 5788899999999999999996 469999999997543 23457889999999999999999999997654 4
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++||||+ +.+|..+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 98 ~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 68999999 5688887742 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYART-LVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 169 ~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 169 RQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp EECCSSC-------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCcc-------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 8765321 23458999999999876 45689999999999999999999999764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=333.72 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=193.0
Q ss_pred ccCcccceeeccCccEEEEEEe----CCCcEEEEEEecccc-----ccHHHHHHHHHHhCCCCC-CCCcceeEEEEeCCe
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL----EDGTSLMVKRLQDSQ-----RSEKEFVAEMATLGSVKN-RNLVPLLGFCMAKKE 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 374 (623)
++|...+.||+|+||+||+|+. .+|+.||+|.++... ...+.+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5689999999999999999985 247899999986532 234568899999999977 899999999999999
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.++|+||+.+|+|.+++... ..+.......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999633 4567788899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCcccccccHHHHHHHHh
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL--VATPKGDVYSFGTVLLELVTGERPTNVAKAPETFKGNLVEWIAQLS 532 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~sfGvil~elltg~~P~~~~~~~~~~~~~l~~~~~~~~ 532 (623)
+....... .......|++.|+|||.+... .++.++||||+||+||||++|+.||......+.. ........
T Consensus 177 ~~~~~~~~---~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~ 249 (322)
T d1vzoa_ 177 KEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRIL 249 (322)
T ss_dssp EECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHH
T ss_pred hhhccccc---ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcc
Confidence 87643221 222334589999999998654 4688999999999999999999999765443221 11111111
Q ss_pred ccCchhhhhchhhhcCCCHHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHH
Q 006982 533 STGQLQDAIDKCLVAKGVDNELFQFLKVACNCVLPTIPKERPT-----MFEVYQ 581 (623)
Q Consensus 533 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~C~~~~~P~~RPs-----~~ev~~ 581 (623)
... ... ....++++..++ ..|+. .||++||| ++|+++
T Consensus 250 ~~~-------~~~-~~~~s~~~~~li---~~~l~-~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSE-------PPY-PQEMSALAKDLI---QRLLM-KDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCC-------CCC-CTTSCHHHHHHH---HHHTC-SSGGGSTTSSTTTHHHHHT
T ss_pred cCC-------CCC-cccCCHHHHHHH---HHHcc-cCHHHcCCCCcccHHHHHc
Confidence 000 000 112344455544 45665 99999994 778765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=330.00 Aligned_cols=195 Identities=23% Similarity=0.291 Sum_probs=158.8
Q ss_pred ccCcccceeeccCccEEEEEEeC-CCcEEEEEEecccc---ccHHHHHHHHHHhCCCCCCCCcceeEEEEeC------Ce
Q 006982 305 NSFSKNNIIGSGRTGTMYKALLE-DGTSLMVKRLQDSQ---RSEKEFVAEMATLGSVKNRNLVPLLGFCMAK------KE 374 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 374 (623)
++|.+.++||+|+||+||+|... +|+.||||++.... ...+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999965 69999999997543 3345688999999999999999999999643 57
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.|+||||+.++.+. .+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 79999999765554 442 3588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
+....... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 167 ~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 167 RTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hccccccc-----cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 86543221 22334899999999999999999999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=327.64 Aligned_cols=196 Identities=24% Similarity=0.366 Sum_probs=165.0
Q ss_pred hccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccc---cHHHHHHHHHHhCCCCCCCCcceeEEEEeC-----Ce
Q 006982 304 TNSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQR---SEKEFVAEMATLGSVKNRNLVPLLGFCMAK-----KE 374 (623)
Q Consensus 304 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 374 (623)
.++|.+.+.||+|+||+||+|+. .+|+.||||++..... ..+.+.+|++++++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 35788999999999999999995 5799999999975432 345688999999999999999999998643 34
Q ss_pred eeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEEeecccc
Q 006982 375 RLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKISDFGLA 454 (623)
Q Consensus 375 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla 454 (623)
.+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 4777888999999999952 4599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 455 RLMNPIDTHLSTFVNGEFGDLGYVAPEYARTL-VATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
...... ..+..||+.|+|||...+. .++.++||||+||++|||++|+.||...
T Consensus 169 ~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 169 RHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp -CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 765321 2234588999999987665 4689999999999999999999999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-34 Score=300.83 Aligned_cols=199 Identities=19% Similarity=0.182 Sum_probs=158.8
Q ss_pred ccCcccceeeccCccEEEEEEe-CCCcEEEEEEeccccccHHHHHHHHHHhCCCC-----------CCCCcceeEEEEeC
Q 006982 305 NSFSKNNIIGSGRTGTMYKALL-EDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK-----------NRNLVPLLGFCMAK 372 (623)
Q Consensus 305 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~ 372 (623)
++|.+.+.||+|+||+||+|+. .+|+.||||+++......+.+.+|++++++++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3588899999999999999996 57999999999876655667788888887775 57899999888653
Q ss_pred --CeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceeeCCCCC----
Q 006982 373 --KERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILLDDDFE---- 445 (623)
Q Consensus 373 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl~~~~~---- 445 (623)
...++++++...+......... .....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 4556777766555433322111 133568889999999999999999998 5 8999999999999986654
Q ss_pred --eEEeecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006982 446 --PKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTVLLELVTGERPTNVA 514 (623)
Q Consensus 446 --~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvil~elltg~~P~~~~ 514 (623)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 899999999865321 12345899999999999999999999999999999999999999754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.9e-30 Score=264.37 Aligned_cols=185 Identities=37% Similarity=0.556 Sum_probs=150.0
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCcccCCCCCCCCCCCCCC--cccceeecCCC-CCcEEEEEecCCCcee--eCCccccCC
Q 006982 29 YGTKEDLACLKSIKDSLEDPFNYLNSSWNFNNDTEGFIC--KFTGVECWHPD-ENRVLNLRLTDMGLKG--QFPRGIRNC 103 (623)
Q Consensus 29 ~~~~~d~~~Ll~~k~~~~~~~~~l~~sW~~~~~~~~~~c--~w~gv~c~~~~-~~~v~~l~l~~~~l~g--~~p~~l~~l 103 (623)
.|.++|++||++||++++||. .+ ++|..++ ||| .|.||+|+... .+||+.|+|++++++| .+|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l-~sW~~~~----d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L 75 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TL-SSWLPTT----DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANL 75 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GG-TTCCTTS----CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGC
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cC-CCCCCCC----CCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcC
Confidence 378999999999999999885 44 5997543 488 59999997532 4589999999999998 689999999
Q ss_pred CCCCEEEcCC-CCCCCCCChhHhhhcCCCCEEEccCccCCCC--------------------------------------
Q 006982 104 SSMTGLDLSS-NKLYGPLPDDISKLVGFLTSLDLSSNNFSGS-------------------------------------- 144 (623)
Q Consensus 104 ~~L~~L~L~~-N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~-------------------------------------- 144 (623)
++|++|+|++ |+++|.||++|+++.+ |++|+|++|+|+|.
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~-L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTT-CSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred ccccccccccccccccccccccccccc-cchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 9999999997 8999999999998643 66666555544432
Q ss_pred ----------CCC-------------------------------------------------------------------
Q 006982 145 ----------IPS------------------------------------------------------------------- 147 (623)
Q Consensus 145 ----------ip~------------------------------------------------------------------- 147 (623)
+|.
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~ 234 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred eccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 221
Q ss_pred ----CCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCCCCCCCCCCCC
Q 006982 148 ----NLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQGLCGEPLDAC 220 (623)
Q Consensus 148 ----~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~l~~~~~~~c 220 (623)
.++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.||....+ .+....+.+|+.+||.|+++|
T Consensus 235 ~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 1122344678999999999999999999999999999999999999976443 566778899999999999888
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.5e-22 Score=189.87 Aligned_cols=167 Identities=14% Similarity=0.151 Sum_probs=119.6
Q ss_pred cccceeeccCccEEEEEEeCCCcEEEEEEeccccc-------------------cHHHHHHHHHHhCCCCCCCCcceeEE
Q 006982 308 SKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQR-------------------SEKEFVAEMATLGSVKNRNLVPLLGF 368 (623)
Q Consensus 308 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~niv~l~~~ 368 (623)
.+.+.||+|+||+||+|...+|+.||||+++.... .......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999998999999998753210 11234568888999999999887765
Q ss_pred EEeCCeeeEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCceeeCCCCCeEE
Q 006982 369 CMAKKERLLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNCNPRIIHRNISSKCILLDDDFEPKI 448 (623)
Q Consensus 369 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk~~NILl~~~~~~kl 448 (623)
. ..+++|||+++..+.+ ++......++.|++++++|||+. +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2479999998865543 23344567999999999999999 99999999999999975 4899
Q ss_pred eecccccccCCCCCcccccccCCCCcccccCcccccCCCCCcchhHHHHHHH
Q 006982 449 SDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYARTLVATPKGDVYSFGTV 500 (623)
Q Consensus 449 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~sfGvi 500 (623)
+|||.|+........ .... ..... ..|.+ ...|+.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~--~~l~---rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR--EILE---RDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH--HHHH---HHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH--HHHH---HHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 999999875432111 0000 00000 01111 3567889999996543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.63 E-value=9.5e-17 Score=149.93 Aligned_cols=131 Identities=21% Similarity=0.244 Sum_probs=105.5
Q ss_pred CCCCCcccceeecCCC--------CCcEEEEEecCCCceeeCC-ccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCE
Q 006982 63 EGFICKFTGVECWHPD--------ENRVLNLRLTDMGLKGQFP-RGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTS 133 (623)
Q Consensus 63 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p-~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~ 133 (623)
.+|.|.|..|.|++.. ...++.|+|++|.+++.++ ..++++++|+.|+|++|.+.+..+..+..+. +|++
T Consensus 4 ~~C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~-~L~~ 82 (192)
T d1w8aa_ 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS-HIQE 82 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT-TCCE
T ss_pred CCCEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccc-ccce
Confidence 4577889999997543 2367889999999987664 4578899999999999999977777777754 4999
Q ss_pred EEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccccccccccccccccccCC
Q 006982 134 LDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 134 L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+
T Consensus 83 L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp EECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred eeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 9999999996556678889999999999999997667778889999999999998876554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.52 E-value=1.2e-14 Score=135.43 Aligned_cols=127 Identities=26% Similarity=0.377 Sum_probs=108.0
Q ss_pred EEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-HhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccC
Q 006982 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDH 162 (623)
Q Consensus 84 ~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~ 162 (623)
.++.++++|+ .||+.|. +++++|+|++|.|++.++.. +..+ .+|+.|+|++|++++..+..+..+++|++|+|++
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l-~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRL-PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCC-ceEeeeeccccccccccccccccccccceeeecc
Confidence 5789999998 7888774 79999999999999767555 4565 4599999999999988889999999999999999
Q ss_pred CcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCC
Q 006982 163 NRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCG 214 (623)
Q Consensus 163 N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~ 214 (623)
|++++..|..|.++++|+.|+|++|+|++..|..+. + .+....+.+|+..|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 999977777899999999999999999998887554 2 455667788887664
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.47 E-value=8.9e-15 Score=147.23 Aligned_cols=110 Identities=29% Similarity=0.409 Sum_probs=98.4
Q ss_pred EEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccC
Q 006982 83 LNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDH 162 (623)
Q Consensus 83 ~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~ 162 (623)
..+++.++.+.|.+|..++.+++|+.|++++|.+.|.+| +++.+. +|+.|+|++|+|+|.+|..|+++++|++|+|++
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~-~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSK-NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCT-TCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred ccccccccccccccccccccccccccccccccccccccc-cccccc-ccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 357888888889999999999999999999999998765 576654 599999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccccccccccccc-cccc-CCc
Q 006982 163 NRFSGQIPPQLGQLGRLKSFSVANNL-LSGS-IPT 195 (623)
Q Consensus 163 N~~~g~iP~~l~~l~~L~~l~l~~N~-l~g~-ip~ 195 (623)
|+|+|.||. ++++++|+.+++++|+ ++|. +|.
T Consensus 278 N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp~ 311 (313)
T d1ogqa_ 278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPA 311 (313)
T ss_dssp SEEEEECCC-STTGGGSCGGGTCSSSEEESTTSSC
T ss_pred CcccccCCC-cccCCCCCHHHhCCCccccCCCCCC
Confidence 999999995 6899999999999997 7875 564
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=6.9e-14 Score=120.05 Aligned_cols=103 Identities=28% Similarity=0.316 Sum_probs=89.9
Q ss_pred EEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCC
Q 006982 84 NLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHN 163 (623)
Q Consensus 84 ~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N 163 (623)
.|+|++|+++ .+| .++.+++|++|||++|.++ .+|+.++.+. +|+.|+|++|+|+ .+| .++++++|++|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~-~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALR-CLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCT-TCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhh-ccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 5899999998 455 5999999999999999999 7999998865 4999999999999 566 5899999999999999
Q ss_pred cCCCCC-Ccccccccccccccccccccccc
Q 006982 164 RFSGQI-PPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 164 ~~~g~i-P~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
+++..- +..++.+++|+.|++++|.++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 999432 25789999999999999999753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1e-12 Score=128.58 Aligned_cols=131 Identities=24% Similarity=0.244 Sum_probs=85.1
Q ss_pred EEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeecc
Q 006982 82 VLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLD 161 (623)
Q Consensus 82 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~ 161 (623)
+..|+|++|.+++ ++..+.++++|+.|+|++|.+.+..+..+.. ..+|+.|++++|.+++..|..+..+++|+.|+++
T Consensus 79 L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~-l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 79 LGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRG-LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp CCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTT-CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ccccccccccccc-cccccccccccccccccccccceeecccccc-ccccccccccccccceeccccccccccchhcccc
Confidence 3444444444432 2334444555555555555554322223333 2336666666777774444556778899999999
Q ss_pred CCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCCC
Q 006982 162 HNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCGE 215 (623)
Q Consensus 162 ~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~~ 215 (623)
+|++++..|..+..+++|+.|+|++|+|+ .||..+. + .+....+.+|++.|..
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 99999877778899999999999999999 7876433 2 4556778899988863
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=6.7e-13 Score=131.29 Aligned_cols=134 Identities=28% Similarity=0.309 Sum_probs=108.1
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..|+|++|++.+..+..+..+.+|+.+++++|+|++..|..+..+ .+|+.|+|++|+|++..|..+.++++|+.++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~-~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL-GNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccc-cchhhcccccCcccccchhhhccccccchhh
Confidence 467888999998887777788888999999999999984334445554 4599999999999976677888899999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCcccc-c-cccccccCCCCCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVN-L-TLSADSVTNNQGLCG 214 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~l~~ 214 (623)
+++|++++..|..+..+++|++|++++|.+++..|..+. + .+....+++|+..|.
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999999988889999999999999999999887776543 1 455667788887774
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=4.5e-12 Score=123.96 Aligned_cols=112 Identities=25% Similarity=0.236 Sum_probs=88.7
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|.+++..+..|.++++|+.|+|++|+|+ .+|. ++.+ ++|++|+|++|+++ .+|..+.++++|+.|+
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l-~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~ 106 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTL-PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCC-TTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccc-cccccccccccccc-cccccccccccccccc
Confidence 35889999999998877778999999999999999998 6664 3454 45999999999998 4577888888888888
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
+++|.+.+..+..+..+.+++.|++++|.+++..|.
T Consensus 107 l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~ 142 (266)
T d1p9ag_ 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142 (266)
T ss_dssp CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred ccccccceeeccccccccccccccccccccceeccc
Confidence 888888876666667777777777777777655444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=3.9e-12 Score=125.62 Aligned_cols=114 Identities=21% Similarity=0.171 Sum_probs=102.9
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..+++++|++++..+..+..+++|+.|+|++|+|++..|..+..+ ++|++|++++|++++..|..|.++++|++|+
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l-~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL-HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccc-cccchhhhhhccccccChhHhhhhhhccccc
Confidence 457899999999998777889999999999999999996556666665 5599999999999998899999999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
+++|++++..|..++++++|+.|++++|.+.+.-+
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999998888899999999999999999997655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.20 E-value=1.3e-11 Score=105.61 Aligned_cols=98 Identities=27% Similarity=0.336 Sum_probs=79.5
Q ss_pred CEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccccccccc
Q 006982 107 TGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVAN 186 (623)
Q Consensus 107 ~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~ 186 (623)
+.|||++|+++ .+|. +..+.. |++|||++|+++ .+|+.++.+++|+.|++++|++++ +| .++++++|+.|++++
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~-L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLL-VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTT-CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CEEEcCCCCCC-CCcc-cccCCC-CCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCC
Confidence 58999999999 7774 888754 999999999999 789999999999999999999994 66 589999999999999
Q ss_pred ccccccCC-cccc-c-cccccccCCCC
Q 006982 187 NLLSGSIP-TFVN-L-TLSADSVTNNQ 210 (623)
Q Consensus 187 N~l~g~ip-~~~~-~-~~~~~~~~~n~ 210 (623)
|+++...+ ..+. + .+....+.+|+
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCc
Confidence 99985432 2221 1 34445566665
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=1.6e-11 Score=109.50 Aligned_cols=106 Identities=19% Similarity=0.215 Sum_probs=83.9
Q ss_pred cccceeecCCCCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCC-CCCCCCChh-HhhhcCCCCEEEccCccCCCCC
Q 006982 68 KFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSN-KLYGPLPDD-ISKLVGFLTSLDLSSNNFSGSI 145 (623)
Q Consensus 68 ~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N-~l~g~ip~~-~~~l~~~L~~L~L~~N~l~g~i 145 (623)
.+.+|+|.+ +++. .+|..+..+++|+.|+|++| .++ .||.. |..+ ++|+.|+|++|+|+..-
T Consensus 9 ~~~~l~c~~-------------~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l-~~L~~L~Ls~N~l~~i~ 72 (156)
T d2ifga3 9 GSSGLRCTR-------------DGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGL-GELRNLTIVKSGLRFVA 72 (156)
T ss_dssp SSSCEECCS-------------SCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSC-CCCSEEECCSSCCCEEC
T ss_pred CCCeEEecC-------------CCCc-cCcccccCccccCeeecCCCcccc-ccCchhhccc-cccCcceeeccccCCcc
Confidence 577788854 2332 45777888999999999876 477 56654 5665 45999999999999655
Q ss_pred CCCCCCCCCCceeeccCCcCCCCCCcccccccccccccccccccc
Q 006982 146 PSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 146 p~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
|..|..+++|++|+|++|+|+ .+|..+....+|+.|+|++|.|.
T Consensus 73 ~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 73 PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp TTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 677999999999999999999 78877666668999999999884
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=4.8e-12 Score=113.78 Aligned_cols=104 Identities=19% Similarity=0.205 Sum_probs=56.1
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCC-CCCCCCCceee
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSN-LANCTYLNSLK 159 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~-~~~l~~L~~l~ 159 (623)
++..|+|++|+++. ||..+..+++|+.|||++|.++ .++ .+..+. +|++|+|++|+++ .+|.. +..+++|++|+
T Consensus 19 ~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~-~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 19 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLR-RLKTLLVNNNRIC-RIGEGLDQALPDLTELI 93 (162)
T ss_dssp SCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCS-SCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred cCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCc-chhhhhccccccc-CCCccccccccccccce
Confidence 34556666666543 3444455666666666666665 443 244432 3666666666666 33333 34466666666
Q ss_pred ccCCcCCCCCC--cccccccccccccccccccc
Q 006982 160 LDHNRFSGQIP--PQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 160 l~~N~~~g~iP--~~l~~l~~L~~l~l~~N~l~ 190 (623)
|++|+++ .++ ..+..+++|+.|++++|.++
T Consensus 94 L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 94 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ecccccc-ccccccccccccccchhhcCCCccc
Confidence 6666665 233 24555566666666666554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=5.2e-11 Score=106.81 Aligned_cols=90 Identities=20% Similarity=0.189 Sum_probs=76.1
Q ss_pred ccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccccc
Q 006982 98 RGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLG 177 (623)
Q Consensus 98 ~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~ 177 (623)
+.+.++.+|+.|||++|+++ .||..+..+ ++|+.|||++|+++ .++ .+..+++|++|+|++|+++...|..+..++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l-~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATL-DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGT-TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCcccccc-ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccc
Confidence 34678889999999999999 788655555 45999999999999 675 589999999999999999953344456899
Q ss_pred cccccccccccccc
Q 006982 178 RLKSFSVANNLLSG 191 (623)
Q Consensus 178 ~L~~l~l~~N~l~g 191 (623)
+|+.|++++|+++.
T Consensus 88 ~L~~L~L~~N~i~~ 101 (162)
T d1a9na_ 88 DLTELILTNNSLVE 101 (162)
T ss_dssp TCCEEECCSCCCCC
T ss_pred ccccceeccccccc
Confidence 99999999999974
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.05 E-value=1.9e-10 Score=114.41 Aligned_cols=126 Identities=26% Similarity=0.338 Sum_probs=101.7
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..+++.+++++ .+|..+ +++|+.|+|++|...+..|..+..+.. ++.|++++|.+++..|..+.++++|++|+|
T Consensus 151 ~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~-l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 151 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN-LAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTT-CCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred ccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccc-ccccccccccccccccccccccccceeeec
Confidence 5778889998876 456543 789999999999999888888888654 999999999999877888999999999999
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCc-ccc--------ccccccccCCCCCC
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT-FVN--------LTLSADSVTNNQGL 212 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~-~~~--------~~~~~~~~~~n~~l 212 (623)
++|+|+ .||..+.++++|+.|+|++|+++. |+. .+. .++....+.+|+.-
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~-i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCC-CCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccc-ccccccccccCCCEEECCCCccCc-cChhhccCcchhcccCCCCEEECCCCcCc
Confidence 999998 789999999999999999999984 442 211 13344556677643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.02 E-value=3e-10 Score=112.91 Aligned_cols=113 Identities=19% Similarity=0.247 Sum_probs=98.3
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|++.+|..++..+..+.+++.++.|++++|.+.+..|..+..+. +|++|+|++|+|+ .||..+.++++|++|+
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~-~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP-HLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST-TCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc-cceeeeccccccc-ccccccccccCCCEEE
Confidence 4688999999999999999999999999999999999977677777764 5999999999999 7899999999999999
Q ss_pred ccCCcCCCCCCc-------ccccccccccccccccccc-ccCCc
Q 006982 160 LDHNRFSGQIPP-------QLGQLGRLKSFSVANNLLS-GSIPT 195 (623)
Q Consensus 160 l~~N~~~g~iP~-------~l~~l~~L~~l~l~~N~l~-g~ip~ 195 (623)
|++|+++ .|+. ....+.+|+.|+|++|.++ +.+|.
T Consensus 249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~ 291 (305)
T d1xkua_ 249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291 (305)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccCcCCH
Confidence 9999999 5543 2346788999999999985 55553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=3.4e-10 Score=100.65 Aligned_cols=112 Identities=16% Similarity=0.142 Sum_probs=89.9
Q ss_pred ccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCcc-CCCCCC-CCCCCCCCCceeeccCCcCCCCCCccccccc
Q 006982 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNN-FSGSIP-SNLANCTYLNSLKLDHNRFSGQIPPQLGQLG 177 (623)
Q Consensus 100 l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~-l~g~ip-~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~ 177 (623)
...+.....++.+++++. .+|..+..+. +|+.|+|++|+ ++ .|| ..|.++++|+.|+|++|+|+..-|..|..++
T Consensus 4 ~C~c~~~~~l~c~~~~~~-~~p~~l~~l~-~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~ 80 (156)
T d2ifga3 4 ACCPHGSSGLRCTRDGAL-DSLHHLPGAE-NLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80 (156)
T ss_dssp SSCCSSSSCEECCSSCCC-TTTTTSCSCS-CCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred CCCcCCCCeEEecCCCCc-cCcccccCcc-ccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccc
Confidence 345566678999999998 7888887764 59999998764 88 565 5699999999999999999976678899999
Q ss_pred cccccccccccccccCCcccc-ccccccccCCCCCCCC
Q 006982 178 RLKSFSVANNLLSGSIPTFVN-LTLSADSVTNNQGLCG 214 (623)
Q Consensus 178 ~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~l~~ 214 (623)
+|+.|+|++|+|+...+..+. +++....+.+|+.-|.
T Consensus 81 ~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp CCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred cccceeccCCCCcccChhhhccccccccccCCCcccCC
Confidence 999999999999954444332 3566777889988774
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.89 E-value=1e-11 Score=115.49 Aligned_cols=107 Identities=18% Similarity=0.244 Sum_probs=60.4
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.+..|+|++|+++ .++ .|..|++|+.|+|++|.++ .+|.....+ +.|+.|++++|+++ .++ .+.++++|+.|+|
T Consensus 49 ~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~-~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 49 ACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVA-DTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHH-HHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred ccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccc-cccccccccccccc-ccc-ccccccccccccc
Confidence 4556666666655 333 3666666666666666665 455443332 23666666666666 333 3555666666666
Q ss_pred cCCcCCCCCC--ccccccccccccccccccccccCC
Q 006982 161 DHNRFSGQIP--PQLGQLGRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 161 ~~N~~~g~iP--~~l~~l~~L~~l~l~~N~l~g~ip 194 (623)
++|+++ .++ ..+..+++|+.|+|++|.++...+
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccchhc-cccccccccCCCccceeecCCCccccCcc
Confidence 666665 233 245566666666666666554433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.86 E-value=1.4e-09 Score=111.11 Aligned_cols=58 Identities=29% Similarity=0.345 Sum_probs=27.2
Q ss_pred CCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccccccccccccccccc
Q 006982 131 LTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 131 L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
++.|+|++|++++. + .+..+++|++|+|++|++++ +| .++++++|+.|++++|++++.
T Consensus 309 l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 309 LTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred cCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCC
Confidence 44444444444432 2 14445555555555555542 22 344555555555555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.86 E-value=2.6e-09 Score=99.04 Aligned_cols=102 Identities=24% Similarity=0.390 Sum_probs=64.0
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
++..|+|++|.+++..| ++++++|++|++++|.+. .+|. +..+. .|+.|++++|.+... ..+..+++|+.|++
T Consensus 63 nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l~~l~-~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l 135 (199)
T d2omxa2 63 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LANLT-NLTGLTLFNNQITDI--DPLKNLTNLNRLEL 135 (199)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GTTCT-TCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred CcCcCccccccccCccc--ccCCcccccccccccccc-cccc-ccccc-ccccccccccccccc--cccchhhhhHHhhh
Confidence 56667777777665332 667777777777777666 4443 55543 377777776666632 23566677777777
Q ss_pred cCCcCCCCCCccccccccccccccccccccc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
++|++.. +| .+..+++|+.|++++|++++
T Consensus 136 ~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 136 SSNTISD-IS-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CSSCCCC-CG-GGTTCTTCSEEECCSSCCCC
T ss_pred hhhhhcc-cc-cccccccccccccccccccC
Confidence 7777652 33 46666677777777776665
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.83 E-value=3e-09 Score=98.60 Aligned_cols=103 Identities=25% Similarity=0.434 Sum_probs=87.1
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.+++.|++++++++. ++ .+..+++|++|+|++|++++ +++ +.++.+ |++|++++|.+. .+| .+.++++|+.|+
T Consensus 40 ~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~-L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTK-LVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp TTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTT-CCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred cCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccC-ccc-ccCCcc-cccccccccccc-ccc-cccccccccccc
Confidence 357889999999874 43 58899999999999999995 554 777654 999999999998 565 489999999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
+++|.+... ..+..+++|+.|++++|+++.
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~ 142 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD 142 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc
Confidence 999999853 347889999999999999874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.80 E-value=5.6e-09 Score=97.56 Aligned_cols=102 Identities=29% Similarity=0.351 Sum_probs=52.1
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
+++.|+|++|.+++. + .+++|++|+.|+|++|+++ .+| .+..+. +|+.|++++|.++ .++ .+..+++|+.+++
T Consensus 69 ~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~-~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 69 NVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK-DLS-SLKDLK-KLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp TCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CGG-GGTTCT-TCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCEEeCCCccccCc-c-ccccCcccccccccccccc-ccc-cccccc-ccccccccccccc-ccc-ccccccccccccc
Confidence 355555555555542 2 2455555555555555555 244 244432 2555555555554 222 3455555555555
Q ss_pred cCCcCCCCCCccccccccccccccccccccc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
++|.+++ +..+..+++|+.+++++|++++
T Consensus 142 ~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 142 GNNKITD--ITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred ccccccc--cccccccccccccccccccccc
Confidence 5555553 2234555556666666665554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.80 E-value=4.7e-09 Score=98.13 Aligned_cols=103 Identities=28% Similarity=0.357 Sum_probs=75.2
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
.++.|+++++.++.. + .|..+++|+.|+|++|.+++ +|+ ++.+. +|++|+|++|+++ .+| .+.++++|+.|++
T Consensus 47 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~~-~~~l~-~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IKP-LANLK-NLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCT-TCCEEECCSSCCC-CGG-GGTTCTTCCEEEC
T ss_pred CccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-ccc-cccCc-ccccccccccccc-ccc-ccccccccccccc
Confidence 466778888877653 2 37778888888888888884 553 55654 4888888888888 455 4777888888888
Q ss_pred cCCcCCCCCCcccccccccccccccccccccc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
++|.++ .+ +.+..+++|+.+++++|.+++.
T Consensus 120 ~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~ 149 (210)
T d1h6ta2 120 EHNGIS-DI-NGLVHLPQLESLYLGNNKITDI 149 (210)
T ss_dssp TTSCCC-CC-GGGGGCTTCCEEECCSSCCCCC
T ss_pred cccccc-cc-cccccccccccccccccccccc
Confidence 888876 33 3577788888888888887754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.79 E-value=2.7e-09 Score=108.95 Aligned_cols=83 Identities=30% Similarity=0.405 Sum_probs=71.5
Q ss_pred cccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCcccccccc
Q 006982 99 GIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQLGR 178 (623)
Q Consensus 99 ~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~l~~ 178 (623)
.+..+++++.|+|++|++++ ++ .+..+. +|+.|+|++|++++ +| .++++++|++|+|++|++++..| +.++++
T Consensus 302 ~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~-~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~ 374 (384)
T d2omza2 302 PISNLKNLTYLTLYFNNISD-IS-PVSSLT-KLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTR 374 (384)
T ss_dssp GGGGCTTCSEEECCSSCCSC-CG-GGGGCT-TCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTT
T ss_pred ccchhcccCeEECCCCCCCC-Cc-ccccCC-CCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCC
Confidence 46778899999999999996 44 367754 59999999999994 55 69999999999999999997544 899999
Q ss_pred cccccccccc
Q 006982 179 LKSFSVANNL 188 (623)
Q Consensus 179 L~~l~l~~N~ 188 (623)
|+.|+|++|.
T Consensus 375 L~~L~L~~Na 384 (384)
T d2omza2 375 ITQLGLNDQA 384 (384)
T ss_dssp CSEEECCCEE
T ss_pred CCEeeCCCCc
Confidence 9999999983
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.75 E-value=1.9e-10 Score=106.71 Aligned_cols=109 Identities=19% Similarity=0.230 Sum_probs=85.4
Q ss_pred CCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCCcCCCCCCccccc
Q 006982 96 FPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHNRFSGQIPPQLGQ 175 (623)
Q Consensus 96 ~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~~~g~iP~~l~~ 175 (623)
+|.++..|++|++|+|++|+++ .++ .+..+.+ |+.|+|++|+++ .+|.....+++|+.|++++|+++. ++ .+.+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~-L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~ 113 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMEN-LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEK 113 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTT-CCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCcc-ccChhhcccccc-cccccccccccccccccccccccc-cc-cccc
Confidence 4567889999999999999999 676 5888755 999999999998 788766667899999999999994 54 5889
Q ss_pred cccccccccccccccccC--Cccccc-cccccccCCCC
Q 006982 176 LGRLKSFSVANNLLSGSI--PTFVNL-TLSADSVTNNQ 210 (623)
Q Consensus 176 l~~L~~l~l~~N~l~g~i--p~~~~~-~~~~~~~~~n~ 210 (623)
+++|+.|++++|+++... .....+ .+....+.+|+
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~ 151 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCc
Confidence 999999999999997431 111111 34445566664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=1.6e-08 Score=96.29 Aligned_cols=109 Identities=17% Similarity=0.243 Sum_probs=59.4
Q ss_pred CCCcccceeecCCCCCcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-HhhhcCCCCEEEccCccCCC
Q 006982 65 FICKFTGVECWHPDENRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLVGFLTSLDLSSNNFSG 143 (623)
Q Consensus 65 ~~c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~~L~~L~L~~N~l~g 143 (623)
|-|.+..|.|.+ .+++ .+|+.+- +++++|||++|+++ .+|.. +.++. +|++|+|++|.+..
T Consensus 6 C~C~~~~i~c~~-------------~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~-~L~~L~ls~n~~~~ 67 (242)
T d1xwdc1 6 CHCSNRVFLCQE-------------SKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFG-DLEKIEISQNDVLE 67 (242)
T ss_dssp EEECSSEEEEES-------------CSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCT-TCCEEEEESCTTCC
T ss_pred CCCcCCEEEEeC-------------CCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccc-hhhhhhhccccccc
Confidence 345666677743 3333 4554442 35666666666665 44442 34433 36666666666655
Q ss_pred CCCC-CCCCCCCCceeecc-CCcCCCCCCccccccccccccccccccccc
Q 006982 144 SIPS-NLANCTYLNSLKLD-HNRFSGQIPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 144 ~ip~-~~~~l~~L~~l~l~-~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
.+|. .+.+++++++|++. .|++....|..+..+++|+.|++++|.++.
T Consensus 68 ~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp EECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred eeeccccccccccccccccccccccccccccccccccccccccchhhhcc
Confidence 4443 35556666666554 345554445555666666666666666553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.61 E-value=1.9e-08 Score=95.01 Aligned_cols=104 Identities=28% Similarity=0.341 Sum_probs=81.6
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..+..++++++...+.. .+...+.+..++++++.+....+ +... ++|+.|++++|.+++.. .++++++|+.|+
T Consensus 107 ~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~--~~~~-~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~ 179 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGL-TNLQYLSIGNAQVSDLT--PLANLSKLTTLK 179 (227)
T ss_dssp TTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGC-TTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred ccccccccccccccccc--hhccccchhhhhchhhhhchhhh--hccc-cccccccccccccccch--hhcccccceecc
Confidence 45778888888776543 36778899999999998885433 4454 44999999999988533 378899999999
Q ss_pred ccCCcCCCCCCcccccccccccccccccccccc
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
|++|++++ +|+ ++++++|+.|+|++|++++.
T Consensus 180 Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 180 ADDNKISD-ISP-LASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBC
T ss_pred cCCCccCC-Chh-hcCCCCCCEEECcCCcCCCC
Confidence 99999985 554 88999999999999999854
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.58 E-value=4.2e-08 Score=98.38 Aligned_cols=100 Identities=27% Similarity=0.334 Sum_probs=83.2
Q ss_pred cEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeec
Q 006982 81 RVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKL 160 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l 160 (623)
++..|+|++++|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .|+.- .+.|++|+|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~----~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP----QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC----TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch----hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 4678999999997 58863 578999999999999 899764 34999999999998 66632 246999999
Q ss_pred cCCcCCCCCCccccccccccccccccccccccCCc
Q 006982 161 DHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPT 195 (623)
Q Consensus 161 ~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~ 195 (623)
++|.++ .+|. ++.+++|+.|++++|.+++..+.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~ 138 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL 138 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC
T ss_pred cccccc-cccc-hhhhccceeeccccccccccccc
Confidence 999999 6785 68999999999999999865543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.43 E-value=1.8e-07 Score=88.08 Aligned_cols=121 Identities=27% Similarity=0.374 Sum_probs=88.8
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
.++..++++++.++ .++ .+.++++|+.|+++++...+..+ +... ..++.++++++.+.... .+.++++|++|+
T Consensus 85 ~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~--~~~~-~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~ 157 (227)
T d1h6ua2 85 TKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LAGL-SNLQVLYLDLNQITNIS--PLAGLTNLQYLS 157 (227)
T ss_dssp CSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGG--GTTC-TTCCEEECCSSCCCCCG--GGGGCTTCCEEE
T ss_pred cccccccccccccc-ccc-cccccccccccccccccccccch--hccc-cchhhhhchhhhhchhh--hhcccccccccc
Confidence 45778888888876 343 58899999999999998885433 3333 34899999999988543 367889999999
Q ss_pred ccCCcCCCCCCccccccccccccccccccccccCCccccc-cccccccCCCC
Q 006982 160 LDHNRFSGQIPPQLGQLGRLKSFSVANNLLSGSIPTFVNL-TLSADSVTNNQ 210 (623)
Q Consensus 160 l~~N~~~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 210 (623)
+++|.+++.. .++++++|+.|+|++|++++ +|....+ .+....+++|.
T Consensus 158 l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 158 IGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSC
T ss_pred ccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCc
Confidence 9999998533 38899999999999999986 4443222 33444555553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1.2e-07 Score=90.16 Aligned_cols=111 Identities=15% Similarity=0.162 Sum_probs=85.0
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChh-HhhhcCCCCEEEcc-CccCCCCCCCCCCCCCCCce
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDD-ISKLVGFLTSLDLS-SNNFSGSIPSNLANCTYLNS 157 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~-~~~l~~~L~~L~L~-~N~l~g~ip~~~~~l~~L~~ 157 (623)
..++.|+|++|.++...+..|.++++|++|+|++|.+...+|.. +..+ ..++.|++. .|++....|..+.++++|++
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l-~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~ 107 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL-PKLHEIRIEKANNLLYINPEAFQNLPNLQY 107 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESC-TTCCEEEEECCTTCCEECTTSEECCTTCCE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccc-cccccccccccccccccccccccccccccc
Confidence 35889999999998766667999999999999999998777764 4444 458999876 57888777778899999999
Q ss_pred eeccCCcCCCCCCc-cccccccccccccccccccc
Q 006982 158 LKLDHNRFSGQIPP-QLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 158 l~l~~N~~~g~iP~-~l~~l~~L~~l~l~~N~l~g 191 (623)
|++++|++...-+. .+..+..+..+..+++.+..
T Consensus 108 l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~ 142 (242)
T d1xwdc1 108 LLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 142 (242)
T ss_dssp EEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred cccchhhhccccccccccccccccccccccccccc
Confidence 99999999843222 33455556666666666653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=5.7e-07 Score=86.35 Aligned_cols=149 Identities=13% Similarity=0.057 Sum_probs=99.4
Q ss_pred HHHHHHhccCcccceeeccCccEEEEEEeCCCcEEEEEEecccc-ccHHHHHHHHHHhCCCC-CCCCcceeEEEEeCCee
Q 006982 298 SDLMKATNSFSKNNIIGSGRTGTMYKALLEDGTSLMVKRLQDSQ-RSEKEFVAEMATLGSVK-NRNLVPLLGFCMAKKER 375 (623)
Q Consensus 298 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 375 (623)
+++.+.-+.|...+..+.++...||+.... +..+++|+..... .....+.+|...+..+. +-.+.+++++..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 455555666665554444445789998754 5567778775432 23334567777765542 33466778888888889
Q ss_pred eEEEecCCCCCHhhhccCCCCCCCccChHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 006982 376 LLVYKHMPNGSLYDLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHHNC------------------------------- 424 (623)
Q Consensus 376 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------- 424 (623)
++||+++++.++.+..... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998887654211 112335566666666676431
Q ss_pred -------------------------CCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 425 -------------------------NPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 425 -------------------------~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
.+.++|+|+.|.||++++++..-|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01378999999999999877778999987763
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.11 E-value=3.5e-06 Score=83.85 Aligned_cols=81 Identities=26% Similarity=0.423 Sum_probs=66.9
Q ss_pred CcEEEEEecCCCceeeCCccccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceee
Q 006982 80 NRVLNLRLTDMGLKGQFPRGIRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLK 159 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~ 159 (623)
..++.|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. +.+.|++|+|++|.++ .+|. ++++++|++|+
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----lp~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----LPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----CCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----hccccccccccccccc-cccc-hhhhccceeec
Confidence 46889999999998 778654 57899999999998 6664 2345999999999999 6885 68999999999
Q ss_pred ccCCcCCCCCCcc
Q 006982 160 LDHNRFSGQIPPQ 172 (623)
Q Consensus 160 l~~N~~~g~iP~~ 172 (623)
+++|.+++ .|..
T Consensus 127 l~~~~~~~-~~~~ 138 (353)
T d1jl5a_ 127 VDNNSLKK-LPDL 138 (353)
T ss_dssp CCSSCCSC-CCCC
T ss_pred cccccccc-cccc
Confidence 99999984 4443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.91 E-value=3e-07 Score=95.27 Aligned_cols=110 Identities=17% Similarity=0.248 Sum_probs=82.3
Q ss_pred cEEEEEecCCCceee-CCccccCCCCCCEEEcCCCCCCC----CCChhHhhhcCCCCEEEccCccCCC----CCCCCCC-
Q 006982 81 RVLNLRLTDMGLKGQ-FPRGIRNCSSMTGLDLSSNKLYG----PLPDDISKLVGFLTSLDLSSNNFSG----SIPSNLA- 150 (623)
Q Consensus 81 ~v~~l~l~~~~l~g~-~p~~l~~l~~L~~L~L~~N~l~g----~ip~~~~~l~~~L~~L~L~~N~l~g----~ip~~~~- 150 (623)
++..||++.+++++. +..-+..+++|++|+|++|+++- .|+..+... ++|+.|||++|.++. .+...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~-~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVN-PALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTC-TTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcC-CCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 588999999999864 23335668999999999998872 233444554 459999999999862 1222232
Q ss_pred CCCCCceeeccCCcCCCC----CCccccccccccccccccccccc
Q 006982 151 NCTYLNSLKLDHNRFSGQ----IPPQLGQLGRLKSFSVANNLLSG 191 (623)
Q Consensus 151 ~l~~L~~l~l~~N~~~g~----iP~~l~~l~~L~~l~l~~N~l~g 191 (623)
..++|++|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 245899999999999853 46667789999999999999864
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.88 E-value=1.5e-06 Score=77.00 Aligned_cols=82 Identities=27% Similarity=0.310 Sum_probs=50.9
Q ss_pred ccCCCCCCEEEcCCCCCCCC--CChhHhhhcCCCCEEEccCccCCCCCCC-CCCCCCCCceeeccCCcCCCCCCcc----
Q 006982 100 IRNCSSMTGLDLSSNKLYGP--LPDDISKLVGFLTSLDLSSNNFSGSIPS-NLANCTYLNSLKLDHNRFSGQIPPQ---- 172 (623)
Q Consensus 100 l~~l~~L~~L~L~~N~l~g~--ip~~~~~l~~~L~~L~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~~~g~iP~~---- 172 (623)
...+++|++|+|++|+++.. ++..+..+ ++|+.|||++|+++ .++. ......+|+.|+|++|.++......
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l-~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~ 138 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKA-PNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHS-TTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhC-CcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHH
Confidence 34677788888888887732 22334444 44888888888877 4443 2223446777888888777655432
Q ss_pred ---ccccccccccc
Q 006982 173 ---LGQLGRLKSFS 183 (623)
Q Consensus 173 ---l~~l~~L~~l~ 183 (623)
+..+++|+.||
T Consensus 139 ~~i~~~~P~L~~LD 152 (162)
T d1koha1 139 SAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHTTSTTCCEET
T ss_pred HHHHHHCCCCCEEC
Confidence 34566666654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=3.2e-05 Score=73.16 Aligned_cols=131 Identities=15% Similarity=0.141 Sum_probs=84.3
Q ss_pred eeeccCc-cEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCC--CCCCcceeEEEEeCCeeeEEEecCCCCCHh
Q 006982 312 IIGSGRT-GTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVK--NRNLVPLLGFCMAKKERLLVYKHMPNGSLY 388 (623)
Q Consensus 312 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 388 (623)
.+..|.. ..||+....++..+++|....... ..+..|.+.++.+. .-.+.+++++..+.+..++||+|++|-++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3444543 679999988888888998754432 23556666665553 234566788888888889999999986654
Q ss_pred hhccCCCCCCCccChHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 006982 389 DLLHPADDTGKSVDWPRRLKIAIGAARGFAWLHH---------------------------------------------- 422 (623)
Q Consensus 389 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~---------------------------------------------- 422 (623)
+.. .. ....+.+++..|+-||+
T Consensus 95 ~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 95 SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 321 00 01122233333333332
Q ss_pred -----cC----CCCcEecCCCCCceeeCCCCCeEEeecccccc
Q 006982 423 -----NC----NPRIIHRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 423 -----~~----~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
.. .+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 12479999999999999887788999987753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.74 E-value=5.5e-07 Score=79.88 Aligned_cols=92 Identities=20% Similarity=0.096 Sum_probs=62.7
Q ss_pred ccCCCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCC--CCCCCCCCCCCceeeccCCcCCCCCCc-ccccc
Q 006982 100 IRNCSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGS--IPSNLANCTYLNSLKLDHNRFSGQIPP-QLGQL 176 (623)
Q Consensus 100 l~~l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~--ip~~~~~l~~L~~l~l~~N~~~g~iP~-~l~~l 176 (623)
+..+..+..|++.+|... .++.....+ +.|++|+|++|+++.. ++..+..+++|+.|+|++|+++ .+++ .....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~-~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~ 114 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENI-PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKG 114 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHC-TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTT
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhC-CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhc
Confidence 444445555554444433 343333344 5699999999999942 2345678999999999999999 4554 33344
Q ss_pred ccccccccccccccccCC
Q 006982 177 GRLKSFSVANNLLSGSIP 194 (623)
Q Consensus 177 ~~L~~l~l~~N~l~g~ip 194 (623)
.+|+.|++++|.++....
T Consensus 115 ~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 115 LKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp CCCSSCCCTTSTTSSSSS
T ss_pred cccceeecCCCCcCcCcc
Confidence 578999999999987655
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=8.4e-07 Score=91.80 Aligned_cols=113 Identities=19% Similarity=0.214 Sum_probs=78.2
Q ss_pred CcEEEEEecCCCceeeCCcc----c-cCCCCCCEEEcCCCCCCCCCChhHhhh---cCCCCEEEccCccCCCC----CCC
Q 006982 80 NRVLNLRLTDMGLKGQFPRG----I-RNCSSMTGLDLSSNKLYGPLPDDISKL---VGFLTSLDLSSNNFSGS----IPS 147 (623)
Q Consensus 80 ~~v~~l~l~~~~l~g~~p~~----l-~~l~~L~~L~L~~N~l~g~ip~~~~~l---~~~L~~L~L~~N~l~g~----ip~ 147 (623)
..+..+++++|.++..-... + .....|+.+++++|.++..-...+..+ ..+|++|||++|+++.. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 45778889998876432221 1 235689999999998875533334332 23599999999998742 333
Q ss_pred CCC-CCCCCceeeccCCcCCC----CCCcccccccccccccccccccccc
Q 006982 148 NLA-NCTYLNSLKLDHNRFSG----QIPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 148 ~~~-~l~~L~~l~l~~N~~~g----~iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
.+. ..+.|++|+|++|+|+. .++..+..+++|++|+|++|+++..
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 343 45679999999999974 2455566778999999999998753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.52 E-value=2.8e-06 Score=84.93 Aligned_cols=109 Identities=15% Similarity=0.199 Sum_probs=55.4
Q ss_pred cEEEEEecCCCcee----eCCccccCCCCCCEEEcCCCCCCCC-----CChhHhhhcCCCCEEEccCccCCCC----CCC
Q 006982 81 RVLNLRLTDMGLKG----QFPRGIRNCSSMTGLDLSSNKLYGP-----LPDDISKLVGFLTSLDLSSNNFSGS----IPS 147 (623)
Q Consensus 81 ~v~~l~l~~~~l~g----~~p~~l~~l~~L~~L~L~~N~l~g~-----ip~~~~~l~~~L~~L~L~~N~l~g~----ip~ 147 (623)
.+..+.+++|.++. .+...+..++.|+.|+|++|+++.. +...+.. .++|+.|+|++|.|+.. +..
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~-~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY-CQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGG-CTTCCEEECCSSCCHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcc-hhhhcccccccccccccccccccc
Confidence 45556666655431 2333345566666666666665521 1111222 23466666666665421 223
Q ss_pred CCCCCCCCceeeccCCcCCCCCCccc----cc--ccccccccccccccc
Q 006982 148 NLANCTYLNSLKLDHNRFSGQIPPQL----GQ--LGRLKSFSVANNLLS 190 (623)
Q Consensus 148 ~~~~l~~L~~l~l~~N~~~g~iP~~l----~~--l~~L~~l~l~~N~l~ 190 (623)
.+..+++|++|+|++|++++.-...+ .. .++|+.|++++|+++
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 44556666666666666654211122 11 235666666666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.44 E-value=8.2e-06 Score=79.17 Aligned_cols=84 Identities=23% Similarity=0.213 Sum_probs=37.1
Q ss_pred CCCCCEEEcCCCCCCCCCChhHhhhcCCCCEEEccCccCCCCCCCCCCCCCCCceeeccCC-cCCCC-CCcccccccccc
Q 006982 103 CSSMTGLDLSSNKLYGPLPDDISKLVGFLTSLDLSSNNFSGSIPSNLANCTYLNSLKLDHN-RFSGQ-IPPQLGQLGRLK 180 (623)
Q Consensus 103 l~~L~~L~L~~N~l~g~ip~~~~~l~~~L~~L~L~~N~l~g~ip~~~~~l~~L~~l~l~~N-~~~g~-iP~~l~~l~~L~ 180 (623)
..+|++|||+++.+++.....+..-.++|++|+|+++.+++..+..++++++|++|+|+++ .++.. +..-..++++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 3455555555555443222222221233555555555555444445555555555555552 33310 111123445555
Q ss_pred cccccc
Q 006982 181 SFSVAN 186 (623)
Q Consensus 181 ~l~l~~ 186 (623)
.|++++
T Consensus 125 ~L~ls~ 130 (284)
T d2astb2 125 ELNLSW 130 (284)
T ss_dssp EEECCC
T ss_pred cccccc
Confidence 555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.26 E-value=5.4e-06 Score=82.80 Aligned_cols=112 Identities=20% Similarity=0.321 Sum_probs=80.1
Q ss_pred CcEEEEEecCCCce--e--eC---------CccccCCCCCCEEEcCCCCCCCC----CChhHhhhcCCCCEEEccCccCC
Q 006982 80 NRVLNLRLTDMGLK--G--QF---------PRGIRNCSSMTGLDLSSNKLYGP----LPDDISKLVGFLTSLDLSSNNFS 142 (623)
Q Consensus 80 ~~v~~l~l~~~~l~--g--~~---------p~~l~~l~~L~~L~L~~N~l~g~----ip~~~~~l~~~L~~L~L~~N~l~ 142 (623)
..++.|++++|.+. | .+ .......+.|+.|++++|.++-. +...+... +.|+.|+|++|+++
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~-~~L~~L~L~~n~i~ 199 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH-RLLHTVKMVQNGIR 199 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC-TTCCEEECCSSCCC
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh-hhhccccccccccc
Confidence 35888999988752 1 11 11234577899999999988632 22233343 45999999999987
Q ss_pred CC-----CCCCCCCCCCCceeeccCCcCCCC----CCcccccccccccccccccccccc
Q 006982 143 GS-----IPSNLANCTYLNSLKLDHNRFSGQ----IPPQLGQLGRLKSFSVANNLLSGS 192 (623)
Q Consensus 143 g~-----ip~~~~~l~~L~~l~l~~N~~~g~----iP~~l~~l~~L~~l~l~~N~l~g~ 192 (623)
.. +...+..+++|+.|+|++|.|+.. +...+..+++|+.|+|++|.+++.
T Consensus 200 ~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 200 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred ccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence 32 344577889999999999998632 445667889999999999998753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.20 E-value=0.00012 Score=70.50 Aligned_cols=107 Identities=21% Similarity=0.245 Sum_probs=76.4
Q ss_pred cEEEEEecCC-Ccee-eCCccccC-CCCCCEEEcCCC--CCCCCCChhHhhhcCCCCEEEccCc-cCCCCCCCCCCCCCC
Q 006982 81 RVLNLRLTDM-GLKG-QFPRGIRN-CSSMTGLDLSSN--KLYGPLPDDISKLVGFLTSLDLSSN-NFSGSIPSNLANCTY 154 (623)
Q Consensus 81 ~v~~l~l~~~-~l~g-~~p~~l~~-l~~L~~L~L~~N--~l~g~ip~~~~~l~~~L~~L~L~~N-~l~g~ip~~~~~l~~ 154 (623)
++..|++++. +++. .+...+.. +++|+.|+|++. .++..--..+....++|++|+|++| .+++..+..++++++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~ 201 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence 5777888774 3432 12222333 578999999864 3443212223332456999999985 588778888999999
Q ss_pred CceeeccC-CcCCCCCCccccccccccccccccc
Q 006982 155 LNSLKLDH-NRFSGQIPPQLGQLGRLKSFSVANN 187 (623)
Q Consensus 155 L~~l~l~~-N~~~g~iP~~l~~l~~L~~l~l~~N 187 (623)
|++|+|++ +++++.....++++++|+.|+++++
T Consensus 202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 99999999 5788777778899999999999877
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.16 E-value=0.00042 Score=69.91 Aligned_cols=74 Identities=11% Similarity=0.106 Sum_probs=45.5
Q ss_pred ceeeccCccEEEEEEeCC-CcEEEEEEeccc--------cccHHHHHHHHHHhCCCC-C--CCCcceeEEEEeCCeeeEE
Q 006982 311 NIIGSGRTGTMYKALLED-GTSLMVKRLQDS--------QRSEKEFVAEMATLGSVK-N--RNLVPLLGFCMAKKERLLV 378 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lV 378 (623)
+.||.|....||+....+ +..+++|.-... .....+...|.+.|..+. + ..+.+++. .+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 468999999999998654 678888864321 112233445776665542 2 23444544 355667899
Q ss_pred EecCCCCC
Q 006982 379 YKHMPNGS 386 (623)
Q Consensus 379 ~e~~~~gs 386 (623)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.00077 Score=66.04 Aligned_cols=136 Identities=13% Similarity=0.078 Sum_probs=80.3
Q ss_pred cEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCCC--ccee-----EEEEeCCeeeEEEecCCCCCHhh--
Q 006982 319 GTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL--VPLL-----GFCMAKKERLLVYKHMPNGSLYD-- 389 (623)
Q Consensus 319 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~e~~~~gsL~~-- 389 (623)
-.||++..++|..+++|+......+.+++..|.+.+..+....+ +..+ ..+......+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 58999999999999999988776677778888887766642221 1111 12234556788999998743311
Q ss_pred ----------------hccCCC-CCCCccChH-------------------HHHHHHHHHHHHHHHHHhc----CCCCcE
Q 006982 390 ----------------LLHPAD-DTGKSVDWP-------------------RRLKIAIGAARGFAWLHHN----CNPRII 429 (623)
Q Consensus 390 ----------------~l~~~~-~~~~~l~~~-------------------~~~~i~~~ia~~l~yLH~~----~~~~i~ 429 (623)
..+... ......++. .+..+...+.+.+..+... ...+++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 001110 011112211 1111222223333333322 234689
Q ss_pred ecCCCCCceeeCCCCCeEEeecccccc
Q 006982 430 HRNISSKCILLDDDFEPKISDFGLARL 456 (623)
Q Consensus 430 H~dlk~~NILl~~~~~~kl~Dfgla~~ 456 (623)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 46899988764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.90 E-value=9.6e-05 Score=65.18 Aligned_cols=108 Identities=13% Similarity=0.140 Sum_probs=64.4
Q ss_pred CcEEEEEecCC-Cceee----CCccccCCCCCCEEEcCCCCCCCC----CChhHhhhcCCCCEEEccCccCCCCC----C
Q 006982 80 NRVLNLRLTDM-GLKGQ----FPRGIRNCSSMTGLDLSSNKLYGP----LPDDISKLVGFLTSLDLSSNNFSGSI----P 146 (623)
Q Consensus 80 ~~v~~l~l~~~-~l~g~----~p~~l~~l~~L~~L~L~~N~l~g~----ip~~~~~l~~~L~~L~L~~N~l~g~i----p 146 (623)
..++.|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+.. .+.|+.|+|++|.++..- -
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~-n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIET-SPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHH-CSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhh-cccccceeeehhhcchHHHHHHH
Confidence 45777888764 34321 334566777888888888877632 2222323 234888888888877421 1
Q ss_pred CCCCCCCCCceeeccCCcCCCC-------CCcccccccccccccccccc
Q 006982 147 SNLANCTYLNSLKLDHNRFSGQ-------IPPQLGQLGRLKSFSVANNL 188 (623)
Q Consensus 147 ~~~~~l~~L~~l~l~~N~~~g~-------iP~~l~~l~~L~~l~l~~N~ 188 (623)
..+...++|++|+|++|.+... +...+...++|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 2355667788888888766521 22333445666667665543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.29 E-value=0.0069 Score=60.64 Aligned_cols=72 Identities=18% Similarity=0.287 Sum_probs=48.0
Q ss_pred ceeeccCccEEEEEEeCCC--------cEEEEEEeccccccHHHHHHHHHHhCCCCCCCC-cceeEEEEeCCeeeEEEec
Q 006982 311 NIIGSGRTGTMYKALLEDG--------TSLMVKRLQDSQRSEKEFVAEMATLGSVKNRNL-VPLLGFCMAKKERLLVYKH 381 (623)
Q Consensus 311 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 381 (623)
+.|+.|-.-.+|+....++ ..|++++... ........+|..+++.+.-.++ .++++++. -.+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 5677788889999986543 4577777653 3334456678888877743344 45666653 2689999
Q ss_pred CCCCCH
Q 006982 382 MPNGSL 387 (623)
Q Consensus 382 ~~~gsL 387 (623)
+++-++
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.16 E-value=0.00033 Score=61.60 Aligned_cols=89 Identities=11% Similarity=0.160 Sum_probs=59.6
Q ss_pred cCCCCCCEEEcCCC-CCCCC----CChhHhhhcCCCCEEEccCccCCCCCCC----CCCCCCCCceeeccCCcCCCC---
Q 006982 101 RNCSSMTGLDLSSN-KLYGP----LPDDISKLVGFLTSLDLSSNNFSGSIPS----NLANCTYLNSLKLDHNRFSGQ--- 168 (623)
Q Consensus 101 ~~l~~L~~L~L~~N-~l~g~----ip~~~~~l~~~L~~L~L~~N~l~g~ip~----~~~~l~~L~~l~l~~N~~~g~--- 168 (623)
.+.++|+.|+|+++ .++.. +-..+... +.|+.|+|++|.+...-.. .+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n-~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNS-KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTC-SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhC-CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 45789999999974 45421 11122232 3499999999998743222 244568899999999998842
Q ss_pred -CCcccccccccccccccccccc
Q 006982 169 -IPPQLGQLGRLKSFSVANNLLS 190 (623)
Q Consensus 169 -iP~~l~~l~~L~~l~l~~N~l~ 190 (623)
+-..+...++|+.|++++|.+.
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHHhCCcCCEEECCCCcCC
Confidence 1223455678999999988654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.90 E-value=0.011 Score=57.07 Aligned_cols=159 Identities=9% Similarity=0.032 Sum_probs=80.6
Q ss_pred cCHHHHHHHhccCccccee-----eccCccEEEEEEeCCCcEEEEEEeccccccHHHHHHHHHHhCCCCCCC--CcceeE
Q 006982 295 MRLSDLMKATNSFSKNNII-----GSGRTGTMYKALLEDGTSLMVKRLQDSQRSEKEFVAEMATLGSVKNRN--LVPLLG 367 (623)
Q Consensus 295 ~~~~~l~~~~~~f~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~ 367 (623)
.+.+|+.....+|...++. ..|---+.|+.+..+|+ +++|+..... ..++...|++++..+.+.. +...+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccce
Confidence 4567777777788765543 34555788999887665 7888875432 2233444555555543221 111111
Q ss_pred ------EEEeCCeeeEEEecCCCCCHhhh--------------cc----CCCCC--CCc-c----------------ChH
Q 006982 368 ------FCMAKKERLLVYKHMPNGSLYDL--------------LH----PADDT--GKS-V----------------DWP 404 (623)
Q Consensus 368 ------~~~~~~~~~lV~e~~~~gsL~~~--------------l~----~~~~~--~~~-l----------------~~~ 404 (623)
+.........++.+..+...... ++ ..... ... . ...
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 12223455667777766433211 00 00000 000 0 001
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCceeeCCCCCeEEeeccccc
Q 006982 405 RRLKIAIGAARGFAWLHH-NCNPRIIHRNISSKCILLDDDFEPKISDFGLAR 455 (623)
Q Consensus 405 ~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlk~~NILl~~~~~~kl~Dfgla~ 455 (623)
.....+......+.-.+. ..+.+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111112222222222211 123379999999999999998878899998875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.11 E-value=0.00088 Score=58.56 Aligned_cols=109 Identities=17% Similarity=0.230 Sum_probs=70.1
Q ss_pred CcEEEEEecCC-Ccee----eCCccccCCCCCCEEEcCCCCCCCCCChhH----hhhcCCCCEEEccCccCCCC----CC
Q 006982 80 NRVLNLRLTDM-GLKG----QFPRGIRNCSSMTGLDLSSNKLYGPLPDDI----SKLVGFLTSLDLSSNNFSGS----IP 146 (623)
Q Consensus 80 ~~v~~l~l~~~-~l~g----~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~----~~l~~~L~~L~L~~N~l~g~----ip 146 (623)
..++.|+|+++ .++. .+-..+...++|+.|+|++|.++..--..+ .. .+.|+.|++++|.++.. +-
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~-~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV-NNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH-CSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhh-cccchhhhhccccccchhHHHHH
Confidence 35777888873 4532 134456678899999999998874322222 23 24589999999888643 12
Q ss_pred CCCCCCCCCceeec--cCCcCCC----CCCccccccccccccccccccc
Q 006982 147 SNLANCTYLNSLKL--DHNRFSG----QIPPQLGQLGRLKSFSVANNLL 189 (623)
Q Consensus 147 ~~~~~l~~L~~l~l--~~N~~~g----~iP~~l~~l~~L~~l~l~~N~l 189 (623)
..+...++|+.++| ++|.+.. .+-..+...++|+.|+++.|..
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 34667788886544 5666653 2344556778888888876654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.40 E-value=0.014 Score=50.39 Aligned_cols=89 Identities=15% Similarity=0.174 Sum_probs=55.8
Q ss_pred ccCCCCCCEEEcCC-CCCCCCCChhHh----hhcCCCCEEEccCccCCCCCCC----CCCCCCCCceeeccCCcCCCC--
Q 006982 100 IRNCSSMTGLDLSS-NKLYGPLPDDIS----KLVGFLTSLDLSSNNFSGSIPS----NLANCTYLNSLKLDHNRFSGQ-- 168 (623)
Q Consensus 100 l~~l~~L~~L~L~~-N~l~g~ip~~~~----~l~~~L~~L~L~~N~l~g~ip~----~~~~l~~L~~l~l~~N~~~g~-- 168 (623)
..+.++|+.|+|++ |.++...=..+. .. +.|+.|+|++|.++..--. .+...++|+.|++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n-~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~ 91 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTN-TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 91 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTC-CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcC-CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence 35678999999997 456422111122 32 3599999999988743211 244578899999999888632
Q ss_pred --CCcccccccccccc--ccccccc
Q 006982 169 --IPPQLGQLGRLKSF--SVANNLL 189 (623)
Q Consensus 169 --iP~~l~~l~~L~~l--~l~~N~l 189 (623)
+-..+...++|+.+ ++++|.+
T Consensus 92 ~~l~~~l~~~~~L~~l~L~l~~n~i 116 (166)
T d1io0a_ 92 LALVEALQSNTSLIELRIDNQSQPL 116 (166)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCC
T ss_pred HHHHHHHHhCccccEEeeccCCCcC
Confidence 22445566777754 4455555
|